IES;ANO DE DEFESA;AUTOR DA TESE;ORIENTADOR;CO-ORIENTADOR;REFERÊNCIAS;ANO DO ARTIGO;TÍTULO DO ARTIGO;OBSERVAÇÃO;
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Akasaka K, Maesawa C, Shibazaki M et al. Loss of Class III ?-Tubulin Induced by Histone Deacetylation Is Associated with Chemosensitivity to Paclitaxel in Malignant Melanoma Cells. J Invest Dermatol 2009; 129:1516-26. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Armstrong B. Melanoma incidence In Europe. Cancer Causes Control 1996; 7:1956. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Ashton-Prolla P, Bakos L, Junqueira G Jr, Giugliani R, Azevedo SJ, Hogg D. Clinical and molecular characterization of patients at risk for hereditary melanoma in southern Brazil. J Invest Dermatol 2008; 128:421-5. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Auroy S, Avril MF, Chompret A, et al. Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect. Genes Chromosomes Cancer 2001; 32:195-202. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on cancer melanoma staging system. J Clin Oncol 2001; 16:3622-34. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Bataille V, Bishop JA, Sasieni P, et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996; 73:16051611. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Berwick M, Erdei E, Hay J. Melanoma epidemiology and public health. Dermatol Clin 2009; 27:205-14. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Bishop JN, Bataille V, Pinney E, et al. Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype. Melanoma Res 1994; 4:199-206. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Bevona C, Goggins W, Quinn T, Fullerton J, Tsao H. Cutaneous melanomas associated with nevi. Arch Dermatol 2003; 139:1620-4. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Bishop JN, Harland M, Randerson-Moor J, Bishop DT. Management of familial melanoma. Lancet Oncol 2007; 8:46-54. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;Bliss JM, Ford D, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995, 62:367–76. ;
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Box NF, Duffy DL, Chen W, et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001; 69:765-73. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Calvo SE, Pagliarini DJ, Mootha VK. Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans. Proc Natl Acad Sci 2009; 106:7507-12. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Carey WP, Thompson CJ, Synnestvedt M, et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanona. Cancer 1994; 74:3118-25. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Chang YM, Barrett JH, Bishop DT, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol 2009; 38:814-30. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Chompret A, Cuellar F, Elder DE, et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 2007; 44:99-106. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Ciotti P, Struewing JP, Mantelli M, et al. A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families. Am J Hum Genet 2000; 67:311-9. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Clark WH Jr, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol 1978; 114:732-8. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Coleman DJ, Silverman RH, Ursea R, Rondeau MJ, Lizzi FL. Ultrasonically induced hyperthermia for adjunctive treatment of intraocular malignant melanoma. Retina 1997; 17:109-17. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Della Torre G, Pasini B, Frigerio S, et al. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germline mutation. Br J Cancer 2001; 85:836-44. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124:869-71. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Fung DC, Holland EA, Becker TM, et al. eMelanoBase: an online locus-specific variant database for familial melanoma. Hum Mutat 2003; 21:2-7. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 41:2040-59. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Gantz I, Konda Y, Tashiro T, et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 1993; 268:8246-50. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009; 27:39. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Gershenwald JE, Soong SJ, Balch CM. TNM Staging System for Cutaneous Melanoma… and Beyond. On behalf of the American Joint Committee on Cancer (AJCC) Melanoma Staging Committee. Ann Surg Oncol 2010; 27:6199-206. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Ghiorzo P, Gargiulo S, Pastorino L et al. Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. Hum Mol Genetics 2006; 15:268289. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Goldstein AM, Fraser MC, Struewing JP, et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 1995; 333:9704. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Goldstein AM, Chan M, Harland M, et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res 2006; 66:9818-28. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Goldstein AM, Chan M, Harland M, Hayward NK, et al. First detection of the melanoma-predisposing proline-48-threonine mutation of p16 in Hungarians: was there a common founder either in Italy or in Hungary? Melanoma Res 2007a; 17:251-4. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Goldstein AM, Chaudru V, Ghiorzo P, et al. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. Int J Cancer 2007b; 121:825-31. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Goldstein AM, Chan M, Harland M, et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 2007c; 44:99-106. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Gonzalez S, Klatt P, Delgado S, et al. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 2006; 440:702-6. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Greene MH, Clark WH Jr, Tucker MA, et al. Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet 1980; 2:1024. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Greene MH. The genetics of hereditary melanoma an nevi. Cancer 1999; 86:246477. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Haferkamp S, Scurr LL, Becker TM, Frausto M, Kefford RF, Rizos H. Oncogeneinduced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors. J Invest Dermatol 2009; 129:1983-91. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Harland M, Holland EA, Ghiorzo P, et al. Mutation screening of the CDKN2A promoter in melanoma families. Genes Chromosomes Cancer 2000; 28:45-57. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Harland M, Mistry S, Bishop T, Newton Bishop JA. A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum Mol Genet 2001; 10:2679-86.  ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Harland M, Taylor CF, Bass S, et al. Intronic sequence variants of the CDKN2A gene in melanoma pedigrees. Genes Chromosomes Cancer 2005; 43:128-36. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J. CDKN2A germline mutations in individuals with multiple cutaneous melanomas. Cancer Res 2000; 60:6864-7.";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Hayward NK. Genetics of melanoma predisposition. Oncogene 2003; 22:3053-62.  ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Holland EA, Schmid H, Kefford RF, Mann GJ. CDKN2A (P16 (INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas. Genes Chromosomes Cancer 1999; 25:339-48. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Hubner J, Ramos ES. The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma. Braz J Med Biol Res 2006; 39:237-41. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nat Genet 1994; 8:15-21.";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264:436-40. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Kannengiesser C, Brookes S, del Arroyo AG, et al. Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanomaprone families or patients. Hum Mutat 2009; 30:564-74.";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and nonmelanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003; 149:1200-6. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001; 117:294300. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Kim WY, Sharpless NE. The regulation of INK4/ARF in cancer and aging. Cell 2006; 127:265-75. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Kraemer KH, Greene MH, Tarone R, et al. Dysplastic naevi and cutaneous melanoma risk. Lancet 1983; 2:1076-7. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004; 150:179-85. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Larre Borges A, Cuéllar F, Puig-Butillé JA, et al. CDKN2A mutations in melanoma families from Uruguay. Br J Dermatol 2009; 161:536-41. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Lilischkis R, Sarcevic B, Kennedy C, Warlters A, Sutherland RL. Cancer-associated missense and deletion mutations impair p16INK4 CDK inhibitory activity. Int J Cancer 1996; 66:249-54. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Lindström MS, Zhang Y. B23 and ARF: friends or foes? Cell Biochem Biophys 2006; 46:79-90. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Lin J, Hocker TL, Singh M, Tsao H. Genetics of melanoma predisposition. Br J Dermatol 2008; 159:286-91.  ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Liu L, Dilworth D, Gao L, Monzon J, Summers A, Lassam N, Hogg D. Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma. Nat Genet 1999; 21:128-32. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Lowe SW, Sherr CJ. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 2003; 13:77-83. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Lynch HT, Frichot BC, Lynch JF. Familial atypical multiple mole-melanoma syndrome. J Med Genet 1978; 15:352-6. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Majore S, De Simone P, Crisi A, Eibenschutz L, et al. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma. Pigment Cell Melanoma Res 2008; 21:209-11. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"McGovern VJ. Melanoblastoma. Med J Aust 1952; 1:139-42. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"MacKie RM, Andrew N, Lanyon WG, Connor JM. CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas. J Invest Dermatol 1998; 111:269-72. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"McKeller RN, Fowler JL, Cunningham JJ, Warner N, Smeyne RJ, Zindy F, Skapek SX. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development. Proc Natl Acad Sci U S A 2002; 99:3848-53. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Mantelli M, Pastorino L, Ghiorzo P, et al. Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. Melanoma Res 2004; 14:443-8. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med 2006; 355:51-65. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Ministério da Saúde. Instituto Nacional de Câncer. Estimativa/2010 incidência de câncer no Brasil. Rio de Janeiro: INCA; 2009. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Molven A, Grimstvedt MB, Steine SJ et al. A large Norwegian familiy with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Gens Chrom Cancer 2005; 44:10-18. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Monzon J, Liu L, Brill H, et al. CDKN2A mutations in multiple primary melanomas. N Engl J Med 1998; 338:879-87. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Naeyaert JM, Brochez L. Dysplastic nevi. N Engl J Med 2003; 349:2233-40. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Newton JA, Bataille V Griffiths K, et al. How common is the atypical mole syndrome phenotype in apparently sporadic melanoma? J Am Acad Dermatol 1993; 29:989-96";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368:753-6. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Palmer JS, Duffy DL, Box NF, Aitken JF, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000; 66:176-86. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Pipitone M, Robinson JK, Camara C, Chittineni B, Fisher SG. Skin cancer awareness in suburban employees: a Hispanic perspective. J Am Acad Dermatol 2002; 47:118-23. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Pjanova D, Engele L, Randerson-Moor JA, et al. CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population. Melanoma Res 2007; 17:185-91. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Pjanova D, Molven A, Akslen LA, et al. Identification of a CDK4 R24H mutationpositive melanoma family by analysis of early-onset melanoma patients in Latvia. Melanoma Res 2009; 19:119-22. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Puig S, Malvehy J, Badenas C, et al. Role of the CDKN2A locus in patients with multiple primary melanomas. J Clin Oncol 2005; 23:3043-51. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83:993-1000. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Rigel DS, Rivers JK, Friedman RJ, et al. Risk gradient for malignant melanoma in individuals with dysplastic nevi. Lancet 1988; 1:352-3. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Rizos H, Scurr LL, Irvine M, Alling NJ, Kefford RF. p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism. Cell Cycl 2007; 6:1741-7. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Roberts WE. Skin type classification systems old and new. Dermatol Clin 2009; 27:529-33. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Ruas M, Brookes S, McDonald NQ, Peters G. Functional evaluation of tumourspecific variants of p16INK4a/CDKN2A: correlation with protein structure information. Oncogene 1999; 18:5423-34. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Ruiz A, Puig S, Malvehy J, et al. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia. J Med Genet 1999; 36:490-3. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Savage SA, Gerstenblith MR, Goldstein AM, et al. Nucleotide diversity and population differentiation of the Melanocortin 1 Receptor gene, MC1R. BMC Genet 2008; 9:31. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Slade J, Marghoob AA, Salopek TG, Rigel DS, Kopf AW, Bart RS. Atypical mole syndrome: Risk factor for cutaneous malignant melanoma and implications for management. J Am Acad Dermatol 1995; 32:479-94. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Satyamoorthy K, Herlyn M. Cellular and molecular biology of human melanoma. Cancer Biol Ther 2002; 1:14-7. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366:704-7. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Sharpless NE. INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 2005; 576:22-38. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-12. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Sherr CJ, Weber JD. The ARF/p53 pathway. Curr Opin Genet Dev 2000; 10:94-9.  ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Sortino-Rachou AM, Curado MP, Latorre MRDO. Melanoma cutâneo: estudo de base populacional em Goiânia, Brasil, de 1988 a 2000. An Bras Dermatol 2006; 81:449-55. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Soufir N, Avril MF, Chompret A, et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum Mol Genet 1998; 7:209-16. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Stratigos AJ, Yang G, Dimisianos R, et al. Germline CDKN2A mutations among greek patients with early-onset and multiple primary cutaneous melanoma. J Invest Dermatol 2006; 126:139-401. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Széll M, Balogh K, Dobozy A, Kemény L, Oláh J. First detection of the melanomapredisposing proline-48-threonine mutation of p16 in Hungarians: was there a common founder either in Italy or in Hungary? Melanoma Res 2007; 17:251-4. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med 2004; 351:998-1012. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi: A central risk factor for cutaneous melanoma. JAMA 1997; 277:1439-44. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Xu LY, Koo J. Predictive value of phenotypic variables for skin cancer: risk assessment beyond skin typing. Int J Dermatol 2006; 45:1275-83. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Wen Y, Liu Y, Xu Y, et al. Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis. Nat Genet 2009; 41:228-33. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Wiestner A, Schlemper RJ, van der Maas AP, Skoda RC. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet 1998; 18:49-52. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003; 95:1276-99. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Youl P, Aitken J, Hayward N, et al. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia. Int J Cancer 2002; 98:92-8. ";
FAP;2010;ALEXANDRE LEON RIBEIRO DE ÁVILA;Dirce Maria Carraro;-x-;"Zuo L, Weger J, Yang Q, et al. Germline mutations in the p15ink4a binding domain of CDK4 in familial melanoma. Nat Genet 1996; 12:97-9. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Ancona N, Maglietta R, Piepoli A, et al. On the statistical assessment of classifiers using DNA microarray data. BMC Bioinformatics 2006; 7:387401. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Barden CB, Shister KW, Zhu B, et al. Classification of follicular thyroid tumors by molecular signature:results of gene profiling. Clin Cancer Res 2003; 9:1792-800. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;Barreto BD. Validação de classificadores moleculares preditores de resposta à quimioterapia combinada com radioterapia em carcinoma epidermóide de laringe e hipofaringe localmente avançado. São Paulo, 2009. [Tese de Doutorado-Fundação Antonio Prudente] ;
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Bartolazzi A, Gasharri A, Papotti M, et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001; 357:1644-50. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Berger JA, Hautaniemi S, Järvinen AK, Edgren H, Mitra SK, Astola J. Optimized LOWESS normalization parameter selection for DNA microarray data. BMC Bioinformatics 2004; 5:194. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Braga ACS. Curvas ROC: aspectos funcionais e aplicações. Braga; 2000. [Tese de Doutorado-Universidade do Minho]. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Boulesteix AL, Strobl C, Augustin T, Daumer M. Evaluating Microarray-based Classifiers: An Overview. Cancer Informatics 2008; 6:77-97. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Brentani RR, Carraro DM, Verjovski-Almeida S, et al. Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol 2005; 54:95-105. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Cardoso F, Van't Veer L, Rutgers E, Loi S, Mook S, Piccart-Gebhart MJ. Clinical application of the 70-gene profile: the MINDACT trial. J Clin Oncol 2008; 26:729-35. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Cerutti JM, Delcelo R, Amadei MJ, et al. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 2004; 113:1234-42";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;Chaplin J. Thyroid lumps and nodules: a patient´s guide. Medic8®Family Health Guide, 2005. Avaliable from: <URL:http://www.medic8.com/healthguide/articles/thyroidlumps.html> [2010 jan 4] ;
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Choumane H, Ha N, Nelep C, et al. Double interference fluorescence enhancement from reflective slides: application to bicolor microarray. Appl Phys Lett 2005; 87:031102. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Clark OH, Noguchi S. Preface. In: Clark OH, Noguchi S, editors. Thyroid cancer: diagnosis and treatment. St Louis, Missouri: Quality Medical Publishing; 2000; p. ix. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Dudoit S, Fridlyand J, Speed T. Comparison of discrimination methods for the classification of tumors using gene expression data. J Am Stat Assoc 2003; 97:77-87. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Esteves GH. Métodos estatísticos para a análise de dados de cDNA microarray em um ambiente computacional integrado. São Paulo; 2007. [Tese de Doutorado-Universidade de São Paulo-Instituto de Matemática e Estatística]. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;[FCM-UNICAMP] Faculdade de Ciências Médicas. Departamento de Anatomia Patológica. Técnicas Histológicas Empregadas. Anatomia Patológica Especial-módulo-Patologia endócrina: adenoma folicular da tireoide/Infiltração da cápsula e vasos. Disponível em: <URL:http://www.fcm.unicamp.br/deptos/anatomia/lamendo13.html> <URL:http://www.fcm.unicamp.br/deptos/anatomia/lamendo15.html> [2010 maio 12] ;
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Foekens JA, Atkins D, Zhang Y, et al. Multicenter validation of a gene expression–based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol 2006; 24:1665-71. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;Ge G, Wong GW Classification of premalignant pancreatic cancer massspectrometry data using decision tree ensembles. BMC Bioinformatics 2008, 9:275-87. ;
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class prediction by gene expression monitoring. Science 1999; 286:531-7. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Gomes LI, Silva RL, Stolf BS, et al. Comparative analysis of amplified and nonamplified RNA for hybridization in cDNA microarray. Anal Biochem 2003; 321:244-51";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Gönen M. Statistical aspects of gene signatures and molecular targets. Gastrointest Cancer Res 2009; 3(2 Suppl):S19-21. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Grebe SKG, Hay ID. Clinical evaluation of thyroid tumors. In: Thawley SE, Panje WR, Batsakis JG, et al., editors. Comprehensive management of head and neck tumors. 2nd ed. Philadelphia: WB Saunders; 1999. p.1694709. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Hamburger JI. Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. J Clin Endocrinol Metab 1994; 79:335-9. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Harach HR, Fransiella KO, Wasenius VM. Occult papillary carcinoma of the thyroid. a ""normal"" finding in Finland. a systematic autopsy study. Cancer 1985; 56:531-8. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Hummel M, Metzeler KH, Buske C, Bohlander SK, Mansmann U. Association between a prognostic gene signature and functional gene sets. Bioinform Biol Insights 2008; 22:329-41. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Inohara H, Honjo Y, Yoshii T, et al. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 1999; 85:2475-84. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Jeffrey SS, Pollack JR. The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions. Breast Cancer Res 2003; 5:320-8. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Kanno J, Onodera H, Furuta K, et al. Tumor-promoting effects of both iodine deficiency and iodine excess in the rat thyroid. Toxicol Pathol 1992; 20:22635. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Kebebew E, Peng M,Reiff E, et al. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg 2005; 242:353-64. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Lemoine LR, Mayall ES, Willie FS, et al. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 1989; 4:159-64.";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Lemoine LR, Mayall ES, Willie FS, et al. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 1989; 4:159-64.";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Mackenzie EJ, Mortimer RH. Thyroid nodules and thyroid cancer. Med J Aust 2004; 180:242-7. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Martins TD, Carrilho F, Leitão P, et al. Anaplastic thyroid tumor: retrospective analysis of 12 cases. Acta Med Port 2004; 17:349-51";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Mary-Huard T, Daudin J, Robin S, Bitton F, Cabannes E, Hilson P. Spotting effect in microarray experiments. BMC Bioinformatics 2004; 5:63. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Mehrotra P, Okpokam A, Bouhaidar R, et al. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 2004; 45:493-500. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Meireles SI, Cristo EB, Carvalho AF, et al. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res 2004; 64:1255-65. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Mills LJ, Poller DN, Yiangou C. Galectin-3 is not useful in thyroid FNA. Cytopathology 2005; 16:132-8. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Murphy D. Gene expression studies using microarrays: principles, problems, and prospects. Adv Physiol Edu 2002; 26:256-70. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Noguchi S. Overview. In: Clark OH, Noguchi S, editors. Thyroid cancer: diagnosis and treatment. St Louis: Quality Medical Pu; 2000. p.3-20. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Perou CM, Jeffrey SS, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. PNAS 1999; 96:9212-7. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406:747-52. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Petalidis L, Bhattacharyya S, Morris GA, Collins VP, Freeman TC, Lyons PA. Global amplification of mRNA by template-switching PCR: linearity and application to microarray analysis. Nucleic Acids Res 2003; 31:e142.";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Quackenbush J. Computational analysis of microarray data. Nat Rev Genet  2001; 2:418-27.";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Ramaswamy S, Tamayo P, Rifkin R. Multiclass cancer diagnosis using tumor gene expression signatures. PNAS 2001; 98:15149-54. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Ramaswamy S, Golub TR. DNA microarrays in clinical oncology. J Clin Oncol 2002; 20:1932-41. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Rosenzweig BA, Pine PS, Domon OE, Morris SM, Chen JJ, Sistare FD. Dye bias correction in dual-labeled cDNA microarray gene expression measurements. Environ Health Perspect 2004; 112:480-7.  ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000; 24:227-35. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Ross JS. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome. Adv Anat Pathol 2009; 16:204-15. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Ransohoff DF. Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 2005; 5:142-9. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;Santos GS. Punção aspirativa por agulha fina. In: Dedivitis RA, Guimarães AV, editores. Patologia cirúrgica da tireoide. São Paulo: Frôntis Editorial, 1999. p.67-74. ;
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270:467-70. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;SCHOTT North America. Reflective optical coating: Nexterion®HiSens slides. Avaliable from: <URL:http://www.us.schott.com/nexterion/english/products/coated_slides/refl ective/reflective.html> [2010 jun 4]. ;
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Simon R, Radmacher MD, Dobbin K, et al. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003; 95:14-8. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Smith J, Cheifetz RE, Schneidereit N, Berean K, Thomson T. Can cytology accurately predict benign follicular nodules? Am J Surg. 2005; 189:592-5.";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;Sontrop HMJ, Moerland PD, Ham RVD, et al. A comprehensive sensitivity analysis of microarray breast cancer classification under feature variability. BMC Bioinformatics 2009, 10:389-411. ;
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Sparano JA, Paik S. Development of the 21-gene assay and its application in clinical practice and clinical trials.J Clin Oncol 2008; 26:721-8. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Stolf BS, Santos MMS, Simao DF, et al. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression. Cancer 2006; 106: 891-900. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"„t Hoen PA, de Kort F, van Ommen GJ, den Dunnen JT. Fluorescent labelling of cRNA for microarray applications. Nucleic Acids Res 2003; 31:e20.";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. PNAS 1990; 87:1663-7.";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Van't Veer L, Dai H, Vijver M van de, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415:530-6. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM. High-fidelity mRNA amplification for gene profiling. Nat Biotechnol 2000; 18:457-9. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Wang X, Hessner MJ, Wu Y, Pati N, Ghosh S. Quantitative quality control in microarray experiments and the application in data filtering, normalization and false positive rate prediction. Bioinformatics 2003; 19:1341-7. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Weber F, Shen L, Aldred MA, et al. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 2005; 90:2512-21. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Wei C, Li J, Bumgarner RE. Sample size for detecting differentially expressed genes in microarray experiments. BMC Genomics 2004; 5:87";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Weiss M, Baruch A, Keydar I, Wreschner DH. Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene. Int J Cancer 1996; 66:55-9. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Yamashita H. Evaluation of thyroid nodules. In: Clark OH, Noguchi S, editors. Thyroid cancer: diagnosis and treatment. St Louis, Missouri: Quality Medical Pu; 2000. p.21-38. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30:e15. ";
FAP;2010;ANA HELENA PAGOTTO;Luiz Fernando Lima Reis ;-x-;"Zeng X, Li G, Yang JY, Yang MQ, Wu G. Dimension reduction with redundant gene elimination for tumor classification. BMC Bioinformatics 2008; 9(Suppl 6):S8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Aboulafia DM, Pantanowitz L, Dezube BJ. AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART. AIDS Read 2004; 14:605-17. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Abreu ES, Ferreira FVA, Rocha-Filho FD, et al. Doença de Hodgkin infantojuvenil no Estado do Ceará e sua relação com o virus de Epstein-Barr: parâmetros clínicos e análises morfológica, imuno-histoquimica e por hibridização in situ. J Bras Patol 1997; 33:178-84. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Aisenberg AC. Historical review of lymphomas. Br J Haematol 2000; 109:466-76. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Aktas S, Kargi A, Olgun N, Diniz G, Erbay A, Vergin C. Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein barr vírus positive and negative pediatric non Hodgkin´s lymphoma. Pathol Oncol Res 2009; 15:345-50. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Alter A. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006; 44(1 Suppl):S6-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Amara K, Trimeche M, Ziadi S, et al. Presence of simian virus 40 in diffuse large  B-cell lymphomas in Tunisia correlates with germinal center B-cell immunophenotype, t(14;18) translocation, and P53 accumulation. Mod Pathol 2008; 21:282-96. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Ambinder RF, Weiss LM. Association of Epstein-Barr virus with Hodgkin’s disease: In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, editors. Hodgkin’s disease. Philadelphia: Lippincott Williams & Wilkins; 1999. p.7998. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Armstrong AA, Alexander FE, Paes RP, et al. Association of Epstein-barr virus with pediatric Hodgkin´s disease. Am J Pathol 1993; 142:1683-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Anagnostopoulos I, Hummel M, Finn T, et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1992; 80:1804-12. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Anagnostopoulos I, Hummel M. Epstein-Barr virus in tumors. Histopathology 1996; 29:297-315. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Andriko JA, Aguilera NS, Nandedkar MA, Abbondanzo SL. Childhood Hodgkin's disease in the United States: an analysis of histologic subtypes and association with Epstein-Barr virus. Mod Pathol 1997; 10:366-71. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Araujo I, Foss HD, Bittencourt A, et al. Burkitt’s lymphoma in Northeast Brazil: expression of Epstein–Barr virus-gene products in Burkitt’s lymphoma in Northeastern Brazil. Blood 1996; 87:5279-86. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Araujo I, Bittencourt AL, Barbosa HS, et al. The high frequeny of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil. Virchows Arch 2006; 449:315-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Araujo LHL, Victorino APOS, Assad DX, et al. Linfoma não Hodgkin de alto grau, revisão da literatura. Rev Bras Cancerol 2008; 54:175-83. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Bacchi CE, Bacchi MM, Rabenhorst SH, et al. Aids-related lymphoma in Brazil: Histopathology, immunophenotype, and association with Epstein-Barr virus. Am J Clin Pathol 1996a; 105:230-7. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Bacchi MM, Bacchi CE, Alvarenga M, Miranda R, Chen YY, Weiss LM. Burkitt’s lymphoma in Brazil: strong association with Epstein-Barr virus. Mod Pathol 1996b; 9:63-7. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Ballestas ME, Kaye KM. The latency associated nuclear antigen a multifunctional protein central to Kaposi´s sarcoma-associated herpesvírus latency. Future Microbiol 2011; 6:1399-413. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Balmain A, Gray, J, Ponder B. The genetics and genomics of cancer. Nat Genet 2003; 33:238-44. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Barreto L. Doença de Hodgkin e AIDS. Rev Bras Cancerol 2002; 48:389-99. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Barros MH, Scheliga A, De Matteo E, et al. Cell cycle characteristics and Epstein barr vírus are differentially associated with aggressive and nonagressive subsets of Hodgkin lymphoma in pediatric patients. Leuk Lymphoma 2010; 51:1513-22. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Bashir R, Okano M, Kleveland K, et al. SCID/human mouse model of central nervous system lymphoproliferative disease. Lab Invest 1991; 65:702-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Bazzeh F, Rihani R, Howard S, Sultan I. Comparing adult and pediatric Hodgkin lymphoma in the surveillance, epidemiology and end results program, 1988-2005: an analysis of 21 734 cases. Leuk Lymphoma 2010; 51:2198-207. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Bello C, Sotomayor EM. Monoclonal antibodies for B-cell lymphomas: ritiximab and beyhond. Hematol Am Soc Hematol Educ Program 2007; 233-42.";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Bennett MH, Tu A, Hudson GV. Analysis of grade 1 Hodgkin's disease (Report no 6). Clin Radiol 1981; 32:491-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Bibas M, Antinori A. EBV and HIV-Related Lymphoma. Mediterr J Hematol Infect Dis 2009; 1:e2009032. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis 2000; 181:1562-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Boccardo E, Villa LL. Vírus e câncer. In: Ferreira CG, Rocha JC, editores. Oncologia molecular. São Paulo: Atheneu; 2004. p.123-32. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 2007; 18:985-90. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Bornkamm GW (2009) Epstein-Barr virus and the pathogenesis of Burkitt’s lymphoma: More questions than answers. Int. J. Cancer 2009; 124:1745– 1755. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995; 1:1274-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Boulanger EL. Human herpesvirus 8 ( HHV-8 ): I. Characteristics and epidemiology. Ann Biol Clin 1998; 56:643-50. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Brousset P, de Araujo V, Gascoyne RD. Immunohistochemical investigation of SV40 large T antigen in hodgkin and non-hodgkin´s lymphoma. Int J Cancer 2004; 112:533-5. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Büyükpamukçu M, Atahan L, Ca?lar M, Kutluk T, Akyüz C, Hazar V. Hodgkin's disease in Turkish children: clinical characteristics and treatment results of 210 patients. Pediatric Hematol Oncol 1999; 16:119-29. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond evolving concepts and practical applications. Blood 2011; 117:5019-32. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIV-associated lymphomas and gamma-herpesviruses. Blood 2008a, 113:1213-24. ;
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;Carbone A, Globhini A, Dotti G. EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist 2008b, 13:577-85. ;
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Carbone A, Spina M, Gloghini A, Tirelli U. Classical Hodgkin´s arising in different host´s conditions: pathobiology parameters, therapeutic options, and outcome. Am J Hematol 2011; 86:170-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Carbone M, Rizzo P, Pass HI. Simian Virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 1997; 15:1877-88. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol 2002; 29:2-17. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Castillo JJ, Beltran BE, Miranda RN, Paydas S, Winer ES, Butera JN. Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far. Oncologist 2011; 16:87-96. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Catalano A, IIand H. Molecular biology of lymphoma in the microarray. Pathology 2005; 37:508-22. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Caterino-de-Araújo A. Human herpesvirus 8 group B and C variants circulating in São Paulo, Brazil. J Infect Dis 1998; 177:1136-7. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Chabay PA, Barros MH, Hassan R, et al. Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pathern and lack of association of Epstein barr virus with clinical outcome. J Pediatr Hematol Oncol 2008; 30:285-91. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Chabay P, Lara J, Lorenzetti M, et al. Epstein barr virus in relation to apoptosis markers and patients outcome in pediatric B-cell non-hodgkin lymphoma. Cancer Letters 2011; 307:221-6. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Chagas CA, Endo LH, Sakano E, Pinto GA, Brousset P, Vassallo J. Detection of herpesvirus type 8 (HHV8) in children's tonsils and adenoids by immunohistochemistry and in situ hybridization. Int J Pediatr Otorhinolaryngol 2006; 70:65-72. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Chang KL, Albújar PF, Chen YY, Johnson RM, Weiss LM. High prevalence of Epstein-Barr in the Reed-Sternberg cells of Hodgkin´s disease occurring in Peru. Blood 1993; 81:496-501. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Chiattone CS. Linfoma extranodal de células NK/T tipo nasal. Rev Bras Hematol Hemoter 2009; 31:26-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;Chindamo M, Spector N, Segadas JA, et al. Prevalence of hepatitis C infection in patients with non Hodgkin's lymphomas. Oncol Rep 2002 9:6579.;
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Claviez A, Tiemann M, Lüders H, et al. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin´s lymphoma. J Clin Oncol 2005; 23:4048-56. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Connors JM, Klimo P, Adams G, et al. Treatment of advanced Hodgkin´s disease with chemotherapy comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the national cancer institute of Canada Clinical trials group. J Clin Oncol 1997; 15:1638-45. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Correa P, O´Conor GT. Epidemiologic pattern of Hodgkin´s disease. Int J Cancer 1971; 8:192-201. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Coupland SE, Charlotte F, Mansour G, Maloum K, Hummel M, Stein H. HHV8 associated T-cell lymphoma in a lymph node with concurrent peritoneal effusion in a HIV-positive man. Am J Surg Pathol 2005; 29:647-52. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Crawford DH. Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 2001; 29; 356:461-73. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"D´Souza BN, Edelstein LC, Pegman PM, et al. Nuclear factor kappa Bdependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. J Virol 2004; 78:1800-16. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"da Silva MC, Zuccherato LW, Lucena FC, et al. Extensive admixture in Brazilian sickle cell patients: implications for the mapping of genetic Modifiers. Blood 2011; 118:4494-5. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"da Silva SR, de Oliveira DE. HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies. Cancer Lett 2011; 305:175-85. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"De Leval L, Gaulard P. Pathology and biology of peripheral T-cell lymphomas. Histopathology 2011; 58: 49-68. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Delfau-Laure MH, de Leval L, Joly B, et al. Targeting intratumoral B-cells with Rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma.A clinicobiological study of the GELA. Haematologica 2012; Feb 27. [Epub ahead of print].  ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Deyrup AT. Epstein-Barr virus-associated epithelial and mesenchumal neoplasms. Hum Pathol 2008; 39:473-83.  ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Diepstra A, van Imhoff GW, Schaapveld M, et al. Latent-Barr infection of tumor cells in classical Hodgkin´s lymphoma predicts adverse outcome in older adult patients. J Clin Oncol 2009; 27:3815-21. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Duggan DB, Petroni GR, Johnson JL, et al. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin´s disease: report of an intergroup trial. J Clin Oncol 2003; 21:607-14. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmabastic variant of Cattleman disease that is linked to HHV-8-positive plasmabastic lymphoma. Blood 2000; 95:1406-12. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Edelman DC Human herpesvirus 8--a novel human pathogen. Virol J 2005; 2:78. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Ekström-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma. A review. Acta Oncol 2006; 45:258-71. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Elgui de Oliveira D, Bacchi MM, Abreu ES, Niero-Melo L, Bacchi CE. Hodgkin disease in adult and juvenile groups from two different geographic regions in Brazil: characterization of clinicopathologic aspects and relationship with Epstein–Barr virus infection. Am J Clin Pathol 2002; 118:25-30. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Engel M, Essop MF, Close P, Hartley P, Pallesen G, Sinclair-Smith C. Improved prognosis of Epstein-Barr virus associated childhood Hodgkin’s lymphoma: study of 47 South African cases. J Clin Pathol 2000; 53:182-6. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Engels EA Infections agents as causes of non Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16:401-4. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Evans AS, Gutensohn NM A population-based case control study of EBV and other viral antibodies among persons with Hodgkin´s disease and their siblings. Int J Cancer 1984; 34:149-57. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Ertem U, Duru F, Da?demir A, et al. Hodgkin´s disease in 82 Turkish children diagnosed over 10-year period. Pediatric Hematol Oncol 1997; 14:359-66. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Faria SL, Vassallo J, Cosset JM, Brandalise SR. Childhood Hodgkins disease in Campinas. Med Pediatr Oncol 1996; 26:90-4. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Farrell K, Jarrett RF The molecular pathogenesis of Hodgkin lymphoma. Histopathology 2011; 58:15-25. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Faulkner GC, Krajewski AS, Crawford DH The ins and outs of EBV infection. Trends Microbiol 2000; 8:185-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;Ferreira JM, Klumb CE, Reis RD, et al. Lymphoma subtype incidence rates in children and adolescents: first report from Brazil. Cancer Epidemiol 2012 Apr 30. [Epub ahead of print] ;
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Ferry JA, Sohani AR, Longtine JA, Schwartz RA, Harris NL HHV8-positive, EBV positive Hodgkin lymphoma like large B cell lymphoma and HHV8positive intravascular large B cell lymphoma. Mod Pathol 2009; 22:618-26. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Flavell KJ, Biddulph JP, Constandinou CM, et al Variation in the frequency of Epstein-Barr virus-associated Hodgkin´s disease with age. Leukemia 2000; 14:748-53. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Foddis R, De Rienzo A, Broccoli D, et al. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002; 21:1434-42.  ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Forstpointer R, Unterhalt M, Dreyling M, et al. Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG). Blood 2006; 108:4003-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Freitas RB, Freitas MR, Linhares AC. Prevalence of Human Herpesvirus 8 antibodies in the population of Belém, Pará, Brazil. Rev Inst Med Trop São Paulo 2002; 44:309-13. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Gail MH, Pluda JM, Rabkin CS, et al. Projections of the incidence of nonHodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst 1991; 83:695-701. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med 1996; 2:925-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Garcia CF, Swerdlow SH. Best practices in contemporary diagnostic immunohistochemistry. panel approach to hematolymphoid proliferations. Arch Pathol Lab Med 2009;133:756-65. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Geissinger E, Bonzheim I, Krenács L, et al. Nodal peripheral T-cell lymphomas correspond to distinct mature T-cell populations. J Pathol 2006; 210:172-80. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Ghosh SK, Perrine SP, Faller DV. Advances in virus-directed therapeutics against Epstein Barr Virus associated malignancies. Adv Virol 2012; 2012:509296. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997; 70:375-82. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Grogg KL, Miller RF, Dogan A. HIV infection and lymphoma. J Clin Pathol 2007; 60:1365-72. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Grulich AE, Wan X, Law MG, et al. B cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin´s lymphoma in people with AIDS. AIDS 2000; 14:133-40. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Gulley ML, Raab-Traub N. Detection of Epstein-Barr virus in human tissues by molecular genetic techniques. Arch Pathol Lab Med 1993; 117:1115-20. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Gulley ML, Eagan PA, Quintanilla-Martinez L, et al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity. Blood 1994; 83:1595-602. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Hahn WC, Dessain SK, Brooks MW, et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002; 22:2111-23. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, et al. Aides-related lymphoma: histopathology, immunophenotype, and association with Epsteinbarr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 1991; 138:149-63. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Hannachi N, Ben Fredj N, Samoud S, et al. Serorevalence and risk factors of human herpes virus 8 infection in central east tunisia. Pathol Biol 2011; Nov 22. [Epub ahead of print] ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Harnly ME, Swan SH, Holly EA, Kelter A, Padian N.Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS). Am J Epidemiol 1988; 128:261-7. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Harris N. The many faces of Hodgkin’s disease around the world: what have we learned from its pathology? Ann Oncol 1998; 9:45-56. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Hassan R, Klumb CE, Felisbino FE et al. Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt’s lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region. Haematology 2008; 93:780-783 ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Heinsohn S, Scholz RS, Kabish HH SV40 and p53 as team players in childhood lymphoproliferative disorders. Int J Oncol 2011; 38:1307-17. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Herbest H, Dallenbach F, Hummel M, et al. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed Sternberg cells. Proc Natl Acad Sci USA 1991; 88:4766-70. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin´s lymphoma after infectious mononucleosis. N Engl J Med 2003; 349:1324-32. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Hoeller S, Tzankov A, Pileri SA, Went P, Dirnhofer S. Epstein-Barr virus– positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations. Hum Pathol 2010; 41, 352-7. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Hofscheier A, Ponciano A, Bonzheim I, et al. Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population. Mod Pathol 2011; 24:1046-54. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Huang X, Nolte I, Gao Z, et al. Epidemiology of classical Hodgkin lymphoma and its association with Epstein Barr virus in Northern China. PLoS ONE 2011; 6:e21152. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Hsu SM, Hsu PL. Autocrine and paracrine functions of cytokines in malignant lymphomas. Biomed Pharmacother 1994; 48:433-44. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Hsu SC, Metzger ML, Hudson MM, et al. Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Pediatr Blood Cancer 2007; 49:139-44. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;[IARC] International Agency for Research on Cancer. Epstein-Barr Virus. 1997. Available from: <URL:http://monographs.iarc.fr/ENG/Monographs/ vol100B/mono100B-6.pdf> [2012 july 13] ;
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Isobe Y, Aritaka N, Setoguchi Y, et al. T/NK cell type chronic active Epstein– Barr virus disease in adults: an underlying condition for Epstein–Barr virusassociated T/NK-cell lymphoma J Clin Pathol 2012; 65:278-82.  ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Ito Y, Kimura H, Maeda Y, et al. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T cell lymphoma, nasal type. Clin Cancer Res 2012; 18:4183-90. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Iwakiri D, Takada K. Role of EBERs in the pathogenesis of EBV infection. Adv Cancer Res 2010; 107:119-36. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008; 112:4384-99. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Jaffe ES. The 2008 WHO classification of lymphomas:implications for clinical practice and translational research Hematol Am Soc Hematol Educ Program 2009; 523-31. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Jarrett RF. Viruses and Hodgkin´s lymphoma. Ann Oncol 2002; 13 Suppl 1:23-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Jarrett RF. Viruses and lymphoma/leukemia. J Pathol 2006; 208:176-86. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Jeong SH. HBV infection as a risk for non-Hodgkin lymphoma. Lancet Oncol 2010; 11:806. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Kaplan LD, Abrams DI, Feigal E, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989; 261:719-24. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996; 2:918-24.";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Keegan THM, Glaser SL, Clarkc CA, et al. Epstein-Barr virus as a marker of survival after Hodgkin´s Lymphoma: a population-based study. J Clin Oncol 2005; 23:7604-12. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Klein G, Powers A, Croce C. Association of SV40 with human tumours. Oncogene 2002; 21:1141-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008; 8:22-33. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Kliche S, Kremmer E, Hammerschmidt W, Koszinowski U, Haas J. Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8. J Virol 1998; 72:8143-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Kluin P, Schuuring E. Molecular cytogenetics of lymphoma: where do we stand in 2010? Histopathology 2011; 58:128-44. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Klumb CE, Hassan R, Elgui de Oliveira D et al. Geographic variation in Epstein-barr virus-associated Burkitt´s lymphoma in children from Brazil. Int J Cancer 2004; 108:66–70. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Koreishi AF, Saenz AJ, Arcila ME, Hedvat C, Fleming S, Teruya-Feldstein J. Syncronous follicular lymphoma, kaposi sarcoma, and castleman´s disease in a HIV-negative patient with EBV and HHV-8 coinfection. Int J Surg Pathol 2011; 19:685-91. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Küppers R. The biology of Hodgkin’s lymphoma. Nat Rev Cancer 2009; 9:15-27. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Laichalk LL, Hochberg D, Babcock GJ, Freeman RB, Thorley-Lawson DA. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity 2002; 16:745-54. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Leão JC, Caterino-de-Araújo A, Porter SR, Scully C. Human Herpesvírus 8 (HHV-8) and the etiopathogenesis of Kaposi´s Sarcoma. Rev Hosp Clin Fac Med São Paulo 2002; 57:175-86. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Levi JA. Three new human herpesviruses (HHV6, 7, 8). Lancet 1997; 349:558-63. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Levine AM, Sullivan-Halley J, Pike MC, et al. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer 1991; 68:2466-72. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Levine PH, Ablashi DV. An etiologic Perspective of the new herpesviruses: HHV-7 and HHV-8. Infect Med 1999; 16:24-34. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Li QX, Young LS, Niedobitek G, et al. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 1992; 356:347-50.  ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Liao JB. Viruses and human cancer. Yale J Biol Med 2006; 79:115-22. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Loureiro MM, Morais JC, Milito CB, Portugal RD, Pulcheri W, Spector N. Expression of Epstein-Barr virus in patients with Hodgkin's disease: report of 64 cases from Rio de Janeiro, Brazil. J Bras Patol Med Lab 2004; 40:37-40. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Lowe DB, Shearer MH, Jumper CA, Kennedy RC. SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen. Cell Mol Life Sci 2007; 64:803-14. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Luppi M, Torelli G. The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and Hepatitis C virus (HCV) in human lymphoproliferative diseases: na overview. Haematologica 1996; 81:265-81. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Mayama S, Cuevas LE, Sheldon J, et al. Prevalence and transmission of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998; 77: 817-20. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"McCune JM. Epstein-Barr virus associated lymphoproliferative disease in mice and men.Lab Invest 1991; 65:377-80. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Mcgeoch DJ, Davidson A. The descent of herpesvirus 8. Semin Cancer Biol 1999; 9:201-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Meneses A, Lopez-Terrada D, Zanwar P, et al. Lymphoproliferative disorders in Costa Rica and simian virus 40. Haematologica 2005; 90:1635-42. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2009 incidência de câncer no Brasil. Rio de Janeiro: INCA; 2008. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2012 incidência de câncer no Brasil. Rio de Janeiro: INCA; 2011. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Mohammed IB, Briere J, Djebbara Z, Beldjord K, Andrieu J-M, Colonna P. Comparasion of Epstein barr irus markers in reed-sternberg cells in adult hodgkin´s disease tissue from an industrialized and a developing country. Leuk Lymphoma 1995; 17:163-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Monteiro TAF, Gomes MLC, Freitas RB, et al. Prevalência de anticorpos para o vírus de Epstein Barr em Belém, Pará, Brasil. Rev Para Med 1998; 12:8-12. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 19922001. Blood 2006; 107: 265-76. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Morton LM, Wang SS, Cozen W, et al. Etiologic heterogeneity among nonHodgkin lymphoma subtypes. Blood 2008; 112: 5150-60. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Musacchio JG, Carvalho G, Morais JC, et al. Detection of free circulating Epstein-Barr virus DNA in plasma of patients with Hodgkin's disease. São Paulo Med J 2006; 124:154-7. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcomaassociated herpes virus. Blood 1996; 88: 645-56. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Nakatsuka S, Liu A, Dong Z, et al. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Res 2003; 63:7606-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Naresh KN, Johnson J, Srinivas V, et al. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol 2000; 11:91-6. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Nicholas J, Ruvolo VR, Burns WH, et al. Kaposi’s sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 1997; 3:287-92. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Nicholas J. Evolutionary aspects of oncogênico herpesviruses. Mol Pathol 2000; 53:222-37. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Nogai H, Dörken B, Lenz G. Pathogenesis of Non-Hodgkin’s Lymphoma. J Clin Oncol 2011; 29:1803-11. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Oguz A, Karadeniz C, Okur V, et al. Prognostic factors and treatment outcome in childhood Hodgkin disease. Pediatr Blood Cancer 2005; 45:670-5. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Ohshima K, Suzumiya J, Kikuchi M. The World Health Organization classification of malignant lymphoma: Incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka. Pathol Int 2002; 52:1-12. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 2007; 13:5124-32. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Paes RAP, Teixeira RAP, Barrezuela LFM, Bruniera P. Três casos de carcinoma de nasofaringe associados ao vírus Epstein-barr (EBV) em crianças: aspectos clínicos, patológicos e imunohistoquímicos. J Bras Patol 1996; 32:76-82. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Pagano JS, Blaser M, Buendia MA, et al. Infections agents and câncer: criteria for a causal relation. Semin Cancer Biol 2004; 14:453-71. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of EpsteinBarr virus latent gene products in tumor cells of Hodgkin´s disease. Lancet 1991; 337:320-2. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Patel NC, Vilchez RA, Killen DE, et al. Detection of polyomavirus SV40 in tonsils from immunocompetent children. J Clin Virol 2008; 43:66-72. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Pedrosa MF, Pedrosa F, Mecneide M, et al. Non-Hodgkin’s lymphoma in childhood: clinical and epidemiological characteristics and survival analysis at a single center in Northeast Brazil. J Pediatr 2007; 83:547-554. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Pena SDJ, Di Pietro J, Fuchshuber-Moraes M, et al. The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS ONE 2011; 6:e17063. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Perna AM, Bonura F, Vitale F, et al. Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol 2000; 29:175-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Piccaluga PP, Agostinelli C, Tripodo C, et al.; for the European T-cell Lymphoma Study Group. Peripheral T-cell lymphoma classification: the matter of cellular derivation. Expert Rev Hematol 2011; 4:415-25. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Pizza M, Bruniera P, Luporini SM, et al. Detection of Epstein-Barr virus in children and adolescents with Burkitt’s lymphoma by in situ hybridization using tissue microarrays. Hematol 2008; 13:114-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Poulin DL, DeCaprio JA. Is there a role for SV40 in human câncer? J Clin Oncol 2006; 24:4356-65. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Poppema S. Immunobiology and pathophysiology of Hodgkin lymphomas. Hematol Am Soc Hematol Educ Program 2005; 231-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Pracchia LF, Buccheri V, Menezes Y, Siqueira SAC, Mori NS, Chamone DAF. Significado prognóstico dos graus histológicos do linfoma de Hodgkin do tipo esclerose nodular. J Bras Patol Med Lab 2005; 41:365-375. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Preston RJ. Molecular epidemiology: potential impacts on the assessment of public halth. Mut Res 2003; 543:121-4. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Quadrelli C, Barozzi G, Riva D, et al. ?-HHVs and HHV-8 in lymphoproliferative disorders. Mediterr J Hematol Infect Dis 2011; 3  e2011043. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Quintanilla-Martinez L, Lome-Maldonado C, Ott G, et al. Primary intestinal non-Hodgkin´s lymphoma and Epstein-Barr virus: high frequency of EBVinfection in T-cell lymphomas of Mexican origin. Leuk Lymphoma 1998; 20:111-121. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Rangarajan A, Hong SJ, Gifford A, Weinberg RA. Species and cell type specific requirements for cellular transformation. Cancer Cell 2004; 6:17183. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Razzouk BI, Gan YJ, Mendonça C, et al. Epstein-Barr virus in pediatric Hodgkin disease: age and histiotype are more predictive the geographic region. Med Pediatr Oncol 1997; 28:248-54. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Richiardi L, De Marco, L, Gillio-Tos A, et al. Persistent infection by HCV and EBV in peripheral blood mononuclear cells and risk of non-Hodgkin´s lymphoma. Cancer Epidemiol 2010; 34:709-12. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Rimar D, Rimar Y, Keynan Y. Human herpesvirus-8: beyond Kaposi´s. Isr Med Assoc J 2006; 8:489-93. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Rizvi MA, Evens AM, Tallman MS, Nelson, BP,Rosen ST. T-cell non-Hodgkin lymphoma. Blood 2006; 107:1255-64. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol 2007; 18 Suppl 1:i3-i8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Roman E, Smith AG. Epidemiology of lymphomas. Histopathology 2011; 58:4-14. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Rummel M. Reassessing the standard of care in indolent lymphomas: a clinical update to improve clinical practice. J Natl Compr Canc Netw 2010; 8 Suppl 6:S1-14; quiz S15. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Saha A, Robertson ES. Epstein barr virus associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin Cancer Res 2011; 17:3056-63. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;Salles GA. Clinical features, prognosis and treatment of follicular lymphoma. Hematology Am Soc Hematol Educ Program 2007:216-25. ;
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;Sandlund JT. Should adolescents with NHL be treated as old children or young adults? Hematology Am Soc Hematol Educ Program 2007:297303. ;
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Sant M, Allemani C, Tereanu C, et al. Working Group. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010; 116:3724-34. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Sarid R, Sato T, Bohenzky J, Russo JJ, Chang Y. Kaposi’s sarcomaassociated herpesvirus encodes a functional bcl-2 homologue. Nat Med 1997; 3:293-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Sarid R, Wiezorek JS, Moore PS, Chang Y. Characterization and cell cycle regulation of the major Kaposi’s sarcoma-associated herpesvirus (HHV8) latent genes and their promoter. J Virol 1999; 73:1438-46. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Sebatier J, Uro-Coste E, Benouaich A, et al. Immunodetection of SV40 large T antigen in human central nervous system tumours. J Clin Pathol 2005; 58:429-31. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Shah KV, Ozer HL, Pond HS, Palma LD, Murphy GP. SV40 neutralizing antibodies in sera of US residents without history of polio-immunization. Nature 1971; 231:448-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Shah MH, Porcu P, Mallery SR, Caligiuri MA. AIDS-associated malignancies. Cancer Chemother Biol Response Modif 2003; 21:717-46. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Shah KV. SV40 and human cancer: A review of recent data. Int J Cancer 2007; 120:215-23. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Shimoyama Y, Asano N, Kojima M, et al. Age-related EBV-associated B-cell lymphoproliferative disorders: Diagnostic approach to a newly recognized clinicopathological entity. Pathol Int 2009; 59:835-43. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Shiramizu B, Barriga F, Neequaye J et al. Patterns of chromosomal breakpoint locations in Burkitt’s lymphoma: relevance to geography and EpsteinBarr virus association. Blood 1991; 77:1516 –26. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Shivapurkar N, Harada K, Reddy J, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002; 359:851-2. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Sjöberg J, Halthur C, Kristinsson SY, et al. Progress in Hodgkin lymphoma: A population-based study on patients diagnosed in Sweden 1973-2009. Blood 2012; 119:990-6. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Soares A, Biasoli I, Scheliga A, et al. Socioeconomic inequality and shortterm outcome in Hodgkin’s lymphoma Int J Cancer 2006; 120:875-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Soulier J, Grollet L, Oksenhendler E, et al. Kaposi’s sarcoma –associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 1995; 86:1276-80. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Souza EM, Baiocchi OC, Zanichelli MA, Alves AC, Oliveira JS. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. Ann Hematol 2009; 88:633-7. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Souza EM, Baiocchi OCG, Zanichelli MA, et al. Impact of epstein barr virus in the clinical evolution of patients with classical Hodgkin´s lymphoma in Brazil. Hematol Oncol 2010; 28:137-41. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Spear PG, Longnecker R. Herpesvirus entry: an update. J Virol 2003; 77:10179-85. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Strickler HD, Goedert JJ, Devesa SS, Lahey J, Fraumeni-Jr JF, Rosenberg PS. Trends in U.S. Pleural Mesothelioma Incidence Rates Following Simian Virus 40 Contamination of Early Poliovirus Vaccines. J Natl Cancer Inst 2003; 95:38-45. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Tan LH. A pratical approach to the understanding and diagnosis of lymphoma: an assessment of the WHO classification based on immunoarchitecture and immune-ontogenic principles. Pathology 2009; 41:305-26. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Tan CS, Ellis LC, Wüthrich C, et al. JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. J Virol 2010; 84:9200-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Taylor GS, Blackbour DJ. Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV. Cancer Lett 2011; 305:263-78. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Tedeschi R, Caggiari L, Silins I, et al. Seropositivity to human herpesvirus 8 in relation to sexual history and risk of sexually transmitted infections. Int J Cancer 2000; 87:232-5. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Toracchio S, Kozinetz CA, Killen DE, et al. Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX. J Clin Virol 2009; 46:154-60. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Tumwine LK, Orem J, Kerchan P, Byarugaba W, Pileri SA. EBV, HHV8 and HIV B cell non Hodgkin lymphoma in Kampala, Uganda. Infect Agent Cancer 2010; 5:12. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Ulrickson M, Press OW, Casper C. Epidemiology, diagnosis, and treatment of HIV-Associated non Hodgkin lymphoma in resource limited settings. Adv Hematol 2012; 2012:932658. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Uner A, Akyurek N, Sagalm A, et al. The presence of Epstein barr vírus (EBV) in diffuse large B cell lymphomas (DLBCLs) in Turkey: special emphasis on EBV-positive DLBCL of the elderly. APMIS 2011; 119:309-16. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Van Oers MHJ, Van Glabbeke M, Teodorovic I, et al. Chimeric anti-CD20 monoclonal antibody (Rituximab;MabThera) in remission induction and maintenance treatment of relapsed/resistant follicular non-Hodgkin’s lymphoma: ?nal analysis of a phase III randomized intergroup clinical trial. Blood 2005; 106:107a. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Vassallo J, Andrade LA, Pedro RJ, Aranha FJ. Peripheral T-cell lymphoma in HIV-positive patients. Rev Paul Med 1993; 111:427-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Vassallo J. Expressão de EBV e de proteínas relacionadas à apoptose em linfomas de Hodgkin clássicos do adulto. Campinas(SP); 2001. [Tese de Doutorado - Faculdade de Ciências Médicas da Unicamp]. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Vassallo J, Metze K, Traina F, Souza CA, Lorand-Metze I. Expression of Epstein barr vírus in classical Hodgkin´s lymphomas in Brazilian adult patients. Haematologica 2001; 86:1227-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Vassallo J, Rebouças I, Brousset P. Detection of HHV-8 in reactive lymphoid tissue of patients from São Paulo state, Brazil. J Clin Pathol 2002; 55:78-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Vassallo J, Metze K, Traina F, de Souza CA, Lorand-Metze I. The relevance of apoptosis-related proteins in classical Hodgkin’s lymphomas. Leuk Lymphoma 2003; 44:483-8. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Vassallo J, Paes RP, Soares FA, et al. Histological classification of 1,025 cases of Hodgkin's lymphoma from the State of São Paulo, Brazil. São Paulo Med J 2005; 123:134-6. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Vilchez RA, Butel JS. SV40 in human brain cancers and non-Hodgkin´s lymphoma. Oncogene 2003; 22:5164-72. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Vilchez RA, Butel JS. Emergent human pathogen simian virus 40 and its role in cancer. Clinical Microbiol Review 2004; 17:495-508. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Vilchez RA, Lopez-Terrada D, Middeleton JR, et al. Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related nonHodgkin’s lymphoma. Virology 2005; 342:38-46. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Vilchez RA, Jauregui MP, Hsi ED, Novoa-Takara L, Chang CC. Simian vírus 40 in post transplant lymphoproliferative disorders. Hum Pathol 2006; 37:1130-6. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Viscidi RP, Rollison DE, Viscidi E, et al. Serological cross reactivities between atibodies to simian vírus 40, BK vírus and JC vírus asessed by virus-like particle based enzyme immunoassays. Clin Diagn Lab Immunol 2003; 10:278-85. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Vockerodt M. Morgan SL, Kuo M, et al. The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin´s Reed-Sternberg-like phenotype. J Pathol 2008; 216:83-92. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Von Wasielewski S, Franklin J, Fischer R, et al. Nodular sclerosing Hodgkin disease: a new grading predicts prognosis in intermediate and advanced stages. Blood 2003; 101:4063-9. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Wada N, Junichiro I, Hori Y, et al. Epstein barr vírus in diffuse large B cell lymphoma in immunocompetent patients in Japan is as low as in western countries. J Med Virol 2011; 83:317-21. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ Detection and localization of Epstein-Barr viral genomes in agioimmunoblastic, lymphadenopathy and andioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992; 79:1789-95. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Wood C, Harrington WJ. AIDS and associated malignances. Cell Res 2005; 15:947-52. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Wüthrich C, Kesari S, Kim WK, et al. Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+)Tcells with JCV-infected glial cells. J Neurovirol 2006;12:116-28. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;Yahalom J. Does radiotherapy still have a place in Hodgkin lymphoma? Curr Hematol Malig Rep 2009, 4:117-24. ;
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Zerbini MCN, Soares FA, Morais JCM, et al. Classificação dos tumores hematopoéticos e linfoides de acordo com a OMS: padronização da nomenclatura em língua portuguesa, 4ª edição. J Bras Patol Med Lab 2011; 47:643-48. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Zhang L, Qi F, Gaudino G, et al. Tissue tropism of SV40 transformation of human cells: role of the viral regulatory regionn and of celluar oncogenes. Genes Cancer 2010; 1:1008-20. ";
FAP;2012;ADRIANA HELENA MOREIRA ; José Vassallo ;-x-;"Zhong W, Wang H, Herndier B, Ganem D. Restricted expression of Kaposi`s sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci U S A 1996; 93:6641-6. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Abd Elmageed ZY, Gaur RL, Williams M, et al. Characterization of coordinated immediate responses by p16INK4A and p53 pathways in UVBirradiated human skin cells. J Invest Dermatol 2009; 129:175-83.  ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249:912-5. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19:3622-34. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Barnhill RL, Katzen J, Spatz A, Fine J, Berwick M. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma. J Cutan Pathol 2005; 32:268-73. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Bastian B.C., Kahani-Sabet M., Hamm H, et al. Gene Amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 2000; 60:1968-73. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Battisti R, Nunes DH, Lebsa-Weber A, Schweitzer LC, Sgrott I. Avaliação do perfil epidemiológico e da mortalidade dos pacientes com diagnóstico de melanoma cutâneo primário no município de Florianópolis - SC, Brasil. An Bras Dermatol 2009; 84:335-42. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Bhatt KV, Spofford LS, Aram G, McMullen M, Pumiglia K, Aplin AE. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling. Oncogene 2005; 24:3459-71. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Bianchi S, Calzolari A, Giannelle E, Giordano A, Zampi G. Expression of retinoblastoma protein in human breast cancer: an immunohistochemical study. Pathologica 1994; 86:146-9. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Bradfort PT, Goldenstein AM, McMastaer ML, Ticker AM. Arch Dermatol 2009; 45:427-34. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Brandão MAR, Souza FFA, Zanvettor P. Clinical, Demographic and histopathological evaluation of 529 melanoma cases diagnosed in the state of Bahia – Brazil. Appl Cancer Res Suppl 2005; 1:9-10. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Nat Acad Sci 1991; 88:10124-8. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Bütter A, Hui T, Chapdelaine J, Beaunoyer M, Flageole H, Bouchard S. Melanoma in children and use sentinel lymph node biopsy. J Pediatr Surg 2005; 409:797-800. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Buzaid AC, Ross MI, Balch CM, et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal a new staging system. J Clin Oncol 1997; 15:103997. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Byers HR, Bhawan J. Pathologic parameters in the diagnosis and    prognosis of primary cutaneous melanoma. Hematol Oncol Clin North Am 1998; 12:717-35. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Cascinelli N, Zurrida S, Galimberti V, et al. Acral Lentiginous Melanoma: a histological type without prognostic significance; J Dermatol Surg Oncol 1994; 20:817-22. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Chana JS, Grover R, Wilson GD, et al. An analysis of p16 tumor suppressor gene expression in acral lentiginous melanoma. Br J Plastic Surg 2000; 53:46-50. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Chang JW, Yeh KY, Wang CH, et al. Malignant melanoma in Taiwan: a prognostic study of 181 cases. Melanoma Res 2004; 14:537-41. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Clark WH Jr, Elder DE, Guerry D 4th, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81:1893904. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Cook MG, Spatz A, Bröcker EB, Ruiter DJ. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. J Pathol 2002; 197:188-93. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Cotran RS, Kumar V, Robbins SL. Robbins patologia estrutural e funcional. 6 ed. Rio de Janeiro: Guanabara Koogam; 2000. Neoplasia; p.281-356. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Coupland SE, Anastassiou G, Stang A. The prognostic value of cyclin D1, p53 and MDM2 protein expression on uveal melanoma. J Pathol 2000; 191:120-6 ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Criado PR, Vasconcelos C, Sittart JAS, et al. Melanoma maligno cutâneo primário: Estudo retrospectivo de 1963 a 1997 no Hospital do Servidor Público Estadual de São Paulo. Rev Ass Med Bras 1999; 45:157-62. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Cress RD, Holly EA. Incidence of cutaneous melanoma among non - Hispanic Whites, Hispanics, Asians, and Blacks: an analysis of California Cancer Registry data, 1988 – 93. Cancer Causes Control 1997; 8:246-52. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353:2135-47. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Dahl C, Guldberg P. The genome and epigenome of malignant melanoma. APMIS 2007; 115:1161-76. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"de Sá BC, Fugimori ML, Ribeiro Kde C, Duprat Neto JP, Neves Rl, Landman G. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas. Melanoma Res 2009; 19:135-41. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Demirkan NC, Kessen Z, Akdag B, Larue L, Delmas V. The effect of the sun on expression of b-catenin, p16 and cyclin d1 proteins in melanocytic lesions. Clin Exper Dermatol 2007; 32:733-9. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Nat Acad Sci 1993; 90:10529-33. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Elder De, Gimotty PA,Guerry D. Cutaneous melamoma:estimating survivaland recurrence risk based on histopathologic features. Dematol Ther 2005; 18:369-85. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Fecher AL, Staci D, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J Clin Oncol 2007; 25:1606-20. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Flockhart RJ, Armstrong JL, Reynolds NJ, Lovat PE. NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma. Br J Cancer 2009; 101:1448-55. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Florell SR, Boucher KM, Garibotti G, et al. Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol 2005; 23:7168-77. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Florenes VA, Holm R, Fodstad O. Accumulation of p53 protein in human malignant melanoma.Relationship toclinical outcome. Melanoma Res 1995; 5:183-7. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Garbe C, Roderick G, McLeod C, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000; 89:1269-78. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Goel VK, Lazr AJF, Warnek CL, Redstonen MS, Haluska FG. Examination of mutations in BRAF, NRAS, and PTEN in Primary Cutaneous Melanoma. J Invest Dermatol 2006; 126:154-60. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Greer RO Jr, Said S, Shroyer KR, Marileila VG, Weed SA. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Oral Oncol 2007; 43:735-41. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Griinwald V, DeGraffenried L, Russel D, Friedrichs WE, Ray RB, Hidalgo M. Inhibitors of mTorreverse doxorubicin ressitance conferred by PTEN status in prostate cancer cells. Cancer Res 2002; 62:6141-45. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Guitart J, Lowe L, Piepkorn M, et al. Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. Arch Dermatol 2002; 138:603-7. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Ha L, Merlino G, Sviderskaya EV.Melanomagenesis: overcoming the barrier of melanocyte senescence. Cell Cycle 2008; 7:1944-8. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;Haas-Kogan D, Shaley N, Wong M, Mills G, Yount G, Stroke D. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor supressor PTEN/MMAC. Curr Biol 1998. 8:1195-8. ;
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Haferkamp S, Tran SL, Becker TM, Scurr LL, Kefford RF, Rizos H. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence. Aging 2009; 1:542-56. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Holland EA, Beaton SC, Becker TM. Analysis of the p16 gene CDKN2, in17 Australian melanoma kindred. Oncogene 1995; 11:2289-94. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Hoolstein M, Sidransky D, Volgestein B Harris CC. P53 mutations cancers. Science 1991; 253:49-53. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Hsieh R, Firmiano A, Sotto MN. Expression of p16 protein in acral lentiginous melanoma. Int J Dermatol 2009; 48:1303-7. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Hussein MR, Haemel AK, Wood GS. Apoptosis and melanoma: molecular mechanisms. J Pathol 2003; 199:275-88. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativas/2010 incidência de Câncer no Brasil. Rio de Janeiro: INCA; 2009. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Ishiara K, Salda R, Otsuka F, Yamazaki M. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol 2008; 13:33-41. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Kageshita T, Hamby CV, Hirai S, Kimura T, Ono T, Ferrone S. Differential clinical significance of alfa-v-beta-3 expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes. Int J Cancer (Pred Oncol) 2000; 89:153-9. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Kaleem Z, Lind AC, Humphrey PA. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?. Mod Pathol 2000; 13:217-22. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Kansta MB, Onyekwere O, Sidransky D, Volgestein B, Craig RW Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51:6304-11. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Kido K, Sumimoto H, Asada S, et al. Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation. Cancer Sci 2009; 100:1863-9. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Korabiowska M, Ruschenburg I, Betke H, et al. Down regulation of the retinoblastoma gene expression in the progression of malignant melanoma. Pathobiology 2001; 69:274-80. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Kuchelmeister C, Schaumburg-Lever G, Garbe C. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol 2000; 143:275-80. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Lane DP. P53, guardian of the genome. Nature 1992; 358:15-6 ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Langley RGB, Fitzpatrick TB, Sober AJ. Clinical characteristics. In: Balch AM, Houghton AN, Sober AJ. Soong SJ, editors. Cutaneous melanoma. 3 ed. Missouri: QMP; 1998. p.90. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Lefevre M, Vergier B, Balme B, et al. Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomas. Am J Surg Pathol 2003; 27:717-24. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Levine AJ. p53, the cellular gate keeper for growth and division. Cell 1997; 88:323-31 ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. Cell Sci 2000; 113:1661-70.  ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Li W, Sanki A, Karim RZ, et al. The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology 2006; 38:287-301. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Lipsker D, Engel F, Cribier B, Velten M, Hedelin G. Trends in melanoma epidemiology suggets three different types of melanoma. Br J Dermatol 2007; 157:338-43 ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Ma J, Martin JD, Zhang H, et al. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination. Biochemistry 2006; 45:9238-45 ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95:1878-90. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Miller C, Mohandas T, Wolf D, Prokocimer M, Rotter V, Koeffler HP. Human p53 gene localized to short arm of chromosome 17. Nature 1986; 319:783-4. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Ming M, He YY. PTEN: new insights into its regulation and function in skin cancer. J Invest Dermatol 2009; 129:2109-12. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Morton DL, Davtyan DG, Wanek LA, Foshag LJ, Cochran AJ. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993; 71:3737-43. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse tumor types. Nature 1989; 342:705-8. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Noonan FP, De Fabo EC. UVB and UVA initiate different pathways to p53dependent apoptosis in melanocytes. J Invest Dermatol 2009; 129:1608-10. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Palmieri G, Capone M, Ascierto ML, et al. Main roads to melanoma. J Transl Med 2009; 7:86. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Pantaleão L, Rochael MC. Estudo da espessura da regressão como fator prognóstico nos melanomas cutâneos finos. J Bras Patol Med Lab 2008; 44:381-9. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Péres-Tenorio G, Stal O. Activiation of AKT/PBK in breast cancer predicts a worse outcome among endocrine treated patients. Br J Cancer 2002; 86:540-5. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Pezzolesi MG, Zbuk KM, Waite KA, Eng C. Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome. Hum Molecular Genet 2007; 16:1058-71. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Phan A, Touzet S, Dalle S, Ronger-SavleS, Balme B, Thomas L. Acral lentiginous melanoma: histopathological prognostic features of 121 cases. Br J Dermatol 2007; 157:311-8. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Poynter JN, Elder JT, Fullen DR, et al. BRAF and NRAS mutations in melanoma and melnocytic nevi. Melanoma Res 2006; 16:267-73. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83:993-1000. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Ramaswamy S, Nakamura N, Vazquez F, et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 1999; 96:2110-5. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Richard MA, Grab JJ, Avril MR Delays in diagnosis and melanoma prognosis: the role of patients. Int J Cancer 2000; 89:271-9. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Ridgeway CA, Hieken TJ, Ronan SG. et al. Acral lentiginous melanoma; Arch Surg 1995; 130:88-92. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Rizos H, Becker TM, Holland EA. Cell cycle regulation in the melanocyte. In: Thompson JR Morton DL, Kroon BBr, editors. Textbook of melanoma. London: Martin Dinitz; 2004. p.13-24. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;[SEER] Surveillance Epidemiology and end Results. SEER Cancer Statistics Review 1975-200. Avaliable from: <URL:http://seer.cancer.gov/csr/1975_2007/results_merged/topic_topfifteen. pdf> [2010 ago 12] ;
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Shaw PH. The role of p53 in cell cycle regulations. Pathol Res Pract 1996; 192:669-75.58. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Shen SS, Zhang PS, Eton O, Prieto VG. Analysis of protein tyrosine kinase  expression in melanocytic lesions by tissue array. J Cutan Pathol 2003; 30:539-47 ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Sini MC, Manca A, Cossu A, et al. Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma. Br J Dermatol 2008; 158:243-50. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Stahl JM, Sharma A, Cheung M, et al. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 2004; 64:7002–10. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Sortino-Rachou AM, Curado MP, Latorre MRDO. Melanoma cutâneo: estudo de base populacional em Goiânia, Brasil, de 1988 a 2000. An Bras Dermatol 2006; 81:449-55. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Srivastava S, Zou Z, Pirollo K, Bllatner W, Chang EH. Germ-line transmition of a mutade p53 in a cancerprone family with Li Fraumeni Syndrome. Nature 1990; 348:747-9. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Stalkup JR, Orengo IF, Katia R. Controversies in acral lentiginous melanoma. Dermatol Surg 2002; 28:1051-9. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Stott FJ, Bates S, James MC, et al. The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998; 17:5001-14. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Swan MC, Hudson DA. Malignant melanoma in South Africans of mixed ancestry: a retrospective analysis. Melanoma Res 2003; 13:415-9. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Takahashi T, Nau MM, Chiba I, et al. P53: a frequent target for genetic abnormalities in lung cancer. Science 1989; 246:491-4. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Thörn M, Pontén F, Bergström R, Sparén P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population based study in Sweden. J Natl Cancer Inst 1994; 86:761-9. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Toschi E, Rotta R, Antonini A, Medillo G, Capogrossi MC. Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloprotinase-2 levels in p53-mutated Human melanoma cells. J Invest Dermatol 2000; 114:118894. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Uribe P, Wistuba II, Gonzalez S. BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Am J Dermatopathol 2003; 25:365-70. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Veierod MB, Weiderpass E, Thorn M, et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer lnst 2003; 95:1530-8. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Vries E, Bray Fl, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer 2003; 107:119-26. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Vries E, Boniol M, Doré JF, Coebergh JW; EUROCARE working group. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe. Eur J Cancer 2004; 40:1045-52. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Wang SS, Cozen W, Severson RK, et al. Cyclin D1 splice variant and risk for non-Hodgkin lymphoma. Hum Genet 2006; 120:297-300. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"[WHO] World Health Organization. Pathology and Genetics of Skin Tumors. Lyon: IARC PRESS; 2006. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Yamamoto M, Takahashi H, Saitoh K, Horikoshi T, Takahashi M. Watanabe W. Expression of the p53 protein in malginant melanomas as a prgnostic indicator. Arch Dermatol 1995; 287:146-51. ";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Zhang H, Rosdahl I. Deletion in p16INK4a and loss of p16 expression in human skin primary and metastatic melanoma cells. Int J Oncol 2004; 24:331-5";
FAP;2010;DÉCIO DE NATALE CALY ; Gilles Landman; Renata de Almeida Coudry ;"Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372:773-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Achatz MI. Modificadores de penetrância de mutações germinativas no gene TP53 em famílias brasileiras com diagnóstico clínico da síndrome de LiFraumeni e Li-Fraumeni like: impacto dos polimorfismos intragênicos do TP53 e de genes que regulam a atividade da p53. Sao Paulo; 2008. [Tese de Doutorado - Faculdade de Medicina da Universidade de Sao Paulo]. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Achatz MI, Olivier M, Le CF, et al. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Cancer Lett 2007; 245:96-102. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Allgayer H. Molecular staging of cancer: concepts of today, therapies of tomorrow. J Surg Oncol 2003; 82:217-23. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Alston RD, Geraci M, Eden TO, Moran A, Rowan S, Birch JM. Changes in cancer incidence in teenagers and young adults (ages 13 to 24 years) in England 1979-2003. Cancer 2008; 113:2807-15. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ambs S, Hussain SP, Harris CC. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 1997; 11:443-8. Ascano JJ, Frierson H Jr., Moskaluk CA, et al. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod Pathol 2001; 14:942-9.  ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172:5-12. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Bacani J, Zwingerman R, di Nicola N, et al. Tumor microsatellite instability in early onset gastric cancer. J Mol Diagn 2005; 7:465-77. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Bacani JT, Soares M, Zwingerman R, di Nicola N, Senz J, Riddell R et al. CDH1/Ecadherin germline mutations in early-onset gastric cancer. J Med Genet 2006; 43:867-72. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Barrow E, Robinson L, Alduaij W, et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 2009; 75:141-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54:3845-52. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Becker KF, Keller G, Hoefler H. The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 2000; 9:5-11. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Bedikian AY, Khankhanian N, Heilbrun LK, Bodey GP, Stroehlein JR, Valdivieso M. Gastric carcinoma in young adults. South Med J 1979; 72:654-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Behrens J, von Kries JP, Kuhl M, et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996; 382:638-42. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Birch JM, Alston RD, McNally RJ, et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 2001; 20:4621-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Birch JM, Hartley AL, Tricker KJ, et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994; 54:1298-304. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994; 1198:11-26. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Block M, Griep AH, Pollard HM. The occurrence of gastric neoplasms in youth. Am J Med Sci 1948; 215:398-404. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Bosari S, Viale G. The clinical significance of p53 aberrations in human tumours. Virchows Arch 1995; 427:229-41. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Bowrey DJ, Griffin SM, Wayman J, Karat D, Hayes N, Raimes SA. Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked.Surg Endosc 2006; 20:1725-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Brabletz T, Jung A, Kirchner T. Beta-catenin and the morphogenesis of colorectal cancer. Virchows Arch 2002; 441:1-11. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Brooks-Wilson AR, Kaurah P, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004; 41:508-17. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Buffart TE, Carvalho B, Hopmans E, et al. Gastric cancers in young and elderly patients show different genomic profiles. J Pathol 2007; 211:45-51. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999; 36:873-80. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Candusso ME, Luinetti O, Villani L, et al. Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value. J Pathol 2002; 197:44-50. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Carneiro F, Oliveira C, Suriano G, Seruca R. Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer. J Clin Pathol 2008; 61:25-30. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Carvalho R, Milne AN, van Rees BP, et al. Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age. J Pathol 2004; 204:75-83. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Cesar AC, Borim AA, Caetano A, Cury PM, Silva AE. Aneuploidies, deletion, and overexpression of TP53 gene in intestinal metaplasia of patients without gastric cancer. Cancer Genet Cytogenet 2004; 153:127-32. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Chompret A, Abel A, Stoppa-Lyonnet D, et al. Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 2001; 38:43-7. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999; 24:73-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Chun YS, Lindor NM, Smyrk TC, et al. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer 2001; 92:181-7. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Chung HW, Noh SH, Lim JB. Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol 2010; 16:25663. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Concolino P, Papa V, Mozzetti S, et al. The unsolved enigma of CDH1 downregulation in hereditary diffuse gastric cancer. J Surg Res 2004; 121:50-5. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48:3554-60. Corso G, Pedrazzani C, Marrelli D, Pinto E, Roviello F. Familial gastric cancer and Li-Fraumeni syndrome. Eur J Cancer Care (Engl ) 2010; 19:377-81. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Costa ML, de Cassia Braga RK, Machado MA, Costa AC, Montagnini AL. Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic, and therapeutic factors.Ann Surg Oncol 2006; 13:843-50. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Cunningham JM, Kim CY, Christensen ER, et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 2001; 69:780-90. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"da Silva FC, de Oliveira LP, Santos EM, et al. Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry.Fam Cancer 2010; 9:563-70. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Debniak T, Kurzawski G, Gorski B, Kladny J, Domagala W, Lubinski J. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer 2000; 36:49-54. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Deutsch F, Zilberstein B, Yagi OK, Crescentini F, Deutsch CR e Gama-Rodrigues JJ. Gastric carcinoma in a 13-year-old girl. Gastric Cancer 2004; 7:178-82. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Dieumegard B, Grandjouan S, Sabourin JC, et al. Extensive molecular screening for hereditary non-polyposis colorectal cancer. Br J Cancer 2000; 82:871-80. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Diez M, Medrano MJ, Gutierrez A, et al. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy. Anticancer Res 2000; 20:3929-33. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Dupont JB, Jr., Lee JR, Burton GR, Cohn I, Jr. Adenocarcinoma of the stomach: review of 1,497 cases. Cancer 1978; 41:941-7. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ebert MP, Yu J, Hoffmann J, et al. Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol 2003; 21:1708-14. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Eguchi T, Takahashi Y, Yamagata M, Kasahara M, Fujii M. Gastric cancer in young patients. J Am Coll Surg 1999; 188:22; 2-26 ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ekstrom AM, Serafini M, Nyren O, Hansson LE, Ye W, Wolk A. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden. Int J Cancer 2000; 87:13340. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A. TP53 and gastric carcinoma: a review. Hum Mutat 2003; 21:258-70. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Fitzgerald RC, Caldas C. E-cadherin mutations and hereditary gastric cancer: prevention by resection? Dig Dis 2002; 20:23-31. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Frebourg T, Barbier N, Yan YX, et al. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 1995; 56:608-15. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333:32-41. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Fujimoto S, Takahashi M, Ohkubo H, et al. Comparative clinicopathologic features of early gastric cancer in young and older patients. Surgery 1994; 115:516-20. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Gabbert HE, Muller W, Schneiders A, Meier S e Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma.Cancer 1995; 76:720-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Gabbert HE, Mueller W, Schneiders A, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 1996; 69:184-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Garber JE, Burke EM, Lavally BL, et al. Choroid plexus tumors in the breast cancersarcoma syndrome. Cancer 1990; 66:2658-60. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Garritano S, Gemignani F, Palmero EI, et al. Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect. Hum Mutat 2010; 31:143-50. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Gammill HS, Nelson JL. Naturally acquired microchimerism.Int J Dev Biol 2010; 54:531-43. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Gayther SA, Gorringe KL, Ramus SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998; 58:40869. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998; 12:2973-83. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Goecke T, Schulmann K, Engel C, et al. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium.J Clin Oncol 2006; 24:4285-92. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Goldthorn JF, Canizaro PC. Gastrointestinal malignancies in infancy, childhood, and adolescence. Surg Clin North Am 1986; 66:845-61. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Gomyo Y, Osaki M, Kaibara N, Ito H. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCRSSCP. Int J Cancer 1996; 66:594-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392:402-5. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Guilford PJ, Hopkins JB, Grady WM, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999; 14:249-55. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Gylling A, Abdel-Rahman WM, et al. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.Gut 2007; 56:926-33. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Hainaut P. The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr Opin Oncol 1995; 7:76-82. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Hainaut PWK. 25 Years of TP53 Research. Dordrecht-Netherlands: Springer; 2004. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005; 352:1851-60. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Hartley AL, Birch JM, Kelsey AM, Marsden HB, Harris M, Teare MD. Are germ cell tumors part of the Li-Fraumeni cancer family syndrome?. Cancer Genet Cytogenet 1989; 42:221-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Hartley AL, Birch JM, Tricker K, et al. Wilms' tumor in the Li-Fraumeni cancer family syndrome. Cancer Genet Cytogenet 1993; 67:133-5. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Haruma K, Komoto K, Kamada T, et al. Helicobacter pylori infection is a major risk factor for gastric carcinoma in young patients. Scand J Gastroenterol 2000; 35:2559. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Hirahashi M, Yao T, Matsumoto T, et al. Intramucosal gastric adenocarcinoma of poorly differentiated type in the young is characterized by Helicobacter pylori infection and antral lymphoid hyperplasia.Mod Pathol 2007; 20:29-34. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Horio Y, Suzuki H, Ueda R, et al. Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. Oncogene 1994; 9:1231-5. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Hosaka N, Ichikawa Y, Ishikawa T, et al. Correlation of immunohistochemical p53 labeling index with inhibition rate in chemosensitivity test in gastric and colon cancer. Anticancer Res 2001; 21:229-35. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Humar B, Graziano F, Cascinu S, et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002; 21:8192-95. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001; 344:1904-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ichiyoshi Y, Oiwa H, Tomisaki S, et al. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer. Hepatogastroenterology 1997; 44:546-53. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ioachim E, Goussia A, Stefanou D, Agnantis NJ. Expression of p53 protein in gastric cancer: an immunohistochemical study with correlation to proliferative activity. Anticancer Res 1997; 17:513-7. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ishigami S, Natsugoe S, Hokita S, et al. Strategy of gastric cancer in patients 85 years old and older. Hepatogastroenterology 1999; 46:2091-5. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Iwamatsu H, Nishikura K, Watanabe H, et al. Heterogeneity of p53 mutational status in the superficial spreading type of early gastric carcinoma. Gastric Cancer 2001; 4:20-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 1997; 112:46-54. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Joo YE, Rew JS, Choi SK, Bom HS, Park CS, Kim SJ. Expression of e-cadherin and catenins in early gastric cancer. J Clin Gastroenterol 2002; 35:35-42. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Joypaul BV, Hopwood D, Newman EL, et al. The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. Br J Cancer 1994; 69:943-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Kakeji Y, Korenaga D, Tsujitani S, et al. Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer 1993; 67:589-93. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Kanemitsu K, Kawasaki K, Nakamura M, et al. MSI is frequently recognized among gastric cancer patients with a family history of cancer. Hepatogastroenterology 2007; 54:2410-4. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Katai H, Sasako M, Sano T, Fukagawa T. Gastric cancer surgery in the elderly without operative mortality. Surg Oncol 2004; 13:235-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Katai H, Sasako M, Sano T, Maruyama K. Gastric carcinoma in young adults. Jpn J Clin Oncol 1996; 26:139-43. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Kath R, Fiehler J, Schneider CP, Hoffken K. Gastric cancer in very young adults: apropos four patients and a review of the literature. J Cancer Res Clin Oncol 2000; 126:233-7. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Kawasaki K, Kanemitsu K, Yasuda T, Kamigaki T, Kuroda D, Kuroda Y. Family history of cancer in Japanese gastric cancer patients. Gastric Cancer 2007; 10:1735. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Keller G, Grimm V, Vogelsang H, et al. Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer. Int J Cancer 1996; 68:571-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Keller G, Vogelsang H, Becker I, et al. Germline mutations of the Ecadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet 2004; 41:89. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ, Kim SK. Clinicopathologic characteristics of gastric carcinoma in elderly patients: a comparison with young patients. World J Gastroenterol 2005; 11:22-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Kim DY, Ryu SY, Kim YJ, Kim SK. Clinicopathological characteristics of gastric carcinoma in young patients. Langenbecks Arch Surg 2003; 388:245-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Kim IJ, Kang HC, Shin Y, et al. A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome. J Hum Genet 2004; 49:591-5. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Kim KM, Lee A, Chae HS, Shim SI. Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters. J Korean Med Sci 1995; 10:406-13. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Koea JB, Karpeh MS, Brennan MF. Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patients. Ann Surg Oncol 2000; 7:346, 45-51. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Kokkola A, Sipponen P. Gastric carcinoma in young adults. Hepatogastroenterology 2001; 48:1552-5. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Koshida Y, Koizumi W, Sasabe M, Katoh Y, Okayasu I. Association of Helicobacter pylori-dependent gastritis with gastric carcinomas in young Japanese patients: histopathological comparison of diffuse and intestinal type cancer cases. Histopathology 2000; 37:124-30. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Kremer M, Quintanilla-Martinez L, Fuchs M, et al. Influence of tumor-associated Ecadherin mutations on tumorigenicity and metastasis. Carcinogenesis 2003; 24:1879-86. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Kusano M, Kakiuchi H, Mihara M, et al. Absence of microsatellite instability and germline mutations of E-cadherin, APC and p53 genes in Japanese familial gastric cancer. Tumour Biol 2001; 22:262-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Lane DP. Cancer. p53, guardian of the genome. Nature 1992; 358: ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:46-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Latronico AC, Pinto EM, Domenice S, et al. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab 2001; 86:4970-3. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Lee HS, Lee HK, Kim HS, Yang HK, Kim WH. Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 2003; 200:39-46. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Lee WJ, Shun CT, Hong RL, Wu MS, Chang KJ, Chen KM. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer. Br J Surg 1998; 85:1138-42. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Lehtola J. Family study of gastric carcinoma; With special reference to histological types. Scand J Gastroenterol Suppl 1978; 50-4. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351:453-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Lewis FR, Mellinger JD, Hayashi A, et al. Prophylactic total gastrectomy for familial gastric cancer. Surgery 2001; 130:612-7. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Li FP, Fraumeni JF, Jr. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 1969; 43:1365-73. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Li FP, Fraumeni JF, Jr., Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988; 48:5358-62. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Lim BH, Soong R, Grieu F, Robbins PD, House AK, Iacopetta BJ. p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma. Int J Cancer 1996; 69:200-4. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Lim S, Lee HS, Kim HS, Kim YI, Kim WH. Alteration of E-cadherin-mediated adhesion protein is common, but microsatellite instability is uncommon in young age gastric cancers. Histopathology 2003; 42:128-36. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Liu XP, Tsushimi K, Tsushimi M, et al. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis. Cancer Lett 2001; 170:183-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ljungman M. Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. Neoplasia 2000; 2:208-25. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Llanos O, Butte JM, Crovari F, Duarte I, Guzman S. Survival of young patients after gastrectomy for gastric cancer. World J Surg 2006; 30:17-20. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Lo NC, Monteverde M, Riba M, et al. Expression profiling and long lasting responses to chemotherapy in metastatic gastric cancer. Int J Oncol 2010; 37:121928. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Maconi G, Kurihara H, Panizzo V, et al. Gastric cancer in young patients with no alarm symptoms: focus on delay in diagnosis, stage of neoplasm and survival.Scand J Gastroenterol 2003; 38:1249-55. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Maehara Y, Emi Y, Tomisaki S, et al. Age-related characteristics of gastric carcinoma in young and elderly patients. Cancer 1996; 77:1774-80. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Malkin D. p53 and the Li-Fraumeni syndrome. Biochim Biophys Acta 1994; 1198:197-213. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250:1233-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Marcus VA, Madlensky L, Gryfe R, et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999; 23:1248-55. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F. p53 expression and prognosis in gastric carcinoma. Int J Cancer 1992; 50:859-62. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 1999; 18:7621-36. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"MC Neer G. Cancer of the stomach in the young. Am J Roentgenol 1941; 45:53750. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"McCulloch P, Taggart T, Ochiai A, O'Dowd G, Nash J, Sasako M. c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. Eur J Surg Oncol 1997; 23:304-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"McGill TW, Downey EC, Westbrook J, Wade D, de la Garza J. Gastric carcinoma in children. J Pediatr Surg 1993; 28:1620-1. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Medina-Franco H, Heslin MJ, Cortes-Gonzalez R. Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol 2000; 7:515-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet 2009; 126:615-28. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Milne AN, Carvalho R, Morsink FM, et al. Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod Pathol 2006; 19:564-72. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ministério da Saúde.Instituo Nacional de Câncer. Estimativas 2010: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2010. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Mitsudomi T, Matsusaka T, Wakasugi K, et al. A clinicopathological study of gastric cancer with special reference to age of the patients: an analysis of 1,630 cases. World J Surg 1989; 13:225-30. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Monig SP, Eidt S, Zirbes TK, Stippel D, Baldus SE, Pichlmaier H. p53 expression in gastric cancer: clinicopathological correlation and prognostic significance. Dig Dis Sci 1997; 42:2463-7. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Nakamura T, Yao T, Niho Y, Tsuneyoshi M. A clinicopathological study in young patients with gastric carcinoma. J Surg Oncol 1999; 71:214-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Nakata B, Chung KH, Ogawa M, et al. p53 protein overexpression as a predictor of the response to chemotherapy in gastric cancer. Surg Today 1998; 28:595-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Nelson JL. Microchimerism in human health and disease. Autoimmunity 2003; 36:5-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325:1132-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Norton JA, Ham CM, Van Dam J, Jeffrey RB, Longacre TA, Huntsman DG et al. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 2007; 245:873-79. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Nottingham J. Signet-ring carcinoma of stomach in a child. Histopathology 1994; 24:490-1. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"O'Farrell TJ, Ghosh P, Dobashi N, Sasaki CY, Longo DL. Comparison of the effect of mutant and wild-type p53 on global gene expression. Cancer Res 2004; 64:8199207. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305:253-64. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Oiwa H, Maehara Y, Ohno S, Sakaguchi Y, Ichiyoshi Y, Sugimachi K. Growth pattern and p53 overexpression in patients with early gastric cancer. Cancer 1995; 75:1454-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Oliveira C, Ferreira P, Nabais S, et al. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer 2004; 40:1897-903. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Oliveira C, Seruca R, Caldas C. Genetic screening for hereditary diffuse gastric cancer. Expert Rev Mol Diagn 2003; 3:201-15. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 2006; 14:21-33. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Oliveira C, Seruca R, Seixas M, Sobrinho-Simoes M. The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different ""target genes"": a study of the TGFbeta RII, IGFII R, and BAX genes. Am J Pathol 1998; 153:1211-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Olivier M, Goldgar DE, Sodha N, et al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003; 63:6643-50. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ottini L, Palli D, Falchetti M, et al. Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany.Cancer Res 1997; 57:4523-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Palli D, Galli M, Caporaso NE, et al. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev 1994; 3:15-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Palmero EI, Schuler-Faccini L, et al. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. Cancer Lett 2008; 261:21-5. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Panani AD. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett 2008; 266:99-115. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Paraf F, Gilquin M, Longy M, et al. MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology 2001; 39:250-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Park JG, Yang HK, Kim WH, Caldas C, Yokota J, Guilford PJ. Report on the first meeting of the International Collaborative Group on Hereditary Gastric Cancer. J Natl Cancer Inst 2000; 92:1781-2. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Park YJ, Shin KH, Park JG. Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea.Clin Cancer Res 2000; 6:2994-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991; 83:640-43. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Pedrazzani C, Corso G, Marrelli D, Roviello F. E-cadherin and hereditary diffuse gastric cancer. Surgery 2007; 142:645-57. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Peek RM, Jr., Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2:28-37. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Petitjean A, Mathe E, Kato S, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007; 28:622-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Pharoah PD, Guilford P, Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001; 121:1348-53. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Pinto EM, Billerbeck AE, Villares MC, Domenice S, Mendonca BB, Latronico AC. Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors. Arq Bras Endocrinol Metabol 2004; 48:647-50. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Pinto M, Wu Y, Mensink RG, Cirnes L, Seruca R, Hofstra RM. Somatic mutations in mismatch repair genes in sporadic gastric carcinomas are not a cause but a consequence of the mutator phenotype. Cancer Genet Cytogenet 2008; 180:110-4. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Pinto-de-Sousa J, Silva F, David L, et al. Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma. Histopathology 2004; 44:323-31. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14:1837-51. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Poremba C, Yandell DW, Huang Q, et al. Frequency and spectrum of p53 mutations in gastric cancer--a molecular genetic and immunohistochemical study. Virchows Arch 1995; 426:447-55. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ramacciato G, Aurello P, D'Angelo F, Cicchini C, Sternberg CN. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?. Hepatogastroenterology 2000; 47:1470-4. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ramesh S, Nash J, McCulloch PG. Reduction in membranous expression of betacatenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Br J Cancer 1999; 81:1392-7. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ramesh S, Nash J, McCulloch PG. Reduction in membranous expression of betacatenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Br J Cancer 1999; 81:1392-7. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ranzani GN, Luinetti O, Padovan LS, et al. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol Biomarkers Prev 1995; 4:223-31. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Renault B, Calistri D, Buonsanti G, Nanni O, Amadori D, Ranzani GN. Microsatellite instability and mutations of p53 and TGF-beta RII genes in gastric cancer.Hum Genet 1996; 98:601-7. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A 2001; 98:9330-5. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Rigau V, Sebbagh N, Olschwang S, et al. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining. Arch Pathol Lab Med 2003; 127:694-700. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Roviello F, Corso G, Pedrazzani C, et al. High incidence of familial gastric cancer in Tuscany, a region in Italy. Oncology 2007; 72:243-47. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Roviello F, Marrelli D, Morgagni P, et al. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 2002; 9:894-900. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Roviello F, Marrelli D, Vindigni C, De SA, Spina D, Pinto E. P53 accumulation is a prognostic factor in intestinal-type gastric carcinoma but not in the diffuse type. Ann Surg Oncol 1999; 6:739-45. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Rugge M, Bovo D, Busatto G, et al. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy. Cancer Epidemiol Biomarkers Prev 1997; 6:171-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Rugge M, Shiao YH, Busatto G, et al. The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location. Mol Pathol 2000; 53:207-10. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Saito A, Kanai Y, Maesawa C, Ochiai A, Torii A, Hirohashi S. Disruption of Ecadherin-mediated cell adhesion systems in gastric cancers in young patients. Jpn J Cancer Res 1999; 90:993-99. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Sanchez-Bueno F, Garcia-Marcilla JA, Perez-Flores D, et al. Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. Br J Surg 1998; 85:255-60. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Santoro R, Carboni F, Lepiane P, Ettorre GM, Santoro E. Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg 2007; 94:737-42. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Sasaki H, Sasano H, Ohi R, et al. Adenocarcinoma at the esophageal gastric junction arising in an 11-year-old girl. Pathol Int 1999; 49:1109-13. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Sasako M. Principles of surgical treatment for curable gastric cancer. J Clin Oncol 2003; 21:274s-5s. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Sasako M, Katai H, Sano T, Maruyama K. Management of complications after gastrectomy with extended lymphadenectomy. Surg Oncol 2000; 9:31-4. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Shaulsky G, Goldfinger N, Tosky MS, Levine AJ, Rotter V. Nuclear localization is essential for the activity of p53 protein. Oncogene 1991; 6:2055-65. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Shun CT, Wu MS, Lin JT, et al. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer. Hepatogastroenterology 1997; 44:604-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 1993; 80:1015-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Siewert JR, Kestlmeier R, Busch R, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996; 83:1144-7. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Silva EM. Morfogênese dos adenocarcinomas gástricos e expressão de Ecaderina, â-catenina, clatrina e mucinas. Sao Paulo; 2005. [Dissertacão de Mestrado-Fundacao Antonio Prudente]. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Silva EM, Begnami MD, Fregnani JH, et al. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma. Gastric Cancer 2008; 11:149-59. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Smith BR, Stabile BE. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young.Arch Surg 2009; 144:506-10. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Sobin LH, Witekind CH. TNM classificação dos tumores malignos. 6 ed.Trad. de INCA.Rio de Janeiro: INCA; 2002. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Solcia E, Fiocca R, Luinetti O, et al. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996; 20 Suppl 1:S8-22. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990; 348:747-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Stephens MR, Lewis WG, White S, et al. Prognostic significance of alarm symptoms in patients with gastric câncer.Br J Surg 2005; 92:840-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Stone J, Bevan S, Cunningham D, et al. Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer. Br J Cancer 1999; 79:1935-37. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Sugano K, Taniguchi T, Saeki M, Tsunematsu Y, Tomaru U, Shimoda T. Germline p53 mutation in a case of Li-Fraumeni syndrome presenting gastric cancer. Jpn J Clin Oncol 1999; 29:513-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Suraweera N, Iacopetta B, Duval A, Compoint A, Tubacher E, Hamelin R. Conservation of mononucleotide repeats within 3' and 5' untranslated regions and their instability in MSI-H colorectal cancer. Oncogene 2001; 20:7442-77. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Suriano G, Oliveira C, Ferreira P, et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet 2003; 12:575-82. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Suriano G, Yew S, Ferreira P, et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 2005; 11:5401-9. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251:1451-5. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Takeno S, Noguchi T, Kikuchi R, Sato T, Uchida Y, Yokoyama S. Analysis of the survival period in resectable stage IV gastric cancer. Ann Surg Oncol 2001; 8:21521. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Tanaka M, Kitajima Y, Edakuni G, Sato S, Miyazaki K. Abnormal expression of Ecadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Br J Surg 2002; 89:236-44. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Theuer CP, de Virgilio C, Keese G, et al. Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg 1996; 172:473-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Tso PL, Bringaze WL, III, Dauterive AH, Correa P, Cohn I, Jr. Gastric carcinoma in the young. Cancer 1987; 59:1362-5. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 1993; 54:759-64. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96:261-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Varley JM. Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 2003; 21:313-20. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Varley JM, McGown G, Thorncroft M, et al. Germ-line mutations of TP53 in LiFraumeni families: an extended study of 39 families. Cancer Res 1997; 57:3245-52. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Victorzon M, Nordling S, Haglund C, Lundin J, Roberts PJ. Expression of p53 protein as a prognostic factor in patients with gastric cancer. Eur J Cancer 1996; 32A:215-20. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol 2007; 211:287-95. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Werner M, Becker KF, Keller G, Hofler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol 2001; 127:207-16. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Windham TC, Termuhlen PM, Ajani JA, Mansfield PF. Adenocarcinoma of the stomach in patients age 35 years and younger: no impact of early diagnosis on survival outcome.J Surg Oncol 2002; 81:118-24. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"World Health Organization. World Cancer Report 2008. Lyon: International Agency for Research on Cancer; 2009. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Yamada H, Shinmura K, Okudela K, et al. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population. Carcinogenesis 2007; 28:2013-8. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Yan Z, Lambert NC, Guthrie KA, et al. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 2005; 118:899-906. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Yokota T, Takahashi N, Teshima S, et al. Early gastric cancer in the young: clinicopathological study. Aust N Z J Surg 1999; 69:443-6. ";
FAP;2010;EDAISE MARIA DA SILVA ; Fernando Augusto Soares;-x-;"Yonemura Y, Fushida S, Tsugawa K, et al. Correlation of p53 expression and proliferative activity in gastric cancer. Anal Cell Pathol 1993; 5:277-88.";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Adamson PC, Reaman G, Finklestein JZ, et al. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer. J Clin Oncol 1997; 15:3330-7. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Adamson PC, Matthay KK, O'Brien M, Reaman GH, Sato JK, Balis FM. A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study. Pediatr Blood Cancer 2007; 49:661-5. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Bailis JM, Forsburg SL. MCM proteins: DNA damage, mutagenesis and repair. Curr Opin Genet Dev 2004; 14:17-21. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Balis FM, Holcenberg JS, Blaney SM. General principles of chemotherapy. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 4th. Philadelphia: Lippincott Williams & Wilkins; 2002. p.237-86. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Bardeesy N, Beckwith JB, Pelletier J. Clonal expansion and attenuated apoptosis in Wilms’ Tumors are associated with p53 gene mutations. Cancer Res 1995; 55:2159. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer 1978; 41:1937-48. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Beckwith JB, Kiviat NB, Bonadio JF. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 1990; 10:1-36. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Beckwith JB. Precursor lesions of Wilms Tumor: clinical and biological implications. Med Pediatr Oncol 1993; 21:158-68. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Beckwith JB, Zuppan CE, Browning NG, Mokness J, Breslow NE. Hitological analysis of aggressiveness and responsiveness in Wilms’ Tumor. Med Pediatr Oncol 1996; 27:422-8. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Beckwith JB. Revised SIOP working classification of renal tumors of childhood. Med Pediatr Oncol 2002; 38:77-8. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Birch JM, Breslow N. Epidemiologic features of Wilms tumor. Hematol Oncol Clin North Am 1995; 9:1157-78. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Boccon-Gibod L, Rey A, Sandstedt B, et al. Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9. Med Pediatr Oncol 2000; 34:183-90. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Bollig F, Perner B, Besenbeck B, et al. A highly conserved retinoic acid responsive element controls wt1a expression in the zebrafish pronephros. Development 2009; 136:2883-92. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Bonadio JF, Storer B, Norkool P, Farewell VT, Beckwith JB, D'Angio GJ. Anaplastic Wilms' tumor: clinical and pathologic studies. J Clin Oncol 1985; 3:51320. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Bown N, Cotterill SJ, Roberts P, et al. Cytogenetic Abnormalities and clinical outcome in Wilms Tumor: a study by the U.K.Cancer Cytogenetics Group and the U.K. Children’s Cancer Study Group. Med Pediatr Oncol 2002; 38:11-21. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Brentani H, Caballero OL, Camargo AA, et al. The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci USA 2003; 100:13418-23. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Brentani RR, Carraro DM, Verjovski-Almeida S, et al. Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol 2005; 54:95105. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Budhu AS, Noy N. Direct channeling of retinoic acid between cellular retinoic acid- binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol Cell Biol 2002; 22:2632-41. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Camargo AA, Samaia HP, Dias-Neto E, et al. The contribution of 700,000 ORF sequence tags to the definition of the human transcriptome. Proc Natl Acad Sci USA 2001; 98:12103-8. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Corbin M, de Reyniès A, Rickman DS, et al. WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries? Genes Chromosomes Cancer 2009; 48:816-27. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Cotton CA, Peterson S, Norkool PA, et al. Early and late mortality after diagnosis of Wilms tumor. J Clin Oncol 2009; 27:1304-9. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Cox WG, Singer VL. Fluorescent DNA hybridization probe preparation using amine modification and reactive dye coupling. Biotechniques 2004; 36:114-22. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"D'Angio GJ, Evans AE, Breslow N, et al. The treatment of Wilms' tumor: Results of the national Wilms' tumor study. Cancer 1976; 38:633-46. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"D'Angio GJ. Pre-or post-operative treatment for Wilms tumor? Who, what, when, where, how, why--and which. Med Pediatr Oncol 2003; 41:545-9. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Dao D, Walsh CP, Yuan L, et al. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting. Hum Mol Genet 1999; 8:1337-52. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"de Camargo B, de Oliveira Santos M, Rebelo MS, et al. Cancer incidence among children and adolescents in Brazil: first report of 14 population-based cancer registries. Int J Cancer 2010; 126:715-20. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"de Kraker J, Graf N, van Tinteren H, et al. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomized controlled trial. Lancet 2004; 364:1229-35. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"de Luca LM. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 1991; 5:2924-33. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"de Souza SJ, Camargo AA, Briones MR, et al. Identification of human chromosome 22 transcribed sequences with ORF expressed sequence tags. Proc Natl Acad Sci USA 2000; 97:12690-3. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Delemarre JF, Sandstedt B, Harms D, Boccon-Gibod L, Vujanic GM. The new SIOP (Stockholm) working classification of renal tumours of childhood. International Society of Paediatric Oncology [letter]. Med Pediatr Oncol 1996; 26:145-6. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Dias CD, Araújo BC, Dutra ES, Nepomuceno JC. Protective effects of beta-carotene against the genotoxicity of doxorubicin in somatic cells of Drosophila melanogaster. Genet Mol Res 2009; 8:1367-75. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Dias Neto E, Correa RG, Verjovski-Almeida S, et al. Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. Proc Natl Acad Sci U S A 2000; 97:3491-6. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Diller L, Ghahremani M, Morgan J, et al. Constitutional WT1 mutations in Wilms' tumor patients. J Clin Oncol 1998; 16:3634-40. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Dome JS, Coppes MJ. Recent advances in Wilms tumor genetics. Curr Opin Pediatr 2002; 14:5-11. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Ducore JM, Parikh-Patel A, Gold EB. Cancer occurrence in Southeast Asian children in California. J Pediatr Hematol Oncol 2004; 26:613-8. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Dudderidge TJ, Stoeber K, Loddo M, et al. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res 2005; 11:2510-7. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Efferth T, Verdorfer I, Miyachi H, et al. Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines. Blood Cells Mol Dis 2002; 29:1-13. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Farber S. Chemotherapy in the treatment of leukemia and Wilms’ tumor. JAMA 1966; 198:826-36. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Farber S, D’Angio, Evans A, Mitus A. Clinical studies of actinomycin D with special reference to Wilms’ tumor in children. 1960. J Urol 2002; 168:2560-2. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Faria P, Beckwith JB, Mishra K, et al. Focal versus diffuse anaplasia in Wilms Tumor – new definitions with prognostic significance: a report from the National Wilms Tumor Study Group. Am J Surg Pathol 1996; 20:909-20. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Fukuzawa R, Breslow NE, Morison IM, et al. Epigenetic differences between Wilms' tumours in white and east-Asian children. Lancet 2004; 363:446-51. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Fukuzawa R, Reeve AE. Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors. J Pediatr Hematol Oncol 2007; 29:589-94. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Fukuzawa R, Anaka MR, Heathcott RW, McNoe LA, Morison IM, Perlman EJ, Reeve AE. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes. J Pathol 2008; 215:377-87. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Fukuzawa R, Anaka MR, Weeks RJ, Morison IM, Reeve AE. Canonical WNT signalling determines lineage specificity in Wilms tumour. Oncogene 2009; 28:1063-75. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Gakiopoulou H, Korkolopoulou P, Levidou G, et al. Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications. Br J Cancer 2007; 97:1124-34. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Giaginis C, Georgiadou M, Dimakopoulou K, et al. Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity. Dig Dis Sci 2009; 54:282-91. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Godzinski J, Moorman-Voestermans CGM, Sawicz-Birkowska K, et al. Paediatric surgical oncology. 5-Nephroblastoma. International Society of Paediatric Oncology (SIOP) Neprhoblastoma Trial and Study Commitee. Eur J Surg Oncol 1995; 21:414-8. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Gomes LI, Silva RL, Stolf BS, et al. Comparative analysis of amplified and nonamplified RNA for hybridization in cDNA microarray. Anal Biochem 2003; 321:244-51. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Green DM, D'Angio GJ, Beckwith JB, et al. Wilms tumor. CA Cancer J Clin 1996; 46:46-63. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Grundy PE, Green DM, Coppes MJ, et al. Renal tumors. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 4th. Philadelphia: Lippincott Williams & Wilkins; 2002. p.865-93. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Hennigar RA, O’Shea PA, Grattan-Smith JD. Clinicopathologic Features of Nephrogenic Rests and Nephroblastomatosis. Adv Anat Pathol 2001; 8:276-89. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Höglund M, Gisselsson D, Hansen GB, Mitelman F. Wilms tumors develop through two distinct karyotypic pathways. Cancer Genet Cytogenet 2004; 150:9-15. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Hong S, Lee MY, Cheong J. Functional interaction of transcriptional coactivator ASC-2 and C/EBPalpha in granulocyte differentiation of HL-60 promyelocytic cell. Biochem Biophys Res Commun 2001; 282:1257-62. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Huang CC, Gadd S, Breslow N, et al. Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group. Clin Cancer Res 2009; 15:1770-8. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Hung IJ, Chang WH, Yang CP, et al. Epidemiology, clinical features and treatment outcome of Wilms' tumor in Taiwan: a report from Taiwan Pediatric Oncology Group. J Formos Med Assoc 2004; 103:104-11. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Hung IJ, Chang WH, Yang CP, et al. Epidemiology, clinical features and treatment outcome of Wilms' tumor in Taiwan: a report from Taiwan Pediatric Oncology Group. J Formos Med Assoc 2004; 103:104-11. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Kiefer C, Hessel S, Lampert JM, et al. Identification and characterization of a mammalian enzyme catalyzing the asymmetric oxidative cleavage of provitamin A. J Biol Chem 2001; 276:14110-6. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Kim MK, McGarry TJ, O Broin P, Flatow JM, Golden AA, Licht JD. An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1. Proc Natl Acad Sci USA 2009; 106:11154-9. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Klamt B, Schulze M, Thate C, et al. Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters. Genes Chromosomes Cancer 1998; 22:287-94. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68:820-3. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Ko EY, Ritchey ML. Current management of Wilms' tumor in children. J Pediatr Urol 2009; 5:56-65. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Kong HJ, Yu HJ, Hong S, et al. Interaction and functional cooperation of the canceramplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation. Mol Cancer Res 2003; 1:948-58. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Kudoh T, Ishidate T, Nakamura T, Toyoshima K, Akiyama T. Constitutive expression of the Wilms tumor suppressor gene WT1 in F9 embryonal carcinoma cells induces apoptotic cell death in response to retinoic acid. Oncogene 1996; 13:1431-9. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Lai PS, Tay JSH. Wilms’ Tumor. In: Kurzrock R, Talpaz M., editors. Molecular biology in cancer medicine. 2nd ed. London: Martin Dunutz; 1999. p.531-47. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Lee SK, Anzick SL, Choi JE, et al. A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J Biol Chem 1999; 274:34283-93. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Lee SK, Na SY, Jung SY, et al. Activating protein-1, nuclear factor-kappaB, and serum response factor as novel target molecules of the cancer-amplified transcription coactivator ASC-2. Mol Endocrinol 2000; 14:915-25. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Lee SY, Kim JW, Jeong MH, et al. Microtubule associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells. FEBS Lett 2008; 582:2826-32. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Lehmann S, Paul C, Torma H. The expression of cellular retinoid binding proteins in non-APL leukemic cells and its association with retinoid sensitivity. Leuk Lymphoma 2002; 43:851-8. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Li CM, Guo M, Borczuk A, et al. Gene expression in Wilms’ Tumor mimics the earliest committed stage in the metanephric mesenchymal epithelial transition. Am J Pathol 2002; 160:2181-90. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Li K, Gao J, Xiao X, Chen L, Zhang L. The enhancing role of vitamin A deficiency on chemically induced nephroblastoma in rats. J Pediatr Surg 2005; 40:1951-6. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Li W, Kessler P, Yeger H, et al. A gene expression signature for relapse of primary wilms tumors. Cancer Res 2005; 65:2592-601. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Li K, Zeng S, Gao J, Chen L, Wang Y. The effect of vitamin A deficiency in maternal rats on tumor formation in filial rats. J Pediatr Surg 2009; 44:565-70. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Li W, Xia JT, Feng Y. Microtubule stability and MAP1B upregulation control neuritogenesis in CAD cells. Acta Pharmacol Sin 2006; 27:1119-26. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25:402-8. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000; 405:827-36. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Macmahon HE, Bedizel M, Ellis CA. Vincristine (leurocristine) sulfate in the treatment of children with metastatic wilms' tumor. Pediatric Division, Southwest Cancer Chemotherapy Group.Pediatrics 1963; 32:880-7. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Mahajan MA, Samuels HH. Nuclear hormone receptor coregulator: role in hormone action, metabolism, growth, and development. Endocr Rev 2005; 26:583-97. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Major MB, Camp ND, Berndt JD, et al. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 2007; 316:1043-6. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Manor D, Shmidt EN, Budhu A, et al. Mammary carcinoma suppression by cellular retinoic acid binding protein-II. Cancer Res 2003; 63:4426-33. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Maschietto M, de Camargo B, Brentani H, et al. Molecular profiling of isolated histological components of wilms tumor implicates a common role for the Wnt signaling pathway in kidney and tumor development. Oncology 2008; 75:81-91. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Matsubara T, Eimoto T, Okabe M, et al. Proliferation and apoptosis of tumour cells before and after neoadjuvant therapy for high-grade extremity sarcomas: divergent associations with tumour response and prognosis. Histopathology 2008; 52:706-16. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Meister B, Fink FM, Hittmair A, Marth C, Widschwendter M. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma. Anticancer Res 1998; 18:1777-86. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Meng MV, Grossfeld GD, Williams GH, et al. Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res 2001; 7:2712-8. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Mincheva A, Todorov I, Werner D, Fink TM, Lichter P. The human gene for nuclear protein BM28 (CDCL1), a new member of the early S-phase family of proteins, maps to chromosome band 3q21. Cytogenet Cell Genet 1994; 65:276-7. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Natrajan R, Little SE, Sodha N, et al. Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour. J Pathol 2007; 211:529. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Obermann EC, Went P, Zimpfer A, et al. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large Bcell lymphoma: a tissue microarray and clinico-pathological analysis. BMC Cancer 2005; 5:162. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Parkin DM, Stiller CA, Draper GJ, Bieber CA. The international incidence of childhood cancer. Int J Cancer 1988; 42:511-20. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Perlman EJ. Pediatric renal tumors: practical updates for the pathologist. Pediatr Dev Pathol 2005; 8:320-38. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Perotti D, Gamba B, Sardella M, et al. Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors. Oncogene 2008; 27:4625-32. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Pfaffl MW. A new mathematical model for relative quantification in real-time RT PCR. Nucleic Acids Res 2001; 29:e45. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Pritchard-Jones K, Hawkins MM. Biology of Wilms Tumor. Lancet 1997; 349:6634. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Pritchard-Jones K. Controversies and advances in the management of Wilms' tumour. Arch Dis Child 2002; 87:241-4. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Ramnath N, Hernandez FJ, Tan DF, et al. MCM2 is an independent predictor of survival in  patients with non-small-cell lung cancer. J Clin Oncol 2001; 19:425966. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Ravenel JD, Broman KW, Perlman EJ, et al. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J Natl Cancer Inst 2001; 93:1698-703. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Reena RM, Mastura M, Siti-Aishah MA, et al. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma. Ann Diagn Pathol 2008; 12:340-3. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Riggs CE Jr. Antitumor antibiotics and related compounds. In: Perry MC, editor. The chemotherapy source book. 2nd ed. Baltimore: Williams & Wilkins; 1996. p.345-85. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Rivera MN, Kim WJ, Wells J, et al. An X chromosome  gene, WTX, is commonly inactivated in Wilms tumor. Science 2007; 315:642-5. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Rodins K, Cheale M, Coleman N, Fox SB. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Clin Cancer Res 2002; 8:1075-81. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Rowinsky EK, Donehower RC. Microtubule-targeting drugs. In: Perry MC, editor. The chemotherapy source book. 2nd ed. Baltimore: Williams & Wilkins; 1996. p.387-423. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Ruteshouser EC, Robinson SM, Huff V. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. Genes Chromosomes Cancer 2008; 47:461-70. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Satoh Y, Nakadate H, Nakagawachi T, et al. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours. Br J Cancer 2006; 95:541-7. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Scharnhorst V, Kranenburg O, van der Eb AJ, Jochemsen AG. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells. Cell Growth Differ 1997; 8:133-43. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Schena M, Heller RA, Theriault TP, Konrad K, Lachenmeier E, Davis RW. Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol 1998; 16:301-6. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Schluth C, Mattei MG, Mignon-Ravix C, et al. Intrachromosomal triplication for the distal part of chromosome 15q. Am J Med Genet A 2005; 136:179-84. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Schumacher V, Schuhen S, Sonner S, et al. Two molecular subgroups of Wilms' tumors with or without WT1 mutations. Clin Cancer Res 2003; 9:2005-14. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Sheng WW, Soukup S, Bove K, Gotwals B, Lampkin B. Chromosome analysis of 31 Wilms' tumors. Cancer Res 1990; 50:2786-93. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Stiller CA, Parkin DM. International variations in the incidence of childhood renal tumours. Br J Cancer 1990; 62:1026-30. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Stock C, Ambros IM, Lion T, et al. Genetic changes of two Wilms tumors with anaplasia and a review of the literature suggesting a marker profile for therapy resistance. Cancer Genet Cytogenet 2002; 135:128-38. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Strong LC. The two-hit model for Wilms' tumor: where are we 30 years later? Genes Chromosomes Cancer 2003; 38:294-9. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Stuart RO, Bush KT, Nigam SK. Changes in global gene expression patterns during development and maturation of the rat kidney. Proc Natl Acad Sci USA 2001; 98:5649-54. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Takahashi M, Yang XJ, Lavery TT, et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res 2002; 62:6598-605. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Takahashi M, Yang XJ, Sugimura J, et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 2003; 22:6810-8. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Tanaka Y, Kawahata K, Nakata T, Hirokawa N. Chronological expression of microtubule-associated proteins (MAPs) in EC cell P19 after neuronal induction by retinoic acid. Brain Res 1992; 596:269-78. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Todd SC, Doctor VS, Levy S. Sequences and expression of six new members of the tetraspanin/TM4SF family. Biochim Biophys Acta 1998; 399:101-4. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Tögel M, Wiche G, Propst F. Novel features of the light chain of microtubule associated protein MAP1B: microtubule stabilization, self interaction, actin filament binding, and regulation by the heavy chain. J Cell Bio 1998; 143:695-707. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Tye BK. MCM proteins in DNA replication. Annu Rev Biochem 1999; 68:649-86. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Vandesompele J, Katleen DP, Filip P, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002; 3:34.1-34.11. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Vernon EG, Malik K, Reynolds P, et al. The parathyroid hormone-responsive B1 gene is interrupted by a t(1;7)(q42;p15) breakpoint associated with Wilms' tumour. Oncogene 2003; 22:1371-80. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Vincent TS, Re GG, Hazen-Martin DJ, Tarnowski BI, Willingham MC, Garvin AJ. All-trans-retinoic acid-induced growth suppression of blastemal Wilms' tumor. Pediatr Pathol Lab Med 1996; 16:777-89. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Vujanic GM, Sandstedt B, Harms D, et al. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol 2002; 38:79-82. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM. High-fidelity mRNA amplification for gene profiling. Nat Biotechnol 2000; 18:457-9. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Wegert J, Wittmann S, Leuschner I, Geissinger E, Graf N, Gessler M. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact. Genes Chromosomes Cancer 2009; 48:1102-11. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Weirich A, Leuschner I, Harms D, et al. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. Ann Oncol 2001; 12:311-9. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Wiener JS, Coppes MJ, Ritchey ML. Current concepts in the biology and management of Wilms tumor. J Urol 1998; 159:1316-25. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Williams RD, Hing SN, Greer BT, et al. Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines. Genes Chromosomes Cancer 2004; 41:65-79. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Yang SH, Seo MY, Jeong HJ, et al. Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients. Clin Cancer Res 2005; 11:612-20. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Yuan E, Li CM, Yamashiro DJ, et al. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors. Mol Cancer Res 2005; 3:493-502. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Zirn B, Samans B, Spangenberg C, Graf N, Eilers M, Gessler M. All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo. Oncogene 2005; 24:5246-51. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Zirn B, Hartmann O, Samans B, et al. Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters. Int J Cancer 2006; 118:195462. ";
FAP;2010;FÁBIO DE SIMONE PICCOLI ;Dirce Maria Carraro ;Beatriz de Camargo ;"Zuppan CW, Beckwith JB, Luckey DW, et al. Anaplasia in unilateral Wilms' tumor: a report from the National Wilms' Tumor Study Pathology Center. Hum Pathol 1988; 19:1199-209.";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Abok K, Brunk U, Jung B, Ericsson J. Morphologic and histochemical studies on the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland. Virchows Arch B Cell Pathol Incl Mol Pathol 1984; 4:443-60. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Al-Qahtani K, Hier MP, Sultanum K, Black MJ. The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101:753-6. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Andreassen CN, Grau C, Lindegaard JC. Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy. Semin Radiat Oncol 2003; 13:62-72. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Andrews N, Griffiths C. Dental complications of head and neck radiotherapy: Part 1. Aust Dent J 2001; 46:88-94. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Anné PR, Machtay M, Rosenthal DI, et al. A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2007; 67:445-52. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Bardow A, Moe D, Nyvad B, Nauntofte B. The buffer capacity and buffer systems of human whole saliva measured without loss of CO2. Arch Oral Biol 2000; 1:1-12. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Berk LB, Shivnani AT, Small W Jr. Pathophysiology and management of radiation-induced xerostomia. J Support Oncol 2005; 3:191-200. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Bernardi R, Perin C, Becker FL, et al. Effect of pilocarpine mouthwash on salivary flow. Braz J Med Biol Res 2002; 35:105-10. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Bonan PR, Pires FR, Lopes MA, Di Hipólito O Jr. Evaluation of salivary flow in patients during head and neck radiotherapy. Pesqui Odontol Bras 2003; 17:156-60. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Braam PM, Terhaard CH, Roesink JM, Raaijmakers CP. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66:975-80. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Brizel DM, Overgaard J. Does amifostine have a role in chemoradiation treatment? Lancet Oncol 2003; 4:378-81. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Burlage FR, Roesink JM, Faber H, et al. Optimum dose range for the amelioration of long term radiation-induced hyposalivation using prophylactic pilocarpine treatment. Radiother Oncol 2008; 86:347-53. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Bussels B, Maes A, Hermans R, Nuyts S, Weltens C, Van den Bogaert W. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 2004; 72:119-27. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensitymodulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001; 4:907-16. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;Cooper JS, Fu K, Marks J, Silverman S. Late effects of Radiation Therapy in the head and Neck Region. Int J Radiat Oncol Biol Phys 1995, 5:1141-64. ;
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Coppes RP, Vissink A, Zeilstra LJ, Konings AW. Muscarinic receptor stimulation increases tolerance of rat salivary gland function to radiation damage. Int J Radiat Biol 1997a; 5:615-25. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Coppes RP, Zeilstra LJ, Vissink A, Konings AW. Sialogogue-related radioprotection of salivary gland function: the degranulation concept revisited. Radiat Res 1997b; 3:240-7. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Coppes RP, Zeilstra LJW, Kapinga HH, Konings AWT. Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists. Br J Cancer 2001; 85:1055-63. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16:297-335. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Demangeat R, Didon-Poncelet A, Cherfan J, Demangeat JL. Stimulated salivary pertechnetate clearance revisited: correlation with dynamic scintigraphic indices in Sicca syndrome. Clin Nucl Med 2001; 25:888-94. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Dirix P, Nuyts S. Evidence-based organ-sparing radiotherapy in head and neck cancer. Lancet Oncol 2010; 11:85-91. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;Edgar WM. Saliva: its secretion, composition and functions.Br Dent J 1992 8:305-12.  ;
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Eisbruch A, Rhodus N, Rosenthal D, et al. How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol 2003; 3:22634. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 3:695-704. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensitymodulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 3:577-87. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Eisbruch A, Ship JA, Martel MK, et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int J Radiat Oncol Biol Phys 1996; 2:469-80. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Epstein JB, Burchell JL, Emerton S, Le ND, Silverman S Jr. A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study. Oral Surg Oral Med Oral Pathol 1994; 6:610-4. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Epstein JB, Emerton S, Lunn R, Le N, Wong FL. Pretreatment assessment and dental management of patients with nasopharyngeal carcinoma. Oral Oncol 1999; 35:33-9. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Fang FM, Chien CY, Tsai WL, et al. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study. Int J Radiat Oncol Biol Phys 2008; 72:356-64. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Ferlito A, Robbins KT, Silver CE, Hasegawa Y, Rinaldo A. Classification of neck dissections: an evolving system. Auris Nasus Larynx 2009; 36:127-34. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Fox PC, Atkinson JC, Macynski AA, et al. Pilocarpine treatment of salivary gland hyposalivation and dry mouth (xerostomia). Arch Intern Med 1991; 6:1149-52. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Franzen L, Funegard U, Ericson T. Parotid gland function during and following radiotherapy of malignancies in the head and neck: a consecutive study of salivary flow and patient disconfort. Eur J Cancer 1992; 28:457-62. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;Gorsky M, Epstein JB, Parry J, Epstein MS, Le ND, Silverman S Jr. The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 2:190-5. ;
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Gornitsky M, Shenouda G, Sultanem K, et al. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98:45-52. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Grisius MM. Salivary Gland dysfunction: a review of systemic therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 156-62. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Haddad P, Karimi M. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Radiother Oncol 2002; 1:29-32. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Handelman SL, Baric JM, Saunders RH, Espeland MA. Hyposalivatory drug use, whole stimulated salivary flow, and mouth dryness in older, long-term care residents. Spec Care Dentist 1989; 9:12-8. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Horiot JC, Lipinski F, Schraub S, et al. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study. Radiother Oncol 2000; 55:233-9. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosthet Dent 2001; 2:162-9. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;ICRU Report 50. Prescripción, registro y elaboración de informes en la terapia com haces de fotones. Trad. de M V Pacheco. Granada: Sociedad Española de Física Médica, 1999. ;
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;ICRU Report 62. Prescripción, registro y elaboración de informes en la terapia com haces de fotones (Suplemento a ICRU Report 50). Trad. de D B Trujillo. Granada: Sociedad Española de Física Médica, 2002. ;
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Jacob RF, Weber RS, King GE. Whole salivary flow rates following submandibular gland resection. Head Neck 1996; 18:242-7. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Jaguar GC, Lima ENP, Kowalski LP, Pellizon AC, Carvalho AL, Alves FA. Impact of submandibular gland excision on salivary gland function in head and neck cancer patients. Oral Oncol 2010; 46: 349-54. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Jensen SB, Pedersen AM, Reibel J, Nauntofte B. Xerostomia and hyposalivation of the salivary glands in cancer therapy. Support Care Cancer 2003; 11: 207-25. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 69:751-60. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;Jha N, Seikaly H, McGaw T, Coulter L. Submandibular salivary gland transfer prevents radiation-induced xerostomia. Int J Radiat Oncol Biol Phys 2000 1:7-11. ;
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Jha N, Seikaly H, Harris J, et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol 2003; 66:283-9. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Jham BC, Teixeira IV, Aboud CG, Carvalho AL, Coelho Mde M, Freire AR. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer. Oral Oncol 2007; 43:137-42 ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Jham BC, Reis PM, Miranda EL, et al. Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clin Oral Investig 2008; 12:19-24. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Kielbassa AM, Beetz I, Schendera A, Hellwig E. Irradiation effects on microhardness of fluoridated and non-fluoridated bovine dentin. Eur J Oral Sci 1997; 105:444-7. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Koga DH, Salvajoli JV, Alves FA. Dental extractions and radiotherapy in head and neck oncology: review of the literature. Oral Dis 2008; 14:40-4. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Koukourakis MI, Kyrias G, Kakolyris S, et al. Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study. J Clin Oncol 2000; 18:2226-33. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Kowalski LP, Magrin J, Waksman G, et al. Supraomohyoid neck dissection in the treatment of head and neck tumors: survival results in 212 cases. Arch Otolaryngol Head Neck Surg 1993; 119:958-63. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Konings AW, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 2005; 4:1187-94. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 2004; 101:1584-93. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Lajtman Z, Krajina Z, Krpan D, Vincelj J, Borci? V, Popovi?-Kovaci? J. Pilocarpine in the prevention of postirradiation xerostomia. Acta Med Croatica 2000; 54:65-7. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Lavelle CLB. Applied oral physiology. London: Boston; 1988. Saliva. p.128-41. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002; 1:12-22. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Leek H, Albertsson M. Pilocarpine treatment of xerostomia in head and neck patients. Mícron 2002; 33:153-5. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Lehnert S. Radiobiologia. In: Salvajoli JV, Souhani L, Faria SL, editores. Radioterapia em oncologia. São Paulo: MEDSI; 1999. p.91-118. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Malpani BL, Jaiswar RK, Samuel AM. Noninvasive scinntigraphic method to quantify unstimulated secretions from individual salivary glands. Auris Nasus Larynx 1999; 4:453-6. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Möller P, Perrier M, Ozsahin M, Monnier P. A prospective study of salivary gland function in patients undergoing radiotherapy for squamous cell carcinoma of the oropharynx. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97:173-89. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Munter MW, Karger CP, Hoffner SG, et al. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys 2004; 1:175-84. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Navazesh M, Kumar SK. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 2008; 139 Suppl:35s-40. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Nagler RM. The enigmatic mechanism of irradiation-induced damage to the major salivary glands. Oral Dis 2002; 3:141-6. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Nauntofte B. Regulation of electrolyte and fluid secretion in salivary acinar cells. Am J Physiol. 1992; 6:23-37. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Ohrn KEO, Wahlin Y, Sjoden P. Oral status during radiotherapy and chemotherapy: a descriptive study of patient experience and the occurrence of oral complications. Supp Care Cancer 2001; 9: 247-57. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"O’Neil MJ. The merck index: an encyclopedia of chemical, drugs, and biologicals. 14th ed. Whitehouse: Merck & Sons; 2006. Bethanechol chloride; p.194. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Pathak KA, Bhalavat RL, Mistry RC, et al. Upfront submandibular salivary gland transfer in pharyngeal cancers. Oral Oncol 2004; 40:960-3. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004; 58:663-73. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Paardekooper GM, Cammelli S, Zeilstra LJ, Coppes RP, Konings AW Radiation-induced apoptosis in relation to acute impairment of rat salivary glandfunction. Int J Radiat Biol 1998; 6:641-8. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Pacholke HD, Amdur RJ, Morris CG, et al. Late xerostomia after intensitymodulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol 2005; 4:351-8. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Pedersen AM, Bardow A, Jensen SB, Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis 2002; 3:117-29. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Pereira JCR, editor. Análise de dados qualitativos: estratégias metodológicas para as ciências da saúde, humanas e sociais. 3 ed. São Paulo: EDUSP; 2001. Processamento e análise de variáveis qualitativas; p.77-100. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Pow EH, McMillan AS, Leung WK, Wong MC, Kwong DL. Salivary gland function and xerostomia in southern Chinese following radiotherapy for nasopharyngeal carcinoma. Clin Oral Investig 2003; 4:230-4. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Pasquali L. Psicometria: teoria dos testes na psicologia e na educação. Rio de Janeiro: Vozes; 2003. Fidedignidade dos testes; p.192-225. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Rades D, Fehlauer F, Bajrovic A, Mahlmann B, Richter E, Alberti W. Serious adverse effects of amifostine during radiotherapy in head an neck cancer patients. Radiother Oncol 2004; 70:261-4. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Rieger J, Seikaly H, Jha N, et al. Submandibular gland transfer for prevention of xerostomia after radiation therapy: swallowing outcomes. Arch Otolaryngol Head Neck Surg 2005; 131:140-5. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Roesink JM, Moerland MA, Hoekstra A, et al. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head and neck câncer: a prospective study of dose-volume response relationships. Int J Radiat Oncol Biol Phys 2004; 5:1451-60. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Rudat V, Münter M, Rades D, et al. Effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy. Radiother Oncol 2008; 89:71-80. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Saarilahti K, Kouri M, Collan J, et al. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol 2006; 78:270-5. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Sangthawan D, Watthanaarpornchai S, Phungrassami T. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia. J Med Assoc Thai 2001; 84:195-203. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Someya M, Sakata K, Nagakura H, Nakata K, Oouchi A, Hareyama M. The changes in irradiated salivary gland function of patients with head and neck tumors treated with radiotherapy. Jpn J Clin Oncol 2003; 33:336-40. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Scarantino C, LeVeque F, Swann RS, et al. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck câncer patients. J Support Oncol 2006; 4:252-8. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Seikaly H, Jha N, McGaw T, Coulter L, Liu R, Oldring D. Submandibular gland transfer: a new method of preventing radiation-induced xerostomia. Laryngoscope 2001; 111:347-52. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Sonis ST. Oral mucositis in cancer therapy. J Support Oncol 2004; 2(6 Suppl 3):3-8. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Stephens LC, Ang KK, Schultheiss TE, et al. Target cell and mode of radiation injury in rhesus salivary glands. Radiother Oncol 1986; 7:165-74. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Ten Cate AR. Histologia bucal. Rio de Janeiro: Guanabara Koogan; 1998. Glândulas salivares; p.297-322. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Turner RJ. Ion transport related to fluid secretion in salivary glands. In: Vergona K, editor. The biology of salivary glands. New Jersey: Telford Press; 1993. p.105-27. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Vartanian JG, Carvalho AL, Yueh B, et al. Brazilian-Portuguese validation of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer. Head Neck 2006; 28:1115-21. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Valdez IH, Wolff A, Atkinson JC, Macynski AA, Fox PC. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer 1993a; 71:1848-51. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Valdez IH, Atkinson JC, Ship JA, Fox PC. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int J Radiat Oncol Biol Phys 1993b; 25:41-7. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Valdes Olmos RA, Keus RB, Takes RP, et al. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands. Cancer 1994; 12:2886-93. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Vivino FB, Al-Hashimi I, Khan Z, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome. Arch Intern Med 1999; 159:174-81. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Vissink A, Gravenmade EJ, Ligeon EE, Konings WT. A functional and chemical study of radiation effects on rat parotid and submandibular/sublingual glands. Radiat Res 1990; 3:259-65. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Vissink A, Kalicharan D, S-Gravenmade EJ, et al. Acute irradiation effects on morphology and function of rat submandibular glands. J Oral Pathol Med 1991; 9:449-56. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Warde P, O'Sullivan B, Aslanidis J, et al. A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002; 54:9-13. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Wasswrman TH, Brizel DM, Henke M, et al. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head and neck cancer: 2 year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys 2005; 63:985-90. ";
FAP;2010;GRAZIELLA CHAGAS JAGUAR ;Fábio de Abreu Alves ; Eduardo Nóbrega Pereira Lima ;"Zimmerman RP, Mark RJ, Tran LM, Juillard GF. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys 1997; 3:571-5. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Aberle H, Bierkamp C, Torchard D, et al. The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc Natl Acad Sci U S A. 1995; 92:6384-8.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Adeyouju AB, Thornhill J, Corr J, Grainger R, McDermontt TED, Butler M. Prognostic factors in squamous cell carcinoma of the penis and implications for management. Br J Urol 1997; 80:937-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Agarwal C, E?mova T, Welter JF, et al. CCAAT/enhancer-binding proteins. A role in regulation of human involucrin promoter response to phorbol ester. J Biol Chem 1999; 274:6190-4. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Alazawi WO, Morris LS, Stanley MA, Garrod DR, Coleman N. Altered expression of desmosomal components in high-grade squamous intraepithelial lesions of the cervix. Virchows Arch 2003; 443:51-6. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Adhikary G, Crish JF, Gopalakrishnan R, Bone F, Eckert RL. Involucrin expression in the corneal epithelium: an essential role for Sp1 transcription factors. Invest Ophthalmol Vis Sci 2005; 46:3109-20. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Alcalai R, Metzger S, Rosenheck S, Meiner V, Chajek-Shaul T. A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder, and woolly hair. J Am Coll Cardiol 2003; 42:319-27.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Alonso L, Fuchs E. Stem cells of the skin epithelium. Proc Natl Acad Sci USA 2003; 100(Suppl. 1):11830-5. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Alves G, Heller A, Fiedler W, et al. Genetics imbalances in 26 cases of penile squamous cell carcinoma. Genes Chromosomes Cancer 2001; 31:48-53 ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Amagai M, Karpati S, Klaus-Kovtun V, Udey MC, Stanley JR. The extracellular domain of pemphigus vulgaris antigen (desmoglein 3) mediates weak homophilic adhesion. J Invest Dermatol 1994; 102:402-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Amagai M. Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sci 1999; 20:92-102. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 2000; 6:1275-7. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Amagai M, Yamaguchi T, Hanakawa Y, Nishifuji K, Sugai M, Stanley JR. Staphylococcal exfoliative toxin B speci?cally cleaves desmoglein 1. J Invest Dermatol 2002; 118:845-50. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Amar LS, Shabana AH, Oboeuf M, Martin N, Forest N. Involvement of desmoplakin phosphorylation in the regulation of desmosomes by protein kinase C, in HeLa cells. Cell Adhes Commun 1999; 7:125-38.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Andl CD, Stanley JR. Central role of the plakoglobin-binding domain for desmoglein 3 incorporation. Dermatology 2001; 117:1068-74. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Akat K, Mennel HD, Kremer P, Gassler N, Bleck CK, Kartenbeck J. Molecular characterization of desmosomes in meningiomas and arachnoidal tissue. Acta Neuropathol (Berl) 2003; 106:337-47. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Amitay R, Nass D, Meitar D, et al. Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma. Am J Pathol 2001;159:43-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignance grading in oral squamous cell carcinoma. Scand J Dent Res 1987; 95:229-49. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Aoyama Y, Owada MK, Kitajima Y. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur J Immunol 1999a; 29:2233-40. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Aoyama Y, Kitajima Y. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol 1999b;112:67-71.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Apt D, Watts RM, Suske G, Bernard HU. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology 1996; 24:281-91. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Asamoto M, Fukushima S, Horike H, Tatemoto Y, Mori M. Involucrin expression in urinary bladder carcinoma. Urol Res 1989; 17:279-83. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Axcrona K, Brennhovd B, Andersen M, Berner A. Sarcomatoid squamous cell carcinoma of the penis. Acta Oncol 2010; 49:128-30. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 2009; 20:449-57. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Baker BH, Spratt LS Jr, Perez-Mesa C, Watson FR, Leduc RJ. Carcinoma of the penis. J Urol 1976; 116:458-61. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Balasubramanian S, Agarwal C, E?mova T, et al. Thapsigargin suppresses phorbol ester-dependent human involucrin promoter activity by suppressing CCAATenhancer-binding protein alpha (C/EBPalpha) DNA binding. Biochem J 2000; 350:791–796. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;Balasubramanian S, Efimova T, Eckert RL. Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes. J Biol Chem 2002, 277:1828-36. ;
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Banks EB, Crish JF, Welter JF, Eckert RL. Characterization of human involucrin promoter distal regulatory region transcriptional activator elements a role for Sp1 and AP1 binding sites. Biochem J 1998; 331:61-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Banks EB, Crish JF, Eckert RL. Transcription factor Sp1 activates involucrin promoter activity in non-epithelial cell types. Biochem J 1999; 337:507-12. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Giuliano AR. Incidence trends in primary malignant penile cancer. Urol Oncol 2007; 25:361-7 ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Bartlett JD, Luethy JD, Carlson SG, et al. Calcium ionophore A23187 induces expression of the growth arrest and DNA damage inducible CCAAT/ enhancerbinding protein (C/EBP)- related gene, gadd153. Ca2 þ increases transcriptional activity and mRNA stability. J Biol Chem 1992; 267:20465-70. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Bauer KD, de la Torre-Bueno J, Diel IJ, et al. Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging. Clin Cancer Res 2000; 6:3552-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Beggs JH, Spratt JS Jr. Epidermoid carcinoma of the penis. J Urol 1964; 91:166-72. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Bezerra AL, Lopes A, Landman G, Alencar GN, Torloni H, Villa LL. Clinicopathologic features and human papillomavirus DNA prevalence of warty and squamous cell carcinoma of the penis. Am J Surg Pathol 2001a; 25:673-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Bezerra AL, Lopes A, Santiago GH, Ribeiro KC, Latorre MR, Villa LL. Human papillomavirus as a prognostic factor in carcinoma of the penis. Cancer 2001b; 91:2315-21. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Biedermann K, Vogelsang H, Becker I, et al. Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. J Pathol 2005; 207:199206. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Bierkamp C, McLaughlin KJ, Schwarz H, Huber O, Kemler R. Embryonic heart and skin defects in mice lacking plakoglobin. Dev Biol 1996; 180:780-5. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Bikle DD, Ng D, Tu CL, et al. Calclium- and vitamin D-regulated keratinocyte differentiation. Mol Cell Endocrinol 2001; 177:161-71. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Bonne S, van Hengel J, Nollet F, Kools P, van Roy F. Plakophilin-3, a novel armadillo-like protein present in nuclei and desmosomes of epithelial cells. J Cell Sci 1999; 112:2265-76. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Bonne S, Gilbert B, Hatzfeld M, Chen X, Green KJ, van Roy F. De?ning desmosomal plakophilin-3 interactions. J Cell Biol 2003; 161:403-16. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Bornslaeger EA, Godsel LM, Corcoran CM, et al. Plakophilin 1 interferes with plakoglobin binding to desmoplakin, yet together with plakoglobin promotes clustering of desmosomal plaque complexes at cell–cell borders. J Cell Sci 2001; 114:727-38. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Brancolini C, Sgorbissa A, Schneider C. Proteolytic processing of the adherens junctions components beta-catenin and gamma-catenin/plakoglobin during apoptosis. Cell Death Differ 1998; 5:1042-50. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Brennan D, Hu Y, Joubeh S, et al. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell Sci 2007; 120:758-71. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Brinton LA, Juan-Yao L, Shou-De R, et al. Risk factors for penile cancer: results from a case-control study in China. Int J Cancer 1991; 47:504-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Broders AC. Epithelioma of the genito-urinary organs. Ann Surg 1922; 75:574-604. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Brumini R. Câncer no Brasil: dados histopatológicos, 1976-80. Rio de Janeiro: Campanha Nacional de Combate ao Câncer-Ministério da Saúde; 1982. Câncer de pênis; p.118-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E. New malignace grading is a better prognostic indicator than Broder`s grading in oral squamous cell carcinoma. J Oral Pathol Med 1989; 18:432-7. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Burdett ID, Sullivan KH. Desmosome assembly in MDCK cells: transport of precursors to the cell surface occurs by two phases of vesicular traf?c and involves major changes in centrosome and Golgi location during a Ca(2+) shift. Exp Cell Res 2002; 276:296-309. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Burges JK, Badalement RA, Drago JR. Penile cancer: clinical presentation, diagnosis, and staging. Urol Clin North Am 1992; 19:247-56. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Burns JE, Walker HF, Schmitz C, Maitland NJ. Phenotypic effects of HPV-16 E2 protein expression in human keratinocytes. Virology. 2010; 401:314-21. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Cabanas RM. An approach for the treatment of the penile carcinoma. Cancer 1977; 39:456-66. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Calkins CC, Hoepner BL, Law CM, et al. The Armadillo family protein p0071 is a VE-cadherin- and desmoplakin-binding protein. J Biol Chem 2003; 278:1774-83. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Calautti E, Cabodi S, Stein PL, Hatzfeld M, Kedersha N, Paolo Dotto G. Tyrosine phosphorylation and src family kinases control keratinocyte cell–cell adhesion. J Cell Biol 1998; 141:1449-65. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Calautti E, Grossi M, Mammucari C, et al. Fyn tyrosine kinase is a downstream mediator of Rho/PRK2 function in keratinocyte cell–cell adhesion. J Cell Biol 2002; 156:137-48. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Caldelari R, de Bruin A, Baumann D, et al. A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol 2001; 153:823-34. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Campos RS, Lopes A, Guimaraes GC, Carvalho AL, Soares FA. E-cadherin, MMP2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients. Urology 2006; 67:797-802. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Canes D, Chiang GJ, Billmeyer BR, et al. Histone deacetylase inhibitors upregulate plakoglobin expression in bladder carcinoma cells and display antineoplastic activity in vitro and in vivo. Int J Cancer 2005; 113:841-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Cassel TN, Nord M. C/EBP transcription factors in the lung epithelium. Am J Physiol Lung Cell Mol Physiol 2003; 285:L773-81. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Catalona WJ. Role of lymphadenectomy in carcinoma of the penis. Urol Clin North Am 1980; 7:785-92. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Charpentier E, Lavker RM, Acquista E, Cowin P. Plakoglobin suppresses epithelial proliferation and hair growth in vivo. J Cell Biol 2000; 149:503-20.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Chaux A, Soares F, Rodríguez I, et al. Papillary squamous cell carcinoma, not otherwise specified (NOS) of the penis: clinicopathologic features, differential diagnosis, and outcome of 35 cases. Am J Surg Pathol 2010a; 34:223-30. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;Chaux A, Tamboli P, Ayala A, et al. Warty-basaloid carcinoma: clinicopathological ;
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"features of a distinctive penile neoplasm: report of 45 cases. Mod Pathol 2010b; 23: 896-904. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Chen X, Bonne S, Hatzfeld M, van Roy F, Green KJ. Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta-catenin signaling. J Biol Chem 2002; 277:10512-22. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Chidgey MA, Yue KK, Gould S, Byrne C, Garrod DR. Changing pattern of desmocollin 3 expression accompanies epidermal organisation during skin development. Dev Dyn 1997; 210:315-27. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Chidgey M. Desmosomes and disease: an update. Histol Histopathol 2002; 17:1179-92. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Chidgey M, Dawson C. Desmosomes: a role in cancer? Br J Cancer 2007; 96:17837. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Choi HJ, Park-Snyder S, Pascoe LT, Green KJ, Weis WI. Structures of two intermediate ?lament-binding fragments of desmolakin reveal a unique repeat motif structure. Nat Struct Biol 2002; 9:612-20. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Coblentz TR, Theodorescu D. Morbidity of modified prophylactic inguinal lymphadenectomy for squamous cell carcinoma of the penis. J Urol 2002; 168:13869.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Cotsarelis G, Cheng SZ, Dong G, et al. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell 1989; 57:201-9.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Courey AJ, Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 1988; 55:887-98. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Courey AJ, Holtzman DA, Jackson SP, Tjian R. Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 1989; 59:827-36. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Cox DR. Regression models and life table. J R Static Soc Br 1972; 34:187-220. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Crish JF, Howard JM, Zaim TM, et al. Tissue-speci?c and differentiationappropriate expression of the human involucrin gene in transgenic mice: An abnormal epidermal phenotype. Differentiation 1993; 53:191-200. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Crish JF, Zaim T, Eckert RL. The distal regulatory region (DRR) of the human involucrin promoter is required for expression in epidermis. J Biol Chem 1998; 273:30460-5. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Crish JF, Bone F, Banks EB, Eckert RL. The human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal differentiation. Oncogene 2002; 21:3826-31. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Cubilla AL, Barreto J, Caballero C, Ayala G, Riveros M. Pathologic features of epidermoid carcinoma of the penis: a prospective study of 66 cases. Am J Surg Pathol 1993; 17:753-63. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Cubilla AL, Reuter VE, Gregoire L, et al. Basaloid squamous cell carcinoma: a distinctive human papilloma virus-related penile neoplasm: a report of 20 cases. Am J Surg Pathol 1998; 22:755-61. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Cubilla AL, Reuter V, Velazquez E, Piris A, Saito S, Young RH. Histologic classification of penile carcinoma and its relation to outcome in 61 patients with primary resection. Int J Surg Pathol 2001; 9:111-20. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Cunha IW, Guimarães GC, Soares F, et al. Pseudoglandular (adenoid, acantholytic) penile squamous cell carcinoma: a clinicopathologic and outcome study of 7 patients. Am J Surg Pathol 2009; 33:551-5.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Dai B, Ye DW, Kong YY, Yao XD, Zhang HL, Shen YJ. Predicting regional lymph node metastasis in Chinese patients with penile squamous cell carcinoma: the role of histopathologic classification, tumor stage and depth of invasion. J Urol 2006; 176:1431-1435. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Dean AL Jr. Epithelioma of the penis. J Urol 1935; 33:252-83. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Dekernion JB, Tynberg P, Persky L, Fegen JP. Carcinoma of the penis. Cancer 1973; 32:1256-62. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Demlehner MP, Schafer S, Grund C, Franke WW. Continual assembly of halfdesmosomal structures in the absence of cell contacts and their frustrated endocytosis: a coordinated Sisyphus cycle. J Cell Biol 1995; 131:745-60. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Denning MF, Guy SG, Ellerbroek SM, Norvell SM, Kowalczyk AP, Green KJ. The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium,serum,andproteinkinase C. Exp Cell Res 1998; 239:50-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Derrick FC Jr, Lynch KM, Kretkowski RC, Yarbrough W. Epidermoid carcinoma of the penis: computer analysis of 87 cases. J Urol 1973; 110:303-5. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Deucher A, Efimova T, Eckert RL. Calcium-dependent involucrin expression is inversely regulated by protein kinase C (PKC)alpha and PKCdelta. J Biol Chem 2002; 277:17032-40. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Duden R, Franke WW. Organization of desmosomal plaque proteins in cells growing at low calcium concentrations. J Cell Biol 1988; 107:1049-63. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Eckert RL, Green H. Structure and evolution of the human involucrin gene. Cell 1986; 46:583-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Eckert RL, Yaffe MB, Crish JF, et al. Involucrin structure and role in envelope assembly. J Invest Dermatol 1993; 100:613-7. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Eckert RL, Welter JF. Epidermal keratinoctyes genes and their regulation. Cell Death Differ 1996; 3:373-83. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Eckert RL, Crish JF, Robinson NA. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 1997a; 77:397-424. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Eckert RL, Crish JF, Banks EB, Welter JF. The epidermis: Genes ongenes off. J Invest Dermatol 1997b; 109:501-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Eckert RL, Crish JF, Efimova T, et al. Regulation of involucrin gene expression. J Invest Dermatol 2004; 123:13-22. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Eckhart L, Declercq W, Ban J, et al. Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation. J Invest Dermatol 2000; 115:1148-51. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Elias PM, Matsuyoshi N, Wu H, et al. Desmoglein isoform distribution affects stratum corneum structure and function. J Cell Biol 2001; 153:243-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Eshkind L, Tian Q, Schmidt A, Franke WW, Windoffer R, Leube RE. Loss of desmoglein 2 suggests essential functions for early embryonic development and proliferation of embryonal stem cells. Eur J Cell Biol 2002; 81:592-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Fawcett TW, Eastman HB, Martindale JL, Holbrook NJ. Physical and functional association between GADD153 and CCAAT/enhancer-binding protein beta during cellular stress. J Biol Chem 1996; 271:14285-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Fleming TP, Garrod DR, Elsmore AJ. Desmosome biogenesis in the mouse preimplantation embryo. Development 1991; 112:527-39. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Fontao L, Favre B, Riou S, et al. Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediate ?laments is mediated by distinct sequences within their COOH terminus. Mol Biol Cell 2003; 14:1978-92. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Fontao L, Favre B, Riou S, et al. Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediate ?laments is mediated by distinct sequences within their COOH terminus. Mol Biol Cell 2003; 14:1978-92. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Fraley EE, Zhang G, Manivel C, Niehans GA. The role of ilioinguinal lymphadenectomy and significance of histological differentiation in treatment of carcinoma of the penis. J Urol 1989; 142:1478-82. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Frew IDO, Jefferies JD, Swinney J. Carcinoma of the penis. Br J Urol 1967; 39:398-404. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Frisch M, Friis S, Kjaer SK, Melbye KM. Falling incidence of penis cancer in an uncircumcised population (Denmark 1943-90). BMJ 1995; 311:1471. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Gallicano GI, Kouklis P, Bauer C, et al. Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J Cell Biol 1998;143:2009-22. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Gambardella L, Barrandon Y. The multifaceted adult epidermal stem cell. Curr Opin Cell Biol 2003;15:771-7. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Garcia-Gras E, Lombardi R, Giocondo MJ, et al. Suppression of canonical Wnt/betacatenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 2006; 116:2012-21. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Garrod DR, Merritt AJ, Nie Z. Desmosomal cadherins. Curr Opin Cell Biol 2002; 14:537-45. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Gat U, DasGupta R, Degenstein L, Fuchs E. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated betacatenin in skin. Cell 1998; 95:605-14. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Gaudry CA, Palka HL, Dusek RL, et al. Tyrosine-phosphorylated plakoglobin is associated with desmogleins but not desmoplakin after epidermal growth factor receptor activation. J Biol Chem 2001; 276:24871-80. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Gentil F, Lima EW, Abrão A. Melanoma of the penis. report of 2 cases. Rev Bras Cir 1965; 50:183-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Gentil FC, Lopes A, Epifânio ITN, Cavalcante SF, Souza E Sá AO. Esvaziamento inguino-ilíco: técnica e tática operatória. Acta Oncol Bras 1986; 6:83-6. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Getsios S, Huen AC, Green KJ. Working out the strength and ?exibility of desmosomes. Nat Rev Mol Cell Biol 2004; 5:271-81. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Gloeckler-Reis LA, Hankey BF, Edwards BK. Cancer Statistic Review 1973-1987. Bethesda: National Institute of Health; 1990. (National Institute of Health Publication nº 90-2789). ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Gloushankova NA, Wakatsuki T, Troyanovsky RB, Elson E, Troyanovsky SM. Continual assembly of desmosomes within stable intercellular contacts of epithelial A-431 cells. Cell Tissue Res 2003; 314:399-410. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Goodman MT, Hernandez BY, Shvestov YB. Demographic and pathologic differences in the incidence of invasive penile câncer in the United States, 19952003. Cancer Epidemiol Biomarkers Prev 2007; 16:1833-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Gottardi CJ, Gumbiner BM. Adhesion signaling: how beta-catenin interacts with its partners. Curr Biol 2001; 11:R792-4. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;Green H. The keratinocyte as differentiated cell type. Harvey Lectures 1980, 74:101-39. ;
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Greene FL, Page D, Morrow M, et al. AJCC Manual de estadiamento do câncer. 6th ed. New York: Springer; 2002. Pênis; p.317-22. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Guerrero D, Guarch R, Ojer A, et al. Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma. BJU Int 2008; 102:747-55. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Guimarães GC, Rodrigues De Souza R, et al. Penile metastasis of chondrosarcoma of the jaw. Urology 2003; 61:837. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Guimarães GC, Lopes A, Campos RS, et al. Front pattern of invasion in squamous cell carcinoma of the penis: new prognostic factor for predicting risk of lymph node metastases. Urology 2006; 68:148-53. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Guimarães GC, Leal ML, Campos RS, et al. Do proliferating cell nuclear antigen and MIB-1/Ki-67 have prognostic value in penile squamous cell carcinoma? Urology 2007; 70:137-42. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Guimarães GC, Leal ML, Campos RS, et al. Do proliferating cell nuclear antigen and MIB-1/Ki-67 have prognostic value in penile squamous cell carcinoma? Urology 2007; 70:137-42. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Gursel EO, Georgountzos C, Uson AC, Melicow MM, Veenema RJ. Penile cancer: clinicopathology study of 64 cases. Urology 1973; 1:569-78. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hadchouel J, Carvajal JJ, Daubas P, et al. Analysis of a key regulatory region upstream of the Myf5 gene reveals multiple phases of myogenesis, orchestrated at each site by a combination of elements dispersed throughout the locus. Development 2003; 130:3415-26. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hakimelahi S, Parker HR, Gilchrist AJ, et al. Plakoglobin regulates the expression of the anti-apoptotic protein BCL-2. J Biol Chem 2000; 275:10905-11. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hall MC, Sanders JS, Vuitch F, Ramirez E, Pettaway CA. Deoxyribonucleic acid flow cytometry and traditional pathologic variables in invasive penile carcinoma assessment of prognostic significance. Urology 1998; 52:11-6. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hanakawa Y, Amagai M, Shirakata Y, Sayama K, Hashimoto K. Different effects of dominant negative mutants of desmocollin and desmoglein on the cell-cell adhesion of keratinocytes. J Cell Sci 2000; 113:1803-11. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hanakawa Y, Selwood T, Woo D, Lin C, Schechter NM, Stanley JR. Calciumdependent conformation of desmoglein 1 is required for its cleavage by exfoliative toxin. J Invest Dermatol 2003; 121:383-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hankins CL, Kotwal S, Majumder S, Weston P, Phipps A, Anathhanam AJ. Multifocal melanoma of the glans penis. Plast Reconstr Surg 2006; 118:33e-8e. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Harish K, Ravi R. The role of tabacco in penile carcinoma. Br J Urol 1995; 75:3757. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hatsell S, Medina L, Merola J, Haltiwanger R, Cowin P. Plakoglobin is Oglycosylated close to the N-terminal destruction box. J Biol Chem 2003; 278:3774552. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hatzfeld M. The armadillo family of structural proteins. Int Rev Cytol 1999; 186:179-224. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hatzfeld M, Green KJ, Sauter H. Targeting of p0071 to desmosomes and adherens junctions is mediated by different protein domains. J Cell Sci 2003; 116:1219-33. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"He W, Cowin P, Stokes DL. Untangling desmosomal knots with electron tomography. Science 2003; 302:109-13. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hegarty PK, Kayes O, Freeman A, Christopher N, Ralph DJ, Minhas S. A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines. BJU Int 2006; 98:526-31. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hellberg D, Valentin J, Eklund T, Nilsson S. Penile cancer: is there an epidemiological role for smoking and sexual behavior? Br Med J 1987; 1295:13068. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Herr HW. Surgery of penile and urethral carcinoma. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED, editors. Campbell’s urology. 6th ed. Philadelphia: W B Saunders; 1992. p.3073-89. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Heyns CF, Van Vollanhoven P, Steenkamp JW, et al. Carcinoma of the penisappraisal of a modified tumor-staging system. Br J Urol 1997; 80:307-12. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Horenblas S, Van Tinteren H, Delemarre JFM, Moonen LMF, LustigG V, Kroger R. Squamous cell carcinoma of the penis: accuracy of the tumors, nodes and metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology. J Urol 1991; 146:1279-83. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Horenblas S, Van Tinteren H, Delemarre JFM, Moonen LMF, Lustig V, Van Waardenburg EW. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 1993; 149:492-7. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Horenblas S, Van Tinteren H. Squamous cell carcinoma of the penis. IV. Prognostic factores of survival: analysis of tumor, nodes and metastasis classification system. J Urol 1994; 151:1239-43. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Horenblas S, Jansen L, Meinhardt W, Hoefnagel CA, Jong D, Nieweg OE. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol 2000; 163:1000-4. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Hu P, Berkowitz P, O’Keefe EJ, Rubenstein DS. Keratinocyte adherens junctions initiate nuclear signaling by translocation of plakoglobin from the membrane to the nucleus. J Invest Dermatol 2003; 121:242-51. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Huber O. Structure and function of desmosomal proteins and their role in development and disease. Cell Mol Life Sci 2003; 60:1872-90. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Huelsken J, Vogel R, Brinkmann V, Erdmann B, Birchmeier C, Birchmeier W. Requirement for beta-catenin in anterior-posterior axis formation in mice. J Cell Biol 2000; 148:567-78. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Huen AC, Park JK, Godsel LM, et al. Intermediate ?lament-membrane attachments function synergistically with actin-dependent contacts to regulate intercellular adhesive strength. J Cell Biol 2002; 159:1005-17. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Huen AC, Park JK, Godsel LM, et al. Intermediate ?lament-membrane attachments function synergistically with actin-dependent contacts to regulate intercellular adhesive strength. J Cell Biol 2002; 159:1005-17. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Ishii K, Norvell SM, Bannon LJ, Amargo EV, Pascoe LT, Green KJ. Assembly of desmosomal cadherins into desmosomesisisoformdependent. J Invest Dermatol 2001; 117:26-35. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Iwasawa A, Kumamoto Y, Fujinaga K. Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. J Urol 1993; 149:59-63. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Johnson DE, Fuerst DE, Ayala AG. Carcinoma of the penis: experience in 153 cases. Urology 1973; 1:404-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Johnson DE, Lo RK. Management of regional lymph nodes in penile carcinoma: five years results following therapeutic groin dissections. Urology 1984; 24:308-11. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Jones JCR, Goldman RD. Intermediate ?laments and the initiation of desmosome assembly. J Cell Biol 1985; 101:506-17. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kajava AV. Alpha-helical solenoid model for the human involucrin. FEBS Lett 2000; 473:127-31. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kamat MR, Kulkarni JN, Tongaonkar HB. Carcinoma of the penis: the Indian experience. J Surg Oncol 1993; 52:50-5. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kaplan EL, Meier P. Nomparametric estimation from incomplete observations. J Am Static Assoc 1958; 53:457-81. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Karnovsky A, Klymkowsky MW. Anterior axis duplication in Xenopus induced by the over-expression of the cadherin-binding protein plakoglobin. Proc Natl Acad Sci USA 1995; 92:4522-6. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Katona TM, Lopez-Beltran A, MacLennan GT, Cheng L, Montironi R, Cheng L. Soft tissue tumors of the penis: a review. Anal Quant Cytol Histol. 2006; 28:193206. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Khan K, Hardy R, Haq A, Ogunbiyi O, Morton D, Chidgey M. Desmocollin switching in colorectal cancer. Br J Cancer 2006; 95:1367-70. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kljuic A, Bazzi H, Sundberg JP, et al. Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell 2003; 113:249-60. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Klymkowsky MW, Williams BO, Barish GD, Varmus HE, Vourgourakis YE. Membrane-anchored plakoglobins have multiple mechanisms of action in Wnt signaling. Mol Biol Cell 1999;10:3151-69. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Klymkowsky MW. Plakophilin, armadillo repeats, and nuclear localization. Microsc Res Tech 1999; 45:43-54. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Koch PJ, Mahoney MG, Ishikawa H, et al. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 1997; 137:1091-2. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kodama S, Ikeda S, Asahara T, Kishida M, Kikuchi A. Axin directly interacts with plakoglobin and regulates its stability. J Biol Chem 1999; 274:27682-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Koeser J, Troyanovsky SM, Grund C, Franke WW. De novo formation of desmosomes in cultured cells upon transfection of genes encoding speci?c desmosomal components. Exp Cell Res 2003; 285:114-30. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kofron M, Spagnuolo A, Klymkowsky M, Wylie C, Heasman J. The roles of maternal alpha-catenin and plakoglobin in the early Xenopus embryo. Development 1997; 124:1553-60. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kolligs FT, Kolligs B, Hajra KM, et al. Gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev 2000; 14:1319-31. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kouklis PD, Hutton E, Fuchs E. Making a connection: direct binding between keratin intermediate ?laments and desmosomal proteins. J Cell Biol 1994; 127:1049-60. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kowalczyk AP, Palka HL, Luu HH, et al. Posttranslational regulation of plakoglobin expression. In?uence of the desmosomal cadherins on plakoglobin metabolic stability. J Biol Chem 1994; 269:31214-23. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kowalczyk AP, Borgwardt JE, Green KJ. Analysis of desmosomal cadherinadhesive function and stoichiometry of desmosomal cadherin-plakoglobin complexes. J Invest Dermatol 1996; 107:293-300. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kowalczyk AP, Bornslaeger EA, Borgwardt JE, et al. The amino-terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes. J Cell Biol 1997; 139:773-84.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kroon BK, Horenblas S, Estourgie SH, Lont AP, Valdes Olmos RA, Nieweg OE. How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J Urol 2004; 171:2191-4.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kroon BK, Horenblas S, Deurloo EE, Nieweg OE, Teertstra HJ. Ultrasonographyguided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int. 2005a; 95:517-21. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kroon BK, Horenblas S, Lont AP, Tanis PJ, Gallee MP, Nieweg OE. Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol. 2005b; 173:816-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kroon BK, Leijte JA, van Boven H, et al. Microarray gene-expression profiling to predict lymph node metastasis in penile carcinoma. BJU Int 2008; 102:510-5. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Kurzen H, Munzing I, Hartschuh W. Expression of desmosomal proteins in squamous cell carcinomas of the skin. J Cutan Pathol 2003; 30:621-30. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;Lazo ND, Downing DT. A mixture of alpha-helical and 3(10)-helical conformations for involucrin in the human epidermal corneocyte envelope provides a scaffold for the attachment of both lipids and proteins. J Biol Chem 1999, 274:37340-4. ;
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Lee JS, Ishimoto A, Yanagawa S. Characterization of mouse dishevelled (Dvl) proteins in Wnt/Wingless signaling pathway. J Biol Chem 1999; 274:21464-70. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Leung CL, Green KJ, Liem RK. Plakins: a family of versatile cytolinker proteins. Trends Cell Biol 2002; 12:37-45. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Lewis JE, Wahl III JK, Sass KM, Jensen PJ, Johnson KR, Wheelock MJ. Cross-talk between adherens junctions and desmosomes depends on plakoglobin. J Cell Biol 1997; 136:919-34. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;Li A, Simmons PJ, Kaur P: Identification and isolation of candidate human Keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA 1998, 95:3902–3907. ;
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Li F, Chong ZZ, Maiese K. Winding through the WNT pathway during cellular development and demise. Histol Histopathol 2006; 21:103-24. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Licklider S. Jewish penile carcinoma. J Urol 1961; 86:98. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Lont AP, Kroon BK, Horenblas S, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 2006; 119:1078-81.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Lopes A, Rossi BM, Nakagawa WT. Oncologia cirurgica. Acta Oncol Bras 1993; 13:2-3. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Lopes A, Rossi BM, Nakagawa WT. Cancer de pênis. Ambito Hospitalar 1994; 58:5-13. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Lopes A. Fatores clínicos e anatomopatológicos envolvidos no risco de metástases linfonodais e no prognóstico dos pacientes portadores de carcinoma de pênis tratados por cirurgia. São Paulo; 1995. [Tese de Doutorado-Faculdade de Medicina da Universidade de São Paulo]. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Lopes A, Rossi BM, Fonseca FP, Morini S. Unrealiability of modified inguinal lymphadenectomy for clinical staging of peneli carcinoma. Cancer 1996a; 77:2099102. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Lopes A, Hildago GS, Kowalski LP, Torloni H, Rossi BM, Fonseca FP. Prognostic factors in carcinoma of penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 1996b; 156:1637-42. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Lopes A, Bezerra AL, Pinto CAL, Serrano SV, Abdon de Mello C, Villa LL. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 2002; 168:81-6. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Lorch JH, Klessner J, Park JK, Getsios S, Wu YL, Stack MS, Green KJ. Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intracellular adhesion in squamous cell carcinoma cells. J Biol Chem 2004; 279:37191-200. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Lowe D, McKee PH. Verrucous carcinoma of the penis(BuschKe-Lowenstein Tumor): a clinicopathological study. Br J Urol 1983; 55:427-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Maatta A, DiColandrea T, Groot K, Watt FM. Gene targeting of envoplakin, a cytoskeletal linker protein and precursor of the epidermal corni?ed envelope. Mol Cell Biol 2001; 21:7047-53. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Maeda O, Usami N, Kondo M, et al. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-de?cient cell line. Oncogene 2004; 23:964-72. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Maden C, Sherman KJ, Beckman AM, et al. History of circuncision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst 1993; 85:19-24. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Marcozzi C, Burdett ID, Buxton RS, Magee AI. Coexpression of both types of desmosomal cadherin and plakoglobin confers strong intercellular adhesion. J Cell Sci 1998; 111:495-509. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Martins ACP, Faria SM, Cologna AJ, Suaid HJ, Tucci Jr S. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol 2002; 167:89-93. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Mattey DL, Garrod DR. Calcium-induced desmosome formation in cultured kidney epithelial cells. J Cell Sci 1986a; 85:95-111. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Mattey DL, Garrod DR. Splitting and internalization of the desmosomes of cultured kidney epithelial cells by reduction in calcium concentration. J Cell Sci 1986b; 85:113-24. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"McCance DJ, Kalache A, Ashdown K, et al. Human papillomavirus types 16 and 18 in carcinomas of the penis from Brazil. Int J Cancer 1986; 37:55-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"McGrath JA. Hereditary diseases of desmosomes. J Dermatol Sci 1999; 20:85-91. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"McKoy G, Protonotarios N, Crosby A, et al. Identi?cation of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000; 355:2119-24. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"McMillan JR, Shimizu H. Desmosomes: structure and function in normal and diseased epidermis. J Dermatol 2001; 28:291-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Meng J-J, Bornslaeger EA, Green KJ, Steinert PM, Ip W. Two hybrid analysis reveals fundamental differences in direct interactions between desmoplakin and cell type speci?c intermediate ?laments. J Biol Chem 1997; 272:21495-503. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Menon GK, Grayson S, Elias PM. Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol 1985; 84:508-12. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Merriam JM, Rubenstein AB, Klymkowsky MW. Cytoplasmically anchored plakoglobin induces a WNT-like phenotype in Xenopus. Dev Biol 1997; 185:67-81. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Merritt AJ, Berika MY, Zhai W, et al. Suprabasal desmoglein 3 expression in the epidermis of transgenic mice results in hyperproliferation and abnormal differentiation. Mol Cell Biol 2002; 22:5846-58. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Millar SE, Willert K, Salinas PC, et al. WNT signaling in the control of hair growth and structure. Dev Biol 1999; 207:133-49. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Miller JR, Moon RT. Analysis of the signaling activities of localization mutants of beta-catenin during axis speci?cation in Xenopus. J Cell Biol 1997; 139:229-43. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Miravet S, Piedra J, Miro F, Itarte E, Garcia de Herreros A, Dunach M. The transcriptional factor Tcf-4 contains different binding sites for b-catenin and plakoglobin. J Biol Chem 2002; 277:1884-91. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Miravet S, Piedra J, Castano J, et al. Tyrosine phosphorylation of plakoglobin causes contrary effects on its association with desmosomes and adherens junction components and modulates beta-catenin-mediated transcription. Mol Cell Biol 2003; 23:7391-402. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Mohs FE, Snow SN, Messing EM, Kuglitsch ME. Microscopically controlled surgery in the treatment of carcinoma of the penis. J Urol 1985; 133:961-6. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Moll I, Kurzen H, Langbein L, Franke WW. The distribution of the desmosomal protein, plakophilin 1, in human skin and skin tumors. J Invest Dermatol 1997; 108:139-46.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Monzon RI, LaPres JJ, Hudson LG. Regulation of involucrin gene expression by retinoic acid and glucocorticoids. Cell Growth Differ 1996; 7:1751-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Mosconi AM, Roila F, Gatta G, Theodore C. Cancer of the penis. Crit Rev Oncol/Hematol 2005; 53:165-77. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Muller J, Ritt DA, Copeland TD, Morrison DK. Functional analysis of C-TAK1 substrate binding and identi?cation of PKP2 as a new C-TAK1 substrate. EMBO J 2003; 22:4431-42. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Nair SA, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai MR. Involucrin and tumor progression in the uterine cervix. Pathobiology 1996; 64:3338. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Narasimharao KL, Chatterjee H, Veliath AJ. Penile carcinoma in the first decade of life. Br J Urol 1985; 57:358. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Narayama AS, Olney LE, Loening AS, Weimar GW, Culp DA. Carcinoma of the penis: analysis of 219 cases. Cancer 1982; 49:2185-91. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Nicolau SM, Camargo CG, Stávale JN, et al. Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection. Urology 2005; 65:251-5. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Norgett EE, Hatsell SJ, Carvajal-Huerta L, et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate ?lament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet 2000; 9:2761-6. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"North AJ, Chidgey MA, Clarke JP, Bardsley WG, Garrod DR. Distinct desmocollin isoforms occur in the same desmosomes and show reciprocally graded distributions in bovine. Proc Natl Acad Sci USA 1996; 93:7701-5. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"North AJ, Bardsley WG, Hyam J, et al. Molecular mapofthedesmosomalplaque. JCell Sci 1999; 112:4325-36. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Nuber UA, Schafer S, Schmidt A, Koch PJ, Franke WW. The widespread human desmocollin Dsc2 and tissue-speci?c patterns of synthesis of various desmocollin subtypes. Eur J Cell Biol 1995; 66:69-74. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Ogata K, Sato K, Tahirov T. Eukaryotic transcriptional regulatory complexes: Cooperativity from near and afar. Curr Opin Struct Biol 2003; 13:40-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Ornellas AU, Seixas ALC, Marota A, Wisnescky A, Campos F, De Moraes JR. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 1994; 151:1244-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Osada K, Seishima M, Kitajima Y, Pemphigus. IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes. J Invest Dermatol 1997; 108:482-7. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Oshiro MM, Kim CJ, Wozniak RJ, et al. Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Res 2005; 7:R669-80. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Palka HL, Green KJ. Roles of plakoglobin end domains in desmosome assembly. J Cell Sci 1997; 110:2359-71. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Pascal E, Tjian R. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev 1991; 5:1646-56.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Pasdar M, Nelson WJ. Kinetics of desmosome assembly in Madin-Darby canine kidney epithelial cells: temporal and spatial regulation of desmoplakin organization and stabilization upon cell–cell contact. I. Biochemical analysis. J Cell Biol 1988a; 106:677-85. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Pasdar M, Nelson WJ. Kinetics of desmosome assembly in Madin-Darby canine kidney epithelial cells: temporal and spatial regula-tion of desmoplakin organization and stabilization upon cell–cell contact. II. Morphological analysis. J Cell Biol 1988b; 106:687-95. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Pasdar M, Nelson WJ. Regulation of desmosome assembly in epithelial cells: kinetics of synthesis, transport, and stabilization of desmoglein I, a major protein of the membrane core domain. J Cell Biol 1989; 109:163-77. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Pasdar M, Krzeminski KA, Nelson WJ. Regulation of desmosome assembly in MDCK epithelial cells: coordination of membrane core and cytoplasmic plaque domain assembly at the plasma membrane. J Cell Biol 1991; 113:645-55. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Pasdar M, Li Z, Chlumecky V. Plakoglobin: kinetics of synthesis, phosphorylation, stability, and interactions with desmoglein and E-cadherin. Cell Motil Cytoskelet 1995a; 32:258-72. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Pasdar M, Li Z, Chan H. Desmosome assembly and disassembly are regulated by reversible protein phosphorylation in cultured epithelial cells. Cell Motil Cytoskelet 1995b; 30:108-21. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Paymaster JC, Gangadharan P. Cancer of the penis in India. J Urol 1967; 97:110-3. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Perinetti E, Crane DB, Catalona WJ. Unrealiability of sentinel lymph node biopsy for staging of penile carcinoma. J Urol 1980; 124:734-5. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Pertz O, Bozic D, Koch AW, Fauser C, Brancaccio A, Engel J. A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of Ecadherin homoassociation. EMBO J 1999; 18:1738-47. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Persky L. Epidemiology of cancer of the penis. Rec Results Cancer Res 1997; 60:97-109. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Persky L, Dekernion J. Carcinoma of the penis. CA Cancer J Clin 1986; 36:258-73. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Pompeu ACL. Linfadenectomia inguinal estagiada em câncer de pênis: avaliação prospectiva de 50 pacientes. São Paulo; 1993. [Tese de Livre-Docência-Faculdade de Medicina da Universidade de São Paulo] ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Poumay Y, Herphelin F, Smits P, et al. High-cell-density phorbol ester and retinoic acid upregulate involucrin and downregulate suprabasal keratin 10 in autocrine cultures of human epidermal keratinocytes. Mol Cell Biol Res Commun 1999; 2:138-44. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Protzel C, Knoedel J, Zimmermann U, Woenckhaus C, Poetsch M, Giebel J. Expression of proliferation marker Ki67 correlates to occurence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas. Histol Histopathol 2007; 22:1197-204. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Protzel C, Kakies C, Kleist B, Poetsch M, Giebel J. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma. Virchows Arch 2008; 452:369-75. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Pulkkinen L, Choi YW, Kljuic A, Uitto J, Mahoney MG. Novel member of the mouse desmoglein gene family: Dsg1-beta. Exp Dermatol 2003;12:11-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Puras A, Gonzales-Flores B, Rodrigues R. Treatment of carcinoma of the penis. Proc Kimbrough Urol Semin 1978; 12:143-52. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Rampazzo A, Nava A, Malacrida S, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2002; 71:1200-6. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Rice RH, Green H. Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: Activation of the cross-linking by calcium ions. Cell 1979; 18:681-94. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Rieger-Christ KM, Ng L, Hanley RS, et al. Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential. Br J Cancer 2005; 92:2153-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Ritchie AW, Foster PW, Fowler S. Penile cancer in the UK. Clinical presentation and outcome in 1998/99. BJU Int 2004; 94:1248-252. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Robinson NA, LaCelle PT, Eckert RL. Involucrin is a covalently crosslinked constituent of highly purified epidermal corneocytes: evidence for a common pattern of involucrin crosslinking in vivo and in vitro. J Invest Dermatol 1996; 107:101-7. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Robinson NA, Lapic S, Welter JF, Eckert RL. S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J Biol Chem 1997; 272:12035-46. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Rosemberg SK, Hennan G, Elfonte E. Sexually Transmited papillomaviral infection in male. VII. Is cancer of penis sexually transmited? Urology 1991; 37:437-40. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Rosen ED. The molecular control of adipogenesis, with special reference to lymphatic pathology. Ann N Y Acad Sci 2002; 979:143-58. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Ruiz P, Brinkmann V, Ledermann B, et al. Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J Cell Biol 1996; 135:215-25. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Runswick SK, O’Hare MJ, Jones L, Streuli CH, Garrod DR. Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat Cell Biol 2001; 3:82330. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Sadot E, Simcha I, Iwai K, Ciechanover A, Geiger B, Ben-Ze’ev A. Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system. Oncogene 2000; 19:1992-2001. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Saisorn I, Lawrentschuk N, Leewansangtong S, Bolton DM. Fine-needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma. BJU Int 2006; 97:1225-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Sarkar FH, Miles BJ, Plieth DH, Crissman JD. Detection of human papillomavirus in squamous neoplasm of the penis. J Urol 1992; 147:389-92. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Scheiner MA, Campos MM, Ornellas AA, Chin EW, Ornellas MH, Andrada-Serpa MJ. Human papillomavirus and penile cancers in Rio de Janeiro, Brazil: HPV typing and clinical features. Int Braz J Urol 2008; 34:467-74. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Schellhammer PF, Jordan GH, Schlossberg SM. Tumors of the penis. In: Walsh PC, Retik AB, Stamey TA, Vaughan Jr ED, editors. Campbell`s urology. 6th ed. Philadelphia: W.B. Saunders; 1992. p.1264-98. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Schmidt A, Langbein L, Rode M, Pratzel S, Zimbelmann R, Franke WW. Plakophilins 1a and 1b: widespread nuclear proteins recruited in speci?c epithelial cells as desmosomal plaque components. Cell Tissue Res 1997; 290:481-99. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Serre G, Mils V, Haftek M, et al. Identi?cation of late differentiation antigens of human corni?ed epithelia, expressed in re-organized desmosomes and bound to cross-linked envelope. J Invest Dermatol 1991; 97:1061-72. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Shiina H, Breault JE, Basset WW, et al. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res 2005; 65:2130-8.";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Simcha I, Shtutman M, Salomon D, et al. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin. J Cell Biol 1998; 141:1433-48. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Simon M, Jonca N, Guerrin M, et al. Re?ned characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem 2001; 276:20292-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Slaton JW, Morgenstern N, Levy DA, et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol 2001; 156:1138-42. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Smith EA, Fuchs E. De?ning the interactions between intermediate ?laments and desmosomes. J Cell Biol 1998; 141:1229-41. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Soares FA, da Cunha IW, Guimarães GC, Nonogaki S, Campos RSM, Lopes A. The expression of metaloproteinases-2 and -9 is different according to the patterns of growth and invasion in squamous cell carcinoma of the penis. Virchows Arch 2006; 449:637-46. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Solsona E, Iborra I, Ricos JV, et al. Corpus cavernosum invasion and tumor grade in the predition of lymph node condition in penile carcinoma. Eur Urol 1992; 22:1158. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Solsona E, Iborra I, Rubio J, Casnova JL, Ricos JV, Calabuig C. Prospective validation of the association of local tumor stage and grades as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal nodes. J Urol 2001; 165:1506-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Srinivas V, Morse MJ, Herr HW, Sogani PC, Whitmore Jr WF. Penile cancer: relation of extent of metastasis to survival. J Urol 1987; 137:880-2. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Srougi M, Simon SD. Câncer urologico. São Paulo: Platina; 1990. Cancer do pênis; p.439-60. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Stappenbeck TS, Green KJ. The desmoplakin carboxyl terminus coaligns with and speci?cally disrupts intermediate ?lament networks when expressed in cultured cells. J Cell Biol 1992; 116:1197-209.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Stappenbeck TS, Lamb JA, Corcoran CM, Green KJ. Phosphorylation of the desmoplakin COOH terminus negatively regulates its interaction with keratin intermediate ?lament networks. J Biol Chem 1994; 269:29351-4. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Staubitz WJ, Melborne HL, Oberkircher OJ. Carcinoma of the penis. Cancer 1955; 8:371-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;Steinert PM, Marekov LN. Direct evidence that involucrin is a major early isopeptide crosslinked component of the keratinocyte cornified cell envelope. J Biol Chem 1997, 272:2021-30. ;
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;Steinert PM, Marekov LN. Initiation of assembly of the cell envelope barrier structure of stratified squamous epithelia. Mol Biol Cell 1999, 10:4247-61. ;
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Sufrin G, Huben R. Benignant and malignant lesions of the penis. In: Gillewnateer JY, editor. Adult and pediatric urology. 2nd ed. Chicago: Year Book Medical; 1987. p.1462-3. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Sun W, Zhang PL, Herrera GA. p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder. Appl Immunohistochem Mol Morphol 2002; 10:327-31. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Suske G. The Sp-family of transcription factors. Gene 1999; 238:291-300. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Tanis PJ, Lont AP, Meinhardt W, et al. Dynamic sentinel node biopsy for penile cancer: realiability af a staging technique. J Urol 2002; 168:76-80. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Taylor G, Lehrer MS, Jensen PJ, et al: Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 2000; 102:451-61. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Thastrup O, Dawson AP, Scharff O, et al. Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. Agents Actions 1989; 27:17-23.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Thastrup O, Cullen PJ, Brobak BK, et al. Thapsigargin, a tumor promoter, discharges intracellular Ca2 þ stores by speci?c inhibition of the endo-plasmic reticulum Ca2 þ -APTase. Proc Natl Acad Sci USA 1990; 87:2466-70. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Tolhuis B, Palstra RJ, Splinter E, et al. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell 2002; 10:1453-65. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Troyanovsky SM, Troyanovsky RB, Eshkind LG, Leube RE, Franke WW. Identi?cation of amino acid sequence motifs in desmocollin, a desmosomal glycoprotein, that are required for plakoglobin binding and plaque formation. Proc Natl Acad Sci USA 1994; 91:10790-4. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Tselepis C, Chidgey M, North A, Garrod D. Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci USA 1998; 95:8064-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Tsuda H, Sakamaki C, Fukutomi T, Hirohashi S. Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites. Br J Cancer 1997; 75:1519-24. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Tsukamoto T. Establishment and characterization of a cell line (KU-8) from squamous cell carcinoma of the penis. Keio J Med 1989; 38:277-93. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"van Hengel J, Gohon L, Bruyneel E, et al. Protein kinase C activation upregulates intercellular adhesion of alpha-catenin-negative human colon cancer cell variants via induction of desmosomes. J Cell Biol 1997; 137:1103-16. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Varma VA, Sanchez-Lanier M, Unger ER, et al. Association of human papillomavirus with penile carcinoma: a study using polymerase chain reaction and in situ hybridization. Hum Pathol 1991; 22:908-13. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Vasioukhin V, Bauer C, Yin M, Fuchs E. Directed actin polymerization is the driving force for epithelial cell–cell adhesion. Cell 2000;100:209-19. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Vasioukhin V, Bowers E, Bauer C, Degenstein L, Fuchs E. Desmoplakin is essential in in epidermal sheet formation. Nat Cell Biol 2001; 3:1076-85. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Vatanasapt V, Martin N, Sriplung MH, et al. Cancer incidence in Thailand, 19881991. Cancer Epidemiol Biomarkers Prev 1995; 4:475-83. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Velazquez EF, Melamed J, Barreto JE, Aguero F, Cubilla AL. Sarcomatoid carcinoma of the penis: a clinicopathologic study of 15 cases. Am J Surg Pathol 2005; 29:1152-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Velazquez EF, Cubilla AF. Penile squamous cell carcinoma. Anatomic, Pathologic and viral studies in Paraguay (1993-2007). Anal Quant Cytol Histol 2007; 29:185198. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Velazquez EF, Ayala G, Liu H, et al. Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm. Am J Surg Pathol 2008; 32:974-9.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Villa LL, Lopes A. Human papillomavirus DNA sequence in penile carcinoma in Brazil. Int J Cancer 1986; 37:853-5. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Wajsman Z, Moure RH, Merrin CE, Murphy GP. Surgical treatment of penile carcinoma: a follow-up report. Cancer 1977; 40:1697-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Wallis S, Lloyd S, Wise I, Ireland G, Fleming TP, Garrod D. The alpha isoform of protein kinase C is involved in signaling the response of desmosomes to wounding in cultured epithelial cells. Mol Biol Cell 2000; 11:1077-92. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Wang S, Saboorian MH, Frenkel EP, et al. Assessment of HER-2/neu status in breast cancer: Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. Am J Clin Pathol 2001; 116:495-503. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Wang L, Liu T, Wang Y, Cao L, Nishioka M, Aguirre RL, Ishikawa A, Geng L, Okada N. Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation. Virchows Arch 2007; 451:959-66. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Weil M, Raff MC, Braga VM. Caspase activation in the terminal differentiation of human epidermal keratinocytes. Curr Biol 1999; 9:361-4. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Weiske J, Schoneberg T, Schroder W, Hatzfeld M, Tauber R, Huber O. The fate of desmosomal proteins in apoptotic cells. J Biol Chem 2001; 276:41175-81. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Welter JF, Crish JF, Agarwal C, Eckert RL. Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity. J Biol Chem 1995; 270:12614-22. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Wesper E, Simon J, Schulman CC. Cabaña approach: is sentinel node biopsy realiable for staging penile carcinoma? Urology 1986; 28:278-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"White P, Aberle H, Vincent JP. Signaling and adhesion activities of mammalian beta-catenin and plakoglobin in Drosophila. J Cell Biol 1998; 140:183-95. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Whittock NV. Genomic sequence analysis of the mouse desmoglein cluster reveals evidence for six distinct genes: characterization of mouse DSG4, DSG5, and DSG6. J Invest Dermatol 2003; 120:970-80. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Whittock NV, Bower C. Genetic evidence for a novel human desmosomal cadherin, desmoglein 4. J Invest Dermatol 2003; 120:523-30. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Wiche G. Role of plectin in cytoskeleton organization and dynamics. J Cell Sci 1998; 111:2477-86. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Wiener JS, Effert PJ, Humphrey PA, YU L, Liu ET, Walther PJ. Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a restropective analysis of primary and metastatic lesions by differential polymerase chain reation. Int J Cancer 1992; 50:694-701. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Wiener JS, Walther PJ. The association of oncogenic human papillomaviruses with urologic malignancy. Surg Oncol Clin North Am 1995; 4:257-76. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Williams BO, Barish GD, Klymkowsky MW, Varmus HE. A comparative evaluation of beta-catenin and plakoglobin signaling activity. Oncogene 2000;19:5720-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Windoffer R, Borchert-Stuhltrager M, Leube RE. Desmosomes: interconnected calcium-dependent structures of remarkable stability with signi?cant integral membrane protein turnover. J Cell Sci 2002;115:1717-32. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Winn RA, Bremnes RM, Bemis L, Franklin WA, Miller YE, Cool C, Heasley LE. Gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 2002; 21:7497-506. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Wu RL, Chen TT, Sun TT. Functional importance of an Sp1- and an NFkB-related nuclear protein in a keratinocyte-speci?c promoter of rabbit K3 keratin gene. J Biol Chem 1994; 269:28450-9. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Wu Y, Zhang X, Zehner ZE. c-Jun and the dominant-negative mutant, TAM67, induce vimentin gene expression by interacting with the activator Sp1. Oncogene 2003; 22:8891-901. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Yaffe MB, Beegen H, Eckert RL. Biophysical characterization of involucrin reveals a molecule ideally suited to function as an intermolecular cross-bridge of the keratinocyte cornified envelope. J Biol Chem 1992; 267:12233-8. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Yanagawa N, Osakabe M, Hayashi M, Tamura G, Motoyama T. Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas. Wirchows Arch 2008; 452:377-82.  ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Yashiro M, Nishioka N, Hirakawa K. Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma. Eur J Cancer 2006; 42:2397-403. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Yin T, Green KJ. Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol 2004;15:665-77. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Young MD, Reda DJ, Walters WB. Penile carcinoma: a twenty-five years experience. Urology 1991; 38:529-32. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Zhurinsky J, Shtutman M, Ben-Ze’ev A. Plakoglobin and beta-catenin: protein interactions, regulation and biological roles. J Cell Sci 2000a;113(Pt 18):3127–39. ";
FAP;2010;GUSTAVO CARDOSO GUIMARÃES;Ademar Lopes;Fernando Augusto Soares;"Zhurinsky J, Shtutman M, Ben-Ze’ev A. Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin. Mol Cell Biol 2000b; 20(12):4238–52. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Aluffi P, Policarpo M, Cherovac C, Olina M, Dosdegani R. Post-thyroidectomy superior laryngeal nerve injury. Eur Arch Otorhinolaryngol 2001; 258:451-4. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Akyildiz S, Ogut F, Akyildiz M, Engin EZ. A multivariate analysis of objective voice changes after thyroidectomy without laryngeal nerve injury. Arch Otolaryngol Head Neck Surg 2008; 134:596-602. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Angelos P. Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues. Surg Clin North Am 2009; 89:1157-69. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Arakawa-Sugueno L. Voz e deglutição de pacientes com e sem mobilidade laríngea após tireoidectomia. São Paulo; 2007. [Tese de doutorado-Universidade de São Paulo]. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Atallah I, Dupret A, Carpentier AS, Weingertner AS, Volkmar PP, Rodier JF. Role of intraoperative neuromonitoring of the recurrent laryngeal nerve in high-risk thyroid surgery. J Otolaryngol Head Neck Surg 2009; 38:613-8. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Baken RJ. Clinical measurement of speech and voice. 3rd ed. San Diego: Singular Publishing Group; 1996. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Behlau M, Madazio G, Feijó D, Pontes P. Avaliação de voz. In: Behlau M, editor. Voz: o livro do especialista. Rio de Janeiro: Revinter; 2001. p.120-1. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Beldi G, Kinsbergen T, Schlumpf R. Evaluation of intraoperative recurrent nerve monitoring in thyroid surgery. World J Surg 2004; 28:589-91. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Benninger MS, Gillen JB, Altman JS. Changing etiology of vocal fold immobility. Laryngoscope 1998; 108:1346-50. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Bhattacharyya N, Fried MP. Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg 2002; 128:389-92. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Bhuta T, Patrick L, Garnett JD. Perceptual evaluation of voice quality and its correlation with acoustic measurements. J Voice 2004; 18:299-304. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Bicknell PG. Mild hypothyroidism and its effects on the larynx. J Laryngol Otol 1973; 87:123-7. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Brauckhoff M, Gimm O, Thanh PN, et al. First experiences in intraoperative neurostimulation of the recurrent laryngeal nerve during thyroid surgery of children and adolescents. J Pediatr Surg. 2002; 37:1414-8. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Brewer DW, Gould LV. Pyriform sinus: functional visualization. Ann Otol 1974; 83:720-4. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Cavicchi O, Caliceti U, Fernandez IJ, et al. The value of neurostimulation and intraoperative nerve monitoring of inferior laryngeal nerve in thyroid surgery. Otolaryngol Head Neck Surg 2009; 140:866-70. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Cernea C, Ferraz A, Fulani J, et al. Indetification of the external branch of the superior laryngeal nerve during thyroidectomy. Am J Surg 1992; 164:634-8. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Chan WF, Lo CY. Pitfalls of intraoperative neuromonitoring for predicting postoperative recurrent laryngeal nerve function during thyroidectomy. World J Surg 2006; 30:806-12. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Chan WF, Lang BH, Lo CY. The role of intraoperative neuromonitoring of recurrent laryngeal nerve during thyroidectomy: a comparative study on 1000 nerves at risk. Surgery 2006; 140:866-72 ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Chiang FY, Lu IC, Kuo WR, Lee KW, Chang NC, Wu CW. The mechanism of recurrent laryngeal nerve injury during thyroid surgery--the application of intraoperative neuromonitoring. Surgery 2008; 143:743-9. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Chiang FY, Lee KW, Chen HC, et al. Standardization of intraoperative neuromonitoring of recurrent laryngeal nerve in thyroid operation. World J Surg 2010; 34:223-9. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Choby G, Hollenbeak CS, Johnson S, Goldenberg D. Surface electrode recurrent laryngeal nerve monitoring during thyroid surgery: normative values. J Clin Neurophysiol 2010; 27:34-7. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Crumley RL. Repair of the recurrent laryngeal nerve. Otolaryngol Clin North Am 1990; 23:553-63. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Dackiw AP, Rotstein LE, Clark OH. Computer-assisted evoked electromyography with stimulating surgical instruments for recurrent/external laryngeal nerve identification and preservation in thyroid and parathyroid operation. Surgery 2002; 132:1100-6. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Debruyne F, Ostyn F, Delaere P, Wellens, W. Acoustic analysis of the speaking voice after thiroidectomy. J Voice 1997a; 11:479-82. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Debruyne F, Ostyn F, Delaere P, Wellens W, Decoster W. Temporary voice changes after uncomplicated thyroidectomy. Acta Otorhinolariryngol Belg 1997b; 51:13740. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"De Pedro Netto I, Fae A, Vartanian JG, et al. Voice and vocal self-assessment after thyroidectomy. Head Neck 2006; 28:1106-14. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Donnellan KA, Pitman KT, Cannon CR, Replogle WH, Simmons JD. Intraoperative laryngeal nerve monitoring during thyroidectomy. Arch Otolaryngol Head Neck Surg 2009; 135:1196-8. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Dralle H, Sekulla C, Haerting J, et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 2004; 136:1310-22. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Dralle H, Sekulla C, Lorenz K, Brauckhoff M, Machens A. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery. World J Surg 2008; 32:1358-66. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Eisele DW. Intraoperative electrophysiologic monitoring of the recurrent laryngeal nerve. Laryngoscope 1996; 106:443-9.  ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Farrag TY, Samlan RA, Lin FR, Tufano RP. The utility of evaluating true vocal fold motion before thyroid surgery. Laryngoscope 2006; 116:235-8. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Friguglietti CUM, Lin CS, Kulcsar MAV. Total thyroidectomy for benign thyroid disease. Laryngoscope 2003; 113:1820-6. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Gonçalves Filho J, Kowalski LP. Surgical complications after thyroid surgery performed in a cancer hospital. Otolaryngol Head Neck Surg 2005; 132:490-4. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Greenblatt DY, Sippel R, Leverson G, Frydman J, Schaefer S, Chen H. Thyroid resection improves perception of swallowing function in patients with thyroid disease. World J Surg 2009; 33:255-60. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Hermann M, Alk G, Roka R, Glaser K, Freissmuth M. Laryngeal recurrent nerve injury in surgery for benign thyroid diseases: effect of nerve dissection and impact of individual surgeon in more than 27,000 nerves at risk. Ann Surg 2002; 235:261-8. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Hermann M, Hellebart C, Freissmuth M. Neuromonitoring in thyroid surgery. Ann Surg 2004; 240:9-17. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Hirano M. Clinical examination of voice. New York: Springer-Verlag; 1981. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Hirano S, Bless DM, Río AM, Connor NP, Ford CN. Therapeutic potential of growth factors for aging voice. Laryngoscope 2004; 114:2161-7. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Holt GR, McMurry GT, Joseph DJ. Recurrent laryngeal nerve injury following thyroid operations. Surg Gynecol Obstet 1977; 144:567-70. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Hong KH, Kim YK. Phonatory characteristics of patients undergoing thyroidectomy without laryngeal nerve injury. Otolaryngol Head Neck Surg 1997; 117:399-404. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Hong KH, Ye M, Kim YM, Kevorkian KF, Berke GS. The role of strap muscles in phonation – in vivo canine laryngeal model. J Voice 1997; 11:23-32. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Horne SK, Gal TJ, Brennan JA. Prevalence and patterns of intraoperative nerve monitoring for thyroidectomy. Otolaryngol Head Neck Surg 2007; 136:952-6. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 2000; 89:202-17. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Isshiki N, Yanagihara N, Morimoto M. Approach to the objective diagnosis of hoarseness. Folia Phoniatr 1966; 18:383-400. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Jacobson BH, Jonson A, Grywalski C, et al. The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 1997; 6:66-70. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Jansson S, Tissel L, Hagne I, et al. Partial superior laryngeal nerve lesions before and after thyroid surgery. World J Surg 1988; 12:522-7. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Jonas J, Bähr R. Neuromonitoring of the external branch of the superior laryngeal nerve during thyroid surgery. Am J Surg 2000; 179:234-6. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Kark AE, Kissin MW, Auerbach R, Meikle M. Voice changes after thyroidectomy: role of the external laryngeal nerve. Br J Med 1984; 289:1412-5. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Kovács V, Teymoortash A, Werner JA, Lichtenberger G. Bilateral vocal cord paralysis associated with laryngeal myxedema. Eur Arch Otorhinolaryngol 2010; 267:565-70. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Lifante JC, McGill J, Murry T, Aviv JE, Inabnet WB 3rd. A prospective, randomized trial of nerve monitoring of the external branch of the superior laryngeal nerve during thyroidectomy under local/regional anesthesia and IV sedation. Surgery 2009; 146:1167-73. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Lombardi CP, Raffaelli M, D'Alatri L, et al. Voice and swallowing changes after thyroidectomy in patients without inferior laryngeal nerve injuries. Surgery 2006; 140:1026-32. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Lombardi CP, Raffaelli M, Crea DC, et al. Long-term outcome o f functional post thyroidectomy voice and swallowing symptoms. Surgery 2009; 146:1174-81. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Lombi AC. Disorders of the voice and hyperthyroidsm. Prensa Med Argent 1961; 48:3217-9. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Lu IC, Chu KS, Tsai CJ, et al.. Optimal depth of NIM EMG endotracheal tube for intraoperative neuromonitoring of the recurrent laryngeal nerve during thyroidectomy. World J Surg 2008; 32:1935-9. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Lundy DS, Casiano RR, Shatz D, Reisberg M, Xue JW. Laryngeal injuries after short- versus long-term intubation. J Voice 1998; 12:360-5. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"McIvor NP, Flint DJ, Gillibrand J, Morton, RP. Thyroid surgery and voice-related outcomes. Aust N Z J Surg 2000; 70:179-83.  ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Mehanna H, Muthu A, Chaplin J, McIvor N, Gilligrand J, Morton R. The effects of division of strap muscles on voice post-thyroidectomy. [Apresentado ao 6th International Conference on Head and Neck Cancer; 2004a agosto; Washington DC, EUA]. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Mehanna H, Muthu A, Chaplin J, McIvor N, Gilligrand J, Morton R. The effects of limited external laryngeal nerve identification voice post-thyroidectomy. [Apresentado ao 6Th International Conference on Head and Neck Cancer; 2004b agosto; Washington DC, EUA]. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Montesinos MR, Falco JE, Sinagra DL, et al. Morbilidad de la tiroidectomía total en el carcinoma diferenciado de tiroides. Rev Argent Cir 1999; 76:8-12. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Page C, Zaatar R, Biet A, Strunski V. Subjective voice assessment after thyroid surgery: a prospective study of 395 patients. Indian J Med Sci 2007; 61:448-54. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Painter NS. Results of surgery in the treatment of toxic goiter – review of 172 cases. Br J Surg 1960; 48:291-6. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Paulsen FP, Rudert HH, Tillmann BN. New insights into the pathomechanism of postintubation arytenoids subluxation. Anesthesiology 1999; 91:659-66. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Parving HH, Hansen JM, Nielsen SL, Rossing N, Munck O, Lassen NA. Mechanisms of edema formation in myxedema-increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med 1979; 301:460-5. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Pereira JA, Girvent M, Sancho JJ, Parada C, Sitges-Serra A. Prevalence of long-term upper aerodigestive symptoms after uncomplicated bilateral thyroidectomy. Surgery 2003; 133:318-22. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Prim MP, Diego JI, Hardisson D, Madero R, Gavilan J. Factors related to nerve injury and hypocalcemia in thyroid gland surgery. Otolaryngol Head Neck Surg 2001; 124:111-4. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Randolph GW, Kamani D. The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. Surgery 2006; 139:357-62. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Roy AD, Gardiner RH, Niblock WM. Thyroidectomy and the recurrent laryngeal nerve. Lancet 1956; I:988-9. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"de Roy van Zuidewijn DB, Songun I, Kievit J, van de Velde CJ. Complications of thyroid surgery. Ann Surg Oncol 1995; 2:56-60. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Sapienza CM. Dutka J. Glottal Air Flow Characteristics of women’s voice production along an aging continum. J Speech Hear Res 1996; 39:322-8. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Sataloff RT, Spiegel JR, Caroll LM, Heuer RJ. Male soprano voice: a rare complication of thyroidectomy. Laryngoscope 1992; 102:90-3. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Shimokojin T, Takenoshita M, Sakai T, Yoshikawa K. Vocal cord bowing as a cause of long-lasting hoarseness after a few hours of tracheal intubation. Anesthesiology 1998; 89:785-7. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Shindo M, Chheda NN. Incidence of vocal cord paralysis with and without recurrent laryngeal nerve monitoring during thyroidectomy. Arch Otolaryngol Head Neck Surg 2007; 133:481-5. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Sinagra DL, Montesinos MR, Tacchi VA, et al. Voice changes after thyroidectomy without recurrent laryngeal nerve injury. J Am Coll Surg 2004; 199:556-60. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Sonkin N. Voice changes in hypothyroidism. RI Med J 1964; 47:19-20. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Song P, Shemen L. Electrophysiologic laryngeal nerve monitoring in high-risk thyroid surgery. Ear Nose Throat J 2005; 84:378-81. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Sorensen JM, Cooper WE. Syntactic coding of fundamental frequency in speech production. In: Cole RA editor. Perception and production of fluent speech. New Jersey: Hillsdale; 1980. p.399-440. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Soylu L, Ozbas S, Uslu HY, Kocak S. The evaluation of the causes of subjective voice disturbances after thyroid surgery. Am J Surg. 2007; 194:317-22. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Stemple JC, Glaze LE, Klaben BG. Clinical voice pathology: theory and management. 3rd ed. San Diego: Singular Publishing Group; 2000. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Steurer M, Passler C, Denk DM, Schneider B, Niederle B, Bigenzahn W. Advantages of recurrent laryngeal nerve identification in thyroidectomy and parathyroidectomy and the importance of preoperative and postoperative laryngoscopic examination in more than 1000 nerves at risk. Laryngoscope 2002; 112:124-33. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Stojadinovic A, Shaha AR, Orlikoff RF, et al. Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg 2002; 236:823-32. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Stojadinovic A, Henry LR, Howard RS, et al. Prospective trial of voice outcomes after thyroidectomy: evaluation of patient-reported and clinician-determined voice assessments in identifying postthyroidectomy dysphonia. Surgery 2008; 143:732-42. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Sturgeon C, Sturgeon T, Angelos P. Neuromonitoring in thyroid surgery: attitudes, usage patterns, and predictors of use among endocrine surgeons. World J Surg 2009; 33:417-25. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Teitelbaum B, Wenig B. Superior laryngeal nerve injury from thyroid surgery. Head Neck 1995; 17:36-40. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Thomusch O, Sekulla C, Walls G, Machens A, Dralle H. Intraoperative neuromonitoring of surgery for benign goiter. Am J Surg 2002; 183:673-8. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Timon CI, Rafferty M. Nerve monitoring in thyroid surgery: is it worthwhile? Clin Otolaryngol Allied Sci 1999; 24:487-90. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Tomoda C, Hirokawa Y, Uruno T, et al. Sensitivity and specificity of intraoperative recurrent laryngeal nerve stimulation test for predicting vocal cord palsy after thyroid surgery. World J Surg 2006; 30:1230-3. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Yeung P, Erskine,C, Matheus P, Crowe PJ. Voice changes and thyroid surgery: is pre- operative indirect laryngoscopy necessary? Aust N Z J Surg 1999; 69:632-4. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;"Witt RL. Recurrent laryngeal nerve electrophysiologic monitoring in thyroid surgery: the standard of care? J Voice 2005; 19:497-500. ";
FAP;2010;IRENE DE PEDRO NETTO;Elisabete Carrara-de-Angelis;Luiz Paulo Kowalski;Wu CW, Lu IC, Randolph GW, et al. Investigation of optimal intensity and safety of electrical nerve stimulation during intraoperative neuromonitoring of the recurrent laryngeal nerve: a prospective porcine model. Head Neck 2010 Jan 20. [Epub ahead of print] ;
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Agresti A. Categorical data analysis. 2nd ed. New York: John Wiley and Sons; 2002. Introduction: distributions and inference for categorical data. p.127 ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Agresti A. Categorical data analysis. 2nd ed. New York: John Wiley and Sons; 2002. Inference for contingency tables. p.70-104. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Barczi SR, Sullivan PA, Robbins J. How should dysphagia care of older adults differ? Establishing optimal practice patterns. Semin Speech Lang 2000; 21:347-61. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Bilton TL. Estudo da dinâmica da deglutição e das suas variações associadas ao envelhecimento, avaliadas por videodeglutoesofagograma, em adultos assintomáticos de 20 a 86 anos. São Paulo; 2000. [Tese de Doutorado-Escola Paulista de Medicina]. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Butler SG, Stuart A, Kemp S. Flexible endoscopic evaluation of swallowing in healthy young and older adults. Ann Otol Rhinol Laryngol 2009a; 118:99106. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Butler SG, Stuart A, Markley L, Rees C. Penetration and aspiration in healthy older adults as assessed during endoscopic evaluation of swallowing. Ann Otol Rhinol Laryngol 2009b; 118:190-8. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Chi-Fishman G, Sonies BC. Motor strategy in rapid sequential swallowing: new insights. J Speech Lang Hear Res 2000; 43:1481-92. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Cook IJ, Weltman MD, Wallace K, et al. Influence of aging on oralpharyngeal bolus transit and clearance during swallowing: scintigraphic study. Am J Physiol 1994; 266:G972-7. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Costa MMB. Uso do bolo contrastado sólido, líquido e pastoso no estudo videofluoroscópico da dinâmica da deglutição. Radiol Bras 1996; 29:35-9. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Daggett A, Logemann J, Rademaker A, Pauloski B. Laryngeal penetration during deglutition in normal subjects of various ages. Dysphagia 2006; 21:270-4. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Daniels SK, Corey DM, Hadskey LD, et al. Mechanism of sequential swallowing during straw drinking in healthy young and older adults. J Speech Lang Hear Res 2004; 47:33-45. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Daniels SK, Foundas AL. Swallowing physiology of sequential straw drinking. Dysphagia 2001; 16:176-82. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Daniels SK, Schroeder MF, DeGeorge PC, Corey DM, Rosenbek JC. Effects of verbal cue on bolus flow during swallowing. Am J Speech Lang Pathol 2007; 16:140-7. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Dantas RO, Kern MK, Massey BT, et al. Effect of swallowed bolus variables on oral and pharyngeal phases of swallowing. Am J Physiol 1990; 258G675-81. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Dantas RO, de Aguiar Cassiani R, dos Santos CM, et al. Effect of gender on swallow event duration assessed by videofluoroscopy. Dysphagia 2009; 24:280-4. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Dejaeger E, Pelemans W, Bibau G, Ponette E. Manofluorographic analysis of swallowing in the elderly. Dysphagia 1994; 9:156-61. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Dejaeger E, Pelemans W, Ponette E, Joosten E. Mechanisms involved in postdeglutition retention in the elderly. Dysphagia 1997; 12:63-7. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Dodds WJ. Physiology of swallowing. Dysphagia 1989; 3:171-8. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Dodds WJ, Stewart ET, Logemann JA. Physiology and radiology of the normal oral and pharyngeal phases of swallowing. AJR Am J Roentgenol 1990; 154:953-63. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Dozier TS, Brodsky MB, Michel Y, Walters BC Jr, Martin-Harris B. Coordination of swallowing and respiration in normal sequential cup swallows. Laryngoscope 2006; 116:1489-93. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue--is it useful? Dysphagia 2008; 23:7-15. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Eisenhuber E, Schima W, Schober E, et al. Videofluoroscopic assessment of patients with dysphagia: pharyngeal retention is a predictive factor for aspiration. AJR Am J Roentgenol 2002; 178:393-8. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Ekberg O, Feinberg MJ. Altered swallowing function in elderly patients without dysphagia: radiologic findings in 56 cases. Am J Roentgenol 1991; 156:1181-4. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Frederick MG, Ott DJ, Grishaw EK, Gelfand DW, Chen MY. Functional abnormalities of the pharynx: a prospective analysis of radiographic abnormalities relative to age and symptoms. AJR Am J Roentgenol 1996; 166:353-7. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Groher ME. Distúrbios da deglutição em idosos. In: Furkin AM, Santini CS, editores. Disfagias orofaríngeas. Carapicuíba: Pró-fono; 1999. p.97-107. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Hamlet SL, Muz J, Patterson R, Jones L. Pharyngeal transit time: assessment with videofluoroscopic and scintigraphic techniques. Dysphagia 1989; 4:4-7. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Han TR, Paik NJ, Park JW. Quantifying swallowing function after stroke: a functional dysphagia scale based on videofluoroscopic studies. Arch Phys Med Rehabil 2001; 82:677-82. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Hind JA, Nicosia MA, Roecker EB, Carnes ML, Robbins J. Comparison of effortful and noneffortful swallows in healthy middle-aged and older adults. Arch Phys Med Rehabil 2001; 82:1661-5. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Kahrilas PJ, Logemann JA, Lin S, Ergun GA. Pharyngeal clearance during swallowing: a combined manometric and videofluoroscopic study. Gastroenterology 1992; 103:128-36. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Kendall KA, McKenzie S, Leonard RJ, Gonçalves MI, Walker A. Timimg of events in normal swallowing: a videofluoroscopic study. Dysphagia 2000; 15:74-83. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Kim Y, McCullough GH, Asp CW. Temporal measurements of pharyngeal swallowing in normal populations. Dysphagia 2005; 20:290-6. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Lederman HM, Bilton TL, Suzuki HS. Videodeglutoesofagograma: mudanças fisiológicas da deglutição provocadas pelo envelhecimento. Rev Imagem 2000; 22:175-7. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Leonard R, McKenzie S. Hyoid-bolus transit latencies in normal swallow. Dysphagia 2006; 21:183-90. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Linden P, Siebens AA. Dysphagia: predicting laryngeal penetration. Arch Phys Med Rehabil 1983; 64:281-4. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Linden P, Tippett D, Johnston J, Siebens A, French J. Bolus position at swallow onset in normal adults: preliminary observations. Dysphagia 1989; 4:146-50. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Lindgren S, Janzon L. Prevalence of swallowing complaints and clinical findings among 50-79-year-old men and women in an urban population. Dysphagia 1991; 6:187-92. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA. Effects of aging on the swallowing mechanism. Otolaryngol Clin North Am 1990; 23:1045-56. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA. Evalution and treatment of swallowing disorders. San Diego, College-Hill Press; 1983a. Disorders of deglutition; p.37-86. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA. Evalution and treatment of swallowing disorders. 1ed. San Diego, College-Hill Press; 1983b. Anatomy and physiology of normal deglutition; p.13-52. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA. Manual for the videofluorography study of swallowing. 2nd ed. Texas: Pro-ed; 1993a. Measurements of swallow from videofluorographic studies; p.115-26. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA. Manual for the videofluorography study of swallowing. 2nd ed. Texas: Pro-ed; 1993b. Normal radiographic anatomy and physiology of the oropharynx; p.7-27. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA. Manual for the videofluorography study of swallowing. 2nd ed. Texas: Pro-ed; 1993c. Radiographic symptoms and swallowing disorders; p.73-114. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA, Kahrilas PJ, Smith CH. Temporal and biomechanical characteristics of oropharyngeal swallow in younger and older men. J Speech Lang Hear Res 2000; 43:1264-74. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA, Pauloski BR, Rademaker AW, Kahrilas PJ. Oropharyngeal swallow in younger and older women: videofluoroscopic analysis. J Speech Lang Hear Res 2002; 45:434-45. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Marchesan IQ. Disfagias orofaríngeas. Carapicuíba: Pró-fono; 1999. Deglutição-normalidade; p.3-18. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Martin-Harris B, Brodsky MB, Michel Y, et al. MBS measurement tool for swallow impairment--MBSImp: establishing a standard. Dysphagia 2008; 23:392-405.  ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Martin-Harris B, Brodsky MB, Michel Y, Ford CL, Walters B, Heffner J. Breathing and swallowing dynamics across the adult lifespan. Arch Otolaryngol Head Neck Surg 2005a; 131:762-70. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Martin-Harris B, Michel Y, Castell DO. Physiologic model of oropharyngeal swallowing revisited. Otolaryngol Head Neck Surg 2005b; 133:234-40. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Martin-Harris B, Brodsky MB, Michel Y, Lee FS, Walters B. Delayed initiation of the pharyngeal swallow: normal variability in adult swallows. J Speech Lang Hear Res 2007; 50:585-94. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Martin-Harris B, Jones B. The videofluorographic swallowing study. Phys Med Rehabil Clin N Am 2008; 19:769-85. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Matsuo K, Palmer JB. Anatomy and physiology of feeding and swallowing: normal and abnormal. Phys Med Rehabil Clin N Am 2008; 19:691-707. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"McConnel FM, Cerenko D, Jackson RT, Guffin TN Jr. Timing of major events of pharyngeal swallowing. Arch Otolaryngol Head Neck Surg 1988a; 114:1413-8. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"McConnel FM. Analysis of pressure generation and bolus transit during pharyngeal swallowing. Laryngoscope 1988b; 98:71-8. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Nilsson H, Ekberg O, Olsson R, Hindfelt B. Quantitative aspects of swallowing in an elderly nondysphagic population. Dysphagia 1996; 11:1804. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Palmer JB, Hiiemae KM, Matsuo K, Haishima H. Volitional control of food transport and bolus formation during feeding. Physiol Behav 2007; 91:6670. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Palmer JB, Kuhlemeier KV, Tippett DC, Lynch C. A protocol for the videofluorographic swallowing study. Dysphagia 1993; 8:209-14. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Perlman AL, Booth BM, Grayhack JP. Videofluoroscopic predictors of aspiration in patients with oropharyngeal dysphagia. Dysphagia 1994; 9:905. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Pikus L, Levine MS, Yang YX, et al. Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol 2003; 180:1613-6. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Robbins J, Hamilton JW, Lof GL, Kempster GB. Oropharyngeal swallowing in normal adults of different ages. Gastroenterology 1992; 103:823-9. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Robbins J, Levine R, Wood J, Roecker EB, Luschei E. Age effects on lingual pressure generation as a risk factor for dysphagia. J Gerontol A Biol Sci Med Sci 1995; 50:257-62. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Robbins JA, Coyle J, Rosenbek J, Roecker E, Wood J. Differentiation of normal and abnormal airway protection during swallowing using the Penetration-Aspiration Scale. Dysphagia 1999; 14:228-32. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetrationaspiration scale. Dysphagia 1996; 11:93-8. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Tracy JF, Logemann JA, Kahrilas PJ, Jacob P, Kobara M, Krugler C. Preliminary observations on the effects of age on oropharyngeal deglutition. Dysphagia 1989; 4:90-4. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Vale-Prodomo LP, Carrara-de Angelis E, Barros APB. Avaliação clínica fonoaudilógica das disfagias. In: Jotz GP, Carrara-de Angelis E, Barros APB, editores. Tratado da deglutição e disfagia: no adulto e na criança. Rio de Janeiro: Revinter; 2009. p.61-7. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Veis S, Logemann JA, Colangelo L. Effects of three techniques on maximum posterior movement of the tongue base. Dysphagia 2000; 15:142-5. ";
FAP;2010;LUCIANA PASSUELLO DO VALE-PRODOMO;Elisabete Carrara-de-Angelis;-x-;"Yoshikawa M, Yoshida M, Nagasaki T, et al. Aspects of swallowing in healthy dentate elderly persons older than 80 years. J Gerontol A Biol Sci Med Sci 2005; 60:506-9. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Aghaloo TL, Moy PK, Freymiller EG. Evaluation of platelet-rich plasma in combination with freeze-dried bone in the rabbit cranium. Clin Oral Implant Res 2005; 16:250-7. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Aghaloo TL, Le AD, Freymiller EG, Avera S, Shimizu K, Nishimura RD. Immunohistochemical analysis of cortical and cancellous bone after radiation and the effect of platelet-rich plasma on autogenous bone grafting. Int J Oral Maxillofac Implants 2006; 21:535-42. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Alsaadi G, Quirynen M, Komárek A, van Steenberghe D. Impact of local and systemic factors on the incidence of late oral implant loss. Clin Oral Implant Res 2008; 19:670-6. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Anitua E. Plasm rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999; 14:529-35. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Asikainen P, Klemetti E, Kotilainen R, et al. Osseointegration of dental implants in bone irradiated with 40, 50 or 60 Gy doses. Clin Oral Implant Res 1998; 9:20-5. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Beck TJ. Avaliação da interface implante/osso de implantes de uso odontológico em tíbias de coelho. São Paulo; 1997. [Tese de DoutoradoInstituto de Ciências Biomédicas-USP]. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Behmer AO, Tolosa EMC, Freitas Neto AG. Manual de técnicas para histologia normal e patológica. São Paulo: Edart; 1976. Coloração do tecido conjuntivo; p.109-31. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Brogniez V, D´Hoore W, Grégoire V, Munting E, Reychler H. Implants placed in an irradiated dog mandible: a morphometric analysis. Int J Oral Maxillofac Implants 2000; 15:511-8. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Brogniez V, Nyssen-Behets C, Grégoire V, Reychler H, Lengelé B. Implant osseointegration in the irradiated mandible. A comparative study in dogs with a microradiographic and histologic assessment. Clin Oral Implant Res 2002; 13:234-42. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Casati MZ, de Vasconcelos Gurgel BC, Gonçalves PF, et al. Platelet-rich plasma does not improve bone regeneration around peri-implant bone defects--a pilot study in dogs. Int J Oral Maxillofac Surg 2007; 36:132-6. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Esser E, Wagner W. Dental implants following radical oral cancer surgery and adjuvant radiotherapy. Int J Oral Maxillofac Implants 1997; 12:552-7. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Fontana S, Olmedo DG, Linares JA, Guglielmotti MB, Crosa ME. Effect of platelet-rich plasma on the peri-implant bone response: an experimental study. lmplant Dentistry  2004; 13:73-8. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Fuerst G, Gruber R, Tangl S, Sanroman F, Watzek G. Effects of fibrin sealant protein concentrate with and without platelet-released growth factors on bony healing of cortical mandibular defects: an experimental study in minipigs. Clin Oral Implants Res 2004; 15:301-7. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Granström G. Osseointegration in irradiated cancer patients: an analysis with respect to implants failures. J Oral Maxillofac Surg 2005; 63:579-85. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Granström G, Bergström K, Tjellström A, Brånemark PI. A detailed analysis of titanium implants lost in irradiated tissues.  Int J Oral Maxillofac Implants 1994; 9:653-62. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Harrison JS, Stratemann S, Redding SW. Dental implants for patients who have had radiation treatment for head and neck cancer. Spec Care Dentist 2003; 23:223-9 ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Ihde S, Kopp S, Gundlach K, Konstantinovic VS. Effects of radiation therapy on craniofacial and dental implants: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107:56-65. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Iizuka T, Häfliger J, Seto I, Rahal A, Mericske-Stern R, Smolka K. Oral rehabilitation after mandibular reconstruction using an osteocutaneous fibula free flap with endosseous implants: factors affecting the functional outcome in patients with oral cancer. Clin Oral Impl Res 2005; 16: 69-79. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Ito K, Yamada Y, Naiki T, Ueda M. Simultaneous implant placement and bone regeneration around dental implants using tissue-engineered bone with fibrin glue, mesenchymal stem cells and platelet-rich plasma. Clin Oral Implant Res 2006; 17:579-86. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Jansen JA. Histological analysis of bone-implant interface. In: An YH, Martin KL, editors. Handbook of histology methods for bone and cartilage. New Jersey: Humana Press Inc; 2003. p.353-60. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Johnsson AA, Sawaii T, Jacobsson M, Granström G, Turesson I. A histomorphometric and biomechanical study of the effect of delayed titanium implant in irradiated rabbit bone. Clin Implant Dent Related Res 2000; 2:429. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Johnsson K, Hansson A, Granström G, Jacobsson M, Turesson I. The effects of hyperbaric oxygenation on bone-titanium implant interface strength with and without preceding irradiation. Int J Oral Maxillofac Implants 1993; 8:415-9. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Kim SG, Kim WK, Park JC, Kim HJ. A comparative study of osseointegration of Avana implants in a demineralized freeze-dried bone alone or with plateletrich plasma. J Oral Maxillofac Surg 2002; 60:1018-25. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"König Jr B. A Study of Different Calcification Areas in Newly Formed Bone Eight Weeks after Insertion of Dental Implants in Rabbit`s Tibias. Ann Anat 1998; 180:471-5. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Larsen PE, Stronczek MJ, Beck FM, Rohrer M Osteointegration of implants in radiated bone with and without adjunctive hyperbaric oxygen. J Oral Maxillofac Surg 1993; 51:280-7. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Lugero GG, Caparbo VF, Guzzo ML, König Jr B, Jorgetti V. Histomorphometric evaluation of titanium implants in osteoporotic rabbits. Implant Dentistry 2000; 9:303-9. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Mayer MN, Yoshikawa H, Moriarity L, Sidhu N. Use of a petroleum-based bolus for photon radiation therapy of distal extremities in dogs. Vet Radiol Ultrasound 2009; 50:235-8. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 1983; 41:283-8. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Marx RE. Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dentistry 2001; 10:225-8. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004; 62:489-96. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Marx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol 1987; 64:379-90. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Marx RE, Morales MJ. The use of implants in the reconstruction of oral cancer patients. Dent Clin North Am 1998; 42:177-202. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Mcgregor AD, Macdonald DG. Post-irradiation changes in the blood vessels of the adult human mandible. Br J Oral Maxillofac Surg 1995; 33:15-8. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Monov G, Fuerst G, Tepper G, Watzak G, Zechner W, Watzek G. The effect of platelet-rich plasma upon implant stability measured by resonance frequency analysis in the lower anterior mandibles. Clin Oral Implants Res 2005; 16:461-5. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Moy PK, Medina D, Shetty V, Aghaloo TL. Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants 2005; 20:569-77. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Nikolidakis D, Van der Dolder J, Wolke JG, Jansen JA. Effect of platelet-rich plasma on the early bone formation around Ca-P-coated and non-coated oral implants in cortical bone. Clin Oral Implants Res 2008; 19:207-13. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Oelgiesser D, Levin L, Barak S, Schwartz-Arad D. Rehabilitation of an irradiated mandible after mandibular resection using implant/tooth-supported fixed prosthesis: a clinical report. J Prosthet Dent 2004; 91:310-4. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Oeschslin CK, Zimmermann AP, Grätz KW, Hermann FS. Histologic evidence of osseointegration in the irradiated and reconstructed mandible: a case report. Int J Oral Maxillofac Implants 1999; 14:113-7. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Parliament M, Alidrisi M, Munroe M, et al. Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy. Int J Oral Maxillofac Surg 2005; 34:114-21. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Peled M, Ardekian, L, Tagger-Green N, Gutmacher, Z, Machtei E. Dental Implants in Patients With Type 2 Diabetes Mellitus: A Clinical Study. Int J Oral Implantol 2003; 12:116-22.  ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Rossi Júnior R, Souza Filho MAP. Obtainment of autologous thrombin: proposition of simplify protocol and easy clinic reproduction. Rev Paulista Odontol 2004; 26:4-9. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Sanchez AR, Eckert SE, Sheridan PJ, Weaver AL. Influence of platelet-rich plasma added to xenogeneic bone grafts on bone mineral density associated with dental implants. Int J Oral Maxillofac Implants 2005; 20:526-32. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Scarano A, Petrone G, Piattelli A. Staining techniques for plastic-embedded specimes. In: An YH, Martin KL, editors. Handbook of histology methods for bone and cartilage. New Jersey: Humana Press Inc; 2003. p.315-20. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Schlegel KA, Kloss FR, Kessler P, Schultze-Mosgau S, Nkenke E, Wiltfang J. Bone conditioning to enhance implant osseointegration: an experimental study in pigs. Int J Oral Maxillofac Implants 2003; 18:505-11. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Schweiger JW. Titanium implants in irradiated dog mandibles. J Prosthet Dent 1989; 62:201-5. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Schön R, Ohno K, Kudo M, Michi K. Peri-implant tissue reaction in bone irradiated the fifth day after implantation in rabbits: histologic and histomorphometric measurements. Int J Oral Maxillofac Implants 1996; 11:228-38. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Silva ASA, Del Carlo RJ, Rizzo D. Iliac crest autograft in rabbit dorsolateral spinal fusion. Braz J Vet Res Anim Sci 2004; 41:254-60. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Simsek B, Simsek S. Evaluation of success rates of immediate and delayed implants after tooth extraction. Chin Med J 2003; 116:1216-9. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Vendramin FS, Franco D, Nogueira CM, Pereira MS, Franco TR. Platelet-rich plasma and growth factors: processing technique and application in plastic surgery. Rev Col Bras Cir 2006; 33:24-8. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Verdonck HWD, Meijer GJ, Laurin T, et al. Implant stability during osseointegration in irradiated and non-irradiated minipig alveolar bone: an experimental study. Clin Oral Impl Res 2008; 19:201-6. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Vidigal GM, Crispino AF, Groisman M, Soares GA. Implants interface with irradiated and nonirradiated bone. Implant Dentistry 2008; 17: 414-21. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Visch LL, Van Waas MAJ, Schmitz PJM, Levendog PC. A clinical evaluation of implants in irradiated oral cancer patients. J Dent Res 2002; 81:856-9. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Wang R, Pilai K, Jones PK. Dosimetric measurement of scattered radiation from dental implants in simulated head and neck radiotherapy. Int J Oral Maxillofac Implants 1998; 13:197-203. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997; 55:1294-9. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Yamada Y, Ueda M, Naiki T, Nagasaka T. Tissue-engineered injectable bone regeneration for osseointegrated dental implants. Clin Oral Implant Res 2004; 15:589-97. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Yerit KC, Posch M, Seemann M, et al. Implant survival in mandibles of irradiated oral cancer patients. Clin Oral Impl Res 2006; 17:337-44. ";
FAP;2010;RICARDO PELLETTI OCAÑA;Fábio de Abreu Alves ;-x-;"Zechner W, Tangl S, Tepper G, et al. Influence of platelet-rich plasma on osseous healing of dental implants: a histologic and histomorphometric study in minipigs. Int J Oral Maxillofac Implants 2003; 18:15-22.";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Bagan JV, Murillo J, Jimenez Y, et al. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 2005; 34:120-3. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Bagan JV, Jimenez Y, Murillo J, et al. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions: study of 20 cases. Oral Oncol 2006; 42:327-9. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Barri YM, Munshi NC, Sukumalchantra S, et al. Podocyte injury associated glomerulopathies induced by pamidronate. Kidney Int 2004; 65:634-41. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Berenson JR, Hillner BE, Kyle RA, et al. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 2002; 20:3719-36. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Body JJ. The risk of cumulative renal effects of intravenous bisphosphonates. Support Cancer Ther 2006; 3:77-83. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Chauhan D, Hideshima T, Mitsiades C, et al. Proteasome inhibitor therapy in multiple myeloma. Mol Cancer Ther 2005; 4:686-92. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Chen T, Berenson J, Vescio R, et al. Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases. J Clin Pharmacol 2002; 42:1228-36. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Clarke BM, Boyette J, Vural E, et al. Bisphosphonates and jaw osteonecrosis: the UAMS experience. Otolaryngol Head Neck Surg 2007; 136:396-400. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Cömlekçi A, Biberoglu S, Hekimsoy Z, et al. Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastasis following administration of pamidronate. Intern Med 1998; 37:396-7. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Conte P, Coleman R. Bisphosphonates in the treatment of skeletal metastases. Semin Oncol 2004; 31:59-63. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Conte P, Guarneri V. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens. Oncologist 2004; 9(Suppl 4):28-37. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Desikan R, Veksler Y, Raza S, Stokes B, et al. Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma. Br J Haematol 2002; 119:496-9. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Durnian JM, Olujohungbe A, Kyle G. Bilateral acute uveitis and conjunctivitis after zoledronic acid therapy. Eye 2005; 19:221-2 ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Edwards BJ, Hellstein JW, Jacobsen PL, et al. Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 2008; 139:1674-7. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Ensrud KE, Barrett-Connor EL, Schwartz A, et al. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res 2004; 19:1259-69. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Ficarra G, Beninati F, Rubino I, et al. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 2005; 32:1123-8. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Fleisch H. Development of bisphosphonates. Breast Cancer Res 2002; 4:30-4. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Fournier P, Boissier S, Filleur S, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 2002; 62:6538-44. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Goranova-Marinova VS, Pechalova-Petrova PF, Goranov SG. Osteonecrosis of the jaw in patients on bisphosphonate treatment. review of literature with contribution of a case of multiple myeloma. Folia Med (Plovdiv) 2009; 51:53-7. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Green JR, Müller K, Jaeggi KA. Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound. J Bone Miner Res 1994; 9:745-51. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Greenberg MS. Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98:259-60. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Hauge EM, Qvesel D, Eriksen EF, et al. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 2001; 16:1575-82. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Hellstein JW, Marek CL. Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 2005; 63:682-9. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Hillner BE, Ingle JN, Chlebowski RT, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003; 21:4042-57. Erratum in: J Clin Oncol 2004; 22:1351. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Katz H. Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: a report of three cases. J Endod 2005; 31:831-4. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Khan AA, Sándor GK, Dore E, et al. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 2008; 35:1391-7. Erratum in: J Rheumatol 2008; 35:2084, and J Rheumatol 2008; 35:1688. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Kyle RA, Yee GC, Somerfield MR, et al. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol 2007; 25:2464-72. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Kyrgidis A, Triaridis S, Vahtsevanos K, Antoniades K. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients. Expert Rev Anticancer Ther 2009; 9:1125-34. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Licata AA. Discovery, clinical development, and therapeutic uses of bisphosphonates. Ann Pharmacother 2005; 39:668-77. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Major PP, Coleman RE. Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program. Semin Oncol 2001; 28:17-24. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61:1115-7. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005; 63:1567-75. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Migliorati CA, Casiglia J, Epstein J, et al. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 2005; 136:1658-68. Erratum in: J Am Dent Assoc 2006; 137:26. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Montebugnoli L, Felicetti L, Gissi DB, Pizzigallo A, Pelliccioni GA, Marchetti C. Bisphosphonate-associated osteonecrosis can be controlled by nonsurgical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104:473-7. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Munshi NC, Barlogie B, Desikan KR, et al. Novel approaches in myeloma therapy. Semin Oncol 1999; 26:28-34. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Odvina CV, Zerwekh JE, Rao DS, et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005; 90:1294-301. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Ott SM. Long-term safety of bisphosphonates. J Clin Endocrinol Metabol 2005; 3:1897-9. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Pires FR, Miranda A, Cardoso ES, et al. Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy. Oral Dis 2005; 11:365-9. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Pogrel MA. Bisphosphonates and bone necrosis. J Oral Maxillofac Surg 2004; 62:391-2. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Rizzoli R, Burlet N, Cahall D, et al. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 2008; 42:841-7. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Rogers MJ, Xiong X, Ji X, Mönkkönen J, Russell RGG, Blackburn GM, et al. Inhibition of growth of Dictyostelium discoideum amoebae by bisphosphonates is dependent on cellular uptake. Pharmacol Res 1997; 14:625-30. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Rogers MJ, Gordon S, Benford HL, et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 2000; 88:2961-78. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Rolfes N, Lümmen G. The value of biphosphonates in the therapy of prostate cancer [abstract]. Urologe A 2009; 48:990, 992, 994-6. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Rosen CJ, Brown S. Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med 2003; 348:1503-4. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Ruggiero SL, Mehrotra B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004; 62:527-34. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006a; 102:433-41. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Ruggiero SL, Gralow J, Marx RE, et al. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2006b; 2:7-14.";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Ryan P, Saleh I, Stassen LF. Osteonecrosis of the jaw: a rare and devastating side effect of bisphosphonates. Postgrad Med J 2009; 85:674-7. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Saad F, Gleason DM, Murray R, et al. Zoledronic Acid Prostate Cancer Study Group. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst 2002; 94:1458-68. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Sato M, Grasser W, Endo N, et al. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 1991; 88:2095-105. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Sietsema WK, Ebetino FH, Salvagno AM, et al. Antiresorptive dose-response relationships across three generations of bisphosphonates. Drugs Exp Clin Res 1989; 15: 389-96. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 2006; 17:897-907.";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Van den Wyngaert T, Huizing MT, Fossion E, Vermorken JB. Scintigraphic evaluation of mandibular bone turnover in patients with solid tumors receiving zoledronic acid. Oral Oncol 2010; 46:214-8. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Wang EP, Kaban LB, Strewler GJ, et al. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 2007; 65:1328-31. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Whyte MP, Wenkert D, Clements KL, et al. Bisphosphonate-induced osteopetrosis. N Engl J Med 2003; 349:457-63. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Wilkinson GS, Kuo YF, Freeman JL, Goodwin JS. Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis. J Natl Cancer Inst 2007; 99:1016-24. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Woo SB, Kalmar JR. Osteonecrosis of the jaws and bisphosphonates. Alpha Omegan 2007; 100:194-202. ";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002; 302:105561.";
FAP;2010;VIRGINIA MARIA CIRCHIA PINTO;Fábio de Abreu Alves ;-x-;"Zervas K, Verrou E, Teleioudis Z, et al. Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients. Br J Haematol 2006; 134:620-3. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"[Anonymous]. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg 2001; 192:708. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Akervall J. Gene profiling in squamous cell carcinoma of the head and neck. Cancer Metastasis Rev 2005; 24:87-94. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Akervall J. Genomic screening of head and neck cancer and its implications for therapy planning. Eur Arch Otorhinolaryngol 2006; 263:297-304. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Ammer AG, Weed SA. Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil Cytoskeleton 2008; 65:687-707. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Andre F, Job B, Dessen P, et al. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 2009; 15:441-51. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Arai H, Ueno T, Tangoku A, et al. Detection of amplified oncogenes by genome DNA microarrays in human primary esophageal squamous cell carcinoma: comparison with conventional comparative genomic hybridization analysis. Cancer Genet Cytogenet 2003; 146:16-21. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Bejjani BA, Shaffer LG. Application of array-based comparative genomic hybridization to clinical diagnostics. J Mol Diagn 2006; 8:528-33. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Bergamo NA, Rogatto SR, Poli-Frederico RC, et al. Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas. Cancer Genet Cytogenet 2000; 119:48-55.  ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Bernardini M, Weberpals J, Squire JA. The use of cytogenetics in understanding ovarian cancer. Biomed Pharmacother 2004; 58:17-23. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Bird-Lieberman EL, Fitzgerald RC. Early diagnosis of oesophageal cancer. Br J Cancer 2009; 101:1-6. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Bryndorf T, Kirchhoff M, Rose H, et al. Comparative genomic hybridization in clinical cytogenetics. Am J Hum Genet 1995; 57:1211-20. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Burrell RA, Juul N, Johnston SR, et al. Targeting chromosomal instability and tumour heterogeneity in HER2 positive breast cancer. J Cell Biochem 2010;  ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Cai JH, Zhao R, Zhu JW, et al. Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma. J Gastrointest Surg 2010; 14:1248-57. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Carneiro A, Isinger A, Karlsson A, et al. Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer. BMC Cancer 2008; 8:98. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Castellsague X, Munoz N, De Stefani E, et al. Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America. Int.J.Cancer 2000; 88:658. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Chidgey M. Desmosomes and disease: an update. Histol Histopathol 2002; 17:1179-92. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Chidgey M, Dawson C. Desmosomes: a role in cancer? Br J Cancer 2007; 96:1783-7. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Choi YW, Bae SM, Kim YW, et al. Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. Int J Gynecol Cancer 2007; 17:687-96. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006; 66:8319-26. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Clark ES, Brown B, Whigham AS, et al. Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene 2009; 28:431-44. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Daly RJ. Cortactin signalling and dynamic actin networks. Biochem J 2004; 382:13-25. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Dancau AM, Wuth L, Waschow M, et al. PPFIA1 and CCND1 are frequently coamplified in breast cancer. Genes Chromosomes Cancer 2010; 49:1-8. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"de Smith AJ, Tsalenko A, Sampas N, et al. Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases. Hum Mol Genet 2007; 16:2783-94. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"De Stefani E, Deneo-Pellegrini H, Ronco AL, et al. Food groups and risk of squamous cell carcinoma of the oesophagus: a case-control study in Uruguay. Br.J.Cancer 2003; 89:1209. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Dedes KJ, Lopez-Garcia MA, Geyer FC, et al. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. Breast Cancer Res Treat 2010;  ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Deng YZ, Chen PP, Wang Y, et al. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling. J Biol Chem 2007; 282:36571-81. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Deshpande A, Sicinski P, Hinds PW. Cyclins and cdks in development and cancer: a perspective. Oncogene 2005; 24:2909-15. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Diaz Prado SM, Medina Villaamil V, Aparicio Gallego G, et al. Expression of Wnt gene family and frizzled receptors in head and neck squamous cell carcinomas. Virchows Arch 2009; 455:67-75. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Dietz J, Pardo SH, Furtado CD, Harzheim E, Furtado AD. [Risk factors related to esophageal cancer in Rio Grande do Sul, Brazil]. Rev Assoc Med Bras 1998; 44:269-72. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Doak SH. Aneuploidy in upper gastro-intestinal tract cancers--a potential prognostic marker? Mutat Res 2008; 651:93-104. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Dusek RL, Godsel LM, Green KJ. Discriminating roles of desmosomal cadherins: beyond desmosomal adhesion. J Dermatol Sci 2007; 45:7-21. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95:1404-13. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Ferlay J, Shin H, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. ; 2008. http://globocan.iarc.fr  ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Freier K, Knoepfle K, Flechtenmacher C, et al. Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer 2010; 49:916. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Freier K, Sticht C, Hofele C, et al. Recurrent coamplification of cytoskeletonassociated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 2006; 45:118-25. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 2004; 145:5439-47. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995; 222:654-62. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Garrod D, Chidgey M. Desmosome structure, composition and function. Biochim Biophys Acta 2008; 1778:572-87. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Gebeshuber CA, Sladecek S, Grunert S. Beta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs. Cells Tissues Organs 2007; 185:51-60. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Grose R, Dickson C. Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev 2005; 16:179-86. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Guner D, Sturm I, Hemmati P, et al. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis. Int J Cancer 2003; 103:445. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Hirakawa H, Shibata K, Nakayama T. Localization of cortactin is associated with colorectal cancer development. Int J Oncol 2009; 35:1271-6. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Hirasaki S, Noguchi T, Mimori K, et al. BAC clones related to prognosis in patients with esophageal squamous carcinoma: an array comparative genomic hybridization study. Oncologist 2007; 12:406-17. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Howe LR, Brown AM. Wnt signaling and breast cancer. Cancer Biol Ther 2004; 3:36-41. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Hsu KF, Lin CK, Yu CP, et al. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma. Dis Esophagus 2009; 22:402-8. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Hsu NY, Yeh KT, Chiang IP, et al. Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis. Dis Esophagus 2008; 21:402-8. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Hu L, Sham JS, Xie D, et al. Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma. Cancer Lett 2007; 252:36-42. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Hughes S, Lim G, Beheshti B, et al. Use of whole genome amplification and comparative genomic hybridisation to detect chromosomal copy number alterations in cell line material and tumour tissue. Cytogenet Genome Res 2004; 105:18-24. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Ikeda Y, Ozawa S, Ando N, et al. Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. Ann Thorac Surg 1996; 62:835-8. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Inazawa J, Inoue J, Imoto I. Comparative genomic hybridization (CGH)arrays pave the way for identification of novel cancer-related genes. Cancer Sci 2004; 95:559-63. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Ishizuka T, Tanabe C, Sakamoto H, et al. Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH. Biochem Biophys Res Commun 2002; 296:152-5. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Jin C, Jin Y, Gisselsson D, et al. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma. Cytogenet Genome Res 2006; 115:99-106. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Kallioniemi OP, Kallioniemi A, Sudar D, et al. Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol 1993; 4:41-6. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Kang JU, Koo SH, Kwon KC, Park JW, Kim JM. Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung. BMC Cancer 2009; 9:237. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Katoh M. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther 2006; 5:1059-64. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Katoh M. FGF signaling network in the gastrointestinal tract (review). Int J Oncol 2006; 29:163-8. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res 2007; 13:4042-5. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Kim DH, Muto M, Kuwahara Y, et al. Array-based comparative genomic hybridization of circulating esophageal tumor cells. Oncol Rep 2006; 16:1053-9. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Kim JK, Diehl JA. Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol 2009; 220:292-6. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Kiuru-Kuhlefelt S, Sarlomo-Rikala M, Larramendy ML, et al. FGF4 and INT2 oncogenes are amplified and expressed in Kaposi's sarcoma. Mod Pathol 2000; 13:433-7. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Klein CA, Schmidt-Kittler O, Schardt JA, et al. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci U S A 1999; 96:4494-9. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Kolligs FT, Bommer G, Goke B. Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 2002; 66:131-44. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Ku GY, Ilson DH. Preoperative therapy for esophageal cancer. Gastroenterol Clin North Am 2009; 38:135-52, ix. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Kuwano H, Nakajima M, Miyazaki T, Kato H. Distinctive clinicopathological characteristics in esophageal squamous cell carcinoma. Ann Thorac Cardiovasc Surg 2003; 9:6-13. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Kwong D, Lam A, Guan X, et al. Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum Pathol 2004; 35:309-16. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Lai SL, Chien AJ, Moon RT. Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis. Cell Res 2009; 19:532-45. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Lambert R, Hainaut P. Esophageal cancer: cases and causes (part I). Endoscopy 2007; 39:550-5. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Leber MF, Efferth T. Molecular principles of cancer invasion and metastasis (review). Int J Oncol 2009; 34:881-95. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Li K, Wang X, He W, Lin N, Fan QX. Expression of N-cadherin in esophageal squamous cell carcinoma and silencing expression of N-cadherin using RNA interference on invasiveness of EC9706 cells. Ai Zheng 2009; 28:8-13. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Li M, Pinkel D. Clinical cytogenetics and molecular cytogenetics. J Zhejiang Univ Sci B 2006; 7:162-3. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Lin YC, Wu MY, Li DR, Wu XY, Zheng RM. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. World J Gastroenterol 2004; 10:3235. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Lioni M, Brafford P, Andl C, et al. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol 2007; 170:709-21. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Liu W, Zhang X, Sun W. Developments in treatment of esophageal/gastric cancer. Curr Treat Options Oncol 2008; 9:375-87. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Luo ML, Shen XM, Zhang Y, et al. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 2006; 66:11690-9. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Luo ML, Wang MR. CTTN (EMS1): an oncogene contributing to the metastasis of esophageal squamous cell carcinoma. Cell Res 2007; 17:298300. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17:9-26. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Martin SA, Hewish M, Lord CJ, Ashworth A. Genomic instability and the selection of treatments for cancer. J Pathol 2010; 220:281-9. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Ministério da Saúde. Secretaria de Atenção à Saúde. Instituto Nacional de Câncer. Coordenação de Prevenção e Vigilância. Estimativa 2008: Incidência de Câncer no Brasil. Rio de Janeiro: INCA; 2007. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Molinolo AA, Amornphimoltham P, Squarize CH, et al. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 2009; 45:324-34. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Moore R, Champeval D, Denat L, et al. Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation. Oncogene 2004; 23:6726-35. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Morgan RJ, Newcomb PV, Hardwick RH, Alderson D. Amplification of cyclin D1 and MDM-2 in oesophageal carcinoma. Eur J Surg Oncol 1999; 25:364. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Murray AW. Recycling the cell cycle: cyclins revisited. Cell 2004; 116:221. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Nair KS, Naidoo R, Chetty R. Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. J Clin Pathol 2005; 58:343-51. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Nakagawa H, Zukerberg L, Togawa K, et al. Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer 1995; 76:541. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Nakagawa S, Kanda T, Kosugi S, et al. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 2004; 198:205-11. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Nakamura Y, Migita T, Hosoda F, et al. Kruppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression. Int J Cancer 2009; 125:1859-67. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Nakano S, Baba M, Natsugoe S, et al. Detection of lymph node metastasis using desmoglein 1 expression in superficial esophageal cancer in relation to the endoscopic mucosal resection. Dis Esophagus 1998; 11:157-61. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Nakashima S, Natsugoe S, Matsumoto M, et al. Biological properties of biopsy specimens are useful for predicting lymph node micrometastasis in esophageal carcinoma. Anticancer Res 2002; 22:2951-6. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Natsugoe S, Aikou T, Shimada M, et al. Expression of desmoglein I in squamous cell carcinoma of the esophagus. J Surg Oncol 1994; 57:105-10. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Niini T, Lopez-Guerrero JA, Ninomiya S, et al. Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study. Genes Chromosomes Cancer 2010; 49:132-43. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Noguchi T, Kimura Y, Takeno S, et al. Chromosomal imbalance in esophageal squamous cell carcinoma: 3q gain correlates with tumor progression but not prognostic significance. Oncol Rep 2003; 10:1393-400. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Ojopi EP, Cavalli LR, Cavalieri LM, Squire JA, Rogatto SR. Comparative genomic hybridization analysis of benign and invasive male breast neoplasms. Cancer Genet Cytogenet 2002; 134:123-6. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Okegawa T, Pong RC, Li Y, Hsieh JT. The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol 2004; 51:445-57. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Or YY, Chung GT, To KF, et al. Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma. J Pathol 2010; 220:97-107. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Pai R, Dunlap D, Qing J, et al. Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling. Cancer Res 2008; 68:5086-95. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005; 37 Suppl:S11-7. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Pittella F, Katsube K, Takemura T, et al. Perinuclear and cytoplasmic distribution of desmoglein in esophageal squamous cell carcinomas. Pathol Res Pract 2001; 197:85-91. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000; 7:165-97. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Qin YR, Wang LD, Fan ZM, Kwong D, Guan XY. Comparative genomic hybridization analysis of genetic aberrations associated with development of esophageal squamous cell carcinoma in Henan, China. World J Gastroenterol 2008; 14:1828-35. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Redon R, Muller D, Caulee K, et al. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res 2001; 61:4122-9. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Ribeiro Pinto LF, Teixeira Rossini AM, Albano RM, et al. Mechanisms of esophageal cancer development in Brazilians. Mutat Res 2003; 544:365-73. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Rizk N, Venkatraman E, Park B, et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 2006; 132:1374-81. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Rogatto S, Rainho, CA. Citogenética sem risco: biossegurança e garantia de qualidade. 1 ed. ed. FUNPEC; 2000. Citogenética Molecular; p.p. 143. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Rosai J. Surgical pathology. 9th ed. London: Mosby Elsevier; 2004. Gastrointestinal tract; p.615-47. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Roschke AV, Glebov OK, Lababidi S, et al. Chromosomal instability is associated with higher expression of genes implicated in epithelialmesenchymal transition, cancer invasiveness, and metastasis and with lower expression of genes involved in cell cycle checkpoints, DNA repair, and chromatin maintenance. Neoplasia 2008; 10:1222-30. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Sakai N, Kjiyama Y, Iwanuma Y, et al. Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions. Dis Esophagus 2009;  ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Salahshor S, Naidoo R, Serra S, et al. Frequent accumulation of nuclear Ecadherin and alterations in the Wnt signaling pathway in esophageal squamous cell carcinomas. Mod Pathol 2008; 21:271-81. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Sarbia M, Stahl M, Fink U, et al. Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities. Int J Cancer 1999; 84:86. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Sato-Kuwabara Y, Neves JI, Fregnani JH, Sallum RA, Soares FA. Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry. BMC Cancer 2009; 9:6. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Schoumans J, Nielsen K, Jeppesen I, et al. A comparison of different metaphase CGH methods for the detection of cryptic chromosome aberrations of defined size. Eur J Hum Genet 2004; 12:447-54. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Sewram V, De Stefani E, Brennan P, Boffetta P. Mate consumption and the risk of squamous cell esophageal cancer in uruguay. Cancer Epidemiol.Biomarkers Prev. 2003; 12:508. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Shih Ie M, Wang TL. Apply innovative technologies to explore cancer genome. Curr Opin Oncol 2005; 17:33-8. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Shimada Y, Imamura M, Shibagaki I, et al. Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy. Ann Surg 1997; 226:162-8. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Shinozaki H, Ozawa S, Ando N, et al. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res 1996; 2:1155. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Shiomi H, Sugihara H, Kamitani S, et al. Cytogenetic heterogeneity and progression of esophageal squamous cell carcinoma. Cancer Genet Cytogenet 2003; 147:50-61. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Smid M, Hoes M, Sieuwerts AM, et al. Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes. Breast Cancer Res Treat 2010;  ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Snijders AM, Pinkel D, Albertson DG. Current status and future prospects of array-based comparative genomic hybridisation. Brief Funct Genomic Proteomic 2003; 2:37-45. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Speicher MR, Carter NP. The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet 2005; 6:782-92. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Squire JA, Bayani J, Luk C, et al. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck 2002; 24:874-87. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Stoecklein NH, Erbersdobler A, Schmidt-Kittler O, et al. SCOMP is superior to degenerated oligonucleotide primed-polymerase chain reaction for global amplification of minute amounts of DNA from microdissected archival tissue samples. Am J Pathol 2002; 161:43-51. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Su M, Chin SF, Li XY, et al. Comparative genomic hybridization of esophageal adenocarcinoma and squamous cell carcinoma cell lines. Dis Esophagus 2006; 19:10-4. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Sugimoto T, Arai M, Shimada H, Hata A, Seki N. Integrated analysis of expression and genome alteration reveals putative amplified target genes in esophageal cancer. Oncol Rep 2007; 18:465-72. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Sugimoto T, Seki N, Shimizu S, et al. The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma. Genes Chromosomes Cancer 2009; 48:132-42. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Suzuki H, Abo S, Kitamura M, et al. Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables. Cancer Invest 1997; 15:411-5. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Tachibana M, Kinugasa S, Yoshimura H, et al. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005; 189:98-109. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Tada K, Oka M, Hayashi H, et al. Cytogenetic analysis of esophageal squamous cell carcinoma cell lines by comparative genomic hybridization: relationship of cytogenetic aberrations to in vitro cell growth. Cancer Genet Cytogenet 2000; 117:108-12. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Tai AL, Sham JS, Xie D, et al. Co-overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma. Cancer 2006; 106:146-55. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Takeuchi H, Ozawa S, Ando N, et al. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Clin Cancer Res 1997; 3:2229. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Takigawa Y, Brown AM. Wnt signaling in liver cancer. Curr Drug Targets 2008; 9:1013-24. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Tan DS, Reis-Filho JS. Comparative genomic hybridisation arrays: highthroughput tools to determine targeted therapy in breast cancer. Pathobiology 2008; 75:63-74. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Tsuda T, Tahara E, Kajiyama G, et al. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res 1989; 49:5505-8. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 2010; 10:116-29. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Uchida M, Tsukamoto Y, Uchida T, et al. Genomic profiling of gastric carcinoma in situ and adenomas by array-based comparative genomic hybridization. J Pathol 2010; 221:96-105. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Ueno T, Tangoku A, Yoshino S, et al. Prediction of nodal metastasis by comparative genomic hybridization in biopsy specimens from patients with superficial esophageal squamous cell carcinoma. Clin Cancer Res 2003; 9:5137-41. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Ueno T, Tangoku A, Yoshino S, et al. Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2002; 8:526-33. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"van Beers EH, Nederlof PM. Array-CGH and breast cancer. Breast Cancer Res 2006; 8:210. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Wang LD, Qin YR, Fan ZM, et al. Comparative genomic hybridization: comparison between esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-incidence area for both cancers in Henan, northern China. Dis Esophagus 2006; 19:459-67. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Wang X, Cao W, Mo M, et al. VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer. J Surg Oncol 2010;  ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Weaver AM. Cortactin in tumor invasiveness. Cancer Lett 2008; 265:157-66. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Weaver AM, Karginov AV, Kinley AW, et al. Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol 2001; 11:370-4.";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Weed SA, Parsons JT. Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene 2001; 20:6418-34. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Wu MY, Zhuang CX, Yang HX, Liang YR. Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study. World J Gastroenterol 2004; 10:476. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Wu WK, Cho CH, Lee CW, et al. Dysregulation of cellular signaling in gastric cancer. Cancer Lett 2010; 295:144-53. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Yagui-Beltran A, Jablons DM. A translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells. Ann Thorac Cardiovasc Surg 2009; 15:213-20. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Yamada SI, Yanamoto S, Kawasaki G, Mizuno A, Nemoto TK. Overexpression of Cortactin Increases Invasion Potential in Oral Squamous Cell Carcinoma. Pathol Oncol Res 2010;  ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Yasar D, Karadogan I, Alanoglu G, et al. Array comparative genomic hybridization analysis of adult acute leukemia patients. Cancer Genet Cytogenet 2010; 197:122-9. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Yen CC, Chen YJ, Chen JT, et al. Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer 2001; 92:2769-77. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Yen CC, Chen YJ, Lu KH, et al. Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction. Int J Oncol 2003; 23:871-81. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Zaharieva BM, Simon R, Diener PA, et al. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol 2003; 201:603-8. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Zardawi SJ, O'Toole SA, Sutherland RL, Musgrove EA. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Histol Histopathol 2009; 24:385-98. ";
FAP;2010;YUKIE SATO KUWABARA;Fernando Augusto Soares;Silvia Regina Rogatto;"Zhang HL, Chen LQ, Liu RL, et al. The number of lymph node metastases influences survival and International Union Against Cancer tumor-nodemetastasis classification for esophageal squamous cell carcinoma. Dis Esophagus 2010; 23:53-8. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Akdogan M, Sasmaz N, Kayhan B, Biyikoglu I, Disibeyaz S, Sahin B. Extraordinarily elevated CA19-9 in benign conditions: a case report and review of the literature. Tumori 2001; 87:337-9. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Alais S, Simoes S, Baas D, et al. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biol Cell 2008; 100:603-15. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;[ACS] American Cancer Society. What are the key statistics about melanoma?. Avaliable from: <URL:http://www.cancer.org/Cancer/SkinCancer-Melanoma/DetailedGuide/ melanoma-skin-cancer-key-statistics> [2011a abril 3] ;
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;[ACS] American Cancer Society. What are the key statistics about pancreatic cancer?. Avaliable from: <URL:http://www.cancer.org/Cancer/PancreaticCancer/DetailedGuide/pancre atic-cancer-key-statistics>. [2011b abril 3] ;
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Amselgruber WM, Buttner M, Schlegel T, Schweiger M, Pfaff E. The normal cellular prion protein (PrPc) is strongly expressed in bovine endocrine pancreas. Histochem Cell Biol 2006; 125:441-8. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Anisowicz A, Messineo M, Lee SW, Sager R. An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. J Immunol 1991; 147:520-7. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Antonacopoulou AG, Grivas PD, Skarlas L, Kalofonos M, Scopa CD, Kalofonos HP. POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance? Anticancer Res 2008;  28:1221-7. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Arantes C, Nomizo R, Lopes MH, Hajj GN, Lima FR, Martins VR. Prion protein and its ligand stress inducible protein 1 regulate astrocyte development. Glia 2009; 57:1439-49. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Arruda-Carvalho M, Njaine B, Silveira MS, Linden R, Chiarini LB. Hop/STI1 modulates retinal proliferation and cell death independent of PrPC. Biochem Biophys Res Commun 2007; 361:474-80. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Balaj L, Lessard R, Dai L et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2011; 2:180. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Balentien E, Mufson BE, Shattuck RL, Derynck R, Richmond A. Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene 1991; 6:111524. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Bennion BJ, Daggett V. Protein conformation and diagnostic tests: the prion protein. Clin Chem 2002; 48:2105-14. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Benson AB, 3rd. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm 2007; 13:S5-18. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Bhatia S, Tykodi SS, Thompson JA. Treatment of metastatic melanoma: an overview. Oncology (Williston Park) 2009; 23:488-96. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Boman BM, Huang E. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol 2008; 26:2828-38. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Brown DR, Besinger A. Prion protein expression and superoxide dismutase activity. Biochem J 1998; 334:423-9. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Bueler H, Fischer M, Lang Y, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356:577-82. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol 2005; 17:879-87. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Carta F, Demuro PP, Zanini C, et al. Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases. Melanoma Res 2005; 15:235-44. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B. Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 1989; 63:175-81. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59:366-78. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2009; 18:1688-94. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Chen R, Pan S, Cooke K, et al. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas 2007; 34:70-9. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Chen WH, Horoszewicz JS, Leong SS, et al. Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro 1982; 18:24-34. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Cheung W, Darfler MM, Alvarez H, et al. Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors. Pancreatology 2008; 8:608-16. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R. Cellular prion protein transduces neuroprotective signals. EMBO J 2002; 21:3317-26. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009; 19:43-51. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Cocucci E, Racchetti G, Rupnik M, Meldolesi J. The regulated exocytosis of enlargeosomes is mediated by a SNARE machinery that includes VAMP4. J Cell Sci 2008; 121:2983-91. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Coghlin C, Murray GI. Current and emerging concepts in tumour metastasis. J Pathol 2010; 222:1-15. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Coitinho AS, Dietrich MO, Hoffmann A, et al. Decreased hyperlocomotion induced by MK-801, but not amphetamine and caffeine in mice lacking cellular prion protein (PrP(C)). Brain Res Mol Brain Res 2002; 107:190-4. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Coitinho AS, Roesler R, Martins VR, Brentani RR, Izquierdo I. Cellular prion protein ablation impairs behavior as a function of age. Neuroreport 2003;  14:1375-9. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Colling SB, Collinge J, Jefferys JG. Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett 1996; 209:49-52. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Colling SB, Khana M, Collinge J, Jefferys JG. Mossy fibre reorganization in the hippocampus of prion protein null mice. Brain Res 1997; 755:28-35. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Collinge J, Whittington MA, Sidle KC, et al. Prion protein is necessary for normal synaptic function. Nature 1994; 370:295-7. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Colombo MP, Maccalli C, Mattei S, Melani C, Radrizzani M, Parmiani G. Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines. Melanoma Res 1992; 2:181-9. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"De Almeida CJ, Chiarini LB, Da Silva JP, Martins MA, Linden R. The cellular prion protein modulates phagocytosis and inflammatory response. J Leukoc Biol 2005; 77:238-46. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 2004; 3:367-78. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146 Suppl 61:1-6. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Dodelet VC, Cashman NR. Prion protein expression in human leukocyte differentiation. Blood 1998; 91:1556-61. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116:544-73. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Ellis V, Daniels M, Misra R, Brown DR. Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner. Biochemistry 2002; 41:6891-6. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Erlich RB, Kahn SA, Lima FR et al. STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 2007; 55:1690-8. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Eustace BK, Jay DG. Extracellular roles for the molecular chaperone, hsp90. Cell Cycle 2004; 3:1098-100. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Fazal S, Saif MW. Supportive and palliative care of pancreatic cancer. JOP 2007; 8:240-53. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Feng Y, Walsh CA. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol 2004; 6:1034-8. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Ferrone CR, Ben Porat L, Panageas KS et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA 2005; 294:1647-54. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Fevrier B, Vilette D, Archer F, et al. Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 2004; 101:9683-8. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Ford MJ, Burton LJ, Li H, et al. A marked disparity between the expression of prion protein and its message by neurones of the CNS. Neuroscience 2002a; 111:533-51. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Ford MJ, Burton LJ, Morris RJ, Hall SM. Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 2002b; 113:177-92. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Fournier JG, Escaig-Haye F, Billette De Villemeur T, et al. Distribution and submicroscopic immunogold localization of cellular prion protein (PrPc) in extracerebral tissues. Cell Tissue Res 1998; 292:77-84. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Gandini S, Botteri E, Iodice S, et al. Tobacco smoking and cancer: a metaanalysis. Int J Cancer 2008; 122:155-64. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Gauczynski S, Peyrin JM, Haik S, et al. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 2001; 20:5863-75. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Gloster HM, Jr., Neal K. Skin cancer in skin of color. J Am Acad Dermatol 2006; 55:741-60; quiz 61-4. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Gonzalez-Iglesias R, Pajares MA, Ocal C, Espinosa JC, Oesch B, Gasset M. Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. J Mol Biol 2002; 319:52740. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Graner E, Mercadante AF, Zanata SM, et al. Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res 2000a;  76:85-92. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Graner E, Mercadante AF, Zanata SM, Martins VR, Jay DG, Brentani RR. Laminin-induced PC-12 cell differentiation is inhibited following laser inactivation of cellular prion protein. FEBS Lett 2000b; 482:257-60. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Graves DT, Barnhill R, Galanopoulos T, Antoniades HN. Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol 1992; 140:9-14. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Gronborg M, Kristiansen TZ, Iwahori A, et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 2006; 5:157-71. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010; 28:264-71. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Hajj GN, Lopes MH, Mercadante AF, et al. Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins. J Cell Sci 2007; 120:1915-26. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Hamada K, Monnai M, Kawai K, et al. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice. Int J Oncol 2008; 32:153-9. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Harris DA. Cellular biology of prion diseases. Clin Microbiol Rev 1999; 12:429-44. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Hart AR, Kennedy H, Harvey I. Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol 2008; 6:275-82. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Haskill S, Peace A, Morris J, et al. Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci U S A 1990; 87:7732-6. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Hendrix A, Maynard D, Pauwels P, et al. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. J Natl Cancer Inst 2010; 102:866-80. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Hoek KS, Schlegel NC, Brafford P, et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 2006; 19:290-302. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Horiuchi M, Yamazaki N, Ikeda T, Ishiguro N, Shinagawa M. A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheep. J Gen Virol 1995; 76:2583-7. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Horonchik L, Tzaban S, Ben-Zaken O, et al. Heparan sulfate is a cellular receptor for purified infectious prions. J Biol Chem 2005; 280:17062-7. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Hundt C, Peyrin JM, Haik S et al. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J 2001; 20:5876-86. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Hussein MR. Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity. Int J Exp Pathol 2006; 87:16376. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Huxley R, Ansary-Moghaddam A, Berrington De Gonzalez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92:2076-83. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008; 393:535-45. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;  61:69-90. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71-96. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Johansen D, Borgstrom A, Lindkvist B, Manjer J. Different markers of alcohol consumption, smoking and body mass index in relation to risk of pancreatic cancer. A prospective cohort study within the Malmo Preventive Project. Pancreatology 2009; 9:677-86. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005  438:820-7. ;
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Katz MH, Hwang R, Fleming JB, Evans DB. Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin 2008; 58:111-25. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Keller S, Sanderson MP, Stoeck A, Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol Lett 2006; 107:102-8. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Klein-Scory S, Kubler S, Diehl H, et al. Immunoscreening of the extracellular proteome of colorectal cancer cells. BMC Cancer 2010; 10:70. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Koomen JM, Haura EB, Bepler G, et al. Proteomic contributions to personalized cancer care. Mol Cell Proteomics 2008; 7:1780-94. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Krebs B, Dorner-Ciossek C, Schmalzbauer R, Vassallo N, Herms J, Kretzschmar HA. Prion protein induced signaling cascades in monocytes. Biochem Biophys Res Commun 2006; 340:13-22. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324:709-15. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Kubosaki A, Yusa S, Nasu Y, et al. Distribution of cellular isoform of prion protein in T lymphocytes and bone marrow, analyzed by wild-type and prion protein gene-deficient mice. Biochem Biophys Res Commun 2001;  282:103-7. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Kubota H, Yamamoto S, Itoh E, et al. Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperones 2010; 15:1003-11. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Lambert R, Sauvaget C, Sankaranarayanan R. Mass screening for colorectal cancer is not justified in most developing countries. Int J Cancer 2009; 125:253-6. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Lassle M, Blatch GL, Kundra V, Takatori T, Zetter BR. Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases. J Biol Chem 1997;  272:1876-84.";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Lauriti G, Cananzi M, Pierro A, Eaton S, De Coppi P. Intestinal ischemiareperfusion injury causes activation of bone marrow-derived progenitor cells. Eur J Pediatr Surg 2009; 19:366-9. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Lee KS, Linden R, Prado MA, Brentani RR, Martins VR. Towards cellular receptors for prions. Rev Med Virol 2003; 13:399-408. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Lee KS, Magalhaes AC, Zanata SM, Brentani RR, Martins VR, Prado MA. Internalization of mammalian fluorescent cellular prion protein and N-terminal deletion mutants in living cells. J Neurochem 2001; 79:79-87. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Li C, Yu S, Nakamura F et al. Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J Clin Invest 2009; 119:2725-36. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Li C, Xin W, Sy MS. Binding of pro-prion to filamin A: by design or an unfortunate blunder. Oncogene 2010; 29:5329-45. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Li D, Morris JS, Liu J, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 2009; 301:2553-62. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Liang J, Pan Y, Zhang D, et al. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. FASEB J 2007; 21:2247-56. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Liang J, Pan YL, Ning XX, et al. Overexpression of PrPC and its antiapoptosis function in gastric cancer. Tumour Biol 2006; 27:84-91. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Lima FR, Arantes CP, Muras AG, Nomizo R, Brentani RR, Martins VR. Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J Neurochem 2007; 103:2164-76.";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Lima LG, Chammas R, Monteiro RQ, Moreira ME, Barcinski MA. Tumorderived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett 2009; 283:168-75. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008;  88:673-728. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Liu T, Li R, Wong BS, et al. Normal cellular prion protein is preferentially expressed on subpopulations of murine hemopoietic cells. J Immunol 2001;  166:3733-42. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Longshaw VM, Dirr HW, Blatch GL, Lassle M. The in vitro phosphorylation of the co-chaperone mSTI1 by cell cycle kinases substantiates a predicted casein kinase II-p34cdc2-NLS (CcN) motif. Biol Chem 2000;  381:1133-8. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Lopes MH, Hajj GN, Muras AG, et al. Interaction of cellular prion and stressinducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J Neurosci 2005; 25:11330-9. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Lynch PM. Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC. Digestion 2007; 76:68-76. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Madore N, Smith KL, Graham CH, et al. Functionally different GPI proteins are organized in different domains on the neuronal surface. EMBO J 1999; 18:6917-26. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Manson J, West JD, Thomson V, Mcbride P, Kaufman MH, Hope J. The prion protein gene: a role in mouse embryogenesis? Development 1992; 115:117-22. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 2010; 22:231-7. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Martins VR, Graner E, Garcia-Abreu J, et al. Complementary hydropathy identifies a cellular prion protein receptor. Nat Med 1997;  3:1376-82. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Mcewan JF, Windsor ML, Cullis-Hill SD. Antibodies to prion protein inhibit human colon cancer cell growth. Tumour Biol 2009; 30:141-7. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Meggio F, Negro A, Sarno S, et al. Bovine prion protein as a modulator of protein kinase CK2. Biochem J 2000; 352 Pt 1:191-6. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Mellman I, Warren G. The road taken: past and future foundations of membrane traffic. Cell 2000; 100:99-112. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Miller EA, Beilharz TH, Malkus PN, et al. Multiple cargo binding sites on the COPII subunit Sec24p ensure capture of diverse membrane proteins into transport vesicles. Cell 2003;  114:497-509. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Ministério da Saúde. Instituto Nacional do Câncer I. Estimativa/2010 incidência de câncer no Brasil. Rio de Janeiro: INCA; 2009. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322:352-8. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Mrowietz U, Schwenk U, Maune S et al. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer 1999;  79:1025-31. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;Murray GI, Telfer CM, Melvin WT. Markers for colorectal cancer. United States Patent Application 20060188883. 2006 Aug 24. ;
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Narayanan DL, Saladi RN, Fox JL. Ultraviolet radiation and skin cancer. Int J Dermatol 2010; 49:978-86. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 2009; 10:148-55. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Nico PB, De-Paris F, Vinade ER, et al. Altered behavioural response to acute stress in mice lacking cellular prion protein. Behav Brain Res 2005;  162:173-81. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Odunuga OO, Longshaw VM, Blatch GL. Hop: more than an Hsp70/Hsp90 adaptor protein. Bioessays 2004; 26:1058-68. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010; 12:1930; sup pp 1-13. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Pan Y, Zhao L, Liang J, et al. Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 2006; 20:1886-8.";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Ca Cancer J Clin 2005; 55:74-108. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Paulitschke V, Kunstfeld R, Mohr T, et al. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells. J Proteome Res 2009; 8:2501-10. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Pavlou MP, Diamandis EP. The cancer cell secretome: a good source for discovering biomarkers? J Proteomics 2010; 73:1896-906. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer 2009; 8:109-17. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21:157-71. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Pleskow DK, Berger HJ, Gyves J, Allen E, Mclean A, Podolsky DK. Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer. Ann Intern Med 1989; 110:704-9. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Politopoulou G, Seebach JD, Schmugge M, Schwarz HP, Aguzzi A. Agerelated expression of the cellular prion protein in human peripheral blood leukocytes. Haematologica 2000; 85:580-7. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Prusiner SB. Molecular biology of prion diseases. Science 1991; 252:151522. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363-83. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009; 9:285-93. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Qian WJ, Jacobs JM, Liu T, Camp DG, 2nd, Smith RD. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics 2006; 5:1727-44. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Ray S, Chattopadhyay N, Biswas N, Chatterjee A. Regulatory molecules in tumor metastasis. J Environ Pathol Toxicol Oncol 1999; 18:251-9. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Richmond A, Thomas HG. Purification of melanoma growth stimulatory activity. J Cell Physiol 1986; 129:375-84. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Roesler R, Walz R, Quevedo J, et al. Normal inhibitory avoidance learning and anxiety, but increased locomotor activity in mice devoid of PrP(C). Brain Res Mol Brain Res 1999; 71:349-53. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Rolny C, Mazzone M, Tugues S, et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 2011; 19:31-44. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Rudd PM, Merry AH, Wormald MR, Dwek RA. Glycosylation and prion protein. Curr Opin Struct Biol 2002; 12:578-86. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Sakudo A, Lee DC, Li S, et al. PrP cooperates with STI1 to regulate SOD activity in PrP-deficient neuronal cell line. Biochem Biophys Res Commun 2005;  328:14-9. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Sales N, Hassig R, Rodolfo K, et al. Developmental expression of the cellular prion protein in elongating axons. Eur J Neurosci 2002; 15:1163-77. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Santuccione A, Sytnyk V, Leshchyns'ka I, Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 2005; 169:341-54. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Scheufler C, Brinker A, Bourenkov G, et al. Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine. Cell 2000; 101:199-210. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Schmitt-Ulms G, Legname G, Baldwin MA, et al. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 2001; 314:1209-25. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Schorl C, Sedivy JM. Analysis of cell cycle phases and progression in cultured mammalian cells. Methods 2007; 41:143-50. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Shibata S, Okano S, Yonemitsu Y, et al. Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene. J Immunol 2006; 177:3564-76. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Singh AD, Rennie IG, Kivela T, Seregard S, Grossniklaus H. The Zimmerman-McLean-Foster hypothesis: 25 years later. Br J Ophthalmol 2004; 88:962-7. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Siveen KS, Kuttan G. Role of macrophages in tumour progression. Immunol Lett 2009; 123:97-102. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Song Y, Masison DC. Independent regulation of Hsp70 and Hsp90 chaperones by Hsp70/Hsp90-organizing protein Sti1 (Hop1). J Biol Chem 2005; 280:34178-85. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Stahl N, Borchelt DR, Hsiao K, Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987; 51:229-40. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Stam-Posthuma JJ, Van Duinen C, Scheffer E, Vink J, Bergman W. Multiple primary melanomas. J Am Acad Dermatol 2001; 44:22-7. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006; 12:895-904. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Suemizu H, Monnai M, Ohnishi Y, Ito M, Tamaoki N, Nakamura M. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice. Int J Oncol 2007; 31:741-51. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Sy MS, Li C, Yu S, Xin W. The fatal attraction between pro-prion and filamin A: prion as a marker in human cancers. Biomark Med 2010; 4:453-64.";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Tan MH, Chu TM. Characterization of the tumorigenic and metastatic properties of a human pancreatic tumor cell line (AsPC-1) implanted orthotopically into nude mice. Tumour Biol 1985; 6:89-98. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2:569-79. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Tian M, Cui YZ, Song GH et al. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 2008; 8:241. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Tjalsma H, Bolhuis A, Jongbloed JD, Bron S, Van Dijl JM. Signal peptidedependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol Mol Biol Rev 2000; 64:515-47. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Tobler I, Gaus SE, Deboer T, et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996; 380:639-42. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Toth B, Lok CA, Boing A, et al. Microparticles and exosomes: impact on normal and complicated pregnancy. Am J Reprod Immunol 2007; 58:389402. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS. Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 2005; 4:409-18. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Walsh N, O'donovan N, Kennedy S, et al. Identification of pancreatic cancer invasion-related proteins by proteomic analysis. Proteome Sci 2009; 7:3. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Walz R, Amaral OB, Rockenbach IC, et al. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 1999; 40:1679-82. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Wang TH, Chao A, Tsai CL, et al. Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics 2010; 9:1873-84. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;[WHO] World Health Organization. Skin cancers. Avaliablbe from: <URL:http://www.who.int/uv/faq/skincancer/en> [2011 abril 3]. ;
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Wu CC, Chen HC, Chen SJ, et al. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 2008; 8:316-32. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Xue H, Lu B, Zhang J, et al. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res 2010; 9:545-55. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Yang AS, Chapman PB. The history and future of chemotherapy for melanoma. Hematol Oncol Clin North Am 2009; 23:583-97, x. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Yehiely F, Bamborough P, Da Costa M, et al. Identification of candidate proteins binding to prion protein. Neurobiol Dis 1997; 3:339-55. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Zanata SM, Lopes MH, Mercadante AF, et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 2002; 21:3307-16. ";
FAP;2011;BRUNO COSTA DA SILVA;Vilma Regina Martins;-x-;"Zbytek B, Carlson JA, Granese J, Ross J, Mihm MC, Slominski A. Current concepts of metastasis in melanoma. Expert Rev Dermatol 2008; 3:569-85. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Aguzzi A, Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 2004; 116:313-27. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Aguzzi A, Weissmann C. Spongiform encephalopathies: a suspicious signature. Nature 1996; 383:666-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Ashok A, Hegde RS. Selective processing and metabolism of diseasecausing mutant prion proteins. PLoS Pathog 2009; 5:e1000479- ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Azzalin A, Ferrara V, Arias A, et al. Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein. Biochem Biophys Res. Commun 2006; 346:108-15. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Bainbridge J, Walker KB. The normal cellular form of prion protein modulates T cell responses. Immunol Lett 2005; 96:147-50. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Basler K, Oesch B, Scott M, et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986; 46:417-28. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Baumann F, Tolnay M, Brabeck C, et al. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J 2007; 26:538-47. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Bennett RL, Blalock WL, Abtahi DM, Pan Y, Moyer SA, May WS. RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection. Blood 2006; 108:821-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Bennion BJ, Daggett V. Protein conformation and diagnostic tests: the prion protein. Clin Chem 2002; 48:2105-14. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Beraldo FH, Arantes CP, Santos TG, et al. Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin gamma1 chain. FASEB J 2011; 25:265-79. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Beraldo FH, Arantes CP, Santos TG, et al. Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J Biol Chem 2010; 285:36542-50. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Beringue V, Herzog L, Reine F, et al.Transmission of atypical bovine prions to mice transgenic for human prion protein. Emerg Infect Dis 2008; 14:1898901. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Berridge MJ. Unlocking the secrets of cell signaling. Annu Rev Physiol 2005; 67:1-21. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Bertram L, Tanzi RE. The genetic epidemiology of neurodegenerative disease. J Clin Invest 2005; 115:1449-57. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Booth DR, Sunde M, Bellotti V, et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 1997; 385:787-93. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Bounhar Y, Zhang Y, Goodyer CG, LeBlanc A. Prion protein protects human neurons against Bax-mediated apoptosis. J Biol Chem 2001; 276:39145-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Bredemeyer AJ, Carrigan PE, Fehniger TA, Smith DF, Ley TJ. Hop cleavage and function in granzyme B-induced apoptosis. J Biol Chem 2006; 281:37130-41. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Brini M, Miuzzo M, Pierobon N, Negro A, Sorgato MC. The prion protein and its paralogue Doppel affect calcium signaling in Chinese hamster ovary cells. Mol Biol Cell 2005; 16:2799-808. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Brown DR. Prion and prejudice: normal protein and the synapse. Trends Neurosci 2001; 24:85-90. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Brown DR, Nicholas RS, Canevari L. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 2002; 67:21124. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Brown DR, Qin K, Herms JW, et al. The cellular prion protein binds copper in vivo. Nature 1997; 390:684-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Brown DR, Schulz-Schaeffer WJ, Schmidt B, Kretzschmar HA. Prion proteindeficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 1997; 146:104-12. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM. Normal prion protein has an activity like that of superoxide dismutase. Biochem J 1999; 344 Pt 1:1-5. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55:1075-81. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995; 5:459-66. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Bueler H, Aguzzi A, Sailer A, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339-47. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Bueler H, Fischer M, Lang Y, et al. Normal development and behaviour of mice lacking the neuronal cell- surface PrP protein. Nature 1992; 356:57782. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Bugiani O, Giaccone G, Piccardo P, Morbin M, Tagliavini F, Ghetti B. Neuropathology of Gerstmann-Straussler-Scheinker disease. Microsc Res Tech 2000; 50:10-5. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Caetano FA, Lopes MH, Hajj GN, et al. Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1. J Neurosci 2008; 28:6691-702. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Calvert CM, Sanders D. Inositol trisphosphate-dependent and-independent Ca2+ mobilization pathways at the vacuolar membrane of Candida albicans. J Biol Chem 1995; 270:7272-80. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Campana V, Sarnataro D, Fasano C, Casanova P, Paladino S, Zurzolo C. Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum. J. Cell Sci 2006; 119:433-42. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Canet D, Last AM, Tito P, et al. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat Struct Biol 2002; 9:308-15. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Carlson GA, Westaway D, DeArmond SJ, Peterson-Torchia M, Prusiner SB. Primary structure of prion protein may modify scrapie isolate properties. Proc Natl Acad Sci U. S. A 1989; 86:7475-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B. Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 1989; 63:175-81. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Caughey B, Raymond GJ. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 1993; 67:643-50. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Chang HC, Nathan DF, Lindquist S. In vivo analysis of the Hsp90 cochaperone Sti1 (p60). Mol Cell Biol 1997; 17:318-25. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Chen JJ. Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. Blood 2007; 109:2693-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R. Cellular prion protein transduces neuroprotective signals. EMBO J 2002; 21:3317-26. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Chiesa R, Harris DA. Fishing for prion protein function. PLoS Biol 2009; 7:e75 ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Cohen FE, Pan KM, Huang Z, Baldwin M, Fletterick RJ, Prusiner SB. Structural clues to prion replication. Science 1994; 264:530-1. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Coitinho AS, Freitas AR, Lopes MH, et al. The interaction between prion protein and laminin modulates memory consolidation. Eur J Neurosci 2006; 24:3255-64. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Colling SB, Collinge J, Jefferys JG. Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett 1996; 209:49-52. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24:519-50. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Collinge J, Whittington MA, Sidle KC, et al. Prion protein is necessary for normal synaptic function. Nature 1994; 370:295-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Criado JR, Sanchez-Alavez M, Conti B, et al. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 2005; 19:255-65. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"de Almeida CJ, Chiarini LB, da Silva JP, PM ES, Martins MA, Linden R. The cellular prion protein modulates phagocytosis and inflammatory response. J Leukoc Biol 2005; 77:238-46. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"de Silva HA, Aronson JK, Grahame-Smith DG, Jobst KA, Smith AD. Abnormal function of potassium channels in platelets of patients with Alzheimer's disease. Lancet 1998; 352:1590-3. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"DeArmond SJ, Sanchez H, Yehiely F, et al. Selective neuronal targeting in prion disease. Neuron 1997; 19:1337-48. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Deslys JP, Marce D, Dormont D. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Gen Virol 1994; 75:23-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Dever TE. Gene-specific regulation by general translation factors. Cell 2002; 108:545-56. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Doh-ura K, Kitamoto T, Sakaki Y, Tateishi J. CJD discrepancy. Nature 1991; 353:801-2. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Dorandeu A, Wingertsmann L, Chretien F, et al. Neuronal apoptosis in fatal familial insomnia. Brain Pathol 1998; 8:531-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Erlich RB, Kahn SA, Lima FR, et al. STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 2007; 55:1690-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Fioriti L, Dossena S, Stewart LR, et al. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J Biol Chem 2005; 280:11320-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Fivaz M, Vilbois F, Thurnheer S, et al. Differential sorting and fate of endocytosed GPI-anchored proteins. EMBO J 2002; 21:3989-4000. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Fournier JG, Escaig-Haye F, Billette DV, et al. Distribution and submicroscopic immunogold localization of cellular prion protein (PrPc) in extracerebral tissues. Cell Tissue Res 1998; 292:77-84. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Fuhrmann M, Bittner T, Mitteregger G, et al. Loss of the cellular prion protein affects the Ca2+ homeostasis in hippocampal CA1 neurons. J Neurochem 2006; 98:1876-85. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Gabriel JM, Oesch B, Kretzschmar H, Scott M, Prusiner SB. Molecular cloning of a candidate chicken prion protein. Proc Natl Acad Sci U. S. A 1992; 89:9097-101. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003; 66:213-39. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Glatzel M, Ott PM, Linder T, et al. Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol 2003; 2:757-63. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Glatzel M, Stoeck K, Seeger H, Luhrs T, Aguzzi A. Human prion diseases: molecular and clinical aspects. Arch Neurol 2005; 62:545-52. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Goggin K, Beaudoin S, Grenier C, Brown AA, Roucou X. Prion protein aggresomes are poly(A)+ ribonucleoprotein complexes that induce a PKRmediated deficient cell stress response. Biochim Biophys Acta 2008; 1783:479-91.";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992; 258:806-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Gorodinsky A, Harris DA. Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J Cell Biol 1995; 129:619-27. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Graner E, Mercadante AF, Zanata SM, et al. Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res 2000; 76:85-92. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Hafner F. Cytosensor Microphysiometer: technology and recent applications. Biosens Bioelectron 2000; 15:149-58. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Hajj GNM, Lopes MH, Mercadante AF, et al. Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins. J Cell Sci 2007; 120:1915-26. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Halfmann R, Alberti S, Lindquist S. Prions, protein homeostasis, and phenotypic diversity. Trends Cell Biol 2010; 20:125-33. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Halfmann R, Lindquist S. Epigenetics in the extreme: prions and the inheritance of environmentally acquired traits. Science 2010; 330:629-32. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 2000; 5:897-904. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Harris DA. Cellular biology of prion diseases. Clin Microbiol Rev 1999; 12:429-44. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18:1926-45. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Hegde RS, Tremblay P, Groth D, DeArmond SJ, Prusiner SB, Lingappa VR. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 1999; 402:822-6. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Herms JW, Korte S, Gall S, Schneider I, Dunker S, Kretzschmar HA. Altered intracellular calcium homeostasis in cerebellar granule cells of prion proteindeficient mice. J Neurochem 2000; 75:1487-92. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Herms JW, Madlung A, Brown DR, Kretzschmar HA. Increase of intracellular free Ca2+ in microglia activated by prion protein fragment. Glia 1997; 21:253-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Herms JW, Tings T, Dunker S, Kretzschmar HA. Prion protein affects Ca2+activated K+ currents in cerebellar purkinje cells. Neurobiol Dis 2001; 8:32430. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Hetz C, Maundrell K, Soto C. Is loss of function of the prion protein the cause of prion disorders? Trends Mol Med 2003; 9:237-43. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Hetz C, Maundrell K, Soto C. Is loss of function of the prion protein the cause of prion disorders? Trends Mol Med 2003; 9:237-43. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997; 389:448-50, 526. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Horiuchi M, Yamazaki N, Ikeda T, Ishiguro N, Shinagawa M. A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheep. J Gen Virol 1995; 76:2583-2587. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Hornshaw MP, McDermott JR, Candy JM, Lakey JH. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun 1995; 214:993-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 1990; 250:1587-90. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Huang Z, Gabriel JM, Baldwin MA, Fletterick RJ, Prusiner SB, Cohen FE. Proposed three-dimensional structure for the cellular prion protein. Proc Natl Acad Sci U. S. A 1994; 91:7139-43. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;Invitrogen life technologies. Avaliable from: <URL:http://products.invitrogen.com/ivgn/product/V79020?ICID=searchproduct> [2011 fev 17] ;
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Kang SW, Rane NS, Kim SJ, Garrison JL, Taunton J, Hegde RS. Substratespecific translocational attenuation during ER stress defines a pre-emptive quality control pathway. Cell 2006; 127:999-1013. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Kevil CG, De BA, Payne DK, Coe LL, Laroux FS, Alexander JS. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int J Cancer 1996; 65:785-90. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Khosravani H, Zhang Y, Tsutsui S, et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Gen Physiol 2008; 131:i5. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Khosravani H, Zhang Y, Tsutsui S, et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 2008; 181:551-65. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Khurana R, Gillespie JR, Talapatra A, et al. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 2001; 40:3525-35. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Kiachopoulos S, Bracher A, Winklhofer KF, Tatzelt J. Pathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchor. J Biol Chem 2005; 280:9320-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Kitamoto T, Ohta M, Doh-ura K, Hitoshi S, Terao Y, Tateishi J. Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Straussler syndrome. Biochem Biophys Res Commun 1993; 191:709-14. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Klamt F, Dal-Pizzol F, Conte da Frota ML JR, et al. Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic Biol Med 2001; 30:1137-44. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. Mutations of the prion protein gene phenotypic spectrum. J Neurol 2002; 249:1567-82. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Koyasu S. The role of PI3K in immune cells. Nat Immunol 2003; 4:313-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Krebs B, Wiebelitz A, Balitzki-Korte B, et al. Cellular prion protein modulates the intracellular calcium response to hydrogen peroxide. J Neurochem 2007; 100:358-67. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Kristensson K, Feuerstein B, Taraboulos A, Hyun WC, Prusiner SB, DeArmond SJ. Scrapie prions alter receptor-mediated calcium responses in cultured cells. Neurology 1993; 43:2335-41. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Kuwahara C, Takeuchi AM, Nishimura T, et al. Prions prevent neuronal cellline death. Nature 1999; 400:225-6. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Ladogana A, Puopolo M, Croes EA, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005; 64:1586-91. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Lee KS, Magalhaes AC, Zanata SM, Brentani RR, Martins VR, Prado MA. Internalization of mammalian fluorescent cellular prion protein and N-terminal deletion mutants in living cells. J Neurochem 2001; 79:79-87. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Lee YJ, Baskakov IV. Treatment with normal prion protein delays differentiation and helps to maintain high proliferation activity in human embryonic stem cells. J Neurochem 2010; 114:362-73. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Li A, Christensen HM, Stewart LR, Roth KA, Chiesa R, Harris DA. Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO J 2007; 26:548-58. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Liang J, Pan Y, Zhang D, et al. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. FASEB J 2007; 21:2247-56. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Liang J, Pan YL, Ning XX, et al. Overexpression of PrPC and its antiapoptosis function in gastric cancer. Tumour Biol 2006; 27:84-91. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Liemann S, Glockshuber R. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 1999; 38:3258-67. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Lima FR, Arantes CP, Muras AG, Nomizo R, Brentani RR, Martins VR. Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J Neurochem 2007; 103:2164-76. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673-28. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Liu D, Si H, Reynolds KA, Zhen W, Jia Z, Dillon JS. Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology 2007; 148:306876. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Lopes MH, Hajj GN, Muras AG, et al. Interaction of cellular prion and stressinducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J Neurosci 2005; 25:11330-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Luckenbill-Edds L. Laminin and the mechanism of neuronal outgrowth. Brain Res Brain Res Rev 1997; 23:1-27. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Ma J, Lindquist S. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 2002; 298:1785-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Magalhaes AC, Silva JA, Lee KS, et al. Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein. J Biol Chem 2002; 277:33311-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Maglio LE, Perez MF, Martins VR, Brentani RR, Ramirez OA. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res 2004; 131:58-64. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Maglio LE, Perez MF, Martins VR, Brentani RR, Ramirez OA. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res 2004; 131:58-64. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Manetto V, Medori R, Cortelli P, et al. Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology 1992; 42:312-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 1994; 8:121-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Mansuy IM. Calcineurin in memory and bidirectional plasticity. Biochem Biophys Res Commun 2003; 311:1195-208. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Martinez A, Hinz JM, Gomez L, et al. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment. Mutat Res 2008; 656:1-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Martins VR, Beraldo FH, Hajj GN, et al. Prion protein: orchestrating neurotrophic activities. Curr Issues Mol Biol 2010; 12:63-86. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Martins VR, Linden R, Prado MA, et al. Cellular prion protein: on the road for functions. FEBS Lett 2002; 512:25-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Mattson MP. Calcium and neurodegeneration. Aging Cell 2007; 6:337-50. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"McCubrey JA, Steelman LS, Abrams SL, et al. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv Enzyme Regul 2006; 46:249-79. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"McEwan JF, Windsor ML, Cullis-Hill SD. Antibodies to prion protein inhibit human colon cancer cell growth. Tumour Biol 2009; 30:141-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"McLennan NF, Brennan PM, McNeill A, et al. Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 2004; 165:227-35. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 2000; 130:1007S-15S. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA, Prusiner SB. Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U. S. A 1986; 83 - 2310-2314. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Morris RJ, Parkyn CJ, Jen A. Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease. FEBS Lett 2006; 580:5565-71. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Mouillet-Richard S, Ermonval M, Chebassier C, et al. Signal transduction through prion protein. Science 2000; 289:1925-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Mukherjee A, Morales-Scheihing D, Gonzalez-Romero D, Green K, Taglialatela G, Soto C. Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival. PLoS Pathog 2010; 6: pii: e1001138. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Munnik T, Irvine RF, Musgrave A. Phospholipid signalling in plants. Biochim Biophys Acta 1998; 1389:222-72. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Muramoto T, DeArmond SJ, Scott M, Telling GC, Cohen FE, Prusiner SB. Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an alpha-helix. Nat Med 1997; 3:750-5. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;[NCBI] National Center Biothecnology Information. Nucleotide: NM_011170. Avaliable from: <URL:http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db= nucleotide> [2008 jan 07] ;
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Nitrini R, Rosemberg S, Passos-Bueno MR, et al. Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 1997; 42:138-46. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Oesch B, Westaway D, Walchli M, et al A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985; 40:735-46. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Oliveira MD, Souza LB, Pinto LP, Freitas RA. [Immunohistochemical study of components of the basement membrane in odontogenic cysts]. Pesqui Odontol Bras 2002; 16:157-62. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Orr AW, Pedraza CE, Pallero MA, et al. Low density lipoprotein receptorrelated protein is a calreticulin coreceptor that signals focal adhesion disassembly. J Cell Biol 2003; 161:1179-89. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Orsi A, Fioriti L, Chiesa R, Sitia R. Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein. J Biol Chem 2006; 281:30431-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Pan Y, Zhao L, Liang J, et al. Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 2006; 20:1886-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Paquet C, Bose A, Polivka M, et al. Neuronal phosphorylated RNAdependent protein kinase in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 2009; 68:190-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Parce JW, Owicki JC, Kercso KM, et al. Detection of cell-affecting agents with a silicon biosensor. Science 1989; 246:243-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Parkyn CJ, Vermeulen EG, Mootoosamy RC, et al. LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein. J Cell Sci 2008; 121:773-83. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Paroo Z, Ye X, Chen S, Liu Q. Phosphorylation of the human microRNAgenerating complex mediates MAPK/Erk signaling. Cell 2009; 139:112-2. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Passos AP, Garcia CR. Inositol 1,4,5-trisphosphate induced Ca2+ release from chloroquine-sensitive and -insensitive intracellular stores in the intraerythrocytic stage of the malaria parasite P. chabaudi. Biochem Biophys Res Commun 1998; 245:155-60. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Pastrana MA, Sajnani G, Onisko B, Castilla J, Morales R, Soto C, Requena JR. Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 2006; 45:15710-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Pattison IH. Scrapie in the welsh mountain breed of sheep and its experimental transmission to goats. Vet Rec 1965; 77:1388-90. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Paulsson M, Aumailley M, Deutzmann R, Timpl R, Beck K, Engel J. Lamininnidogen complex. Extraction with chelating agents and structural characterization. Eur J Biochem 1987; 166:11-19. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Peters PJ, Mironov A, Jr., Peretz D, et al. Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol 2003; 162:703-17. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Petersen RB, Parchi P, Richardson SL, Urig CB, Gambetti P. Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem 1996; 271:12661-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Prado MA, Alves-Silva J, Magalhaes AC, et al. PrPc on the road: trafficking of the cellular prion protein. J Neurochem 2004; 88:769-781. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Preissner KT. Structure and biological role of vitronectin. Annu Rev Cell Biol 1991; 7:275-310. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Prestori F, Rossi P, Bearzatto B, et al. Altered neuron excitability and synaptic plasticity in the cerebellar granular layer of juvenile prion protein knock-out mice with impaired motor control. J Neurosci 2008; 28:7091-3. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Priola SA, Caughey B. Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol Neurobiol 1994; 8:113-20. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Prusiner SB. Molecular biology of prion diseases. Science 1991; 252:151522. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Prusiner SB. Prion diseases and the BSE crisis. Science 1997; 278:245-51. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Prusiner SB. Prions. Proc Natl Acad Sci U. S. A 1998; 95:13363-83. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Rangel A, Burgaya F, Gavin R, Soriano E, Aguzzi A, Del Rio JA. Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: Role of AMPA/kainate receptors. J Neurosci Res 2007; 85:2741-55. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Rangel A, Burgaya F, Gavin R, Soriano E, Aguzzi A, Del Rio JA. Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: Role of AMPA/kainate receptors. J Neurosci Res 2007; 85:2741-55. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Richardson EP, Jr., Masters CL. The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system. Brain Pathol 1995; 5:33-41. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Richter JD, Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 2005; 433:477-80. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997; 9:180-6. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Rockwell PL, Storey BT. Determination of the intracellular dissociation constant, K(D), of the fluo-3. Ca(2+) complex in mouse sperm for use in estimating intracellular Ca(2+) concentrations. Mol Reprod Dev 1999; 54:418-28. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Rodriguez A, Freixes M, Dalfo E, Martin M, Puig B, Ferrer I. Metabotropic glutamate receptor/phospholipase C pathway: a vulnerable target to Creutzfeldt-Jakob disease in the cerebral cortex. Neuroscience 2005; 131:825-32. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Rodriguez A, Martin M, Albasanz JL, et al. Group I mGluR signaling in BSEinfected bovine-PrP transgenic mice. Neurosci Lett 2006; 410:115-20. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Roffe M, Beraldo FH, Bester R, et al. Prion protein interaction with stressinducible protein 1 enhances neuronal protein synthesis via mTOR. Proc Natl Acad Sci U. S. A 2010; 107:13147-52. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Ron D. Translational control in the endoplasmic reticulum stress response. J Clin Invest 2002; 110:1383-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 1993; 13:7358-63. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;[RSC] Advancing the Chemical Sciences. Battle with the prions. Avaliable from: <URL:http://www.rsc.org/chemistryworld/Issues/2005/October/prions. asp> [2011 jan 12] ;
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Rudd PM, Merry AH, Wormald MR, Dwek RA. Glycosylation and prion protein. Curr Opin Struct Biol 2002; 12:578-86. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Sabatini DM. mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 2006; 6:729-34. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Sales N, Hassig R, Rodolfo K, et al. Developmental expression of the cellular prion protein in elongating axons. Eur J Neurosci 2002; 15:1163-77. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Santuccione A, Sytnyk V, Leshchyns'ka I, Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 2005; 169:341-54. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999; 19:2435-44. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;Schneider P. Über die Bedeutung zellwandfreier Bakterienformen (CWD) auch in Bezug auf (Para-) Tuberkulose, Morbus Crohn und BSE. Elektronische Bücher (Ebooks). [serial online]. 2000. Avaliable from: <URL:http://www.pferdemedizin.com/cwd> [2011 jan 12] ;
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Schumacher RJ, Hurst R, Sullivan WP, McMahon NJ, Toft DO, Matts RL. ATP-dependent chaperoning activity of reticulocyte lysate. J Biol Chem 1994; 269:9493-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Shaked GM, Meiner Z, Avraham I, Taraboulos A, Gabizon R. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods. J Biol Chem 2001; 276:14324-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Shors TJ. Memory traces of trace memories: neurogenesis, synaptogenesis and awareness. Trends Neurosci 2004; 27:250-6. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Shyng SL, Heuser JE, Harris DA. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J Cell Biol 1994; 125:1239-50. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Shyu WC, Lin SZ, Chiang MF, et al. Overexpression of PrPC by adenovirusmediated gene targeting reduces ischemic injury in a stroke rat model. J Neurosci 2005; 25:8967-77. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Sigurdson CJ, Nilsson KP, Hornemann S, et al. A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest 2010; 120:2590-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Singh A, Mohan ML, Isaac AO, et al. Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesis. PLoS One 2009; 4:e4468. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Smith DF, Sullivan WP, Marion TN,et al. Identification of a 60-kilodalton stress-related protein, p60, which interacts with hsp90 and hsp70. Mol Cell Biol 1993; 13:869-76. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Stahl N, Borchelt DR, Hsiao K, Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987; 51:229-40. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Stockel J, Safar J, Wallace AC, Cohen FE, Prusiner SB. Prion protein selectively binds copper(II) ions. Biochemistry 1998; 37:7185-93. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Stoica L, Zhu PJ, Huang W, Zhou H, Kozma SC, Costa-Mattioli M. Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc Natl Acad Sci U. S. A 2011;  ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Sunyach C, Jen A, Deng J, et al. The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J 2003; 22:3591601. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Supattapone S, Bosque P, Muramoto T, et al. Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice. Cell 1999; 96:869-78. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Taylor DR e Hooper NM. The prion protein and lipid rafts. Mol Membr Biol 2006; 23:89-99. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Taylor DR, Watt NT, Perera WS, Hooper NM. Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copperstimulated, clathrin-dependent endocytosis. J Cell Sci 2005; 118:5141-53. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Telling GC, Haga T, Torchia M, Tremblay P, DeArmond SJ, Prusiner SB. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev 1996; 10:1736-50. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Telling GC, Scott M, Hsiao KK, et al. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U. S. A 1994; 91:9936-40. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83:79-90. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Tobler I, Deboer T, Fischer M. Sleep and sleep regulation in normal and prion protein-deficient mice. J Neurosci 1997; 17:1869-79. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Tobler I, Gaus SE, Deboer T, et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996; 380:639-642. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Torres M, Castillo K, Armisen R, Stutzin A, Soto C, Hetz C. Prion protein misfolding affects calcium homeostasis and sensitizes cells to endoplasmic reticulum stress. PLoS One 2010; 5:e15658. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Tribl GG, Strasser G, Zeitlhofer J, et al. Sequential MRI in a case of Creutzfeldt-Jakob disease. Neuroradiology 2002; 44:223-6. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Tsai MT, Su YC, Chen YH, Chen CH. Lack of evidence to support the association of the human prion gene with schizophrenia. Mol Psychiatry 2001; 6:74-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Tuite MF, Serio TR. The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat Rev Mol Cell Biol 2010; 11:823-33. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"van der Kamp MW, Daggett V. The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel 2009; 22:461-8. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"van der Kamp MW, Daggett V. Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding. J Mol Biol 2010; 404:732-48. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Vassallo N, Herms J. Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 2003; 86:538-44. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Vassallo N, Herms J, Behrens C, et al. Activation of phosphatidylinositol 3kinase by cellular prion protein and its role in cell survival. Biochem Biophys Res Commun 2005; 332:75-82. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Venneti S. Prion diseases. Clin Lab Med 2010; 30:293-309. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Venstrom KA, Reichardt LF. Extracellular matrix. 2: Role of extracellular matrix molecules and their receptors in the nervous system. FASEB J 1993; 7:996-1003. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJ. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 1997; 89:73-82. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Walz R, Amaral OB, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, Martins VR, Brentani RR. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 1999; 40:1679-82. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Wang JM, Chao JR, Chen W, Kuo ML, Yen JJ, Yang-Yen HF. The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol Cell Biol 1999; 19:6195-206. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Warner RG, Hundt C, Weiss S, Turnbull JE. Identification of the heparan sulfate binding sites in the cellular prion protein. J Biol Chem 2002; 277:18421-30. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Watanabe Y, Hiraoka W, Shimoyama Y, Horiuchi M, Kuwabara M, Inanami O. Instability of familial spongiform encephalopathy-related prion mutants. Biochem Biophys Res Commun 2008; 366:244-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Weise J, Crome O, Sandau R, Schulz-Schaeffer W, Bahr M, Zerr I. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett 2004; 372:146-50. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Weise J, Sandau R, Schwarting S, et al. Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke 2006; 37:12961300. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Wek RC, Cavener DR. Translational control and the unfolded protein response. Antioxid Redox Signal 2007; 9:2357-71. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Westergard L, Christensen HM, Harris DA. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 2007; 1772:629-44. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Whatley SA, Powell JF, Politopoulou G, Campbell IC, Brammer MJ, Percy NS. Regulation of intracellular free calcium levels by the cellular prion protein. Neuroreport 1995; 6:2333-7. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Wickner RB, Edskes HK, Ross ED, Pierce MM, Shewmaker F, Baxa U, Brachmann A. Prions of yeast are genes made of protein: amyloids and enzymes. Cold Spring Harb Symp Quant Biol 2004; 69:489-96. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Wickner RB, Edskes HK, Shewmaker F, Nakayashiki T, Engel A, McCann L, Kryndushkin D. Yeast prions: evolution of the prion concept. Prion 2007; 1:94-100. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Windl O, Giese A, Schulz-Schaeffer W, et al. Molecular genetics of human prion diseases in Germany. Hum Genet 1999; 105:244-52. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Wong C, Xiong LW, Horiuchi M, et al. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of proteaseresistant prion protein. EMBO J 2001; 20:377-86. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Wong K, Qiu Y, Hyun W, et al. Decreased receptor-mediated calcium response in prion-infected cells correlates with decreased membrane fluidity and IP3 release. Neurology 1996; 47:741-50. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Yamauchi T. Neuronal Ca2+/calmodulin-dependent protein kinase II-discovery, progress in a quarter of a century, and perspective: implication for learning and memory. Biol Pharm Bull 2005; 28:1342-54. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Yang W, Cook J, Rassbach B, Lemus A, DeArmond SJ, Mastrianni JA. A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP. J Neurosci 2009; 29:10072-80. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Zaccolo M, Pozzan T. CAMP and Ca2+ interplay: a matter of oscillation patterns. Trends Neurosci 2003; 26:53-55. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Zanata SM, Lopes MH, Mercadante AF, et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 2002; 21:3307-16. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Zerr I, Schulz-Schaeffer WJ, Giese A, et al. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 2000; 48:323-9. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Zimmer SG, DeBenedetti A, Graff JR. Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis. Anticancer Res 2000; 20:134351. ";
FAP;2011;CLEITON FAGUNDES MACHADO;Vilma Regina Martins;-x-;"Zimmermann K, Turecek PL, Schwarz HP. Genotyping of the prion protein gene at codon 129. Acta Neuropathol (Berl) 1999; 97:355-8.";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Aarnio M, Mecklin JP, Aaltonen LA Nyström-Lahti M, Järvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995; 64:430-3. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Aarnio M, Salovaara R, Aaltonen LA, Mecklin JP, Jarvinen HJ. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 1997; 74:551-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81:214-8. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Achatz MI, Hainaut P, Ashton-Prolla P. Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening? Lancet Oncol 2009; 10:920-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Ainsworth PJ, Koscinski D, Frasier BP, Stuart JA. Family cancer histories predictive of a high risk of hereditary non-polyposis colorectal cancer associate significantly with a genomic rearrangement in HMSH2 or HMLH1. Clin Genet 2004; 66:183-8. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Aebi S, Kurdi-Haider B, Gordon R et al: Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 1996; 56:3087-90. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Akiyama M, Sato H, Yamada T, et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 1997; 57:3920-3. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Alvarez K, Hurtado C, Hevia MA, et al. Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome. Dis Colon Rectum 2010; 53:450-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Arnold CN, Goel A, Boland CR. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Int J Cancer 2003; 106:66-73. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Bachinski LL, Olufemi SE, Zhou X, et al. Genetic mapping of a third LiFraumeni syndrome predisposition locus to human chromosome 1q23 Cancer Res 2005; 65:427-31. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Bandipalliam P. Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer 2005; 4:323-33. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Baudhuin LM, Ferber MJ, Winters JL, et al. Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients. Gastroenterology 2005; 129:846-54. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Beck NE, Tomlinson IP, Homfray T, Hodgson SV, Harocopos CJ, Bodmer WF. Genetic testing is important in families with a history suggestive of hereditary nonpolyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg 1997; 84:233-7. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Berends MJ, Wu Y, Sijmons RH, et al. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 2002; 70:26-37. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Bevan S, Houlston RS. Genetic predisposition to gastric cancer. QJM 1999; 92:5-10. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Birch JM, Hartley AL, Tricker KJ, et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994; 54:1298-304. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Boland CR, Koi M, Chang DK, Carethers JM. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Fam Cancer 2008; 7:41-52. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58:5248-57. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Boland CR. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer 2005; 4:211-8. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Boyd J, Rhei E, Federici MG, et al. Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 1999; 53:87-91. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Brown AL, Lee CH, Schwarz JK, Mitiku N, Piwnica-Worms H, Chung JH. A human Cds1-related kinase that functions downstream of ATM protein in thecellular response to DNA damage. Proc Natl Acad Sci USA 1999; 96:3745-50. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Bunyan DJ, Eccles DM, Sillibourne J, et al. Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 2004; 91:1155-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Burchell AN, Winer RL, de Sanjose S, Franco EL. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006; 24(Suppl 3):s52-61. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Buttin BM, Powell MA, Mutch DG, et al. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet 2004; 74:1262-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Caldes T, Godino J, Sanchez A et al. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Oncol Rep 2004; 12:621-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Candido PBM, Santos EMM, Rossi CS, et al. Frequency of colorectal cancer and extra- colonic tumors in families that meet amsterdam criteria I and II: Results from Hospital A.C. Camargo Hereditary Colorectal Cancer Registry. Applied Cancer Res 2007; 27:18-22. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Cederquist K, Emanuelsson M, Goransson I, et al. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden. Int J Cancer 2004; 109:370-6. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Cesinaro AM, Ubiali A, Sighinolfi P, Trentini GP, Gentili F, Facchetti F. Mismatch repair proteins expressions and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous câncer. Am J Dermatopathol 2007; 29:351-58. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Charames GS, Millar AL, Pal T, Narod S, Bapat B. Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium? Hum Genet 2000; 107:623-629. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Chompret A. The Li-Fraumeni syndrome. Biochimie 2002; 84:75-82. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Clendenning M, Hampel H, LaJeunesse J, et al. Long-range PCR facilitates the identification of PMS2-specific mutations. Hum Mutat 2006; 27:490-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 1991; 90:60613. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Cossio SL, Koehler-Santos P, Pessini AS, et al. Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil. Fam Cancer 2010; 9:131-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Crijnen TE, Janssen-Heijnen ML, Gelderblom H, et al. Survival of patients with ovarian cancer due to a mismatch repair defect. Fam Cancer 2005; 4:301-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Cybulski C, Gorski B, Huzarski T, et al. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 2004; 75:1131-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Cyr JL, Heinen CD. Hereditary cancer-associated missense mutations in hMSH6 uncouple ATP hydrolysis from DNA mismatch binding. J Biol Chem 2008; 283:31641-8. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"de Leeuw WJ, Dierssen J, Vasen HF, et al. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. J Pathol 2000; 192:328-35. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"de Leeuw WJ, van Puijenbroek M, Tollenaar RA, Cornelisse CJ, Vasen HF, Morreau H. Correspondence re: A. Müller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 2002; 62:1014-9. Comment on: Cancer Res 2003; 63:1148-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"De Rosa M, Fasano C, Panariello L, et al. Evidence for a recessive inheritance of Turcot’s syndrome caused by compound heterozygous mutations within the PMS2 gene. Oncogene 2000; 19:1719-1723. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P, et al. Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 2003; 52:1752-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15:7-12. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Dominguez MV. Caracterização de mutações por meio de sequenciamento dos genes hMLH1 e hMSH2 em pacientes com suspeita de Síndrome de Lynch. São Paulo; 2009. [Tese de DoutoradoFundação Antônio Prudente]. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Eisen DB, Michael DJ. Sebaceous lesions and their associated syndromes: Part II. J Am Acad Dermatol 2009; 61:563-78. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Fearnhead NS, Wilding JL, Bodmer WF. Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull 2002; 64:27-43. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Felton KE, Gilchrist DM, Andrew SE Constitutive deficiency in DNA mismatch repair. Clin Genet 2007; 71:483-98. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase nº. 10 [Internet]. Avaliable from: <URL:http://globocan.iarc.fr> [2011 fev 12] ;
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Franco EL, Villa LL, Ruiz A, Costa MC. Transmission of cer- vical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J Infect Dis 1995; 172:756-63. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Franco EL, Duarte-Franco E. Epidemiologia e fatores de risco  do câncer colorretal. In: Rossi BM, Nakagawa WT, Ferreira FO, Aguiar Junior S, Lopes A, editores. Câncer de cólon, reto e ânus. São Paulo: Lemar/Tecmedd; 2005. p.255-61. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Friedrichsen DM, Malone KE, Doody DR, Daling JR, Ostrander EA. Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women. Breast Cancer Res 2004; 6:R629-35. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Gazolli I, Loda M, Syngal S, Klodner RD. A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res 2002; 62:3925- 8. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Gille JJ, Hogervorst FB, Pals G, et al. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 2002; 87:892-7. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Goecke T, Schulmann K, Engel C, et al. German HNPCC Consortium. Genotype phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 2006; 24:4285-92.";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Goodfellow PJ, Buttin BM, Herzog TJ, et al. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci USA 2003; 100:5908-13. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Grabowski M, Mueller-Koch Y, Grasbon-Frodl E, et al. Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal câncer (HNPCC) families. Genet Test 2005; 9:13846. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology 2003; 124:1574-94. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Gylling A, Abdel-Rahman WM, Juhola M et al. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. Gut 2007; 56:926-33. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005; 352:185160. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Hampel H, Frankel W, Panescu J, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 2006; 66:7810-7. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Henderson TO, Amsterdam A, Bhatia S, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med 2010; 152:444-55. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Hendriks YM, Wagner A, Morreau H, et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 2004; 127:17-25. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Hendriks YM, de Jong AE, Morreau H, et al. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin 2006a; 56:213-25. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Hendriks YM, Jagmohan-Changur S, van der Klift HM, et al. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Gastroenterology 2006b; 130:312-22. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Hitchins M, Williams R, Cheong K, et al. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology 2005; 129:1392-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Hitchins MP, Wong JJ, Suthers G, et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med 2007; 356:697-705. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Huang J, Kuismanen SA, Liu T, et al. MSH6 and MSH3 are rarely involved in genetic predisposition to non-polipotic colon cancer. Cancer Res 2001; 61:1619-23. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Itoh H, Houlston RS, Harocopos C, Slack J. Risk of cancer death in firstdegree relatives of patients with hereditary non- polyposis cancer syndrome (Lynch type II): a study of 130 kindreds in the United Kingdom. Br J Surg 1990; 77:1367-70. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Iyer RR, Pluciennik A, Burdett V, Modrich PL. DNA mismatch repair: functions and mechanisms. Chem Rev 2006; 106:302-23. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Jasperson KW, Tuohy TM, Neklason DW, Burt RW, Hereditary and familial colon cancer. Gastroenterology 2010; 138:2044-58. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Jass JR, Stewart SM, Stewart J, Lane MR. Hereditary non-polyposis colorectal cancer-morphologies, genes and mutations. Mutat Res 1994; 310:125-33. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Jass JR. Pathology of hereditary non-polyposis colorectal cancer. Ann NY Acad Sci 2000; 910:62-73. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Jass JR, Young J, Leggett BA. Evolution of colorectal cancer: change of pace and change of direction. J Gastroenterol Hepatol 2002; 17:17-26. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Jass JR. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 2006; 12:4943-50. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Jenkins MA, Hayashi S, O'Shea AM, et al. Colon Cancer Family Registry. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 2007; 133:48-56. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Jensen UB, Sunde L, Timshel S, et al. Mismatch repair defective breast cancer in the hereditary non-polyposis colorectal cancer syndrome. Breast Cancer Res Treat 2010; 120:777-82. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Jiricny J, Nyström-Lahti M. Mismatch repair defects in cancer. Curr Opin Genet Dev 2000; 10:157-61. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Jiricny J. Mediating mismatch repair. Nat Genet. 2000; 24:6-8. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001; 96:2992-3003. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Kariola R, Raevaara TE, Lonnqvist KE, Nystrom-Lahti M. Functional analysis of MSH6 mutations linked to kin- dreds with putative hereditary non-polyposis colorectal cancer syndrome. Hum Mol Genet 2002; 11:1303-10. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Kariola R, Otway R, Lonnqvist KE, et al. Two mismatch repair gene mutations found in a colon cancer patient – which one is pathogenic? Hum Genet 2003; 112:105-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Kariola R, Hampel H, Frankel WL, Raevaara TE, de la Chapelle A, NystromLahti M. MSH6 missense mutations are often associated with no or low cancer susceptibility. Br J Cancer 2004; 91:1287-92. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Kato S, Han SY, Liu W, et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by highresolution missense mutation analysis. Proc Natl Acad Sci USA 2003; 100:8424-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Kerber R, Neklason DW, Samowitz WS, Burt RW. Frequency of familial colon cancer and hereditary nonpolyposis colorectal cancer in a large population database. Fam Cancer 2005; 4:239-244. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Kim SK, DO JE, Kang HY, Lee ES, Kim YC. Combination of topical 5- aminolevulinic acid photodynamic therapy with carbon dioxide laser for sebaceous hyperplasia. J Am Acad Dermatol 2007; 56:523-4. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Kjaer SK, Chackerian B, van den Brule AJ, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomark Prev 2001; 10:101-6. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma.. Proc Natl Acad Sci 1971; 68:820-3. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Kolodner RD, Marsischky GT. Eukariotic DNA mismatch repair. Current Opinion in Genetics & Development 1999a; 9:89-95. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Kolodner RD, Tytell JD, Schmeits JL et al. Germ-line msh6 mutations in colorectal cancer families. Cancer Res 1999b; 59:5068-74. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Laccarino I, Marra G, Palombo F, Jirincny J. hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMUTS?. EMBO J 1998; 17:2677-86. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Lee JS, Collins KM, Brown AL, Lee CH, Chung JH. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 2000; 404:201-4. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005; 293:1979-85. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996; 2:16974. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Loukola A, Vilkki S, Singh J. Germline and somatic mutation analysis of MLH3 in MSI-Positive colorectal cancer. Am J Pathol 2000; 157:347-52. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor  spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an update review. Gastroenterology 1993; 104:1535-49. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Lynch HT, Smyrk T, Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 1997; 93:84-99. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Lynch HT, Watson P, Shaw TG, et al. Clinical impact of molecular genetic diagnosis, genetic couseling, and management of hereditary cancer. Part 1: studies of cancer families. Cancer 1999; 86:1629-36. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999; 36:801-18. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Lynch HT. Family Information Service and Hereditary Cancer, Cancer 2001; 91:625-8. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Lynch HT, Grady W, Suriano G, Huntsman D. Gastric cancer: new genetic developments. J Surg Oncol 2005; 90:114-33. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Lynch HT, Boland CR, Gong G. et al. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 2006; 14:390-402. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Lynch HT, Lynch JF, Attard TA. Diagnosis and management of Hereditary colorectal cancer syndromes: Lynch syndrome as a model. CMAJ 2009a; 181:273-80. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 2009b; 76:1-18. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Mangold E, Pagenstecher C, Leister M, et al. A genotype correlation in HNPCC: strong predominance of MSH2 mutations in 41 patients with MuirTorre syndrome. J Med Genet 2004; 41:567-72. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995; 87:1114-25. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Martinez SL, Kolodner RD. Functional analysis of human mismatch repair gene mutations identifies weak alleles and polymorphisms capable of polygenic interactions. Proc Natl Acad Sci USA 2010; 107:5070-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Mecklin JP, Jarvinen HJ, Virolainen M. The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma. Cancer. 1992; 69:1112-4. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Meijers-Heijboer H, van den Ouweland A, Klijn J, et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nature Genet 2002; 31:55-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Meijers-Heijboer H, Wijnen J, Vasen H et al. The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 2003; 72:1308-14. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Menko FH, Kaspers GL, Meijer GA, Claes K, van Hagen JM, Gille JJ. A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma  and rectal cancer. Fam Cancer 2004; 3:123-7. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2010 incidência de câncer no Brasil. Rio de Janeiro: INCA; 2009. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Miyaki M, Konishi M, Tanaka K et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997; 17:271272. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Miyakura Y, Sugano K, Akasu T, et al. Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin Gastroenterol Hepatol 2004; 2:147-56. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Modrich P. Mechanisms in Eukariotic mismatch repair. J Biol Chem 2006; 281:30305-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Mueller-Koch Y, Vogelsang H, Kopp R, et al. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 2005; 54:1733-40. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Muller A, Edmonston TB, Corao DA, et al. Exclusion of breast cancer as an integral tumor of hereditary non-polyposis colorectal cancer. Cancer Res 2002; 62:1014-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Nakagawa H, Hampel H, La Chapelle A. Identification and characterization of genomic rearrangments of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques. Hum Mutat 2003; 22:258. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Nakagawa H, Lockman JC, Frankel WL, et al. Mismatch repair gene PMS2: Disease-causing germline mutations are frequent in pacients whose tumors stain negative for PMS2 protein, but paralogous genes abscure mutation detection and interpretation. Cancer Res 2004; 64:4721-7. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Nelson CL, Sellers TA, Rich SS, Potter JD, McGovern PG, Kushi LH. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Genet Epidemiol 1993; 10:235-44. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371:7580. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Niessen RC, Sijmons RH, Berends MJ, Ou J, Hofstra RM, Kleibeuker JH. Hereditary non-polyposis colorectal cancer: identification of mutation carriers and assessing pathogenicity of mutations. Scand J Gastroenterol 2004; 241:70-7. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001; 11:863-74. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Nussbaum RL, McInnes RR, Willard HF. Thompson e Thompson genética médica. 6 ed. Rio de Janeiro: Guanabara Koogan; 2002. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Ohmiya N, Matsumoto S, Yamamoto H, Baranovskaya S, Malkhosyan SR, Perucho M. Germeline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phonotype. Gene 2001; 272:301-13. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Oliveira Ferreira F, Napoli Ferreira CC, Rossi BM, et al. Frequency of extracolonic tumors in hereditary nonpolyposis CRC (LS) and familial CRC (FCC) Brazilian families: an analysis by a Brazilian Hereditary CRC Institutional Registry. Fam Cancer 2004; 3:41-7. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Oliveira LP. Avaliação de instabilidade de microssatélites e expressão imunoistoquímica das proteínas hMLH1 e hMSH2 em pacientes com suspeita de câncer colorretal hereditário sem polipose. São Paulo; 2008. [Dissertação de Mestrado-Fundação Antonio Prudente]. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Olivier M, Goldgar DE, Sodha N, et al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003; 63:6643-50. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Orta L, Klimstra DS, Qin J, et al. Towards identification of hereditary of DNA mismatch repair deficiency: Sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient’s age or other clinical characteristics. Am J Surg Pathol 2009; 33:934-44. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Pagenstecher C, Wehner M, Friedl W et al. Aberrant splicing in MLH1 and MSH2 due to éxonsic and íntronic variants. Hum Genet 2006; 119:9-22. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Palmero EI, Schüler-Faccini L, Caleffi M, et al. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. Cancer Lett 2008; 261:21-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Papp J, Kovacs ME, Olah E. Germline MLH1 e MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary nonpolyposis colorectal cancer families: Implications for genetic testing. World J Gastroenterol 2007; 13:2727-32. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Parc Y, Boisson C, Thomas G Olschwang S. Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet 2003; 40:208-13. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of the collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997; 113:1146-58. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Peltomaki P. DNA mismatch repair and cancer. Mutat Res 2001; 488:77-85. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003; 21:1174-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Peltomaki P, Vasen H. Mutations associated with HNPCC predisposition- Update of ICG-HNPCC/InSiGHT mutation database. Dis Markers 2004; 20:269-276. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Peltomaki P. Lynch syndrome genes. Fam Cancer 2005; 4:227-232. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Peterlongo P, Nafa K, Lerman GS et al. MSH6 germline mutations are rare in colorectal cancer families. Int J Cancer 2003; 107:571-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001; 183:1554-64. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Pitorius S, Görgens H, Plaschke J, et al. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett 2007; 248:89-93. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Plaschke J, Engel C, Kruger S, et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations com- pared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 2004; 22:4486-94. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Plaschke J, Kruppa C, Tischler R, et al. Sequence analysis of the mismatch repair gene hMLH6 in the germiline of pacientes with familial and sporadic colorectal cancer. Int J Cancer 2000; 85:606-13. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Ponti G, Leon MP. Muir -Torre Syndrome. Lancet Oncol 2005; 6:980-87. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Ponti G, Venesio T, Losi L et al. BRAF Mutations in multiple sebaceous hyperplasias of patients belonging to MYH: associated polyposis pedigrees. J Invest Dermatol 2007; 127:1387-91. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002; 30:3894-900. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Ripperger T, Beger C, Rahner N, et al. Constitutional mismatch repair deficiency and childhood leukemia/lymphoma-report on a novel biallelic MSH6 mutation. Haematologica 2010; 95:841-4. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Risinger JI, Barrett JC, Watson P Lynch HT, Boyd J. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary non-polyposis colorectal carcinoma syndrome. Cancer 1996; 77:1836-43. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines. J Natl Cancer Inst 1997; 89:1758-62. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Rodriguez-Bigas MA, Vasen HF, Lynch HT, et al. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer 1998; 83:240-4. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Rossi BM, Lopes A, Ferreira FO, et al. hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. Ann Surg Oncol2002; 9:555-61. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Rountree MR, Bachman KE, Herman JG, Baylin SB. DNA methylation, chromatin inheritance, and cancer. Oncogene 2001; 20:3156-65. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Schulmann K, Brasch FE, Kunstmann E, et al. HNPCC-associated small bowel cancer: Clinical and molecular characteristics. Gastroenterology 2005; 128:590-9.";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Scott RJ, McPhillips M, Meldrum CJ et al. Hereditary non-polyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001; 68:118-27.";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Senter L, Clendenning M, Sotamaa K, et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 2008; 135:419-28. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Shimizu Y, Ikeda S, Fujimori M, et al. Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer 2002; 33:73-81. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Shin K, Shin J, Kim J, Park J. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene. Cancer Res 2002; 62:38-42. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Sijmons RH, Kiemeney LA, Witjes JA, Vasen HF. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options. J Urol 1998; 60:466-70. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Silva FC, Valentin MD, Ferreira F de O, Carraro DM, Rossi BM. Mismatch repair genes in Lynch syndrome: a review. Sao Paulo Med J 2009; 127:4651. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Singh RS, Grayson W, Redston M, et al. Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. Am J Surg Pathol 2008; 32:936-42. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Suchy J, Cybulski C, Woko?orczyk D, et al. CHEK2 mutations and HNPCCrelated colorectal cancer. Int J Cancer 2010; 126:3005-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Suter CM, Martin DI, Ward RL. Germ-line epimutation of MLH1 in individuals with multiple cancers. Nat Genet 2004; 36:497-501. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Tanyi M, Olasz J, Lukács G, et al. Pedigree and genetic analysis of a novel mutation carrier patient suffering from hereditary nonpolyposis colorectal cancer. World J Gastroenterol 2006; 12:1192-7. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Tate PH, Bird AP. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev 1993; 3:226-31. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"The CHEK2 Breast Cancer Consortium 2004: CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 2004; 74:1175-82. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260:846-19. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"van den Bos M, van den Hoven M, Jongejan E, et al. More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colon. Am J Surg Pathol 2004; 28:706-11. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34:424-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Vasen HF, Nagengast FM, Khan PM. Interval cancers in hereditary nonpolyposis colorectal cancer (Lynch syndrome). Lancet 1995; 345:1183-4. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Vasen HF, Sanders EA, Taal BG, et al. The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). Int J Cancer 1996a; 65:422-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996b; 110:1020-7. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116:1453-6. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Vasen HF, Morreau H, Nortier JW. Is breast cancer part of the tumor spectrum of hereditary non-polyposis colorectal cancer? Am J Hum Genet 2001a; 68:1533-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Vasen HF, Stormorken A, Menko FH et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001b; 19:4074-4080. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Vasen HFA. Clinical description of the Lynch syndrome [Hereditary nonpolyposis colorectal cancer (HNPCC)]. Fam cancer 2005; 4:219-25. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Vasen HF, Möslein G, Alonso A, et al. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 2010; 9:109-15. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Vernez M, Hutter P, Monnerat C, Halkic N, Gugerli O, Bouzourene H. A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene. Fam Cancer 2007; 6:141-5. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Wagner A, Hendriks Y, Meijers-Heijboer EJ et al. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet 2001; 38:318-22. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Wagner A, Barrows A, Wijnen JT et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 2003; 72:1088-100.";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Walsh MD, Buchanan DD, Walters R, et al. Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis. Fam Cancer 2009; 8:313-23. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Wang Y, Friedl W, Lamberti C, et al. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Int J Cancer 2003; 103:636-41. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Wasielewski M, Vasen H, Wijnen J, et al. CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer. Clin Cancer Res 2008; 14:498994. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71:677-85. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Watson P, Lynch HT. Cancer risk in mismatch repair gene mutation carriers. Fam Cancer 2001; 1:57-60. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Watson P, Vasen HF, Mecklin J-P, et al. The Risk of Extra-colonic, extraendometrial Cancer in the Lynch Syndrome. Int J Cancer 2008; 123:444-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Westenend PJ, Schütte R, Hoogmans MM, Wagner A, Dinjens WN. Breast cancer in an MSH2 gene mutation carrier. Hum Pathol 2005; 36:1322-6. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Wijnen J, Khan PD, Vasen H, et al. Hereditary nonpolyposis colorectal cancer families nor complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet 1997; 61:329-35. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Wijnen J, van der Klift H, Vasen H, et al. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 1998; 20:326-8. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;Wijnen J, de Leeuw W, Vasen H et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 1999: 23:142-4. ;
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Wimmer K, Etzler J. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet 2008; 124:10522. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH, Li FP, Syngal S. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology. 2006; 130:73-9. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Woods MO, Hyde AJ, Curtis FK, et al. High frequency of hereditary colorectal cancer in Newfoundland likely involves novel susceptibility genes. Clin Cancer Res 2005; 11:6853-61. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Wu Y, Berends MJ, Mensink RG, et al. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 1999; 65:12918.";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Yang H, Sasaki T, Minoshima S, Shimizu N. Identification of three novel proteins (SGSM1, 2, 3) which modulate small G protein (RAP and RAB)mediated signaling pathway. Genomics 2007; 90:249-60. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Yap HL, Chieng WS, Lim JR, et al. Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore. Fam Cancer 2009; 8:85-94. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Yuan ZQ, Gottlieb B, Beitel LK, et al. Polymorphisms and HNPCC: PMS2MLH1 protein interactions diminished by single nucleotide polymorphisms. Hum Mutat 2002; 19:108-13. ";
FAP;2011;FELIPE CAVALCANTI CARNEIRO DA SILVA;Fábio de Oliveira Ferreira;Dirce Maria Carraro/Benedito Mauro Rossi;"Zhang J, Lindroos A, Ollila S, et al. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carries. Cancer Res 2006; 2:659-64. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Abou Youssif T, Fahmy MA, Koumakpayi IH, et al. The mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal cell carcinoma metastases. Cancer 2011; 117:290-300. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Amiel A, Ohali A, Fejgin M, et al. Molecular cytogenetic parameters in Ewing sarcoma. Cancer Genet Cytogenet 2003; 140:107-12. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Andrade VP, Cunha IW, Silva EM, et al. O arranjo em matriz de amostras teciduais (tissue microarray): larga escala e baixo custo ao alcance do patologista. J Bras Patol Med Lab 2007; 43:55-60. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Arai Y, Honda S, Haruta M, et al. Genome-wide analysis of allelic imbalances reveals 4q deletions as a poor prognostic factor and MDM4 amplification at 1q32.1 in hepatoblastoma. Genes Chromosomes Cancer 2010; 49:596609. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Armengol G, Tarkkanen M, Virolainen M, et al. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. Br J Cancer 1997; 75:1403-9.  ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with nonmetastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 2004; 40:73-83. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Baudis M, Cleary ML. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 2001; 17:1228-9. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;Baudis M. Progenetix oncogenomic online resource. 2009. Avaliable from: <URL:www.progenetix.net> [2011 maio 12].  ;
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Bernstein M, Kovar H, Paulussen M, et al. Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In: Pizzo PA, Poplack DG, editors. Principles and pratice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. 35: p.1003-32. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Bertolotti A, Lutz Y, Heard DJ, Chambon P, Tora L. Htaf (II) 68, a novel RNA/ssDBA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J 1996; 15:5022-31. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Betts DR, Avoledo P, von der Weid N, Greiner J, Niggli FK. Cytogenetic characterization of Ewing tumors with high-ploidy. Cancer Genet Cytogenet. 2005; 159:160-3. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Blaschke S, Mueller CA, Markovic-Lipkovski J, et al. Expression of cadherin8 in renal cell carcinoma and fetal kidney. Int J Cancer 2002; 101:327-34. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Boormans JL, Korsten H, Ziel-van der Made AC, van Leenders GJ, Verhagen PC, Trapman J. E17K substitution in AKT1 in prostate cancer. Br J Cancer 2010; 102:1491-4. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Braselmann H, Kulka U, Baumgartner A, et al. SKY and FISH analysis of radiation-induced chromosome aberrations: a comparison of whole and partial genome analysis. Mutat Res 2005; 578:124-33. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Brown LA, Huntsman D. Fluorescent in situ hybridization on tissue microarrays: challenges and solutions. J Mol Hist 2007; 38:151-7. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Burchill SA. Ewing´s sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities. J Clin Pathol 2003; 56:96-102. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Cahill DP, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998; 392:300-3. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Corson TW, Huang A, Tsao MS, Gallie BL. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene 2005; 24:4741-53. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Corson TW, Zhu CQ, Lau SK, Shepherd FA, Tsao MS, Gallie BL. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Clin Cancer Res 2007; 13:3229-34. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Costa CML, Rondinelli P, Campbell B. Tumor neuroectodérmico primitivo da infância: relato de 13 casos e revisão de literatura. J Oncol 2000; 46:293-8. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol 2000; 18:3108-14. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"de Alava E, Antonescu CR, Panizo A. Prognostic impact of p53 status in Ewing sarcoma. Cancer 2000a; 89:783-92. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"de Alava E, Panizo A, Antonescu CR, et al. Association transactivation by alternative EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing´s sarcoma. Am J Pathol 2000b; 156: 849-55. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNAbinding domain caused by chromosome translocation in human tumours. Nature 1992; 359:162-5. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors – a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994; 331:294-9. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Delattre O. Ewing's tumours, genetic and cellular aspects. Pathol Biol (Paris) 2008; 56:257-9. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Desmaze C, Zucman J, Delattre O, Melot T, Thomas G, Aurias A. Interphase molecular cytogenetics of Ewing’s sarcoma and peripheral neuroepithelioma t(11,22) with flanking and overlapping cosmid probes. Cancer Genet Cytogenet 1994; 74:13-8. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Dorey FJ, Korn EL. Effective sample sizes for confidence intervals for survival probabilities. Stat Med 1987; 6:679-87. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Douglass EC, Rowe ST, Valentine M, Parham D, Meyer WH, Thompson EI. A second nonrandom translocation, der(16)t(1,16)(q21,q13), in Ewing sarcoma and peripheral neuroectodermal tumor. Cytogenet Cell Genet 1990; 53:87-90. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Dracopoli NC. Current protocols in human genetics. In: Dracopoli NC, Haines JL, Korf BR, et al. editors. Cytogenetics. New York: John Wiley & Sons; 2001. p.22-35. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Dracopoli NC. Development of oncology drug response markers using transcription profiling. Curr Mol Med 2005; 5:103-10. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Embree LJ, Azuma M, Hickstein DD. Ewing sarcoma fusion protein EWSR1/FLI1 interacts with EWSR1 leading to mitotic defects in zebrafish embryos and human cell lines. Cancer Res 2009; 69:4363-71. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Ewing J. The classic: difuse endothelioma of the bone. Proceedings of the New York Pathological Society. 1921;12:17. Clin Orthop Relat Res 2006; 450:25-7. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Fagioli F, Cuneo A, Bardi A, et al. Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome: a multiparameter analysis combining conventional cytogenetics, DNA in situ hybridization, and bone marrow culture studies. Cancer Genet Cytogenet 1995; 82:116-22. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Ferreira BI, Alonso J, Carrillo J, et al. Array CGH and gene-expression profiling reveals distinct genomicinstability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma. Oncogene 2008; 27:2084-90. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Fizazi K, Dohollou N, Blay JY, et al. Ewing's family of tumors in adults: multivariate analysis of  survival and long-term results of multimodality therapy in 182 patients. J Clin Oncol 1998; 16:3736-43. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Forus A, Weghuis DO, Smeets D, Fodstad 0, Myklebost 0, van Kessel AG Comparative genomic hybridization analysis of human sarcomas. I.Occurrence of genomic imbalances and identification of a novel major amplicon at Iq21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 2005; 14:8-14. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Foster K, Wang Y, Zhou D, Wright C. Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival. Cancer Chemother Pharmacol 2009; 63:783-91. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Grier HE. The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am 1997; 44:991-1004. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Gruneberg U, Neef R, Li X, Chan EH, Chalamalasetty RB, Nigg EA, Barr FA. KIF14 and citron kinase act together to promote efficient cytokinesis. J Cell Biol 2006; 172:363-72. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res 1994; 54:2331-3. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Hattinger CM, Rumpler S, Ambros IM, et al. Demonstration of the translocation der(16)t(1,16)(q12,q11.2) in interphase nuclei of Ewing tumors. Genes Chromosomes Cancer 1996; 17:141-50. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Hattinger CM, Rumpler S, Strehl S, et al. Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors. Genes Chromosomes Cancer 1999; 24:243-54. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Hattinger CM, Potschger U, Tarkkanen M, et al. Prognostic impact of chromossomal aberrations in Ewing Tumors. Br J Cancer 2002; 86:1763-9. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Horowitz ME, Tsokos MG, DeLaney TF. Ewing's sarcoma. CA Cancer J Clin 1992; 42:300-20. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Hu-Lieskovan S, Zhang J, Wu L, et al: EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Res 2005; 65:4633-44.";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Hu-Lieskovan S, Zhang J, Wu L, et al: EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Res 2005; 65:4633-44.";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Janknecht R. EWS-ETS oncoproteins: the linchpins of Ewing Tumors. Gene 2005; 363:1-14. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Jürgens H, Exner U, Gadner H, et al. Multidisciplinary treatment of primary Ewing’s sarcoma of bone: a 6-year experience of a European Cooperative Trial. Cancer 1988; 61:23-32. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Jürgens H Ewing’s sarcoma and peripheral primitive neuroectodermaltumor. Curr Opin Oncol 1994; 6:391-6. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Kawai T, Hiroi S, Nakanishi K, Sakurai Y, Torikata C. Abnormalities in chromosome 17 and p53 in lung carcinoma cells detected by fluorescence in situ hybridization. Pathol Int 2004; 54:413–9. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Ko E, Rademaker A, Martin R. Microwave decondensation and codenaturation: a new methodology to maximize FISH data from donors with very low concentrations of sperm. Cytogenet Cell Genet 2001; 95:143-5. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Khoury JD. Ewing Sarcoma Family of Tumors. Adv Anat Pathol 2005; 12:212-20. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Knobbe CB, Trampe-Kieslich A, Reifenberger G. Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas. Neuropathol Appl Neurobiol 2005; 31:48690. Erratum in: Neuropathol Appl Neurobiol 2005; 31:662. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Korshunov A, Sycheva R, Gorelyshev S, Golanov A. Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhood. Mod Pathol 2005;18:1258–63. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Koscielniak E, Jurgens H, Winkler K, et al. Treatment of soft tissue sarcoma in childhood and adolescence: a report of the German Cooperative Soft Tissue Sarcoma Study. Cancer 1992; 70:2557-67. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Kosyakova N, Weise A, Mrasek K, Claussen U, Liehr T, Nelle H. The hierarchically organized splitting of chromosomal bands for all human chromosomes. Mol Cytogenet 2009; 2:4. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Kovar H, Jug G, Aryee DNT, et al. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene 1997; 15:2225-32. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Kovar H. Downstream EWS/FLI1 - upstream Ewing's sarcoma. Genome Med 2010; 2:8. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Kremmidiotis G, Baker E, Crawford J, Eyre HJ, Nahmias J, Callen DF. Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity. Genomics 1998; 49:467-71. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Kullendorff CM, Mertens F, Donner M, Wiebe T, Akerman M, Mandahl N. Cytogenetic aberrations in Ewing sarcoma: are secondary changes associated with clinical outcome? Med Pediatr Oncol 1999; 32:79-83.  ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Ladanyi M, Lewis R, Jhanwar SC, Gerald W, Huvos AG, Healey JH. MDM2 and CDK4 gene amplification in Ewing's sarcoma. J Pathol 1995; 175:211-7. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Lahl M, Fisher VL, Laschinger K. Ewing's sarcoma family of tumors: an overview from diagnosis to survivorship. Clin J Oncol Nurs 2008; 12:89-97. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Lam S, Lodder K, Teunisse AF, Rabelink MJ, Schutte M, Jochemsen AG. Role of Mdm4 in drug sensitivity of breast cancer cells. Oncogene 2010; 29:2415-26. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Laurie NA, Donovan SL, Shih CS, et al. Inactivation of the p53 pathway in retinoblastoma. Nature 2006; 444:61-6. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Lazar A, Abruzzo LV, Pollock RE, Lee S, Czerniak B. Molecular diagnosis of sarcomas: chromosomal translocations in sarcomas. Arch Pathol Lab Med 2006; 130:1199-207. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Le Deley MC, Delattre O, Schaefer KL, et al: Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative EuroE.W.I.N.G. 99 trial. J Clin Oncol 2010; 28:1982-8. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Li H, Gao Q, Guo L, Lu SH. The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells. Cancer Biol Ther 2011; 11:950-8. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Madhavan J, Coral K, Mallikarjuna K, et al. High expression of KIF14 in retinoblastoma: association with older age at diagnosis. Invest Ophthalmol Vis Sci 2007; 48:4901-6. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Maire G, Brown CW, Bayani J, et al. Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review. Cancer Genet Cytogenet. 2008; 181:81-92. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Maire G, Yoshimoto M, Chilton-MacNeill S, Thorner PS, Zielenska M, Squire JA. Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma. Neoplasia 2009; 11:260-8, 3p following 268. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Marchong MN, Chen D, Corson TW, et al. Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma. Mol Cancer Res 2004; 2:495-503. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Markowski J, Tyszkiewicz T, Jarzab M, et al. Metal-proteinase ADAM12, kinesin 14 and checkpoint suppressor 1 as new molecular markers of laryngeal carcinoma. Eur Arch Otorhinolaryngol 2009; 266:1501-7. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Markus MA, Reichmuth C, Atkinson MJ, et al: Cadherin-11 is highly expressed in rhabdomyosarcomas and during differentiation of myoblasts in vitro. J Pathol 1999; 187:164-72. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Maurici D, Perez-Atayde A, Grier HE, Baldini N, Serra M, Fletcher JA. Frequency and implications of chromosome 8 and 12 gains in Ewing sarcoma. Cancer Genet Cytogenet 1998; 100:106-10. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"McKeon C, Thiele CJ, Ross RA, et al. Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma. Cancer Res 1988; 48:4307-11. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"McTiernan AM, Cassoni AM, Driver D, Michelagnoli MP, Kilby AM, Whelan JS. Improving outcomes after relapse in Ewing's sarcoma: analysis of 114 patients from a single institution. Sarcoma 2006; 2006:83548.  ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Merscher S, Marondel I, Pedeutour F, Gaudray P, Kucherlapati R, Turc-Carel C. Identification of new translocation breakpoints at 12q13 in lipomas. Genomics 1997; 46:70-7. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Mezzelani A, Alasio L, Bartoli C, et al. c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates. Br J Cancer 1999; 80:519-25. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Mhawech-Fauceglia P, Herrmann F, Penetrante R, et al. Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies. Histopathology 2006; 49:569-75. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Mitelman F. ISCN an International System for Human Cytogenetic Nomenclature. Basel; Karger; 1995. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations and gene fusions in cancer. Avaliable from: <URL:http://cgap.nci.nih.gov/Chromosomes/Mitelman> [2011 jun 15].  ;
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Morohoshi F, Arai K, Takahashi EI, Tanigami A, Ohki M. Cloning and maping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins. Genomics 1996; 38:51-7. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Mugneret F, Lizard S, Aurias A, Turc-Carel C. Chromosomes in Ewing’s sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1,16). Cancer Genet Cytogenet 1988; 32:239-45. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Nakajima G, Patino-Garcia A, Bruheim S, et al. CDH11 expression is associated with survival in patients with osteosarcoma. Cancer Genomics Proteomics 2008; 5:37-42. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Ng TL, O'Sullivan MJ, Pallen CJ, et al. Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J Mol Diagn 2007; 9:437-40. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Ohali A, Avigad S, Zaizov R, et al. Prediction of high risk Ewing's sarcoma by gene expression profiling. Oncogene 2004; 23:8997-9006.  ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Pfeifer JD. Tumors of soft tissue and bone. Philadelphia: Lippincott Williams & Wilkins; 2006. Molecular genetic testing in surgical pathology; p.186-231. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Picci P, Böhling T, Bacci G, et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing’s sarcoma of the extremities. J Clin Oncol 1997; 15:1553-9. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Pierga JY, Reis-Filho JS, Cleator SJ, Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy. Br J Cancer 2007; 96:341-51. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Riemenschneider MJ, Knobbe CB, Reifenberger G. Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target. Int J Cancer 2003; 104:752-7. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, Reiss M. Tissue microarray: a new technology for amplification of tissue resources. Cancer J 2001; 7:24-31. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Roberts P, Burchill SA, Brownhill S, et al. Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: a study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group. Genes Chromosomes Cancer 2008; 47:207-20. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Rossi E, Ubiali A, Balzarini P, Cadei M, Alpi F, Grigolatoi PG. High-level detection of gene amplification and chromosome aneuploidy in extracted nuclei from paraffin-embedded tissue of human cancer using FISH: a new approach for retrospective studies. Eur J Histochem 2005; 49:53-8. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Sandberg AA, Bridge JA. Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet 2000; 123:1-26. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Savola S, Klami A, Tripathi A, et al. Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors. BMC Cancer 2009; 14:9:17. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Saxena R, Sait S, Mhawech-Fauceglia P. Ewing sarcoma/primitive neuroectodremal tumor of the kidney: a case report diagnosed by immunohistochemical and molecular analysis. Ann Diag Pathol 2006; 10:363-6. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Schaefer KL, Eisenacher M, Braun Y, et al. Microarray analysis of Ewing’s sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur J Cancer 2008; 44:699-709. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Schlaeger C, Longerich T, Schiller C, et al. Etiology-dependent  molecular mechanisms in human hepatocarcinogenesis. Hepatology 2008; 47:511-20. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Schulz S, Becker KF, Braungart E, et al. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours. J Pathol 2000; 191:162-9. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Selvarajah S, Yoshimoto M, Prasad M, et al. Characterization of trisomy 8 in pedriatric undifferentiated sarcomas using advanced molecular cytogenetic techiques. Cancer Genet Cytogenet 2007; 174:35-41. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Shing DC, McMullan DJ, Roberts P, et al. FUS/ERG gene fusions in Ewing´s tumors. Cancer Res 2003; 63:4568-76. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Shvarts A, Steegenga WT, Riteco N, et al. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J 1996; 15:534957. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Sjöblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314:268-74. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Slater RM, Mannens MM. Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet Cytogenet 1992; 61:111-21. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Sorensen PH, Liu XF, Delattre O, et al. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagn Mol Pathol 1993; 2:147-57. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Squire J, Gallie BL, Phillips RA. A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet 1985; 70:291-301. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Stark B, Mor C, Jeison M, et al. Additional chromosome 1q aberrations and der(16) t (1,16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors. J Neurooncol 1997; 31:3-8. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Sugimura H. Detection of chromosome changes in pathology archives: an application of microwave-assisted fluoresce in situ hybridization to human carcinogenesis studies. Carcinogenesis 2008; 29:681-87. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Suijkerbuijk RF, Olde Weghuis DEM, Van Den Berg M, et al. Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well-differentiated liposarcomas. Genes Chrom Cancer 1994; 9:292-5. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Szuhai K, Ljszenga M, Tanke HJ, et al. Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma. Cancer Genet Cytogenet 2007; 172:12-22. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Szymanska J, Mandahl N, Mertens F, Tarkkanen M, Karaharju E, Knuutila S Ring chromosomes in parosteal osteosarcoma contain sequences from 2q13-15. A combined cytogenetic and comparative genomic hybridization study. Genes Chrom Cancer 1996; 16:31-4. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Tarkkanen M, Karhu R, Kallioniemi A, et al. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 1995; 55:1334-8. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Tarkkanen M, Kiuru-Kuhlefelt S, Blomqvist C, et al. Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors. Cancer Genet Cytogenet 1999; 114:35-41. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Thorner PS, Squire JA. Molecular genetics in the diagnosis and prognosis of solid pediatric tumors. Pediatr Dev Pathol 1998; 1:337-65. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Toledo F, Wahl GM. MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int J Biochem Cell Biol 2007; 39:1476-82. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Traer CJ, Foster FM, Abraham SM, Fry MJ. Are class II phosphoinositide 3kinases potential targets for anticancer therapies? Bull Cancer 2006; 93:E53-8.";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Trakhtenbrot L, Cohen N, Betts DR, et al. Interphase fluorescence in situ hybridization detection of chromosome 17 and 17q region gains in neuroblastoma: are they secondary events? Cancer Genet Cytogenet 2002; 137:95-101.";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Turc-Carel C, Philip I, Berger MP, Philip T, Lenoir GM. Chromosomal translocations in Ewing’s sarcoma. N Engl J Med 1983; 309:497-8. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Uren A, Wolf V, Sun YF, et al. Wnt/frizzled signaling in Ewing sarcoma. Pediatr Blood Cancer 2004; 43:243-9. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Valentin-Vega YA, Barboza JA, Chau GP, El-Naggar AK, Lozano G. High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas. Hum Pathol 2007; 38:1553-62. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"van den Boom J, Wolter M, Kuick R, et al. Characterization of gene expression profiles associated with glioma progression using oligonucleotidebased microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003; 163:1033-43. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Varella-Garcia M, Chen L, Zheng X, Yu L, Dixon D. Karyotypic characteristics of human uterine leiomyoma and myometrial cell lines following telomerase induction. Cancer Genet Cytogenet 2006; 170:71-5. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Varella-Garcia M, Diebold J, Eberhard DA, et al. EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer. J Clin Pathol 2009; 62:970-7. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Ventura RA, Martin-Subero JI, Jones M, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffinembedded tissue. J Mol Diagn 2006; 8:141-51. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Vivanco I, Palaskas N, Tran C, et al. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. Cancer Cell 2007; 11:555-69. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH. Centromeric copy of chromosome 7 is strongly correlated with tumorgrade and labeling index in human bladder cancer. Cancer Res 1991; 51:3807-13. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Wang L, Bhargava R, Zheng T, et al. Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J Mol Diagn 2007; 9:498-509. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Wei G, Antonescu CR, de Alava E, et al. Prognostic impact of INK4A deletion in Ewing sarcoma. Cancer 2000; 89:793-9. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Weise A, Mrasek K, Kosyakova N, et al. ISH Probes derived from BACs, including Microwave treatment for better FISH results. In: Liehr T, editor. Fluorescence in situ hybridization (FISH). New York: Springer Protocols; 2009. p.53-60. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Whang-Peng J, Triche TJ, Knutsen T, Miser J, Douglass EC, Israel MA. Chromosome translocation in peripheral neuroepithelioma. N Engl J Med 1984; 311:584-5. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Wyandt HE, Chinnappan D, Ioannidou S, Salama M, O'Hara C. Fluorescence in situ hybridization to assess aneuploidy for chromosomes 7 and 8 in hematologic disorders. Cancer Genet Cytogenet 1998; 102:114-24. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Zielenska M, Zhang ZM, Ng K, et al. Acquisition of secondary structural chromosomal changes in pediatric Ewing Sarcoma is a probable prognostic factor for tumor response and clinical outcome. Cancer 2001; 91:2156-64. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Zhou Z, Bolontrade MF, Reddy K, et al. Suppression of Ewing’s sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy. Clin Cancer Res 2007; 13:4867-73. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Zoubek A, Dockhorn-Dworniczak B, Delattre O, et al. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 1996; 14:1245–51. ";
FAP;2011;FERNANDA ROCHA ROJAS AYALA;Fernando Augusto Soares;Isabela Werneck da Cunha;"Zwerner JP, Joo J, Warner KL, et al. The EWS/FLI1 oncogenic transcription factor deregulates GLI1. Oncogene 2008; 27:3282-91. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Ackland ML, Newgreen DF, Fridman M, et al. Epidermal growth factor stimulates epithelio-mesenchymal transition in the stable human breast carcinoma cell line variant PMC42-LA. Lab Invest 2003; 83:435-48. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Biologia molecular da célula. 4ª ed. Porto Alegre: Artmed, 2004. Estrutura da membrana: organização interna da célula; p.583-614. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Andrade E, Andrade PM, Borra RC, Claro J, Srougi M. cDNA microarray analysis of differentially expressed genes in penile tissue after treatment with tadalafil. BJU Int 2008; 101:508-12. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Andrade JB. Correlação clínico-patológica da expressão protéica do complexo CD44/ERM (Ezrina/Radixina/Moesina) no carcinoma de pênis. São Paulo; 2009. [Dissertação de Mestrado-Fundação Antônio Prudente]. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Barros EM, Melo MCB. Câncer de pênis: perfil sócio-demográfico e respostas emocionais à penectomia em pacientes atendidos no Serviço de Psicologia do Hospital do Câncer de Pernambuco. Rev SBPH 2009; 12: 53-68. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Basu D, Nguyen TT, Montone KT, et al. Evidence for mesenchymal-like subpopulations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity. Oncogene 2010; 29:4170-82. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Batlle E, Sancho E, Francí C, et al. The transcription factor snail is a repressor of Ecadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2:84-9. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Beavon IR. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 2000; 36:1607-20. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Bezerra ALR, Lopes A, Landman G, Alencar GN, Torloni H, Villa LL. Clinicopathologic features and human papillomavirus DNA prevalence of warty and squamous cell carcinoma of the penis. Am J Surg Pathol 2001a; 25:673-8. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Bezerra ALR, Lopes A, Santiago GH, Ribeiro KCB, Latorre MRDO, Villa LL. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer 2001b; 91:2315-21. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol 2009; 27:141-50. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Boyer B, Valles AM, Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 2000; 60:1091-9. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Brinton LA, Li JY, Rong SD, et al. Risk factors for penile cancer: results from a case-control study in China. Int J Cancer 1991; 47:504-9. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Brumini R. Câncer no Brasil: dados histopatológicos 1976-80. Rio de Janeiro: Ministério da Saúde; 1982.  ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Campos RS, Lopes A, Guimarães GC, Carvalho AL, Soares FA. Ecadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients. Urology 2006; 67:797-802. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Cavallaro U, Christofori G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta 2001; 1552:39-45. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Cavallaro U, Schaffhauser B, Cristofori G. Cadherins and the tumor progression: is it all a swith? Cancer Lett 2002; 176:123-8.  ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Chaux A, Caballero C, Soares FA, et al. The prognostic index: a useful pathologic guide for prediction of nodal metastases and survival in penile squamous cell carcinoma. Am J Surg Pathol 2009a; 33:1049-57. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Chaux A, Reuter V, Lezcano C, Velazquez EF, Torres J, Cubilla AL. Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases. Am J Surg Pathol 2009b; 33:1299306. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006; 66:831926. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Cubilla AL, Barreto J, Caballero C, Ayala G, Riveros M. Pathologic features of epidermoid carcinoma of the penis: a prospective study of 66 cases. Am J Surg Pathol 1993; 17:753-63. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Cubilla AL, Reuter V, Velazquez E, Piris A, Saito S, Young RH. Histologic classification of penile carcinoma and its relation to outcome in 61 patients with primary resection. Int J Surg Pathol 2001; 9:111-20. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Cubilla AL, Ayala G, Lopes A, et al. Perineural invasion (PNI) predicts mortality in penile squamous cell carcinoma: a long-term outcome study comparing clinicopathologic features. Lab Invest 2007; 87:142A. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Cubilla AL. The role of pathologic prognostic factors in squamous cell carcinoma of the penis. World J Urol 2009; 27:169-77. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Cunha IW, Guimaraes GC, Soares FA, et al. Pseudoglandular (adenoid, acantholytic) penile squamous cell carcinoma: a clinicopathologic and outcome study of 7 patients. Am J Surg Pathol 2009; 33:551-5. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in situ and invasive disease. Int J Cancer 2005; 116:606-16. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Dean AL Jr. Epithelioma of the penis. J Urol 1935; 33:252-83. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Derrick FC Jr, Lynch KM Jr, Kretkowski RC, Yarbrough WJ. Epidermoid carcinoma of the penis: computer analysis of 87 cases. J Urol 1973; 110:303-5. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Derycke LD, Bracke ME. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol 2004; 48:463-76. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Diniz-Freitas M, Garcia-Caballero T, Antunez-Lopez J, Gandara-Rey JM, GarciaGarcia A. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 2006; 42:190–200. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Droller MJ. Carcinoma of the penis: an overview. Urol Clin North Am 1980; 7:7834. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Dutsch-Wicherek M. RCAS1, MT, and Vimentin as potencial markers of tumor microenvironment remodelling. Am J Reprod Immunol 2010; 63:181-8. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti. AJCC cancer staging manual. 7th. New York: Springer-Verlag; 2009. Penis; p.447-55. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology & genetics tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004. Penile cancer; p.279-98. (IARC WHO Classification of Tumours, nº 6). ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Favorito LA, Nardi AC, Ronalsa M, Zequi SC, Sampaio FJ, Glina S. Epidemiologic study on penile cancer in Brazil. Int Braz J Urol 2008; 34:587-93. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Ficarra V, Martignoni G, Maffei N, et al. Predictive pathological factors of lymph node involvement in the squamous cell carcinoma of the penis. Int Urol Nephrol 2002; 32:245-50. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Ficarra V, Zattoni F, Artibani W, et al. Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. J Urol 2006; 175:1700-5. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Fraley EE, Zhang G, Manivel C, Niehans GA. The role of ilioinguinal lymphadenectomy and significance of histological differentiation in treatment of carcinoma of the penis. J Urol 1989; 142:1478-82.  ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Frew ID, Jefferies JD, Swinney J. Carcinoma of the penis. Br J Urol 1976; 39:398404. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Frisch M, Friis S, Kjaer SK, Melbye M. Falling incidence of penis cancer in an uncircumcised population. BMJ 1995; 311:1471. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Gloeckler-Reis LA, Hankey BF, Edwards BK. Cancer statistic review 1973-1987. Bethesda: National Institute of Health; 1990. (National Institute of Health Publication, 90-2789). ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Gould Rothberg BE, Bracken MB. E-cadherin immunohistochemical expression as a  prognostic factor in infiltrating ductal carcinoma of the breast: a systematic review and meta-analysis. Breast Cancer Res Treat 2006; 100:139-48. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Guidoni LRM. Imunoexpressão e valor prognóstico de CD9 no carcinoma epidermóide de pênis. São Paulo; 2010. [Dissertação de Mestrado-Fundação Antônio Prudente]. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Guimarães GC. Estudos de fatores prognósticos e da expressão imunoistoquímica de PCNA e MIB-1 / KI-67 em pacientes portadores de CEC de pênis. São Paulo; 2003. [Dissertação de Mestrado-Fundação Antônio Prudente]. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Guimarães GC, Lopes A, Campos RS, et al. Front pattern of invasion in squamous cell carcinoma of the penis: new prognostic factor for predicting risk of lymph node metastases. Urology 2006; 68:148-53. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Guimarães GC, Leal ML, Campos RS, et al. Do proliferating cell nuclear antigen and MIB-1/Ki-67 have prognostic value in penile squamous cell carcinoma? Urology 2007; 70:137-42. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Guimarães GC, Cunha IW, Soares FA, et al. Penile squamous cell carcinoma clinicopathological features, nodal metastasis and outcome in 333 cases. J Urol 2009; 182:528-34; discussion 534. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Guimarães GC. Análise de fatores prognósticos e da expressão imunoistoquimica da involucrina, e das proteínas da placa desmossômica: desmogleina, plakoglobina e desmoplakina através da técnica de ""tissue microarray"" em pacientes portadores de carcinoma epidermóide do pênis. São Paulo, 2010. [Tese de Doutorado-Fundação Antônio Prudente]. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Guimarães GC, Rocha RM, Zequi SC, Cunha IW, Soares FA. Penile cancer: epidemiology and treatment. Curr Oncol Rep 2011; 13:231-9. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Gursel EO, Georgountzos C, Uson AC, Melicow MM, Veenema RJ. Penile cancer: clinicopathology study of 64 cases. Urology 1973; 1:569-78. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Handschuh G, Candidus S, Luber B, et al. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 1999; 18:4301-12. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 2002; 34:255-68. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Harish K, Ravi R. The role of tobacco in penile carcinoma. Br J Urol 1995; 75:3757. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Hellberg D, Valentin J, Eklund T, Nilsson S. Penile cancer: is there an epidemiological role for smoking and sexual behavior? Br Med J (Clin Res Ed) 1987; 1295:1306-8. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Horenblas S, van Tinteren H, Delemarre JF, Moonen LM, Lustig V, van Waardenburg EW. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 1993; 149:492-7. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Huber MA, Kraut N, Beug H. Molecular requirements for epithelial–mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17:548-58. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration and signaling. Exp Cell Res 2007; 313:2050-62. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Jin H, Morohashi S, Sato F, et al. Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis. Biomed Res 2010; 31:105-12. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Johnson DE, Fuerst DE, Ayala AG. Carcinoma of the penis: experience in 153 cases. Urology 1973; 1:404-8. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Junqueira LC, Carneiro J. Biologia celular e molecular. Rio de Janeiro: Guanabara Koogan; 1997. Membrana plasmática: digestão intracelular; p.94- 100. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications to fibrosis. J Clin Invest 2003; 112:1776-84. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420-8. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009; 119:1417-9. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Kleer CG, Giordano TJ, Braun T, Oberman HA. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol 2001; 14:185-90. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Leal MLO. Estudo da expressão imuno-histoquímica de componentes da via wnt no carcinoma espeno-celular do pênis. São Paulo; 2008. [Tese de DoutoradoUniversidade Federal de São Paulo] ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Levi E, Rahal P, Sarkis AS, Villa LL. Human papillomavirus DNA and p53 status in penile carcinomas. Int J Cancer 1998; 76:779-83. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Lewis-Tuffin LJ, Rodriguez F, Giannini C, et al. Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. PLoS One 2010; 5:e13665. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Li M, Zhang B, Sun B, et al. A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis. J Exp Clin Cancer Res 2010; 29:109. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Lin Q, Li M, Shen ZY, et al. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I nonsmall cell lung cancer. Jpn J Clin Oncol 2010; 40:670-6. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Liu LK, Jiang XY, Zhou XX, Wang DM, Song XL, Jiang HB. Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol 2010; 23:213-24. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Lodish H, Benk A, Zipurski SL, Matsudaira P, Baltimore D, Darnell J. Molecular cell biology. 4th ed. New York: W.H. Freeman; 2000. Integratind cells into tissues; p.968-76.  ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Lopes A, Rossi BM, Nakagawa WT. Câncer de pênis. Âmbito Hospitalar 1994; 58:5-13. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Lopes A, Hidalgo GS, Kowalski LP, Torloni H, Rossi BM, Fonseca FP. Prognostic factors in carcinoma of penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 1996a; 156:1637-42. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Lopes A, Rossi BM, Fonseca FP, Morini S. Unrealiability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma. Cancer 1996b; 77:2099102. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Lopes A, Bezerra AL, Serrano SV, Hidalgo GS. Iliac nodal metastases from carcinoma of the penis treated surgically. BJU Int 2000; 86:690-3. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Lopes A, Bezerra AL, Pinto CA, Serrano SV, de Mello CA, Villa LL. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 2002; 168:81-6. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"McInroy L, Määttä A. Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 2007; 360:109-14. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Maddineni SB, Lau MM, Snagar VK. Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer. BMC Urol 2009; 9:8. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Maden C, Sherman KJ, Beckman AM, et al. History of circuncision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst 1993; 85:19-24. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Mandal M, Myers JN, Lippman SM, et al. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 2008; 112:2088-100. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Martins ACP, Faria SM, Cologna AJ, Suaid HJ, Tucci S Jr. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol 2002; 167:89-93. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Mattijssen V, Peters HM, Schalkwijk L, et al. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer 1993; 55:580-5. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Ministério da Saúde. Instituo Nacional de Câncer. Estimativa/2010 incidência de câncer no Brasil. Rio de Janeiro: INCA; 2009. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol 2004; 5:240-7. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Moura JF Correlação clínico-patológica da reatividade imunoistoquímica dos receptores acoplados a proteína G pela técnica de “tissue microarray” no CP/ São Paulo; 2009. [Dissertação de Mestrado-Fundação Antônio Prudente]. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Naora H, Montell DJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 2005; 5:355-66. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Narasimharao KL, Chatterjee H, Veliath AJ. Penile carcinoma in the first decade of life. Br J Urol 1985; 57:358. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Narayana AS, Olney LE, Loening SA, Weimar GW, Culp DA. Carcinoma of the penis: analysis of 219 cases. Cancer 1982; 49:2185-91. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Natsugoe S, Uchikado Y, Okumura H, et al. Snail plays a key role in E-cadherinpreserved esophageal squamous cell carcinoma. Oncol Rep 2007; 17:517-23. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Okubo T, Truong TK, Yu B, et al. Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH) Cancer Res 2001; 61:1338-46. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Parkin DM, Whelam SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents vol VII. Lyon: IARC; 1997. (IARC Scientific Publications, 143). ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Paymaster JC, Gangadharan P. Cancer of the penis in India. J Urol 1967; 97:110-3. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 2004; 48:365-75. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Persky L, deKernion J. Carcinoma of the penis. CA Cancer J Clin 1986; 36:258-73. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;Pompeo ACL, Koff W, Damião R, et al. Carcinoma do pênis - Parte II. Projeto Diretrizes – Associação Médica Brasileira e Conselho Federal de Medicina. 2006. p.1-9. Disponível em: <URL:http://www.projetodiretrizes.org.br/6_volume/13CarcinomaPenisParteII.pdf>. [2011 março 12]. ;
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Puras A, Gonzales-Flores B, Rodrigues R. Treatment of carcinoma of the penis. Proc Kimbrough Urol Semin 1978; 12:143-52. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Radisky DC. Epithelial–mesenchymal transition. J Cell Sci 2005; 118:4325-6. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Raju GC, Naraynsingh V, Venu PS. Carcinoma of the penis in the West Indies: a Trinidad Study. Trop Geogr Med 1985; 37:334-6. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Rosemberg SK, Hennan G, Elfonte E. Sexually transmitted papillomaviral infection in the male. VII. Is cancer of penis sexually transmitted? Urology 1991; 37:437-40. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Salvioni R, Necchi A, Piva L, Colecchia M, Nicolai N. Penile cancer. Urol Oncol 2009; 27:677-85. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Sarkar FH, Miles BJ, Plieth DH, Crissman JD. Detection of human papillomavirus in squamous neoplasm of the penis. J Urol 1992; 147:389-92. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991; 51, 6328-37. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Schock F, Perrimon N. Molecular mechanisms of epithelial morphogenesis. Ann Rev Cell Dev Biol 2002; 18:463-93. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Silva AMT. Estudo da expressão protéica da família ErbB no carcinoma peniano. São Paulo; 2010. [Dissertação de Mestrado-Fundação Antônio Prudente]. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Slaton JW, Morgenstern N, Levy DA, et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol 2001; 165:1138-42. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Soares FA, da Cunha IW, Guimarães GC, Nonogaki S, Campos RS, Lopes A. The expression of metaloproteinases-2 and -9 is different according to the patterns of growth and invasion in squamous cell carcinoma of the penis. Virchows Arch 2006; 449:637-46. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Sobin LH, Wittekind Ch. TNM classificação de tumores malignos. 6ª ed. Rio de Janeiro: INCA; 2004. Tumores urológicos: pênis; p.187-9. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Souza Neto AM. Estudo da expressão imunoistoquímica da ciclina D1 em carcinoma espinocelular de pênis: correlação com variáveis clínicas e anatomopatológicas para identificação e avaliação de fatores prognósticos. São Paulo; 2008. [Dissertação de Mestrado-Fundação Antônio Prudente]. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Streit M, Schmidt R, Hilgenfeld RU, Thiel E, Kreuser ED. Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors. J Mol Med  (Berl) 1996; 74:253-68. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Strumane K, Berx G, Van Roy F. Cadherins in cancer. In: Behrens J, Nelson NW, editors. Cell adhesion. Berlin: Springer; 2004. p.69-103. (Handbook of experimental pharmacology, 165). ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Sundfeldt K. Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule. Mol Cell Endocrinol 2003; 202:89-96. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Thiery JP. Epithelial-mesenchymal transition in tumor progression. Nat Rev Cancer 2002; 2:442-54. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Ting AH, McGarvey KM, Baylin SB. The cancer epigenome--components and functional correlates. Genes Dev 2006; 20:3215-31. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Tornesello ML, Duraturo ML, Losito S, et al. Human Papillomavirus genotypes and HPV16 variantes en penile carcinoma. Int J Cancer 2008; 122:132-7. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Tsen HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a populationbased case-control study in Los Angeles County (United States). Cancer Causes Control 2001; 12:267–77. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"van Aken E, De Wever O, Correia da Rocha AS, Mareel M Defective ECADherin/catenin complexes in human cancer. Virchows Arch 2001; 439:725–51. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Varma VA, Sanchez-Lanier M, Unger ER, et al. Association of human papillomavirus with penile carcinoma: a study using polymerase chain reaction and in situ hybridization. Hum Pathol 1991; 22:908-13. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Vatanasapt V, Martin N, Sriplung H, et al. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol Biomarkers Prev 1995; 4:475-83. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Velazquez EF, Soares FA, Cunha IW, Lopes A, Barreto JE, Cubilla AL. Penile verruciform tumors: extended classification, differential diagnosis and outcome in 104 cases. Lab Invest 2007; 87:182A. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Velazquez EF, Ayala G, Liu H, et al. Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile suqamous cell carcinoma invading 5 to 10mm. Am J Surg Pathol 2008; 32:974-9. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Villa LL, Lopes A. Human Papillomavirus DNA sequence in penile carcinomas in Brazil. Int J Cancer 1986; 37:853-5. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Wheelock MJ, Soler AP, Knudsen KA. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia 2001; 6:275-85. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Wheelock MJ, Johnson KR. Cadherins as modulators of cellular phenotype. Ann Rev Cell Dev Biol 2003; 19:207-35. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Wiener JS, Walther PJ. The association of oncogenic human papillomaviruses with urologic malignancy. Surg Oncol Clin N Am 1995; 4:257-76. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Yang J, Mani SA, Donaher JL, et al. Twist, a master Regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117:927–39. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14:818-29. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119:1429-37. ";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Zhou K, Wang G, Wang Y, Jin H, Yang S, Liu C. The potential involvement of Ecadherin and beta-catenins in meningioma. PLoS One 2010; 5:e11231.";
FAP;2011;MARIA JOSÉ LEONARDO SOUZA;Fernando Augusto Soares;Ademar Lopes;"Zhu Y, Zhou XY, Yao XD, Dai B, Ye DW. The prognostic significance of p53, Ki67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery. BJU Int 2007; 100:204-8.  ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 19752007 based on November 2009 SEER data submission, posted to the SEER web site, 2010. Avaliable from: <URL:http://seer.cancer.gov/csr/1975_2007>. [ ;
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Antoniazzi AS, Dell’Aglio DD, Bandeira DR. O conceito de coping: uma revisão teórica. Estudos Psicologia 1998; 3:273-94. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Bak-Drabik K, Ziora D. [The impact of socioeconomic status on the quality of life in patients with chronic obstructive pulmonary disease]. Pneumonol Alergol Pol 2010; 78:3-13. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Baylor CR, Yorkston KM, Eadie TL. The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences. J Commun Disord 2005; 38:395-419. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Bech P. Quality of life in psychosomatic research. a psychometric model. Psychopathology 1987; 20:169-79. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Behlau M, Oliveira G, Santos Lde M, Ricarte A. Validation in Brazil of selfassessment protocols for dysphonia impact. Pro Fono 2009; 21:326-32. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Behlau M, Hogikyan ND, Gasparini G. Quality of life and voice: study of a Brazilian population using the voice-related quality of life measure. Folia Phoniatr Logop 2007; 59:286-96. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Benninger MS. The impact of cigarette smoking and environmental tobacco smoke  on nasal and sinus disease: a review of the literature. Am J Rhinol. 1999 NovDec;13(6):435-8.  ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Benninger MS, Ahuja AS, Gardner G, Grywalski C. Assessing outcomes for dysphonic patients. J Voice 1998; 12:540-50. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Bergsma J, Engel GL. Quality of life: does measurement help? Health Policy 1988; 10:267-79. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Billante CR, Spector B, Hudson M, Burkard K, Netterville JL. Voice outcome following thyroplasty in patients with cancer-related vocal fold paralysis. Auris Nasus Larynx 2001; 28:315-21. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Bjordal K, Kaasa S. Psychometric validation of the EORTC Core Quality of Life  Questionnaire, 30-item version and a diagnosis-specific module for head and neck  cancer patients. Acta Oncol 1992; 31:311-21. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Blood GW, Luther AR, Stemple JC. Coping and adjustment in alaryngeal speakers. Am J Clin Speech Lang Pathol 1992; 1:63-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Bouwers F, Dikkers FG. A retrospective study concerning the psychosocial impact of voice disorders: Voice Handicap Index change in patients with benign voice disorders after treatment (measured with the Dutch version of the VHI). J Voice 2009; 23:218-24. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Carr AJ, Higginson IJ. Are quality of life measures patient centred? BMJ 2001; 322:1357-60. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Christensen U, Schmidt L, Kriegbaum M, Hougaard CØ, Holstein BE. Coping with unemployment: does educational attainment make any difference? Scand J Public Health 2006; 34:363-70. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Chung MC, Werrett J, Easthope Y, Farmer S. Coping with post-traumatic stress: young, middle-aged and elderly comparisons. Int J Geriatr Psychiatr 2004; 19:33343. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Ciconelli RM. Tradução para o português e validação do questionário genérico de avaliação de qualidade de vida “medical outcomes study 36 – item short form health survey (SF-36). São Paulo; 1997. [Tese de Doutorado-Escola Paulista de Medicina de São Paulo da Universidade Federal de São Paulo].  ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Ciconelli RM, Ferraz MB, Santos W, Meinao I, Quaresma MR. Tradução para a lingual portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36. Rev Bras Reumatol 1999; 39:143-50. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Clark A, Fallowfield LJ. Quality of life measurements in patients with malignant disease: a review. J R Soc Med 1986; 79:165-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Cohen SM. Self-reported impact of dysphonia in a primary care population: an epidemiological study. Laryngoscope 2010; 120:2022-32. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull 1985; 98:310-57.  ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Coupland VH, Chapman P, Linklater KM, Sehgal A, Møller H, Davies EA. Trends in the epidemiology of larynx and lung cancer in south-east England, 1985-2004. Br J Cancer 2009; 100:167-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"de Moraes LO, Peniche Ade C. [Anxiety and coping mechanisms used by ambulatory surgery patients]. Rev Esc Enferm USP 2003; 37:54-62. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Debi R, Mor A, Segal O, et al. Differences in gait patterns, pain, function and quality of life between males and females with knee osteoarthritis: a clinical trial. BMC Musculoskelet Disord 2009; 10:127. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Deleyiannis FWB, Weymuller EA, Coltrera MD, Futran N. Quality of life after laryngectomy: are functional disabilities important. Head Neck 1998; 21:319-24. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Deshpande MS, Kakade AC, Chaukar DA, et al. Validation and assessment of voicerelated quality of life in Indian patients undergoing total laryngectomy and primary tracheoesophageal puncture. Head Neck 2009; 31:37-44. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Dropkin MJ. Coping with disfigurement and dysfunction after head and neck cancer surgery: a conceptual framework. Semin Oncol Nurs 1989; 5:213-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Eadie TL, Doyle PC. Auditory-perceptual scaling and quality of life in tracheoesophageal speakers. Laryngoscope 2004; 114:753-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Engquist CL, Davis JE, Bryce RH. Can quality of life be evaluated? Hospitals 1979; 53:97, 99-100. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Epstein R, Hirani SP, Stygall J, Newman SP. How do individuals cope with voice disorders? Introducing the Voice Disability Coping Questionnaire. J Voice 2009; 23:209-17. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Finizia C, Bergman B. Health-related quality of life in patients with laryngeal cancer: a post-treatment comparison of different modes of communication. Laryngoscope 2001; 111:918-23. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Finizia C, Bergman B, Lindström J. A cross-sectional validation study of SelfEvaluation of Communication Experiences after Laryngeal Cancer-a questionnaire for use in the voice rehabilitation of laryngeal cancer patients. Acta Oncol 1999; 38:573-80. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Finizia C, Hammerlid E, Westin T, Lindström J. Quality of life and voice in patients with laryngeal carcinoma: a posttreatment comparison of laryngectomy (salvage surgery) versus radiotherapy. Laryngoscope 1998; 108:1566-73. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Flanders WD, Rothman KJ. Interaction of alcohol and tobacco in laryngeal cancer. Am J Epidemiol 1982; 115:371-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Folkman S, Lazarus RS. An analysis of coping in a middle-aged community sample. J Health Soc Behav. 1980 Sep;21(3):219-39.  ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Folkman S, Lazarus RS. If it changes it must be a process: study of emotion and coping during three stages of a college examination. J Personal Social Psychol 1985; 1:150-70. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Folkman S, Lazarus RS. Coping as a mediator of emotion. J Pers Soc Psychol 1988; 54:466-75. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Folkman S, Lazarus RS, Pimley S, Novacek J. Age differences in stress and coping processes. Psychol Aging 1987; 2:171-84. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Folkman S, Lazarus RS, Dunkel-Schetter C, DeLongis A, Gruen RJ. Dynamics of a stressful encounter: cognitive appraisal, coping, and encounter outcomes. J Pers Soc Psychol 1986; 50:992-1003. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Folkman S, Lazarus RS, Gruen RJ, DeLongis A. Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol 1986; 50:571-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Folkman S, Moskowitz JT. Coping: pitfalls and promise. Annu Rev Psychol. 2004; 55:745-74.  ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Franic DM, Bramlett RE, Bothe AC. Psychometric evaluation of disease specific quality of life instruments in voice disorders. J Voice 2005; 19:300-15. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Freedman ND, Abnet CC, Leitzmann MF, Hollenbeck AR, Schatzkin A. Prospective investigation of the cigarette smoking-head and neck cancer association by sex. Cancer 2007; 110:1593-601. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Fung K, Yoo J, Leeper HA, et al. Vocal function following radiation for nonlaryngeal versus laryngeal tumors of the head and neck. Laryngoscope 2001; 111:1920-4. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Gallegos-Carrillo K, Mudgal J, Sánchez-García S, et al. Social networks and healthrelated quality of life: a population based study among older adults. Salud Publica Mex 2009; 51:6-13. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Gallus S, Bosetti C, Franceschi S, Levi F, Negri E, La Vecchia C. Laryngeal cancer in women: tobacco, alcohol, nutritional, and hormonal factors. Cancer Epidemiol Biomarkers Prev 2003; 12:514-7. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Garret CG, Ossof RH, Hwang J, Courey MS. Quality-of-life outcomes following laryngeal endoscopic surgery for non-neoplastic vocal fold lesions. Ann Otol Rhinol Laryngol 2004; 113:597-601. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;Gasparini G, Behlau M. Validação do questionário de avaliação de qualidade de vida em voz – QVV. Anais do XIV Congresso Brasileiro de Fonoaudiologia, 2006. ;
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Gasparini G, Behlau M. Quality of life: validation of the Brazilian version of the voice-related quality of life (V-RQOL) measure. J Voice 2009; 23:76-81. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Gerwin JM, Culton GL. Quality of life in prosthetic voice users. Otolaryngol Head Neck Surg 2005; 133:685-8. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Glas K, Hoppe U, Eysholdt U, Rosanowski F. Smoking, carcinophobia and Voice Handicap Index. Folia Phoniatr Logop 2008; 60:195-8. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Goodinson SM, Singleton J. Quality of life: a critical review of current concepts, measures and their clinical implications. Int J Nurs Stud 1989; 26:327-41. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Grahn G. “Learning to cope” – an intervention in cancer care. Support Care Cancer 1993; 1:266-71. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Grønning K, Rødevand E, Steinsbekk A. Paid work is associated with improved health-related quality of life in patients with rheumatoid arthritis. Clin Rheumatol 2010; 29:1317-22. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Grossi G. Coping and emotional distress in a sample of Swedish unemployed. Scand J Psychol 1999; 40:157-65. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Guitérrez-Bedmar M, Seguí-Gómez M, Gómez-Gracia E, Bes-Rastrollo M, Martínez-González MA. Smoking status, changes in smoking status and healthrelated quality of life: findings from the SUN (""Seguimiento Universidad de Navarra"") cohort. Int J Environ Res Public Health 2009; 6:310-20. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Guyatt G. Measuring health status in chronic airflow limitation. Eur Respir J 1988; 1:560-4. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Haddad L, Abrahão M, Cervantes O, Ceccon FP, et al. Vocal assessment in patients submited to CO2 laser cordectomy. Braz J Otorhinolaryngol 2006; 72:295-30. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Hammerlid E, Taft C. Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer 2001; 84:149-56. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Happ MB, Roesch T, Kagan SH. Communication needs, methods, and perceived voice quality following head and neck surgery: a literature review. Cancer Nurs 2004; 27:1-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Harkonmäki K, Rahkonen O, Martikainen P, K, Lahelma E. Associations of SF-36 mental health functioning and work and family related factors with intentions to retire early among employees.Occup Environ Med2006;63:558-63. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Harwood AR, Rawlinson E. The quality of life of patients following treatment for laryngeal cancer. Int J Radiat Oncol Biol Phys 1983; 9:335-8. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2009; 18:541-50. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Herr HW. Strategies for the management of recurrent and advanced urologic cancers. Quality of life. Cancer 1987; 60(3 Suppl):623-30. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Herrington-Hall BL, Lee L, Stemple JC, Niemi KR, McHone MM. Description of  laryngeal pathologies by age, sex, and occupation in a treatment-seeking sample. J Speech Hear Disord 1988; 53:57-64. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Hogikyan ND, Sethuraman G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voic. 1999; 13:557-69. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Jacobson BH, Johnson A, Grywalski C, et al. The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 1997; 6:66-70. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Johns MM, Garrett CG, Hwang J, Ossoff RH, Courey MS. Quality-of-life outcomes following laryngeal endoscopic surgery for non-neoplastic vocal fold lesions. Ann Otol Rhinol Laryngol 2004; 113:597-601. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Kandogan T, Sanal A. Quality of life, functional outcome, and voice handicap index in partial laryngectomy patients for early glottic cancer. BMC Ear Nose Throat Disord 2005; 5(1):3. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Kazi R, De Cordova J, Singh A, et al. Voice-related quality of life in laryngectomees: assessment using the VHI and V-RQOL symptom scales. J Voice 2007; 21:728-34. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Kirchman MM, Loomis B. A longitudinal study assessing the quality of occupational therapy. Am J Occup Ther 1980; 34:582-6. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Krauth J. Objective measurements of the quality of life. Experientia Suppl 1982; 41:402-51. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Krischke S, Weigelt S, Hoppe U, et al. Quality of life in dysphonic patients. J Voice 2005; 19:132-7. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Larsson U, Karlsson J, Sullivan M. Impact of overweight and obesity on healthrelated quality of life--a Swedish population study. Int J Obes Relat Metab Disord 2002; 26:417-24. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Lazarus RS. Coping theory and research: past, present, and future. Psychosom Med 1993; 55:234-47. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Lazarus RS, Folkman S. Stress, appraisal and coping. New York: Springer Pu; 1984. (LIVRO INTEIRO????) ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Li CE, DiGiuseppe R, Froh J. The roles of sex, gender, and coping in adolescent depression. Adolescence 2006; 41:409-15. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Lima MG, Barros MB, César CL, Goldbaum M, Carandina L, Ciconelli RM. Health related quality of life among the elderly: a population-based study using SF-36 survey. Cad Saude Publica 2009; 25:2159-67. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"List MA, Rutherford JL, Stracks J, et al. Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients. Head Neck 2004; 26:163-70. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Lorencetti A, Simonetti JP. [Patients' coping strategies during radiotherapy]. Rev Lat Am Enfermagem 2005; 13:944-50. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Loughran S, Calder N, MacGregor FB, Carding P, MacKenzie K. Quality of life and voice following endoscopic resection or radiotherapy for early glottic cancer. Clin Otolaryngol 2005; 30:42-7. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"MacKenzie K, Millar A, Wilson JA, Sellars C, Deary IJ. Is voice therapy an effective treatment for dysphonia? A randomised controlled trial. BMJ 2001; 323:658-61. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Maguire P, Selby P. Assessing quality of life in cancer patients. Br J Cancer. 1989 Sep;60(3):437-40. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"McDougall GJ, Becker H, Delville CL, Vaughan PW, Acee TW. Alcohol use and older adults: a little goes a long way. Int J Disabil Hum Dev 2007; 6:431-40. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"McHugh-Munier C, Scherer KR, Lehmann W, Scherer U. Coping strategies, personality, and voice quality in patients with vocal fold nodules and polyps. J Voice 1997; 11:452-61. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Moerman M, Martens JP, Dejonckere P. Application of the Voice Handicap Index in 45 patients with substitution voicing after total laryngectomy. Eur Arch Otorhinolaryngol 2004; 261:423-8. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Mosconi P, Cifani S, Crispino S, Fossati R,  Apolone G. The performance of SF-36 health survey in patients with laryngeal cancer. Head and Neck 2000; 22:175-82. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Muller R, Paneff J, Kolner V, Koch R. Quality of life of patients with laryngeal carcinoma: a post treatment study. Eur Arch Otorhinolaryngol 2001; 258:276-80. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Murry T, Medrado R, Hogikyan ND, Aviv JE. The relationship between ratings of voice quality and quality of life measures. J Voice 2004; 18:183-92. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Murry T, Rosen CA. Outcome measurements and quality of life in voice disorders. Otolaryngol Clin North Am 2000; 33:905-16. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Nõu E. Bronchial carcinoma. III. Quantitative measurements of the quality of survival. a prospective randomized study of the result of therapy in inoperable patients with localized disease. Scand J Respir Dis Suppl 1979; 104:107-30. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;Orley J. WHOQOL-BREF introduction, administration, scoring and generic version of the assessment. Avaliable from: <URL:http://www.who.int/en/http://www.who.int/mental_health/media/en/76.pdf> [2010 nov 12] ;
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Otto RA, Dobie RA, Lawrence V, Sakai C. Impact of a laryngectomy on quality of life: perspective of the patient versus that of the health care provider. Ann Otol Rhinol Laryngol 1997; 106:693-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Paro HB, Morales NM, Silva CH, et al. Health-related quality of life of medical students. Med Edu. 2010; 44:227-35. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Peeters AJ, van Gogh CD, Goor KM, Verdonck-de Leeuw IM, Langendijk JA, Mahieu HF. Health status and voice outcome after treatment for T1a glottic carcinoma. Eur Arch Otorhinolaryngol 2004; 261:534-40. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Peterson BD, Newton CR, Rosen KH, Skaggs GE. Gender differences in how men and women who are referred for IVF cope with infertility stress. Hum Reprod 2006; 21:2443-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Pimenta FA, Simil FF, Tôrres HO, Amaral CF, Rezende CF, Coelho TO, Rezende NA. [Retiree quality of life assessment with SF-36 questionnaire]. Rev Assoc Med Bras 2008; 54:55-60. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Portone CR, Hapner ER, McGregor L, Otto K, Johns MM 3rd. Correlation of the Voice Handicap Index (VHI) and the Voice-Related Quality of Life Measure (VRQOL). J Voice 2007; 21:723-7. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Ramírez MJ, Ferriol EE, Doménech FG, et al. Psychosocial adjustment in patients surgically treated for laryngeal cancer. Otolaryngol Head Neck Surg 2003; 129:927. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Rasch T, Günther S, Hoppe U, Eysholdt U, Rosanowski F. Voice-related quality  of life in organic and functional voice disorders. Logoped Phoniatr Vocol 2005; 30:913. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Relic A, Mazemda P, Arens C, Koller M, Glanz H. Investigating quality of life and coping resources after laryngectomy. Eur Arch Otorhinolaryngol 2001; 258:514-7 ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Resnick B, Perry D, Applebaum G, et al. The impact of alcohol use in communitydwelling older adults. J Community Health Nurs 2003; 20:135-45. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Reynolds P, Hurley S, Torres M, Jackson J, Boyd P, Chen VW. Use of coping strategies and breast cancer survival: results from the black/white cancer survival study. Am J Epidemiol 2000; 152:940-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Rosen C.A., Murry T, Zinn A., Zullo T., Sonbolian M. Voice Handicap Index change following treatment of voice disorders. J Voice 2000; 14:619-23. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Roy N, Bless DM, Heisey D. Personality and voice disorders: a multitraitmultidisorder analysis. J Voice 2000; 14:521-48. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Sartor SG, Eluf-Neto J, Travier N, Wünsch Filho V, Arcuri AS, Kowalski LP, Boffetta P. [Occupational risks for laryngeal cancer: a case-control study.]. Cad Saude Publica 2007; 23:1473-81. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Savoia MG. Escalas de eventos vitais e de estratégias de enfrentamento (Coping). Rev. Psiq Clin 1999; 26:1-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Savoia MG, Santana P, Mejias NP. Adaptação do inventário de estratégias de coping de folkman e lazarus para o português. Rev Psicol USP 1996; 7:183-201. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;Savoia MG. Instrumentos para avaliação de eventos vitais e de estratégias de enfrentamento (coping) em situações de estresse. In: Gorenstein C, Andrade LHSG, Zuardi AW, organizadores. Escalas de avaliação clínica em psiquiatria e psicofarmacologia. São Paulo: Lemos editorial, 2000, v. , p. 377-386. ;
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Seidl EMF. Enfrentamento, aspectos clínicos e sociodemográficos de pessoas vivendo com HIV/AIDS. Psicol Estud 2005; 10:421-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Schmitz N, Kruse J, Kugler J. Disabilities, quality of life, and mental disorders associated with smoking and nicotine dependence. Am J Psychiatr 2003; 160:16706. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Schuster M, Lohscheller J, Kummer P, Hoppe U, Eysholdt U, Rosanowski F. Quality of life in laryngectomees after prosthetic voice restoration. Folia Phoniatr Logop 2003; 55:211-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Schuster M, Hoppe U, Kummer P, Eysholdt U, Rosanowski F. [Coping strategies in laryngectomy patients]. HNO 2003; 51:337-43. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Selby PJ, Chapman JA, Etazadi-Amoli J, Dalley D, Boyd NF. The development of a method for assessing the quality of life of cancer patients. Br J Cancer 1984; 50:1322. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Sharp HM, List M, MacCracken E, Stenson K, Stocking C, Siegler M. Patients' priorities among treatment effects in head and neck cancer: evaluation of a new assessment tool. Head Neck 1999; 21:538-46. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Smith JC, Johnson JT, Cognetti DM, et al. Quality of life, functional outcome, and costs of early glottic cancer. Laryngoscope 2003; 113:68-76. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Smith E, Verdolini K. Gray S, et al. Effect of voice disorders on quality of life. J Med Speech-Lang Pathol 1996; 4:223-44. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Silva JDT, Müller MC, Bonamigo RR Estratégias de coping e níveis de estresse em pacientes portadores de psoríase. An Bras Dermatol 2006; 81(2):143-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Spector BC, Netterville JL, Billante C, Clary J, Reinisch L, Smith TL. Quality-of-life assessment in patients with unilateral vocal cord paralysis. Otolaryngol Head Neck Surg 2001; 125:176-82. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Spina AL, Maunsell R, Sandalo K, et al. Correlação da qualidade de vida e voz com atividade profissional. Braz J Otorhinolaryngol 2009; 75:275-9. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Stewart MG, Chen AY, Stach CB. Outcomes analysis of voice and quality of life in patients with laryngeal cancer. Arch Otolaryngol Head Neck Surg 1998; 124:1438. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;[SEER] Surveillance, Epidemiology and End Results. Program - National Cancer Inctitute http://seer.cancer.gov/csr/1975_2007. ;
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Talamini R, Bosetti C, La Vecchia C, et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control 2002; 13:957-64. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Thomsen TG, Rydahl-Hansen S, Wagner L. A review of potential factors relevant to coping in patients with advanced cancer. J Clin Nurs 2010; 19:3410-26. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"van Gogh CD, Verdonck-de Leeuw IM, et al. A screening questionnaire for voice problems after treatment of early glottic cancer. Int J Radiat Oncol Biol Phys 2005; 62:700-5. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"van Gogh CD, Verdonck-de Leeuw IM, et al. The efficacy of voice therapy in patients after treatment for early glottic carcinoma. Cancer 2006; 106:95-105. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"van Gogh CD, Mahieu HF, Kuik DJ, et al. Voice in early glottic cancer compared to benign voice pathology. Eur Arch Otorhinolaryngol 2007; 264:1033-8. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Vartanian JG, Carvalho AL, Yueh B, et al. Long Term quality of life evaluation after head and neck cancer treatment in a developing country. Arch Otolaryngol Head Neck Surg 2004; 130:1209-13. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Vartanian JG, Carvalho AL, Yueh B, et al. Brazilian-Portuguese validation of the University of Washington Quality of Life Questionnaire  for patients with head and neck cancer. Head Neck 2006; 28:1115-21. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Vilaseca I, Chen AY, Backscheider AG. Long-term quality of life after total laryngectomy. Head Neck 2006; 28:313-20. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Vivan Ade S, Argimon II. [Coping strategies, functional difficulties, and associated factors in institutionalized elderly]. Cad Saude Publica 2009; 25:436-44. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-83. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Walters SJ, Munro JF, Brazier JE. Using the SF-36 with older adults: a crosssectional community-based survey. Age Ageing 2001; 30:337-43. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"West E, Wållberg-Jonsson S. Health-related quality of life in Swedish men and women with early rheumatoid arthritis. Gend Med 2009; 6:544-54. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"[WHO] World Health Organization. The economics of health and disease. WHO Chronicles 1971; 25:20-4. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Wilson JA, Deary IJ, Millar A, Mackenzie K. The quality of life impact of dysphonia. Clin Otolaryngol Allied Sci 2002; 27:179-82. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Wünsch Filho V. The epidemiology of laryngeal cancer in Brazil. São Paulo Med J 2004; 122:188-94. ";
FAP;2011;MONICA CAIAFA BRETAS;Elisabete Carrara-de-Angelis;-x-;"Wyss K, Wagner AK, Whiting D, Mtasiwa DM, Tanner M, Gandek B, Kilima PM. Validation of the Kiswahili version of the SF-36 Health Survey in a representative sample of an urban population in Tanzania. Qual Life Res 1999; 8:111-20. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Abraham A, Appaji L. Cognitive assessment of children with acute lymphoblastic leukemia: preliminary findings. Indian J Med Paediatr Oncol 2009; 30:14-9. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Aguirre E, Spector A, Hoe J, et al. Maintenance Cognitive stimulation therapy (CST) for dementia: A single-blind, multi-centre, randomized controlled trial of maintenance CST vs. CST for dementia. Trials 2010; 28:11-46. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Ahles TA, Saykin AJ, Noll WW, et al. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 2003; 12:612–619. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Anderson FS, Kunin-Batson AS. Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function. Pediatr Blood Cancer 2009; 52:159–164. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Almeida OP. Mini mental state examination and the diagnosis of dementia in Brazil. Arq Neuropsiquiatr 1998; 56:605-12. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Armstrong GT. Long-term survivors of childhood central nervous system malignancies: the experience of the childhood cancer survivor study. Eur J Paediatr Neurol 2010; 14:298–303. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Askins MA, Moore BD. Preventing neurocognitive late effects in childhood cancer survivors. J Child Neurol 2008; 23:1160-71. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Assumpção Jr FB, Kuccznski E, Sprovieri MH, Aranha EMG. Escala de avaliação de QV (AUQEI – Autoquestionnaire qualité de vie enfante imagé) Validade e confiabilidade de uma escala para QV em crianças de 4 a 12 anos. Arq Neuropsiquiatr 2000; 58:119-27. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Auger N, Kelly KP, Bayles A, et al. Consensus statements investigating cognitive consequences fou childhood acute lymphoblastic leukemia. Semin Oncol Nurs 2000; 16:298-99. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Barr RD, Sala A. Quality-adjusted survival: a rigorous assessment of cure after cancer during childhood and adolescence. Pediatr Blood Cancer 2005; 44:201-4. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Barreire SG, Oliveira OA, Kazama W, Kimura M, Santos VLCG. QV de crianças ostomizadas na ótica das crianças e das mães. J Pediatr (Rio J) 2003; 79:55-62. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Blaauwbroek R, Stant AD, Groenier KH, et al. Health-related quality of life and adverse late effects in adult (very) long-term childhood cancer survivors. Eur J Cancer 2007; 43:122–13. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh G.  An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-71. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood 2003; 101:3809-17. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Brandalise SR, Odone V, Pereira W, Andrea M, Zanichelli M, Aranega V. Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group. Leukemia 1993; 7 Suppl 2:S142-5. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Brandalise SR, Pinheiro VR, Aguiar SS, et al. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-Protocol ALL-99. J Clin Oncol 2010; 28:191118. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Brown RT, Sawyer MG, Antoniou G, et al. Longitudinal follow-up of the intellectual and academic functioning of children receiving central nervous system-prophylactic chemotherapy for leukemia: a four-year final report. J Dev Behav Pediatr 1999; 20:373-77. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. Sugestões para o uso do mini-exame do estado mental no Brasil. Arq Neuropsiquiatr 2003; 61:777-81. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Buizer AI, de Sonneville LM, Veerman AJ. Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature. Pediatr Blood Cancer 2009; 52:447–54. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Calaminus G, Barr R. Economic evaluation and health-related quality of life. Pediatr Blood Cancer 2008; 50:1112-5. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Calaminus G, Weinspach S, Teske C, Göbel U. Quality of Life in children and adolescents with cancer: first results of an evaluation of 49 patients with the PEDQOL® questionnaire. Klin Padiatr 2000; 212:211-15. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"de Camargo B, Santos MO, Rebelo MS, et al. Cancer incidence among children and adolescents in Brazil: first report of 14 population-based cancer registries. Int J Cancer 2010; 126:715-20. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Campbell LK, Scaduto M, Sharp W, et al. A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 2007; 49:65-73. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;Cheng J, Liu B, Zhang X, et al. Health-lrelated quality of life in glioma patients in China. BMC Cancer 2010, 10:305. ;
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Conklin HM, Helton S, Ashford J, et al. Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo controlled, crossover trial. J Pediatr Psychol 2010; 35:144-55. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;Costa CL. Avaliação de aspectos psicossociais da população de pacientes fora de tratamento de câncer infantil: qualidade de vida, morbidade psiquiátrica. São Paulo, 2005. 111 p. Tese (Doutorado)-Fundação Antonio Prudente. ;
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"DeVellis RF. Scale development: theory and applications. 2nd ed. London: Thousand Oaks; 2003.  ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;Eiser C, Eiser JR, Stride CB. Quality of life in children newly diagnosed with cancer and their mothers. Health Qual Life Outcomes 2005, 3:29. ;
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Eiser C, Davies H, Jenney M, Stride C, Glaser A. HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer 2006; 46:35-9. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Espy KAMI, Kaufmann PM, Kramer JH, et al. Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study. J Pediatr Psychol 2001; 26:19. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Farhi DC, Rosenthal NS. Acute lymphoblastic leukemia. Clin Lab Med 2000; 20:17-28. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Figueiredo VLM, Nascimento E. Desempenhos nas duas tarefas do subteste dígitos do WISC-III e do WAIS-III. Psic Teor Pesq 2007; 23:313-8. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Feeny DH, Torrance GW, Furlong WJ. Health Utilities Index. In: Spilker B, editor. Quality of Life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven; 1996. p.239-52. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Feeny D, Furlong W, Torrance G, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care 2002; 40:113-28. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Felder-Puig R, Frey E, Sonnleithner G, et al. German cross-cultural adaptation of the Health Utilities Index and its application to a sample of childhood cancer survivors. Eur J Paediatr 2000; 159:283-8. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Fluchel M, Horsman JR, Furlong W, et al.Self and proxy-reported health status and health-related quality of life in survivors of childhood cancer in uruguay. Pediatr Blood Cancer 2008; 50:838-43. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Fu L, Talsma D, Baez F, et al. Measurement of health-related quality of life in survivors of cancer in childhood in Central America: feasibility, reliability, and validity. J Pediatr Hematol Oncol 2006; 28:331-41. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Furlong WJ, Feeny DH, Torrance GW, et al. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001; 33:375-84. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Gaynon PS, Angiolillo AL, Carroll WL, et al. Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report. Leukemia 2010; 24:28597. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Giesler RB, Miles BJ, Cowen ME, Kattan MW. Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings. Qual Life Res 2000; 9:645-65. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Gorenstein C, Andrade L. Validation of a Portuguese version of the beck depression Inventory and State-Trait Anxiety Inventory in Brazilian Subjects. Braz J Med Biol Res 1996; 29:453-57. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Gorenstein C, Andrade L. Inventário de depressão de Beck: Propriedades Psicométricas da Versão em Português. Rev Psiq Clin 1998; 25:245-50. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Grant MM, Rivera LM. Evolution of quality of life in oncology and oncology nursing. In: King CR, Hinds P, editors. Quality of life from nursing patients perspective: theory, research, practice. London: Jones & Bartlett Learning; 1998. p.3-22. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Grant J, Cranston A, Horsman J, et al. Health status and health-related quality of life in adolescent survivors of cancer in childhood. J Adolesc Health 2006; 38:504-10. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Hall P, Adami HOl, Trichopoulos D, et al. Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: swedish population based cohort study. BMJ 2004; 328:19. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Hardy KK, Willard VW, Bonner MJ. Computerized cognitive training in survivors of childhood cancer: a pilot study. J Pediatr Oncol Nurs 2011; 28:27-33. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Harila MJ, Winqvist S, Lanning M, Bloigu R, Harila-Saari AH. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2009; 53:156-61. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Harila J, Salo J, Lanning M, Vilkkumaa I Harila-Saari AH. High health-related quality of life among long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2010; 55:331-6. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Hata M, Ogino I, Aida N, et al. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors.Int J Cancer 2001; 96:S117-24. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Hicks MD, Lavender R. Psychosocial practice trends in pediatric oncology. J Pediatr Oncol Nurs 2001; 18:143-53. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Hill JM, Kornblith AB, Jones D, et al. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 1998; 82:208-18.  ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Hinds PS, King C. Nursing and patients perspectives on quality of life. In: King C, Hinds PS, editors. Quality of life from nursing patients perspective: theory, research, practice. London: Jones & Bartlett Learning; 1998. p.413-25.  ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Hinds PS, Gattuso JS, Fletcher A, et al. Quality of life as conveyed by pediatric patients with cancer. Qual Life Res 2004; 13:761-72. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Humpl T, Fritsche M, Bartels U, Gutjahr P. Survivors of childhood cancer for more than twenty years. Acta Oncol 2001; 40:44-9. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Jarfelt M, Bjarnason R, Lannering B. Young adult survivors of childhood acute lymphoblastic leukemia: spontaneous GH secretion in relation to CNS radiation. Pediatr Blood Cancer 2004; 42:582-8. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Kadan-Lottick NS, Brouwers P, Breiger D, et al. Acomparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia. Blood 2009; 114:1746-52. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Kaleita TA, Reaman GH, MacLean WE, et al. Neurodevelopmental outcomes of infants with acute lymphoblastic leukemia: a children’s cancer group report. Cancer 1999; 85:1859-65. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Kesler SR, Tanaka H, Koovakkattu D. Cognitive reserve and brain volumes in pediatric acute lymphoblastic leukemia. Brain Imaging Behavior 2010; 4:256-69. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Kingma A, VanDommelen R, Mooyart E, et al. No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study. J Pediatr Hematol/Oncol 2002; 24:106-14. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Krull KR, Okcu MF, Potter B, et al. Screening for neurocognitive impairment in pediatric cancer long-term survivors. J Clin Oncol 2008a; 26:4138-43. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Krull KR, Brouwers P, Jain N, et al. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr 2008b; 152:101-5. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Kuczynski E, Assumpção FB. Definições atuais sobre o conceito de QV na infância e adolescência. Pediatria Moderna 1999; 35:73-78. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Kurita GP. Alteração cognitiva e o tratamento da dor oncológica. São Paulo; 2006. [Tese de Doutorado-Universidade de São Paulo]. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Langer T, Martus P, Ottensmeier H, Hertzberg H, Beck JD, Meier W. CNS late effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol 2002; 38:320-8.  ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Leite EP, Muniz MTC, Azevedo ACAC, et al. Fatores prognósticos em crianças e adolescentes com leucemia linfóide aguda. Rev Bras Saúde Matern Infant 2007; 413-21. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Leung W, Hudson M, Zhu Y, et al. Late effects in survivors of infant leukemia. Leukemia 2000; 14:1185-90. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Lichtenfeld L. Cancer care and survivorship planning: promises and challenges. J Oncol Practice 2009; 5:116-8. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Lo Biondo-Wood G, Haber J. Pesquisa em enfermagem: métodos, avaliação crítica e utilização. 4ª ed. Rio de Janeiro: Guanabara Koogan; 2001. Confiabilidade e validade; p.186-99. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Lofstad GE, Reinfjell T, Hestad K, Diseth TH. Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only. Acta Pædiatrica 2009; 98:180-6. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Löning L, Zimmermann M, Reiter A, et al. Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 2000; 95:2770-5. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Lopes LF, De Camargo B, Bianchi A. Os efeitos tardios do tratamento do câncer na infância. Rev Ass Med Bras 2000; 46:277-84. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Mabbott DJ, Spiegler BJ, Greenberg ML, Rutka JT, Hyder DJ, Bouffet E. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol 2005; 23:2256-63. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Maunsell E, Pogany L, Barrera M, Shaw AK, Speechley KN. Quality of life among long-term adolescent and adult survivors of childhood cancer. J Clin Oncol 2006; 24:2527-35. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Matioli MNPS. Estudo comparativo do desempenho em testes neuropsicológicos de indivíduos com diagnóstico de doença de Alzheimer e demência vascular. São Paulo; 2005. [Dissertação de Mestrado-Universidade de São Paulo]. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Mennes M, Stiers P, Vandenbussche E, et al. Attention and Information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.Pediatr Blood Cancer 2005; 44:479-86. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Meeske KA, Siegel S , Globe DR. Mack WJ.Bernstein L. Prevalence and correlates of fatigue in long-term survivors of childhood leukemia. J Clin Oncol 2005; 23:5501-10. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;Ministério da Educação. Lei de diretrizes e bases. Disponível em: http://portal.mec.gov/arquivos/pdf/ldb.pdf, [2011 fev 18]. ;
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Mitby PA, Robison LL, Whitton JA, et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer a report from the childhood cancer survivor study Cancer 2003; 97:1115-26. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Mitchell CD, Richards SM, Kinsey SE, Lilleyman J, Vora A, Eden TOB. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK medical research council ALL97 randomized trial. Br J Haematol 2005; 129:734-45. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Moore IM, Espy KA, Kaufmann P,et al. Consequences and central nervous system injury following treatment fou childhood leukemia. Semin Oncol Nurs 2000; 16:279-90. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Moore IM. Advancing biobehavioral research in childhood cancer. J Pediatr Oncol Nurs 2004; 21:128-31.  ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Moore BD. Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychology 2005; 30:51-63. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Moll J, de Oliveira-Souza R, Moll FT, Bramati IE, Andreiuolo PA. The cerebral correlates of set-shifting: an fMRI study of the trail making test. Arq Neuropsiquiatr 2002; 60:900-5.  ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Montour-Proulx I, Kuehn SM, Keene DL, et al. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol. J Child Neurol 2005; 20:129-33. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Mulhern RK, Horowitz ME, Ochs J. Assessment of quality of life among pediatric patients with cancer: psychological assessment. J Consult Clin Psychol 1989; 1:130-35. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;[NCI] National Cancer Institute. Estimated number of cancer survivors in the United States from 1971 to 2005. Avaliable from: <URL:http://plan2009.cancer.gov/pdf/nci2009plan.pdf>. [2011 jan 15]. ;
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Nathan PC, Furlong W, Barr RD. Challenges to the measurement of healthrelated quality of life in children receiving cancer therapy. Pediatr Blood Cancer 2004; 43:215-23. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Nathan PC, Patel SK, Dilley K, et al. Guidelines for Identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer a report from the children’s oncology group. Arch Pediatr Adolesc Med 2007; 161:798-806. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Nitrini R, Caramelli P, Bottino CM, Damasceno BP, Brucki SM, Anghinah R; Diagnosis of Alzheimer's disease in Brazil: cognitive and functional evaluation. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology]. Arq Neuropsiquiatr 2005; 63:720-7. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Oeffinger KC, Mertens C, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355:1572-82. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Parkin DM, Stiller CA, Draper GJ, et al. The international incidence of childhood cancer. Int J Cancer 1988; 42:511-20. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Patel SK, Katz ER, Richardson R, Rimmer M, Kilian S. Cognitive and problem solving training in children with cancer: a pilot project. J Pediatr Hematol Oncol 2009; 31:670-77. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Pemberger S, Jagsch R, Frey E, et al. Quality of life in long-term childhood cancer survivors and the relation of late effects and subjective well-being. Support Care Cancer 2005; 13:49-56. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Pereira WV. Aspectos epidemiológicos, biotipologia e evolução do tratamento da leucemia linfocítica aguda na infância e adolescência no Rio Grande do Sul. São Paulo; 2010. [Tese de Doutorado-Faculdade de Medicina da Universidade de São Paulo] ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Peterson CC, Johnson E, Ramirez LY, et al. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008; 51:99-104. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Picado SBR, Castro CC, Casella EB, Cristófani M, Filho VO. Avaliação de parâmetros evolutivos e alterações de imagens em 28 crianças sobreviventes de leucemia linfoblástica aguda (LLA) fora de terapia há 5 anos ou mais conforme o tipo de profilaxia em sistema nervoso central. Rev Pediatr 1998; 20:179-90.";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Pinto D. Uma análise linguística da adaptação brasileira do inventário beck de depressão. J Bras Psiq 1997; 46:249-53. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Pogany L, Barr RD, Shaw A, Speechley KN, Barrera M, Maunsell E. Health status in survivors of cancer in childhood and adolescence. Qual Life Res 2006; 15:143-57. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Polit DF, Beck CT, Hungler BP. Fundamentos de pesquisa em enfermagem. 5[ ed. Porto Alegre: Artmed; 2004. Análise dos dados de pesquisa; p.309-55. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Pui CH, Evans W. Drug therapy: treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354:166-78. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;Pui CH. Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. Hematology Am Soc Hematol Educ Program 2006:142-6. ;
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Reiter A, Schrappe M, Ludwig WD, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84:3122-33. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Ribeiro KB, Lopes LF, de Camargo B. Trends in childhood leukemia mortality in Brazil and correlation with social inequalities. Cancer 2007; 110:1823-31. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Riehm H, Feickert HJ, Schrappe M, Henze G, Schellong G: Therapy results in five ALL-BFM studies since 1970. Implications of risk factors for prognosis. Haematol Blood Transfus 1987; 30:139-46. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Rigon H, Lopes LF, Latorre MR, et al. The GEPETTO program for surveillance of long-term survivors of childhood cancer: a preliminary report from a single institution in Brazil. Med Pediatr Oncol 2003; 40:405-6. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Robison LL. The childhood cancer survivor study: a resource for research of long-term outcomes among adult survivors of childhood cancer. Minn Med 2005; 88:45-9. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Robinson KE, Livesay KL, Campbell LK, et al. Working memory in survivors of childhood acute lymphocytic leukemia: functional neuroimaging analyses. Pediatr Blood Cancer 2010; 54:585-90. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Shimasaki N, Mori T, Torii C, et al. Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol Oncol 2008; 30:347-52. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Shimoda S, de Camargo B, Horsman J, et al. Translation and cultural adaptation of Health Utilities Index (HUI) Mark 2 (HUI2) and Mark 3 (HUI3) with application to survivors of childhood cancer in Brazil. Qual Life Res 2005; 14:1407-12. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Shimoda S. QV dos sobreviventes do câncer pediátrico em uma instituição brasileira. São Paulo; 2005. [Dissertação de MestradoFundação Antônio Prudente] ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Shimoda S, Horsman J, Furlong W, Barr RD, de Camargo B. Disability and health-related quality of life in long-term survivors of cancer in childhood in Brazil. J Pediatr Hematol Oncol 2008; 30:563-70. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Shusterman S, Meadows AT. Long term survivors of childhood leukemia. Curr Opin Hematol 2000; 7:217-22. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Spencer J. The Role of Cognitive Remediation in childhood cancer survivors experiencing neurocognitive late effects. J Pediatr Oncol Nurs 2006; 26:321-5. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Spiegler BJ, Kennedy K, Maze R, et al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 2006; 24:3858-64. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Spilker B. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott- Raven;1996. Introduction; p.1-10. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Streiner DL, Norman GR. Health measurement scales: a practical guide do their development and use. 3 ed. Oxford: Oxford Univerisy Press; 2003.  ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Surtees R, Clelland J, Hann I. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies. J Clin Oncol 1998; 16:1505-11. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Temming P, Jenney MEM. The neurodevelopmental sequelae of childhood leukaemia and its treatment. Arch Dis Child 2010; 95:936-40. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q. Multiattribute utility function for a comprehensive health status classification system: Health Utilities Mark 2. Med Care 1996; 34:702-22. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Van Dongen-Melman JEWM, De Groot A, Van Dongen JJM, et al. Cranial irradiation is the major cause of learning problems in children treated for leukemia and lymphoma: a comparative study. Leukemia 1997; 11:1197200. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"van Kooten Niekerk PB, Schmiegelow K, Schroeder H. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate. Eur J Haematol 2008; 81:391-98. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Vardy J, Rourke S, Tannock F. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 2007; 25:2455-63. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Veerman AJ, Hahlen K, Kamps WA, et al. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocolALLVI from the dutch childhood leukemia study group. J Clin Oncol 1996; 14:911-18. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Vitiello APP, Ciríaco JGM, Takahashi DY Nitrini R, Caramelli P. Avaliação cognitiva breve de indivíduos atendidos em ambulatório de neurologia geral Arq Neuropsiquiatr 2007; 65:299-303. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Vora A. Acute lymphoblastic leukemia: optimizing treatment strategies in children. Paediatr Drugs 2002; 4:405-16. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Von der Weid N. Late effects in long-term survivors of ALL in childhood: experiences from the SPOG late effects study. Swiss Med Wkly 2001; 131:180-7. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Waber DP, Tarbell NJ. Toxicity of CNS prophylaxis for childhood leukemia. Oncology (Williston Park) 1997; 11:259-64; discussion 264-5. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Waber, DP; Carpentieri C, Klar N, et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. J Pediatr Hematol/Oncol 2000; 22:06-213. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Waber DP, Silverman LB, Catania L, et al. Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity. Clin Oncol 2004; 22:2701-7. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Zebrack BJ, Yi J, Petersen L, Ganz PA. The impact of cancer and quality of life for long-term survivors. Psycho-Oncology 2008; 17:891-900. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Zeltzer LK, Lu Q, Leisenring W, et al. Psychosocial outcomes and healthrelated quality of life in adult childhood cancer survivors: a report from the childhood cancer survivor study cancer. Epidemiol Biomarkers Prev 2008; 17:435-46. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Ziegler DS, Dalla Pozza L, Waters KD, Marshall GM. Advances in childhood leukaemia: successful clinical-trials research leads to individualised therapy. Med J Aust 2005; 182:78-81. ";
FAP;2011;SANDRA SHIMODA;Beatriz de Camargo;-x-;"Ziereisen F, Dan B, Azzi N, et al. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features. Pediatr Radiol 2006; 36:205-212. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Ahluwalia MS, de Groot J, Liu WM, Gladson CL. Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies. Cancer Lett 2010; 2:139-49.";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Arantes C, Nomizo R, Lopes MH, Hajj GN, Lima FR, Martins VR. Prion protein and its ligand stress inducible protein 1 regulate astrocyte development. Glia 2009; 57:1439-49. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Bartek J, Hodny Z. SUMO boosts the DNA damage response barrier against cancer. Cancer Cell 2010; 1:9-11.";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Bawa-Khalfe T, Cheng J, Lin SH, Ittmann MM, Yeh ET. SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J Biol Chem 2010; 33:25859-66.";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Bawa-Khalfe T, Yeh ET. SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression. Genes Cancer 2010; 7:748-52.";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Borkovich KA, Farrelly FW, Finkelstein DB, Taulien J, Lindquist S. hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures. Mol Cell Biol 1989; 9:3919-30. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Breinig M, Mayer P, Harjung A, et al. Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors. Clin Cancer Res 2011; 8:2237-49. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Cai Q, Robertson ES. Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization. PLoS One 2010; 5:e12636. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Cai Q, Verma SC, Kumar P, Ma M, Robertson ES. Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification. PLoS One 2010; 5:e9720.  ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Campbell JW, Pollack IF. Cerebellar astrocytomas in children. J Neurooncol 1996; 28:223-31. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Chamberlain MC. Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas. Cancer 2010; 116:3988-99. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Chen T, Yan W, Wells RG, et al. Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases. Int J Cancer 2001; 93:653-61. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Cheng J, Bawa T, Lee P, Gong L, Yeh ET. Role of desumoylation in the development of prostate cancer. Neoplasia 2006; 8:667-76. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R. Cellular prion protein transduces neuroprotective signals. Embo J 2002; 21:3317-26. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Chung CD, Liao J, Liu B, et al. Specific inhibition of Stat3 signal transduction by PIAS3. Science 1997; 278:1803-5. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Daniel S, Bradley G, Longshaw VM, Söti C, Csermely P, Blatch GL. Nuclear translocation of the phosphoprotein Hop (Hsp70/Hsp90 organizing protein) occurs under heat shock, and its proposed nuclear localization signal is involved in Hsp90 binding. Biochim Biophys Acta 2008; 1783:1003-14. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"De Witt Hamer PC. Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies. Neuro Oncol 2010; 12:304-16.";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Deng H, Lin Y, Badin M, et al. Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9. Biochem Biophys Res Commun 2011; 404:667-71. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Desterro JM, Thomson J,Hay RT. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett 1997; 417:297-300. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Devarajan E, Huang S. STAT3 as a central regulator of tumor metastases. Curr Mol Med 2009; 9:626-33. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Devoy A, Soane T, Welchman R, Mayer RJ. The ubiquitin-proteasome system and cancer. Essays Biochem 2005; 41:187-203. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Dziennis S, Alkayed NJ. Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev Neurosci 2008; 19:341-61. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Erlich RB, Kahn SA, Lima FR, et al. STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 2007; 55:1690-8. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Eustace BK, Jay DG. Extracellular roles for the molecular chaperone, hsp90. Cell Cycle 2004; 3:1098-100. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev 2004; 18:2046-59. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Graner MW, Raynes DA, Bigner DD, Guerriero V. Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfaces. Cancer Sci 2009; 100:1870-9. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Grier JT, Batchelor T. Low-grade gliomas in adults. Oncologist 2006; 11:681-93.";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Gupta S, Knowlton AA. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol 2007; 292:H3052-6. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Hannoun Z, Greenhough S, Jaffray E, Hay RT, Hay DC. Post-translational modification by SUMO. Toxicology 2010; 278:288-93. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Hay RT. SUMO: a history of modification. Mol Cell 2005; 18:1-12.";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Heinlein CA, Chang C. Androgen receptor (AR) coregulators: an overview. Endocr Rev 2002; 23:175-200. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Honoré B, Leffers H, Madsen P, Rasmussen HH, Vandekerckhove J, Celis JE. Molecular cloning and expression of a transformation-sensitive human protein containing the TPR motif and sharing identity to the stress-inducible yeast protein STI1. J Biol Chem 1992; 267:8485-91. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;INVITROGEN. Manual Invitrogen dos vetores pLenti4/V5-DEST, pLenti6/V5DEST, Lenti6.2/V5-DEST e pLenti6/UbC/V5-DEST Gateway® Vector Kits: Catalog nos. V496–10, V498–10, V499–10, V368–20, 7 June 2010. Disponível em :<URL:http://toolszh.invitrogen.com/content/sfs/manuals/plenti_dest_man.pdf> [2011 12 maio]. ;
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;Jego G, Hazoume A, Seigneuric R, Garrido C. Targeting heat shock proteins in cancer. Cancer Lett 2010 Nov 13. [Epub ahead of print] ;
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Jiang L, Huang CG, Lu YC, et al. Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors. Brain Res 2008; 1201:161-6. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Jiang L, Bao Y, Luo C, et al. Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro. J Cancer Res Clin Oncol 2010; 136:211-7. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Johnson ES, Blobel G. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J Biol Chem 1997; 2725:26799-802. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Johnson ES. Protein modification by SUMO. Annu Rev Biochem 2004; 73:355-82. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Kang JS, Saunier EF, Akhurst RJ, Derynck R. The type I TGF-beta receptor is covalently modified and regulated by sumoylation. Nat Cell Biol 2008; 10:654-64. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Kim JH, Choi HJ, Kim B, et al. Roles of sumoylation of a reptin chromatinremodelling complex in cancer metastasis. Nat Cell Biol 2006; 8:631-9. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Kim KI, Baek SH. SUMOylation code in cancer development and metastasis. Mol Cells 2006; 22:247-53. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Kim JH, Lee JM, Nam HJ, et al. SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer cells. Proc Natl Acad Sci U S A 2007; 104:20793-8. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Kleihues P, Sobin LH. World Health Organization classification of tumors. Cancer 2000; 88:2887. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Kubota H, Yamamoto S, Itoh E, et al. Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperones 2010; 15:1003-11. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Li QQ, Cao XX, Xu JD, et al. The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel. Cell Mol Life Sci 2009; 66:504-15. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Li J, Richter K, Buchner J. Mixed Hsp90-cochaperone complexes are important for the progression of the reaction cycle. Nat Struct Mol Biol 2011; 18:61-6. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Lima FR, Arantes CP, Muras AG, Nomizo R, Brentani RR, Martins VR. Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J Neurochem 2007; 103:2164-76. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673-728. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Longshaw VM, Baxter M, Prewitz M, Blatch GL. Knockdown of the co-chaperone Hop promotes extranuclear accumulation of Stat3 in mouse embryonic stem cells. Eur J Cell Biol 2009; 88:153-66. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Lopes MH, Hajj GN, Muras AG, et al. Interaction of cellular prion and stressinducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J Neurosci 2005; 25:11330-9. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114:97-109. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Maher EA, Furnari FB, Bachoo RM, et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001; 15:1311-33. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Martins VR, Graner E, Garcia-Abreu J, et al. Complementary hydropathy identifies a cellular prion protein receptor. Nat Med 1997; 3:1376-82. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"McDoniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA, You M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 2002; 8:1127-38. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"McEwan JF, Windsor ML, Cullis-Hill SD. Antibodies to prion protein inhibit human colon cancer cell growth. Tumour Biol 2009; 30:141-7. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Melchior F. SUMO--nonclassical ubiquitin. Annu Rev Cell Dev Biol 2000; 16:591626. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Messick TE, Greenberg RA. The ubiquitin landscape at DNA double-strand breaks. J Cell Biol 2009; 187:319-26. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Mo YY, Moschos SJ. Targeting Ubc9 for cancer therapy. Expert Opin Ther Targets 2005; 9:1203-16. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Mo YY, Yu Y, Theodosiou E, Rachel Ee PL, Beck WT. A role for Ubc9 in tumorigenesis. Oncogene 2005; 24:2677-83. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Morris JR. More modifiers move on DNA damage. Cancer Res 2010a; 70:3861-3. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Morris JR. SUMO in the mammalian response to DNA damage. Biochem Soc Trans 2010b; 38:92-7. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Nakagawa K, Yokosawa H. PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Lett 2002; 530:204-8. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Nalepa G, Rolfe M, Harper JW. Drug discovery in the ubiquitin-proteasome system. Nat Rev Drug Discov 2006; 5:596-613. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Nickel W. Pathways of unconventional protein secretion. Curr Opin Biotechnol 2010; 21:621-6. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Nicolet CM., Craig EA. Isolation and characterization of STI1, a stress-inducible gene from Saccharomyces cerevisiae. Mol Cell Biol 1989; 9:3638-46. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Odunuga OO, Longshaw VM, Blatch GL. Hop: more than an Hsp70/Hsp90 adaptor protein. Bioessays 2004; 26:1058-68.";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Pfaffl MW. A new mathematical model for relative quantification in real-time RTPCR. Nucleic Acids Res 2001; 29:e45. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001; 70:503-33. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Pickart CM, Eddins MJ. Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 2004; 1695:55-72. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Poukka H, Karvonen U, Janne AO, Palvimo JJ. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci U S A 2000; 97:14145-50. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN. Molecularly targeted therapy for malignant glioma. Cancer 2007; 110:13-24. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Sehat B, Tofigh A, Lin Y, et al. SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci Signal 2010; 3:ra10. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Sims JD, McCready J, Jay DG. Extracellular heat shock protein (hsp)70 and hsp90alpha assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion. PLoS One 2011; 6:e18848. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Stupp R, Hegi ME, van den Bent MJ, et al. Changing paradigms--an update on the multidisciplinary management of malignant glioma. Oncologist 2006; 11:165-80. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Van Meter ME, Kim ES. Bevacizumab: current updates in treatment. Curr Opin Oncol 2010; 22:586-91. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Walsh N, Larkin A, Swan N, et al. RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation. Cancer Lett 2011; 306:180-9.";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Wang L, Banerjee S. Differential PIAS3 expression in human malignancy. Oncol Rep 2004; 11:1319-24. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Wang TH, Chao A, Tsai CL, et al. Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics 2010; 9:1873-84. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Wang X, Song X, Zhuo W, et al. The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy. Proc Natl Acad Sci U S A 2009; 106:2128893. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Welchman RL, Gordon C, Mayer RJ. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 2005; 6:599-609.";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Wible BA, Wang L, Kuryshev YA, Basu A, Haldar S, Brown AM. Increased K+ efflux and apoptosis induced by the potassium channel modulatory protein KChAP/PIAS3beta in prostate cancer cells. J Biol Chem 2002; 277:17852-62. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Yan S, Sun X, Xiang B, et al. Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90. EMBO J 2010; 29:3773-86. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Yeh ET. SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem 2009; 284:8223-7.";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;"Zanata SM, Lopes MH, Mercadante AF, et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 2002; 21:3307-16. ";
FAP;2011;NICOLLE GILDA TEIXEIRA DE QUEIROZ;Vilma Regina Martins;Marilene Hohmuth Lopes/Fernando Augusto Soares;Zhuang D, Liu Y, Mao Y, et al. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells. Int J Cancer 2011 Feb 15. [Epub ahead of print] ;
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"[Breast Cancer Linkage Consortium] Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999; 91:1310-6. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Abuzallouf S, Dayes I, Lukka H. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 2004; 171: 2122-7. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Afnan J, Tempany CM. Update on prostate imaging. Urol Clin North Am 2010; 37:23-5. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Albertsen PC, Fryback DG, Storer BE, et al. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995; 274:62631. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Albertsen PC, Hanley JA, Harlan LC, et al. The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis. J Urol 2000; 163:1138-43. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Anderson DE, Badzioch MD. Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst 1992; 84:1114-7. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Andriole GL, Crawford ED, Grubb RL 3rd, PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009; 360:1310-9. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Andriole GL, Bostwick DG, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med 2010; 362:1192-202. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Bostwick DG. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 1994; 18:796803. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Bostwick DG, Shan A, Qian J, et al. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer 1998; 83:1995-2002. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Bueschen AJ, Lockhart ME. Evolution of urological imaging. Int J Urol 2011; 18 :102-12. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Bussemakers MJ, van Bokhoven A, Verhaegh GW, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999; 59:5975-9. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;[CDC] Center for Diseases Cancer and Prevention. 1999-2007 cancer incidence and mortality data. Available from:<UR:http>//www.cdc.gov/uscs> [2011 fev 12] ;
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Canby-Hagino E, Hernandez J, Brand TC, et al. Looking back at PCPT: looking forward to new paradigms in prostate cancer screening and prevention. Eur Urol 2007; 51:27-33. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324:1156-61. Erratum in: N Engl J Med 1991; 325:1324. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Chodak GW, Keller P, Schoenberg HW. Assessment of screening for prostate cancer using the digital rectal examination. J Urol 1989; 141:11368.";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Chute CG, Panser LA, Girman CJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993; 150:85-9. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 2000; 92:61-8. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Coley CM, Barry MJ, Fleming C, et al. Early detection of prostate cancer.  Part I: Prior probability and effectiveness of tests. The American College of Physicians. Ann Intern Med 1997; 126:394-406. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280:969-74. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"D'Amico AV, Schultz D, Silver B, et al. The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2001; 49:679-84. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003; 21:2163-72. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"D'Amico AV, Chen MH, Roehl KA, Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 2004; 351:125-35. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"D'Amico AV, Renshaw AA, Sussman B, Chen MH. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA 2005; 294:440-7. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Delongchamps NB, Singh A, Haas GP. The role of prevalence in the diagnosis of prostate cancer. Cancer Control 2006; 13:158-68. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Divrik RT, Eroglu A, Sahin A, et al. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. Urol Oncol 2007; 25:376-82. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Djulbegovic M, Beyth RJ, Neuberger MM, et al. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ 2010; 341:c4543. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Edwards SM, Kote-Jarai Z, Meitz J, et al. Two percent of men with earlyonset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 2003; 72:1-12. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Edwards SM, Evans DG, Hope Q et al. Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis. Br J Cancer 2010; 103:918-24. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Efstathiou JA, Chen MH, Renshaw AA, et al. Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer. Cancer 2007; 109:1493-8. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Epstein JI. An update of the Gleason grading system. J Urol 2010; 183:43340.  ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Ferdowsian HR, Barnard ND. The role of diet in breast and prostate cancer survival. Ethn Dis 2007; 17(2 Suppl 2):S2-18-22. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Flanigan RC, McKay TC, Olson M, et al. Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Urology 1996; 48:428-32. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Forman JD, Lee WR, Roach M 3rd, et al. Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215 Suppl:1373-82. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Freedland SJ, Sun L, Kane CJ, et al. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. BJU Int 2008; 102:969-74.  ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Gillanders EM, Xu J, Chang BL, et al. Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst 2004; 96:1240-7. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Gleason DF, Mellinger GT. The Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111:58-64. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992; 23:273-9. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Gong Z, Agalliu I, Lin DW, et al: Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middleaged men. Cancer 2007; 109:1192-202. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Gudmundsson J, Johannesdottir G, Bergthorsson JT, et al. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12q13. Cancer Res 1995; 55:4830-2. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Hoffman RM, Gilliland FD, Eley JW, et al. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2001; 93:388-95. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Hsing AW, Chua S Jr, Gao YT, et al. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 2001; 93:783-9. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci 2006; 11:1388-413. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Hubert A, Peretz T, Manor O, et al. The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am J Hum Genet 1999; 65:921-4. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Humphrey PA. Gleason grading and prognostic factors in carcinoma of the prostate. Mod Pathol 2004; 17:292-306.  ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Inman BA, Davies JD, Rangel LJ, et al. Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or = 50 ng/mL. Cancer 2008; 113:1544-51. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Isariyawongse BK, Sun L, Bañez LL, et al. Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen. Urology 2008; 72:882-6.  ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Johannesdottir G, Gudmundsson J, Bergthorsson JT, et al. High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res 1996; 56:3663-5. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Joniau S, Van Poppel H. Localized prostate cancer: can we better define who is at risk of unfavourable outcome? BJU Int 2008; 101 Suppl 2:5-10. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Kaul LL, Martinez AA, Stromberg JS, et al. The role of diet in prostate cancer. Nutr Cancer 1987; 9:123-8. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Kavanaugh CJ, Trumbo PR, Ellwood KC. The U.S. food and drug administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J Natl Cancer Inst 2007; 99:1074-85.  ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"King CR, McNeal JE, Gill H, et al. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Oncol Biol Phys 2004; 59:386-91. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Kirsh VA, Peters U, Mayne ST, et al. Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 2007; 99:1200-9.  ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Kulkarni GS, Lockwood G, Evans A, et al. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy. Cancer 2007; 109:2432-8. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. Recurrent gene fusions in prostate cancer. Nat Rev Cancer 2008; 8:497-511. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Kuroiwa K, Shiraishi T, Ogawa O, et al. Discrepancy between local and central pathological review of radical prostatectomy specimens. J Urol 2010; 183:952-7. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Lagiou P, Signorello LB, Trichopoulos D, Tzonou A, Trichopoulou A, Mantzoros CS. Leptin in relation to prostate cancer and benign prostatic hyperplasia. Int J Cancer 1998; 76:25-8. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343:78-85.";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Llaverias G, Danilo C, Wang Y, et al. A western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. Am J Pathol 2010; 177:3180-91. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Master VA, Chi T, Simko JP, et al. The independent impact of extended pattern biopsy on prostate cancer stage migration. J Urol 2005; 174:178993. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Meeks JJ, Loeb S, Helfand BT, et al. Characteristics of prostate cancers detected at prostate specific antigen levels less than 2.5 ng/ml. J Urol 2009; 181:2515-8. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Mellinger GT, Gleason D, Bailar. III J. The histology and prognosis of prostatic cancer. J Urol 1967; 97:331-337. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Mikaelsdottir EK, Valgeirsdottir S, Eyfjord JE, et al. The Icelandic founder mutation BRCA2 999del5: analysis of expression. Breast Cancer Res 2004; 6:284-90. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2012 Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2011. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Mitra A, Fisher C, Foster CS, et al. Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer 2008; 98:502-7. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Moro L, Arbini AA, Yao JL, Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9. Cancer Sci 2008; 99:553-63. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Nakanishi H, Groskopf J, Fritsche HA, et al. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance. J Urol 2008; 179:1804–9. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Nam RK, Sugar L, Yang W, et al. Expression of the TMPRSS2: ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer. Br J Cancer 2007; 97:1690-5. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004; 4:665-76.  ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Noguchi M, Stamey TA, Neal JE, et al. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol 2000; 163:1751-5. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Partin AW, Yoo J, Carter HB, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993; 150:110-4.  ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Perner S, Demichelis F, Beroukhim R, et al. TMPRSS2: ERG fusionassociated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 2006; 66:8337-41. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Pierorazio PM, Ferrucci L, Kettermann A, et al. Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging. BJU Int 2010; 105:824-9. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Reese AC, Cooperberg MR, Carroll PR. Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease. J Urol 2010; 184:114-9. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Rifkin MD, Zerhouni EA, Gatsonis CA, et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: results of a multi-institutional cooperative trial. N Engl J Med 1990; 323:6216.";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Roach M 3RD, Lu J, Pilepich MV, et al. Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials. Int J Radiat Oncol Biol Phys 2000; 47:617-27. Erratum in: Int J Radiat Oncol Biol Phys 2000; 48:313. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Roach M 3rd, Weinberg V, McLaughlin PW, Grossfeld G, Sandler HM. Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate. Urology 2003; 61:730-5.  ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Roddam AW, Allen NE, Appleby P, et al. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008; 100:170-83. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Schröder FH, Hugosson J, Roobol MJ, et al. ERSPC Investigators. Prostatecancer mortality at 11 years of follow-up. N Engl J Med 2012; 366:981-90. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 2000; 408:429-32. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Shimizu H, Ross RK, Bernstein L, et al. Cancers of the prostate and breast among Japanese and immigrants in Los Angeles Conty. Cancer 1991; 63:963-66. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 1999; 28:1598-604. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Sigurdsson S, Thorlacius S, Tomasson J, et al. BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med 1997; 75:758-61. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Srinivasan M, Sedmak D, Jewell S. Effects of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 2002; 162:196171. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Stanford JL, Ostrander EA. Familial prostate cancer. Epidemiol Rev 2001; 23:19-23. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Steinberg GD, Carter BS, Beaty TH, et al. Family history and the risk of prostate cancer. Prostate 1990; 17:337-47. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336:1401-8. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Thiessen EU. Concerning a familial association between breast cancer and both prostatic and uterine malignancies. Cancer 1974; 34:1102-7. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003; 349:215–24. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Tryggvadóttir L, Vidarsdóttir L, Thorgeirsson T, et al. Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst 2007; 99:929-35.  ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Tulinius H, Egilsson V, Olafsdóttir GH, et al. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ 1992; 10:855-7. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Tulinius H, Olafsdottir GH, Sigvaldason H, et al. The effect of a single BRCA2 mutation on cancer in Iceland. J Med Genet 2002; 39:457-62. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Villers A, McNeal JE, Redwine EA, et al. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 1989; 142:763-8. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Willems AJ, Dawson SJ, Samaratunga H, et al. Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation. Clin Cancer Res 2008; 14:2953-61. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Williams C, Poten F, Moberg C, et al. A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol 1999; 155:1467-71. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Wise AM, Stamey TA, McNeal JE, et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 2002; 60:264-9. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960; 13:739-44. ";
FAP;2012;ADRIANO TESTON;Antonio Cassio Assis Pellizzon  ;Dirce Maria Carraro;"Yan L, Spitznagel EL. Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 2005; 117:667-9.";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Abrahamson PE, Gammon MD, Lund MJ, et al. Recreational physical activity and survival among women with breast cancer. Cancer 2006; 107:1777-85.";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"[ACSM] American College of Sports Medicine. ACSM´s Guideline for exercise prescriprion. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. Pre-Participation Health Screening And Risk Stratification Section II. Exercise Testing.";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Adamsen L, Midtgaard J, Rorth M, et al. Feasibility, physical capacity, and health benefits of a multidimensional exercise program for cancer patients undergoing chemotherapy. Support Care Cancer 2003; 11:707-16.";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Adamsen L, Quist M, Andersen C, et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ 2009; 339:b3410. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Aghili M, Farhan F, Rade M. A pilot study of the effects of programmed aerobic exercise on the severity of fatigue in cancer patients during external radiotherapy. Eur J Oncol Nurs 2007; 11:179-82. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. J Clin Oncol 2008; 26:5689-96. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Alicikus ZA, Gorken IB, Sen RC, et al. Psychosexual and body image aspects of quality of life in Turkish breast cancer patients: a comparison of breast conserving treatment and mastectomy. Tumori 2009; 95:212-8. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Anderson KO, Getto C J, Mendoza TR, et al. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and communitydwelling adults. J Pain Symptom Manage 2003; 25:307-18. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Andritsch E, Dietmaier G, Hofmann G, Zloklikovits S, Samonigg H. Global quality of life and its potential predictors in breast cancer patients: an exploratory study. Support Care Cancer 2007; 15:21-30. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32:498-504. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Arndt V, Stegmaier C, Ziegler H, Brenner H. A population based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis. Cancer 2006; 107:2496-503. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Badger TA, Braden CJ, Mishel MH. Depression burden, self-help interventions, and side effect experience in women receiving treatment for breast cancer. Oncol Nurs Forum 2001; 28:567-74. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Baider L, Andritsch E, Uziely B, et al. Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings. Crit Rev Oncol Hematol 2003; 46:5-16. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Bardwell WA, Major JM, Rock CL, et al. Health-related quality of life in women previously treated for early-stage breast cancer. Psychooncology 2004; 13:595-604. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Bárez M, Blasco T, Fernández-Castro J, Viladrich C. Perceived control and psychological distress in women with breast cancer: a longitudinal study. J Behav Med 2009; 32:187-96";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Basen-Engquist K, Taylor CL, Rosenblum C, et al. Randomized pilot test of a lifestyle physical activity intervention for breast cancer survivors. Patient Educ Couns 2006; 64:225-34. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Basen-Engquist K, Hughes D, Perkins H, Shinn E, Taylor CC. Dimensions of physical activity and their relationship to physical and emotional symptoms in breast cancer survivors. J Cancer Surviv 2008; 2:253-61. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Bastani P, Ahmad Kiadaliri A. Health-related quality of life after chemotherapy cycle in breast cancer in Iran. Med Oncol 2011; 28 Suppl 1:70-4. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Bender CM, Ergÿn FS, Rosenzweig MQ, Cohen SM, Sereika SM. Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nurs 2005; 28:219-25. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;Bifulco G, De Rosa N, Tornesello ML, et al. Quality of life, lifestyle behavior and employment experience: a comparison between young and midlife survivors of gynecology early stage cancers. Gynecol Oncol 2011. [Epub ahead of print]. ;
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv 2009; 3:223-32. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Braithwaite D, Satariano WA, Sternfeld B, et al. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst 2010; 102:1468-77. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Brandão MRF. Perfil sócio-psicológico da equipe nacional de voleibol masculino: uma análise à luz da ecologia do desenvolvimento humano. Santa Maria; 1996. [Dissertação de Mestrado-Universidade Federal de Santa Maria]. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Browall M, Ahlberg K, Karlsson P, et al. Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women. Eur J Oncol Nurs 2008; 12:180-9. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Brown JK, Byers T, Doyle C, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2003; 53:268-91. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 2005; 330:702. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Burnhan TR, Wilcox A. Effects of exercise on physiological and psychological variables in cancer survivors. Med Sci Sports Exerc 2002; 34:1863-7. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Butler L, Downe-Wamboldt B, Melanson P, et al. Prevalence, correlates and costs of patients with poor adjustment to mixed cancers. Cancer Nurs 2006; 29:9-16. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4:579-91. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Carlson LE, Garland S. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress, and fatigue. Int J Behav Med 2005; 12:27885";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Carpenter JS. Self-esteem and well-being among women with breast cancer and women in age-matched comparison group. J Psychosoc Oncol 1997; 15:59-80. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Cella D, Kallich J, McDermott A, Xu X. The longitudinal relationship of hemoglobin, fatigue and quality of life inanemic cancer patients: results from five randomized clinical trials. Ann Oncol 2004; 15:979-86. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Cintra JRD, Guerra MR, Bustamante-Teixeira MT. Sobrevida específica de pacientes com câncer de mama não-metastático submetidas à quimioterapia adjuvante. Rev Assoc Med Bras 2008; 54:339-46. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Chachaj A, Mayszczak K, Pyszel K, et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology 2010; 19:299-305. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Colditz GA, Sellers TA, Trapido E. Epidemiology - identifying the causes and preventability of cancer? Nat Rev Cancer 2006; 6:75-83. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Courneya KS. Exercise in cancer survivors: an overview of research. Med Sci Sports Exerc 2003; 35:1846-52. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Cronin KA, Twomey M, O'Reilly M, Carney DN. An unusual case of dyspnea in metastatic breast carcinoma. J Pain Symptom Manage 2011; 41:e1-3. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Culos-Reed N, Shields N, Brawley LR. Breast cancer survivors involved in vigorous team physical activity: psychosocial correlates of maintenance participation. Psychooncology 2005; 14:594-605. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Curado MP, Edwards HR, Shin HR, et al. Cancer incidence in five continents: volume IX. France: IARC; 2007. [IARC Scientific Publications, n.160].";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Daley AJ, Crank H, Saxton JM, Mutrie N, Coleman R, Roalfe A. Randomized trial of exercise therapy in women treated for breast cancer. J Clin Oncol 2007; 25:1713-21. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Daley A, Stokes-Lampard H, Wilson S, et al. What women want? Exercise preferences of menopausal women. Maturitas 2011; 68:174-8. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"De Angelis R, Tavilla A, Verdecchia A, et al. Breast cancer survivors in the United States: geographic variability and time trends, 2005-2015. Cancer 2009; 115:1954-66. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Debess J, Riis JØ, Pedersen L, Ewertz M. Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark. Acta Oncol 2009; 48:532-540. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"De Backer IC, Van Breda E, Vreugdenhil A, et al. High-intensity strength training improves quality of life in cancer survivors. Acta Oncol 2007; 46:1143-51. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Delgado-Guay M, Yennurajalingam S, Parsons H, Palmer JL, Bruera E. Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J Pain Symptom Manage 2011; 41:819-27. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;den Heijer M, Vos J, Seynaeve C, et al. The impact of social and personal resources on psychological distress in women atrisk for hereditary breast cancer. Psychooncology. 2010. [Epub ahead of print] ;
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"den Heijer M, Seynaeve C, Vanheusden K, et al. The contribution of selfesteem and self-concept in psychological distress in women at risk of hereditary breast cancer. Psychooncology 2011; 20:1170-5. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Dimeo FC. Effects of exercise on cancer-related fatigue. Cancer 2001; 92:1689-93. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Dolbeault S, Cayrou S, Bredart A, et al. The effectiveness of a psychoeducational group after early-stage breast cancer treatment: results of a randomized French study. Psychooncology 2009; 18: 647-56. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Dorn J, Vena J, Brasure J, et al. Lifetime physical activity and breast cancer risk in pre-and postmenopausal women. Med Sci Sports Exerc 2003; 35:278-85. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Duijts SF, Oldenburg HS, van Beurden M, Aaronson NK. Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment-induced menopause: design of a multicenter trial. BMC Womens Health 2009; 9:15. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Duijts SF, Faber MM, Oldenburg HS, van Beurden M, Aaronson NK. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors-a meta-analysis. Psychooncology 2011; 20:115-26. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Donavan KA, Small BJ, Andrykowski MA, Schimitt FA, Munster P, Jacobsen PB. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 2005; 104:2499-507. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Edwards AJ, Bacon TH, Elms CA, Verardi R, Felder M, Knight SC. Changes in the population of lymphoid cells in human peripheral blood following physical exercise. Clin Exp Immunol 1984; 58:420-7. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Emery CF, Yang HC, Frierson GM, Peterson LJ, Suh S. Determinants of physical activity among women treated for breast cancer in a 5- year longitudinal follow-up investigation. Psychooncology 2009; 18:377-86. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Esplen MJ, Stuckless N, Hunter J, et al. The BRCA selfconcept scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers. Psychooncology 2009; 18:1216-29. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Evangelista AL, Latorre MRDO, Ribeiro KCB, Mourão Neto M, Pizão PE. Variação da qualidade de vida em pacientes tratadas com câncer de mama e submetidas a um programa de exercícios aeróbios. RBM. Rev Bras Med (Rio de Janeiro) 2009; 66:200-6. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;Evangelista AL, Santos EM. Cluster of symptoms in women with breast cancer treated with curative intent. Supp Care Cancer 2011. [Epub ahead of print]. ;
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Eyigor S, Karapolat H, Yesil H, Uslu R, Durmaz B. Effects of pilates exercises on functional capacity, flexibility, fatigue, depression and quality of life in female breast cancer patients: a randomized controlled study. Eur J Phys Rehabil Med 2010; 46:481-7. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Effects of exercise training on fasting insulin, insulin resistance, insulin growth factors, and insulin-like growth factor binding proteins in post-menopausal breast cancer survivors: a randomized controlled Trial. Cancer Epidemiol Biomarkers Prev 2003; 12:721-7. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Fann JR, Thomas-Rich AM, Katon WJ, et al. Major depression after breast cancer: a review of epidemiology and treatment General Hospital. Psychiatry 2008; 30:112-26. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Fardell JE, Vardy J, Shah JD, Johnston IN. Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology 2012; 220:183-93. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18:581-92. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Field TS, Bosco JL, Prout MN, et al. Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer. J Am Coll Surg 2011; 213:757-65. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Florindo AA, Latorre MRDO, Jaime PC, Tanaka T, Zerbini F. Metodologia para a avaliação da atividade física habitual em homens com 50 anos ou mais. Rev Saúde Públ 2004; 38:307-14. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Fobair P, Stewart SL, Chang S, D'Onofrio C, Banks PJ, Bloom JR. Body image and sexual problems in young women with breast cancer. Psychooncology 2006; 15:579-94. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Friedenreich CM, Orestein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 2002; 132:3456S3464S. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Friedenreich CM, Cust AE. Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 2008; 42:636-47. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Galvão D, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol 2005; 23:899-909. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998; 16:501-14. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 2003; 21:4184-93. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011; 43:1334-59. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Garlick M, Wall K, Corwin D, Koopman C. Psycho-spiritual integrative therapy for women with primary breast cancer. J Clin Psychol Med Settings 2011; 18:78-90. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Gärtner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 2009; 302:1985-92. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Gilbody SM, House AO, Sheldon TA. Routinely administered questionnaires for depression and anxiety: systematic review. BMJ 2001; 322:406-9. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Gorisek B, Krajnc P, Krajnc I. Quality of life and the effect on social status among Slovenian women after breast cancer treatment. J Int Med Res 2009; 37:557-66. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Granai CO, Orr JW Jr. Improving breast care: providing, guiding, expertise, and leadership. Clin Obstet Gynecol 2011; 54:85-90. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to apain clinic. J Pain Symptom Manage 1994; 9:372-82. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Gross GJ, Ott CD, Lindsey AM, Twiss JJ, Waltman N. Postmenopausal breast cancer survivors at risk for osteoporosis: physical activity, vigor, and vitality. Oncol Nurs Forum 2002; 29:1295-300. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Guedes DP. Composição corporal: princípios, técnicas e aplicações. 2ª ed. Londrina: APEF; 1994.  ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Hack TF, Degner LF. Coping responses following breast cancer diagnosis predict psychological adjustment three years later. Psychooncology 2004; 13:235-47. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Harrison S, Hayes SC, Newman B. Level of physical activity and characteristics associated with change following breast cancer diagnosis and treatment. Psychooncology 2009; 18:387-94. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Hatam N, Ahmadloo N, Ahmad Kia Daliri A, Bastani P, Askarian M. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil). Arch Gynecol Obstet 2011; 284:215-20. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Helms RL, O'Hea EL, Corso M. Body image issues in women with breast cancer. Psychol Health Med 2008; 13:313-25. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Hong S, Bardwell A, Loki N, et al. Correlates of physical activity level in breast cancer survivors participating in the Women's Healthy Eating and Living (WHEL) Study. Breast Cancer Res Treat 2007; 101:225-32. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Hsu HT, Dodd MJ, Guo SE, Lee KA, Hwang SL, Lai YH. Predictors of exercise frequency in breast cancer survivors in Taiwan. J Clin Nurs 2011; 20:1923-35.";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Irwin ML, McTiernan A, Bernstein L, et al. Physical activity levels among breast cancer survivors. Med Sci Sports Exerc 2004; 36:1484-91. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Irwin ML, Alvarez-Reeves M, Cadmus L, et al. Exercise improves body fat, lean mass, and bone mass in breast cancer survivors. Obesity 2009; 17:1534-41. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Ivanauskiené R, Kregzdyte R, Padaiga Z. Evaluation of health-related quality of life in patients with breast cancer. Medicina 2010; 46:351-9. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Jackson AZ, Pollock ML, Ward A. Generalized equations for predicting body density for women. Med Sci Sports 1980; 12:175-81. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Jun EY, Kim S, Chang SB, Oh K, Kang HS, Kang SS. The effect of a sexual life reframing program on marital intimacy, body image, and sexual function among breast cancer survivors. Cancer Nurs 2011; 34:142-9.";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Kaltsatou A, Mameletzi D, Douka S. Physical and psychological benefits of a 24-week traditional dance program in breast cancer survivors. J Bodyw Mov Ther 2011; 15:162-7. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Karabulut N, Erci B. Sexual desire and satisfaction in sexual life affecting factors in breast cancer survivors after mastectomy. J Psychosoc Oncol 2009; 27:332-43.";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Key TI, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001; 2:133-40. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Kielhofner G. A model of human occupation: theory and application. 2nd ed. Baltimore: Williams & Wilkins; 1995.  ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Kim SH, Son BH, Hwang SY, et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manage 2008; 35:644-55. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Klee M, Groenvold M, Machin, D. Quality of life of danish women: populationbased norms for the EORTC QLQ-C30. Qual Life Res 1997; 6:27-34. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Knobf MT. Psychosocial responses in breast cancer survivors. Semin Oncol Nurs. 2007; 23:71-83. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Knobf MT. Clinical update: psychosocial responses in breast cancer survivors. Semin Oncol Nurs 2011; 27:e1-e14. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Knols RH, de Bruin ED, Shirato K, Uebelhart D, Aaronson NK. Physical activity interventions to improve daily walking activity in cancer survivors. BMC Cancer 2010; 10:406. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Kruger J, Yore MM, Kohl HW 3rd Leisure-time physical activity patterns by weight control status: 1999-2002 NHANES. Med Sci Sports Exerc 2007; 39:788-95. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2004; 111:762-71. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Lahmann PH, Schulz M, Hoffmann K et al. Long term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer 2005; 93:582-9. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Lankester KJ, Phillips JE, Lawton PA. Weight gain during adjuvant and neoadjuvant chemotherapy for breast cancer: An audit of 100 women receiving FEC or CMF chemotherapy. Clin Oncol (R Coll Radiol) 2002; 14: 64-7. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"LaStayo PC, Marcus RL, Dibble LE, Smith SB, Beck SL. Eccentric exercise versus usual-care with older cancer survivors: the impact on muscle and mobility--an exploratory pilot study. BMC Geriatr 2011; 11:5. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Lauridsen MC, Overgaard M, Overgaard J, Hessov IB, Cristiansen P. Shoulder disability and late symptoms following surgery for early breast cancer. Acta Oncol 2008; 47:569-75. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Lee IM. Physcal activity and cancer prevention- data from epidemiologic studies. Med Sci Sports Exerc 2003; 35:1823-7. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Lee J, Dibble SL, Pickett M, et al. Chemotherapy induced nausea-vomiting and functional status in women treated for breast cancer. Cancer Nurs 2005; 28:249-55. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Lee MK, Son BH, Hwang SY, et al. Factors affecting health-related quality of life in women with recurrent breast cancer in Korea. Qual Life Res 2007; 16:559-69. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Lee TS, Kilbreath SL, Refshauge KM, Herbert RD, Beith JM. Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat 2008; 110:19-37. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Lester J. Breast cancer in 2007: incidence, risk assessment and risk reduction strategies. Clin J Oncol Nurs 2007; 11:619-22. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Littman AJ, Tang MT, Rossing MA. Longitudinal study of recreational physical activity in breast cancer survivors. J Cancer Surviv 2010; 4:119-27. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Liu L, Marler MR, Parker BA, et al. The relationship between fatigue and light exposure during chemotherapy. Support Care Cancer 2005; 13:1010-7. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Loprinzi PD, Cardinal BJ. Effects of physical activity on common side effects of breast cancer treatment. Breast Cancer 2012; 19:4-10. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;Lorhisch C, Piccart M. Câncer de mama. In: Pollock RE, Doroshow JH, Khayat D, Nakao A, O'Sullivan B, editores. Manual de oncologia clínica da UICC. 8ª ed. São Paulo: Fundação Oncocentro de São Paulo, 2006. p. 50536. ;
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"MacKenzie DC, Kalda AL. Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol 2003; 21:463-6. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Martin M, Lluch A, Seguí MA, et al. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocytecolony stimulating factor to the TAC regimen. Ann Oncol 2006; 17:1205-12. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 2006; 175:34-41. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Medeiros MC, Veiga DF, Sabino Neto M, Abla LE, Juliano Y, Ferreira LM. Depression and conservative surgery for breast cancer. Clinics 2010; 65:1291-4. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Metcalfe KA, Foulkes WD, Kim-Sing C, et al. Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation. Clin Genet 2008; 73:474-9. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Miedema B, Hamilton R, Tatemichi S, et al. Do breast cancer survivors' postsurgery difficulties with recreational activities persist over time? J Cancer Surviv 2011; 5:405-12. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Min SY, Kim HY, Jung SY, et al. Oncological safety and quality of life associated with mastectomy and immediate breast reconstruction with a latissimus dorsi myocutaneous flap. Breast J 2010; 16:356-61. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Ministério da Saúde. Instituto Nacional de Câncer. Estimativa/2012 Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2011.  ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Mock V, Dow KH, Meares CJ, et al. Effects of exercise on fatigue, physical functioning and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997; 24:991-1000. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008; 29:27-32. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Mosher CE, Duhamel KN, Egert J, et al. Self-efficacy for coping with cancer in a multiethnic sample of breast cancer patients: associations with barriers to pain management and distress. Clin J Pain 2010; 26:227-34. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Moulder S, Hortobagyi GN. Advances in the treatment of breast cancer. Clin Pharmacol Ther 2008; 83:26-36. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Nahleh Z. Breast cancer, obesity and hormonal imbalance: a worrisome trend. Expert Rev Anticancer Ther 2011; 11:817-9. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Nelson JE, Meier DE, Oei EJ, et al. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 2001; 29:277-82. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Nesvold IL, Fosså SD, Naume B, Dahl AA. Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivors. Breast Cancer Res Treat 2009; 117:281-8. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Nesvold IL, Fosså SD, Holm I, Naume B, Dahl AA. Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncol 2010; 49:347-53. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Nesvold IL, Reinertsen KV, Fosså SD, Dahl AA. The relation between arm/shoulder problems and quality of life in breast cancer survivors: a crosssectional and longitudinal study. J Cancer Surviv 2011; 5:62-72. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Nieman DC. Exercise, upper respiratory infection and the immune system. Med Sci Sports Exerc 1994; 26:128-39. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"O'Donnell JF. Insomnia in cancer patients. Clin Cornerstone 2004; 6 suppl 1D:S6-14. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Ogce F, Ozkan S. Changes in functional status and physical and psychological symptoms in women receiving chemotherapy for breast cancer. Asian Pac J Cancer Prev 2008; 9:449-52. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Oldervoll LM, Kaasa S, Hjermstad MJ, Lund JA, Log JH. Physical exercise results in the improved subjective well-being of a few or is effective rehabilitation for all cancer patients? Eur J Cancer 2004; 40:951-62. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Ohnishi N, Kataoka T, Okamura H. Relationships between roles and mental states and role functional QOL in breast cancer outpatients. Jpn J Clin Oncol 2011; 41:1112-8. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Pandey M, Singh SP, Behere PB, Roy SK, Singh S, Shukla VK. Quality of life in patients with early and advanced carcinoma of the breast. Eur J Surg Oncol 2000; 26:20-4. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Parker PA, Youssef A, Walker S, et al. Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol 2007; 14:3078-89. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Pasacreta JV. Depressive phenomena, physical symptom distress, and functional status among women with breast cancer. Nurs Res 1997; 46:21421. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Patrick DL, Ferketich SL, Frame PS, et al. National Institutes of Health Stateof-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst Monogr 2004; (32):9-16. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Payne R, Medina E, Hampton JW. Quality of life concerns in patients with breast cancer: evidence for disparity of outcomes and experiences in pain management and palliative care among African-American women. Cancer 2003; 97:311-7. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Phillips K, Aldridge J, Ribi K, et al. Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial. Breast Cancer Res Treat 2011; 126: 221-6. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Phipps AI, Chlebowski RT, Prentice R, et al. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 2011; 20:454-63. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Pickett SC, Mock V, Ropka M, et al. Adherence to moderate-intensity exercise during breast cancer therapy. Cancer Pract 2002; 10:284-92. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Pinto BM, Maruyama NC, Clark MM, Cruess DG, Park E, Roberts M. Motivation to modify lifestyle risk behaviors in women treated for breast cancer. Mayo Clin Proc 2002; 77:122-9. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Pinto BM, Clark MM, Maruyama NC, Feder SI. Psychological and fitness changes associated with exercise participation among women with breast cancer. Psychooncology 2003; 12:118-26. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Pinto BM, Trunzo JJ. Body esteem and mood among sedentary and active breast cancer survivors. Mayo Clin Proc 2004; 79:181-6. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Pinto BM, Frieson GM, Rabin C, Trunzo JJ, Marcus BH. Home-based activity intervention for breast cancer patients. J Clin Oncol 2005; 23:3577-87. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Pitanga FJG, Lessa I. Prevalência e fatores associados ao sedentarismo no lazer em adultos. Cad Saúde Pública 2005; 21:870-7. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Porter LS, Keefe FJ. Psychosocial issues in cancer pain. Curr Pain Headache Rep 2011; 15:263-70. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Rahnama N, Nouri R, Rahmaninia, F. Damirchi A, Emami H. The effects of exercise training on maximum aerobic capacity, resting heart rate, blood pressure and anthropometric variables of postmenopausal women with breast cancer. J Res Med Sci 2010; 15:78-83. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Reddick BK, Nanda JP, Campbell L, Ryman DG, Gaston-Johansson F. Examining the influence of coping with pain on depression, anxiety, and fatigue among women with breast cancer. J Psychosoc Oncol 2005; 23:137-57. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 2008; 110:9-17. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Reid-Arndt SA, Yee A, Perry MC, et al. Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol 2009; 27:415-34. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 2011; 19:8537.";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Rietman JS, Dijkstra PU, Hoekstra HJ, et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 2003; 29:229-38. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Rietman JS, Geertzen JH, Hoekstra HJ, et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 2006; 32:148-52. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Rim A, Chellman-Jeffers M. Trends in breast cancer screening and diagnosis. Cleve Clin J Med 2008; 75(Suppl 1):S2-9. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Roehrs T, Roth T. Sleep disorders: an overview. Clin Cornerstone 2004; 6(Suppl 1C):S6-16. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Rogers LQ, Markwell SJ, Courneya KS, McAuley E, Verhulst S. Physical activity type and intensity among rural breast cancer survivors: patterns and associations with fatigue and depressive symptoms. J Cancer Surviv 2011; 5:54-61. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Roiland RA, Heidrich SM. Symptom clusters and quality of life in older adult breast cancer survivors. Oncol Nurs Forum 2011; 38:672-80. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Roundtree AK, Giordano SH, Price A, Suarez-Almazor ME. Problems in transition and quality of care: perspectives of breast cancer survivors. Support Care Cancer 2011; 19:1921-9. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Rumble M, Keefe F, Edinger JD, Affleck G, Marcom PK, Shaw HS. Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast cancer survivors: a daily process analysis. Sleep 2010; 33:1501-9. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Salles-Costa R, Heilborn ML, Werneck GL, Faerstein E, Lopes CS. Gênero e prática de atividade física de lazer. Cad Saúde Pública 2003; 19(Suppl 2):S325-S33. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Sagen A, Kåresen R, Sandvik L, Risberg MA. Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study. Acta Oncol 2009; 27:1111-8. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Segar ML, Katch VL, Roth RS, et al. The effect of aerobic on self-esteem and depressive and anxiety symptoms among breast cancer survivors. Oncol Nurs Forum 1998; 25:107-13. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Schilder CM, Seynaeve C, Beex WB, et al. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol 2010; 28:1294-300. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;Schilder CM, Seynaeve C, Linn SC, et al. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study. Psychooncology 2011. [Epub ahead of print]. ;
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Schmid-Buchi S, Halfens RJ, Dassen T, van den Borne B. A review of psychosocial needs of breast-cancer patients and their relatives. J Clin Nurs 2008; 17:2895-909. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Schmitz KH. Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors. Exerc Sport Sci Rev 2010; 38:17-24. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Schmitz K. Physical activity and breast cancer survivorship. Recent Results Cancer Res 2011; 186:189-215. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Schreier AM, Williams SA. Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer. Oncol Nurs Forum 2004; 31:127-30. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Shi J, Zhang M, Li L, et al. body mass index and its change in adulthood and breastcancer risk in China. Asian Pacific J Cancer Prev 2011; 11:1213-8. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Silva FA. Validação e reprodutibilidade de questionários de qualidade de vida específicos para câncer de mama. São Paulo; 2008. [Dissertação de Mestrado-Fundação Antônio Prudente]. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 2000; 62:613-22. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Speck RM, Gross CR, Hormes JM, et al. Changes in the body image and Relationship scale following a one-year strength training trial for breast cancer survivors with or at risk for lymphedema. Breast Cancer Res Treat 2010; 121:421-30. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Spence RR, Heesch KC, Brown WJ. Exercise and cancer rehabilitation: a systematic review. Cancer Treat Rev 2010; 36:185-94. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;Spector D, Battaglini C, Alsobrooks A, et al. Do Breast cancer survivors increase their physical activity and enhance their health-related quality of life after attending community-based wellness workshops? J Cancer Educ 2011. [Epub ahead of print]. ;
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Sprangers MAG, Groenvold M, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996; 14:2756-68. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Stanton AL, Ganz PA, Kwan L, et al. Outcomes from the moving beyond cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol 2005; 23:6009-18. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Staren ED, Gupta D, Braun DP. The prognostic role of quality of life assessment in breast cancer. Breast J 2011; 17:571-8. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Steinbach S, Hummel T, Böhner C, et al. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol 2009; 27:1899905. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Stevinson C, Lawlor DA, Fox KR. Exercise interventions for cancer patients: systematic review of controlled trials. Cancer Causes Control 2004; 15:1035-56. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Stone P, Richardson A, Ream E, et al. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol 2000; 11:971-5. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Theobald DE. Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin Cornerstone 2004; 6(Suppl 1D):S15-21. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Thorsen L, Skovlund E, Stromme SB, Hornslien K, Dahl AA, Fossa SD. Effectiveness of physical activity on cardiorespiratory fitness and healthrelated quality of life in young and middle-aged cancer patients shortly after chemotherapy. J Clin Oncol 2005; 23:2378-88. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, et al. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet 2007; 71:35-42. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Vilholm OJ, Cold S, Rasmussen L, Sindrup SH. The postmastectomy pain syndrome: an epidemiological study on the prevalence of chronic pain after surgery for breast cancer. Br J Cancer 2008; 99:604-10. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"[WHO]. World Health Organization. Development of the WHOQOL: rationale and current status. Int J Ment Health 1994; 23:24-56. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"[WHO]. The World Health Report 1998: life in the 21st century: a vision for all. Genebra: WHO; 1998.  ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Webber K, Mok K, Bennett B, et al. If I am in the mood, I enjoy it: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer. Oncologist 2011; 16:1333-44. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Winningham ML, Macvicar MG, Bondoc M, Anderson JI, Minton JP. Effect of aerobic exercise on body weight and composition in patients with breast cancer on adjuvant chemotherapy. Oncol Nurs Forum 1989; 16:683-9. ";
FAP;2012;ALEXANDRE LOPES EVANGELISTA;Erika Maria Monteiro Santos;Mário Mourão Netto;"Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology 2001; 10:19-28. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Abeti R, Abramov AY, Duchen MR. Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain 2011; 134:1658-72.";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 2001; 15:2177-96. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Adamec E, Vonsattel JP, Nixon RA. DNA strand breaks in Alzheimer's disease. Brain Res 1999; 849:67-77. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Alberini CM. Transcription factors in long-term memory and synaptic plasticity. Physiol Rev 2009; 89:121-45. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Aluise CD, Robinson RA, Beckett TL, et al. Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiol Dis 2010; 39:221-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Alzheimer's Association, Thies W, Bleiler L. Alzheimer's disease facts and figures. Alzheimers Dement 2011; 7:208-44. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Amé JC, Spenlehauer C, de Murcia G. The PARP super- family. Bioessays 2004; 26:882-93.";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Andjelkovic M, Alessi DR, Meier R, et al. Role of translocationin the activation and function of protein kinase B. J Biol Chem 1997; 272:31515-24. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Anderson AJ, Su JH, Cotman CW. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 1996; 16:1710-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;Angus SP, Nevins JR. A role for Mediator complex subunit MED13L in Rb/E2Finduced growth arrest. Oncogene 2012 [Epub ahead of print] ;
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Arendt T, Rödel L, Gärtner U, Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 1996; 7:3047-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Arendt T, Brückner MK, Mosch B, Lösche A. Selective cell death of hyperploid neurons in Alzheimer's disease. Am J Pathol 2010; 177:15-20. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Ashford JW. APOE genotype effects on Alzheimer's disease onset and epidemiology. J Mol Neurosci 2004; 23:157-65. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Avila J, Santa-Maria I, Perez M, Hernandez F, Moreno F. Tau phosphorylation, aggregation, and cell toxicity. J Biomed Biotechnol 2006; 2006:74539. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Avila J, Gómez de Barreda E, Engel T, et al. Tau kinase I overexpression induces dentate gyrus degeneration. Neurodegener Dis 2010; 7:13-5. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Aybek H, Ercan F, Aslan D, Sahiner T. Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset al.zheimer's disease in Denizli, Turkey. Clin Biochem 2007; 40:172-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421:499–506. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Balazs L, Leon M. Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem Res 1994; 19:1131-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Baldeiras I, Santana I, Proença MT, et al. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease. J Alzheimers Dis 2008; 15:11728 ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78:547-81. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bekris LM, Yu CE, Bird TD, Tsuang DW. Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol 2010; 23:213-27. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006; 66:1837-44. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bertram L, Lill CM, Tanzi RE. The genetics of Alzheimer disease: back to the future. Neuron 2010; 68:270-81. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Beukelaers P, Vandenbosch R, Caron N, Nguyen L, Moonen G, Malgrange B. Cycling or not cycling: cell cycle regulatory molecules and adult neurogenesis. Cell Mol Life Sci 2012; 69:1493-503. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bhatti S, Kozlov S, Farooqi AA, Naqi A, Lavin M, Khanna KK. ATM protein kinase: The linchpin of cellular defenses to stress. Cell Mol Life Sci 2011; 68:29773006. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bihaqi SW, Schumacher A, Maloney B, Lahiri DK, Zawia NH. Do epigenetic pathways initiate late onset al.zheimer disease (LOAD): towards a new paradigm. Curr Alzheimer Res 2012; 9:574-88. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Blacker D, Haines JL, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 1997; 48:139-47. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Boissonneault V, Plante I, Rivest S, Provost P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 2009; 284:1971-81. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bonda DJ, Baji? VP, Spremo-Potparevic B, et al. Review: cell cycle aberrations and neurodegeneration. Neuropathol Appl Neurobiol 2010; 36:157-63. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bosco EE, Mayhew CN, Hennigan RF, Sage J, Jacks T, Knudsen ES. RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult. Nucleic Acids Res 2004; 32:25-34. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bosetti F, Brizzi F, Barogi S, et al. Cytochrome c oxidase and mitochondrial F1F0ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging 2002; 23:371-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, et al. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 2001; 30:235-41. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82:239-59. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bradley MA, Markesbery WR, Lovell MA. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med 2010; 48:1570-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bradley MA, Xiong-Fister S, Markesbery WR, Lovell MA. Elevated 4hydroxyhexenal in Alzheimer's disease (AD) progression. Neurobiol Aging 2012; 33:1034-44. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Bradley WG, Polinsky RJ, Pendlebury WW, et al. DNA repair deficiency for alkylation damage in cells from Alzheimer's disease patients. Prog Clin Biol Res 1989; 317:715-32. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Brazil DP, Hemmings A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 2001; 26:657-64. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Burkle A, Brabeck C, Diefenbach J, Beneke S. The emerging role of poly (ADPribose) polymerase-1 in longevity. Int J Biochem Cell Biol 2005; 37:1043-53. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001; 276:42462-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Butterfield DA, Poon HF, St Clair D, et al. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer’s disease. Neurobiol Dis 2006a; 22:223-32. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Butterfield DA, Reed T, Perluigi M, et al. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci Lett 2006b; 397:170-3. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Cahoy JD, Emery B, Kaushal A, et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 2008; 28:264-78. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Campos AH, Aldred VL, Ribeiro KC, Vassallo J, Soares FA. Role of immunoexpression of nitric oxide synthases by Hodgkin and Reed-Sternberg cells on apoptosis deregulation and on clinical outcome of classical Hodgkin lymphoma. Mol Cell Biochem 2009; 321:95-102. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Cardoso SM, Proença MT, Santos S, Santana I, Oliveira CR. Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging 2004; 25:105-10. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Castellano JM, Kim J, Stewart FR, et al. Human apoE isoforms differentially regulate brain amyloid-? peptide clearance. Sci Transl Med 2011; 3:89ra57. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Cavallucci V, D'Amelio M, Cecconi F. A? toxicity in Alzheimer's disease. Mol Neurobiol 2012; 45:366-78. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Cecchi C, Fiorillo C, Sorbi S, et al. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free Radic Biol Med 2002; 33:1372-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Chaitanya GV, Steven AJ, Babu PP. PARP-1 cleavage fragments: signatures of celldeath proteases in neurodegeneration. Cell Commun Signal 2010; 8:31. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Chasseigneaux S, Dinc L, Rose C, et al. Secreted amyloid precursor protein beta and secreted amyloid precursor protein alpha induce axon outgrowth in vitro through Egr1 signaling pathway. PLoS One 2011; 6:e16301. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Chasseigneaux S, Allinquant B. Functions of A?, sAPP? and sAPP?: similarities and differences. J Neurochem 2012; 120(Suppl 1):99-108. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Chen F, David D, Ferrari A, Götz J. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals. Curr Drug Targets 2004; 5:503-15. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Chen D, Opavsky R, Pacal M, et al. Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a. PLoS Biol 2007; 5:e179. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Cheng C, Zochodne DW. Sensory neurons with activated caspase-3 survive longterm experimental diabetes. Diabetes 2003; 52:2363-71. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Cheng CJ, Mulholland DJ, Valamehr B, Mosessian S, Sellers WR, Wu H. PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression. Mol Cell Biol 2008; 28:3281-9.  ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Chia JY, Gajewski JE, Xiao Y, Zhu HJ, Cheng HC. Unique biochemical properties of the protein tyrosine phosphatase activity of PTEN-demonstration of different active site structural requirements for phosphopeptide and phospholipid phosphatase activities of PTEN. Biochim Biophys Acta 2010; 1804:1785-95.  ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Chiarugi A, Moskowitz MA. Poly(ADP-ribose) polymerase-1 activity promotes NFkappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem 2003; 85:306-17. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Chung JH, Eng C. Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res 2005; 65:8096-100. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Chouliaras L, Rutten BP, Kenis G, et al. Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog Neurobiol 2010; 90:498-510. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Cipriani G, Dolciotti C, Picchi L, Bonuccelli U. Alzheimer and his disease: a brief history. Neurol Sci 2011; 32:275-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, te Riele H. Requirement for a functional Rb-1 gene in murine development. Nature 1992; 359:328-30. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Cleaver JE. ?H2Ax: biomarker of damage or functional participant in DNA repair ‘‘all that glitters is not gold!’’. Photochem Photobiol 2011; 87:1230-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Cogswell JP, Ward J, Taylor IA, et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008; 14:27-41. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Cohen-Armon M, Visochek L, Rozensal D, et al. DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Mol Cell 2007; 25:297-308. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Cookson MR, Ince PG, Usher PA, Shaw PJ. Poly(ADP-ribose) polymerase is found in both the nucleus and cytoplasm of human CNS neurons. Brain Res 1999; 834:182-5.";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Copani A, Caraci F, Hoozemans JJ, Calafiore M, Sortino MA, Nicoletti F. The nature of the cell cycle in neurons: focus on a ""non-canonical"" pathway of DNA replication causally related to death. Biochim Biophys Acta 2007; 1772:409-12. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Copani A, Guccione S, Giurato L, et al. The cell cycle molecules behind neurodegeneration in Alzheimer's disease: perspectives for drug development. Curr Med Chem 2008; 15:2420-32. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Coppedè F, Migliore L. DNA damage and repair in Alzheimer's disease. Curr Alzheimer Res 2009; 6:36-47. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Culmsee C, Zhu X, Yu QS, et al. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J Neurochem 2001; 77:220-8.  ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Currais A, Hortobágyi T, Soriano S. The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease. Aging (Albany NY) 2009; 1:363-71. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Curti D, Rognoni F, Gasparini L, et al. Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients. Neurosci Lett 1997; 236:13-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Davis RE, Miller S, Herrnstadt C, et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset al.zheimer disease. Proc Natl Acad Sci USA 1997; 94:4526-31. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Day JJ, Sweatt JD. Epigenetic mechanisms in cognition. Neuron 2011; 70:813-29.";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"de La Monte SM, Sohn YK, Wands JR. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 1997; 152:73-83. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"de La Monte SM, Wands JR. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J Alzheimers Dis 2006; 9:167-81. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"de Murcia JM, Niedergang C, Trucco C, et al. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci U S A 1997; 94:7303-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Derheimer FA, Kastan MB. Multiple roles of ATM in monitoring and maintaining DNA integrity. FEBS Lett 2010; 584:3675-81. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Ding Q, Markesbery WR, Cecarini V, Keller JN. Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer’s disease. Neurochem Res 2006; 31:705-10. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Diniz M, Pereira CAB, Polpo A, Stern JM, Wechsler S. Relationship between Bayesian and frequentist significance indices. Int J Uncertainty Quantification 2012; 2:161-72. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Rad Biol Med 2002; 32:1102-15. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Dorszewska J, Florczak J, Rózycka A, Jaroszewska-Kolecka J, Trzeciak WH, Kozubski W. Polymorphisms of the CHRNA4 gene encoding the alpha4 subunit of nicotinic acetylcholine receptor as related to the oxidative DNA damage and the level of apoptotic proteins in lymphocytes of the patients with Alzheimer's disease. DNA Cell Biol 2005; 24:786-94. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Dorszewska J, Kempisty B, Jaroszewska-Kolecka J, et al. Expression and polymorphisms of gene 8-oxoguanine glycosylase 1 and the level of oxidative DNA damage in peripheral blood lymphocytes of patients with Alzheimer's disease. DNA Cell Biol 2009; 28:579-88. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Dragunow M, Faull RL, Lawlor P, et al. situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 1995; 6:1053-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Driscoll I, Troncoso J. Asymptomatic Alzheimer's disease: a prodrome or a state of resilience? Curr Alzheimer Res 2011; 8:330-5. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Eilam R, Peter Y, Elson A, et al. Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice. Proc Natl Acad Sci U S A 1998; 95:126536. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Eilam R, Peter Y, Groner Y, Segal M. Late degeneration of nigro-striatal neurons in ATM-/- mice. Neuroscience 2003; 121:83-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Evans TA, Raina, AK, Delacourte A. et al. BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease. Int J Med Sci 2007; 4:140-45. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Fang M, Wang J, Zhang X, et al. The miR-124 regulates the expression of BACE1/?secretase correlated with cell death in Alzheimer's disease. Toxicol Lett 2012; 209:94-105. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Farioli-Vecchioli S, Saraulli D, Costanzi M, et al. The timing of differentiation of adult hippocampal neurons is crucial for spatial memory. PLoS Biol 2008; 6:e24. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Ferguson KL, McClellan KA, Vanderluit JL, et al. A cell-autonomous requirement for the cell cycle regulatory protein, Rb, in neuronal migration. EMBO J 2005; 24:4381-91. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Fontán-Lozano A, Suárez-Pereira I, Horrillo A, del-Pozo-Martín Y, Hmadcha A, Carrión AM. Histone H1 poly[ADP]-ribosylation regulates the chromatin alterations required for learning consolidation. J Neurosci 2010; 30:13305-13. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Frank CL, Tsai LH. Alternative functions of core cell cycle regulators in neuronal migration, neuronal maturation, and synaptic plasticity. Neuron 2009; 62:312-26. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Fraser MM, Bayazitov IT, Zakharenko SS, Baker SJ. Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. Neuroscience 2008; 151:476-88. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Freeman DJ, Li AG, Wei G, et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 2003; 3:117-30. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Freude KK, Penjwini M, Davis JL, LaFerla FM, Blurton-Jones M. Soluble amyloid precursor protein induces rapid neural differentiation of human embryonic stem cells. J Biol Chem 2011; 286:24264-74. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Friesner JD, Liu B, Culligan K, Britt AB. Ionizing radiation-dependent gammaH2AX focus formation requires ataxia telangiectasia mutated and ataxia telangiectasia mutated and Rad3-related. Mol Biol Cell 2005; 16:2566-76 ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Furnari FB, Lin H, Huang H S, Cavenee W K. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 1997; 94:12479-84. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Gabbita SP, Lovell MA, Markesbery WR. Increased nuclear DNA oxidation in the brain in Alzheimer’s disease. J Neurochem 1998; 71: 2034-40. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Gackowski D, Rozalski R, Siomek A, et al. Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia. J Neurol Sci 2008; 266:57-62. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Gao C, Hölscher C, Liu Y, Li L. GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease. Rev Neurosci 2011; 23:1-11. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Gatz M, Reynolds CA, Fratiglioni L, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 2006; 63:168-74. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Geekiyanage H, Chan C. MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid ?, novel targets in sporadic Alzheimer's disease. J Neurosci 2011; 31:14820-30. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Genin E, Hannequin D, Wallon D, et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 2011; 16:903-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Gilman CP, Chan SL, Guo Z, Zhu X, Greig N, Mattson MP. p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults. Neuromol Med 2003; 3:159-72. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Gimm O, Perren A, Weng L P, et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol 2000; 156:1693-1700. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Glenner GG, Wong CW. Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984; 122:1131-5. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Goate A, Hardy J. Twenty years of Alzheimer's disease-causing mutations. J Neurochem 2012; 120 (Suppl 1):3-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Godbolt AK, Cipolotti L, Watt H, Fox NC, Janssen JC, Rossor MN. The natural history of Alzheimer disease: a longitudinal pre-symptomatic and symptomatic study of a familial cohort. Arch Neurol 2004; 61:1743-48. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006; 314:777-81. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Gómez de Barreda E, Pérez M, Gómez Ramos P, et al. Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits. Neurobiol Dis 2010; 37:622-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Greilberger J, Koidl C, Greilberger M, et al. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease. Free Radic Res 2008; 42:633-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Griffin RJ, Moloney A, Kelliher M, et al. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J Neurochem 2005; 93:105-117. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Grinberg LT, Ferretti RE, Farfel JM, et al. Brain bank of the Brazilian aging brain study group - a milestone reached and more than 1,600 collected brains. Cell Tissue Bank 2007; 8:151-62. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Guenette S, Chang Y, Hiesberger T, et al. Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development. EMBO J 2006; 25:42031. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. ATM activation by oxidative stress. Science 2010; 330:517-21. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Gulyaeva NV, Kudryashov IE, Kudryashova IV. Caspase activity is essential for long-term potentiation. J Neurosci Res 2003; 73:853-64. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59:1609-23. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Halliwell B, Gutteridge JMC. Free radicals in biology and medicine .4th ed. New York: Oxford University Press Inc; 2007. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Hampton MB, Fadeel B, Orrenius S. Redox regulation of the caspases during apoptosis. Ann N Y Acad Sci 1998; 854:328-35. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991; 12:383-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256:184-5. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297:353-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 2009; 41:1088-93. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Harrington EA, Bruce JL, Harlow E, Dyson N. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A 1998; 95:1194550. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Hartmann D, De Strooper B, Saftig P. Presenilin-1 deficiency leads to loss of CajalRetzius neurons and cortical dysplasia similar to human type 2 lissencephaly. Curr Biol 1999; 9:719-27. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Hayashi T, Shishido N, Nakayama K, et al. Lipid peroxidation and 4-hydroxy-2nonenal formation by copper ion bound to amyloid-beta peptide. Free Radic Biol Med 2007; 43:1552-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Hébert SS, Horré K, Nicolaï L, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A 2008; 105:6415-20. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Hermon M, Cairns N, Egly J-M, Fery A, Labudova O, Lubec G. Expression of DNA excision-repair-cross-complementing proteins p80 and p89 in brain of patients with Down Syndrome and Alzheimer’s disease. Neurosci Lett 1998; 251:45-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Herms J, Anliker B, Heber S, et al. Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J 2004; 23:4106-15. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Hernandez AI, Wolk J, Hu JY, et al.: Poly-(ADP- ribose) polymerase-1 is necessary for long-term facilitation in Aplysia. J Neurosci 2009; 29:9553-62. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Hernández-Ortega K, Quiroz-Baez R, Arias C. Cell cycle reactivation in mature neurons: a link with brain plasticity, neuronal injury and neurodegenerative diseases? Neurosci Bull 2011; 27:185-96. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Herrera E Jr, Caramelli P, Silveira AS, Nitrini R. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord 2002; 16:103-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Herrup K, Neve R, Ackerman SL, Copani A. Divide and die: cell cycle events as triggers of nerve cell death. J Neurosci 2004; 24:9232-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Herrup K, Yang Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci 2007; 8:368-78. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Herrup K. Reimagining Alzheimer's disease--an age-based hypothesis. J Neurosci 2010; 30:16755-62. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Holton JL, Ghiso J, Lashley T, et al. Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 2001; 158:515-26. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Holton JL, Lashley T, Ghiso J, et al. Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloidbeta. J Neuropathol Exp Neurol 2002; 61:254-67. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Homburg S, Visochek L, Moran N, et al. A fast signal-induced activation of Poly(ADP-ribose) polymerase: a novel downstream target of phospholipase C. J Cell Biol 2000; 150:293-307. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Hung LW, Ciccotosto GD Giannakis, E. et al. Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity. J Neurosci 2008; 28:11950-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Inoue Y, Kitagawa M, Taya Y. Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J 2007; 26:2083-93. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Iourov IY, Vorsanova SG, Liehr T, Yurov YB. Aneuploidy in the normal, Alzheimer’s disease and ataxia-telangiectasia brain: differential expression and pathological meaning. Neurobiol Dis 2009; 34:212-20. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Iourov IY, Vorsanova SG, Yurov YB. Genomic landscape of the Alzheimer's disease brain: chromosome instability--aneuploidy, but not tetraploidy--mediates neurodegeneration. Neurodegener Dis 2011; 8:35-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Isella V, Villa L, Russo A, Regazzoni R, Ferrarese C, Appollonio IM. Discriminative andpredictive power of an informant report in mildcognitive impairment. J Neurol Neurosurg Psychiatr 2006; 77:166-71. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 1992; 359:295-300. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Jacobsen E, Beach T, Shen Y, Li R, Chang Y. Deficiency of the Mre11 DNA repair complex in Alzheimer's disease brains. Brain Res Mol Brain Res 2004; 128:1-7. Jicha GA, Bowser R, Kazam IG, Davies P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 1997; 48:128-32.";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Jori FP, Napolitano MA, Melone MA, Cipollaro M, Cascino A, Giordano A, Galderisi U. Role of RB and RB2/P130 genes in marrow stromal stem cells plasticity. J Cell Physiol 2004; 200:201-12. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Jun G, Naj AC, Beecham GW, et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 2010; 67:1473-84. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Kauppinen TM. Multiple roles for poly (ADP-ribose) polymerase-1 in neurological disease. Neurochem Int 2007; 50:954-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005; 64:1152-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;[KEGG] Kyoto Encyclopedia of Genes and Genomes. Kegg pathway. Avaliable from: <URL:http://www.genome.jp/kegg> [2012 jan 12] ;
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Kerr F, Rickle A, Nayeem N, Brandner S, Cowburn RF, Lovestone S. PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3. FEBS Lett 2006; 580:3121-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Arch Gen Psychiatry 2004; 61:518-24. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Khan SM, Cassarino DS, Abramova NN, et al. Alzheimer’s disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann Neurol 2000; 48:14855. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Kim WY, Shen J. Presenilins are required for maintenance of neural stem cells in the developing brain. Mol Neurodegener 2008; 3:2 ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y, Taniguchi T. Changes of p53 in the brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 1997; 232:418-21. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I. Microtubuleassociated protein tau abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 1993; 268:24374-84. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Krantic S, Mechawar N, Reix S, Quirion R. Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci 2005; 28:670-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Krishnakumar R, Kraus WL. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell 2010; 39:8-24 ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;Kudryashov IE, Onufriev MV, Kudryashova IV, Gulyaeva NV. Periods of postnatal maturation of hippocampus: synaptic modifications and neuronal disconnection. Brain Res Dev Brain Res 2001: 132:113-20. ;
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Kudryashov IE, Yakovlev AA, Kudryashova I, Gulyaeva NV. Foot-shock stress alters early postnatal development of electrophysiological responses and caspase-3 activity in rat hippocampus. Neurosci Lett 2002; 332:95-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lachyankar MB Sultana, N Schonhoff CM et al. A role for nuclear PTEN in neuronal differentiation. J Neuroscience 2000; 20:1404-13. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lanni C, Racchi M, Mazzini G, et al. Conformationally altered p53: a novel Alzheimer's disease marker? Mol Psychiatry 2008; 13:641-7.  ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lanni C, Uberti D, Racchi M, Govoni S, Memo M. Unfolded p53: a potential biomarker for Alzheimer's disease. J Alzheimers Dis 2007; 12:93-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lai Y, Chen Y, Watkins SC, et al. Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury. J Neurochem 2008; 104:1700-11 ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lapucci A, Pittelli M, Rapizzi E, Felici R, Moroni F, Chiarugi A. Poly(ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription. Mol Pharmacol 2011; 79:932-40. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995; 89:35-41. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lauretto MS, Nakano F, Faria SR Jr, Pereira CA, Stern JM. A straight forward multiallelic significance test for the Hardy-Weinberg equilibrium law. Genet Mol Biol 2009; 32:619-25. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992; 359:288-94. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lee EY, Hu N, Yuan SS, Cox LA, Bradley A, Lee WH, Herrup K. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev 1994; 8:2008-21. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lee HG, Casadesus G, Zhu X, Joseph JA, Perry G, Smith MA. Perspectives on the amyloid-beta cascade hypothesis. J Alzheimers Dis 2004; 6:137-45. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lee SH, Kim I, Chung BC. Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease. Clin Biochem 2007; 40:936-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lee Y, McKinnon PJ. Responding to DNA double strand breaks in the nervous system. Neuroscience 2007; 145:1365-74. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;Leite F. Envelhecimento populacional e a composição etária de beneficiários de planos de saúde. [texto online]. 2011. Disponível em: <URL:http://www.iess.org.br/TDIESS00422011EnvelhecimentoFE.pdf>[2012 maio 12;
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lesné S, Koh MT, Kotilinek L, et al. A specific amyloid-beta protein assembly in the brain impairsmemory. Nature 2006; 440:352-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lezi E, Swerdlow RH. Mitochondria in neurodegeneration. Adv Exp Med Biol 2012; 942:269-86. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57:2124-29. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Li JC, Kaminskas E. Deficient repair of DNA lesions in Alzheimer's disease fibroblasts. Biochem Biophys Res Commun 1985; 129:733-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated inhuman brain, breast, and prostate cancer. Science 1997; 275:1943-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Liu JL, Mao Z, LaFortune TA, et al. Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade. Cancer Res 2007; 67:11054-63. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Long JM, Lahiri DK. MicroRNA-101 downregulates Alzheimer's amyloid-? precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 2011; 404:889-95. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lorenzo A, Yankner BA. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A 1994; 91:12243-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Love S, Barber R, Wilcock GK. Increased poly (ADP-ribosyl) ation of nuclear proteins in Alzheimer's disease. Brain 1999; 122:247-53. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lovell MA, Ehmann WD, Butler SM, Markesbury WR. Elevated thiobarbituric acidreactive substances and antioxidant enzyme activity in the brain in Alzheimer’s disease. Neurology 1995; 45:1594-601. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lovell MA, Gabbita SP, Markesbery WR. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J Neurochem 1999; 72:771-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lovell MA, Xie C, Markesbery WR. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic Biol Med 2000; 29:714-20. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lovell MA, Xie C, Markesbery WR. Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 2001; 22:18794. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer’s disease. Nucleic Acids Res 2007a; 35:7497-504. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lovell MA, Markesbery WR. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res 2007b; 85:3036-40. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lovell MA, Soman S, Bradley MA. Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech Ageing Dev 2011; 132:443-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lovestone S, Reynolds CH. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 1997; 78:309-24. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lowndes NF, Toh GW-L. DNA repair: The importance of phosphorylating histone H2AX. Curr Biol 2005; 15:R99-R102. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lucassen PJ, Chung WC, Kamphorst W, Swaab DF. DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol 1997; 56:887-900. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lucassen PJ, Chung WC, Vermeulen JP, et al. Microwave-enhanced in situ endlabeling of fragmented DNA: parametric studies in relation to postmortem delay and fixation of rat and human brain. J Histochem Cytochem 1995; 43:1163-71. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Lyras L, Cairns NJ, Jenner A, Jenner P, Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem 1997; 68:2061-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Mancuso M, Filosto M, Bosetti F, et al. Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Exp Neurol 2003; 182:421-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Mantamadiotis T, Lemberger T, Bleckmann SC, et al. Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 2002; 31:47-54. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Markesbery WR, Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer’s disease. Neurobiol Aging 1998; 19:33-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 2005; 58:7305. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Martin LJ, Liu Z, Pipino J, Chestnut B, Landek MA. Molecular regulation of DNA damage–induced apoptosis of neurons in cerebral cortex. Cereb Cortex 2009; 19:1273-93. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Martín-Aragón S, Bermejo-Bescós P, Benedí J, et al. Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease. Neurochem Res 2009; 34:373-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Martins RN, Harper CG, Stokes GB, et al. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer’s disease may reflect oxidative stress. J Neurochem 1986; 46:1042-45. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985; 82:4245-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Matsuoka S, Ballif BA, Smogorzewska A, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316:1160-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"McGahan L, Hakim AM, Robertson GS. Hippocampal Myc and p53 expression following transient global ischemia. Brain Res Mol Brain Res 1998; 56:133–45. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"McGrath LT, McGleenon BM, Brennan S, McColl D, McILroy S, Passmore AP. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM 2001; 94:485-90. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Mead S, James-Galton M, Revesz T, et al. Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings. Brain 2000; 123:975-91. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994; 36:747-51. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Mecocci P, Polidori MC, Ingegni T, et al. Oxidative damage to DNA in lymphocytes from AD patients. Neurology 1998; 51:1014-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Morrison RS, Kinoshita Y, Johnson MD, Guo W, Garden GA. p53- dependent cell death signaling in neurons. Neurochem Res 2003; 28:15–27. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S. Abeta-degrading enzymes in Alzheimer’s disease. Brain Pathol 2008; 18:240-52. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41:479-86. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Moh C, Kubiak JZ, Bajic VP, Zhu X, Smith MA, Lee HG. Cell cycle deregulation in the neurons of Alzheimer’s disease. Results Probl Cell Differ 2011; 53:565-76. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Moreira PI, Santos MS, Oliveira CR, et al. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 2008; 7:3-10. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Morris JC, McKeel DW Jr, Storandt M, et al. Verymild Alzheimer’s disease: informant-based clinical, psychometric and pathologic distinction from normalaging. Neurology 1991; 41:469-78. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Morsch R, Simon W, Coleman PD. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 1999; 58:188-97. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Mosch B, Morawski M, Mittag A, Lenz D, Tarnok A, Arendt T. Aneuploidy and DNA Replication in the Normal Human Brain and Alzheimer’s Disease. J Neurosci 2007; 27:6859-67. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Mullaart E, Boerrigter ME, Ravid R, Swaab DF, Vijg J. Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients. Neurobiol Aging 1990; 11:169-73. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Myung NH, Zhu X, Kruman II, et al. Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age (Dordr) 2008; 30:20915.";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Nagy Z. Cell cycle regulatory failure in neurones: causes and consequences. Neurobiol Aging 2000; 21:761-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Nakamura M, Shishido N, Nunomura A, et al. Three histidine residues of amyloidbeta peptide control the redox activity of copper and iron. Biochemistry 2007; 46:12737-43. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Nunomura A, Perry G, Pappolla MA, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease. J Neurosci 1999; 19:1959-64. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001; 60:759-67. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Nunomura A, Chiba S, Lippa CF, et al. Neuronal RNA oxidation is a prominent feature of familial Alzheimer’s disease. Neurobiol Dis 2004; 17:108-13. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Nunomura A, Tamaoki T, Motohashi N, et al. The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons. J Neuropathol Exp Neurol 2012; 71:233-41. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Oliveira DVNP. Avaliacão da expressão dos genes processadores de danos oxidativos em pacientes com Alzheimer. Ribeirão Preto; 2007. [Dissertação de Mestrado-Universidade de São Paulo].";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Ozcankaya R, Delibas N. Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: crosssectional study. Croat Med J 2002; 43:28-32. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2010; 469:6-10. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Palmer AM, Bums MA. Selective increase in lipid peroxidation in the inferiortemporal cortex in Alzheimer’ s disease. Brain Res 1994; 645:338-42. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Perren A, Weng L P, Boag A H, et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol 1999; 155:1253-60. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Pei JJ, Tanaka T, Tung Y-C, Braak E, Iqbal K, Grundke-Iqbal I. Distribution, levels and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 1997; 56:70-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Pei JJ, Braak E, Braak H, et al. Distribution of active glycogen syn- thase kinase 3? (GSK-3?) in brains staged for Alzheimer dis- ease neurofibrillary changes. J Neuropathol Exp Neurol 1999; 58:1010-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Pei JJ, Khatoon S, An WL, et al. Role of protein kinase B in Alzheimer's neurofibrillary pathology. Acta Neuropathol 2003; 105:381-92. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Pereira CAB, Nakano F, Stern JM, Whittle MR. Genuine Bayesian multiallelic significance test for the Hardy-Weinberg equilibrium law. Genet Mol Res 2006; 5:619-31. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Pereira CAB, Stern JM, Wechsler S. Can a significance test be a genuinely Bayesian? Bayesian Anal 2008; 3:79-100. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Pfaffl M. A new mathematical model for relative quantification in real-time RTPCR. Nucleic Acids Res 2001; 29:e45. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Pieper AA, Blackshaw S, Clements EE, et al. Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Proc Natl Acad Sci U S A 2000; 97:1845-50. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Pinto DM, Flaus A. Structure and function of histone H2AX. Subcell Biochem 2010; 50:55-78. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Pocernich CB, Butterfield DA. Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox Res 2003; 5:51520.";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol 1995; 45:358-68. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Price JL, McKeel DW Jr, Buckles VD, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 2009; 30:1026-36. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Raina AK, Zhu X, Rottkamp CA, Monteiro M, Takeda A, Smith MA. Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res 2000; 61:128-33. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Raina AK, Hochman A, Zhu X, et al. Abortive apoptosis in Alzheimer's disease. Acta Neuropathol 2001a; 101:305-10. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Raina AK, Zhu X, Monteiro M, Takeda A, Smith MA. Abortive oncogeny and cell cycle-mediated events in Alzheimer disease. Prog Cell Cycle Res 2001b; 4:235-42. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Raina AK, Zhu X, Smith MA. Alzheimer's disease and the cell cycle. Acta Neurobiol Exp (Wars) 2004; 64:107-12. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Revesz T, Holton JL, Lashley T, et al. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 2009; 118:115-30. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Rickle A, Bogdanovic N, Volkmann I, et al. PTEN levels in Alzheimer's disease medial temporal cortex. Neurochem Int 2006; 48:114-23. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Robison SH, Munzer JS, Tandan R, Bradley WG. Alzheimer's disease cells exhibit defective repair of alkylating agent-induced DNA damage. Ann Neurol 1987; 21:250-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Rogaeva E, Meng Y, Lee JH, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007; 39:168-77. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Rossi MN, Carbone M, Mostocotto C, et al. Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity. J Biol Chem 2009; 284:31616-24 ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, editors. Bioinformatics methods and protocols: methods in molecular biology. Totowa, NJ: Humana Press; 2000. p.36586. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Sano T, Lin H, Chen X, et al. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 1999; 59:1820-24. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 4Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997; 68:2092-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Schmetsdorf S, Gärtner U, Arendt T. Constitutive expression of functionally active cyclin-dependent kinases and their binding partners suggests noncanonical functions of cell cycle regulators in differentiated neurons. Cereb Cortex 2007; 17:1821-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Schonrock N, Ke YD, Humphreys D, et al. Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One 2010; 5:e11070. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Scovassi AI. Mitochondrial poly(ADP-ribosylation): from old data to new perspectives. FASEB J 2004; 18:1487-8 ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Sekler A, Jiménez JM, Rojo L, et al. Cognitive impairment and Alzheimer's disease: Links with oxidative stress and cholesterol metabolism. Neuropsychiatr Dis Treat 2008; 4:715-22. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Selkoe DJ. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 1997; 275:630-1. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 2001; 81:741-66. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Shan X, Tashiro H, Lin CL. The identification and characterization of oxidized RNAs in Alzheimer's disease. J Neurosci 2003; 23:4913-21. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Shankar GM, Li S, Mehta TH, et al. Amyloid-beta protein dimers isolated directlyfrom Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 2008; 14:837-42. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Shao C, Xiong S, Li GM, et al. Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer’s disease brain. Free Radic Biol Med 2008; 45:813-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Shen WH, Balajee AS, Wang J, et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 2007; 128:157-70. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Shiloh Y ATM and related protein kinases: safeguarding genome integrity. Nat Cancer Rev 2003; 3:155-68. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Simmons LK, May PC, Tomaselli KJ, et al. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 1994; 45:373-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Simpson JE, Ince PG, Haynes LJ, et al. Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer-type pathology in the ageing brain. Neuropathol Appl Neurobiol 2010; 36:25-40. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Smith MA, Casadesus G, Joseph JA, Perry G. Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med 2002; 33:1194-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Sng JC, Taniura H, Yoneda Y. A tale of early response genes. Biol Pharm Bull 2004; 27:606-12. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Soini Y, Puhakka A, Kahlos K, et al. Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1. Histopathology 2001; 39:179-86. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Sonoda Y, Mukai H, Matsuo K, et al. Accumulation of tumor-suppressor PTEN in Alzheimer neurofibrillary tangles. Neurosci Lett 2010; 471:20-4. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on AgingAlzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7:280-92. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidatetumour suppressor gene, MMAC1, at chromosome 10q23.3 that ismutated in multiple advanced cancers. Nat Genet 1997; 15:356-62. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002; 8:448-60. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord 2006; 20:112-7. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Strosznajder JB, Czapski GA, Adamczyk A, Strosznajder RP. Poly (ADP-ribose) Polymerase-1 in Amyloid Beta Toxicity and Alzheimer's Disease. Mol Neurobiol 2012; 46:78-84.";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Su JH, Deng G, Cotman CW. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain. Brain Res 1997; 774:193-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Subbarao KV, Richardson JS, Ang LC. Autopsy samples of Alzheimer’s cortex show increased peruxidation in vitro. J Neurochem 1990; 55:342-45. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Sultana R, Boyd-Kimball D, Poon HF, et al. Oxidative modification and downregulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiol Aging 2006; 27:918-25. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Sung YJ, Ambron RT. PolyADP-ribose polymerase-1 (PARP-1) and the evolution of learning and memory. Bioessays 2004; 26:1268-71. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Swerdlow RH, Khan SM. A ‘‘mitochondrial cascade hypothesis’’ for sporadic Alzheimer’s disease. Med Hypotheses 2004; 63:8-20. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Swerdlow RH. Pathogenesis of Alzheimer’s disease. Clin Interv Aging 2007; 2:347-59. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Swerdlow RH. Alzheimer's disease pathologic cascades: who comes first, what drives what. Neurotox Res 2012; 22:182-94. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Tamagno E, Bardini P, Obbili A, et al. Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 2002; 10:279-88. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Tamagno E, Parola M, Bardini P, et al. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem 2005; 92:628-36. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Tanaka T, Nishiyama Y, Okada K, et al. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion. Lab Invest 1997; 77:145-55. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Tang Y, Eng C. PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner. Cancer Res 2006; 66:736-42. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Te Koppele JM, Lucassen PJ, Sakkee AN, et al. 8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease. Neurobiol Aging 1996; 17:819-26. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Teunissen CE, de Vente J, Steinbusch HW, De Bruijn C. Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiol Aging 2002; 23:485-508. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Torres LL, Quaglio NB, de Souza GT, et al. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2011; 26:5968.";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Toyokuni S, Tanaka T, Hattori Y, et al. Quantitative immunohistochemical determination of 8-hydroxy-2’-deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76:365-74. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Townsend M, Mehta T, Selkoe DJ. Soluble A? inhib- its specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem 2007; 282:3330512. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Troncoso JC, Cataldo AM, Nixon RA, et al. Neuropathology of preclinical and clinical late-onset al.zheimer’s disease. Ann Neurol 1998; 43:673-6. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Udvardy A. The role of controlled proteolysis in cell-cycle regulation. Eur J Biochem 1996; 240:307-13. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP. Identification of a tumour suppressor network opposing nuclear Akt function. Nature 2006; 441:523-7 ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Trotman LC, Wang X, Alimonti A, et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007; 128:141-56. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Troy CM, Salvesen GS. Caspases on the brain. J Neurosci Res 2002; 69:145-50. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Tucker AM, Stern Y. Cognitive reserve in aging. Curr Alzheimer Res 2011; 8:35460. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Uberti D, Belloni M, Grilli M, Spano P, Memo M. Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids. Eur J Neurosci 1998; 10:246–54. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Uberti D, Carsana T, Bernardi E, Rodella L, Grigolato P, Lanni C et al. Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer’s disease patients. J Cell Sci 2002; 115:3131-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Uberti D, Lanni C, Carsana T, et al. Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer’s disease patients. Neurobiol Aging 2006; 27:1193-201. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2'-deoxyguanosine (8OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2009; 27:120-39. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Venkateshappa C, Harish G, Mahadevan A, Srinivas Bharath MM, Shankar SK. Elevated Oxidative Stress and Decreased Antioxidant Function in the Human Hippocampus and Frontal Cortex with Increasing Age: Implications for Neurodegeneration in Alzheimer's Disease. Neurochem Res 2012; 37:1601-14. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Visochek L, Steingart RA, Vulih-Shultzman I, et al. PolyADP-ribosylation is involved in neurotrophic activity. J Neurosci 2005; 25:7420-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Vincent I, Rosado M, Davies P. Mitotic mechanisms in Alzheimer's disease? J Cell Biol 1996; 132:413-25. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;[WHO] World Health Organization. ICD-10 classification of mental and behavioural disorders. Avaliable from: <URL:http://www.who.int/substance_abuse/terminology /icd_10/en/index.html> [2012 maio 12] ;
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Walsh DM, Selkoe DJ. Oligomers the brain: the emerging role of solubleprotein aggregates in neurodegeneration. Protein Pept Lett 2004; 11:213-28. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Walsh DM, Selkoe DJ. A beta oligomers - a decade of discovery. J Neurochem 2007; 101:1172-84. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Wang H, Yu SW, Koh DW, et al. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J Neurosci 2004; 24:10963-73. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer’s disease. J Neurochem 2005; 93:953-62.";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Wang J, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem 2006; 96:825-32. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Wang WX, Rajeev BW, Stromberg AJ, et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 2008; 28:1213-23. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Wang ZQ, Stingl L, Morrison C, et al. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev 1997; 11:2347-58. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81:32330. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Whang Y E, Wu X, Suzuki H, et al. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 1998; 95:5246-50. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Williams TI, Lynn BC, Markesbery WR, Lovell MA. Increased levels of 4hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer’s disease. Neurobiol Aging 2006; 27:1094-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Woodhouse BC, Dianov GL. Poly ADP-ribose polymerase-1: an international molecule of mystery. DNA Repair 2008; 7:1077-86. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yaari R, Corey-Bloom J. Alzheimer's disease. Semin Neurol 2007; 27:32-41. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yang J, Xu ZP, Huang Y, Hamrick HE, Duerksen-Hughes PJ, Yu YN. ATM and ATR: sensing DNA damage. World J Gastroenterol 2004; 10:155-60. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yang Y, Geldmacher DS, Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 2001; 21:2661-8. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yang Y, Mufson EJ, Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci 2003; 23:2557-63. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yang Y, Herrup K. Loss of neuronal cell cycle control in ataxia-telangiectasia:a unified disease mechanism. J Neurosci 2005; 25:2522-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yang Y, Varvel NH, Lamb BT, Herrup K. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J Neurosci 2006; 26:775-84. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yang Y, Herrup K. Cell division in the CNS: protective response or lethal event in post-mitotic neurons? Biochim Biophys Acta 2007; 1772:457-66. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yu SW, Wang H, Poitras MF, et al. Mediation of poly (ADP-ribose) polymerase-1dependent cell death by apoptosis-inducing factor. Science 2002; 297:259-63. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yu Y, Ren QG, Zhang ZH, et al. Phospho-Rb mediating cell cycle reentry induces early apoptosis following oxygen-glucose deprivation in rat cortical neurons. Neurochem Res 2012; 37:503-11. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000; 407:802-9. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yung TM, Satoh MS. Functional competition between poly(ADP-ribose) polymerase and its 24-kDa apoptotic fragment in DNA repair and transcription. J Biol Chem 2001; 276:11279-86. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Yurov YB, Vorsanova SG, Iourov IY. The DNA replication stress hypothesis of Alzheimer's disease. SciWorld J 2011; 11:2602-12. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Zana M, Janka Z, Kálmán J. Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease. Neurobiol Aging 2007; 28:648-76. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Zhu X, Raina AK, Perry G, Smith MA. Alzheimer disease, the two-hit hypothesis. Lancet Neurol 2004; 3:219-26. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Zhu X, Lee HG, Perry G, Smith MA. Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta 2007; 1772:494-502. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Zhu X, Castellani RJ, Moreira PI, et al. Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. Free Radic Biol Med 2012; 52:699-704. ";
FAP;2012;ANA CECÍLIA FEIO DOS SANTOS;Helena Brentani;Luiz Fernando Lima Reis;"Ziu M, Fletcher L, Rana S, Jimenez DF, Digicaylioglu M. Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury. PLoS One 2011; 6:e14724.";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;[ACS] American Cancer Society. Cancer facts e figures 2012. Available from: <URL:http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-031941.pdf> [2012 set 12] ;
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"[ATA] American Thyroid Association. Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19:1167-214. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Adeniran AJ, Zhu Z, Gandhi M, et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 2006; 30:216-22. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Agah A, Aghajan M, Mashayekhi F, et al. A multi-enzyme model for pyrosequencing. Nucleic Acids Res 2004; 32:e166. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Ahmadian A, Ehn M, Hober S. Pyrosequencing: history, biochemistry and future. Clin Chim Acta 2006; 363:83-94. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 2012; 367:705-15. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS. Thyroid cancer incidence patterns in the United States by histologic type, 1992–2006. Thyroid 2011; 21:125-34. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol 2008; 36:425-37. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Basolo F, Pisaturo F, Pollina LE, et al. N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression. Thyroid 2000; 10:19-23. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Belfiore A, Giuffrida D, La Rosa GL, et al. High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol 1989; 121:197202. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. GenBank. Nucleic Acids Res 2011; 39(Database issue):D32-7. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Bilimoria KY, Bentrem DJ, Ko CY, et al Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007; 246:375-81; discussion 381-4. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49:4682-9. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in a random adult population. Radiology 1991; 181:683-7. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Broderick DK, Di Ch, Parrett TJ, et al. Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas and medulloblastomas. Cancer Res 2004; 64:5048-50. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Bruneton JN, Balu-Maestro C, Marcy PY, Melia P, Mourou MY. Very high frequency (13 MHz) ultrasonographic examination of the normal neck: detection of normal lymph nodes and thyroid nodules. J Ultrasound Med 1994; 13:87-90. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Bruni P, Boccia A, Baldassarre G, et al. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1. Oncogene 2000; 19:3146-55. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Burns JS, Blaydes JP, Wright PA, et al. Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression. Mol Carcinog 1992; 6:129-39. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Campbell IG, Russell SE, Choong DY, et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 2004; 64:7678-81. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Cantara S, Capezzone M, Marchisotta S, et al. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 2010; 95:1365-9. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3kinase/AKT pathway. Proc Natl Acad Sci U S A 1999; 96:4240-5. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Castro P, Rebocho AP, Soares RJ, et al. PAX8-PPAR gamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 2006; 91:213-20. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Cibas ES, Ali SZ; NCI Thyroid FNA State of the Science Conference. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol 2009; 132:658-65. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Cantara S, Capezzone M, Marchisotta S, et al. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 2010; 95:1365-9. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Dahia PL, Marsh DJ, Zheng Z, et al. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 1997; 57:4710-3. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295:2164-7. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004. [WHO Classification of Tumours, v. 8; IARC WHO Classification of Tumours, nº 8] ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Di Cristofaro J, Marcy M, Vasko V, et al. Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of Nras mutation in codon 61 with follicular variant. Hum Pathol 2006; 37:824-30. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Durante C, Puxeddu E, Ferretti E, et al. BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab 2007; 92:2840-3. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC: Thyroid. AJCC cancer staging manual. 7ª ed. New York: SpringerVerlag; 2010 p 87-96. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Elisei R, Romei C, Vorontsova T, et al. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 2001; 86:3211-6. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Elisei R, Ugolini C, Viola D, et al. BRAF (V600E) mutation and outcome of patients with papillary thyroid carcinoma: a year median follow-up study. J Clin Endocrinol Metab 2008; 93:3943-9. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Espinosa AV, Porchia L, Ringel MD. Targeting BRAF in thyroid cancer. Br J Cancer 2007; 96:16-20. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Fagin JA. Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Mol Endocrinol 2002; 16:903-11. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Finley DJ, Lubitz CC, Wei C, Zhu B, Fahey TJ 3rd. Advancing the molecular diagnosis of thyroid noudles: defining benign lesions by molecular profiling. Thyroid 2005; 15:562-8. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"French CA, Alexander EK, Cibas ES, et al. Genetic and biological subgroups of low-stage follicular thyroid cancer. Am J Pathol 2003; 162:1053-60. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Frisk T, Foukakis T, Dwight T, et al. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer. Genes Chromosomes Cancer 2002; 35:74-80. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Fukushima T, Suzuki S, Mashiko M, et al. BRAF mutations in papillary carcinomas of the thyroid. Oncogene 2003; 22:6455-7. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Garcia-Rostan G, Zhao H, Camp RL, et al. Ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol 2003; 21:3226-35. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Gimm O, Perren A, Weng LP, et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue and benign and malignant epithelial thyroid tumors. Am J Pathol 2000; 156:1693-700. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Goellner JR, Gharib H, Grant CS, Johnson DA. Fine-needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol 1987; 31:587-90. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner JR. Long-term followup of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery 1989; 106:980-5; discussion 985-6. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Grieco M, Santoro M, Berlingieri MT, et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 1990; 60:557-63. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Guerra A, Sapio MR, Marotta V, Campanile E, Rossi S, Forno I, Fugazzola L, Budillon A, Moccia T, Fenzi G, Vitale M. The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. J Clin Endocrinol Metab 2012; 97(2):517-24";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Halachmi N, Halachmi S, Evron E, et al. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer 1998; 23:239-43. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002; 26:879-85. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Hegedus L. Clinical practice: the thyroid nodule. N Engl J Med 2004; 351:1764-71. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Hou P, Liu D, Shan Y, et al. Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res 2007; 13:1161-70. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;Howell GM, Nikiforova MN, Carty SE, et al. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann Surg Oncol 2012 Sep 1. [Epub ahead of print] ;
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Hu S, Ewertz M, Tufano RP, et al. Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. J Clin Endocrinol Metab 2006; 91:98-104. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Jo YS, Huang S, Kim YJ, et al. Diagnostic value of pyrosequencing for the BRAF(V600E) mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas. Clin Endocrinol 2009; 70:139-44. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Kebebew E, Weng J, Bauer J, Ranvier G, et al. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg 2007; 246:466-70; discussion 470-61. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Kim SK, Kim DL, Han HS, et al. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagn Mol Pathol 2008; 17:118-25. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signalling pathway in papillary thyroid carcinoma. Cancer Research 2003;63:1454-7. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Knauf JA, Ma X, Smith EP, et al. Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation. Cancer Res 2005; 65:4238-45. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006; 6:292-306. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Kroll TG, Sarraf P, Pecciarini L, et al. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science 2000; 289:1357-60. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Lazzereschi D, Mincione G, Coppa A, et al. Oncogenes and antioncogenes involved in human thyroid carcinogenesis. J Exp Clin Cancer Res 1997; 16:325-32. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Lee JW, Soung YH, Kim SY, et al. PIK3CA gene is frequently mutated in breast and hepatocellular carcinomas. Oncogene 2005; 24:1477-80. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Levine DA, Bogomolniy F, Yee CJ, et al. Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res 2005; 11:2875-8. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Liu Z, Hou P, Ji M, et al. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. J Clin Endocrinol Metab 2008; 93:3106-16. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Maciel RM, Kimura ET, Cerutti JM. Pathogenesis of differentiated thyroid cancer (papillary and follicular). Arq Bras Endocrinol Metabol 2005; 49(5):691-700.";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Manenti G, Pilotti S, Re FC, Della Porta G, Pierotti MA. Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas. Eur J Cancer 1994; 30A:987-93. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Marques AR, Espadinha C, Catarino AL, et al. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 2002; 87:3947-52. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2012 incidência de câncer no Brasil. Rio de Janeiro: INCA; 2011.  ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Namba H, Rubin SA, Fagin JA. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol Endocrinol 1990; 4:1474-9. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;[NCI] National Cancer Institute. SEER Cancer Statistics Review 1975-2009 (Vintage 2009 Populations). 2012. Avaliable from: <http://www.seer.cancer.gov/csr/1975_2009_pops09/index.html> [2012 set 12] ;
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE. PAX8- PPAR gamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 2002; 26:1016-23. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Nikiforova MN, Lynch RA, Biddinger PW, et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 2003; 88:2318-26. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Nikiforov YE, Steward DL, Robinson-Smith TM, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 2009; 94:2092-8. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 2011; 7:569-80. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011; 96:3390-7. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Nordstrom T, Alderborn A, Nyrén P. Method for one-step preparation of double-stranded DNA template applicable for use with Pyrosequencing technology. J Biochem Biophys Methods 2002; 52:71-82. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"O’Neill CJ, Bullock M, Chou A, et al. BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring preoperative surgery in patients with papillary thyroid cancer. Surgery 2010; 148:1139-45; discussion 1145-6. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Peyssonnaux C, Eychène A. The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell 2001; 93:53-62. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer 2005; 103:2261-8. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Ricarte-Filho JC, Ryder M, Chitale DA, et al. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res 2009; 69:4885-93. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Ringel MD, Hayre N, Saito J, et al. Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res 2001; 61:6105-11. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Rosai J, Carcangiu ML, De Lellis RA. Atlas of tumor pathology: tumors of the thyroid gland. Washington, D.C.: Armed Forces Institute of Pathology; 1992. [Third series, Fascicle 5, Atlas of tumor pathology]. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Rubino C, de Vathaire F, Dottorini ME, et al. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003; 89:1638-44. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Saal LH, Holm K, Maurer M, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res 2005; 65:2554-9. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992; 75:714-20. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004; 304:554. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Sanders LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 1998; 133:419-25. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Sansal I, Sellers WR. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 2004; 22:2954-63. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Santoro M, Carlomagno F, Hay ID, et al. Ret oncogene activation in human  hyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 1992; 89:1517-22. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Santoro M, Dathan NA, Berlingieri MT, et al. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Oncogene 1994; 9:509-16. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Shaha AR, Shah JP, Loree TR. Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg 1997; 174:474-6. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Shaha AR. Thyroid cancer: extent of thyroidectomy. Cancer Control 2000; 7:240-5. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol 2010; 22:395-404. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Stamataki M, Anninos D, Brountzos E, et al. The role of liquid-based cytology in the investigation of thyroid lesions. Cytopathology 2008; 19:11-8. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Sugg SL, Ezzat S, Zheng L, Freeman JL, Rosen IB, Asa SL Oncogene profile of papillary thyroid carcinoma. Surgery 1999; 125:46-52. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Trovisco V, Soares P, Sobrinho-Simoes M. B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas. Hum Pathol 2006; 37:781-6. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Vasko V, Ferrand M, Di Cristofaro J, Carayon P, Henry JF, de Micco C. Specific pattern of RAS oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab 2003; 88:2745-52. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Vasko V, Saji M, Hardy E, et al. Akt activation and localisation correlate with tumor invasion and oncogene expression in thyroid cancer. J Med Genet 2004; 41:161-70. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Wang Y, Hou P, Yu H, et al. High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors. J Clin Endocrinol Metab 2007; 92:2387-90. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Ward LS, Marrone M, Camargo RY, et al. Low-risk differentiated thyroid carcinoma-literature review and management guidelines. Arq Bras Endocrinol Metabol 2006; 50(3):550-7";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Weng LP, Gimm O, Kum JB, et al. Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Hum Mol Genet 2001; 10:251-8. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Werk EE Jr, Vernon BM, Gonzalez JJ, Ungaro PC, McCoy RC. Cancer in thyroid nodules. A community hospital survey. Arch Intern Med 1984; 144:474-6. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Wynford-Thomas D. Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms. Horm Res 1997; 47:145-57. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer 2005; 12:245-62. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007; 28:742-62. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer 1990; 65:1173-9. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Yang J, Schnadig V, Logorno R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 2007; 111:306-15. ";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Yip L, Nikiforova MN, Carty SE, et al. Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation. Surgery 2009; 146:1215-23.";
FAP;2012;ANDRÉ LOYOLA DUARTE;Victor Piana de Andrade;Renata de Almeida Coudry;"Zhu Z, Gandhi M, Nikiforova MN, Fischer AH, Nikiforov YE. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 2003; 120:71-7. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997; 16:3797-804. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Aoki K, Taketo MM. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci 2007; 120:3327-35. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Beckwith JB. Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center. Hum Pathol 1983; 14:481-92. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Beckwith JB. Precursor lesions of Wilms tumor: clinical and biological implications. Med Pediatr Oncol 1993; 21:158-68. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Beniers AJ, Efferth T, Fuzesi L, Granzen B, Mertens R, Jakse G. p53 expression in Wilms' tumor: a possible role as prognostic factor. Int J Oncol 2001; 18:133-9. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Beroud C, Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 1996; 24:121-4. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Bienz M, Hamada F. Adenomatous polyposis coli proteins and cell adhesion. Curr Opin Cell Biol 2004; 16:528-35. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Bilic J, Huang YL, Davidson G, et al. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 2007; 316:1619-22. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Birch JM, Alston RD, McNally RJ, et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 2001; 20:46218. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Birchmeier W, Hulsken J, Behrens J. Adherens junction proteins in tumour progression. Cancer Surv 1995; 24:129:40. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Breslow N, Beckwith JB, Ciol M, Sharples K. Age distribution of Wilms’ tumor: report from the National Wilms’ Tumor Study. Cancer Res 1988; 48:1653-7. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Buckley KS. Pediatric genitourinary tumors. Curr Opin Oncol 2011; 23:297302. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Ceschel S, Cassoto V, Valsecchi GM, et al. Survival after relapse in children with solid tumors: a follow up study from Italian off-therapy registry. Pediatr Blood Cancer 2006; 47:560-6. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Cheah PL, Looi LM, Chan LL. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia. Histopathology 1996; 28:49-54. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Corbin M, de Reyniès A, Rickman DS, et al. WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries? Genes Chromosomes Cancer 2009; 48:816-27. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Davies JA, Ladomery M, Hohenstein P, et al. Development of an siRNAbased method for repressing specific genes in renal organ culture and its use to show that the WT1 tumour suppressor is required for nephron differentiation. Hum Mol Genet 2004; 13:235-46. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"De Camargo B, de Oliveira Santos M, Rebelo MS, et al. Cancer incidence among children and adolescents in Brazil: first report of 14 population-based cancer registries. Int J Cancer 2010; 126:715-20. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Dehner LP. The evolution of the diagnosis and understanding of primitive and embryonic neoplasms in children: living through an epoch. Mod Pathol 1998; 11:669-85. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Dome JS, Coppes MJ. Recent advances in Wilms tumor genetics. Curr Opin Pediatr 2002; 14:5-11. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006; 101:385-98. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Grohmann A, Tanneberger K, Alzner A, Schneikert J, Behrens J. AMER1 regulates the distribution of the tumor suppressor APC between microtubules and the plasma membrane. J Cell Sci 2007; 120:3738-47. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Guertl B, Leuschner I, Guelly C, Ebner B, Kronberger C, Hoefler G. Is predisposition for nephroblastoma linked to polymorphisms of the WTX gene? Pathol Oncol Res 2010; 16:189-91. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Hanson CA, Miller JR. Non-traditional roles for the Adenomatous Polyposis Coli (APC) tumor suppressor protein. Gene 2005; 361:1-12. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Haruta M, Arai Y, Sugawara W, et al. Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities. Genes Chromosomes Cancer 2008; 47:71227. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Hastie ND. The genetics of Wilms tumor: a case of disrupted development. Annu Rev Genet 1994; 28:523-58. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Hastie ND. Life, sex, and WT1 isoforms--three amino acids can make all the difference. Cell 2001; 106:391-4. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281:1509-12. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Henderson BR, Fagotto F. The ins and outs of APC and ?-catenin nuclear transport. EMBO Rep 2002; 3:834-9. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Huff V. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer 2011; 11:111-21. Review. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Hurley JH, Grobler JA. Protein kinase C and phospholipase C: bilayer interactions and regulation. Curr Opin Struct Biol 1997; 7:557-65. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Jenkins ZA, van Kogelenberg M, Morgan T, et al. Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis. Nat Genet 2009; 41:95-100. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Kaneda A, Wang CJ, Cheong R, et al. Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk. Proc Natl Acad Sci U S A 2007; 104:20926-31.  ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Kaneko Y, Homma C, Maseki N, Sakurai M, Hata J. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors. Cancer Res 1991; 51:5937-42. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Kimelman D, Xu W. beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 2006; 25:7482-91. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer 2008; 8:387-98. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Koesters R, Ridder R, Kopp-Schneider A, et al. Mutational activation of the betacatenin proto-oncogene is a common event in the development of Wilms’ tumors. Cancer Res 1999; 59:3880-2. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;Koesters R, Niggli F, von Knebel Doeberitz M, Stallmach T. Nuclear accumulation of beta-catenin protein in Wilms’ tumours dagger. J Pathol 2003, 199:68-76. ;
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275:1784-7. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Kreidberg JA, Sariola H, Loring JM, et al. WT-1 is required for early kidney development. Cell 1993; 74:679-91. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Kusafuka T, Miao J, Kuroda S, Udatsu Y, Yoneda A. Codon 45 of the ?catenin gene, a specific mutational target site of Wilms’ tumor. Int J Mol Med 2002; 10:395-9. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Larsson SH, Charlieu JP, Miyagawa K, et al. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 1995; 81:391-401. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Li CM, Guo M, Borczuk A, et al. Gene expression in Wilms tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 2002; 160:2181-90. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Li W, Kessler P, Williams BR. Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia. Oncogene 2005; 24:457-68. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Little J. Epidemiology of childhood cancer. Lyon: International Agency for Research on Cancer, World Health Organization; 1999. Introduction; p.1-9. (IARC Scientific Publications nº 149). ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Loman NJ, Misra RV, Dallman TJ, et al. Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol 2012; 30:434-9. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Maiti R, Alam R, Amos CI, Huff V. Frequent Association of b-Catenin and WT1 Mutations in Wilms Tumors. Cancer Res 2000; 60:6288-92. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Major MB, Camp ND, Berndt JD, et al. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 2007; 316:1043-6. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Mannens M, Slater RM, Heyting C, et al. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet 1988; 81:41-8. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Maschietto M, De Camargo B, Brentani H, et al. Molecular profiling of isolated histological components of Wilms tumor implicates a common role for Wnt signaling pathways in the kidney development and in the tumor. Oncology 2008; 75:81-91. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Maschietto M, Trapé AP, Piccoli FS, et al. Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset. Cell Death Dis 2011; 2:e224. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Maw MA, Grundy PE, Millow LJ, et al. A third Wilms' tumor locus on chromosome 16q. Cancer Res 1992; 52:3094-8. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"McCartney BM, Näthke IS. Cell regulation by the Apc protein Apc as master regulator of epithelia. Curr Opin Cell Biol 2008; 20:186-93. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Messahel B, Williams R, Ridolfi A, et al. Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study. Eur J Cancer 2009; 45:819-26. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Miyaki M, Iijima T, Kimura J, et al. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 1999; 59:4506-9. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Moore AW, McInnes L, Kreidberg J, Hastie ND, Schedl A. YAC complementation shows a requirement for WT1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 1999; 126:1845-57. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Morin PJ, Sparks AB, Korinek V, et al. Activation of b-catenin–Tcf signaling in colon cancer by mutations in b-catenin or APC. Science 1997; 275:1787-90. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Moser AR, Dove WF, Roth KA, Gordon JI. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 1992; 116:1517-26. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Mrowka C, Schedl A. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features. J Am Soc Nephrol 2000; 11(Suppl 16):S106-15. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular b-catenin levels by the adenomatous polyposis coli (APC) tumorsupressor protein. Proc Natl Acad Sci USA 1995; 92:3046-50. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Neufeld KL, Zhang F, Cullen BR, White RL. APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep 2000; 1:519-23. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Niksic M, Slight J, Sanford JR, Caceres JF, Hastie ND. The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet 2004; 13:463-71. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012; 149:97993. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Nusse R. Cancer: converging on ?-Catenin in Wilms Tumor. Science 2007; 316:988-9. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smokingassociated cancers. Oncogene 2002; 21:7435-51. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Pfeifer GP, You YH, Besaratinia A. Mutations induced by ultraviolet light. Mut Res 2005; 571:19-31. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Pleasance ED, Cheetham KR, Stephens PJ, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010; 463, 191-6. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14:1837-51. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev 2007; 17:45-51. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Rivera MN, Haber DA. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 2005; 5:699-712. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Rivera MN, Kim WJ, Wells J, et al. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 2007; 315:642-5. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Rivera MN, Kim WJ, Wells J, et al. The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity. Proc Natl Acad Sci USA 2009; 106:8338-43. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Roberts SG. Transcriptional regulation by WT1 in development. Curr Opin Genet Dev 2005; 15:542-7. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Rong Y, Cheng L, Ning H, et al. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor. Cancer Res 2006; 66:804957. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Rosin-Arbesfeld R, Townsley F, Bienz M. The APC tumour suppressor has a nuclear export function. Nature 2000; 406:1009-12. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Rosin-Arbesfeld R, Cliffe A, Brabletz T, Bienz M. Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription. EMBO J 2003; 22:1101-13. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 1996; 272:1023-6. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997; 275:1790-2. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Ruteshouser EC, Robinson SM, Huff V. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. Genes Chromosomes Cancer 2008; 47:461-70. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Schedl A. Renal abnormalities and their developmental origin. Nat Rev Genet 2007; 8:791-802. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Schumacher V, Schneider S, Figge A, et al. Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci USA 1997; 94:3972-7. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Schwarz-Romond T, Fiedler M, Shibata N, et al. The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization. Nat Struct Mol Biol 2007; 14:484-92. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Scott RH, Douglas J, Baskcomb L, et al. Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat Genet 2008; 40:1329-34. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Skotnicka-Klonowicz G, Rieske P, Bartkowiak J, Szymik-Kantorowicz S, Daszkiewicz P, Debiec-Rychter M. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance. Eur J Surg Oncol 2000; 26:61-6. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences ofhumanbreast and colorectal cancers. Science 2006; 314:268-74. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Slater RM, Mannens MM. Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet Cytogenet 1992; 61:111-21. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998; 58:1130-4. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Sredni ST, Gadd S, Huang CC, et al. Subsets of very low risk Wilms tumor show distinctive gene expression, histologic, and clinical features. Clin Cancer Res 2009; 15:6800-9. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Steenman M, Redeker B, de Meulemeester M, et al. Comparative genomic hybridization analysis of Wilms tumors. Cytogenet Cell Genet 1997; 77:296303. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Sugiyama H. WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy. Jpn J Clin Oncol 2010; 40:377-87. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Tanneberger K, Pfister AS, Kriz V, Bryja V, Schambony A, Behrens J. Structural and functional characterization of the Wnt inhibitor APC membrane recruitment 1 (Amer1). J Biol Chem 2011; 286:19204-14. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398:422-6. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Tsuchiya T, Tamura G, Sato K, et al. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 2000; 19:3642-6. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Vainio S, Lin Y. Coordinating early kidney development: lessons from gene targeting. Nat Rev Genet 2002; 3:533-43. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Vajjhala PR, Macmillan E, Gonda T, Little M. The Wilms' tumour suppressor protein, WT1, undergoes CRM1-independent nucleocytoplasmic shuttling. FEBS Lett 2003; 554:143-8. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Wegert J, Wittmann S, Leuschner I, Geissinger E, Graf N, Gessler M. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact. Genes Chromosomes Cancer 2009; 48:1102-11. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998; 14:59-88. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Yashima K, Maitra A, Timmons CF, et al. Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis. Hum Pathol 1998; 29:536-42. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Yu P, Constien R, Dear N, et al. Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry. Immunity 2005; 22:451-65. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Zhang F, White RL, Neufeld KL. Phosphorylation near nuclear localization signal regulates nuclear import of adenomatous polyposis coli protein. Proc Natl Acad Sci USA 2000; 97:12577-82. ";
FAP;2012;BRUNA DURÃES DE FIGUEIREDO BARROS;Direce Maria Carraro;-x-;"Zhuang Z, Merino MJ, Vortmeyer AO, et al. Identical genetic changes in different histologic components of Wilms' tumors. J Natl Cancer Inst 1997; 89:1148-52. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Adachi Y, Hiramatsu S, Tokuda N, et al. Fatty acid-binding protein 4 (FABP4) and FABP5 modulate cytokine production in the mouse thymic epithelial cells. Histochem Cell Biol 2012; 138:397-406. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Allavena P, Mantovani A. Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin Exp Immunol 2012; 167:195-205. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Ayers SD, Nedrow KL, Gillilan RE, Noy N. Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4. Biochemistry 2007; 46:6744-52. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Barbour AP, Thomas J, Suffolk J, Beller E, Smithers BM. Isolated limb infusion for malignant melanoma: predictors of response and outcome. Ann Surg Oncol 2009; 16:3463-72. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Bedikian AY, Millward M, Pehamberger H, et al. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. J Clin Oncol 2006; 24:4738-45. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Biron-Shental T, Schaiff WT, Ratajczak CK, Bildirici I, Nelson DM, Sadovsky Y. Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol 2007; 197:516.e1-6. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Camacho LH, Antonia S, Sosman J, et al. Phase I/II trial of tremelimumab in patients with metastatic melanoma. J Clin Oncol 2009; 27:1075-81. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Carmeliet PL, Moons, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7:575-83. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Cha ST, Talavera D, Demir E, Nath AK, Sierra-Honigmann MR. A method of isolation and culture of microvascular endothelial cells from mouse skin. Microvasc Res 2005; 70:198-204. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364:2507-16. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Chen P, Wang SJ, Wang HB, et al. The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis. J Mol Histol 2012; 43:63-70. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Cornett WR, McCall LM, Petersen RP, et al. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol 2006; 24:4196-201. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"da Silva EN Jr, de Deus CF, Cavalcanti BC, et al. 3-arylamino and 3-alkoxy-norbeta-lapachone derivatives: synthesis and cytotoxicity against cancer cell lines. J Med Chem 2010; 53:504-8.  ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Deroose JP, Eggermont AM, van Geel AN, Verhoef C. Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha. Curr Opin Oncol 2011; 23:183-8. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Dong QG, Bernasconi S, Lostaglio S, et al. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler Thromb Vasc Biol 1997; 17:1599-604. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Ebnet K, Aurrand-Lions M, et al. The junctional adhesion molecule (JAM) family members JAM-2 and Jam-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity. J Cell Science 2003; 116:3679-91. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Elmasri H, Ghelfi E, Yu CW, et al. Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway. Angiogenesis 2012; 15:457-68. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Fang L, Wang Y, Du D,et al. Cell polarity protein Par3 complexes with DNA-PK via Ku70 and regulates DNA double-strand break repair. Cell Res 2007; 17:100-16. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J Clin Oncol 2007; 25:1606-20.  ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Francia G, Man S, Teicher B, Grasso L, Kerbel RS. Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents. Mol Cell Biol 2004; 24:6837-49. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Frongia C, Lorenzo C, Gianni F, Prevost GP, Ducommun B, Lobjois V. 3D imaging of the response to CDC25 inhibition in multicellular spheroids. Cancer Biol Ther 2009; 8:2230-36. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Gazzaniga S, Bravo AI, Guglielmotti A, et al. Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol 2007; 127:2031-41. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Gérard A, Mertens AE, van der Kammen RA, Collard JG. The Par polarity complex regulates Rap1- and chemokine-induced T cell polarization. J Cell Biol 2007; 176:863-75. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Ghosh S, Spagnoli GC, Martin I, et al. Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study. J Cell Physiol 2005; 204:522-31. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Gillilan RE, Ayers SD, Noy N. Structural basis for activation of fatty acid-binding protein 4. J Mol Biol 2007; 372:1246-60. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Gutman M, Sofer D, Lev-Chelouche D, Merimsky O, Klausner JM. Synergism of tumor necrosis factor-alpha and melphalan in systemic and regional administration: animal study. Invasion Metastasis 1997; 17:169-75. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Hayes AJ, Neuhaus SJ, Clark MA, Thomas JM. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma. Ann Surg Oncol 2007; 14:230-8. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Herrmann R, Fayad W, Schwarz S, Berndtsson M, Linder S. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids. J Biomol Screen 2008; 13:1-8. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Hersey P, Sosman J, O'Day S, et al. A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma. Cancer 2010; 116:1526-34. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Hida K, Hida Y, Shindoh M. Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies. Cancer Sci 2008; 99:459-66. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711-23. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Hong E, Jayachandran P, Brewster R. The polarity protein Pard3 is required for centrosome positioning during neurulation. Dev Biol 2010; 341:335-45. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Iden S, Rehder D, August B, et al. A distinct PAR complex associates physically with VE-cadherin in vertebrate endothelial cells. EMBO Rep 2006; 7:1239-46. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Ives NJ, Stowe RL, Lorigan P, Wheatley K. Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients. J Clin Oncol 2007; 25:5426-34. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Jensen TO, Schmidt H, Møller HJ, et al. Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. J Clin Oncol 2009; 27:3330-7. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Kabbarah O, Nogueira C, Feng B, et al. Integrative genome comparison of primary and metastatic melanomas."" PLoS One 2010; 5:e10770. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Kerbel RS, St Croix B, Florenes VA, Rak J. Induction and reversal of cell adhesiondependent multicellular drug resistance in solid breast tumors. Hum Cell 1996; 9:257-64. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Kirkwood JM, Tarhini AA, Panelli MC, et al. Next generation of immunotherapy for melanoma. J Clin Oncol 2008; 26:3445-55. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Kobayashi H, Man S, Graham CH, Kapitain SJ, Teicher BA, Kerbel RS. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci U S A 1993; 90:3294-8. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Kobayashi S, Ito E, Honma R, et al. Dynamic regulation of gene expression by the Flt-1 kinase and Matrigel in endothelial tubulogenesis. Genomics 2004; 84:185-92. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Kohn M, Steinbach P, Hameister H, Kehrer-Sawatzki H. A comparative expression analysis of four MRX genes regulating intracellular signalling via small GTPases. Eur J Hum Genet 2004; 12:29-37. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Kroon HM, Moncrieff M, Kam PC, Thompson JF. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients. Ann Surg Oncol 2009; 16:1184-92. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Lejeune FJ, Rüegg C. Recombinant human tumor necrosis factor: an efficient agent for cancer treatment. Bull Cancer 2006; 93:E90-100. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Li L, Xu H, Spaulding BO, et al. Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors. Hum Pathol 2008; 39:1205-11. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Lima VCC. Análise do perfil de expressão gênica em melanomas cutâneos malignos murinos após tratamento sistêmico com o fator de necrose tumoral (TNF) associado ou não a melfalano (MEL). São Paulo; 2007. [Tese de Doutorado-Fundação Antônio Prudente]. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Liu RZ, Li X, Godbout R. A novel fatty acid-binding protein (FABP) gene resulting from tandem gene duplication in mammals: transcription in rat retina and testis. Genomics 2008; 92:436-45. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Lorigan P, Eisen T, Hauschild A. Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future? Exp Dermatol 2008; 17:383-94. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem 2005; 280:12888-95. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Marrero B, Messina JL, Heller R. Generation of a tumor spheroid in a microgravity environment as a 3D model of melanoma. In Vitro Cell Dev Biol Anim 2009; 45:523-34. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"McDermott DF, Sosman JA, Gonzalez R, et al. Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group. J Clin Oncol 2008; 26:2178-85. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Menendez D, Krysiak O, Inga A, Krysiak B, Resnick MA, Schönfelder G. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network. Proc Natl Acad Sci U S A 2006; 103:1406-11. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Menon C, Ghartey A, Canter R, Feldman M, Fraker DL. Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin. Ann Surg 2006; 244:781-91. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Mentrikoski MJ, Ma L, Pryor JG, et al. Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes. Mod Pathol 2009; 22:15827. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Middleton MR, Grob JJ, Aaronson N, et al. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000; 18:158-66. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Min W, Ghosh S, Lengyel P. The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities. Mol Cell Biol 1996; 16:359-68. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Ministério da Saúde. Instituto Nacional de Câncer. Estimativa/2012: incidência do câncer no Brasil. Rio de Janeiro: INCA; 2011. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Mizuno K, Suzuki A, Hirose T, et al. Self-association of PAR-3-mediated by the conserved N-terminal domain contributes to the development of epithelial tight junctions. J Biol Chem 2003; 278:31240-50. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Mocellin S, Provenzano M, Rossi CR, et al. Induction of endothelial nitric oxide synthase expression by melanoma sensitizes endothelial cells to tumor necrosis factor-driven cytotoxicity. Clin Cancer Res 2004; 10:6879-86. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Mocellin S, Rossi CR, Pilati P, Nitti D. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev 2005; 16:35-53. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Nagy A, Armatis P, Cai RZ, Szepeshazi K, Halmos G, Schally AV. Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. Proc Natl Acad Sci U S A 1997; 94:652-6. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Nashan D, Müller ML, Grabbe S, Wustlich S, Enk A. Systemic therapy of disseminated malignant melanoma: an evidence-based overview of the state-of-theart in daily routine. J Eur Acad Dermatol Venereol 2007; 21:1305-18. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Nodé-Langlois R, Muller D, Boda B. Sequential implication of the mental retardation proteins ARHGEF6 and PAK3 in spine morphogenesis. J Cell Sci 2006; 119(Pt 23):4986-93. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Panchanathan R, Duan X, Arumugam M, Shen H, Liu H, Choubey D. Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE. Mol Immunol 2011; 49:27380. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Pectasides D, Dafni U, Bafaloukos D, et al. Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected highrisk melanoma. J Clin Oncol 2009; 27:939-44. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Pfaffl MW. A new mathematical model for relative quantification in real-time RTPCR. Nucleic Acids Res 2001; 29:e45. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Rosenberger G, Gal A, Kutsche K. AlphaPIX associates with calpain 4, the small subunit of calpain, and has a dual role in integrin-mediated cell spreading. J Biol Chem 2005; 280:6879-89. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Rossi CR, Russano F, Mocellin S, et al. TNF-based isolated limb perfusion followed by consolidation biotherapy with systemic low-dose interferon alpha 2b in patients with in-transit melanoma metastases: a pilot trial. Ann Surg Oncol 2008; 15:121823. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Rowinsky EK. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J Clin Oncol 2005; 23:9394-407. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Ruggiero V, Latham K, Baglioni C. Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells. J Immunol 1987; 138:2711-7. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;[SEER] Surveillance, Epidemiology and End Results. SEER Cancer Statistics Review 1975-2009 (Vintage 2009 Populations). Updated August 20, 2012. Avaliable from: <URL:http://seer.cancer.gov/csr/1975_2009_pops09/index.html> [2012 agos 25] ;
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Sanki A, Kam PC, Thompson JF. Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology. Ann Surg 2007; 245:591-6. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Schwartzentruber DJ, Lawson DH, Richards JM, et al. gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med 2011; 364:211927. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett 2008; 267:204-15. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Singh N, Jani PD, Suthar T, Amin S, Ambati BK. Flt-1 intraceptor induces the unfolded protein response, apoptotic factors, and regression of murine injury-induced corneal neovascularization. Invest Ophthalmol Vis Sci 2006; 47:4787-93. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Sondak VK, Smalley KS, Kudchadkar R, Grippon S, Kirkpatrick P. Ipilimumab. Nat Rev Drug Discov 2011; 10:411-2. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Stroka KM, Vaitkus JA, Aranda-Espinoza H. Endothelial cells undergo morphological, biomechanical, and dynamic changes in response to tumor necrosis factor-?. Eur Biophys J 2012; 41:939-47. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Szanto A, Balint BL, Nagy ZS, et al. STAT6 transcription factor is a facilitator of the nuclear receptor PPARgamma-regulated gene expression in macrophages and dendritic cells. Immunity 2010; 33:699-712. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Szarvas T, Dorp FV, Niedworok C, et al. High insulin-like growth factor mRNAbinding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer. BJU Int 2012; 110:E308-17. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Takenaka K, Katakura H, Chen F, et al. The ratio of membrane-bound form Flt-1 mRNA to VEGF mRNA correlates with tumor angiogenesis and prognosis in nonsmall cell lung cancer. Cancer Lett 2007; 246:34-40. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Trinh VA. Current management of metastatic melanoma. Am J Health Syst Pharm 2008; 65(Suppl 9):S3-8. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Tsuda M, Inoue-Narita T, Suzuki A, Itami S, Blumenberg M, Manabe M. Induction of gene encoding FABP4 in Pten-null keratinocytes. FEBS Lett 2009; 583:1319-22. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Walter O, Prasad M, Lu S, Quinlan RM, Edmiston KL, Khan A. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. Hum Pathol 2009; 40:1528-33. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"van Horssen R, Ten Hagen TL, Eggermont AM. TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 2006; 11:397408. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Venetsanakos E, Mirza A, Fanton C, Romanov SR, Tlsty T, McMahon M. Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells. Exp Cell Res 2002; 273:21-33. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Wang T, Ge Y, Xiao M, et al. Melanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature. Pigment Cell Melanoma Res 2012; 25:493-505. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Wang Y, Du D, Fang L, et al. Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling. EMBO J 2006; 25:5058-70. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Weber J. Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010). Oncologist 2008; 13(Suppl 4):16-25. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Wong C, Vosburgh E, Levine AJ, Cong L, Xu EY. Human neuroendocrine tumor cell lines as a three-dimensional model for the study of human neuroendocrine tumor therapy. J Vis Exp 2012; (66)e:4218. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Xin H, D'Souza S, Jørgensen TN, et al. Increased expression of Ifi202, an IFNactivatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis. J Immunol 2006; 176:5863-70. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Yamamoto A, Kumakura S, Uchida M, Barrett JC, Tsutsui T. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone. Int J Cancer 2003; 106:301-9. ";
FAP;2012;CARLOS FREDERICO LOPES BENEVIDES;Vladmir Cláudio Cordeiro de Lima;-x-;"Zito CR, Kluger HM. Immunotherapy for metastatic melanoma. J Cell Biochem 2012; 113:725-34. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11:155-68.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Allred DC, Wu Y, Mao S, et al. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 2008; 14:370-8. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Amari M, Moriya T, Ishida T, et al. Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast. Jpn J Clin Oncol 2003; 33:556-62. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"André F, Michiels S, Dessen P, et al. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis. Lancet Oncol 2009; 10:381-90.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Bacus SS, Gudkov AV, Esteva FJ, Yarden Y. Expression of erb-B receptors and their ligands in breast cancer: implications to biological behavior and therapeutic response. Breast Dis 2000; 11:63-75. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM. Pro-gesterone receptor status signi?cantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol 2003; 21:1973-9.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Benchekroun M, DeGraw J, Gao J,et al. Impact of fixative on recovery of mRNA from paraffin-embedded tissue. Diagn Mol Pathol 2004; 13:116-25.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Bergamaschi A, Kim YH, Wang P, et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 2006; 45:1033-40.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Bindra RS, Glazer PM. Genetic instability and the tumor micro-environment: towards the concept of microenvironment-induced mutagenesis. Mutat Res 2005; 569:75-85.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol 2011; 223:307-17.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Brasky SH, Karlin NJ. Myoepithelial cells: autocrine and paracrine suppressors of breast progression. J Mammary Gland Biol Neoplasia 2005; 10:249-60.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Bret C, Moreaux J, Schved JF, Hose D, Klein B. SULFs in human neoplasia:implication as progression and prognosis factors. J Transl Med 2011; 21:9:72. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med 2004; 350:1430-41. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;Cancer Research UK. Invasive ductal breast cancer. Avaliable from: <URL:http://cancerhelp.cancerresearchuk.org/type/breast-cancer/about/type /invasive-ductal-breast-cancer> [2012 jun 12] ;
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Carraro DM, Ferreira EN, de Campos Molina G, et al.Poly (A)+ transcriptome assessment of ERBB2-induced alterations in breast cell lines. PLoS One 2011; 6:e21022.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Castro NP, Osorio CA, Torres C, et al. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res 2008; 10:R87. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Chang BH, Chan L. Regulation of Triglyceride Metabolism. III. Emerging role of lipid droplet protein ADFP in health and disease. Am J Physiol Gastrointest Liver Physiol 2006; 292:G1465-8. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Cheang MC, Voduc D, Bajdik C, et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 2008; 14:1368-76.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Cianfrocca M, Gradishar W. New molecular classifications of breast cancer. CA Cancer J Clin 2009; 59:303-13.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Clark SE, Warwick J, Carpenter R, Bowen RL, Duffy SW, Jones JL. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in preinvasive disease. Br J Cancer 2011; 104:120-7.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Colot V, Rossignol JL. Eukaryotic DNA methylation as an evolutionary device. Bioessays 1999; 21:402-11. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Come SE, Buzdar AU, Arteaga CL, et al. Second international conference on recent advances and future directions in endocrine manipulation of breast cancer: summary consensus statement. Clin Cancer Res 2003; 9:443S-6S. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Conforti-Froes NDT, Rossit A. Susceptibilidade genética, biometabolismo e câncer. Rev Soc Bras Cancerol 2000; 10 26-31. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Curtis C, Shah SP, Chin SF, et al. The genomic and transcriptomicarchitecture of 2,000 breast tumours reveals novel subgroups. Nature 2012; 486:346-52.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Delaney G, Ung O, Bilous M, Cahill S, Greenberg ML, Boyages J. Ductal carcinoma in situ. Part I: definition and diagnosis. Aust NZ J Surg 1997; 67:81-93. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Di Cosimo S, Baselga J. Management of breast cancer with targeted agents:importance of heterogeneity. Nat Rev Clin Oncol 2010; 7:139-47.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"DiGiovanna MP, Chu P, Davison TL, et al. Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlates. Cancer Res 2002; 62:6667-73.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Dube P, Herzog F, Gieffers C et al. Localization of the coactivator Cdh1 and the cullin subunit Apc2 in a cryo-electron microscopy model of vertebrate APC/C. Mol Cell 2005; 20:867-79.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Eisenberg ALM, Koifman S. Câncer de Mama : Marcadores Tumorais. Ver Bras Cancerol 2001; 47:377-88.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Erbas B, Provenzano E, Armes J, Gertig D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 2006; 97:135-44.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Erler JT, Giaccia AJ. Lysyl oxidase mediates hypoxic control of metastasis. Cancer Res 2006; 66:10238-41.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Ernster VL, Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr 1997; (22):151-6.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Espina V, Liotta LA. What is the malignant nature of human ductal carcinoma in situ? Nat Rev Cancer 2011; 11:68-75.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Faverly DR, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994; 11:193-8.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Ferreira EN, Galante PA, Carraro DM, de Souza SJ. Alternative splicing: a bioinformatics perspective. Mol Biosyst 2007; 3:473-7.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Ferreira EN, Maschietto M, Silva SD, Brentani H, Carraro DM. Evaluation of quantitative rt-PCR using nonamplified and amplified RNA. Diagn Mol Pathol 2010a; 19:45-53.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Ferreira EN, Rangel MC, Galante PF, et al. Alternative splicing enriched cDNA libraries identify breast cancer-associated transcripts. BMC Genomics 2010b; 11:S4.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3:453-8.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 2001; 28:400-18.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Frye CA. An overview of oral contraceptives: mechanism of action and clinical use. Neurology 2006 Mar 28;66. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Gage M, Wattendorf D, Henry LR. Translational advances regarding hereditary breast cancer syndromes. J Surg Oncol 2012; 105:444-51.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003; 21:1624-36. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Gonzalez ME, Peterson EA, Privette LM, Loffreda-Wren JL, Kalikin LM, Petty EM. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res 2007; 67:8554-64. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Hall MC, Torres MP, Schroeder GK, Borchers CH. Mnd2 and Swm1 are core subunits of the Saccharomyces cerevisiae anaphase-promoting complex. J Biol Chem 2003; 278:16698-705. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med 2010; 134:e4872.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Hannemann J, Velds A, Halfwerk JB, Kreike B, Peterse JL, van de Vijver MJ. Classification of ductal carcinoma in situ by gene expression profiling. Breast Cancer Res 2006; 8:R61.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007; 25:5287-312.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Hill AD, Doyle JM, McDermott EW, O'Higgins NJ. Hereditary breast cancer. Br J Surg 1997; 84:1334-9. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Hood FE, Royle SJ. Functional equivalence of the clathrin heavy chains CHC17 and CHC22 in endocytosis and mitosis. J Cell Sci 2009; 122(Pt 13):2185-90. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Hu M, Yao J, Carroll DK, et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008; 13:394-406. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Hu X, Stern HM, Ge L, et al. Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol Cancer Res 2009; 7:511-22. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Huang F, Khvorova A, Marshall W, Sorkin A. Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference. J Biol Chem 2004; 279:16657-61.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Hynes NE, Lane HA. ERBB receptors and cancer: inhibitors. Nat Rev Cancer 2005; 5:341-54. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Hynes NE, Macdonald G. ErbB receptors and signaling pathways in cancer. Current Opinion in Cell Biology 2009; 21:1-8. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Jensen EV, Jordan VC. The estrogen receptor: a model for molecular medicine. Clin Cancer Res 2003; 9:1980-9. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Kao J, Salari K, Bocanegra M, et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. Plos One 2009; 4:e6146. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Kedra D, Peyrard M, Fransson I, et al. Characterization of a second human clathrin heavy chain polypeptide gene (CLH-22) from chromosome 22q11. Hum Mol Genet 1996; 5:625-31.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Khramtsov AI, Khramtsova GF, Tretiakova M, Huo D, Olopade OI, Goss KH. Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol 2010; 176:2911-20. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Khurana A, Liu P, Mellone P, et al. HSulf-1 modulates FGF2- and hypoxiamediated migration and invasion of breast cancer cells. Cancer Res 2011; 71:2152-61.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Khurana A, McKean H, Kim H, et al. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo. Breast Cancer Res 2012; 14:R43.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Kirschmann DA, Seftor EA, Nieva DR, Mariano EA, Hendrix MJ. Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Res Treat 1999; 55:127-36.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Kuerer HM, Albarracin CT, Yang WT, et al. Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol 2009; 27:27988. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss PE. Breast cancer in Brazil: present status and future goals. Lancet Oncol 2012; 13:e95-e102.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 2004; 96:906-20. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 11:1427-31. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Li M, Zhang P. The function of APC/CCdh1 in cell cycle and beyond. Cell Div 2009; 4:2. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Liang M, Zhang P, Fu J. Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells. Cancer Lett 2007; 258:31-7.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Liu SH, Towler MC, Chen E, et al. A novel clathrin homolog that codistributes with cytoskeletal components functions in the trans-Golgi network. EMBO J 2001; 20:272-84.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Livasy CA, Perou CM, Karaca G, et al. Identification of a basal-like subtype of breast ductal carcinoma in situ. Hum Pathol 2007; 38:197-204. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Loi S. Molecular analysis of hormone receptor positive (luminal) breast cancers: what have we learnt? Eur J Cancer 2008; 44:2813-8.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Long KR, Trofatter JA, Ramesh V, McCormick MK, Buckler AJ. Cloning and characterization of a novel human clathrin heavy chain gene (CLTCL). Genomics 1996; 35:466-72.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 2003; 100:5974-9. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, McDonaldJA, Daling JR, Bernstein L, Malone KE, Wingo PA, Simon MS, Norman SA, Strom BL,Ursin G, Weiss LK, Burkman RT, Spirtas R. Oral contraceptive formulation and risk of breast cancer. Contraception 2012; 85:342-50. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Martins LAM. Definição dos dinucleotídeos CpG metilados no promotor do gene PLCG2 e de sua influência na repressão transcricional em tumor de Wilms. São Paulo; 2011 [Dissertação de Mestrado-Fundação Antonio Prudente]. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer 2007; 7:961-7. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Matos I, Dufloth R, Alvarenga M, Zeferino LC, Schmitt F. p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch 2005; 447:688-94.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"McPherson K, Steel CM, Dixon JM. ABC of breast diseases: breast cancerepidemiology, risk factors, and genetics. BMJ 2000; 9;321:624-8. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Meijnen P, Peterse JL, Antonini N, Rutgers E, Vijver MJ. Immunohistochemical categorisation of ductal carcinoma in situ of the breast. Br J Cancer 2008; 98:137-42. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Millis RR, Bobrow LG, Barnes DM. Immunihistochemical evaluation of biologic markers in mammary carcinoma in situ: correlation with morphological features and recently proposed schemes for histological classification. Breast 1996; 5:113-22. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Min C, Kirsch KH, Zhao Y, et al. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res 2007; 67:1105-12.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2012 Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2011. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Mocker K, Holland H, Ahnert P, et al. Multiple meningioma with different grades of malignancy: case report with genetic analysis applying singlenucleotide polymorphism array and classical cytogenetics. Pathol Res Pract 2011; 207:67-72.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Molina R, Barak V, van Dalen A, et al. Tumor markers in breast cancer - European Group on Tumor Markers recommendations. Tumour Biol 2005; 26:281-93. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Moon SY, Zheng Y. Rho GTPase-activating proteins in cell regulation. Trends Cell Biol 2003; 13:13-22. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Morrissey JJ, London AN, Luo J, Kharasch ED. Urinary biomarkers for the early diagnosis of kidney cancer. Mayo Clin Proc 2010; 85:413-21. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007; 8:379-93. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Narita K, Staub J, Chien J, et al. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Res 2006; 66:6025-32.  Nasmyth K. A prize for proliferation. Cell 2001; 107:689-701. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer 2003; 98:413-23.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004; 10:5367-74.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Nishidate T, Katagiri T, Lin ML, et al. Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis.  Int J Oncol 2004; 25:797-819. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Nogueira M, Kim HL. Molecular markers for predicting prognosis of renal cell carcinoma. Urol Oncol 2008; 26:113-24. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Oliveira MMC, Torresan C, de Oliveira SFV, et al. Epidemiologia do câncer de mama em pacientes do Sul do Brasil. Bol Epidemiol Paulista (Online) 2009; 6:4-14. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Osborne CK. Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 1998; 51:227-38. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004; 351:2817-26. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Park K, Han S, Kim HJ, Kim J, Shin E. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry. Histopathology 2006; 48:702-7. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37:8:54-66. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Payne SL, Hendrix MJ, Kirschmann DA. Paradoxical roles for lysyl oxidases in cancer-a prospect. J Cell Biochem 2007; 101:1338-54.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Pegram MD, Pauletti G, Slamon DJ. HER-2/neu as a predictive marker of response to breast cancer therapy. Breast Cancer Res Treat 1998; 52:6577. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature 2000; 406:747-52. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Peters JM. The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol Cell 2002; 9:931-43. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Piccart-Gebhart MJ. Adjuvant trastuzumab therapy for HER2-overexpressing breast cancer: what we know and what we still need to learn. Eur J Cancer 2006; 42:1715-9.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004; 51:55-67. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Polyak K, Hu M. Do myoepithelial cells hold the key for breast tumor progression? J Mammary Gland Biol Neoplasia 2005; 10:231-47. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;Portal de Oncologia Português. O que é o cancro da mama?. Disponível em: <URL:http://www.pop.eu.com/portal/publico-geral/tipos-decancro/cancro-da-mama/o-cancro-da-mama.html> [2012 jun 12]. ;
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Porter D, Lahti-Domenici J, Keshaviah A, et al. Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res 2003; 1:362-75. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Pyrzynska B, Pilecka I, Miaczynska M. Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis. Mol Oncol 2009; 3:32138.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Qiao X, Zhang L, Gamper AM, Fujita T, Wan Y. APC/C-Cdh1: from cell cycle to cellular differentiation and genomic integrity. Cell Cycle 2010; 9:3904-12.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Rakha EA, Reis-Filho JS, Baehner F, et al. Breast cancer prognosticclassification in the molecular era: the role of histological grade. Breast Cancer Res 2010; 12:207. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Royle SJ, Bright NA, Lagnado L. Clathrin is required for the function of the mitotic spindle. Nature 2005; 434:1152-7.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Saraiva TF, Castro NP, Pineda PHB, et al. Effects of oligo dT-T7 RNA primer in RNA amplification from paraffin-embedded tissue for microarray experiments. Appl Cancer Res 2006; 26:14-20. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Sarma SN, Kim YJ, Ryu JC. Differential gene expression profiles of human leukemia cell lines exposed to benzene and its metabolites. Environ Toxicol Pharmacol 2011; 32:285-95.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Schnitt SJ. Normal anatomy and development. In: Hayes DF, editor. Atlas of breast cancer. London: Mosby; 1995a. p.3.2-3.4. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Schnitt SJ. Pathology of breast cancer. In: Hayes DF, editor. Atlas of breast cancer. London: Mosby; 1995b. p.8.1-8.11. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Schorr MC, Pedrini JL, Savaris RF, Zettler CG. Are the pure in situ breast ductal carcinomas and those associated with invasive carcinoma the same? Appl Immunohistochem Mol Morphol 2010; 18:51-4.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Schuetz CS, Bonin M, Clare SE, et al. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res 2006; 66:5278-86. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Schwartz GF. Consensus conference on the classi?cation of ductal carcinoma in situ: the current treatment of ductal carcinoma in situ. Breast J 2001;7:308–10. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Schwickart M, Havlis J, Habermann B, et al. Swm1/Apc13 is an evolutionarily conserved subunit of the anaphase-promoting complex stabilizing the association of Cdc16 and Cdc27. Mol Cell Biol 2004; 24:3562-76. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Sens-Abuázar C, Napolitano E Ferreira E, Osório CA, et al. Down-regulation of ANAPC13 and CLTCL1: early events in the progression of preinvasive ductal carcinoma of the breast. Transl Oncol 2012; 5:113-23.";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Shiau AK, Barstad D, Loria PM, et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998; 95:927-37. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 1989; 244:707-12. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Sobin LH, Wittekind Ch. TNM classificação dos tumores malignos. 6ª ed. Rio de Janeiro: INCA; 2004. Tumores de mama; p.137-148.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98:10869-74. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Spector NL, Xia W, Bums III H, et al. Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies. J Clin Oncol 2005; 23:2502-12. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Steinman S, Wang J, Bourne P, Yang Q, Tang P. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Ann Clin Lab Sci 2007; 37:127-34.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Stuart K, Boyages J, Brennan M, Ung O. Ductal carcinoma in situ management update. Aust Fam Physician 2005; 34:949-54. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Svensson S, Nilsson K, Ringberg A, Landberg G. Invade or proliferate? Two contrasting events in malignant behavior governed by p16(INK4a) and an intact Rb pathway illustrated by a model system of basal cell carcinoma. Cancer Res 2003; 63:1737-42.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Taneja P, Maglic D, Kai F, et al. Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. Clin Med Insights Oncol 2010; 4:15-34.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Tewari M, Pradhan S, Singh U, Shukla HS. Estrogen and progesterone receptor status in breast cancer: effect of oral contraceptive pills and hormone replacement therapy. Breast 2007;5:540-5.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Tiezzi DG. Epidemiologia do câncer de mama. Rev Bras Ginecol Obstet 2009; 31:213-5. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Tse GM, Tan PH. Diagnosing breast lesions by ?ne needle aspiration cytology or core biopsy: which is better? Breast Cancer Res Treat 2010; 123:1-8. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Van’t Veer L, Dai H, Van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-36. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Vieira AV, Lamaze C, Schmid SL. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 1996; 274:2086-9.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Vogel VG. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer. Menopause 2008; 15(4 Suppl):782-9. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Vos CB, Ter Haar NT, Rosenberg C, et al. Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type. Br J Cancer 1999; 81:1410-8. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Warnberg F, Nordgren H, Bergkvist L, Holmberg L. Tumour markers in breast carcinoma correlate with grade  rather than with invasiveness. Br J Cancer 2001; 85:869-74. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Wäsch R, Robbins JA, Cross FR. The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression. Oncogene 2010; 29:1-10. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Wellings SR, Jensen HM. On the origin and progression of ductal carcinoma in the human breast. J Natl Cancer Inst 1973; 50:1111-8.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975; 55:231-73. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Wiley HS, Burke PM. Regulation of receptor tyrosine kinase signaling by endocytic trafficking. Traffic 2001; 2:12-8.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007; 25:118-45. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Wolins NE, Quaynor BK, Skinner JR, Schoen?sh MJ, Tzekov A, Bickel PE. S3-12, adipophilin, and TIP47 package lipid in adipocytes. J Biol Chem 2005; 280:19146–55. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Yao M, Huang Y, Shioi K, et al. Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma. Clin Cancer Res 2007; 13:152-60.  ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Yoon HJ, Feoktistova A, Wolfe BA, Jennings JL, Link AJ, Gould KL. Proteomics analysis identifies new components of the fission and budding yeast anaphase-promoting complexes. Curr Biol 2002; 12:2048-54. ";
FAP;2012;CAROLINA SENS ABUÁZAR;Dirce Maria Carraro;-x-;"Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert-Buck MR. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 1995; 55:467-71. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Aisem S. Braquiterapia de alta taxa de dose no tratamento do colo uterino: resultados de controle local, sobrevida e complicações. São Paulo; 2003. [Tese de Doutorado-Faculdade de Medicina da USP].  ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Aisem S. Braquiterapia de alta taxa de dose no tratamento do colo uterino: resultados de controle local, sobrevida e complicações. São Paulo; 2003. [Tese de Doutorado-Faculdade de Medicina da USP].  ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Al-Mansour Z, Verschraegen C. Locally advanced cervical cancer: what is the standard of care? Curr Opin Oncol 2010; 22:503-12. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Atahan IL, Onal C, Ozyar E, et al. Long-term outcome and prognostic factores in patients with cervical carcinoma: a retrospective study. Int J Gynecol Cancer 2007; 17:833-42. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Barillot I, Horiot JC, Pigneux J, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys 1997; 38:969-78. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Borowsky ME, Elliot KS, Pezzullo JC, et al. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer. Bull Cancer 2005; 92:E19-24. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;Buzaid AC, Maluf FC. Manual de oncologia clínica do Brasil. [documento da internet]. Disponível em: <URL:http://mocbrasil.com/manual/> [2011 dez 11]  ;
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Campos C, Salvajoli JC, Novaes PE, et al. External radiotherapy for locally advanced cervical cancer: the influence of the timing of pelvic external irradiation and high dose rate brachytherapy in the local control and 5 and 10 years survival rates. Radiother Oncol 2010; 96(supp1):S299. [Presented at ESTRO 29 Barcelona, Spain. September 12-12, 2010] ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Chen SW, Liang JA, Yang SN, et al. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol 2003; 67:69-76. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Cooke SL, Temple J, Macarthur S, et al. Intra-tumoral genetic heterogeneity and poor chemoradiotherapy response in cervical cancer. Br J Cancer 2011; 104:361-8. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Datta NR, Agrawal S. Does the evidence support the use of concurrent chemoradiotherapy as a standard in the management of locally advanced cancer of the cervix, especially in developing countries? Clin Oncol (R Coll Radiol) 2006; 18:306-12. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Duclos M, Souhami L, Corms R, et al. Cervical cancer: timing of high-dose rate brachytherapy with external beam radiotherapy. Int J Radiat Oncol Biol Phys 2001; 58(Suppl 1):S14. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;Dueñas-González A, Zarbá JJ, Patel F, et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol 2011:1678-85. ;
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Dunst J, Haensgen G. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.  Strahlenther Onkol 2001; 177:635-40. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004; 22:87280.  ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Eifel PJ. Chemotherapy in the treatment of cervical cancer. Semin Radiat Oncol 2006; 16:177-85. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Erridge SC, Kerr GR, Downing D, et al. The effect of overall treatment time on the survival and toxicity of radical radiotherapy for cervical carcinoma. Radiother Oncol 2002; 63:59-66. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Fagundes H, Perez CA, Grigsby PW, et al. Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1992; 24:197-204. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Ferrigno R, dos Santos Novaes PE, Pellizzon AC, et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys 2001; 50:112335. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Fyles AW, Pintilie M, Kirkbride P, et al. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol 1995; 35:107-17. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Gibbons SK, Keys HM. Advanced cervical cancer. Curr Treat Opin Oncol 2000; 1:157-60. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Girinsky T, Rey A, Roche B, Haie C, et al. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993; 27:1051-6. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Glynne-Jones R, Hoskin P. Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm? J Clin Oncol 2007; 25:5281-86. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2001a; (4):CD002225. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001b; 358:781-6. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Hacker NF, Ngan HYS, Benedet JL. Staging classification and clinical practice guidelines for gynecologycal cancers. 2nd ed. Limerick; Elsevier; 2000. Staging classification; p.37-52. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Hong JH, Chen MS, Lin FJ, Tang SG. Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys 1991; 22:913-7. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Hoskin PJ, Bownes P. Innovative Technologies in Radiation Therapy: Brachytherapy. Semin Radiat Oncol 2006; 16:209-17. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Hreshshyshyn MM, Aron BS, Boronow RC, Franklin EW, Shingleton HM, Blessing JA. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys 1979; 5:31722. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"[ICRU] International Commission on Radiation Units and Measurements. Dose and volume specification for reporting intracavitarytherapy in gynecology. USA: Intl Commission on Radiation; 1985. p.1-20. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Kazumoto T, Kato S, Tabushi K, et al. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration. Int J Radiat Oncol Biol Phys 2007; 69:1157-66. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Kidd EA, Grigsby PW. Intratumoral metabolic heterogeneity of cervical cancer. Clin Cancer Res 2008; 14:5236-41. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Lanciano RM, Won M, Coia LR, et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care study. Int J Radiat Oncol Biol Phys 1991; 20:667-76. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999; 43:763-75. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;Long HJ 3rd. Current research directions for locally advanced cervix cancer. Curr Oncol Rep 2003, 5:468-72. ;
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Lorvidhaya V, Tonusin A, Changwiwit W, et al. High-dose-rate afterloading brachytherapy in carcinoma of the cervix:an experience of 1992 patients. Int J Radiat Oncol Biol Phys 2000; 46:1185-91. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Magné N, Chargari C, Vicenzi L, et al. New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET. Cancer Treat Rev 2008; 34:671-81. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Malfetano J, Keys H, Kredentser D, et al. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma. Cancer 1993; 71:3703-6. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Mayer A, Nemeskéri C, Petneházi C, et al. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma: a comparison of continuous versus sequential regimens. Strahlenther Onkol 2004; 180:209-15. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Mayr NA, Yuh WT, Zheng J, et al. Tumor size evaluated by pelvic examination compared with 3-D MR quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiation Oncol Biol Phys 1997; 39:395-404. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;Ministério da Saúde. Instituto Nacional do Câncer. Estimativa /2010 incidência de câncer no Brasil. Rio de Janeiro: INCA, 2009. ;
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2012 incidência de câncer no Brasil. Rio de Janeiro: INCA, 2011a. ;
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;Ministério da Saúde. DataSUS. [documento da internet]. Disponível em: <URL:http://tabnet.datasus.gov.br/cgi/deftohtm.exe> [2011b dez 10] ;
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Monk BJ, Tian C, Rose PG, et al. Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials. Gynecol Oncol 2007; 105:427-33. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Montana GS, Fowler WC, Varia MA, et al Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer 1986; 57:148-54. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Nag S, Erickson B, Thomadsen B, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 48:201-11. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;[NCCN]. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: cervical cancer. 2012. Avaliable from: <URL:http://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf> [2011 nov 20] ;
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Novaes PERS. Fatores clínicos e técnicos relacionados ao prognóstico do carcinoma espinocelular avançado do colo uterino (estádio IIIB) tratado por radioterapia externa e braquiterapia de alta taxa de dose. São Paulo; 2001. [Tese de Doutorado-Faculdade de Medicina da USP]. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002; 20:966-72. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Patel FD, Rai B, Mallick I, et al. High-dose-rate brachytherapy in uterine cervical carcinoma. Int J Radiat Oncol Biol Phys 2005; 62:125-30. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105:103-4. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Perez CA, Grigsby PW, Castro-Vita H, et al. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995; 32:1527-9. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Parker K, Gallop-Evans E, Hanna L, et al. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution. Int J Radiat Oncol Biol Phys 2009; 74:140-6. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 1999; 43:359-66. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Roman TN, Souhami L, Freeman CR, et al. High dose rate afterloading intracavitary therapy in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1997; 20:921-6. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Rose PG. Concurrent chemoradiation for locally advanced carcinoma of the cervix: where are we in 2006? Ann Oncol 2006; 17(suppl 10):s224-9. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Saibishkumar EP, Patel FD, Sharma SC, et al. Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: a retrospective analysis of 556 patients from India. Radiother Oncol 2006; 79:142-6. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Shakespeare TP, Lim KH, Lee KM, et al. Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable? Int J Gynecol Cancer 2006; 16:277-82.";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"[SBRT] Sociedade Brasileira de Radioterapia. Radioterapia baseada em evidências: recomendações da Sociedade Brasileira de Radioterapia. São Paulo: Sociedade Brasileira de Radioterapia; 2011. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Sood BM, Gorla G, Gupta S, et al. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy. Int J Radiat Oncol Biol Phys 2002; 53:702-6. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Souhami L, Corns R, Duclos M, et al. Long-term results of high-dose brachytherapy in cervix cancer using a small number of fractions. Gynecol Oncol  2005; 97:508-13. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Symonds P, Kirwan J, Williams C. Concomitant hydroxyurea plus radiotherapy for carcinoma of the uterine cervix. Cochrane Database Syst Rev 2004; (1):CD003918. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;Teh J, Yap SP, Tham I, et al. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors. Int J Gynecol Cancer 2010. 20:428-33. ;
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Thomas G. Cervical cancer: treatment challenges in the developing world. Radiother Oncol 2006; 79:139-41. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Vale C, Tierney JF, Stewart LA, et al. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008; 26:5802-12. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Viani GA, Manta GB, Stefano EJ, et al. Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy - a meta-analysis of clinical trials. J Exp Clin Cancer Res 2009; 28:47.  ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Viswanathan A, Erickson B. Three-dimensional imaging gynecologic brachytherapy: a survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2010; 76:104-9. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Wang CJ, Huang EY, Sun LM, et al. Clinical comparison of  two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2004; 59:179-89. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Wang N, Guan QL, Wang K, et al. Radiochemotherapy versus radiotherapy in locally advanced cervical cancer: a meta-analysis. Arch Gynecol Obstet 2011; 283:103-8. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Wang X, Liu R, Ma B, et al. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Cochrane Database Syst Rev 2010; 7:CD007563. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Whitney CW, Sause W, Bundy BN. Randomized comparison of fluouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecology Group Study. J Clin Oncol 1999; 17:1339-48. ";
FAP;2012;CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS;João Victor Salvajoli;Marcelo Gurgel Carlos da Silva;"Windschall A, Ott OJ, Sauer R, Strnad V. Radiation Thaeray abd simultaneous chemotherapy for recurrent cervical carcinoma. Strahlenther Onkol 2005; 181:54550.";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Ainamo J, Löe H. Anatomical characteristics of gingiva: a clinical and microscopic study of the free and attached gingiva. J Periodontol 1966; 37:5-13. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Anneroth G, Batsakis J, Luna M. Review of literature and recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 1987; 95:229-49. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Avery JK. Oral development and histology. 2nd ed. New York: Thieme Medical; 1994. Histology of the periodontium: alveolar bone, cementum and periodontal ligament; p.144-63. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Barasch A, Gofa A, Krutchkoff DJ, Eisenberg E. Squamous cell carcinoma of the gingiva. A case series analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80:183-7. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene Akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991; 254:274-7.  ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Bill TJ, Reddy VR, Ries KL, Gampper TJ, Hoard MA. Adolescent gingival squamous cell carcinoma: reporto of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91:682-5. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Binahmed A, Charles M, Campisi P, Forte V, Carmichael RP, Sándor GK. Primary squamous cell carcinoma of the maxillary alveolus in a 10-year-old girl. J Can Dent Assoc 2007; 73:715-8. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Binahmed A, Nason RW, Hussain A, Abdoh AA, Sándor GK. Treatment outcomes in squamous cell carcinoma of the maxillary alveolus and palate: a population-based study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105:750-4.";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Brown J. Mechanisms of cancer invasion of the mandible. Curr Opin Otolaryngol Head Neck Surg 2003; 11:96-102. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Cady B, Catlin D. Epidermoid carcinoma of the gum: a 20-year survey. CA Cancer J Clin 1970; 20:44-7. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Cantley LC, Neel BG. New insights into tumor suppression:PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1999; 6:4240-5. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Chambard JC, Lefloch R, Pouysségur J, Lenormand P. ERK implication in cell cycle regulation. Biochem Biophys Acta 2007; 1773:1299-310. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Choi EJ, Zhang X, Kim HJ, Nam W, Cha IH. Prognosis of gingival squamous cell carcinoma diagnosed after invasive procedures. Asian Pacific J Cancer Prevention 2011; 12:2649-52.  ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Clark C, Shah S, Herman-Ferdinandez L, et al. Teasing out the best molecular marker in the Akt/mTOR pathway in head and neck squamous cell cancer patients. Laryngoscope 2010; 120:1159-65. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Coletta RD, Cotrim P, Almeida OP, Alves VA, Wakamatsu A, Vargas PA. Basaloid squamous carcinoma of oral cavity: a histologic and immunohistochemical study. Oral Oncol 2002; 38:723-9. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Cui QL, Almazan G. IGF-I-induced oligodendrocyte progenitor proliferation requires PI3K/Akt, MEK/ERK, and Src-like tyrosine kinases. J Neurochem 2007; 100:1480-93. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Cully M, You H, Levine AJ, Mak TW. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature 2006; 6:184-92. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell 2000; 100:387-90. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Dibb NJ, Dilworth SM, Mol CD. Switching on kinases: oncogenic activation of BRAF and the PDGFR family. Nat Rev Cancer 2004; 4:718-27. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Enslen H, Davis RJ. Regulation of MAP kinases by docking domains. Bio Cell 2001; 93:5-14. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Evans JF, Shah JP. Epidermoid carcinoma of the palate. Am J Surg 1981; 142:4515. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Gericke A, Munson M, Ross AH. Regulation of PTEN phosphatase. Gene 2006; 374:1-9. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"González-García R, Naval-Gías L, Sastre-Pérez J, et al. Contralateral lymph neck node metastasis of primary squamous cell carcinoma of the tongue: a retrospective analytic study of 203 patients. Int J Oral Maxillofac Surg 2007; 36:507-13. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Gu J, Tamura M, Pankov R, et al. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 1999; 146:389-403. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Harding MW. Immunophilins, mTOR, and pharmacodynamic strategies for a targeted cancer therapy. Clin Cancer Res 2003; 9:2882-6. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Hassell TM. Tissues and cells of the periodontium. Periodontol 2000 1993; 3:9-38. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18:1926-45. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4:988-1004. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Hong SX, Cha IH, Lee EW, Kim J. Mandibular invasion of lower gingival carcinoma in the molar region: its clinical implications on the surgical management. Int J Oral Maxillofac Surg 2001; 30:130-8. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Huang S, Houghton PJ. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curr Opin Investig Drugs 2002; 3:295-304. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Huang S, Houghton PJ0. Targeting mTOR signaling for cancer therapy. Curr Opin Pharmacol 2003; 3:371-77. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Irié T, Aida T, Tachikawa T. Gene expression profiling of oral squamous cell carcinoma using laser microdissection and cDNA microarray. Med Electron Microsc 2004; 37:89-96. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Khan SM, Gossweiler MK, Zunt SL, Edwards MD, Blanchard SB. Papillary squamous cell carcinoma presenting on the gingiva. J Periodontol 2005; 76:231621. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Kirsch C. Oral cavity cancer. Top Magn Reson Imaging 2007; 18:269-80. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Koduganti RR, Sehrawat S, Reddy PV. Gingival squamous cell carcinoma: a diagnostic impediment. J Indian Soc Periodontol 2012; 16:104-7. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 2000; 351:289-305. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Kuratomi K, Yano H, Tsuneoka M, Sakamoto K, Kusukawa J, Kojiro M. Immunohistochemical expression of Mina53 and Ki67 proteins in human primary gingival squamous cell carcinoma. Kurume Med J 2006; 53:71-8. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Kurita H, Koike T, Narikawa JN, et al. Clinical predictors for contralateral neck lymph node metastasis from unilateral squamous cell carcinoma in the oral cavity. Oral Oncol 2004; 40:898-903. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Lee JO, Yang H, Georgescu MM, et al. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 1999; 99:323-34. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Lee JI, Soria JC, Hassan KA, et al. Loss of PTEN expression as a prognostic marker for tongue cancer. Arch Otolaryngol Head Neck Surg 2001; 127:1441-5.  ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Lee JJ, Cheng SJ, Lin SK, Chiang CP, Yu CH, Kok SH. Gingival squamous cell carcinoma: mimicking a dentoalveolar abscess: report of a case. J Endod 2007; 33:177-80. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 1997; 275:1943-7. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Li PY, Auyeung L, Huang SC. Squamous cell carcinoma of the mandibular gingiva. Chang Gung Med J 2004; 27:777-80. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Li AG, Piluso LG, Cai X, Wei G, Sellers WR, Liu X. Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell 2006; 23:575-87. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA. Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat 2008; 11:32-50. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Mavros A, Hahn M, Wieland I, et al. Infrequent genetic alterations of the tumor suppressorgene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity. J Oral Pathol Med 2002; 31:270-6. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Mirza AM, Gysin S, Malek N, Nakayama K, Roberts JM, McMahon M. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol Cell Biol 2004; 24:10868-81. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2012 incidência de câncer no Brasil. Rio de Janeiro: INCA; 2011.  ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Murayama T, Inokuchi M, Takagi Y, et al. Relation between outcomes and localization of p-mTOR expression in gastric cancer. Br J Cancer 2009; 100:782-8. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Myers MP, Tonks NK. PTEN: sometimes taking it off can be better than putting it on. Am J Hum Genet 1997; 61:1234-8. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Nakatani K, Thompson DA, Barthel A, et al. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 1999; 274:21528-32. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Laryngoscope 2002; 112:2129-40. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Nathan CO, Amirghahari N, Abreo F, et al. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway. Clin Can Res 2004; 10:5820-27. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Nathanson A, Jakobsson PA, Wersäll J. Prognosis of squamous-cell carcinoma of the gums. Acta Otolaryngol 1973; 75:301-3. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002; 14:381-95. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Pedrero JM, Carracedo DG, Pinto CM, et al. Frequent genetic and biochemical alterations of the PI3K/Akt/PTEN pathway in head and neck squamous cell carcinoma. Int J Cancer 2005; 114:242-8. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Potter GD. The hard palate. Am J Roentgenol Radium Ther Nucl Med 1973; 118:415-9. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 2004; 303:1179-81.  ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Razis E, Briasoulis E, Vrettou E, et al. Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study. BMC Cancer 2008; 8:234. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol 2004; 68:32044. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Sacks DB. The role of scaffold proteins in MEK/ERK signalling. Biochem Soc Trans 2006; 34:833-6. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Schoelch ML, Regezi JA, Dekker NP, et al. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 1999; 35:333-42. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Seoane J, Varela-Centelles PI, Walsh TF, Lopez-Cedrun JL, Vazquez I. Gingival squamous cell carcinoma: diagnostic delay or rapid invasion? J Periodontol 2006; 77:1229-33. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Silva SD, Perez DE, Nishimoto IN, et al. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings. Oral Dis 2008; 14:37682. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of malignant tumours. 7th ed. New Jersey: Wiley-Blackwell; 2011. Lip and oral cavity; p.25-9. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Soo KC, Spiro RH, King W, Harvey W, Strong EW. Squamous carcinoma of the gums. Am J Surg 1988; 156:281-5. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Squarize CH, Castilho RM, Santos Pinto D Jr. Immunohistochemical evidence of PTEN in oral squamous cell carcinoma and its correlation with the histological malignancy grading system. J Oral Pathol Med 2002; 31:379-84. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Staal SP. Molecular cloning of the Akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci 1987; 84:5034-7. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15:356-62. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Stolk-Liefferink SA, Dumans AG, van der Meij EH, Knegt PP, van der Wal KG. Oral squamous cell carcinoma in children; review of an unusual entity. Int J Pediatr Otorhinolaryngol 2008; 72:127-31. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Stugis EM. A review of social and behavioral efforts at oral cancer preventions in India. Head Neck. 2004; 26:937-44. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Suba Z. Gender-related hormonal risk factors for oral cancer. Pathol Oncol Res 2007; 13:195-202. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Subramanian S, Sankaranarayanan R, Bapat B, et al. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bull World Health Organ 2009; 87:200-6. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;Sunnybrook Research Institute. Human tumour tissue microarrays. Available from: <URL:http://sunnybrook.ca/research/content/?page=sri_core_genom_equip_8 _8> [2012 jun 13]. ;
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. Inhibition of cell migation, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998; 280:1614-7. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Testa JR, Bellacosa A. Akt plays a central role in tumorigenesis. Proc Natl Acad Sci 2001; 98:10983-5. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Thompson FH, Nelson MA, Trent JM, et al. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Cancer Genet Cytogenet 1996; 87:55-62. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Tiwari R. Squamous cell carcinoma of the superior gingivolabial sulcus. Oral Oncol 2000; 36:461-5. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Tolman A, Jerrold L, Alarbi M. Squamous cell carcinoma of attached gingival. Am J Orthod Dentofacial Orthop 2007; 132:378-81. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Vazquez F, Sellers WR. The PTEN tumor suppressor protein:an antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 2000; 1470:M21-35. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Williams HK Molecular pathogenesis of oral squamous carcinoma. Mol Pathol 2000; 53:165-72. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;Wilson TG Jr. Compliance and its role in periodontal therapy. Periodontology 2000 1996, 12:16-23. ;
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Yorozu A, Sykes AJ, Slevin NJ. Carcinoma of the hard palate treated with radiotherapy: a retrospective review of 31 cases. Oral Oncol 2001; 37:493-7. ";
FAP;2012;DARKLÊ FERREIRA MODESTO;Maria Dirlei Ferreira de Souza Begnami;Silvia Vanessa Lourenço;"Yu G, Wang J, Chen Y, et al. Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastases and prognosis of chinese patients with gastric cancer. Clin Cancer Res 2009; 15:1821-9. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;[ACS] American Cancer Society. Cancer facts and figures 2011. Available from: <URL:http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/docum ents/document/acspc-029771.pdf> [2011 nov 3]. ;
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;Agarwal J, Palwe V, Dutta D, et al. Objective assessment of swallowing function after definitive concurrent (chemo)radiotherapy in patients with head and neck cancer. Dysphagia 2011 Feb 23.  ;
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Allen JE, White CJ, Leonard RJ, Belafsky PC. Prevalence of penetration and aspiration on videofluoroscopy in normal individuals without dysphagia. Otolaryngol Head Neck Surg 2010; 142:208-13. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"[Anonymous] National Dysphagia Diet Guidelines: standardization fot optimal care. Chicago, IL: American Dietetic Association; 2002. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Bingjie L, Tong Z, Xinting S, Jianmin X, Guijun J. Quantitative videofluoroscopic analysis of penetration-aspiration in post-stroke patients. Neurol India 2010; 58:427. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Butler SG, Stuart A, Leng X, Rees C, Williamson J, Kritchevsky SB. Factors influencing aspiration during swallowing in healthy older adults. Laryngoscope 2010; 120:2147-52. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Butler SG, Stuart A, Case LD, Rees C, Vitolins M, Kritchevsky SB. Effects of liquid type, delivery method, and bolus volume on penetration-aspiration scores in healthy older adults during flexible endoscopic evaluation of swallowing. Ann Otol Rhinol Laryngol 2011a; 120:288-95. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Butler SG, Stuart A, Leng X, Wilhelm E, Rees C, Williamson J, Kritchevsky SB. The relationship of aspiration status with tongue and handgrip strength in healthy older adults. J Gerontol A Biol Sci Med Sci 2011b; 66:452-8. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Cassiani RA, Santos CM, Parreira LC, Dantas RO. The relationship between the oral and pharyngeal phases of swallowing. Clinics (Sao Paulo) 2011; 66:1385-8. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Choi KH, Ryu JS, Kim MY, Kang JY, Yoo SD. Kinematic analysis of dysphagia: significant parameters of aspiration related to bolus viscosity. Dysphagia 2011; 26:392-8. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Cook IJ, Weltman MD, Wallace K, et al. Influence of aging on oral-pharyngeal bolus transit and clearance during swallowing: scintigraphic study. Am J Physiol 1994; 266(Pt 1):G972-7. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Daggett A, Logemann J, Rademaker A, Pauloski B. Laryngeal penetration during deglutition in normal subjects of various ages. Dysphagia 2006; 21:270-4.  ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Daniels SK, Foundas AL. Swallowing physiology of sequential straw drinking. Dysphagia 2001; 16:176-82. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Daniels SK, Corey DM, Hadskey LD, et al. Mechanism of sequential swallowing during straw drinking in healthy young and older adults. J Speech Lang Hear Res 2004; 47:33-45. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Dantas RO, Kern MK, Massey BT, et al. Effect of swallowed bolus variables on oral and pharyngeal phases of swallowing. Am J Physiol 1990; 258:G675-81. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Daniels SK, Schroeder MF, DeGeorge PC, Corey DM, Rosenbek JC. Effects of verbal cue on bolus flow during swallowing. Am J Speech Lang Pathol 2007; 16:140-7.";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Dantas RO, de Aguiar Cassiani R, dos Santos CM, Gonzaga GC, Alves LM, MazinSC. Effect of gender on swallow event duration assessed by videofluoroscopy. Dysphagia 2009; 24:280-4. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Dejaeger E, Pelemans W, Ponette E, Joosten E. Mechanisms involved in postdeglutition retention in the elderly. Dysphagia 1997; 12:63-7. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Dodds WJ, Logemann JA, Stewart ET. Radiologic assessment of abnormal oral and pharyngeal phases of swallowing. AJR Am J Roentgenol 1990; 154:965-74.  ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Dusick A. Investigation and management of dysphagia. Semin Pediatr Neurol 2003; 10:255-64. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue--is it useful? Dysphagia 2008; 23:7-15. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for headand-neck cancer. Int J Radiat Oncol Biol Phys 2002; 53:23-8. Comment in: Int J Radiat Oncol Biol Phys 2002; 53:4-5. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004; 60:1425-39.  ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Eisenhuber E, Schima W, Schober E, et al. Videofluoroscopic assessment of patients with dysphagia: pharyngeal retention is a predictive factor for aspiration. AJR Am J Roentgenol 2002; 178:393-8. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Ekberg O, Feinberg MJ. Altered swallowing function in elderly patients without dysphagia: radiologic findings in 56 cases. AJR Am J Roentgenol 1991; 156:11814. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Frederick MG, Ott DJ, Grishaw EK, Gelfand DW, Chen MY. Functional abnormalities of the pharynx: a prospective analysis of radiographic abnormalities relative to age and symptoms. AJR Am J Roentgenol 1996; 166:353-7. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Frowen J, Cotton S, Corry J, Perry A. Impact of demographics, tumor characteristics, and treatment factors on swallowing after (chemo)radiotherapy for head and neck cancer. Head Neck 2010; 32:513-28. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Furia CL, Carrara-de Angelis E, Martins NM, Barros AP, Carneiro B, Kowalski LP. Video fluoroscopic evaluation after glossectomy. Arch Otolaryngol Head Neck Surg 2000; 126:378-83. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Inamoto Y, Fujii N, Saitoh E, et al. Evaluation of swallowing using 320-detector-row multislice CT. Part II: kinematic analysis of laryngeal closure during normal swallowing. Dysphagia 2011; 26:209-17. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Hamlet SL, Muz J, Patterson R, Jones L. Pharyngeal transit time: assessment with videofluoroscopic and scintigraphic techniques. Dysphagia 1989; 4:4-7. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Hirai H, Omura K, Harada H, Tohara H. Sequential evaluation of swallowing function in patients with unilateral neck dissection. Head Neck 2010; 32:896-904. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Humbert IA, Fitzgerald ME, McLaren DG, et al. Neurophysiology of swallowing: effects of age and bolus type. Neuroimage 2009; 44:982-91. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Kang BS, Oh BM, Kim IS, Chung SG, Kim SJ, Han TR. Influence of aging on movement of the hyoid bone and epiglottis during normal swallowing: a motion analysis. Gerontology 2010; 56:474-82.  ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Kendall KA, McKenzie S, Leonard RJ, Gonçalves MI, Walker A. Timing of events in normal swallowing: a videofluoroscopic study. Dysphagia 2000; 15:74-83. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Kim Y, McCullough GH. Maximal hyoid excursion in poststroke patients. Dysphagia 2010; 25:20-5. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Kowalski LP, Carvalho AL, Sanabria A. Câncer da hipofaringe. In: Kowalski LP, Guimarães CG, Salvajoli JV, Feher O, Antoneli CBG, editores. Manual de condutas diagnósticas e terapêuticas em oncologia. São Paulo: Âmbito; 2006a. p.403-6. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Kowalski LP, Sanabria A, Carvalho AL, Feher O, Pelizzon AC. Câncer da laringe. In: Kowalski LP, Guimarães CG, Salvajoli JV, Feher O, Antoneli CBG, editores. Manual de condutas diagnósticas e terapêuticas em oncologia. São Paulo: Âmbito; 2006b. p.407-12. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Kurosu A, Logemann JA. Gender effects on airway closure in normal subjects. Dysphagia 2010; 25:284-90. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Lang IM. Brain stem control of the phases of swallowing. Dysphagia 2009; 24:33348. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Lazarus CL. Effects of chemoradiotherapy on voice and swallowing. Curr Opin Otolaryngol Head Neck Surg 2009; 17:172-8. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA. Evaluation and treatment of swallowing disorders. San Diego: College-Hills Press; 1983. Disorders of deglutition; p.13-86. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA. Effects of aging on the swallowing mechanism. Otolaryngol Clin North Am 1990; 23:1045-56. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA. Manual for the videofluorography study of swallowing. 2nd ed. Texas: Pro Ed; 1993a. Measurements of swallow from videofluorographic studies; p.115-26. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA. Manual for the videofluorography study of swallowing. Texas: Pro Ed; 1993b. Normal radiographic anatomy and phisiology of the oropharynx; p.7-27. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Logemann JA, Rademaker A, Pauloski BR, et al. What information do clinicians use in recommending oral versus nonoral feeding in oropharyngeal dysphagic patients? Dysphagia 2008; 23:378-84. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Manikantan K, Khode S, Sayed SI, et al. Dysphagia in head and neck cancer. Cancer Treat Rev 2009; 35:724-32. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Martin-Harris B, Michel Y, Castell DO. Physiologic model of oropharyngeal swallowing revisited. Otolaryngol Head Neck Surg 2005; 133:234-40. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Martin-Harris B, Brodsky MB, Michel Y, Lee FS, Walters B. Delayed initiation of the pharyngeal swallow: normal variability in adult swallows. J Speech Lang Hear Res 2007; 50:585-94. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Martin-Harris B, Jones B. The videofluorographic swallowing study. Phys Med Rehabil Clin N Am 2008; 19:769-85. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Mendell DA, Logemann JA. Temporal sequence of swallow events during the oropharyngeal swallow. J Speech Lang Hear Res 2007; 50:1256-71. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Miller AJ. Oral and pharyngeal reflexes in the mammalian nervous system: their diverse range in complexity and the pivotal role of the tongue. Crit Rev Oral Biol Med 2002; 13:409-25. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Mittal BB, Pauloski BR, Haraf DJ, et al. Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 2003; 57:1219-30. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Murphy BA, Gilbert J. Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. Semin Radiat Oncol 2009; 19:35-42. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Murry T, Carrau RL. Clinical management of swallowing disorders. 2nd ed. San Diego: Plural Publishing; 2006. Anatomy and function of the swallowing mechanism; p.17-23. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"O'Neill PA. Swallowing and prevention of complications. Br Med Bull 2000; 56:457-65. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Ozaki K, Kagaya H, Yokoyama M, et al. The risk of penetration or aspiration during videofluoroscopic examination of swallowing varies depending on food types. Tohoku J Exp Med 2010; 220:41-6. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Palmer JB. Bolus aggregation in the oropharynx does not depend on gravity. Arch Phys Med Rehabil 1998; 79:691-6. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Palmer JB, Hiiemae KM, Matsuo K, Haishima H. Volitional control of food transport and bolus formation during feeding. Physiol Behav 2007; 91:66-70. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Patterson JM, McColl E, Carding PN, Kelly C, Wilson JA. Swallowing performance in patients with head and neck cancer: a simple clinical test. Oral Oncol 2009; 45:904-7. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Patterson J, Wilson JA. The clinical value of dysphagia preassessment in the management of head and neck cancer patients. Curr Opin Otolaryngol Head Neck Surg 2011; 19:177-81. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Pauloski BR, Logemann JA, Rademaker AW, et al. Speech and swallowing function after oral and oropharyngeal resections: one-year follow-up. Head Neck 1994; 16:313-22. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Pauloski BR, Rademaker AW, Logemann JA, et al. Pretreatment swallowing function in patients with head and neck cancer. Head Neck 2000; 22:474-82. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Pauloski BR, Rademaker AW, Logemann JA, et al. Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy. Head Neck 2006; 28:1069-76. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Pauloski BR, Rademaker AW, Lazarus C, Boeckxstaens G, Kahrilas PJ, Logemann JA. Relationship between manometric and videofluoroscopic measures of swallow function in healthy adults and patients treated for head and neck cancer with various modalities. Dysphagia 2009; 24:196-203. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;Perry JL, Bae Y, Kuehn DP. Effect of Posture on Deglutitive Biomechanics in Healthy Individuals. Dysphagia 2011 Apr 13. [Epub ahead of print]. ;
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Pouderoux P, Logemann JA, Kahrilas PJ. Pharyngeal swallowing elicited by fluid infusion: role of volition and vallecular containment. Am J Physiol 1996; 270(Pt 1):G347-54. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Purkey MT, Levine MS, Prendes B, Norman MF, Mirza N. Predictors of aspiration  pneumonia following radiotherapy for head and neck cancer. Ann Otol Rhinol Laryngol 2009; 118:811-6. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Robbins J, Hamilton JW, Lof GL, Kempster GB. Oropharyngeal swallowing in normal adults of different ages. Gastroenterology 1992; 103:823-9. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Rofes L, Arreola V, Romea M, et al. Pathophysiology of oropharyngeal dysphagia in the frail elderly. Neurogastroenterol Motil 2010; 22:851-8. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Rosenbeck JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetrationaspiration scale. Dysphagia 1996; 11:93-8. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Steele CM, Bailey GL, Chau T, et al. The relationship between hyoid and laryngeal displacement and swallowing impairment. Clin Otolaryngol 2011; 36:30-6. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Stephen JR, Taves DH, Smith RC, Martin RE. Bolus location at the initiation of the pharyngeal stage of swallowing in healthy older adults. Dysphagia 2005; 20:266-72. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Tracy JF, Logemann JA, Kahrilas PJ, Jacob P, Kobara M, Krugler C. Preliminary observations on the effects of age on oropharyngeal deglutition. Dysphagia 1989; 4:90-4. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Vale-Prodomo LP. Caracterização videofluoroscópica da fase faríngea da deglutição. São Paulo; 2010. [Tese de Doutorado-Fundação Antonio Prudente]. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Wu CH, Hsiao TY, Ko JY, Hsu MM. Dysphagia after radiotherapy: endoscopic examination of swallowing in patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2000; 109:320-5. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Yamada EK, Siqueira KO, Xerez D, Koch HA, Costa MM. [The influence of oral and pharyngeal phases on the swallowing dynamic]. Arq Gastroenterol 2004; 41:18-23. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Youmans SR, Stierwalt JA. normal swallowing acoustics across age, gender, bolus viscosity, and bolus volume. Dysphagia 2011; 26:374-84. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Zoratto DC, Chau T, Steele CM. Hyolaryngeal excursion as the physiological source of swallowing accelerometry signals. Physiol Meas 2010; 31:843-55. ";
FAP;2012;ELMA HEITMANN MARES AZEVEDO;Elisabete Carrara-de-Angelis;-x-;"Zu Y, Yang Z, Perlman AL. Hyoid displacement in post-treatment câncer patients: preliminary findings. J Speech Lang Hear Res 2011; 54:813-20. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Abdulkarin B, Sabri S, Deutsch E, et al. Antiviral agent Cidofovir restores p53 function and enhances radiosensitivity in HPV-associated cancers. Oncogene 2002; 21:2334-46. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Adimi P, Steffensen KD, Schledermann D, Rasmussem ER, Jakobsen A. The prognostic importance of EGFR and COX-2 expression in cervix cancer stages IIB-IVA. J Cancer Ther 2011; 2:9-15. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Akerman GS, Tolleson WH, Brown KL, et al. Human Papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes. Cancer Res 2001; 61:3837-43. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Bachtiary B, Schindl M, Potter R, et al. Overexpression of hypoxia-inducible factor 1? indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radiotherapy for cervical cancer. Clin Cancer Res 2003; 9:2234-40. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Badaracco G, Savarese A, Micheli A, et al. Persistent of HPV after radiochemotherapy in locally cervical cancer. Oncol Rep 2010; 23:1093-9. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Barcellos-Hoff MH, Park C, Wright EG. Radiation and microenvironment- tumorigenesis and therapy. Nat Rev Cancer 2005; 5:867-75. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 2008; 8:545-54. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Baumann M, Krause M. CD44: a cancer stem cell- related biomarker with predictive potential for radiotherapy. Clin Cancer Res 2010; 16:5091-3.";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Belatti F, Gasparri ML, Beneditti-Panici P. Is there a real standard for stage IVa cervical cancer? Gynecol Oncol 2011; 123:174-5. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Boccardo E, Villa LL. Viral origins of human cancer. Curr Med Chem 2007; 14:2526-39. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Bomken S, Fiser K, Heidenreich O, Vormoor J. Understanding the cancer stem cell. Br J Cancer 2010; 103:439-45. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Bouda J, Boudova L, Hes O, et al. CD44v6 as a prognostic factor in cervical carcinoma FIGO Stage IB. Anticancer Res 2005; 25:617-22. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Bristow RG, Hill RP. Molecular and cellular basis of radiotherapy. In Tannock IF, Hill RP, Bristow RG, Harringtton L, editors. 4th ed. The basic science of oncology. Canada: McGraw-Hill Companies; 2005. p.261-84. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Bristow RG, Hill R. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 2008; 8:180-92. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration, Vale C, Tierney JF, et al. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008; 26:5802-12. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Choy H, Milas L. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance? J Natl Cancer Inst 2003; 95:1440-52. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Coleman CN. Clinical application of molecular biology in radiation oncology. Semin Radiat Oncol 1996; 6:245-9. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Covello KL, Kehler J, Yu H, et al. HIF-2? regulates OCT-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 2006; 20:557-68.";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Datta NR, Agrawal S. Does the evidence support the use of concurrent chemoradiotherapy as a standard in management of locally advanced cancer of the cervix, especially in developing countries? Clin Oncol (R Coll Radiol) 2006; 18:306-12. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Datta NR, Kumar P, Singh S, Gupta D, Srivastava A, Dhole T. Does pretreatment human papillomavirus (HPV) titer predict radiation response and survival outcomes in cancer cervix? A pilot study. Gynecol Oncol 2006; 103:100-5. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"De Jong MC, Pramana J, van der Wal JE, et al. CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res 2010; 16:532938. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Debucquoy A, Machiels J, Mcbride WH, HaistermansK. Integration of epidermal grouth factor receptor inhibitors with preoperative chemoradiation. Clin Cancer Res 2010; 16:2709-14. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Dellas K, Bacher M, Pigorsch SU, et al. Prognostic impact of HIF-1? expression in patients with definitive radiotherapy for cervical cancer. Strahlenther Onkol 2008; 184:169-74. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Doobar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006; 110:525-41. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Eifel P. Radiation therapy. In: Berek JS, Hacker NF, editors. Gynaecologic oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2010. p.83-119. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Farley J, Sill MW, Birrer M, et al. Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancer of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynaecologic Oncology Group study. Gynecol Oncol 2011; 121:303-8. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Feng D, Peng C, Li C, et al. Identification and characterization of cancer stem– like cells from primary carcinoma of the cervix uteri. Oncol Rep 2009; 22:112934. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Ferrandina G, Lauriola L, Distefano MG, et al. Increased cyclooxigenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. J Clin Oncol 2002; 20:973-81. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Ferrandina G, Ranelletti FO, Legge F, et al. Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery. Int J Radiat Oncol Biol Phys 2003; 55:21-7. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Ferrigno R, dos Santos Novaes PE, Pellizzon AC, et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys 2001; 50:1123-35.";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Fyles AW, Milosevic M, Pintilie M, Syed A, Hill RP. Anaemia, hypoxia and transfusion in patients with cervix cancer a review. Radiother Oncol 2000; 57:13-9. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Gaffney DK, Winter K, Dicker AP, et al. Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Oncol Biol Phys 2007; 69:1117.";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;Goldthwaite CA. Are stem cells involved in cancer? 2011. Available at <URL:http://stemcells.nih.gov/info/regenerative_medicine/2006chapter9> [2012 maio 12] ;
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Hacker NF, Friedlander M. Cervical cancer. In: Berek JS, Hacker NF, editors. Gynaecologic oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2010. p.341-95. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Harrington K, Jankowska P, Hingorani M. Molecular biology for the radiation oncologist: the 5 Rs of radiobiology meet the hallmarks of cancer. Clin Oncol (R Coll Radiol) 2007; 19:561-71. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Heddeston JM, Li Z, Latia JD, Bao S, Hjelmeland AB, Rich JN. Hypoxia inducible factors in cancer stem cells. Br J Cancer 2010; 102:789-95. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Heider K, Kuthan H, Stehle G, Munzert G. CD44v6: a target for antibody-based cancer therapy. Cancer Immunol Immunother 2004; 53:567-79. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Hellner K, Münger K. Human papillomaviruses as therapeutic targets in human cancer. J Clin Oncol 2011; 29:1785-94. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Hill RP, Marie-Egyptienne DT, Hedley D. Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol 2009; 19:106-11. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Hittelman WN, Liao Y, Wang L, Milas L. Are cancer stem cell radioresistant? Future Oncol 2010; 6:1563-76. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Horn LC, Raptis G, Fischer U, et al. CD44-v6 concentrations in carcinoma of the uterine cervix: lack of prognostic significance. Arch Gynecol Obstet 2005; 273:104-6. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Imtiyaz HZ; Willians EP, Hickey MM, et al. Hypoxia inducible factor 2? regulates macrophage function in mouse models of acute end tumor inflammation. J Clin Invest 2010; 120:2699-714. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Ishikawa H, Sakurai H, Hasegawa M, et al. Expression of hypoxic-inducible factor 1? predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2004; 60:513-21. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Ishikawa H, Ohno T, Kato S, et al. Cox-2 expression inhibits radiation-induced apoptosis. Nat Rev Clin Oncol 2007; 4:143-4. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006; 355:1253-61. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Kainz CH, Kohlberger P, Sliutz G, et al. Splice variants of CD44 in human cervical cancer stage IB to IIB. Ginecol Oncol 1995a; 57:383-7. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Kainz CH, Kohlberger P, Tempfer C, et al. Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur J Cancer 1995b; 31A:1706-9. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Kawanaka T, Kubo A, Ikushima H, Sano T, Takegawa Y, Nishitam H. Prognostic significance of HIF-2 alpha expression on tumor infiltrating macrophages in patients with uterine cervical cancer undergoing radiotherapy. J Med Invest 2008; 55:78-86. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007; 129:465-72. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Keith B, Jonson RS, Simon MC. HIF-1? and HIF-2?: sibiling rivalry in hypoxia tumor growth and progression. Nat Rev Cancer 2011; 12:9-22. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Kim JJ, Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 2005; 5:516-25. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Kim MK, Kim HS, Kim SH, et al. Human papillomavirus type 16 E5 oncoprotein as a neu target for cervical cancer treatment. Biochem Pharmacol 2010; 80:19305. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Kim MK, Kim TJ, Sung CO, et al. Clinical significance of HIF-2 ? immunostaing area in radioresistant cervical cancer. J Gynecol Oncol 2011; 22:44-8. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Kim YB, Kim GE, Cho NH, et al. Overspression of cyclooxygenase -2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Cancer 2002; 95:531-9. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Kim YB, Lee IJ, Kim SY, et al. Tumor heterogeneity of FIGO stage III carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2009; 75:1323-8. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Koch U, Krause M, Baumann M. Cancer Stem Cell at the crossroads of current cancer therapy failures- Radiation oncology perspective. Semin Cancer Biol 2010; 20:116-24. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Koukouraks MI, Bentzen SM, Giatromanolaki A, et al. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer. patients recruited in the CHART randomized trial. J Clin Oncol 2006; 24:727-5. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Kunos C, Ali S, Abdul-Karim FW, Stehman FB, Waggoner S. Posttherapy residual disease associates with long-term survival after chemoradiation for bulk stage 1b cervical carcinoma: a Gynecologic Oncology Group study. Am J Obstet Gynecol 2010; 203:351.e1-8. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: analysis prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Biol Phys 1999; 43:763-75. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Maluf FC, Leiser AL, Aghajanian C, et al. Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer. Int J Gynecol Cancer 2006; 16:1165-71. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Marotta LL, Polyak K. Cancer stem cells: a model in the making. Curr Opin Genet Dev 2009; 19:44-50. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Mazumdar J, Hickey MM, Pant DK, et al. HIF-2? delectation promotes Krasdriven lung tumor development. Proc Natl Acad Sci U S A 2010; 107:14182-7. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Milas L. Cyclooxigenase-2(COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse. Semin Radiat Oncol 2001; 4:290-9. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Milas L, Hittelman W. Cancer stem cell and tumor response to therapy: current problems and future prospects. Semin Radiat Oncol 2009; 19:96-105. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;Ministério da Saúde. Instituto Nacional do Câncer. Câncer de colo do útero. Disponível em: <URL://http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer /site/home/colo_utero > [2011 nov 25]. ;
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Monk BJ, Tian C, Rose PG, Lanciano R. Wich clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials. Gynecol Oncol 2006; 105:427-33.";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinomas: state of art and future direction. J Clin Oncol 2007; 25:2952-65. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Munagala R, Dona MG, Rai S, et al. Significance of multiple HVP infection in cervical cancer patients and its impact on treatment response. Int J Oncol 2009; 34:263-71. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Nagay Y, Toma T, Moromizato H, et al. Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy. Am J Obstet Gynecol 2004; 191:1907-13. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Nakamura M, Bodily JM, Beglin M, Kyo S, Inoue M, Laimins LA. Hypoxia– specific stabilization of HIF-1? by human papillomaviruses. Virology 2009; 387:442-8. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Nakano T, Ohno T, Ishikawa H, Suzuki Y, Takahashi T. Current advancement in radiation therapy for uterine cervical cancer. J Radiat Res 2010; 51:1-8. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Noordhuis MG, Eusink JJ, Roossink F, et al. Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo) radiation: a systematic review. Int J Radiat Oncol Biol Phys 2011; 79:325-34. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Novaes PERS, Ferrigno R, Ferreira PRF, Rosa DD. Radioterapia. In: Coelho FRG, Soares FA, Focchi J, et al. editores. Câncer do colo do útero. São Paulo: Tecmed; 2008. p.496-541. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Pályi-Krekk Z, Barok M, Kovács T, et al. EGFR and ERbB2 are functionally coupled to CD44 and regulate shedding, internalization and mitogenic effect of CD44. Cancer Lett 2008; 263:231-41. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995; 32:1275-88. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signaling regulators. Nat Rev Cancer 2003; 4:33-45. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Prise KM, O’Sullivan JM. Radiation-induced bystander signaling in cancer therapy. Nat Rev Cancer 2009; 9:351-9. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Raimondi C, Gianni W, Cortesi E, Gazzaniga P. Cancer stem cells and epithelial- mesenchymal transition: revising minimal residual disease. Curr Cancer Drug Targets 2010; 10:496-508. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Randall LM, Monk BJ, Moon J, et al. Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: A Southwest Oncology Study. Gynecol Oncol 2010; 119:417-21. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Rischin D, Narayan K, Oza AM, et al. Phase 1 study of tirapazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer. Int J Gynecol Cancer 2010; 20:827-33. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Rocha RM, Vassallo J, Soares FA, Miller K, Gobbi H. Digital slides: present of a tool for consultation, teaching, and quality control in pathology. Pathol Res Pract 2009a; 205:735-41. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Rocha RM, Miller K, Soares FA, Schenka N, Vassallo J, Gobbi H. Biotin-free systems provide stronger immunohistochemical signal in estrogen receptor evaluation of breast cancer. J Clin Pathol 2009b; 62:699-704. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Rose PG, Ali S, Whitney CW, Lanciano R, Stehman FB. Outcome of stage IVa cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a gynecology oncology group study. Gynecol Oncol 2011; 121:542-5. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Saibishkumar SC, Petel FD, Sharma SC, et al. Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: A retrospective analysis of 556 patients from India. Radiother Oncol 2006; 79:1426. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Sell S. On the stem cell origin of cancer. Am J Pathol 2010; 176:2584-94. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Schatton T, Frank NY, Frank MH. Identification and targeting of cancer stem cells. Bioassays 2009; 31:1038-49. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Song YJ; Kim J, Lee S, et al. Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer. Int J Cancer 2011; 129:896-902. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Soonthorrmthum T, Arias-Pulido H, Joste N, et al. Epidermal growth factor receptor as a biomarker for cervical cancer. Ann Oncol 2011; 22:2166-78. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Speiser P, Wanner C, Tempfer C, et al. CD44 is an independent prognostic factor in early-stage cervical cancer. Int J Cancer 1997; 74:185-8.  ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Subbaramaiah K, Dannenberg AJ. Cyclooxigenase-2 transcription is regulated by human papillomavirus 16E6 and E7 oncoproteins: evidence of a co repressor/coativator exchange. Cancer Res 2007; 67:3976-85.";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Swami M. Hypoxia: the HIF-2? puzzle. Nat Rev Cancer 2010; 10:603. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Szumiel I. Intrinsic radiation sensitivity: cellular signaling is the key. Radiat Res 2008; 169:249-58. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Tan LT, Zahra M. Long-term survival and late toxicity after chemoradiotherapy for cervical cancer - the Addenbrooke´s experience. Clin Oncol (R Coll Radiol) 2008; 20:358-64. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Tang X, Zhang Q, Nishitani J, Brown J, Shi S, Le AD. Overexpression of human papillomavirus type 16 oncoprotein enhances hypoxia-inducible factor 1? protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin Cancer Res 2007; 13:2568-76. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Takabe N, Harris PJ, Warren Q, Ivy P. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol 2011; 8:97-106. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Toole BP. Hyaluronan-Cd44 interactions in cancer: paradoxes and possibilities. Clin Cancer Res 2009; 15:7462-8. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Visvader JE, Lindeman GJ. Cancer stem cells in solid tumors: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8:755-68. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Wang C, Lai C, Huang H, et al. Clinical effect of human papillomavirus genotypes in patients with cervical cancer undergoing primary radiotherapy. Int J Radiat Oncol Biol Phys 2010; 7:1111-20. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Wang X, Schneider A. HIF-2? mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia. Carcinogenesis 2010; 31:1202-10. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Winter WE 3rd, Maxwell GL, Tian C, et al. Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecology Oncology Group study. Gynecol Oncol 2004; 94:495-501.";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Wobus M, Kuns R, Wolf C, et al. CD44 mediates constitutive type i receptors signaling in cervical cancer cells. Gynecol Oncol 2001; 83:227-34. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Yeung AR, Amdur RJ, Morris CG, Morgan LS, Mendenhall WM. Long term outcome after radiotherapy for FIGO stage IIIB and IVA carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2007; 67:1445-50. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Young JL, Jazaeri AA, Darus CJ, Modesitt SC. Cyclooxygenase-2 in cervical neoplasia: a review. Gynecol Oncol 2008; 109:140-5. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Yoshimura H, Dhar DK, Khno H, et al. Prognostic impact of hypoxia –inducible factors 1? and 2 ? in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res 2004; 10:855460.";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Zöller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 2011; 11:254-67. ";
FAP;2012;ELZA MIEKO FUKAZAWA;Fernando Augusto Soares;Paulo Eduardo Ribeiro Novaes;"Zhu X, Zhou X, Lewis MT, Xia L, Wong S. Cancer stem cell, niche and EGFR decide tumor development and treatment response: a bio-computational simulation study. J Theor Biol 2011; 269:138-49.";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Acquaviva C, Pines J. The anaphase-promoting complex/cyclosome: APC/C. J Cell Sci 2006; 119:2401-04. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Aggarwal S, van de Loosdrecht AA, Alhan C, Ossenkoppele GJ, Westers TM, Bontkes HJ. Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy. Br J Haematol 2011; 153:568-81. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Watson P. Molecular biology of the cell. 5th ed. New York: Garland Science; 2008. The cell cycle; p.1053-114. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Anand S, Penrhyn-Lowe S, Venkitaraman AR. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 2003; 3:51-62.  ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Ayton PM, Cleary ML. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 2003; 17:2298307. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Bejar R, Levine R, Ebert BL. Unraveling the molecular pathophysiology of myelodysplastic syndromes. J Clin Oncol 2011; 29:504-15. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51:189-99. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Bernasconi P. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions – a review. Br J Haematol 2008; 142:695-708. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Bolanos-Garcia VM. Aurora kinases. Int J Biochem Cell Biol 2005; 37:1572-7. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Braunstein I, Miniowitz S, Moshe Y, Hershko A. Inhibitory factors associated with anaphase-promoting complex/cylosome in mitotic checkpoint. Proc Natl Acad Sci USA 2007; 104:4870-75. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Briassouli P, Chan F, Savage K, Reis-Filho JS, Linardopoulos S. Aurora-A regulation of nuclear factor-kappa B signaling by phosphorylation of IkappaBalpha. Cancer Res 2007; 67:1689-95. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Brito DA, Rieder CL. Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol 2006; 16:1194-200. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Burum-Auensen E, Skotheim RI, Schjølberg AR, Røislien J, Lothe RA, Clausen OP. Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumors. J Carcinog 2010; 9:1. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Camacho E, Beà S, Salaverría I, et al. Analysis of Aurora-A and hMPS1 mitotic kinases in mantle cell lymphoma. Int J Cancer 2006; 118:357-63. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Careta FP, Gobessi S, Panepucci RA, et al. The Aurora A and B kinases are upregulated in bone marrow-derived chronic lymphocytic leukemia cells and represent potential therapeutical targets. Rev Bras Hematol Hemoter 2011; 33:136-7. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Carmena M, Ruchaud S, Earnshaw WC. Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins. Curr Opin Cell Biol 2009; 21:796-805. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;Carneiro FF, Almeida VES. Brasil é o país que mais usa agrotóxico no mundo [periódico on line]. J Agrosoft 01 jul 2010. Disponível em: <URL:http://www.agrosoft.org.br/agropag/214789.htm> [2011 nov 07]. ;
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Catenacci DV, Schiller GJ. Myelodysplasic syndromes: a comprehensive review. Blood Rev 2005; 19:301-19. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Chamuleau ME, Westers TM, van Dreunen L, et al. Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome. Haematologica 2009; 94:496-506. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Chan AC, Neeson P, Leeansyah E, et al. Testing the NKT cell hypothesis in lenolidomide-treated myelodysplastic syndrome patients. Leukemia 2010; 24:592-600. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Chauffaille MLLF, Yamamoto M, Moncau JE, Braga GW, Souto EX, Kerbauy J. Cytogenetic abnormalities as prognostic factors in acute myeloid leukemia. Rev Assoc Med Bras 1996; 42:200-4. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Chen B, Zhao WL, Jin J, et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia 2005; 19:767-75. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Chen RH, Waters JC, Salmon ED, Murray AW. Association of spindle assembly checkpoint component XMAD2 with unattached kinetochores. Science 1996; 274:242-46. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Clute P, Pines J. Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol 1999; 1:82-7. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Cordoba I, Gonzalez-Porras JR, Such E, et al. The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndromes. Leuk Res 2012; 36:287-92. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Dakshinamurthy AG, Novitzky N, Bharadwaj R, Prakhya BM. Cytogenetic analysis of 52 Indian patients with de novo myelodysplastic syndromes-a comparative analysis of results with reports from Asia. Ann Hematol 2005; 84:298-303. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Davidson AJ, Ernst P, Wang Y, et al. Cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox genes. Nature 2003; 425:300-6. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Dayyani F, Conley AP, Strom SS, et al. Cause of death in patients with lower-risk myelodysplastic syndrome. Cancer 2012; 2174-79. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Della Porta MG, Malcovati L, Boveri E, et al. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. J Clin Oncol 2009; 27:754-62. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Dewar H, Tanaka K, Nasmyth K, et al. Tension between two kinetochores suffices for their bi-orientation on the mitotic spindle. Nature 2004; 428:93-7. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Díaz-Rodríguez E, Álvarez-Fernández S, Chen X, et al. Deficient spindle assembly checkpoint in multiple myeloma. PLoS One 2011; 6:e27583. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Disperati P, Ichim CV, Tkachuk D, Chun K, Schuh AC, Wells RA. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology. Leuk Res 2006; 30:233-39. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Dobles M, Liberal V, Scott ML, et al. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 2000; 101:635-45. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Ducat D, Zheng Y. Aurora kinases in spindle assembly and chromosome segregation. Exp Cell Res 2004; 301:60-7. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Dutertre S, Prigent C. Aurora-A overexpression leads to override of the microtubule-kinetochore attachment checkpoint. Mol Interv 2003; 3:127-30. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Enjoji M, Iida S, Sugita H, et al. BubR1 and AURKB overexpression are associated with a favorable prognosis in gastric cancer. Mol Med Report 2009; 2:589-96.  ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Epling-Burnette PK, Bai F, Painter JS, et al. Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood 2007; 109:4816-24. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Fang G, Yu H, Kirschner MW. The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev 1998; 12:1871-83. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Fang G, Yu H, Kirschner MW. Control of mitotic transitions by the anaphasepromoting complex. Philos Trans R Soc Lond B Biol Sci 1999; 354:158390. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Farruggio DC, Townsley FM, Ruderman JV. Cdc20 associates with the kinase aurora2/Aik. Proc Natl Acad Sci USA 1999; 96:7306-11. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Germing U, Strupp C, Kündgen A, et al. No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 2004; 89:905-10. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Germing U, Aul C, Niemeyer CM, Haas R, Bennett JM. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann Haematol 2008; 87:691-9. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89:207988. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Gritsko TM, Coppola D, Paciga JE, et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 2003; 9:1420-6. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Haase D, Germing U, Schanz J, et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007; 110:4385-95. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Haase D. Cytogenetic features in myelodysplastic syndromes. Ann Hematol 2008; 87:515-26. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Hagting A, Den Elzen N, Vodermaier HC, et al. Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1. J Cell Biol 2002; 157:1125-37. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Hamada M, Yakushijin Y, Ohtsuka M, Kakimoto M, Yasukawa M, Fujita S. Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin’s lymphoma. Br J Haematol 2003; 121:439-47. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Heckman CA, Mehew JW, Boxer LM. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene 2002; 21:3898-908. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Heredia F, Sousa J, Magalhães S, Pinheiro R. Therapy-related myelodysplastic syndrome with 17p deletion following long-term azathioprine treatment. Leuk Res 2010; 34:e311-2. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Hirai H. Molecular mechanisms of myelodysplastic syndrome. Jpn J Clin Oncol 2003; 33:153-60. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Huang XF, Luo SK, Xu J, et al. Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia. Blood 2008; 111:2854-65. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Hyun CL, Lee HE, Kim KS, et al. The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer. J Clin Pathol 2008; 61:317-21. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;[IBGE] Instituto Brasileiro de Geografia e Estatística. Censo agropecuário 2006: resultados preliminares. 2007. Disponível em: <URL:http://www.ibge.gov.br/home/estatistica/economia/agropecuaria/censo agro/2006/tabela1_3_10.pdf> [2011 dez 12]. ;
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;[IBGE] Instituto Brasileiro de Geografia e Estatística. Projeção da população. Disponível em: <URL:http://www.ibge.gov.br/home/estatistica/populacao/projecao_da_popul acao/2008/piramide/piramide.shtm> [2011 nov 07]. ;
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Ikezoe T, Yang J, Nishioka C, et al. A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia. Mol Cancer Ther 2007; 6:1851-57. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Ikezoe T, Takeuchi T, Yang J, et al. Analysis of Aurora B kinase in nonHodgkin lymphoma. Lab Invest 2009; 89:1364-73.  ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Intragumtornchai T, Prayoonwiwat W, Swasdikul D, et al. Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases. Leuk Res 1998; 22:453-60. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Ishibashi M, Tamura H, Ogata K. Disease progression mechanism in myelodysplastic syndromes: insight into the role of the microenvironment. Leuk Res 2011; 35:1449-52. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Jaffe ES, Harris NL, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. (IARC WHO Classification of Tumours, n.2).  ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 2004; 10:2065-71. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Jeong SJ, Shin HJ, Kim SJ, et al. Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis. Cancer Res 2004; 64:8666-73. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Jiang J, Jedinak A, Sliva D. Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA. Biochem Biophys Res Commun 2011; 415:325-9. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Ke YW, Dou Z, Zhang J, Yao XB. Function and regulation of Aurora/Ipl1p kinase family in cell division. Cell Res 2003; 13:69-81. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Kim JM, Sohn HY, Yoon SY, et al. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed gastric cancer cells. Clin Cancer Res 2005; 11:473-82. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Kitagawa M, Kamiyama R, Kasuga T. Increase in number of bone marrow macrophages in patients with myelodysplastic syndromes. Eur J Haematol 1993; 51:56-8.";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Kita-Sasai Y, Horiike S, Misawa S, et al. International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome. Br J Haematol 2001; 115:309-12. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Komrokji RS, Zhang L, Bennett JM. Myelodysplastic syndromes classification and risk stratification. Hematol Oncol Clin North Am 2010; 24:443-57. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Kordasti SY, Afzali B, Lim Z, et al. IL-17 producing CD4(+) T cells, proinflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome. Br J Haematol 2009; 145:64-72. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Kotsianidis I, Bouchliou I, Nakou E, et al. Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS). Leukemia 2009; 23:510-8. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Krishnamurti U, Hammers JL, Atem FD, et al. Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma. Mod Pathol 2009; 22:1044-48. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Lad L, Lichtsteiner S, Hartman JJ, Wood KW, Sakowicz R. Kinetic analysis of Mad2-Cdc20 formation: conformational changes in Mad2 are catalyzed by a C-Mad2-ligand complex. Biochemistry 2009; 48:9503-15. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Lassmann S, Danciu M, Müller M, et al. Aurora A is differentially expressed and regulated in chromosomal and microsatellite instable sporadic colorectal cancers. Mod Pathol 2009; 22:1385-97. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Lee JJ, Kim HJ, Chung IJ, et al. Comparisons of prognostic scoring systems for myelodysplastic syndromes: a Korean multicenter study. Leuk Res 1999; 23:425-32. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Leone G, Pagano L, Ben-Yehuda D, Voso MT. Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 2007; 92:138998. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Li D, Zhu J, Firozi PF, et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 2003; 9:991-7. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Li GQ, Zhang HF. Mad2 and p27 expression profiles in colorectal cancer and its clinical significance. World J Gastroenterol 2004; 10:3218-20. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Li M, Fang X, Wei Z, et al. Loss of spindle assembly checkpoint–mediated inhibition of Cdc20 promotes tumorigenesis in mice. J Cell Biol 2009; 185:983-94. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Li Y, Benezra R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 1996; 274:246-8. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Li Y, Gorbea C, Mahaffey D, Rechsteiner M, Benezra R. MAD2 associates with the cyclosome/anaphase-promoting complex and inhibits its activity. Proc Natl Acad Sci USA 1997; 94:12431-6. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Lima DS, Cordeiro J, Magalhães SM, Pinheiro RF. Interphase-FISH provides additional relevant information in myelodysplastic syndromes. Leuk Res 2012; 36:12-4. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Lin ZZ, Jeng YM, Hu FC, et al. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC. BMC Cancer 2010; 10:461. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Littlepage LE, Ruderman JV. Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit. Genes Dev 2002; 16:2274-85. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Liu Q, Hirohashi Y, Du X, Greene MI, Wang Q. Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: A mechanism for aneuploidy in cancer. Exp Mol Pathol 2010; 88:225-33. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Loh JK, Lieu AS, Chou CH, et al. Differential expression of centrosomal proteins at different stages of human glioma. BMC Cancer 2010; 10:268. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;Look AT. Molecular pathogenesis of MDS. Hematology Am Soc Hematol Educ Program 2005:156-60. ;
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Leuk Res 2004; 28:587-94. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Lucena-Araujo AR, de Oliveira FM, Leite-Cueva SD, dos Santos GA, Falcao RP, Rego EM. High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia. Leuk Res 2011; 35:260-4. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Lukasiewicz KB, Lingle WL. Aurora A, centrosome structure, and the centrosome cycle. Environ Mol Mutagen 2009; 50:602-19. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Ma L, Ceuppens J, Kasran A, Delforge M, Boogaerts M, Vandenberghe P. Immature and mature monocyte-derived dendritic cells in myelodysplastic syndromes of subtypes refractory anemia or refractory anemia with ringed sideroblasts display an altered cytokine profile. Leuk Res 2007; 31:1373-82. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer 2007; 109:1536-42. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Magalhães SMM, Lorand-Metze I. Síndromes mielodisplásicas – protocolo de exclusão. Rev Bras Hematol Hemoter 2004; 26:263-7. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Magalhães SMM, Madeira TS, Bittencourt R, et al. Epidemiological and clinicopathological data from the Brazilian registry of patients with myelodysplastic syndromes and comparative analysis between different geographic areas. Blood 2010; 116: abstract 1884. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Malcovati L, Porta MG, Pascutto C, et al. Prognostic factors and life expectancy in MDS classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol 2005; 23:7594-603. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Malcovati L, Della Porta MG, Strupp C, et al. Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS). Haematologica 2011; 96:1433-40. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Marucci G, Morandi L, Magrini E, et al. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20. Virchows Arch 2008; 453:599-609. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 2002; 21:483-92. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Michel L, Bezerra R, Diaz-Rodriguez E. MAD2 dependent mitotic checkpoint defects in tumorigenesis and tumor cell death: a double edged sword. Cell Cycle 2004a; 3:990-2. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Michel L, Diaz-Rodriguez E, Narayan G, Hernando E, Murty VV, Benezra R. Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells. Proc Natl Acad Sci USA 2004b; 101:4459-64. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Michel LS, Liberal V, Chatterjee A, et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 2001; 409:355-9. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Micheva I, Thanopoulou E, Michalopoulou S, et al. Defective tumor necrosis factor alpha-induced maturation of monocyte-derived dentritic cells in patients with myelodysplastic syndromes. Clin Immunol 2004; 113:310-7. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Molldrem JJ, Jiang YZ, Stetler-Stevenson M, Mavroudis D, Hensel N, Barrett AJ. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. Br J Haematol 1998; 102:1314-22. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Molldrem JJ, Akande O, Estey E, et al. Imunossupressive therapy with ATG in low risk patients with myelodysplastic syndrome [abstract]. Leuk Res 2005; 29(Suppl 1):S12-3. Presented at the 8th International Symposium on Myelodysplastic Syndromes, May, 12-15, 2005, Nagasaki, Japan. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Mondal G, Sengupta S, Panda CK, Gollin SM, Saunders WS, Roychoudhury S. Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral câncer. Carcinogenesis 2007; 28:81-92. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Murata-Hori M, Tatsuka M, Wang YL. Probing the dynamics and functions of Aurora B kinase in living cells during mitosis and cytokinesis. Mol Biol Cell 2002; 13:1099-108. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007; 8:379-93. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Mutfi GJ. Pathobiology, classification, and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol 2004; 17:543-57. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Nigg EA. Cell biology: a licence for duplication. Nature 2006; 442:874-5. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Nigg EA. Centrosome duplication: of rules and licenses. Trends Cell Biol 2007; 17:215-21.  ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Nimer SD. An update on the molecular pathogenesis of myelodysplastic syndromes. Biol Blood Marrow Transplant 2011; 17:S11-4. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Nisse C, Haguenoer JM, Grandbastien B, et al. Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol 2001; 112:927-35. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Offman J, Opelz G, Doehler B, et al. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood 2004; 104:822-8. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Oguma S, Yoshida Y, Uchino H, Maekawa T, Nomura T, Mizoguchi H. Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a cooperative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare. Leuk Res 1995; 19:219-25. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Ota T, Suto S, Katayama H, et al. Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Res 2002; 62:5168-77. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Ouellet V, Guyot MC, Le Page C, et al. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int J Cancer 2006; 119:599607. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Park HS, Park WS, Bondaruk J, et al. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection. J Natl Cancer Inst 2008; 100:1401-11.  ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Patra D, Dunphy WG. Xe-p9, a Xenopus Suc1/Cks protein, is essential for the Cdc2-dependent phosphorylation of the anaphase-promoting complex at mitosis. Genes Dev 1998; 12:2549-59. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;Pedersen-Bjergaard J, Andersen MT, Andersen MK. Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2007:3927. ;
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Peters JM. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol 2006; 7:644-56.  ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Pinheiro RF, Chauffaille MLLF. Síndrome mielodisplásica secundária à quimio ou radioterapia – SMD relacionada a tratamento. Rev Bras Hematol Hemoter 2006; 28:201-3. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Pinheiro RF, Silva MR, Chauffaille Mde L. The 5q- syndrome and autoimmune phenomena: report of three cases. Leuk Res 2006; 30:507-10. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Pinheiro RF, Moreira Ede S, Silva MR, Greggio B, Alberto FL, Chauffaille Mde L. FLT3 mutation and AML/ETO in a case of myelodysplastic syndrome in transformation corroborates the two hit model of leukemogenesis. Leuk Res 2007; 31:1015-8. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Pinheiro RF, de Sá Moreira E, Silva MR, Alberto FL, Chauffaille M de L. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia. Cancer Genet Cytogenet 2008; 183:89-93. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Pinheiro RF, Chauffaille ML. Comparison of I-FISH and G-banding for the detection of chromosomal abnormalities during the evolution of myelodysplastic syndrome. Braz J Med Biol Res 2009; 42:1110-2. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Pinheiro RF, Metze K, Silva MR, Chauffaille Mde L. The ambiguous role of interferon regulatory factor-1 (IRF-1) immunoexpression in myelodysplastic syndrome. Leuk Res 2009; 33:1308-12. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Pinto M, Soares MJ, Cerveira N, et al. Expression changes of the MAD mitotic checkpoint gene family in renal cell carcinomas characterized by numerical chromosome changes. Virchows Arch 2007; 450:379-85. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Poppe B, Vandesompele J, Schoch C, et al. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood 2004; 103:22935.";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010; 464:852-7. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Rajkumar T, Sabitha K, Vijayalakshmi N, et al. Identification and validation of genes involved in cervical tumourigenesis. BMC Cancer 2011; 11:80. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Rhodes DR, Yu J, Shanker K, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004; 101:930914. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Rigolin GM, Cuneo A, Roberti MG, et al. Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. Br J Haematol 1998; 103:189-97. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Rojanala S, Han H, Muñoz RM, et al. The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer. Mol Cancer Ther 2004; 3:451-7. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Romeo M, Chauffaille Mde L, Silva MR, Bahia DM, Kerbauy J. Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients. Leuk Res 2002; 26:993-6. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Sabbattini P, Canzonetta C, Sjoberg M, et al. A novel role for the Aurora B kinase in epigenetic marking of silent chromatin in differentiated postmitotic cells. EMBO J 2007; 26:4657-69. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Sadahira Y, Kanzaki A, Wada H, Yawata Y. Immunohistochemical identification of erythroid precursors in paraffin embedded bone marrow sections: spectrin is a superior marker to glycophorin. J Clin Pathol 1999; 52:919-21. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Sakakura C, Hagiwara A, Yasuoka R, et al. Tumour-amplified kinase BTAKis amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer 2001; 84:824-31. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;[SEER] Surveillance, Epidemiology, and End Results. Cancer statistics. Available from: <URL:http://seer.cancer.gov/statistics/> [2011 nov 07].  ;
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Schanz J, Tuchler H, Solé F, et al. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol 2012; 30:820-29. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Sen S, Zhou H, Zhang RD, et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 2002; 94:1320-9. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Shaffer LG, Tommerup N. ISCN 2005: An International System for Human Cytogenetic Nomenclature. Switzerland: ISCN; 2005. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences 2nd. New York: McGraw-Hill; 1988. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Solé F, Luño E, Sanzo C, et al. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica 2005; 90:1168-78. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Sorrentino R, Libertini S, Pallante PL, et al. Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cella proliferation. J Clin Endocrinol Metab 2005; 90:928-35. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Sotillo R, Hernando E, Díaz-Rodríguez E, et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007; 11:9-23. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;Steensma DP. The changing classification of myelodysplastic syndromes: what’s in a name? Hematology Am Soc Hematol Educ Program 2009:64555. ;
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Sternberg A, Killick S, Littlewood T, et al. Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome. Blood 2005; 106:2982-91. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Sudakin V, Chan GK, Yen TJ. Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 2001; 154:925-36. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. (IARC WHO Classification of Tumours, n.2).  ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Tefferi A, Vardiman JW. Mechanisms of disease: myelodysplastic syndromes. N Engl J Med 2009; 361:1872-85. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Tien HF, Wang CH, Chuang SM, et al. Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndromes: a study on 68 Chinese patients in Taiwan. Cancer Genet Cytogenet 1994; 74:40-9. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Tong T, Zhong Y, Kong J, et al. Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin Cancer Res 2004; 10:7304-10. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Tsou MF, Stearns T. Mechanism limiting centrosome duplication to once per cell cycle. Nature 2006; 442:947-51. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Tsou MF, Wang WJ, George KA, Uryu K, Stearns T, Jallepalli PV. Polo kinase and separase regulate the mitotic licensing of centriole duplication in human cells. Dev Cell 2009; 17:344-54. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Twu NF, Yuan CC, Yen MS, et al. Expression of Aurora kinase A and B in normal and malignant cervical tissue: High Aurora A kinase expression in squamous cervical cancer. Eur J Obstet Gynecol Reprod Biol 2009; 142:57-63. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Vagnarelli P, Earnshaw WC. Chromosomal passengers: the four-dimensional regulation of mitotic events. Chromosoma 2004; 113:211-22. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Valent P, Bain BJ, Bennett JM, et al. Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS. Leuk Res 2012; 36:1-5. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034 ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Varshney D, Zhou YY, Geller SA, et al. Determination of HER-2 Status and Chromosome 17 Polysomy in Breast Carcinomas Comparing HercepTest and PathVysion FISH Assay. Am J Clin Pathol 2004; 121:70-77. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Vassallo J, Magalhães SMM. Síndromes mielodisplásicas e mielodisplásicas/mieloproliferativas. Rev Bras Hematol Hemoter 2009; 31:267-72. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Veerakumarasivam A, Goldstein LD, Saeb-Parsy K, et al. AURKA overexpression accompanies dysregulation of DNA-damage response genes in invasive urothelial cell carcinoma. Cell Cycle 2008; 7:3525-33. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Verdaasdonk JS, Bloom K. Centromeres: unique chromatin structures that drive chromosome segregation. Nat Rev Mol Cell Biol 2011; 12:320-32. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Vischioni B, Oudejans JJ, Vos W, Rodriguez JA, Giaccone G. Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Mol Cancer Ther 2006; 5:2905-13. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Wang L, Yin F, Du Y, et al. MAD2 as a key component of mitotic checkpoint: a probable prognostic factor for gastric cancer. Am J Clin Pathol 2009; 131:793-801. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Wang X, Jin DY, Wong YC, et al. Correlation of defective mitotic checkpoint with aberrantly reduced expression of MAD2 protein in nasopharyngeal carcinoma cells. Carcinogenesis 2000; 21:2293-7. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Wang X, Jin DY, Ng RW, et al. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res 2002; 62:1662-8. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Warner SL, Bearss DJ, Han H, Von Hoff DD. Targeting aurora-2 kinase in cancer. Mol Cancer Ther 2003; 2:589-95. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Wei Y, Yu L, Bowen J, Gorovsky MA, Allis CD. Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell 1999; 97:99-109. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Ye D, Garcia-Manero G, Kantarjian HM, et al. Analysis of Aurora kinase A expression in CD34+ blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia. J Hematop 2009; 2:2-8. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Yuan B, Xu Y, Woo JH, et al. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res 2006; 12:405-10. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Zaravinos A, Lambrou GI, Boulalas I, Delakas D, Spandidos DA. Identification of common differentially expressed genes in urinary bladder cancer. PLoS One 2011; 6:e18135. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Zhang SH, Xu AM, Chen XF, Li DH, Sun MP, Wang YJ. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma. Hum Pathol 2008; 39:1827-34.  ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Zheng Z, Qianqiao Z, Qi H, Feng X, Chunkang C, Xiao L. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome. Exp Hematol 2010; 38:677-84. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Zou JX, Rollison DE, Boulware D, et al. Altered naive and memory CD4+ T cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome. Leukemia 2009; 23:1288-96. ";
FAP;2012;FABÍOLA FERNANDES HEREDIA;Alex Fiorini de Carvalho;Ronald Feitosa Pinheiro;"Zhao WL, Xu L, Wu W, et al. The myelodysplastic syndromes: analysis of prognostic factor and comparison of prognostic systems in 128 Chinese patients from a single institution. Hematol J 2002; 3:137-44. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Abel EL, Kruger ML, Friedl J. How do physicians define ""light,"" ""moderate,"" and ""heavy"" drinking? Alcohol Clin Exp Res 1998; 22:979-84. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Abrahante JE, Daul AL, Li M, et al. The Caenorhabditis elegans hunchbacklike gene lin-57/hbl-1 controls developmental time and is regulated by microRNAs. Dev Cell 2003; 4:625-37. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Achatz MI, Olivier M, Le Calvez F, et al. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Cancer Lett 2007; 245:96-102.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Achatz MI, Hainaut P, Ashton-Prolla P. Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening? Lancet Oncol 2009; 10:920-5. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Adelstein DJ, Rodriguez CP. Current and emerging standards of concomitant chemoradiotherapy. Semin Oncol 2008; 35:211-20. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ahmed SM, Mubeen, Jigna VR. Molecular biology: an early detector of oral cancers. Ann Diagn Pathol 2009; 13:140-5. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Alter BP, Joenje H, Oostra AB, Pals G. Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism. Arch Otolaryngol Head Neck Surg 2005; 131:635-9.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ambatipudi S, Gerstung M, Gowda R, et al. Genomic profiling of advancedstage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. PLoS One 2011; 6:e17250.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ambros V. A hierarchy of regulatory genes controls a larva-to-adult developmental switch in C. elegans. Cell 1989; 57:49-57.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003; 113:673-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ambrosio EP, Rosa FE, Domingues MA, et al. Cortactin is associated with perineural invasion in the deep invasive front area of laryngeal carcinomas. Hum Pathol 2011; 42:1221-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;AmiGO. The Gene Ontology. Avaliable from: <URL:http://amigo.geneontology.org/cgi-bin/amigo/go.cgi> [2012 abr 3]. ;
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363:24-35.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ankathil R, Bhattathiri NV, Francis JV, et al. Mutagen sensitivity as a predisposing factor in familial oral cancer. Int J Cancer 1996; 69:265-7.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Arlt MF, Durkin SG, Ragland RL, Glover TW. Common fragile sites as targets for chromosome rearrangements. DNA Repair (Amst) 2006; 5:1126-35. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ashman JN, Patmore HS, Condon LT, Cawkwell L, Stafford ND, Greenman J. Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation. Br J Cancer 2003; 89:864-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Auluck A, Hislop G, Bajdik C, Poh C, Zhang L, Rosin M. Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer 2010; 116:2635-44.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ayoub C, Wasylyk C, Li Y, Thomas E, et al. ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines. Br J Cancer 2010; 103:715-26. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Baker LA, Allis CD, Wang GG. PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. Mutat Res 2008; 647:3-12. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL. Multiple microalterations detected at high frequency in oral cancer. Cancer Res 2005; 65:7561-7.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Barh D, Parida S, Parida BP, Viswanathan G. Let-7, mir-125, mir-205, and mir-296 are prospective therapeutic agents in breast cancer molecular medicine. Gene Ther Mol Biol 2008; 12:189-206. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Barh D, Malhotra R, Ravi B, Sindhurani P. MicroRNA let-7: an emerging next-generation cancer therapeutic. Curr Oncol 2010; 17:70-80. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Barros Filho MC. Expressão de grupos de genes como marcadores moleculares preditivos de resposta à quimioterapia neoadjuvante com doxorrubicina e ciclofosfamida em pacientes com câncer de mama. São Paulo; 2009. [Dissertação Mestrado-Faculdade de Medicina de São Paulo]. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Bauer VL, Braselmann H, Henke M, et al. Chromosomal changes characterize head and neck cancer with poor prognosis. J Mol Med (Berl) 2008; 86:1353-65.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Baykul T, Yilmaz HH, Aydin U, Aydin MA, Aksoy M, Yildirim D. Early diagnosis of oral cancer. J Int Med Res 2010; 38:737-49.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000; 16:168-74. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Benn PA, Hsu LY. Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Milunsky A, editor. Genetic disorders and the fetus. 5th ed. Baltimore: The Johns Hopkins University Press; 2004. p.271-4. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Bennett V, Chen L. Ankyrins and cellular targeting of diverse membrane proteins to physiological sites. Curr Opin Cell Biol 2001; 13:61-7.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Bérgamo NA, da Silva Veiga LC, dos Reis PP, et al. Classic and molecular cytogenetic analyses reveal chromosomal gains and losses correlated with survival in head and neck cancer patients. Clin Cancer Res 2005; 11:62131. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Berger AH, Pandolfi PP. Haplo-insufficiency: a driving force in cancer. J Pathol 2011; 223:137-46.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Bertonha FB. O gene PHF21B como candidato à predisposição familial em cânceres de cabeça e pescoço. Botucatu; 2008. [Dissertação Mestrado-Universidade Estadual Paulista, Campus de Botucatu]. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Bhalla KN. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. J Clin Oncol 2005; 23:3971-93. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Bienz M. The PHD finger, a nuclear protein-interaction domain. Trends Biochem Sci 2006; 31:35-40. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Blumrich A, Zapatka M, Brueckner L, Zheglo D, Schwab M, Savelyeva L. The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers. Hum Mol Genet 2011; 20:1488-501.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Bockmühl U, Schlüns K, Küchler I, Petersen S, Petersen I. Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 2000; 157:369-75. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Boelens MC, Kok K, van der Vlies P, et al. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. Lung Cancer 2009; 66:372-8. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Bonazzi VF, Irwin D, Hayward NK. Identification of candidate tumor suppressor  genes inactivated by promoter methylation in melanoma. Genes Chromosomes Cancer 2009; 48:10-21. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010; 17:F19-36. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Brueckner B, Stresemann C, Kuner R, et al. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 2007; 67:1419-23.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Cabanillas R, Astudillo A, Valle M, et al. Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas. Head Neck 2011; 15. [Epub ahead of print]  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004; 101:2999-3004. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006a; 6:857-66.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006b; 66:7390-4.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Campo-Trapero J, Cano-Sánchez J, Palacios-Sánchez B, Sánchez-Gutierrez JJ, González-Moles MA, Bascones-Martínez A. Update on molecular pathology in oral cancer and precancer. Anticancer Res 2008; 28:1197-205.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Candiloro IL, Mikeska T, Hokland P, Dobrovic A. Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene. Epigenetics Chromatin 2008; 1:7. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Canevari R, Rogatto SR. Câncer de cabeça e pescoço. In: Ferreira CG, Rocha JC, editores. Oncologia molecular. São Paulo: Atheneu; 2004. p.189-202. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Cardesa A, Nadal A. Carcinoma of the head and neck in the HPV era. Acta Dermatovenerol Alp Panonica Adriat 2011; 20:161-73.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Carew JS, Giles FJ, Nawrocki ST. Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett 2008; 269:7-17. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Carninci P, Kasukawa T, Katayama S, et al. The transcriptional landscape of the mammalian genome. Science 2005; 309:1559-63. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Carter NP. Methods and strategies for analyzing copy number variation using DNA microarrays. Nat Genet 2007; 39(7 Suppl):S16-21.   ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Carvalho AL, Jeronimo C, Kim MM, et al. Evaluation of promoter hypermethylation detection in body fluids as ascreening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 2008; 14:97-107. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Cassidy J, Bissett D, Roy AJ, Payne M. Head and neck cancers. In: Cassid J, Bissett D, Obe RAJS, editors. Oxford handbook of oncology. 3rd ed. Oxford: Oxford University Press; 2010. p.443-62. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Castells A, Ino Y, Louis DN, Ramesh V, Gusella JF, Rustgi AK. Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer. Gastroenterology 1999; 117:831-7.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Castells A, Gusella JF, Ramesh V, Rustgi AK. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. Cancer Res 2000; 60:2836-9.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Cavenee WK, White RL. The genetic basis of cancer. Sci Am 1995; 272:729.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Cha JD, Kim HJ, Cha IH. Genetic alterations in oral squamous cell carcinoma progression detected by combining array-based comparative genomic hybridization and multiplex ligation-dependent probe amplification. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 111:594-607.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Chalfie M, Horvitz HR, Sulston JE. Mutations that lead to reiterations in the cell lineages of C. elegans. Cell 1981; 24:59-69.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Chang G, Xu S, Dhir R, et al. Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer. Clin Cancer Res 2010; 16:5390-401.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Chang SS, Jiang WW, Smith I, et al. MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 2008; 123:2791-7. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature 1998; 395:89-93.";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Choi HR, Sturgis EM, Rosenthal DI, Luna MA, Batsakis JG, El-Naggar AK. Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and  progression from conventional squamous cell carcinomas. Am J Surg Pathol 2003; 27:1216-20.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 2008; 87:14-32. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Choi YW, Choi JS, Zheng LT, et al. Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung. Lung Cancer 2007; 55:43-51. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Christensen BC, Avissar-Whiting M, Ouellet LG, et al. Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res 2010; 16:3713-20. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Chujo M, Noguchi T, Miura T, Arinaga M, Uchida Y, Tagawa Y. Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung. Lung Cancer 2002; 38:23-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Claverie JM. Fewer genes, more noncoding RNA. Science 2005; 309:152930.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Cloos J, Steen I, Timmerman AJ, van der Schans GP, Snow GB, Braakhuis BJ. DNA-damage processing in blood lymphocytes of head-and-necksquamous-cell-carcinoma patients is dependent on tumor site. Int J Cancer 1996; 68:26-9.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Colnaghi R, Carpenter G, Volker M, O'Driscoll M. The consequences of structural genomic alterations in humans: genomic disorders, genomic instability and cancer. Semin Cell Dev Biol 2011; 22:875-85.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Conley BA, Wright JJ, Kummar S.Targeting epigenetic abnormalities with histone deacetylase inhibitors. Cancer 2006; 107:832-40. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Copper MP, Jovanovic A, Nauta JJ, et al. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1995; 121:157-60.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 1997; 89:215-25. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Croce CM, Sozzi G, Huebner K. Role of FHIT in human cancer. J Clin Oncol. 1999; 17:1618-24. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Croucher DR, Rickwood D, Tactacan CM, Musgrove EA, Daly RJ. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells. Mol Cell Biol 2010; 30:5057-70. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Curado MP, Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 2009; 21:194-200.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Curtis C, Shah SP, Chin SF, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012; 486:346-52. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Czajkowski R, Placek W, Drewa G, Czajkowska A, Ucha?ska G. FAMMM syndrome: pathogenesis and management. Dermatol Surg 2004; 30:291-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell  carcinoma. Oral Dis 2009; 15:206-13. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Dahlstrand H, Näsman A, Romanitan M, Lindquist D, Ramqvist T, Dalianis T. Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res 2008; 28:1133-8.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Daly RJ. Cortactin signalling and dynamic actin networks. Biochem J 2004; 382:13-25. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"de Andrade M, Amos CI, Foulkes WD. Segregation analysis of squamous cell carcinoma of the head and neck: evidence for a major gene determining risk. Ann Hum Genet 1998; 62:505-10.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"De Herdt MJ, Baatenburg de Jong RJ. HGF and c-MET as potential orchestrators  of invasive growth in head and neck squamous cell carcinoma. Front Biosci 2008; 13:2516-26.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"de Oliveira LR, Ribeiro-Silva A, Zucoloto S. Prognostic impact of p53 and p63 immunoexpressionin oral squamous cell carcinoma. J Oral Pathol Med 2007; 36:191–197. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"de Villiers EM, Gunst K, Stein H, Scherübl H. Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences. Int J Cancer 2004; 109:253-8.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Debacker K, Kooy RF. Fragile sites and human disease. Hum Mol Genet 2007; 15;16 Spec No. 2:R150-8.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Deshpande AM, Wong DT. Molecular mechanisms of head and neck cancer. Expert Rev Anticancer Ther 2008; 8:799-809.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Deshpande AM, Wong DT. Molecular mechanisms of head and neck cancer. Expert Rev Anticancer Ther 2008; 8:799-809.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Drusco A, Pekarsky Y, Costinean S, et al. Common fragile site tumor suppressor genes and corresponding mouse models of cancer. J Biomed Biotechnol 2011; 2011:984505.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199:1263-9.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"D'Souza G, Dempsey A. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med 2011; 1:53 Suppl 1:S5-S11.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Duvvuri U, Shiwarski DJ, Xiao D, et al. TMEM16A Induces MAPK and Contributes Directly to Tumorigenesis and Cancer Progression. Cancer Res 2012; 72:3270-3281. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Eckstein F. Small non-coding RNAs as magic bullets. Trends Biochem Sci 2005; 30:445-52.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2009. Head and neck: introduction and general rules (Part II.); p.29-40. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Eke I, Deuse Y, Hehlgans S, et al. ??Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. J Clin Invest 2012; 122:1529-40. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Erber R, Conradt C, Homann N, et al. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene 1998; 16:1671-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8:286-98. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358 :1148–59. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Estivill X, Armengol L. Copy number variants and common disorders: filling the gaps and exploring complexity in genome-wide association studies. PLoS Genet 2007; 3:1787-99.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002; 420:629-35. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Fakhry C, D'Souza G, Sugar E, et al. Relationship between prev alent oral and cervical human papillomavirus infections in human immunode ficiency virus-positive and -negative women. J Clin Microbiol 2006; 44, 4479-85. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Fanciulli M, Petretto E, Aitman TJ. Gene copy number variation and common human disease. Clin Genet 2010; 77:201-13. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006; 7:85-97. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Fisher E, Scambler P. Human haploinsufficiency--one for sorrow, two for joy.  Nat Genet 1994; 7:5-7.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Foulkes WD, Brunet JS, Kowalski LP, Narod SA, Franco EL. Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. Int J Cancer 1995; 63:769-73. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Foulkes WD, Brunet JS, Sieh W, Black MJ, Shenouda G, Narod SA. Familial risks of squamous cell carcinoma of the head and neck: retrospective casecontrol study. BMJ 1996; 313:716-21.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Foulkes WD, Brunet JS, Sieh W, Black MJ, Shenouda G, Narod SA. Familial risks of squamous cell carcinoma of the head and neck: retrospective casecontrol study. BMJ 1996; 313:716-21.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Freier K, Knoepfle K, Flechtenmacher C, et al. Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer 2010; 49:916.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Fukazawa T, Maeda Y, Durbin ML, et al. Pulmonary adenocarcinomatargeted gene therapy by a cancer- and tissue-specific promoter system. Mol Cancer Ther 2007; 6:244-52.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Fung C, Grandis JR. Emerging drugs to treat squamous cell carcinomas of the head and neck. Expert Opin Emerg Drugs 2010; 15:355-73.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Gallagher PG, Forget BG. An alternate promoter directs expression of a truncated, muscle-specific isoform of the human ankyrin 1 gene. J Biol Chem 1998; 273:1339-48. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Garavello W, Foschi R, Talamini R, et al. Family history and the  risk of oral and pharyngeal cancer. Int J Cancer 2008; 122:1827-31.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196:261-82. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Garnis C, Baldwin C, Zhang L, Rosin MP, Lam WL. Use of complete coverage array comparative genomic hybridization to define copy number alterations on chromosome 3p in oral squamous cell carcinomas. Cancer Res 2003; 63:8582-5. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Gibcus JH, Kok K, Menkema L, et al. High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications. Hum Genet 2007; 121:187-201.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92:709-20.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Glover TW, Stein CK. Induction of sister chromatid exchanges at common fragile sites. Am J Hum Genet 1987; 41:882-90.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Glover TW, Stein CK. Chromosome breakage and recombination at fragile sites. Am J Hum Genet 1988; 43:265-73.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Gold KA, Lee HY, Kim ES. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 2009; 115:922-35.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Goldstein AM, Pastakia B, DiGiovanna JJ, et al. Clinical findings in two African-American families with the nevoid basal cell carcinoma syndrome (NBCC). Am J Med Genet 1994; 50:272-81.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Gollin SM. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 2001; 23:23853.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Gotte K, Riedel F, Neubauer J, et al. The relationship between allelic imbalance on 17p, p53 mutationand p53 overexpression in head and neck cancer. Int J Oncol 2001; 19:331-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ha PK, Califano JA. Promoter methylation and inactivation of tumoursuppressor genes in oral squamous-cell carcinoma. Lancet Oncol 2006; 7:77-82.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Hafkamp HC, Speel EJ, Haesevoets A, et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 2003; 107:394-400. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Hall PA, Reis-Filho JS, Tomlinson IP, Poulsom R. An introduction to genes, genomes and disease. J Pathol 2010; 220:109-13.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Hara H, Ozeki S, Shiratsuchi Y, Tashiro H, Jingu K. Familial occurrence of oral cancer: report of cases. J Oral Maxillofac Surg 1988; 46:1098-102.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Harty LC, Caporaso NE, Hayes RB, et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst 1997; 89:1698-705.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007; 99:777-89.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Hayatsu H. The bisulfite genomic sequencing used in the analysis of epigenetic states, a technique in the emerging environmental genotoxicology research. Mutat Res 2008; 659:77-82.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Henrichsen CN, Chaignat E, Reymond A. Copy number variants, diseases and gene expression. Hum Mol Genet 2009; 18:R1-8.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Hitchins MP. Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility. Adv Genet 2010; 70:201-43.   ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Hocking JS, Stein A, Conway EL, et al. Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPVassociated oropharyngeal cancers. Br J Cancer 2011; 104:886-91.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Hopkins J, Cescon DW, Tse D, et al. Genetic polymorphisms and head and neck cancer outcomes: a review. Cancer Epidemiol Biomarkers Prev 2008; 17:490-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Huang X, Godfrey TE, Gooding WE, McCarty KS Jr, Gollin SM. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer 2006; 45:1058-69. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Hui AB, Lenarduzzi M, Krushel T, et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010; 16:1129-39.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005; 5:127-35.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2012 Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2011. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ionita-Laza I, Rogers AJ, Lange C, Raby BA, Lee C. Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis. Genomics 2009; 93:22-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Iwase S, Januma A, Miyamoto K, et al. Characterization of BHC80 in BRAFHDAC complex, involved in neuron-specific gene repression. Biochem Biophys Res Commun 2004; 322:601-8.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Jakymiw A, Patel RS, Deming N, et al. Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer 2010; 49:549-59. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Jares P, Nadal A, Fernández PL, et al. Disregulation of p16MTS1/CDK4I protein and mRNA expression is associated with gene alterations in squamous-cell carcinoma of the  larynx. Int J Cancer 1999; 81:705-11.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Järvinen AK, Autio R, Haapa-Paananen S, et al. Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene 2006; 25:6997-7008. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Järvinen AK, Autio R, Kilpinen S, et al. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosomes Cancer 2008; 47:500-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Jazdzewski K, Liyanarachchi S, Swierniak M, et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci U S A 2009; 106:1502-5.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Jefferies S, Edwards SM, Hamoudi RA, et al. No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours. Br J Cancer 2001; 85:1383-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. Cancer J Clin 2006; 56:106-30.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Jiang J, Lee EJ, Gusev Y, Schmittgen TD. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 2005; 33:5394-403. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Jin C, Jin Y, Wennerberg J, Akervall J, Dictor M, Mertens F. Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck. Cancer Genet Cytogenet 2002; 132:85-96. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Jin C, Jin Y, Wennerberg J, Annertz K, Enoksson J, Mertens F. Cytogenetic abnormalities in 106 oral squamous cell carcinomas. Cancer Genet Cytogenet 2006; 164:44-53. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Johnson CD, Esquela–Kerscher A, Stefani G, et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007; 67:7713-22. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120:635-47.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Johnstone CN, Castellví-Bel S, Chang LM et al. ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers. Gene 2004; 336:59-71. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 2002; 1:287-99. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 21:163-7. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kaminagakura E, Villa LL, Andreoli MA, et al. High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer 2012; 130:1726-32.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Karsai S, Abel U, Roesch-Ely M, et al. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis. J Pathol 2007; 11:314-322. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kehrer-Sawatzki H. What a difference copy number variation makes. Bioessays 2007; 29:311-3.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kim L, King T, Agulnik M. Head and neck cancer: changing epidemiology and public health implications. Oncology (Williston Park) 2010; 24:915-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kim VN, Nam JW. Genomics of microRNA. Trends Genet 2006; 22:165-73.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Klein JD, Grandis JR. The molecular pathogenesis of head and neck cancer. Cancer Biol Ther 2010; 9:1-7.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kleinjan DA, van Heyningen V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 2005; 76:8-32. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68:820-3.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999; 109:1544-51.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Koch WM, Nance M. Classification, clinical features, and molecular genetic models. In: Olshan AF, editor. Epidemiology, pathogenesis, and preventions of head and neck cancer. New York: Springer; 2010.p.1-22. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kong Q, Wu M, Wang Z, et al. Effect of trichostatin A and 5-Aza-2'deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells. Mol Cell Biochem 2011; 355:157-65. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Koolen DA, Vissers LE, Pfundt R, et al. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet 2006; 38:999-1001.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kostrzewska-Poczekaj M, Giefing M, Jarmuz M, et al. Recurrent amplification in the 22q11 region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene. Cancer Biomark 2010-2011; 8:11-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kouzarides T. Chromatin modifications and their function. Cell 2007; 128:693-705.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Koy S, Plaschke J, Luksch H, et al. Microsatellite instability and loss of heterozygosity in squamous cell carcinoma  of the head and neck. Head Neck 2008; 30:1105-13. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kreimer AR, Alberg AJ, Daniel R, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004; 189:686-98.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kreimer AR, Bhatia RK, Messeguer AL, González P, Herrero R, Giuliano AR. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010; 37:386-91.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Krepischi AC, Achatz MI, Santos EM, et al. Germline DNA copy number variation in familial and early-onset breast cancer. Breast Cancer Res 2012; 14:R24.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kresse SH, Szuhai K, Barragan-Polania AH, et al. Evaluation of highresolution microarray platforms for genomic profiling of bone tumours. BMC Res Notes 2010; 3:223. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kristensen LS, Wojdacz TK, Thestrup BB, Wiuf C, Hager H, Hansen LL. Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM. BMC Cancer 2009; 9:453. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kuismanen SA, Holmberg MT, Salovaara R, De La Chapelle A, Peltomäki P. Genetic and epigenetic modification of mlh1 accounts for a major share ofmicrosatellite-unstable colorectal cancers. Am J Pathol 2000; 156:1773-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kulis M, Esteller M. Dna methylation and cancer. Adv genet 2010; 70:27-56.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kumar MS, Erkeland SJ, Pester RE, et al. Suppression of non-small cell lung tumor development by the let-7 microrna family. Proc Natl Acad Sci U S A 2008; 105:3903-8. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Kutler DI, Wreesmann VB, Goberdhan A, et al. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 2003; 95:1718-21. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lai EC. MicroRNAs: runts of the genome assert themselves. Curr Biol 2003; 13:R925-36.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lajer CB, von Buchwald C. The role of human papillomavirus in head and neck cancer. APMIS 2010; 118:510-9.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lan F, Collins RE, De Cegli R, et al. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature 2007; 448:718-22.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lange JC, Borchers J, Danahey D, et al. Mutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16/p14arf. Int J Oncol 2002; 21:401-8. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Latchford A, Volikos E, Johnson V, et al. APC mutations in FAP-associated desmoid tumours arenon-random but not 'just right'. Hum Mol Genet. 2007; 16(1):78-82. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lee YS, Dutta A. The tumor suppressor micrornalet-7 re-presses the HMGA2 oncogene. Genes Dev 2007; 21:1025-30. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11:9-22. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Li B, Gogol M, Carey M, Lee D, Seidel C, Workman JL. Combined action of PHD and chromo domains directs the Rpd3S HDAC to transcribed chromatin. Science 2007; 316:1050-4.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Li H, Fischle W, Wang W, et al. Structural basis for lower lysine methylation state-specific readout by MBT repeats of L3MBTL1 and an engineered PHD finger. Mol Cell 2007; 28:677-91.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lin SY, Johnson SM, Abraham M, et al. The C elegans hunchback homolog, hbl-1, controls temporal patterning and is a probable microRNA target. Dev Cell 2003; 4:639-50. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lindemann RK, Gabrielli B, Johnstone RW. Histone-deacetylase inhibitors for the treatment of cancer. Cell Cycle 2004; 3:779-88. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Liu CJ, Lin SC, Chen YJ, Chang KM, Chang KW. Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas. Mol Carcinog 2006; 45:721-31. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Liu K, Zuo C, Luo QK, Suen JY, Hanna E, Fan CY. Promoter hypermethylation and inactivation of hMLH1, a DNA mismatch repair gene, in head and neck squamous cell carcinoma. Diagn Mol Pathol 2003; 12:50-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lockwood WW, Chari R, Chi B, Lam WL. Recent advances in array comparative genomic hybridization technologies and their applications in human genetics. Eur J Hum Genet 2006; 14:139-48. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Long XB, Sun GB, Hu S, et al. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncol Rep 2009; 22:1189-95. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. Pathology and genetics of head and neck tumors. IARC Press: Lyon; 2007. (WHO Classification of Tumours, v. 9; IARC WHO Classification of Tumours, nº 9). ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lowy DR, Munger K. Prognostic implications of HPV in oropharyngeal cancer. N Engl J Med 2010; 363:82-4. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 2007; 67:1011722.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lukusa T, Fryns JP. Human chromosome fragility. Biochim Biophys Acta 2008; 1779:3-16. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Lynch HT, Brand RE, Hogg D, et al. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanomapancreatic carcinoma-prone families: the familial atypical mole melanomapancreatic carcinoma syndrome. Cancer 2002; 94:84-96. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250:1233-8. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Marichalar-Mendia X, Rodriguez-Tojo MJ, Acha-Sagredo A, Rey-Barja N, Aguirre-Urizar JM. Oral cancer and polymorphism of ethanol metabolising genes. Oral Oncol 2010; 46:9-13. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Marks PA, Xu WS. Histone deacetylase inhibitors: Potential in cancer therapy. J Cell Biochem 2009; 107:600-8. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Marron M, Boffetta P, Zhang ZF, et al. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol 2010; 39:182-96.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Marsh D, Zori R. Genetic insights into familial cancers-- update and recent discoveries. Cancer Lett 2002; 181:125-64.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Martin CL, Reshmi SC, Ried T, et al. Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol 2008; 44:369-82.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Martone T, Gillio-Tos A, De Marco L, et al. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin Cancer Res 2007; 13:5089-94. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Matthews AG, Kuo AJ, Ramón-Maiques S, et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature 2007; 450:1106-10.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Mattick JS, Makunin IV. Small regulatory RNAs in mammals. Hum Mol Genet 2005; 14:R121-32. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"McCarroll SA, Hadnott TN, Perry GH, et al. Common deletion polymorphisms in the human genome. Nat Genet 2006; 38:86-92.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"McLaughlin-Drubin ME, Münger K. Oncogenic activities of human papillomaviruses. Virus Res 2009; 143:195-208.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Mellor J. It takes a PHD to read the histone code. Cell 2006; 126:22-4.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Mertens F, Johansson B, Höglund M, Mitelman F. Chromosomal imbalance maps of  malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 1997; 57:2765-80. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Meurman JH. Infectious and dietary risk factors of oral cancer. Oral Oncol 2010; 46:411-3.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Mi S, Lu J, Sun M, et al. Micrornaexpression signatures accu-rately discriminate acute lymphoblastic leukemia from acute my-eloid leukemia. Proc Natl Acad Sci U S A 2007; 104:19971-6. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med 2006; 355:51-65.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Mimori K, Druck T, Inoue H, et al. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc Natl Acad Sci U S A 1999; 96:7456-61.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;Mitelman F, Johansson BE, Mertens F. Mitelman database of chromosome aberrations and gene fusions in cancer. 2008. Avaliable from: <URL:http://cgap.nci.nih.gov/chromosomes/mitelman>. [2012 mai 12]  ;
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;Mitelman F, Bertil J, Fredrik M. Mitelman database of chromosome aberrations and gene fusions in cancer. Available from: <URL:http://www.research.med.lu.se/en_projektdetaljer.php?Proj=203> [2012 jan 25]. ;
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Miyakawa A, Wang XL, Nakanishi H, et al. Allelic loss on chromosome 22 in oral cancer: possibility of the existence of a tumor suppressor gene on 22q13. Int J Oncol 1998; 13:705-9.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 2009; 45:324-34.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Musco G, Peterson P. PHD finger of autoimmune regulator: an epigenetic link between the histone modifications and tissue-specific antigen expression in thymus. Epigenetics 2008; 3:310-4.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Musselman CA, Kutateladze TG. PHD fingers: epigenetic effectors and potential drug targets. Mol Interv 2009; 9:314-23.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Nadal A, Jares P, Pinyol M, et al. Association of CDK4 and CCND1 mRNA overexpression in laryngeal squamous cell carcinomas occurs without CDK4 amplification. Virchows Arch 2007; 450:161-7.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Naidu A, Wright JM. The role of the human papillomavirus in oropharyngeal cancer. Tex Dent J 2011; 128:447-54.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Nam S, Kim B, Shin S, Lee S. MirGator: an integrated system for functional annotation of micrornas. Nucleic Acids Res 2008; 36:D159-64. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Negri E, Boffetta P, Berthiller J, et al. Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer 2009; 124:394-401.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Oliveira C, Sousa S, Pinheiro H, et al. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009; 136:2137-48. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Oliver RJ, Dearing J, Hindle I. Oral cancer in young adults: report of three  cases and review of the literature. Br Dent J 2000; 188:362-5.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2010; 2:a001008. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ollikainen M, Hannelius U, Lindgren CM, Abdel-Rahman WM, Kere J, Peltomäki P. Mechanisms of inactivation of mlh1 in hereditary nonpolyposis colorectalcarcinoma: a novel approach. Oncogene 2007; 26:4541-9.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Olshan AF, Weissler MC, Watson MA, Bell DA. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2000; 9:185-91.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"O'Regan EM, Toner ME, Smyth PC, et al. Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients. Head Neck 2006; 28:330-8.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Parise O, Janot F, Guerry R, et al. Chromosome-11q13 gene amplifications in head and neck squamous-cell carcinomas - relation with lymph-node invasion. Int J Oncol 1994; 5:309-13. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Park SM, Shell S, Radjabi AR, et al. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 2007; 6:2585-90. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Pehlivan D, Gunduz E, Gunduz M, et al. Loss of heterozygosity  at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas. J Cancer Res Clin Oncol 2008; 134:1267-76. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Pelucchi C, Tramacere I, Boffetta P, Negri E, La Vecchia C. Alcohol consumption and cancer risk. Nutr Cancer 2011; 63:983-90.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Pérez-Sayáns M, Somoza-Martín JM, Barros-Angueira F, Reboiras-López MD, Gándara Rey JM, García-García A. Genetic and molecular alterations associated with oral squamous cell cancer (Review). Oncol Rep 2009; 22:1277-82.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:e45.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Pfeifer K. Mechanisms of genomic imprinting. Am J Hum Genet 2000; 67:777-87.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Pinkel D, Albertson DG. Comparative genomic hybridization. Annu Rev Genomics Hum Genet 2005; 6:331-54.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Piovezan GC. Prevalência do alelo TP53 R337H no Estado do Paraná. Paraná; 2006. [Dissertação Mestrado-Universidade Federal do Paraná]. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Piriyapongsa J, Jordan IK. A family of human microRNA genes from miniature inverted-repeat transposable elements. PLoS One 2007; 2:e203. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Pohl G, Shih IeM. Principle and applications of digital PCR. Expert Rev Mol Diagn 2004; 4:41-7.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Poli-Frederico RC, Bergamo NA, Reis PP, et al. Chromosome 22q a frequent site of allele loss in head and neck carcinoma. Head Neck 2000; 22:585-90. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010; 465:1033-8. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Press JZ, DE Luca A, Boyd N, et al. Ovarian carcinomas with genetic and epigenetic brca1 loss have distinct molecular abnormalities. BMC Cancer 2008; 8:17.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Prime SS, Thakker NS, Pring M, Guest PG, Paterson IC. A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma. Oral Oncol 2001; 37:1-16.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Prystowsky MB, Adomako A, Smith RV, et al. The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines. J Pathol 2009; 218:467-77. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Puri SK, Si L, Fan CY, Hanna E. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol 2005; 26:12-7.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ramdas L, Giri U, Ashorn CL, Coombes KR, El-Naggar A, Ang KK, Story MD. miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck 2009; 31:642-54. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Rampias T, Sasaki C, Weinberger P, Psyrri A. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst 2009; 101:412-23.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Rasamny JJ, Allak A, Krook KA, et al. Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2012; 146:923-31. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Rassool FV, McKeithan TW, Neilly ME, et al. Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites. Proc Natl Acad Sci U S A 1991; 88:6657-61.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444:444-54.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000; 403:901-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Reis PP, Poli-Frederico RC, dos Santos RM, Nishimoto IN, Kowalski LP, Rogatto SR. Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas. Med Sci Monit 2002a; 8:BR89-94. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Reis PP, Rogatto SR, Kowalski LP, et al. Quantitative real-time PCR identifies a critical region  of deletion on 22q13 related to prognosis in oral cancer. Oncogene 2002b; 21:6480-7.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A 2001; 98:9330-5.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet 2000; 1:11-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Rodrigo JP, García-Carracedo D, García LA, et al. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 2009; 217:51623. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Rodrigo JP, Coto E, Gonzalez MV, Maldonado M, Suarez C. P53 allelic loss and outcome in patientswith squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol 2001; 258:255-8. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Rodriguez T, Altieri A, Chatenoud L, et al. Risk factors for oral and pharyngeal cancer  in young adults. Oral Oncol 2004; 40:207-13.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997; 89:1758-62.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Rodriguez-Revenga L, Mila M, Rosenberg C, Lamb A, Lee C. Structural variation in the human genome: the impact of copy number variants on clinical diagnosis. Genet Med 2007; 9:600-6. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Roh HJ, Shin DM, Lee JS, et al. Visualization of the timing of gene amplification during multistep head and neck tumorigenesis. Cancer Res 2000; 60:6496-502. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101:822-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Rothhammer T, Bosserhoff AK. Epigenetic events in malignant melanoma. Pigment Cell Res 2007; 20:92-111.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;Roush S, Slack FJ. The let-7 family of microRNAs.Trends Cell Biol 2008:18:505-16. ;
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ruano Y, Mollejo M, de Lope AR, Hernández-Moneo JL, Martínez P, Meléndez B.  Microarray-based comparative genomic hybridization (arrayCGH) as a useful tool for identifying genes involved in Glioblastoma (GB). Methods Mol Biol 2010; 653:35-45.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ruby JG, Jan C, Player C, et al. Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell 2006; 127:1193-207. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Ruthenburg AJ, Allis CD, Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 2007; 25:15-30.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Sampson VB, Rong NH, Han J, et al. Micrornalet-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007; 67:9762-70. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977; 74:5463-7. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Scherer SW, Lee C, Birney E, et al. Challenges and standards in integrating surveys of structural variation. Nat Genet 2007; 39:S7-15.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Schindler U, Beckmann H, Cashmore AR. HAT3.1, a novel Arabidopsis homeodomain protein containing a conserved cysteine-rich region. Plant J 1993; 4:137-50.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 2008; 18:549-57.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck  squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 2000; 36:311-27. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Seidinger AL, Mastellaro MJ, Paschoal Fortes F, et al. Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil. Cancer 2011; 117:222835.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brainexpressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 2004; 5:R13. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Sempere LF, Christensen M, Silahtaroglu A, et al. Altered micrornaexpression confined to specific epithelial cell sub-populations in breast cancer. Cancer Res 2007; 67:11612-20. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer 2007; 109:703-12. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Shanesmith R, Allen RA, Moore WE, et al. Comparison of 2 line blot assays for defining HPV genotypes in oral and oropharyngeal squamous cell carcinomas. Diagn Microbiol Infect Dis 2011; 70:240-5.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Shao Y, Gao Z, Marks PA, Jiang X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA 2004; 101:18030–5. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Shaw-Smith C, Pittman AM, Willatt L, et al. Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat Genet 2006; 38:1032-7. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79:551–555. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Shi H, Wang MX, Caldwell CW. CpG islands: their potential as biomarkers for cancer. Expert Rev Mol Diagn 2007; 7:519-31. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Shikauchi Y, Saiura A, Kubo T, et al. SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma. Mol Cell Biol 2009; 29:1944-58.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Shukla S, Bharti AC, Mahata S, et al. Infection of human papillomaviruses in cancers of different human organ sites. Indian J Med Res 2009; 130:222-33.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Smith EM, Swarnavel S, Ritchie JM, Wang D, Haugen TH, Turek LP. Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J 2007; 26:83640. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Smith J, Tho LM, Xu N, Gillespie DA. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 2010; 108:73-112.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Snijders AM, Schmidt BL, Fridlyand J, et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 2005; 24:4232-42. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Solinas-Toldo S, Lampel S, Stilgenbauer S, et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997; 20:399-407. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Sparano A, Quesnelle KM, Kumar MS, et al. Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope 2006; 116:735-41.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Stanich JE, Gibbons SJ, Eisenman ST, et al. Ano1 as a regulator of proliferation. Am J Physiol Gastrointest Liver Physiol 2011; 301:G104451. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Stranger BE, Forrest MS, Dunning M, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007; 315:848-53.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Struski S, Doco-Fenzy M, Cornillet-Lefebvre P. Compilation of published comparative genomic hybridization studies. Cancer Genet Cytogenet 2002; 135:63-90.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Suárez C, Rodrigo JP, Ferlito A, Cabanillas R, Shaha AR, Rinaldo A. Tumours of familial origin in the head and neck. Oral Oncol 2006; 42:96578.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Sun W, Wright FA, Tang Z, et al. Nordgard SH, Van Loo P, Yu T, Kristensen VN, Perou CM. Integrated study of copy number states and genotype calls using high-density SNP arrays. Nucleic Acids Res 2009; 37:5365-77.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Sy SM, Fan B, Lee TW, et al. Spectral karyotyping indicates complex rearrangements in lung adenocarcinoma of nonsmokers. Cancer Genet Cytogenet 2004; 153:57-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin 2010; 60:376-92. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64:3753-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Tan KD, Zhu Y, Tan HK, et al. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 2008; 47:353-62. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Tashiro H, Abe K, Tanioka H. Familial occurrence of cancer of the mouth. J Oral Maxillofac Surg 1986; 44:322-3.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Tawfik HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene. Am J Otolaryngol 2011; 32:528-36.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Termine N, Giovannelli L, Matranga D, et al. Oral human papillomavirus infection in women with cervical HPV infection: new data from an Italian cohort and a metanalysis of the literature. Oral Oncol 2011; 47:244-50.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Thiagalingam S, Laken S, Willson JK, et al. Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci U S A 2001; 98:2698-702.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Thomson JM, Parker J, Perou CM, Hammond SM. A custom microarray platform for analysis of microRNA gene expression. Nat Methods 2004; 1:47-53. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM. Extensive post-transcriptional regulation of microRNAs and its impli-cations for cancer. Genes Dev 2006; 20:2202-7. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Toner M, O'Regan EM. Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 2. Head Neck Pathol 2009; 3:249-51.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Torossian JM, Beziat JL, Philip T, Bejui FT. Squamous cell carcinoma of the  tongue in a 13-year-old boy. J Oral Maxillofac Surg 2000; 58:1407-10.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Torrisani J, Bournet B, du Rieu MC, et al. Let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum Gene Ther 2009; 20:831-44.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Toyota M, Suzuki H. Epigenetic drivers of genetic alterations. Adv Genet 2010; 70:309-23.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Tsantoulis PK, Kastrinakis NG, Tourvas AD, Laskaris G, Gorgoulis VG. Advances in the biology of oral cancer. Oral Oncol 2007; 43:523-34.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Tuzun E, Sharp AJ, Bailey JA, et al. Fine-scale structural variation of the human genome. Nat Genet 2005; 37:727-32. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Tycko B, Ashkenas J. Epigenetics and its role in disease. J Clin Invest 2000; 105:245-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Umar A, Risinger JI, Hawk ET, Barrett JC. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 2004; 4:153-8.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34:424-5.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116:1453-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Verma RS, Triantafillou NG. Oncogenetic map of human genome. Cancer Genet Cytogenet 1998; 100:88-90.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Vidal L, Gillison ML. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin North Am 2008; 22:1125-42. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Vinarsky V, Fine RL, Assaad A, et al. Head and neck squamous cell carcinoma in FAMMM syndrome. Head Neck 2009; 31:1524-7. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Virgin JB, Hurley PM, Nahhas FA, et al. Isochromosome 8q formation is associated with 8p loss of heterozygosity in a prostate cancer cell line. Prostate 1999; 41:49-57. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Vissers LE, Veltman JA, van Kessel AG, Brunner HG. Identification of disease genes by whole genome CGH arrays. Hum Mol Genet 2005; 14:R215-23.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Viswanathan M, Tsuchida N, Shanmugam G. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 2003; 105:41-6.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Vogelstein B, Kinzler KW. Digital PCR. Proc Natl Acad Sci U S A 1999; 96:9236-41. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Walsh JE, Lathers DM, Chi AC, Gillespie MB, Day TA, Young MR. Mechanisms of  tumor growth and metastasis in head and neck squamous cell carcinoma. Curr Treat Options Oncol 2007; 8:227-38.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Weinberg RA. Tumor suppressor genes. Science 1991; 254:1138-46.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Weiss D, Basel T, Sachse F, Braeuninger A, Rudack C. Promoter methylation ofcyclin a1 is associated with human papillomavirus 16 induced head and necksquamous cell carcinoma independently of p53 mutation. Mol Carcinog 2011; 50:680-8. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Welkoborsky HJ, Bernauer HS, Riazimand HS, et al. Patterns of chromosomal aberrations in metastasizing and nonmetastasizing squamous cell carcinomas of the oropharynx and hypopharynx. Ann Otol Rhinol Laryngol 2000; 109:401-10. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248:76-9.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res 2008; 14:366-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Wijnhoven SW, Kool HJ, van Teijlingen CM, van Zeeland AA, Vrieling H. Loss of heterozygosity in somatic cells of the mouse. An important step in cancer initiation? Mutat Res 2001; 473:23-36.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Wilke CM, Guo SW, Hall BK, et al. Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma. Genomics 1994; 22:319-26.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MSHRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic acids Res 2007; 35:e41.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Wojdacz TK, Dobrovic A, Algar EM. Rapid detection of methylation change at H19 in human imprinting disorders using methylation-sensitive highresolution melting. Hum Mutat 2008; 29:1255-60. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Worm J, Aggerholm A, Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem 2001; 47:1183-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Worsham MJ, Chen KM, Stephen JK, Havard S, Benninger MS. Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer. Otolaryngol Head Neck Surg 2010; 143:116-21.";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Wu ZS, Wu Q, Wang CQ, et al. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer 2010; 10:542.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Wulczyn FG, Smirnova L, Rybak A, et al. Post-transcriptional regulation of the let-7 microRNA during neural cell specification. FASEB J 2007; 21:415426.";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Wyandt HE, Tonk VS, editors. Atlas of human chromosome heteromorphisms. Boston: Kluwer Academic Publishers; 2004. Plates; p.279. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Xu WS, Perez G, Ngo L, Gui CY, Marks PA. Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects. Cancer Res 2005; 65:7832-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Yakut T, Schulten HJ, Demir A, et al. Assessment of molecular events in squamous and non-squamous cell lung carcinoma. Lung Cancer 2006; 54:293-301.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9:189-98. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Yarbrough WG. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma. Laryngoscope 2002; 112:211428.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Yeung AT, Patel BB, Li XM, et al. One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposis. Cancer Res 2008; 68:7579-86.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Yoshihara K, Tajima A, Adachi S, et al. Germline copy number variations in BRCA1-associated ovarian cancer patients. Genes Chromosomes Cancer 2011; 50:167-77. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Yu CC, Chen YW, Chiou GY, et al. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol 2011; 47:202-10.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Yu GP, Zhang ZF, Hsu TC, Spitz MR, Schantz SP. Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett 1999; 146:93-101.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Yu KK, Zanation AM, Moss JR, Yarbrough WG. Familial head and neck cancer: molecular analysis of a new clinical entity. Laryngoscope 2002; 112:1587-93.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302:1-12.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"Zhang ZF, Morgenstern H, Spitz MR, et al. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2000; 9:1043-9. ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;zur Hausen H. Papillomaviruses in human cancers. In: Rigby PWJ, Wilkie NM, editors. Viruses and cancer. Cambridge: Cambridge Univ. Press: 1986. p.83-90. (Society for General Microbiology Symposia). ;
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"zur Hausen H. Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta 1996; 1288:F55-78.  ";
FAP;2012;FERNANDA BERNARDI BERTONHA;Silvia Regina Rogatto;-x-;"zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2:342-50.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Agarwal N, Ulahannan MJ, Mandile MA, Cayten CG, Pitchumoni CS. Increased risk of colorectal cancer following breast cancer. Ann Surg 1986; 203:307-10. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Anglim PP, Galler JS, Koss MN, et al. Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer. Mol Cancer 2008; 7:62.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"[Anonymous]. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999; 91:1310-6.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Arakawa H. Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 2004; 4:978-87.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375:1624-33.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Backes FJ, Cohn DE. Lynch syndrome. Clin Obstet Gynecol 2011; 54:199214. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Bae JS, Choi JS, Baik SH, et al. Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast. World J Surg Oncol 2010; 8:32. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Banham AH, Beasley N, Campo E, et al. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res 2001; 61:8820-9.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Banyard J, Barrows C, Zetter BR. Differential regulation of human thymosin beta 15 isoforms by transforming growth factor beta 1. Genes Chromosomes Cancer 2009; 48:502-9.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Beckmann JS, Estivill X, Antonarakis SE. Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet 2007; 8:639-46. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Bianchi F, Raponi M, Piva F, et al. An intronic mutation in MLH1 associated with familial colon and breast cancer. Fam Cancer 2011; 10:27-35. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Blokhuis MM, Goldberg PA, Pietersen GE, et al. The extracolonic cancer spectrum in females with the common 'South African' hMLH1 c.C1528T mutation. Fam Cancer 2008; 7:191-8.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Bode BP, Fuchs BC, Hurley BP, et al. Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells. Am J Physiol Gastrointest Liver Physiol 2002; 283:G1062-73.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58:5248-57. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Boland CR. Molecular screening for Lynch syndrome. Nat Clin Pract Gastroenterol Hepatol 2005; 2:392-3. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Boyd J, Rhei E, Federici MG, et al. Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 1999; 53:87-91.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Braude I, Vukovic B, Prasad M, et al. Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia. BMC Genomics 2006; 7:138. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Buerki N, Gautier L, Kovac M, et al. Evidence for breast cancer as an integral part of Lynch syndrome. Genes Chromosomes Cancer 2012; 51:83-91. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 1997; 277:997-1003. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Callahan R, Egan SE. Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia 2004; 9:145-63. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Campbell IG, Choong D, Chenevix-Trench G, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer. Breast Cancer Res 2004; 6:R366-71.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Case AS, Zighelboim I, Mutch DG, et al. Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair. Gynecol Oncol 2008; 108:438-44. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Chatterjee S, Pal JK. Role of 5'- and 3'-untranslated regions of mRNAs in human diseases. Biol Cell  2009; 101:251-62. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Chédotal A, Kerjan G, Moreau-Fauvarque C. The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ 2005; 12:1044-56.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Chédotal A. Slits and their receptors. Adv Exp Med Biol 2007; 621:65-80.";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Chung GT, Sundaresan V, Hasleton P, Rudd R, Taylor R, Rabbitts PH. Sequential molecular genetic changes in lung cancer development. Oncogene 1995; 11:2591-8.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"da Silva FC, de Oliveira LP, Santos EM, et al. Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry. Fam Cancer 2010; 9:563-70.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Dallol A, Forgacs E, Martinez A, et al. Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers. Oncogene 2002; 21:3020-8.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Dallol A, Morton D, Maher ER, Latif F. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 2003; 63:1054-8.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"De Blasi A, Conn PJ, Pin J, Nicoletti F. Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci 2001; 22:114-20.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"de Jong MM, Nolte IM, Te Meerman GJ, et al. Colorectal cancer and the CHEK2 1100delC mutation. Genes Chromosomes Cancer 2005; 43:37782. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"de la Chapelle A. The incidence of Lynch syndrome. Fam Cancer 2005; 4:233-7.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"de Leeuw WJ, van Puijenbroek M, Tollenaar RA, Cornelisse CJ, Vasen HF, Morreau H. Correspondence re: A. Müller et al. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res., 62: 1014-1019, 2002. Cancer Res 2003; 63:1148-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Diskin SJ, Hou C, Glessner JT, et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature 2009; 459:987-91.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Dominguez MV, Bastos EP, Silva SD, Rossi BM. [Molecular research methods in the detection of germinal mutations in hereditary colorectal cancer]. Rev Gastroenterol Peru 2009; 29:247-53. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Estivill X, Armengol L. Copy number variants and common disorders: filling the gaps and exploring complexity in genome-wide association studies. PLoS Genet 2007; 3:1787-99. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Fanciulli M, Petretto E, Aitman TJ. Gene copy number variation and common human disease. Clin Genet 2010; 77:201-13. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997; 278:1043-50. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Fletcher O, Houlston RS. Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 2010; 10:353-61. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343:692-5. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Franco A, Sikalidis AK, Solís Herruzo JA. Colorectal cancer: influence of diet and lifestyle factors. Rev Esp Enferm Dig 2005; 97:432-48. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Frank B, Hoffmeister M, Klopp N, Illig T, Chang-Claude J, Brenner H. Colorectal cancer and polymorphisms in DNA repair genes WRN, RMI1 and BLM. Carcinogenesis 2010; 31:442-5. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature 2005; 435:964-8. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Friedman E, Kotsopoulos J, Lubinski J, et al. Spontaneou and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Research 2006; 8:R15. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Fuqua SA. The role of estrogen receptors in breast cancer metastasis. J Mammary Gland Biol Neoplasia 2001; 6:407-17. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Gala M, Chung DC. Hereditary colon cancer syndromes. Semin Oncol 2011; 38:490-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Garg K, Soslow RA. Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma. J Clin Pathol 2009; 62:679-84. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Gayther SA, Batley SJ, Linger L, et al. Mutations truncating the EP300 acetylase in human cancers. Nat Genet 2000; 24:300-3. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"German J. Bloom syndrome: a mendelian prototype of somatic mutational disease. Medicine (Baltimore) 1993; 72:393-406.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Ghosh S, Ghosh A, Maiti GP, et al. Alterations of ROBO1/DUTT1 and ROBO2 loci in early dysplastic lesions of head and neck: clinical and prognostic implications. Hum Genet 2009; 125:189-98. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Groden J, Nakamura Y, German J. Molecular evidence that homologous recombination occurs in proliferating human somatic cells. Proc Natl Acad Sci U S A 1990; 87:4315-9.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Groden J, German J. Bloom's syndrome. XVIII. Hypermutability at a tandemrepeat locus. Hum Genet 1992; 90:360-7. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Guerrero K, Wang Z, Bachvarova M, et al. A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation. Gynecol Oncol 2012; 125:720-6. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Hägglund MG, Sreedharan S, Nilsson VC, et al. Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons. J Biol Chem 2011; 286:20500-11. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Hampel H, Sweet K, Westman JA, Offit K, Eng C. Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 2004; 41:81-91.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Hastings PJ, Lupski JR, Rosenberg SM, Ira G. Mechanisms of change in gene copy number. Nat Rev Genet 2009; 10:551-64.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"He L, Vasiliou K, Nebert DW. Analysis and update of the human solute carrier (SLC) gene superfamily. Hum Genomics 2009; 3:195-206. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Hermans E, Challiss RA. Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-proteincoupled receptors. Biochem J 2001; 359(Pt 3):465-84.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Hirshfield KM, Rebbeck TR, Levine AJ. Germline mutations and polymorphisms in the origins of cancers in women. J Oncol 2010; 2010:297671. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Hodgson D, Acher P, Cahill D. An update on localised prostate cancer. Int J Clin Pract 2007; 61:315-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Höglund PJ, Nordström KJ, Schiöth HB, Fredriksson R. The solute carrier families have a remarkably long evolutionary history with the majority of the human families present before divergence of Bilaterian species. Mol Biol Evol 2011; 28:1531-41. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Hohenester E. Structural insight into Slit-Robo signalling. Biochem Soc Trans 2008; 36(Pt 2):251-6. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Hung J, Kishimoto Y, Sugio K, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995; 273:1908.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;Ijichi N, Shigekawa T, Ikeda K, et al. Association of Double-Positive FOXA1 and FOXP1 Immunoreactivities with Favorable Prognosis of TamoxifenTreated Breast Cancer Patients. Horm Cancer 2012 Apr 3 [Epub ahead of print]. ;
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Jang JH, Cotterchio M, Gallinger S, Knight JA, Daftary D. Family history of hormonal cancers and colorectal cancer risk: a case-control study conducted in Ontario. Int J Cancer 2009; 125:918-25.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Jensen UB, Sunde L, Timshel S, et al. Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 2010; 120:777-82.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Kaufmann E, Knöchel W. Five years on the wings of fork head. Mech Dev 1996; 57:3-20. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Khusial PR, Vadla B, Krishnan H, et al. Src activates Abl to augment Robo1 expression in order to promote tumor cell migration. Oncotarget 2010; 1:198-209.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Kilpivaara O, Laiho P, Aaltonen LA, Nevanlinna H. CHEK2 1100delC and colorectal cancer. J Med Genet 2003; 40:e110.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Klarskov L, Holck S, Bernstein I, Nilbert M. Hereditary colorectal câncer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome. J Clin Pathol 2012; 65:352-6.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68:820-3.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Koh PK, Kalady M, Skacel M, et al. Familial colorectal cancer type X: polyp burden and cancer risk stratification via a family history score. ANZ J Surg 2011; 81:537-42.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Komatsu A, Nagasaki K, Fujimori M, Amano J, Miki Y. Identification of novel deletion polymorphisms in breast cancer. Int J Oncol 2008; 33:261-70. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Koon HB, Ippolito GC, Banham AH, Tucker PW. FOXP1: a potential therapeutic target in cancer. Expert Opin Ther Targets 2007; 11:955-65.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Krepischi AC, Achatz MI, Santos EM, et al. Germline DNA copy number variation in familial and early-onset breast cancer. Breast Cancer Res 2012a; 14:R24. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Krepischi AC, Pearson PL, Rosenberg C. Germline copy number variations and cancer predisposition. Future Oncol 2012b; 8:441-50. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Kuiper RP, Ligtenberg MJ, Hoogerbrugge N, Geurts van Kessel A. Germline copy number variation and cancer risk. Curr Opin Genet Dev 2010; 20:2829. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Kwei KA, Kung Y, Salari K, Holcomb IN, Pollack JR. Genomic instability in breast cancer: pathogenesis and clinical implications. Mol Oncol 2010; 4:255-66.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Lai E, Prezioso VR, Tao WF, Chen WS, Darnell JE Jr. Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. Genes Dev 1991; 5:416-27.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Lastella P, Patruno M, Forte G, et al. Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation. Fam Cancer 2011; 10:285-95.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Legg JA, Herbert JM, Clissold P, Bicknell R. Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration. Angiogenesis 2008; 11:13-21.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Lin KM, Ternent CA, Adams DR, et al. Colorectal cancer in hereditary breast cancer kindreds. Dis Colon Rectum 1999; 42:1041-5.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Lipton L, Thomas HJ, Eeles RA, et al. Apparent Mendelian inheritance of breast and colorectal cancer: chance, genetic heterogeneity or a new gene? Fam Cancer 2001; 1:189-95. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Lynch HT, Lanspa SJ, Boman BM, et al. Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II. Gastroenterol Clin North Am 1988; 17:679-712. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Lynch HT, Lynch JF. Hereditary nonpolyposis colorectal cancer. Semin Surg Oncol. 2000; 18:305-13. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Lynch HT, Boland CR, Gong G, et al. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 2006; 14:390-402. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. Review of the  Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 2009; 76:1-18. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"MacDonald DJ. Germline mutations in cancer susceptibility genes: an overview for nurses. Semin Oncol Nurs 2011; 27:21-33. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Mackenzie B, Erickson JD. Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family. Pflugers Arch 2004; 447:784-95. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 2001; 1:222-31. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Meijers-Heijboer H, van den Ouweland A, Klijn J, et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31:55-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Meijers-Heijboer H, Wijnen J, Vasen H, et al. The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 2003; 72:1308-14. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Meyerson M, Enders GH, Wu CL, et al. A family of human cdc2-related protein kinases. EMBO J 1992; 11:2909-17. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Mills RE, Walter K, Stewart C, et al. Mapping copy number variation by population-scale genome sequencing. Nature 2011; 470:59-65.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2012 Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2012.  ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Mirzaei H, Syed S, Kennedy J, Schmidt KH. Sgs1 truncations induce genome rearrangements but suppress detrimental effects of BLM overexpression in Saccharomyces cerevisiae. J Mol Biol 2011; 405:877-91. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Monteiro Santos EM, Valentin MD, Carneiro F, et al. Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries. BMC Cancer 2012 Feb 9;12:64. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Müller A, Edmonston TB, Corao DA, et al. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 2002; 62:1014-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Muraoka M, Konishi M, Kikuchi-Yanoshita R, et al. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 1996; 12:1565-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Nagy R, Sweet K, Eng C. Highly penetrant hereditary cancer syndromes. Oncogene 2004; 23:6445-70. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Narayan G, Goparaju C, Arias-Pulido H, et al. Promoter hypermethylationmediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer 2006; 5:16. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Naseem H, Boylan J, Speake D, et al. Inherited association of breast and colorectal cancer: limited role of CHEK2 compared with high-penetrance genes. Clin Genet 2006; 70:388-95. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Nilbert M, Wikman FP, Hansen TV, et al. Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population. Fam Cancer 2009; 8:75-83. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Nishiyama T, Takahashi K, Tango T, et al. A scan statistic to extract causal gene clusters from case-control genome-wide rare CNV data. BMC Bioinformatics 2011; 12:205. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Nordgard SH, Johansen FE, Alnaes GI, et al. Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients. Genes Chromosomes Cancer 2008; 47:680-96. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Oliveira Ferreira F, Napoli Ferreira CC, Rossi BM, et al. Frequency of extracolonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: an analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry. Fam Cancer 2004; 3:417. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Olsen JH, Seersholm N, Boice JD Jr, Krüger Kjaer S, Fraumeni JF Jr. Cancer risk in close relatives of women with early-onset breast câncer - a population-based incidence study. Br J Cancer 1999; 79:673-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Ortiz P, Vanaclocha F, López-Bran E, et al. Genetic analysis of the GRM1 gene in human melanoma susceptibility. Eur J Hum Genet 2007; 15:1176-82. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Ostrovnaya I, Nanjangud G, Olshen AB. A classification model for distinguishing copy number variants from cancer-related alterations. BMC Bioinformatics 2010; 11:297. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Peltomäki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997; 113:1146-58. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Pesole G, Grillo G, Larizza A, Liuni S. The untranslated regions of eukaryotic mRNAs: structure, function, evolution and bioinformatic tools for their analysis. Brief Bioinform 2000; 1:236-49. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Peters GN, Fodera T, Sabol J, Jones S, Euhus D. Estrogen replacement therapy after breast cancer: a 12-year follow-up. Ann Surg Oncol 2001; 8:828-32. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995; 34:1-26. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Pollock PM, Cohen-Solal K, Sood R, et al. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 2003; 34:108-12. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Rayoo M, Yan M, Takano EA, Bates GJ, et al. Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers. J Clin Pathol 2009; 62:896-902. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444:444-54. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Reedijk M, Odorcic S, Zhang H, et al. Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol 2008; 33:1223-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Ren S, Rollins BJ. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell 2004; 117:239-51. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 1996; 77:1836-43. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Robson M, Gilewski T, Haas B, et al. BRCA-associated breast cancer in young women. J Clin Oncol 1998; 16:1642-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Rush LJ, Raval A, Funchain P, et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004; 64:2424-33. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Sawasaki T, Shigemasa K, Gu L, Beard JB, O'Brien TJ. The transmembrane protease serine (TMPRSS3/TADG-12) D variant: a potential candidate for diagnosis and therapeutic intervention in ovarian cancer. Tumour Biol 2004; 25:141-8. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Schang LM, Bantly A, Schaffer PA. Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4. J Virol 2002; 76:7724-35. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Schutte M, Seal S, Barfoot R, et al. Variants in CHEK2 other than 1100delC do not make a major contribution to breast  cancer susceptibility. Am J Hum Genet 2003; 72:1023-8. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Scott KL, Plon SE. CHES1/FOXN3 interacts with Ski-interacting protein and acts as a transcriptional repressor. Gene 2005; 359:119-26. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Selamat SA, Galler JS, Joshi AD, et al. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma. PLoS One 2011; 6:e21443. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Shelling AN, Ferguson LR. Genetic variation in human disease and a new role for copy number variants. Mutat Res 2007; 622:33-41. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Shen F, Liu X, Geng JG, Guo SW. Increased immunoreactivity to SLIT/ROBO1 in ovarian endometriomas: a likely constituent biomarker for recurrence. Am J Pathol 2009; 175:479-88. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Shigekawa T, Ijichi N, Ikeda K, et al. FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5year recurrence-free survival of patients with tamoxifen-treated breast cancer. Horm Cancer 2011; 2:286-97. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Shlien A, Tabori U, Marshall CR, et al. Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome. Proc Natl Acad Sci U S A 2008; 105:11264-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Shlien A, Malkin D. Copy number variations and cancer. Genome Med 2009; 1:62. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Shlien A, Malkin D. Copy number variations and cancer susceptibility. Curr Opin Oncol 2010; 22:55-63. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Shulman LP. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome. Obstet Gynecol Clin North Am 2010; 37:109-33. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Solomou EE, Sfikakis PP, Kotsi P, et al. 13q deletion in chronic lymphocytic leukemia: characterization of E4.5, a novel chromosome condensation regulator-like guanine nucleotide exchange factor. Leuk Lymphoma 2003; 44:1579-85. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Speyer CL, Smith JS, Banda M, DeVries JA, Mekani T, Gorski DH. Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res Treat 2012; 132:565-73. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med 2010; 61:437-55. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Sundaresan V, Chung G, Heppell-Parton A, et al. Homozygous deletions at 3p12 in breast and lung cancer. Oncogene 1998; 17:1723-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Sundberg BE, Wååg E, Jacobsson JA, et al. The evolutionary history and tissue mapping of amino acid transporters belonging to solute carrier families SLC32, SLC36, and SLC38. J Mol Neurosci 2008; 35:179-93. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett 2005; 219:125-35. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Thean LF, Loi C, Ho KS, Koh PK, Eu KW, Cheah PY. Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients. Genes Chromosomes Cancer 2010; 49:99-106. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Theile M, Seitz S, Arnold W, et al. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene 1996; 13:677-85. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Thélu J, Rossio P, Favier B. Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing. BMC Dermatol 2002; 2:7. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Thompson D, Easton D. Breast Cancer Linkage Consortium. Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev 2002; 11:329-36. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Thompson D, Easton D. The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 2004; 9:221-36. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Turley H, Wu L, Canamero M, Gatter KC, Hickson ID. The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells. Br J Cancer 2001; 85:261-5. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Ueno T, Emi M, Sato H, et al. Genome-wide copy number analysis in primary breast cancer. Expert Opin Ther Targets 2012; 16 Suppl 1:S31-5. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96:261-8. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Urban TJ, Sebro R, Hurowitz EH, et al. Functional genomics of membrane transporters in human populations. Genome Res 2006; 16:223-30. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Vahteristo P, Bartkova J, Eerola H, et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002; 71:432-8. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Valentin MD, da Silva FC, dos Santos EM, et al. Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals. Fam Cancer 2011; 10:641-7. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34:424-5. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116:1453-6. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Vasen HF, Stormorken A, Menko FH, et al. MSH2 mutation carriers are at higher risk of câncer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001; 19:4074-80. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Vasen HF. Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]. Fam Cancer 2005; 4:219-25. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Venkatachalam R, Verwiel ET, Kamping EJ, et al. Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients. Int J Cancer 2011; 129:1635-42. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002; 108:171-82. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Wallrapp C, Hähnel S, Müller-Pillasch F, et al. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res 2000; 60:2602-6. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Walsh CS, Ogawa S, Scoles DR, et al. Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas. Clin Cancer Res 2008; 14:7645-51. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Wang J, Luo MH, Zhang ZX, et al. Clinical and molecular analysis of hereditary non-polyposis colorectal cancer in Chinese colorectal cancer patients. World J Gastroenterol 2007; 13:1612-7. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Wang J, Wang L, Liu FF, et al. Robo1 expression in breast cancer and its relationship to brain metastasis (abstract). Zhonghua Zhong Liu Za Zhi 2011; 33:447-51. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Watson P, Lynch HT. The tumor spectrum in HNPCC. Anticancer Res 1994; 14:1635-9. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Wattenhofer M, Shibuya K, Kudoh J, et al. Isolation and characterization of the UBASH3A gene on 21q22.3 encoding a potential nuclear protein with a novel combination of domains. Hum Genet 2001; 108:140-7. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Willet KE, McMenamin P, Pinkerton KE, et al. Lung morphometry and collagen and elastin content: changes during normal development and after prenatal hormone exposure in sheep. Pediatr Res 1999; 45:615-25. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Xian J, Clark KJ, Fordham R, Pannell R, Rabbitts TH, Rabbitts PH. Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene. Proc Natl Acad Sci U S A 2001; 98:15062-6. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Xian J, Aitchison A, Bobrow L, et al. Targeted disruption of the 3p12 gene, Dutt1/Robo1, predisposes mice to lung adenocarcinomas and lymphomas with methylation of the gene promoter. Cancer Res 2004; 64:6432-7. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Xu Y, Peng B, Fu Y, Amos CI. Genome-wide algorithm for detecting CNV associations with diseases. BMC Bioinformatics 2011; 12:331. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Yoshihara K, Tajima A, Adachi S, et al. Germline copy number variations in BRCA1-associated ovarian cancer patients. Genes Chromosomes Cancer 2011; 50:167-77. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Yuan B, Xu Y, Woo JH, et al. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res 2006; 12:405-10. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 2007; 178:93-105. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Zheng D, Cho YY, Lau AT, et al. Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation. Cancer Res 2008; 68:7650-60. ";
FAP;2012;FRANCINE BLUMENTAL DE ABREU;Silvia Regina Rogatto;-x-;"Zhou X, Münger K. Clld7, a candidate tumor suppressor on chromosome 13q14, regulates pathways of DNA damage/repair and apoptosis. Cancer Res 2010; 70:9434-43. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"[Anonymous]. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999; 91:1310-6. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Abate-Shen C, Shen MM, Gelmann E. Integrating differentiation and cancer: the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis.  Differentiation 2008; 76:717-27. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Aihara M, Wheeler TM, Ohori M, Scardino PT. Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology 1994; 43:60-6; discussion 66-7. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Albadine R, Latour M, Toubaji A, et al. TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma. Mod Pathol 2009; 22:1415-22. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Amling C. Biochemical recurrence after localized treatment. Urol Clin North Am 2006; 33:147-59. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Asatiani E, Huang WX, Wang A, et al. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res 2005; 65:1164-73. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Ashida S, Nakagawa H, Katagiri T, et al. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene- expression profiles of prostate cancers and PINs. Cancer Res 2004; 64:5963-72. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;Baggerly K, Deng L, Morris J, Aldaz C. Differential expression in SAGE: accounting for normal between-library variation. Bioinformatics 2003, 19:1477-83. ;
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Barry MJ. Screening for prostate cancer-the controversy that refuses to die. N Engl J Med 2009; 360:1351-4. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Berger MF, Levin JZ, Vijayendran K, et al. Integrative analysis of the melanoma transcriptome. Genome Res 2010; 20:413-27. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Best CJ, Leiva IM, Chuaqui RF, et al. Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagn Mol Pathol 2003; 12:63-70. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Bethel CR, Faith D, Li X, et al. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. Cancer Res 2006; 66:10683-90. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Bickers B, Aukim-Hastie C New molecular biomarkers for the prognosis and management of prostate cancer – The Post PSA Era. Anticancer Res 2009; 29:3289-98. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Bostwick DG, Shan A, Qian J, et al. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer 1998; 83:1995-2002. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Bowen C, Gelmann EP. NKX3.1 activates cellular response to DNA damage. Cancer Res 2010; 70:3089-97. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Brenner S, Johnson M, Bridgham J, et al. Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol 2000;18:630-4. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Brentani RR, Carraro DM, Verjovski-Almeida S, et al. Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol 2005; 54:95-105. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Burdick MJ, Reddy CA, Ulchaker J, et al. Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer. Int J Radiat Oncol Biol Phys 2009; 73:1439-45. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Bussemakers MJ, van Bokhoven A, Verhaegh GW, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999; 59:5975-9. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Cardillo MR, Gentile V, Ceccariello A, Giacomelli L, Messinetti S, Di Silverio F. Can p503s, p504s and p510s gene expression in peripheral-blood be useful as a marker of prostatic cancer? BMC Cancer 2005; 5:111. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Carraro DM, Brentani HP, Soares FA, et al. From tissue samples to tumor markers. In: Krishanarao A, editor. From basics to diagnostics. New Jersey: Humana Press; 2007. p.17-28. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Carraro DM, Ferreira EN, de Campos Molina G, et al. Poli (A)+ transcriptome assessment of ERBB2-induced alterations in breast cell lines. PLoS One 2011; 6:e21022. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Carver BS, Tran J, Gopalan A, et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 2009; 41:619-24. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Castro NP, Osório CA, Torres C, et al. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res 2008; 10:R87. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Chan TY, Partin AW, Walsh PC, Epstein JI. Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. Urology 2000; 56:823-7. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Chen ML, Xu PZ, Peng XD, et al. The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice. Genes Dev 2006; 20:1569-74. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Clark J, Merson S, Jhavar S, et al. Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene 2007; 26:2667-73. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Clark J, Attard G, Jhavar S, et al. Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene 2008; 27:1993-2003. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Coppée JY. Do DNA microarrays have their future behind them? Microbes Infect 2008; 10:1067-71. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Cussenot O, Azzouzi AR, Nicolaiew N, et al. Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alphareductase inhibitors. Eur Urol 2007; 52:1082-7. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"D’Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280:969-74. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"DE Kok JB, Verhaegh GW, Roelofs RW, et al. DD3 (PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 2002; 62:2695-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"DeMarzo AM, Nelson WG, Isaacs WB, Epstein JI. Pathological and molecular aspects of prostate cancer. Lancet 2003; 361:955-64. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman MR, Lisanti MP. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle 2009; 8:2420-4. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Ellwood-Yen K, Graeber TG, Wongvipat J, et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 2003; 4:223-38. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Emmert-Buck MR, Vocke CD, Pozzatti RO, et al. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995; 55:2959-62. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Ewing B, Hillier L, Wendl MC, et al. Base-calling of automated sequencer traces using phred Accuracy assessment. Genome Res 1998; 8:175-85. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Febbo PG. Genomic approaches to outcome prediction in prostate cancer. Cancer 2009; 115:3046-57. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Folgueira MA, Carraro DM, Brentani H, et al. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res 2005; 11:7434-43. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Fradet Y. Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen. Curr Opin Urol 2009; 19:243-6. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Gao H, Ouyang X, Banach-Petrosky WA, Gerald WL, Shen MM, Abate-Shen C. Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proc Natl Acad Sci U S A 2006; 103:14477-82. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Gelmann EP. Searching for the gatekeeper oncogene of prostate cancer. Crit Rev Oncol Hematol 2003; 46 Suppl:S11-20. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Gillanders EM, Xu J, Chang BL, et al. Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst 2004; 96:1240-7. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966; 50:125-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Glinsky GV, Glinskii AB, Stephenson AJ, Hoffman RM, Gerald WL. Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest 2004; 113:913-23. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Godiska R, Mead D, Dhodda V, et al. Linear plasmid vector for cloning of repetitive or unstable sequences in Escherichia coli. Nucleic Acids Res 2010; 38:e88. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Grisanzio C, Signoretti S. p63 in prostate biology and pathology. J Cell Biochem 2008; 103:1354-68. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Gurel B, Iwata T, Koh CM, et al. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.  Mod Pathol 2008; 21:1156-67. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Häggman MJ, Wojno KJ, Pearsall CP, Macoska JA. Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma. Urology 1997; 50:643-7. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Halvorsen OJ, Oyan AM, Bø TH, et al. Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation. Int J Oncol 2005; 26:329-36. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001; 28:555-65. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoen- zymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30:445-600. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"He X, He L, Hannon GJ. The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 2007; 67:11099-101. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci 2006; 11:1388-413. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Hsu F, Kent WJ, Clawson H, et al. The UCSC known genes. Bioinformatics 2006; 22:1036-46. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Hu Y, Dobi A, Sreenath T, et al. Delineation of TMPRSS2-ERG splice variants in prostate cancer. Clin Cancer Res 2008; 14:4719-25. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Hugosson J, Aus G, Lilja H, Lodding P, Pihl CG. Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma. Cancer 2004; 100:1397405. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Humphrey PA. Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol 2007; 60:35-42. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Iljin K, Wolf M, Edgren H, et al. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. Cancer Res 2006; 66:10242-6. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Ilyin SE, Belkowski SM, Plata-Salamán CR. Biomarker discovery and validation: technologies and integrative approaches. Trends Biotechnol 2004; 22:411-6. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Jerónimo C, Henrique R, Hoque MO, et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 2004; 10:8472-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683-92. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999; 17:1499-507. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Kent WJ. BLAT--the BLAST-like alignment tool. Genome Res 2002; 12:65664. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Khanduja KL, Avti PK, Kumar S, et al. Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: a Bcl-2 independent mechanism. Biochim et Bioph Acta 2006; 1760:283-9. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, et al. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res 2002a; 62:2999-3004.";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Kim MJ, Cardiff RD, Desai N, et al. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A 2002b; 99:2884-9. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Kim J, Eltoum IE, Roh M, Wang J, Abdulkadir SA. Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer. PLoS Genet 2009; 5:e1000542. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"King JC, Xu J, Wongvipat J, et al. Cooperativity of TMPRSS2-ERG with PI3kinase pathway activation in prostate oncogenesis. Nat Genet 2009; 41:5246. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Kirby RS, Fitzpatrick JM, Irani J. Prostate cancer diagnosis in the new millennium: strengths and weaknesses of pros- tate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3). BJU Int 2009; 103:441-5. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Kristiansen G, Pilarsky C, Wissmann C, et al. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol 2005; 205:359-76. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Kuefer R, Varambally S, Zhou M, et al. Alpha-methylacyl-CoA racemase: expression levels of this novel cancer biomarker de- pend on tumor differentiation. Am J Pathol 2002; 161:841-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Lapointe J, Li C, Higgins JP, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 2004; 101:811-6. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"LaTulippe E, Satagopan J, Smith A, et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 2002; 62:4499-506. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Lee WH, Morton RA, Epstein JI, et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A 1994; 91:117337. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer:prediction, detection and monitoring. Nat Rev Cancer 2008; 8:26878. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Luo J, Duggan DJ, Chen Y, et al. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 2001; 61:4683-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Maattanen L, Hakama M, Tammela TL, et al. Specificity of serum prostatespecific antigen determination in the Finnish prostate cancer screening trial. Br J Cancer 2007; 96:56-60. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Macintosh CA, Stower M, Reid N, Maitland NJ. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res 1998; 58:23-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Mackinnon AC, Yan BC, Joseph LJ, et al. Molecular biology underlying the clinical. Arch Pathol Lab Med 2009; 133:1033-40. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Magee JA, Araki T, Patil S, et al. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 2001; 61:5692-6. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Maher CA, Kumar-Sinha C, Cao X, et al. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009; 458:97-101. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Mahon SM. Screening for prostate cancer: informing men about their options. Clin J Oncol Nurs 2005; 9:625-7. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005; 437:376-80. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 2008; 18:1509-17. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Marks LS, Fradet Y, Deras IL, et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology 2007; 69:532-5. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Markowski MC, Bowen C, Gelmann EP. Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1. Cancer Res 2008; 68:6896-901. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Maschietto M, de Camargo B, Brentani H, et al. Molecular profiling of isolated histological components of wilms tumor implicates a common role for the Wnt signaling pathway in kidney and tumor development. Oncology 2008; 75:8191. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Mehra R, Han B, Tomlins SA, et al. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol 2007; 20:538-44. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Meyer M, Stenzel U, Myles S, Prüfer K, Hofreiter M. Targeted highthroughput sequencing of tagged nucleic acid samples. Nucleic Acids Res 2007; 35:e97.";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Miller DC, Hafez KS, Stewart A, Montie JE, Wei JT. Prostate carcinoma presentation, diagnosis, and staging: an update from the National Cancer Data Base. Cancer 2003; 98:1169-78. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Mosquera JM, Perner S, Genega EM, et al. Characterization of TMPRSS2ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res 2008; 14:3380-5. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008; 5:621-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Motoyama M, Yamazaki S, Eto-Kimura A, Takeshige K, Muta T. Positive and negative regulation of nuclear factor-kappaB-mediated transcription by IkappaB-zeta, an inducible nuclear protein. J Biol Chem 2005; 280:7444-51. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Mulholland DJ, Dedhar S, Wu H, Nelson CC. PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene 2006; 25:329-37. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Nacu S, Yuan W, Kan Z, et al. Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples. BMC Med Genomics 2011; 4:11. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Nagalakshmi U, Wang Z, Waern K, et al. The transcricional landscape of the yeast genome defined by RNA sequencing. Science 2008; 320:1344-9. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Nygaard S, Okayama T, Okazaki Y, et al. The transcricional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet 2009; 41:553-62. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Ohl F, Jung M, Xu C, et al. Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization? J Mol Med 2005; 83:1014-24. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Okino ST, Pookot D, Li LC, et al. Epigenetic inactivation of the dioxinresponsive cytochrome P4501A1 gene in human prostate cancer. Cancer Res 2006; 66:7420-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Okubo K, Hori N, Matoba R, et al. Large scale cDNA sequencing for analysis of quantitative and qualitative aspects of gene expression. Nat Genet 1992; 2:173-9. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Orr B, Riddick AC, Stewart GD, et al. Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate. Oncogene 2012; 31:1130-42. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Otero JM, Papadakis MA, Udatha DB, Nielsen J, Panagiotou G. Yeast biological networks unfold change the interplay of antioxidants, genome and phenotype, and reveal a novel regulator of the oxidative stress response. PLoS One 2010; 5:e13606. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Ouyang X, DeWeese TL, Nelson WG, Abate-Shen C. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res 2005; 65:6773-9. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Paparel P, Cronin AM, Savage C, Scardino PT, Eastham JA. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Eur Urol 2009; 55:404-10. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Perner S, Demichelis F, Beroukhim R, et al. TMPRSS2:ERG fusionassociated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 2006; 66:8337-41. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Pryor MB, Schellhammer PF. The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasoundguided prostate biopsies. Clin Prostate Cancer 2002; 1:172-6. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Pulukuri SM, Patibandla S, Patel J, Estes N, Rao JS. Epigenetic inactivation of the tissue inhibitor of metalloproteinase-2 (TIMP-2) gene in human prostate tumors. Oncogene 2007; 26:5229-37. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Rasiah KK, Stricker PD, Haynes AM, et al. Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma. Cancer 2003; 98:2560-5. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Reynolds MA, Kastury K, Groskopf J, Schalken JA, Rittenhouse H. Molecular markers for prostate cancer. Cancer Lett 2007; 249:5-13. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Rogers CG, Yan G, Zha S, et al. Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein. J Urol 2004; 172:1501-3. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Saeed AI, Sharov V, White J, et al. TM4: A free open-source system for microarray data management and analysis. BioTechniques 2003; 34:374-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell 2008; 133:403-14. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Saraiva TF. Identificação de marcadores moleculares em câncer de mama relacionados à progressão e metástase. São Paulo; 2008. [Dissertação de Mestrado-Fundação Antônio Prudente]. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Saramäki OR, Harjula AE, Martikainen PM, Vessella RL, Tammela TL, Visakorpi T. TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis. Clin Cancer Res 2008; 14:3395-400. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Sardana G, Dowell B, Diamandis EP. Emerging biomarkers for the diagnosis and prognosis of prostate cancer. Clin Chem 2008; 54:1951-60. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression atterns with a complementary DNA microarray. Science 1995; 270:467-70. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Shappell SB, Thomas GV, Roberts RL, et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004; 64:2270-305. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Shen MM, Abate-Shen C. Pten inactivation and the emergence of androgenindependent prostate cancer. Cancer Res 2007; 67:6535-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Singal R, Ferdinand L, Reis IM, Schlesselman JJ. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease. Oncol Rep 2004; 12:631-7. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Singh D, Febbo PG, Ross K, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002; 1:203-9. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Sreekumar A, Laxman B, Rhodes DR, et al. Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer. J Natl Cancer Inst 2004; 96:834-43. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Stark JR, Perner S, Stampfer MJ, et al. Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?. J Clin Oncol 2009; 27:3459-64. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Stephenson AJ, Smith A, Kattan MW, et al. Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy. Cancer 2005; 104:290-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Thomas GV, Horvath S, Smith BL, et al. Antibody-based profiling of the phosphoinositide 3-kinase pathway in clinical prostate cancer. Clin Cancer Res 2004; 10:8351-6. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Thompson TC, Tahir SA, Li L, et al. The role of caveolin-1 in prostate cancer: clinical implications. Prostate Cancer Prostatic Dis 2010; 13:6-11. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310:644-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;Totzke G, Essmann F, Pohlmann S, et al. A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding. J Biol Chem 2006, 281:12645-54. ;
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Trapnell C, Williams BA, Pertea G, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010; 28:511-5. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Trinh DV, Zhu N, Farhang G, Kim BJ, Huxford T. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA. J Mol Biol 2008; 379:122-35. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Tricoli JV, Schoenfeldt M, Conley BA. Detection of prostate cancer and predicting progression: current and future diagnos- tic markers. Clin Cancer Res 2004; 10:3943-53. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Tuch BB, Laborde RR, Xu X, et al. Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations. PLoS One 2010; 5:e9317. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"True L, Coleman I, Hawley S, et al. A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc Natl Acad Sci U S A 2006; 103:10991-6. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Uzgare AR, Isaacs JT. Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells. Cancer Res 2004; 64:6190-9. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Uziel T, Karginov FV, Xie S, et al. The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci U S A 2009; 106:2812-7. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Varambally S, Dhanasekaran SM, Zhou M, et al. The policomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419:624-9. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Varambally S, Yu J, Laxman B, et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 2005; 8:393-406. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;Varuzza L, Pereira CAB. Comparative enumeration gene expression [serial on line] Nature Precidings 2008. Avaliable from: <URL:http://precedings.nature.com/documents/2002/version/1/files/npre2008 2002-1.pdf> [2012 jul 12] ;
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Van Waes C. Nuclear Factor-?B in development, prevention, and therapy of cancer. Clin Cancer Res 2007; 13:1076-82. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995; 270:484-7. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Vickers AJ, Ulmert D, Serio AM, et al. The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically based screening strategy. Int J Cancer 2007; 121:2212-7. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Vickers AJ, Lilja H. Cutpoints in clinical chemistry: time for fundamental reassessment. Clin Chem 2009; 55:15-7. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Vocke CD, Pozzatti RO, Bostwick DG, et al. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 1996; 56:2411-6. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Wang GP, Garrigue A, Ciuffi A, et al. DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer. Nucleic Acids Res 2008; 36:e49. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Wang J, Cai Y, Ren C, Ittmann M. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Cancer Res 2006; 66:8347-51. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Welsh JB, Sapinoso LM, Su AI, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001; 61:5974-8. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;Wu Z, Zhang X, Yang J, et al. Nuclear protein IkappaB-zeta inhibits the activity of STAT3. Biochem Biophys Res Commun 2009, 387:348-52. ;
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Wyman SK, Parkin RK, Mitchell PS, et al. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One 2009; 4:e5311. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Yamazaki S, Muta T, Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factorkappaB in the nuclei. J Biol Chem 2001; 276:27657-62. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Yu YP, Landsittel D, Jing L, et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 2004; 22:2790-9. ";
FAP;2012;GUSTAVO DE CAMPOS MOLINA;Dirce Maria Carraro;-x-;"Zha S, Ferdinandusse S, Denis S, et al. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res 2003; 63:7365-76. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Abdel-Rahman MH, Yang Y, Zhou X-P, Craig EL, Davidorf FH, Eng C. High frequency of submicroscopic hemizygous deletions is a major mechanism of loss of expression of PTEN in uveal melanoma. J Clin Oncol 2006; 24:288-95. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Abdel-Rahman MH, Pilarski R, Cebulla CM, et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 2011; 48:856-9. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Alsuhaibani AH. Uveal melanoma in the Saudi Arabian population: two decades of management at the King Khaled Eye Specialist Hospital. Saudi J Ophthalmol 2009; 23:157-63. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Ashida A, Takata M, Murata H, Kido K, Saida T. Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas. Int J Cancer 2009; 124:862-8. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Augsburger JJ, Corrêa ZM, Shaikh AH. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma. Trans Am Ophthalmol Soc 2008; 106:12837; discussion 135-7. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Avery RB, Diener-West M, Reynolds SM, Grossntklaus HE, Green R, Albert DM. Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherpay in the collaborative ocular melanoma study. Arch Ophthalmol 2008; 126:202-12.";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Aziz AS, Davies M, Pick E, et al. Phaosphatidylinositol-3-Kinase as a therapeutic target in melanoma. Clin Cancer Res 2009; 15:3029-36. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F. The PI3K/mTOR/P70S6K signalling pathways in human uveal melanomas cells: interaction with B-Raf /ERK. Invest Ophthalmol Vis Sci 2010; 51:421-9. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Bansal N, Yendluri V, Wenham RM. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control 2009; 16:8-13. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Bernards R. It´s diagnostics stupid. Cell 2010; 141:13-7. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Bastian BC, Leboit PE, Hamm H, Bröcker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas determined by comparative genomic hybridization. Cancer Res 1998; 58:2170-5. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Bastian BC, Oishen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003; 163:1765-70. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Bauer J, Kilic E, Vaarwater J, Bastian BC, Garbe C, de Klein A. Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer 2009; 101:813-5. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Beadling C, Jacobson-Dunlop E, Hodi FS, et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 2008; 14:6821-8. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Bergaman L, Seregard S, Nilsson B, Lundell G, Ringborg U, Ragnarsson-Olding B. Uveal melanoma survival in Sweden from 1960-1998. Invest Ophthalmol Vis Sci 2003; 44:3282-7.  and BERGMAN  ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Biswas J, Krishnakumar S, Shanmugam MP. Uveal melanoma in Asian Indians: a clinicopathological study. Arch Ophthalmol 2002; 120:522-3. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Biswas J, Kabra S, Krishnakumar S, Shanmugam MP. Clinical and Histopathological characteristics of uveal melanoma in Asian Indians. A study of 103 patients. Ind J Ophthalmol 2004; 52:41-44. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Bronkhorst IHG, Maat W, Jordanava ES, et al. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma. Arch Pathol Lab Med 2011; 135:10427. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Calvisi DF, Ladu S, Gorden A, et al. Mechanistic and prognostic significance of abberent methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 2007; 117:2713-22. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364:2507-16.  ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Char DH, KrollS, Phillips TL, Quivey JM. Late radiation failures after Iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or helium) therapy. Ophthalmology 2002; 109:1850-4. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Cheung M, Sharma A, Madhunapantula SV, Robertson GP. Akt3 and mutant V600E BRaf cooperate to promote early melanoma development. Cancer Res 2008; 68:3429-39. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Cohen Y, Goldenberg-Cohen N, Parrella P, et al. Lack of BRAF mutation in primary uveal melanoma. Invest Ophthalmol Vis Sci 2003; 44:2876-8. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"[COMS] Collaborative Ocular Melanoma Study Group. Mortality in patients with small choroidal melanoma. COMS report no. 4. The Collaborative Ocular Melanoma Study Group. Arch Ophthalmol 1997a; 115:886-93. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"[COMS] Collaborative Ocular Melanoma Study Group. Factors predictive of growth and treatment of small choroidal melanomas. COMS Report no 5. Collaborative Ocular Melanoma Study Group. Arch Ophthalmol 1997b; 115:1537-44. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"[COMS] Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled. COMS no. 9. Am J Ophthalmol 1998a; 125:767-78. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"[COMS] Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report No 10 Am J Ophthalmol 1998b; 125:779-96. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"[COMS] Collaborative Ocular Melanoma Study Group. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS). COMS Report No. 15. Arch Ophthalmol 2001; 119:670-6. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"[COMS] Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS Report No.28. Arch Ophthalmol 2006; 124:1684-93. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Cruz F 3rd, Rubin BP, Wilson D, et al. Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res 2003; 63:5761-6. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activiation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24:4340-6. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Damato B. Ocular tumors: diagnosis and treatment. Oxford: Publishers ButterworthHeinemann; 2000. Uveal melanoma; p.58-93. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Damato B. Time to treatment of uveal melanoma in the United Kingdom. Eye (Lond) 2001; 15:155-8. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Damato B, Patel I, Campbell IR, Mayles HM, Errington RD. Local tumor control after 106Ru brachytherapy of choroidal melanoma. Int J Radiat Onc Bio Phys 2005; 62:385-91. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Dankort D, Curley DP, Cart.lidge RA, et al. BRaf (V600E) cooperates with PTEN loss to induce metastatic melanoma. Nat Genet 2009; 41:544-52. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Davies MA, Stemke-Hale K, Lin E, et al. Integrated molecular and clinical analysis of AKT Activation in Metastatic Melanoma. Clin Cancer Res 2009; 15:7538-46. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Dhomen N, Reis-Filho JS, da Rocha Dias S, et al. Oncogenic braf induces melanocyte senescence and melanoma in mice. Cancer Cell 2009; 15:294-303. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Diener-West M, Renolds SM, Agugliaro DJ, et al. Screening for metastases from choroidal melanoma: The Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol 2004; 22:2438-44.  ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Diener-West M, Reynolds SM, Agugliaro DJ, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No.26. Arch Ophthalmol 2005; 123:1639-43. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Edmunds Sc, Cree IA, Dí Nicolantonio F, Hungerford JL, Hurren JS, Kelsell DP. Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas. Br J Cancer 2003; 88:1403-5. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Eskelin S, Kivelä T. Mode of presentation and time to treatment of uveal melanoma in Finland. Br J Ophthalmol 2002; 86:333-8. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Fecher LA, Amaravadi RK, Flaherty KT. The MAPK pathway in melanoma. Curr Opin Oncol 2008; 20:183-9. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Gaudi S, Messina JL. Molecular basis of cutaneous and uveal melanomas. Patholog Res Int 2011; 2011:159421. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Gerami P, Jewell SS, Morrison LE, et al. Fluorescence in-situ Hy bridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol 2009; 33:1146-56. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Gerami P, Zembowicz A. Update on fluorescence in situ hybridization in melanoma. Arch Pathol Lab Med 2011; 135:30-7.  ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Gibbons A. Human evolution. Aboriginal genome shows two-wave settlement of Asia. Science 2011; 333:1689-91. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Graell X, Caminal JM, Masuet C, et al. Age distribution of uveal melanoma and its relationship to survival. Arch Soc Esp Oftalmol 2007; 82:343-7. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Guénel P, Laforest L, Cry D, et al. Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case control study in France. Cancer Causes Control 2001; 12:451-9. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74.  ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010; 330:1410-3.  ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Hu DN, Yu GP, McCormick SA, Schneider S, Finger PT. Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol 2005; 140:612-7. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Hu DN, McCormick SA, Yu GP. Latitude and uveal melanoma. Ophthalmology 2008; 115:757. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Isager P, Osterlind A, Engholm G et al. Uveal and conjunctival melanoma in Denmark, 1943-97: Incidence and validation study. Ophthalmic Epidemiol 2005; 12:223-32. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS Report no.19. Ophthalmology 2002; 109:2197-206. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Janssen CS, Sibbett R, Henriquez FL, McKay IC, Kemp EG, Roberts F. The T1799A point mutation is present in posterior uveal melanoma. Br J Cancer 2008; 99:1673-7. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Khan MK, Khan N, Almasan A, Macklis R. Future of radiation therapy for malignant melanoma in an era of newer more effective biological agents. Onco Targets Ther 2011; 4:137-48. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Kiliç E, Bruggenwirth HT, Verbiest MM, et al. The RAS-BRAF kinase pathway is not involved in uveal melanoma. Melanoma Res 2004; 14:203-5. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Kiliç E, Naus NC, van Gils W, et al. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased Disease-Free Survival in uveal melanoma patients. Invest Ophthalmol Vis Sci 2005; 46: 2253-7. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Kim D, Sun M, He L, et al. A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation. J Biol Chem 2010; 285:8383-94. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Kodjikian L, Grange JD, Baldo S, Baillif S, Garweg JG, Rivoire M. Prognostic factors of liver metastases from uveal melanoma. Graefes Arch Clin Exp Ophthalmol 2005; 243:985-93. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Kong Y, Kumar SM, Xu X. Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells. Arch Pathol Lab Med 2010; 134:1740-9. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53 induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344-52. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Kujala E, Mäkitie T, Kivelä T. Very long term prognosis of patients with malignant uveal melanoma. Invest Opthalmol Vis Sci 2003; 44:4651-9. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Kuo PK, Puliafito CA, Wang KM, Liu HS, Wu BF. Uveal melanoma in China. Int Opthalmol Clin 1982; 22:57-71. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Lake SL, Copeland SE, Taktak AFG, Damato BE. Whole genome microarray detects deletion and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest Ophthalmol Vis Sci 2010; 51:4884-91. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Lee CS, Lee J, Choi JJ, et al. Cytogenetics and prognosis for uveal melanoma in Korean patients. Acta Ophthalmol 2011; 89:e310-4. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Lefevre G, Glotin AL, Calipel A, et al. Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis. J Biol Chem 2004; 279:31769-79. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Li L, Ross AH. Why is PTEN and important tumor suppressor? J Cell Biochem 2007; 102:1368-74. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Ligresti G, Militello L, Steelman LS, et al. PI3KCA mutations in human solid tumors: role in sensitivity to various therapeutic approaches. Cell Cylcle 2009; 8:1352-8. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Limdi NA, Wadwlius M, Cavallari L, et al. Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood 2010; 115:3827-34. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Lins TC, Vieira RG, Abreu BS, Grattapaglia D, Pereira RW. Genetic composition of Brazilian population samples based on a set of 28 ancestry informative SNPs. Am J Hum Biol 2010; 22:187-92. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Lins TC, Vieira RG, Abreu BS, et al. Genetic heterogeneity of self-reported ancestry groups in an admixed Brazilian population. J Epidemiol 2011; 21:240-5. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Liu S, Ren S, Howell P, Fodstad O, Riker AI. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pig Cell Mel Res 2008; 21:545-58. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Lommatzsch PK, Werschnik C, Schuster E. Long-term follow-up of Ru-106/Rh106 braquitherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol 2000; 238:129-37. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Maat W, Jordanova ES, van Zelderen-Bhola SL, et al. The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine needle aspiration biopsies. Arch Path Lab Med 2007; 131:91-6. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Maat W, Kilic E, Luyten GP, et al. Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma. Invest Ophthalmol Vis Sci 2008; 49:23-7. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Madhunapantula SV, Robertson GP. The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma. Pigment Cell Melanoma Res 2009; 22:400-19. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Margo CE. The Collaborative Ocular Melanoma Study: an overview. Cancer Control 2004; 11:304-9. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Margo CE. Mulla Z, Billiris K. Incidence of surgical treated uveal melanoma by race and ethnicity. Ophthalmology 1998; 105:1087-90. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Mariani P, Piperno-Neumann S, Servois V, et al. Surgical management of liver metastases from uveal melanoma: 16 years’ experience at the Institut Curie. Eur J Surg Oncol 2009; 35:1192-7. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Martelli AM, Evangelista C, Chiarini F, McCubrey JA. The phosphatidylinositol 3kinase /Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. Oncotarget 2010; 1:89-103. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Merhavi E, Cohen Y, Avraham BC, et al. Promotor methylation status of multiple genes in uveal melanoma. Invest Ophthalmol Vis Sci 2007; 48:4403-6. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Michailidou C, Jones M, Walker P, Kamarashev J, Kelly A, Hurlstone AF. Dissecting the roles of Raf-and the PI3K-signalling pathways in melanoma formation and progression in a zebrafish model. Dis Model Mech 2009; 2:399-411. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Miller B, Abrahams C, Cole GC, Proctor NS. Ocular malignant melanoma in South African blacks. Br J Ophthalmol 1981; 65:720-2. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Moore MW, Gasparini R. FISH as an effective diagnostic tool for the management of challenging melanocytic lesions. Diagn Pathol 2011; 6:76-81. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Mouriaux F, Kherrouche Z, Maurage CA, Demailly FX, Labalette P, Saule S. Expression of the c-kit receptor in choroidal melanomas. Melanoma Res 2003; 13:1616. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;NHS Cancer Services. Cancer Reform Strategy. Avaliable from: <URL:http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPoli cyAndGuidance/DH_081006> [ 2011 nov 28]. ;
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Naus NC, Verhoeven ACA, van Drunen CM, Paridaens DA, Luyten GPM, de Klein A. Detection of genetic prognostic markers in uveal melanoma biopsies using Fluorescence in situ Hybridization. Clin Cancer Res 2002; 8:534-9. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"North JP, Vetto JT, Murali R, White KP, White CR, Bastian BC. Assessment of copy number status of chromosome of 6 and 11 by FISH provides independent prognostic information in primary melanoma. Am J Surg Pathol 2011; 35:1146-50. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Onken MD, Worley LA, Long MD, et al. Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 2008; 49:5230-4. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Panasyuk G, Nemazanyy I, Zhvloup A, et al. mTOR? splicing isoform promotes cell proliferation and tumorigenesis. J Biol Chem 2009; 284:30807-14. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Pena SD, Bastos-Rodrigues L, Pimenta JR, Bydlowski SP. DNA tests probe the genomic ancestry of Brazilians. Braz J Med Biol Res 2010; 42:870-6. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Perone C, Medeiros GS, Del Castillo DM, de Aguiar MJB, Januário JN. Frequency of 8 CFTR gene mutations in cystic fibrosis patients in Minas Gerais, Brazil, diagnosed by neonatal screening. Br J Med Biol Res 2010; 43:134-8.  ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Phillpotts BA, Sanders RJ, Shields JA, Griffiths JD, Augsburger JA, Shields CL. Uveal melanoma in black patients: a case series and comparative review. J Natl Med Assoc 1995; 87:709-14.  ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Pons F, Plana M, Caminal JM, et al. Metastatic uveal melanoma: is there a role for conventional chemotherapy? – A single center study based on 58 patients. Melanoma Res 2011; 21:217-22. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Pópulo H, Soares P, Rocha AS, Silva P, Lopes MJ. Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma. Melanoma Res 2010; 20:107-17. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Pópulo H, Soares P, Faustino A, et al. mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics. Pigment Cell Melanoma Res 2011a; 24:254-7. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Pópulo H, Vinagre J, Lopes JM, Soares P. Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas. Br J Ophthalmol 2011b; 95:7159. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Poynter JN, Elder JT, Fullen DR, et al. BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res 2006; 16:267-73. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Prasad R, Sharma H, Kaur G. Molecular basis of cystic fibrosis disease: an Indian perspective. Indian J Clin Biochem 2010; 25:335-41. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Prescher G, Bonfield N, Becher R Nonrandom chromosomal abnormalities in Primary uveal melanoma. J Natl Cancer Inst 1990; 82:1765-9. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Pu X, Hildebrandt MA, Lu C, et al. PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinumbased chemotherapy. Lung Cancer 2011; 71:82-8. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Richtig E, Langmann G, Muller K, Richtig G, Smolle J. Calculated tumor volume as a prognostic parameter for survival in choroidal melanomas. Eye (Lond) 2004; 18:619-23. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB. Variates of survival in metastatic uveal melanoma. J Clin Oncol 2005; 23:8076-80. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Roa J, Tena-Sempere M. Energy balance and puberty onset: emerging role of central mTOR signaling. Trends Endocrinol Metab 2010; 21:519-28. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Sakamoto M, Sakamoto T, Yoshikawa H, et al. Histologic findings and prognosis of uveal malignant melanoma in Japanese patients. Am J Ophthalmol 1996; 121:276-83. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Santos PC, Soares RA, Santos DB, et al. CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population. BMC Med Genet 2011; 12:13. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Saraivo VS, Caissie AL, Segal L, Edelstein C, Burnier MN Jr. Immunohistochemical expression of phospho-Akt in uveal melanoma. Melanoma Res 2005; 15:245-50. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Schoenfield L, Pattey J, Tubbs RR, Singh AD. Variation of monosomy 3 status within uveal melanoma. Arch Pathol Lab Med 2009; 133:1219-22. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;Senetta R, Paglierani M, Massi D. Fluorescence in-situ hybridization analysis for melanoma diagnosis. Histopathology 2011 Oct 18. [Epub ahead of print] ;
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Seregard S, aft Trampe E, Lax I, Kock E, Lundell G. Results following episcleral ruthenium plaque radiotherapy for posterior uveal melanoma. The Swedish experience. Acta Ophthalmol Scand 1997; 75:11-6. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Shah CP, Weis E, Lajous M, Shields JA, Shields CL. Intermittent and chronic light exposure and uveal melanoma: a meta-analysis. Ophthalmology 2005; 112:1599-617. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Shen MM, Abate-Shen C. Pten inactivation and the emergence of androgen – independent prostate cancer. Cancer Res 2007; 67:6535-8. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Shields CL, Furuta M, Thangappan A, et al. Metastases of uveal melanoma millimeterby millimeter in 8033 consecutive eyes. Arch Ophthalmol 2009; 127:989-98. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Simpson L, Parsons R. PTEN: life as a tumor suppressor. Exp Cell Res 2001; 264:2941. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Opthalmology 2003; 110:956-61. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Singh AD, Terman S, Sculley L. Estimating choroidal melanoma volume: comparison of methods. Ophthalmology 2007; 114:1212-4. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Singh AD, Turell ME, Topham AK. Uveal Melanoma: trends in incidence, treatment and survival. Ophthalmology 2011; 118:1881-5. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Sisley K, Rennie GI, Cottam DW, Potter AM, Potter CW, Rees RC. Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3,6 and 8. Genes Chromos Cancer 1990; 2:205-9. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Sisley K, Doherty R, Cross NA. What hope for the future? GNAQ and uveal melanoma. Br J Ophthalmol 2011; 95:620-3. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Slipicevic A, Holm R, Nguyen MT, Bohler PJ, Davidson B, Florenes VA. Expression of activated Akt and PTEN with clinical outcome in malignant melanomas: relationship with clinical outcome. Am J Clin Pathol 2005; 124:528-36. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Spendlove HE, Damato BE, Humphreys J, Barker KT, Hiscott PS, Houslton RS. BRAF mutations are detectable in conjunctival but not uveal melanomas. Melanoma Res 2004; 14:449-52. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Stahl JM, Sharma A, Cheung M, et al. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 2004; 64:7002-10. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Steelman LS, Chappell WH, Abrams SL, et al. Roles of the Raf/MEK/ERK/ and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapyimplications for cancer and aging. Aging (Albany NY) 2011; 3:192-222. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Vajdic CM, Kricker A, Giblin M, et al. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer 2002; 101:175-82. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009; 457:599-602. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Veenhuizen KCW, de Witt PEJ, Mooi WJ, Scheffer E, Verbeek ALM, Ruiter DJ. Quality assessment by expert opinion in melanoma pathology: Experience of the pathology panel of the Dutch Melanoma Working Party. J Pathol 1997; 182:266-72. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Virgili G, Gatta G, Ciccolallo L, et al. Incidence of uveal melanoma in Europe. Ophthalmology 2007; 114:2309-15. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Virgili GV, Gatta G, Ciccolallo L, et al. Survival in patients with uveal melanoma in Europe. Arch Ophthalmol 2008; 126:1413-8. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Wang X, Trotman L, Koppie T, et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 2007; 128:129-39. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Wong CW, Fan YS, Chan TL, et al. BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs. J Clin Pathol 2005; 58:640-4. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Wu H, Goel V, Haluska FG. PTEN signaling pathways in melanoma. Oncogene 2003; 22:3113-9. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Xie P, Williams DS, Atilla-Gokcumen GE, et al. Structure-based design of an organoruthenium phosphatidyl-inositol-3-kinase inhibitor reveals a switch governing lipid kinase potency and selectivity. ACS Chem Biol 2008; 3:305-16. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Yang N, Kaur S, Volinia S, et al. Micro RNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 2008; 68:10307-14. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Ye M, Hu D, Tu L, et al. Involvement of PI3K/Akt signaling pathway in Hepatocyte growth factor-induced migration of uveal melanoma cells. Invest Ophthalmol Vis Sci 2008; 49:497-504. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells. Br J Ophthalmol 1978; 62:420-5. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Zipfel PA, Brady DC, Kashatus DF, Ancrile BD, Tyler DS, Counter CM. Ral activation promotes melanomagenesis. Oncogene 2010; 29:4859-64. ";
FAP;2012;GWENYTH MAY FREEMAN;Fernando Augusto Soares;Maria Dirlei Begnami;"Zuidervaart W, van Nieuwpoort F, Stark M, et al. Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. Br J Cancer 2005; 92:2032-8. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Alsner J, Yilmaz M, Guldberg P, et al. Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients. Clin Cancer Res 2000; 6:392331. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Arai N, Nomura D, Yokota K, et al. Immunologically distinct p53 molecules generated by alternative splicing. Mol Cell Biol 1986; 6:3232-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Ashktorab H, Brim H, Al-Riyami M, et al. Sporadic Colon Cancer: Mismatch Repair Immunohistochemistry and Microsatellite Instability in Omani Subjects. Dig Dis Sci 2008; 53:2723-31.  ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Auclair J, Busine MP, Navarro C, et al. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat 2006; 27:145-54. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Balic M, Pichler M, Strutz J, et al. High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis. J Mol Diagn 2009; 11:102-8. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet 2005; 42:737-48. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Beckman G, Birgander R, Sjalander A, et al. Is p53 polymorphism maintained by natural selection? Hum Hered 1994; 44:266-70. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Bergamaschi D, Samuels Y, Sullivan A, et al. iASPP preferentially binds p53 proline-rich region andmodulates apoptotic function of codon 72-polymorphic p53. Nat Gen 2006; 38:1133-41. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Berget SM, Moore C, Sharp PA. Spliced segments at the 5' terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci U S A 1977; 74:3171-5. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Béroud C, Soussi T. The UMD-p53 database: new mutations and analysis tools. Hum Mutat 2003; 21:176-81. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Boldrini L, Gisfredi S, Ursino S, et al: Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) prognosis. Cancer Invest 2008; 26:168-72. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Bourdon JC, Fernandes K, Murray-Zmijewski F, et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev 2005; 19:2122-37. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Bourdon JC. p53 and its isoforms in cancer. Br J Cancer 2007; 97:277-82. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Bray NJ, Buckland PR, Owen MJ, et al. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet 2003; 113:149-53. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Cann HM, de Toma C, Cazes L, et al. A human genome diversity cell line panel. Science 2002; 122:261-2. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Casillas S, Pelley RJ, Milsom JW. Adjuvant therapy for colorectal cancer: present and future perspectives. Dis Colon Rectum 1997; 40:977-92. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Chao HK, Hsiao KJ, Su TS. A silent mutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria. Hum Genet 2001; 108:14-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Cheung VG, Bruzel A, Burdick JT, et al. Monozygotic twins reveal germline contribution to allelic expression differences. Am J Hum Genet 2008; 82:1357-60. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Chung CC, Chanock SJ. Current status of genome-wide association studies in cancer. Hum Genet 2011; 130:59-78. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Clancy S. RNA splicing: introns, exons and spliceosome. Nat Educ 2008; 1(1). ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Coggi G, Bosari S, Roncalli M, et al. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer 1997; 79:425-32. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Cooper K, Haffajee Z. bcl-2 and p53 protein expression in follicular lymphoma. J Pathol 1997; 182:307-10. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Costa S, Pinto D, Pereira D, et al. Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer 2008; 29:8-32. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Courtois S, Verhaegh G, North S, et al. DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53. Oncogene 2002; 21:6722-8. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Czech A, Fedyunin I, Zhang G, et al. Silent mutations in sight: co-variations in tRNA abundance as a key to unravel consequences of silent mutations. Mol Biosyst 2010; 6:1767-72. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"da Silva FC, de Oliveira LP, Santos EM, et al. Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry. Fam Cancer 2010; 9:563-70. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Dearth LR, Qian H, Wang T, et al. Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers. Carcinogenesis 2007; 28:289-98. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Demaria S, Pikarsky E, Karin M, et al. Cancer and inflammation: promise for biologic therapy. J Immunother 2010; 33:335-51. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet 2001; 109:121-24. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Deschoolmeester V, Baay M, Van Marck E, et al. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunol 2010; 12:11-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Desmet FO, Hamroun D, Lalande M, et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acid Res 2009; 37:e67. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356:215-21. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"el-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/CIP1 is induced in p53mediated G1 arrest and apoptosis. Cancer Res 1994; 54:1169-74. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Feinberg AP, Gehrke CW, Kuo KC, et al. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 1988; 48: 1159-61. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-917. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Filippini G, Griffin S, Uhr M, et al. A novel flow cytometric method for the quantification of p53 gene expression. Cytometry 1998; 31:180-6. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Flaman JM, Waridel F, Estreicher A, et al. The human tumour suppressor gene p53 is alternatively spliced in normal cells. Oncogene 1996; 15:813-8. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Franco ED, Franco EL. Epidemiologia e fatores de risco em câncer colorretal. In: Rossi BM, Nakagawa WT, Ferreira FO, Aguiar Junior S, Lopes A, editores. Câncer de cólon, reto e ânus. Lemar/Tecmedd; São Paulo: 2005. p.3-22. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Fuchs CS, Mayer RJ. Adjuvant Chemotherapy for Colon and Rectal Cancer. Semin Radiat Oncol 1993; 3:29-41. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Gatalica Z, Torlakovic E. Pathology of the hereditary colorectal carcinoma. Fam Cancer 2008; 7:15-26. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Gemignani F, Moreno V, Landi S, et al. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene 2004; 23:1954-6. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Ghosh A, Stewart D, Matlashewski G. Regulation of human p53 activity and cell localization by alternative splicing. Mol Cell Biol 2004; 24:7987-97. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Giaccia AJ, Kastan MB. The complexity ofp53 modulation: emerging patterns from divergent signals. Genes Dev 1998; 12:2973-83. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Gimelbrant A, Hutchinson JN, Thompson BR, et al. Widespread monoallelic expression on human autosomes. Science 2007; 318:1136-40. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Goelz SE, Vogelstein B, Hamilton SR, et al. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985; 228:187-90. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Grantham R. Amino acid difference formula to help explain protein evolution. Science 1974; 185:862-4. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Grochola LF, Zeron-Medina J, Mériaux S, et al. Single-nucleotide polymorphisms in the p53 signaling pathway. Cold Spring Harb Perspect Biol 2010; 2:a001032. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Hainaut P. The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr Opin Oncol 1995; 7:76-82. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Hancox RJ, Poulton R, Welch D, et al. Accelerated decline in lung function in cigarette smokers is associated with TP53/MDM2 polymorphisms. Hum Genet 2009; 126:559-65. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Hanski C, Tiecke F, Hummel M, et al. Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas. Cancer Lett 1996; 103:163-70. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 1993; 329:1318-27. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005; 24:2899-908. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Hirshfield KM, Rebbeck TR, Levine AJ. Germline mutations and polymorphisms in the origins of cancers in women. J Oncol 2010; 2010:297671. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Hiscock R, Bauld L, Amos A, et al. Socioeconomic status and smoking: a review. Ann N Y Acad Sci 2012; 1248:107-23. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Hollstein M, Hainaut P. Massively regulated genes: the example of TP53. J Pathol 2010; 220:164-73. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Holmila R, Fouquet C, Cadranel J, et al. Splice mutations in the p53 gene: case report and review of the literature. Hum Mutat 2003; 21:101-2. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Hu Z, Li X, Qu X, et al. Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. Carcinogenesis 2010; 31:643-7. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Iacopetta B. TP53 mutation in colorectal cancer. Hum Mutat 2003; 21:271-6. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"International HapMap Consortium.The International HapMap Project. Nature 2003; 426:789-96. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987; 1:1303-6. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;Joerger AC, Fersht AR. Structural biology of the tumor suppressor p53. Annu Rev Biochem 2008 77:557-82. ;
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Kato S, Han SY, Liu W, et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by highresolution missense mutation analysis. Proc Natl Acad Sci USA 2003; 100:8424-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Kim JG, Sohn SK, Chae YS, et al. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin. Cancer Chemother Pharmacol 2009; 64:355-60. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Komar AA. A pause for thought along the co-translational folding pathway. Trends Biochem Sci 2009; 34:16-24. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Kouidou S, Malousi A, Maglaveras N. Methylation and repeats in silent and nonsense mutations of p53. Mutat Res 2006; 599:167-77. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Krypuy M, Newnham GM, Thomas DM, et al. High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer. BMC Cancer 2006; 6:295. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Krypuy M, Ahmed AA, Etemadmoghadam D, et al. High resolution melting for mutation scanning of TP53 exons 5-8. BMC Cancer 2007; 7:168-81. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Lamolle G, Marin M, Alvarez-Valin F. Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers. Mutat Res 2006; 600:102-12. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Lane DP. Cancer, p53, guardian of the genome. Nature 1992; 358: 15-6. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Levine AJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ 2006; 13:1027-36. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351:453-6. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Lim DHK, Maher ER. Genomic imprinting syndromes and cancer. In: Zdenko H, Toshikazu U, editors. Advances in genetics. Academic Press; 2010. p. 145–75. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Lima JM, Serafim PV, Silva ID, et al. Role of the genetic polymorphism of p53 (codon 72) gene in colorectal cancer. Arq Gastroenterol 2006; 43:8-13. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Ljungman M. Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. Neoplasia 2000; 2:208-25. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Lo HS, Wang Z, Hu Y, et al. Allelic variation in gene expression is common in the human genome. Genome Res 2003; 13:1855-62. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Mammano E, Belluco C, Bonafé M, et al. Association of p53 polymorphisms and colorectal cancer: modulation of risk and progression. Eur J Surg Oncol 2009; 35:415-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Marcel V, Palmero EI, Falagan-Lotsch P, et al. TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis. J Med Genet 2009; 46:766-72. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Marcel V, Hainaut P. p53 isoforms - a conspiracy to kidnap p53 tumor suppressor activity? Cell Mol Life Sci 2009; 66:391-406. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Marcel V, Dichtel-Danjoy ML, Sagne C, et al. Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ 2011; 18:1815-24. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Marin MC, Jost CA, Brooks LA, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 2000; 25:47-54. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Marin M. Folding at the rhythm of the rare codon beat. Biotechnol J 2008; 3:1047-57. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Marqueta A, Nerín I, Jiménez-Muro A, et al. Predictors of outcome of a smoking cessation treatment by gender. Gac Sanit 2012; 23. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Matlashewski G, Lamb P, Pim D, et al. Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. EMBO J 1984; 3:3257-62. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Matlashewski G, Pim D, Banks L, et al. Alternative splicing of human p53  transcripts. Oncogene Res 1987; 1:77-85. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene1999; 18:7621-36. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Milani L, Gupta M, Andersen M, et al. Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells. Nucleic Acids Res 2007; 35:e34 ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Milani L, Lundmark A, Nordlund J, et al. Allele-speci?c gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation. Genome Res 2009; 19:1-11. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2012 Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2011. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Monteiro Santos EM, Valentin MD, Carneiro F, et al. Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries. BMC Cancer 2012; 9:12-64. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36:2251-70. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Nakamura Y, Gojobori T, Ikemura T. Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res 2000; 28:292. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Nicholls CD, McLures KG, Shields MA, et al. Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers. J Biol Chem 2002; 277:12937-45. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Nomoto K, Tsuta K, Takano T, et al. Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high resolution melting analysis. Am J Clin Pathol 2006; 126:608-15. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"O'Farrell TJ, Ghosh P, Dobashi N, et al. Comparison of the effect of mutant and wild-type p53 on global gene expression. Cancer Res 2004; 64:8199207. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2010; 2:a001008. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Olschwang S, Laurent-Puig P, Vassal A, et al. Characterization of a requent polymorphism in the coding sequence of the Tp53 gene in colonic cancer patients and a control population. Hum Genet 1991; 86:369-70. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Orban TI, Olah E. Purifying selection on silent sites - a constraint from splicing regulation? Trends Genet 2001; 17:252-3. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Palmero EI, Achatz MI, Ashton-Prolla P, et al. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. Curr Opin Oncol 2010; 22:64-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Paluszkiewicz P, Berbe? H, Paw?owska-Wakowicz B, et al. p53 protein accumulation in colorectal cancer tissue has prognostic value only in leftsided colon tumours. Cancer Detect Prev 2004; 28:252-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Pandith AA, Shah ZA, Khan NP, et al. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genet Cytogenet 2010; 203:263-8. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Pant PV, Tao H, Beilharz EJ, et al. Analysis of allelic differential expression in human white blood cells. Genome Res 2006; 16:331-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Pastinen T, Sladek R, Gurd S, et al. A survey of genetic and epigenetic variation affecting human gene expression. Physiol Genomics 2004; 16:184-193. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Pastinen T, Ge B, Hudson TJ. In?uence of human genome polymorphism on gene expression. Hum. Mol Genet 2006; 1:R9-16. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Pastinen T, Hudson TJ. Cis-acting regulatory variation in the human genome. Science 2004; 306:647-50. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Perfumo C, Bonelli L, Menichini P, et al. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype. Digestion 2006; 74:228-35.  ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Petitjean A, Mathe E, Kato S, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007; 28:6229. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Phang BH, Chua HW, Li H, et al. Characterization of novel and uncharacterized p53 SNPs in the Chinese population--intron 2 SNP cosegregates with the common codon 72 polymorphism. PLoS One 2011; 6:e15320";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Pharoah PD, Day NE, Caldas C. Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer 1999; 80:1968-73. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 2004; 108:196-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Pinheiro H, Bordeira-Carriço R, Seixas S, et al. Allele-speci?c CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet 2010; 19:943–52. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Powell BL, van Staveren IL, Roosken P, et al. Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer. Carcinogenesis 2002; 23:311-5. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007; 50:151-62. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Prives C, Hall PA. The p53 pathway. J Pathol 1999; 187:112-26. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Renninson J, Baker BW, McGown AT, et al. Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features. Br J Cancer 1994; 69:609-12. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990; 87:7555-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Runnebaum IB, Tong XW, König R, et al. p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet 1995; 345:1250. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Schmid M, Haaf T, Grunert D. 5-Azacytidine-induced undercondensations in human chromosomes. Hum Genet 1984; 67: 257-63. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Senapathy P, Shapiro MB, Harris ML. Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Meth Enzymol 1990; 183:252-78. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Serre D, Gurd S, Ge B, et al. Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet 2008; 29:e1000006. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Szybka M, Zakrzewska M, Rieske P, et al. cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer. BMC Cancer 2009; 9:278. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Schadt EE, Monks SA, Drake TA, et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 2003; 422:297-302. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Scherhammer AS, Ogino S, Fuchs CS. Folate and vitamin B6 intake and risk of colon cancer in relation to P53 mutational status. Gastroenterology 2008; 135:770-80. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Shi H, Tan SJ, Zhong H, et al. Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia. Am J Hum Genet 2009; 84:534-41. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Siddique MM, Balram C, Fiszer-Maliszewska L, et al. Evidence for selective expression of the p53 codon 72 polymorphs: implications in cancer development. Cancer Epidemiol Biomarkers Prev 2005; 14:2245-52. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Sohn DK, Chang HJ, Park JW, et al. Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type. J Clin Pathol 2007; 60:912-5. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Soussi T, Béroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001; 1:233-40. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Stadler ZK, Vijai J, Thom P, et al. Genome-wide association studies of cancer predisposition. Hematol Oncol Clin North Am 2010; 24:973-96. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Steele RJ, Lane DP. P53 in cancer: a paradigm for modern management of cancer. Surgeon 2005; 3:197-205. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Stephen CW, Helminen P, Lane DP. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions. J Mol Biol 1995; 248:58-78. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Storey JD, Madeoy J, Strout JL et al. Gene-expression variation within and among human populations. Am J Hum Genet 2007; 80:502-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Sullivan A, Syed N, Gasco M, et al. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 2004; 23:3328-37. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Tan AC, Fan JB, Karikari C, et al. Allele-speci?c expression in the germline of patients with familial pancreatic cancer: an unbiased approach to cancer gene discovery. Cancer Biol Ther 2008; 7:135-44. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Tang NP, Wu YM, Wang B, Ma J. Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer. Eur J Surg Oncol 2010; 36:431-8. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"The International HapMap Consortium. The Internation HapMap project. Nature 2003; 426:789-96. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Tobacco Free Initiative (TFI). WHO report on the global tobacco epidemic, 2011: warning about the dangers of tobacco. Geneva: World Health Organization; 2011. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Valentin MD, da Silva FC, dos Santos EMM, et al. Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals. Fam Cancer 2011; 10:641-7. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Vojt?sek B, Bártek J, Midgley CA, et al. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992; 151:237-44. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Vossen RH, Aten E, Roos A, et al. High-resolution melting analysis (HRMA): more than just sequence variant screening. Hum Mutat 2009; 30:860-6. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8:275-83. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Waldman YY, Tuller T, Sharan R, Ruppin E. TP53 cancerous mutations exhibit selection for translation efficiency. Cancer Res 2009; 69:8807-13. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Walker C, Robertson LJ, Myskow MW, et al. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 1994; 70:297-303. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Walker EJ, Zhang C, Castelo-Branco P, et al. Monoallelic expression determines oncogenic progression and outcome in benign and malignant brain tumors. Cancer Res 2012; 72:636-44. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Wang-Gohrke S, Rebbeck TR, Besenfelder W, et al. p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res 1998; 18:2095-9.  ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Wang-Gohrke S, Weikel W, Risch H, et al. Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. Br J Cancer 1999; 81:179-83. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Wang-Gohrke S, Becher H, Kreienberg R, et al. Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years. Pharmacogenetics 2002; 12:269-72. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Weston A, Pan CF, Ksieski HB, et al. p53 haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev 1997; 6:105-12. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer 2009; 9:95-107. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Wilkinson NW. Adjuvant chemotherapy for colorectal cancer-new perspectives for effective treatment. US Gastroenterol Hepatol Rev 2007; 1:91-3. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Willmore-Payne C, Holden JA, Tripp S, et al. Human malignant melanoma: detection of BRAF and c-kit activating mutations by high resolution amplicon melting analysis. Hum Pathol 2005; 36:486-93. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Willmore-Payne C, Holden JA, Layfield LJ. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression. Hum Pathol 2006; 37:755-63. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Wolf D, Harris N, Goldfinger N, et al. Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule. Mol Cell Biol 1985; 5:127-32. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Wu X, Zhao H, Amos CI, et al. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst 2002; 94:681-90. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Yan H, Yuan W, Velculescu VE, et al. Allelic variation in human gene expression. Science 2002; 297:1143. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Zlobec I, Baker K, Minoo P, et al. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups. Cancer 2009; 115:4021-9. ";
FAP;2012;LIGIA PETROLINI DE OLIVEIRA;Renata de Almeida Coudry;Benedito Mauro Rossi;"Zlobec I, Terracciano LM, Lugli A. Local recurrence in mismatch repairproficient colon cancer predicted by an infiltrative tumor border and lack of CD8+tumor-infiltrating lymphocytes. Clin Cancer Res 2008; 14:3792-7. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"[Anonymous]. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000; 92:397-402. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Atkins K. p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: p16/Ki-67 in cervical papanicolaou Tests. Cancer Cytopathol 2011; 119:145-7. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Bergeron C, Cas F, Fagnani F, Didailler-Lambert F, Poveda JD. Human papillomavirus testing with a liquid-based system: feasibility and comparison with reference diagnoses. Acta Cytol 2006; 50:16-22. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Blomjous EC, Schipper NW, Baak JP, Vos W, De Voogt HJ, Meijer CJ. The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma. Am J Clin Pathol 1989; 91:243-8. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Boyle P, Levin B. World Cancer Report 2008. Lyon France: IARC; 2007.  ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Brismar-Wendel S, Froberg M, Hjerpe A, Andersson S, Johansson B. Agespecific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions. Br J Cancer 2009; 101:511-7. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Cappiello G, Garbuglia AR, Salvi R, et al. HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: an analysis of HPV genotypes. DIANAIDS Collaborative Study Group. Int J Cancer 1997; 72:982-6. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol 2011; 12:880-90. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Cenci M, Mancini R, Nofroni I, Vecchione A. Endocervical atypical glandular cells of undetermined significance. I. Morphometric and cytologic characterization of cases that ""cannot rule out adenocarcinoma in situ"". Acta Cytol 2000; 44:319-26. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Cox JT. Management of women with cervical cancer precursor lesions. Obstet Gynecol Clin North Am 2002; 29:787-816. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Cuschieri KS, Cubie HA, Whitley MW, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004; 57:68-72. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Cu-Uvin S, Hogan JW, Warren D, et al. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis 1999; 29:1145-50. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008; 26(Suppl 10):K29-41. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cytopathol 1994; 11:390-6. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Dehn D, Torkko KC, Shroyer KR. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer 2007; 111:114. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"DeMay RM. The art and science of cytopathology. Chicago: American Society of Clinical; 1996. The pap smear; p.1638-89. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Dona MG, Vocaturo A, Giuliani M, et al. p16/Ki-67 dual staining in cervicovaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy. Gynecol Oncol 2012; 126:198-202. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000; 283:1031-7. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Eversole GM, Moriarty AT, Schwartz MR, et al. Practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology, 2006. Arch Pathol Lab Med 2010; 134:331-5. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Fernandes JV, Meissner Rde V, de Carvalho MG, Fernandes TA, de Azevedo PR, Villa LL. Prevalence of HPV infection by cervical cytologic status in Brazil. Int J Gynaecol Obstet 2009; 105:21-4. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Ferris DG, Litaker MS, ALTS Group. Prediction of cervical histologic results using an abbreviated Reid Colposcopic Index during ALTS. Am J Obstet Gynecol 2006; 194:704-10. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Flores ER, Allen-Hoffmann BL, Lee D, Sattler CA, Lambert PF. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology 1999; 262:34454. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Gerber S, De Grandi P, Petignat P, Mihaescu A, Delaloye JF. Colposcopic evaluation after a repeat atypical squamous cells of undetermined significance (ASCUS) smear. Int J Gynaecol Obstet 2001; 75:251-5. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Helliwell TR, Atkinson MW, Cooke TG, Cooke LD, Stell PM. Morphometric analysis, ploidy and response to chemotherapy in squamous carcinomas of the head and neck. Pathol Res Pract 1989; 185:755-9. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169:235-40. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Available from: <URL:http://seer.cancer.gov/csr/1975_2009_pops09/> [2012 set 12 ;
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Hubbard RA. Human papillomavirus testing methods. Arch Pathol Lab Med 2003; 127:940-5. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Jeon S, Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 1995; 92:1654-8. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Juskevicius R, Zou KH, Cibas ES. An analysis of factors that influence the ASCUS/SIL ratio of pathologists. Am J Clin Pathol 2001; 116:331-5. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Kendall BS, Bush AC, Olsen CH, Zahn CM. Reflex high-risk human papillomavirus testing for women with atypical squamous cells of undetermined significance in cytologic smears: effects since implementation in a large clinical practice. Am J Clin Pathol 2005; 123:524-8. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Klein S, Koretz RL. Nutrition support in patients with cancer: what do the data really show? Nutr Clin Pract 1994; 9:91-100. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Koss LG, Melamed MR. Koss' diagnostic cytology and its histopathologic bases. 5th ed. New York: Lippincott Williams & Wilkins; 2006. Squaous carcinoma of the uterine cervix and its precursors; p.282-394. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327:1272-8. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Lee SJ, Jung KL, Lee JW, et al. Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management. Int J Gynecol Cancer 2006; 16:664-9. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007; 357:1579-88. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9:425-34. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998; 92(Pt 2):727-35. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Ministério da Saúde. Instituto Nacional de Câncer. Estimativas/2008: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2007. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Ministério da Saúde. Instituto Nacional de Câncer. Estimativa/2012: Incidência de Câncer no Brasil. Rio de Janeiro: INCA; 2011. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Monk BJ, Brewster WR. Does the ALTS trial apply to the community-based practitioner? Am J Obstet Gynecol 2003; 188:1381-2. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, et al. High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer 2002; 87:75-80. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Petry KU, Schmidt D, Scherbring S, et al. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology. Gynecol Oncol 2011; 121:505-9. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Rozendaal L, Westerga J, van der Linden JC, et al. PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol 2000; 53:606-11. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Runowicz CD. Molecular screening for cervical cancer--time to give up Pap tests? N Engl J Med 2007; 357:1650-3. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000; 283:87-93. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med 2003; 127:946-9. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Schmidt D, Bergeron C, Denton KJ, et al. p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Cancer Cytopathol 2011; 119:158-66. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Selvaggi SM. ASC-US and high-risk HPV testing: performance in daily clinical practice. Diagn Cytopathol 2006; 34:731-3. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Shaeffer J, Tegeler JA, Kuban DA, Philput CB, el-Mahdi AM. Nuclear roundness factor and local failure from definitive radiation therapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys 1992; 24:431-4. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002a; 287:2114-9. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Solomon D, Schiffman M, Tarone R. ASCUS LSIL Triage Study (ALTS) conclusions reaffirmed: response to a November 2001 commentary. Obstet Gynecol 2002b; 99:671-4. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Stoler MH. ASC, TBS, and the power of ALTS. Am J Clin Pathol 2007; 127:489-91. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Stoler MH, Castle PE, Solomon D, Schiffman M, American Society for Colposcopy and Cervical Pathology. The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. Am J Clin Pathol 2007; 127:335-7. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Stoler MH, Wright TC Jr, Sharma A, et al. The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV study. Am J Clin Pathol 2012; 137:295-303. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997; 337:1343-9. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Swartz R, West L, Boiko I, et al. Use of nuclear morphometry characteristics to distinguish between normal and abnormal cervical glandular histologies. Anal Cell Pathol 2003; 25:193-200. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Tindle RW. Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer 2002; 2:59-65. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Vassilakos P, Petignat P, Boulvain M, Campana A. Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing. Br J Cancer 2002; 86:382-8. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Walker JL, Wang SS, Schiffman M, Solomon D, ASCUS LSIL Triage Study Group. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). Am J Obstet Gynecol 2006; 195:341-8. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007; 7:11-22. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007; 197:346-55. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Yacoub SF, Shaeffer J, el-Mahdi AM, Faris L, Zhu A. Nuclear morphometry as a predictor of response to neoadjuvant chemotherapy plus radiotherapy in locally advanced cervical cancer. Gynecol Oncol 1994; 54:327-32. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Zheng H, Lin DC, Hong BT, Yao XY. Nuclear morphometry and its prognostic significance in laryngeal squamous cell carcinomas. Chin Med J (Engl) 1992; 105:410-4. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"Zuna RE, Wang SS, Rosenthal DL, et al. Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS). Cancer 2005; 105:253-62. ";
FAP;2012;LOUISE DE BROT ANDRADE;Victor Piana de Andrade;Isabela Werneck da Cunha;"zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2:342-50. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;[ACS] American Cancer Society. Cancer facts & figures 2011. Available from: <URL:http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/can cer-facts-figures-2011> [2012 jan 12] ;
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"[Anonymous]. Adjuvant therapy for patients with colon and rectal cancer. Conn Med 1990; 54:573-81. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"[Anonymous] Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Meta-Analysis Group in Cancer. J Clin Oncol 1998a; 16:3537-41. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"[Anonymous]. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group in Cancer. J Clin Oncol 1998b; 16:301-8. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"[Anonymous]. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol 1999; 17:1356-63. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"[Anonymous]. Palliative chemotherapy for advanced or metastatic colorectal cancer. Cochrane Colorectal Meta-analysis Collaboration. Cochrane Database Syst Rev 2000; (2):CD001545. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Al-Dasooqi N, Gibson RJ, Bowen JM, Logan RM, Stringer AM, Keefe DM. Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat. Exp Biol Med (Maywood) 2010; 235:1244-56. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Al-Dasooqi N, Bowen JM, Gibson RJ, Logan RM, Stringer AM, Keefe DM. Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the dark agouti rat. Int J Exp Pathol 2011; 92:357-65. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Alexander DD, Weed DL, Cushing CA, Lowe KA. Meta-analysis of prospective studies of red meat consumption and colorectal cancer. Eur J Cancer Prev 2011; 20:293-307.";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Alimonti A, Satta F, Pavese I, Burattini E, Zoffoli V, Vecchione A. Prevention of irinotecan plus 5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer. Ann Oncol 2003; 14:805-6. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26:162634. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"André T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27:3109-16. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Basch E, Prestrud AA, Hesketh PJ, et al. Antiemetics: American Society of clinical oncology clinical practice guideline update. J Clin Oncol 2011; 29:4189-98. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Benson AB 3rd, Ajani JA, Catalano RB, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004; 22:2918-26. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Bijlsma PB, Peeters RA, Groot JA, Dekker PR, Taminiau JA, Van Der Meer R. Differential in vivo and in vitro intestinal permeability to lactulose and mannitol in animals and humans: a hypothesis. Gastroenterology 1995; 108:687-96. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Bingham SA, Day NE, Luben R, et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 2003; 361:1496-501. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Blijlevens NM, Donnelly JP, de Pauw BE. Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant. Bone Marrow Transplant 2005; 35:707-11. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Bow EJ, Loewen R, Cheang MS, Shore TB, Rubinger M, Schacter B. Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remissioninduction therapy for acute myeloid leukemia in adults. J Clin Oncol 1997; 15:225461. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Bow EJ, Meddings JB. Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia. Leukemia 2006; 20:208792. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Braden B, Halliday J, Aryasingha S, et al. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2012; 10:303-8. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Carneiro-Filho BA, Lima IP, Araujo DH, et al. Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig Dis Sci 2004; 49:6572. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Chan AT, Arber N, Burn J, et al. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) 2012; 5:164-78. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Côté JF, Kirzin S, Kramar A, et al. UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan. Clin Cancer Res 2007; 13:3269-75. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Cross AJ, Ferrucci LM, Risch A, et al. A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res 2010; 70:2406-14. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Cross HS, Nittke T, Kallay E. Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer. Mol Cell Endocrinol 2011; 347:70-9. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Cunningham D, Pyrhonen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998; 352:1413-8. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004; 351:337-45. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Daenen S, Muskiet FA, Marrink J, Halie MR. Aggressive chemotherapy for acute leukaemia frequently causes intestinal protein leakage. Eur J Cancer 1991; 27:5526. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Daniele B, Perrone F, Gallo C, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut 2001a; 48:28-33. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Daniele B, Secondulfo M, De Vivo R, et al. Effect of chemotherapy with 5fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 2001b; 32:228-30. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Davies JM, Goldberg RM. Treatment of metastatic colorectal cancer. Semin Oncol 2011; 38:552-60. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"De Boissieu D, Dupont C, Badoual J. Allergy to nondairy proteins in mother's milk as assessed by intestinal permeability tests. Allergy 1994; 49:882-4. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18:2938-47. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Delellis Henderson K, Duan L, Sullivan-Halley J, et al. Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study. Am J Epidemiol 2010; 171:415-25. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000; 355:1041-7. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Douillard JY, Siena S, Cassidy J, et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol 2010; 28:4697-705. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Dvorák J, Melichar B, Hyspler R, et al. Intestinal permeability, vitamin A absorption, alpha-tocopherol, and neopterin in patients with rectal carcinoma treated with chemoradiation. Med Oncol 2010; 27:690-6. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Dworakowska D, Gueorguiev M, Kelly P, et al. Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines. Eur J Endocrinol 2010; 163:21-8. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7ª ed. New York: Springer-Verlag, 2010. Colon and rectum; p.14364. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45:22847. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Ellis M, Zwaan F, Hedstrom U, et al. Recombinant human interleukin 11 and bacterial infection in patients with [correction of] haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. Lancet 2003; 361:275-80. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Engelking C, Rutledge DN, Ippoliti C, Neumann J, Hogan CM. Cancer-related diarrhea: a neglected cause of cancer-related symptom distress. Oncol Nurs Forum 1998; 25:859-60. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Enker WE. Total mesorectal excision--the new golden standard of surgery for rectal cancer. Ann Med 1997; 29:127-33. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Fazeny-Dorner B, Veitl M, Wenzel C, et al. Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine). Cancer Chemother Pharmacol 2002; 49:294-8. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-917. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Ferraldeschi R, Minchell LJ, Roberts SA, et al. UGT1A1*28 genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan. Pharmacogenomics 2009; 10:733-9. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol 2004; 22:3395-407. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Flick ED, Habel LA, Chan KA, et al. Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs 2009; 69:1445-57. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Freitas HC. Envolvimento da Interleucina 18 (IL-18) na patogênese da mucosite gastrintestinal induzida por cloridrato de irinotecano. Fortaleza; 2007. [Dissertação de Mestrado-Universidade Federal do Ceará]. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Fuchs CS, Marshall J, Barrueco J. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study. J Clin Oncol 2008; 26:689-90. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Gala M, Chung DC. Hereditary colon cancer syndromes. Semin Oncol 2011; 38:490-9. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Giantonio BJ, Catalano PJ, Meropol NJ, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007; 25:1539-44. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Gifoni JMM. Mucosite e disfunção da barreira intestinal: modelo de estudo experimental em ratos com o uso de metotrexate e em pacientes portadores de Câncer submetidos a tratamento quimioterápico. Fortaleza; 2003. [Tese de Doutorado-Universidade Federal do Ceará]. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Gill S, Loprinzi CL, Sargent DJ, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?. J Clin Oncol 2004; 22:1797-806. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004; 22:23-30. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Grimes DA, Lobo RA. Perspectives on the Women's Health Initiative trial of hormone replacement therapy. Obstet Gynecol 2002; 100:1344-53. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004; 22:120914. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Grothey A, Sargent D. Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line. J Clin Oncol 2005; 23:9441-2. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Haller DG, Tabernero J, Maroun J, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 2011; 29:1465-71. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Hebels DG, Sveje KM, de Kok MC, et al. Red meat intake-induced increases in fecal water genotoxicity correlate with pro-carcinogenic gene expression changes in the human colon. Food Chem Toxicol 2012; 50:95-103. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Hjartaker A, Langseth H, Weiderpass E. Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 2008; 630:72-93. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Hoff PM, Ansari R, Batist G, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 2001; 19:2282-92. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350:2335-42. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Ikuno N, Soda H, Watanabe M, Oka M. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. J Natl Cancer Inst 1995; 87:187683. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Inutsuka S, Takesue F, Yasuda M, et al. Assessment of the intestinal permeability following postoperative chemotherapy for human malignant disease. Eur Surg Res 2003; 35:22-5. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Iyer L, Ratain MJ. Clinical pharmacology of camptothecins. Cancer Chemother Pharmacol 1998; 42:S31-S43. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Jawad N, Direkze N, Leedham SJ. Inflammatory bowel disease and colon cancer. Recent Results Cancer Res 2011; 185:99-115. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Jiang Y, Ben Q, Shen H, Lu W, Zhang Y, Zhu J. Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol 2011; 26:863-76. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Johnson MR, Diasio RB. Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil. Adv Enzyme Regul 2001; 41:151-7. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Katsanos KH, Tatsioni A, Pedersen N, et al. Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study. J Crohns Colitis 2011; 5:430-42. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Kawato Y, Aonuma M, Hirota Y, Kuga H, Sato K. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 1991; 51:4187-91. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Kawato Y, Sekiguchi M, Akahane K, et al. Inhibitory activity of camptothecin derivatives against acetylcholinesterase in dogs and their binding activity to acetylcholine receptors in rats. J Pharm Pharmacol 1993; 45:444-8. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE. Effect of highdose chemotherapy on intestinal permeability in humans. Clin Sci (Lond) 1997; 92:385-9. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Keefe DM, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47:632-7. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Keefe DM, Schubert MM, Elting LS, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007; 109:820-31. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Kemeny N, Seiter K. Colon and rectal carcinoma. In: Droz JP, Cvitkovic E, Armand JP, Kroury S, editors. Handbook of chemotherapy in clinical oncology. London: SCI Ltd; 1993. p.589-94. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Kohout P, Cerman J, Bratova M, Zadak Z. Small bowel permeability in patients with cytostatic therapy. Nutrition 1999; 15:546-9. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Koopman M, Antonini NF, Douma J, et al. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet 2007; 370:135-42. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007; 25:2198-204. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Lalla RV, Pilbeam CC, Walsh SJ, Sonis ST, Keefe DM, Peterson DE. Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study. Support Care Cancer 2010; 18:95-103. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Leitão RF, Brito GA, Oria RB, et al. Role of inducible nitric oxide synthase pathway on methotrexate-induced intestinal mucositis in rodents. BMC Gastroenterol 2011; 11:90. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Lima AA, Silva TM, Gifoni AM, et al. Mucosal injury and disruption of intestinal barrier function in HIV-infected individuals with and without diarrhea and cryptosporidiosis in northeast Brazil. Am J Gastroenterol 1997; 92:1861-6. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Lima AA, Moore SR, Barboza MS, Jr., et al. Persistent diarrhea signals a critical period of increased diarrhea burdens and nutritional shortfalls: a prospective cohort study among children in northeastern Brazil. J Infect Dis 2000; 181:1643-51. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Lima-Junior RC. Estudo morfofuncional e dos mediadores inflamatórios envolvidos na patogênese da mucosite intestinal induzida por irinotecano (CPT11) em camundongos: Papel da Caspase-1, Inlerleucina-18 e óxido nítrico. Fortaleza; 2008. [Tese de Doutorado-Universidade Federal do Ceará]. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Lima-Junior RC, Figueiredo AA, Freitas HC, et al. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation. Cancer Chemother Pharmacol 2012; 69:931-42. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DM. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol 2008a; 62:33-41. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther 2008b; 7:1139-45. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Lopes NN, Plapler H, Chavantes MC, Lalla RV, Yoshimura EM, Alves MT. Cyclooxygenase-2 and vascular endothelial growth factor expression in 5fluorouracil-induced oral mucositis in hamsters: evaluation of two low-intensity laser protocols. Support Care Cancer 2009; 17:1409-15. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Luo W, Cao Y, Liao C, Gao F. Diabetes mellitus and the incidence and mortality of colorectal cancer: A meta-analysis of twenty four cohort studies. Colorectal Dis 2012; 14:1307-12. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Lynch HT, Lynch JF. Hereditary nonpolyposis colorectal cancer. Semin Surg Oncol 2000; 18:305-13. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Maddens S, Charruyer A, Plo I, et al. Kit signaling inhibits the sphingomyelinceramide pathway through PLC gamma 1: implication in stem cell factor radioprotective effect. Blood 2002; 100:1294-301. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Mamounas E, Wieand S, Wolmark N, et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C02, C-03, and C-04). J Clin Oncol 1999; 17:1349-55. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Maughan TS, Adams R, Smith CG, et al. Identification of potentially responsive subsets when cetuximab is added to oxaliplatin-fluoropyrimidine chemotherapy (CT) in first-line advanced colorectal cancer (aCRC): mature results of the MRC COIN Trial. J ClinOncol 2010; 28:15s. [Presented at Annual Meeting-ASCO; 2010 June 48; Chicago (USA)]. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Melichar B, Dvorak J, Kohout P, Melicharova K, Solichova D, Zadak Z. Intestinal permeability in colorectal cancer patients treated by raltitrexed or irinotecan. J Clin Gastroenterol 2003; 37:192-3. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Melichar B, Hyspler R, Dragounova E, Dvorak J, Kalabova H, Ticha A. Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. BMC Cancer 2007; 7:155. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Melichar B, Hyspler R, Dragounova E, Kalabova H, Dvorak J. Intestinal permeability and toxicity of second-line therapeutic agents in ovarian cancer. Tumori 2008; 94:624-6. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Melichar B, Dvorak J, Kalabova H, et al. Intestinal permeability, vitamin A absorption and serum alpha-tocopherol during therapy with gefitinib. Scand J Clin Lab Invest 2010; 70:180-7. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Melichar B, Zezulova M. The significance of altered gastrointestinal permeability in cancer patients. Curr Opin Support Palliat Care 2011; 5:47-54. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Melo ML, Brito GA, Soares RC, et al. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide. Cancer Chemother Pharmacol 2008; 61:775-84. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;Ministério da Saúde. Instituto Nacional do Câncer. Atlas de mortalidade por câncer. 2011a. Disponível em: <URL:http://mortalidade.inca.gov.br/Mortalidade/> [2011 dez 10]. ;
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;Ministério da Saúde. Instituto Nacional do Câncer. Estimativas/2012: incidência do câncer no Brasil. Rio de Janeiro: INCA, 2011b. ;
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Mota MLS. Avaliação dos efeitos do agente citoprotetor amifostina na mucosite oral e disfunção da barreira intestinal: modelos experimentais em ratos e em pacientes portadores de câncer submetidos a quimioterapia. Fortaleza; 2004. [Tese de Doutorado-Universidade Federal do Ceará]. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;[NCI] National Cancer Institute. Common terminology criteria for adverse events version 4.0. Available from: <URL:http://evs.nci.nih.gov/ftp1/CTCAE/About.html> [2011 dez 12]. ;
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Newman LA, Lee CT, Parekh LP, et al. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Cancer 2006; 106:188-95. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371:1007-16. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Odegaard AO, Koh WP, Yu MC, Yuan JM. Body mass index and risk of colorectal cancer in Chinese Singaporeans: the Singapore Chinese Health Study. Cancer 2011; 117:3841-9. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Parrilli G, Iaffaioli RV, Capuano G, Budillon G, Bianco AR. Changes in intestinal permeability to lactulose induced by cytotoxic chemotherapy. Cancer Treat Rep 1982; 66:1435-6. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Parrilli G, Iaffaioli RV, Martorano M, et al. Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Res 1989; 49:3689-91. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Pearson AD, Craft AW, Pledger JV, Eastham EJ, Laker MF, Pearson GL. Small bowel function in acute lymphoblastic leukaemia. Arch Dis Child 1984; 59:460-5. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Peeters M, Price TJ, Cervantes A, et al. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol 2010; 28:4706-13. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Peterson DE, Bensadoun RJ, Roila F, ESMO Guidelines Working Group. Management of oral and gastrointestinal mucositis: ESMO clinical recommendations. Ann Oncol 2008; 19(Suppl 2):ii122-5. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Pham NM, Mizoue T, Tanaka K, et al. physical activity and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012; 42:2-13. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Pledger JV, Pearson AD, Craft AW, Laker MF, Eastham EJ. Intestinal permeability during chemotherapy for childhood tumours. Eur J Pediatr 1988; 147:123-7. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Printz C. Folate may help lower risk of colorectal cancer. Cancer 2011; 117:5249. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Quasar Collaborative Group, Gray R, Barnwell J, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007; 370:2020-9. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Raman M, Milestone AN, Walters JR, Hart AL, Ghosh S. Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer. Therap Adv Gastroenterol 2011; 4:49-62. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Raymond E, Faivre S, Woynarowski JM, Chaney SG. Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol 1998; 25(Suppl 5):4-12. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Renehan AG, O'Connell J, O'Halloran D, et al. Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications. Horm Metab Res 2003; 35:712-25. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Richardson G, Dobish R. Chemotherapy induced diarrhea. J Oncol Pharm Pract 2007; 13:181-98. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Rocha-Filho DR. Estudo prospectivo da incidência, das características clínicopatológicas e da hiperalgesia na síndrome mão-pé induzida por capecitabina. São Paulo; 2010. [Dissertação de Mestrado-Fundação Antonio Prudente]. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Rosen LS, Abdi E, Davis ID, et al. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol 2006; 24:5194-200. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Rothenberg ML, Meropol NJ, Poplin EA, Van CE, Wadler S. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. J Clin Oncol 2001; 19:3801-7. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Rothenberg ML, Oza AM, Bigelow RH, et al. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 2003; 21:2059-69. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Rougier P, Van Cutsem E, Bajetta E, et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998; 352:1407-12. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;[RTOG] Radiation Therapy Oncology Group. Acute radiation morbidity scoring criteria. Available from: <URL:http://www.rtog.org/ResearchAssociates/AdverseEventReporting/AcuteRadia tionMorbidityScoringCriteria.aspx> [2011 dez 12]. ;
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Saliba F, Hagipantelli R, Misset JL, et al. Pathophysiology and therapy of irinotecaninduced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment. J Clin Oncol 1998; 16:2745-51. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000; 343:90514. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Saltz, L, Clarke S, Diaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic coclorectal cancer: A randimized phase III study. J Clin Oncol 2008; 26:2013-9. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Sargent DJ, Niedzwiecki D, O'Connell MJ, Schilsky RL. Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. N Engl J Med 2001; 345:144-5. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351:1731-40. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Schmittel A, Jahnke K, Thiel E, Keilholz U. Neomycin as secondary prophylaxis for irinotecan-induced diarrhea. Ann Oncol 2004; 15:1296. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2associated cytokines. Immunity 2005; 23:479-90. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Schulz C, Boeck S, Heinemann V, Stemmler HJ. UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy? Anticancer Drugs 2009; 20:867-79. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Selby PJ, Lopes N, Mundy J, Crofts M, Millar JL, McElwain TJ. Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy. Br J Cancer 1987; 55:531-3. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Seymour MT, Maughan TS, Ledermann JA, et al. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. Lancet 2007; 370:143-52. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Shulman K, Cohen I, Barnett-Griness O, et al. Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients. Cancer 2011; 117:3156-62. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Siber GR, Mayer RJ, Levin MJ. Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy for metastatic colon carcinoma. Cancer Res 1980; 40:3430-6. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Simon MS, Rosenberg CA, Rodabough RJ, et al. Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk. Ann Epidemiol 2012; 22:17-27. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Slatter JG, Schaaf LJ, Sams JP, et al. Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients. Drug Metab Dispos 2000; 28:423-33. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Soares PM, Lima-Junior RC, Mota JM, et al. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemother Pharmacol 2011; 68:713-20. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Sobrero A, Guglielmi A, Grossi F, Puglisi F, Aschele C. Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy. Semin Oncol 2000; 27(Suppl 10):72-7. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Sobrero AF, Maurel J, Fehrenbacher L, et al. EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26:2311-9. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004; 100:1995-2025. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Sonis ST. New thoughts on the initiation of mucositis. Oral Dis 2010; 16:597-600. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Spence RR, Heesch KC, Brown WJ. A systematic review of the association between physical activity and colorectal cancer risk. Scand J Med Sci Sports 2009; 19:76481. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Srikrishna G, Freeze HH. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009; 11:615-28. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Stringer AM, Gibson RJ, Bowen JM, Logan RM, Yeoh AS, Keefe DM. Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment. J Support Oncol 2007; 5:259-67. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Sundstrom GM, Wahlin A, Nordin-Andersson I, Suhr OB. Intestinal permeability in patients with acute myeloid leukemia. Eur J Haematol 1998; 61:250-4. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Takasuna K, Hagiwara T, Hirohashi M, et al. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Cancer Res 1996; 56:3752-7. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Tepper RE, Simon D, Brandt LJ, Nutovits R, Lee MJ. Intestinal permeability in patients infected with the human immunodeficiency virus. Am J Gastroenterol 1994; 89:878-82. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Tooley KL, Howarth GS, Butler RN. Mucositis and non-invasive markers of small intestinal function. Cancer Biol Ther 2009; 8:753-8. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Toriola AT, Kurl S, Laukanen JA, Mazengo C, Kauhanen J. Alcohol consumption and risk of colorectal cancer: the Findrink study. Eur J Epidemiol 2008; 23:395401. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22:229-37. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Tveit K, Guren T, Glimelius B, Randomized phase III study of 5-fluorouracil, folinate, oxaliplatin given continuously or intermittently with or without cetuximabe, as first line treatment of metastatic colorectal cancer: the NORDIC VII study. [periódico online]. J Clin Oncol 2011; 29. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"van Cutsem E, Twelves C, Cassidy J, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 2001; 19:4097-106. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"van Cutsem E, Peeters M, Siena S, et al. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol 2007; 25:165864. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"van Cutsem E, Kohne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009; 360:1408-17. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"van Cutsem E, Kohne CH, Lang I, et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol 2011; 29:2011-9. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"van Vliet MJ, Tissing WJ, Rings EH, et al. Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients. Pediatr Blood Cancer 2009; 53:1188-94. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21:3737-43. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Vogelsang H, Schwarzenhofer M, Oberhuber G. Changes in gastrointestinal permeability in celiac disease. Dig Dis 1998; 16:333-6. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Wang D, DuBois RN. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2010; 29:781-8. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Welch S, Spithoff K, Rumble RB, Maroun J, Gastrointestinal Cancer Disease Site Group. Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review. Ann Oncol 2010; 21:1152-62. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"[WHO] World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization; 1979. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Wu ZQ, Han XD, Wang Y, et al. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice. Cancer Chemother Pharmacol 2011; 68:87-96. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Yeoh AS, Gibson RJ, Yeoh EE, et al. A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2. Mol Cancer Ther 2007; 6:2319-27. ";
FAP;2012;MARKUS ANDRET CAVALCANTE GIFONI;Ronaldo Albuquerque Ribeiro;-x-;"Zhang Y, Lee B, Thompson M, et al. Lactulose-mannitol intestinal permeability test in children with diarrhea caused by rotavirus and cryptosporidium. Diarrhea Working Group, Peru. J Pediatr Gastroenterol Nutr 2000; 31:16-21. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Adán-Merino L, Gómez-Senent S, Froilán-Torres C, et al. Gastric adenocarcinoma in young adults: a comparative study with elderly patients. Rev Gastroenterol Mex 2010; 75:253-60. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Advani AS, Hunger SP, Burnett AK. Acute leukemia in adolescents and young adults. Semin Oncol 2009; 36:213-26. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Aksglaede L, Olsen LW, Sorensen TI, et al. Forty years trends in timing of pubertal growth spurt in 157,000 Danish school children. PLos ONE 2008; 3:e2728. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Al-Barrak J, Gill S. Presentation and outcomes of patients aged 30 years and younger with colorectal cancer: a 20-year retrospective review. Med Oncol 2011; 28:105861. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Albritton K, Bleyer WA. The management of cancer in the older adolescent. Eur J Cancer 2003; 39:2584-99. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Alexander FE, Jarrett RF, Lawrence D, et al. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents. Br J Cancer 2000; 82:1117-21. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Al-Jaberi TM, Yaghan RJ, El-Heis HA. Colorectal cancer in young patients under 40 years of age. Comparison with old patients in a well defined Jordanian population. Saudi Med J 2003; 24:871-4. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Alston RD, Geraci M, Eden TOB, Moran A, Rowan S, Birch JM. Changes in Cancer Incidence in Teenagers and Young Adults (Ages 13 to 24 Years) in England 19792003. Cancer 2008; 10: 2807-2815. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Alves CMM, Guerra MR, Bastos RR. Tendência de mortalidade por câncer de colo de útero para o Estado de Minas Gerais, Brasil, 1980-2005. Cad Saúde Pública 2009; 25:1693-700. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Amégbor K, Darré T, Padaro E, Pegbessou EP, Bagny A, Napo-Koura G. Profil histoépidémiologique des lymphomes au Togo: à propos de 755 cas observés au CHU Tokoin de Lomé. Prog Urol 2009;19:125-5. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Amiri M, Kunst AE, Janssen F, et al. Trends in stomach cancer mortality in relation to living conditions in childhood. A study among cohorts born between 1860 and 1939 in seven European countries. Eur J Cancer 2006; 42:3212-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Amiri M, Janssen, F, Kunst, AE. The decline in stomach cancer mortality: exploration of future trends in seven European countries. Eur J Epidemiol 2011; 26:23-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"An HJ, Kim KR, Kim IS, et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol 2005; 18:528-34. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Anders CK, Hsu DS, Broadwater G, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 2008; 26:3324-30. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Anders CK, Johnson R, Litton J, et al. Breast cancer before age 40 years. Semin Oncol 2009; 36:237-49. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Anderson WF, Chen BE, Brinton LA, et al. Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers. Cancer Causes Control 2007; 18:1187-98. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Anderson WF. Cancer surveillance research. Cancer Epidemiol Biomarkers Prev 2009; 18:1669-71. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Anderson WF, Camargo MC, Fraumeni JF Jr, et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 2010; 303:1723-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Andrade FA. Penetração civilizadora. 1987. Disponível em: <URL:http://www.institutodoceara.org.br/aspx/images/revporano/1987TE/1987TEPenetracaoCivilizadora.pdf>. [2008 jul 24] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Anttila A, Ronco G, Clifford G, et al. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 2004; 91:935-41. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Arab M, Khayamzadeh M, Mohit M, et al. Survival of ovarian cancer in Iran: 20002004. Asian Pac J Cancer Prev 2009; 10:555-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Arab M, Khayamzadeh M, Hashemi M, Hosseini M, Tabatabaeefar M, Anbiaee R, et al. Crude and age-specific incidence rate patterns for histopathologic subtypes of ovarian cancer in Iran. Arch Iran Med 2010; 13:203-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Aragonés N, Pollán M, López-Abente G, et al. Time trend and age-period-cohort effects on gastric cancer incidence in Zaragoza and Navarre, Spain. J Epidemiol Community Health 1997; 51:412-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Arbyn M, Geys H. Trend of cervical cancer mortality in Belgium (1954-1994): tentative solution for the certification problem of unspecified uterine cancer. Int J Cancer 2002; 102:649–54. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ariad S, Lipshitz I, Benharroch D, et al. A sharp rise in the incidence of Hodgkin's lymphoma in young adults in Israel. Isr Med Assoc J 2009; 11:453-5. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Arora RS, Alston RD, Eden TO, et al. Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003. Eur J Cancer 2010; 46:1607-16. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 2011; 21:12534. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Autier P, Boniol M, La Vecchia C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 2010; 341:c3620. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ayturk S, Gursoy A, Kut A, et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-tomoderate iodine-deficient area. Eur J Endocrinol 2009; 161:599-605. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Baghestani AR, Hajizadeh E, Fatemi SR. Bayesian analysis for survival of patients with gastric cancer in Iran. Asian Pac J Cancer Prev 2009; 10:823-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bai Y, Li ZS. Endoscopic, clinicopathological features and prognosis of very young patients with gastric cancer. J Gastroenterol Hepatol 2011; 26:1626-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bani-Hani KE. Clinicopathological comparison between young and old age patients with gastric adenocarcinoma. Int J Gastrointest Cancer 2005; 35:43-52. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Barnabas RV, Laukkanen P, Koskela P, et al. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PloS Med 2006; 3:e138. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Barry EV, Silverman LB. Acute lymphoblastic leukemia in adolescents and young adults. Curr Hematol Malig Rep 2008; 3:161-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Beaglehole R, Yach D. Globalisation and the prevention and control of noncommunicable disease: the neglected chronic diseases of adults. Lancet 2003; 362:903-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Benharroch D, Shemer-Avni Y, Myint YY, et al. Measles virus: evidence of an association with Hodgkin's disease. Br J Cancer 2004; 91:572-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bertuccio P, Edefonti V, Bravi F, et al. Nutrient dietary patterns and gastric cancer risk in Italy. Cancer Epidemiol Biomarkers Prev 2009; 18:2882-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bezerra CFS, Oliveira LR, Gomes TNA, et al. Punção aspirativa por agulha fina em lesão nodular de tireoide. Rev Col Bras Cir 2003; 30:164-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bhayat F, Das-Gupta E, Smith C, McKeever T, et al. The incidence of and mortality from leukaemias in the UK: a general population-based study. BMC Cancer 2009; 9:252. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bhurgri Y, Pervez S, Bhurgri A, et al. Increasing incidence of non-Hodgkin’s lymphoma in Karachi, 1995-2002. Asian Pacific J Cancer Prev 2005; 6:364-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bilimoria KY, Phillips JD, Rock CE, et al. Effect of surgeon training, specialization, and experience on outcomes for cancer surgery: a systematic review of the literature. Ann Surg Oncol. 2009; 16:1799-808. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Birch JM, Alston RD, Kelsey AM, et al. Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer 2002; 87:1267-74. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bittencourt RI, Fernandes FB, Paz AA, et al. Leucemia mieloide aguda: o olhar dos anos 2000 no serviço de hematologia do Hospital de clínicas de Porto Alegre-RS. Rev Bras Hematol Hemoter 2008; 30:202-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009; 7:887-94. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Blaser MJ, Nomura A, Lee J, et al. Early-life family structure and microbially induced cancer risk. PLoS Med 2007; 4:e7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bleyer WA. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival and importance of clinical trials. Med Pediatr Oncol 2002; 38:110. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bleyer A, Viny A, Barr R. Cancer in 15 to 29-year-olds by primary site. Oncologist 2006; 11:590-601. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bleyer A. Young adult oncology: the patients and their survival challenges. CA Cancer J Clin 2007; 57:242-55. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Boffetta P. Epidemiology of adult non-Hodgkin lymphoma. Ann Oncol 2011; 22:iv27-iv31. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Boing AF, Vargas SAL, Boing AC. A carga das neoplasias no Brasil: mortalidade e morbidade hospitalar entre 2002-2004. Rev Assoc Med Bras 2007; 53:317-22. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55:244-65. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bosetti C, Levi F, Ferlay J, et al. The recent decline in mortality from Hodgkin lymphomas in central and eastern Europe. Ann Oncol 2009; 20:767-74. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Botterweck AA, van den Brandt PA, Goldbohm RA. A prospective cohort study on vegetable and fruit consumption and stomach cancer risk in The Netherlands. Am J Epidemiol 1998; 148:842-53. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bouchardy C, Morabia A, Verkooijen HM, et al. Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy. BMC Cancer. 2006; 22:78 ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bouchardy C, Fioretta G, Verkooijen HM, et al. Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer. 2007; 96:1743-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bozas G, Dimopoulos MA, Kastritis E, et al. Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: a single institution experience. Oncology 2006; 70:265-72. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Møller H, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005a; 14:67786. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bray F, Loos AH, Tognazzo S, et al. Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer 2005b; 113:977-90. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Brennan M, French J, Houssami N, et al. Breast cancer in young women. Aust Fam Physician 2005; 34:805-96. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Brenner H, Hoffmeister M, Arndt V, et al. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 2007; 96:828-31. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Brenner H, Gondos A, Pulte D. Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients. Blood 2008a; 111:2977-83. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Brenner H, Gondos A, Pulte D. Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level. Haematologica 2008b; 93:1544-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Brenner H, Gondos A, Pulte D. Survival expectations of patients diagnosed with Hodgkin's lymphoma in 2006-2010. Oncologist 2009; 14:806-13. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Brewster D. Improving the quality of cancer registration data. J R Soc Med 1995; 88:268-71. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Brindel P, Doyon F, Rachédi F, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol 2008; 167:219-29. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Brinton LA, Sherman ME, Carreon JD, et al. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 2008; 100:1643-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Britto L, Biasoli I, Azambuja D, et al. Advanced Hodgkin's lymphoma: Results in 216 patients treated with ABVD in Brazil. Rev Bras Hematol Hemoter 2010; 32:303-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Broccia G, Cocco P, Casula P, et al. Incidence of non-Hodgkin’s lymphoma and Hodgkin’s disease in Sardinia, Italy: 1974-1993. Haematologica 2001; 86:58-63. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Brown M, Schrot R, Bauer K, Letendre D. Incidence of first primary central nervous system tumors in California, 2001-2005. J Neurooncol 2009; 94:249-61. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Buffart TE, Louw M, van Grieken NC, et al. Gastric cancers of Western European and African patients show different patterns of genomic instability. BMC Med Genomics 2011; 4:7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bulk S, Visser O, Rozendaal L, et al. Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 2005; 113:1005-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Burk RD, Terai M, Gravitt PE, et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 2003; 63:7215-20. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Bustamante-Teixeira MT, Faerstein E, Mariotto A, et al. Sobrevida em pacientes com câncer gástrico em Campinas, São Paulo, Brasil. Cad Saude Publica 2006; 22(8):1611-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Buti L, Spooner E, Van der Veen AG, et al. Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci U S A 2011; 108:9238-43. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cabanes A, Vidal E, Pérez-Gómez B, et al. Age-specific breast, uterine and ovarian cancer mortality trends in Spain: changes from 1980 to 2006. Cancer Epidemiol. 2009; 33:169-75. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cai HB, Liu XM, Huang Y, et al. Trends in cervical cancer in young women in Hubei, China. Int J Gynecol Cancer 2010; 20(7):1240-3. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Campbell PT, Sloan M, Kreiger N. Dietary patterns and risk of incident gastric adenocarcinoma. Am J Epidemiol 2008; 167:295-304. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;[CCS] Canadian Cancer Society. National Cancer Institute of Canada. Canada Cancer Statisics. Cancer incidence in young adults. 2002. Avaliable from: <URL:http://www.phac-aspc.gc.ca/publicat/cyac-cjac06/pdf/cyac-cjac-2002_e.pdf>. [2011 ago 10]  ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;[CCS]. Canadian Cancer Society. National Cancer Institute of Canada. Cancer in young adults in Canada. 2006. Avaliable from: <URL:http://www.phacaspc.gc.ca/publicat/cyac-cjac06/pdf/cyac-cjac-2006_e.pdf> [2011 ago 10] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Carmo EH, Barreto ML, Silva Junior JB. Mudanças nos padrões de morbimortalidade da população brasileira: os desafios para um novo século. Epidemiol Serv Saúde 2003; 12:63-75. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cartwright R, McNally R, Roman E, et al. Incidence and time trends in Hodgkin's disease: from parts of the United Kingdom (1984-1993). Leuk Lymphoma 1998; 31:367-77. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Carvalho R, Milne AN, van Rees BP, et al. Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age. J Pathol 2004; 204:75-83. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Carvalho EBS, Loureiro AOF, Oliveira JL, et al. A pobreza no Ceará: o tamanho do desafio e uma proposta. 2010. nº 68 Disponível em: <URL:http://www.ipece.ce.gov.br/publicacoes/textos_discussao/TD_68.pdf>.[2011 jun 10] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Castellsagué X, Díaz M, de Sanjosé S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006; 98:303-15. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Castro MGGM, Ferreira AP, Mattos IE. Uso de agrotóxicos em assentamentos de reforma agrária no Município de Russas (Ceará, Brasil): um estudo de caso. Epidemiol Serv Saúde 2011; 20:245-54. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Castro Junior FM, Ferreira LAA, Arruda LR, et al. Microcarcinoma papilífero da tireoide: análise em 523 tireoidectomias. Rev Bras Cir Cabeça Pescoço 2010; 39:88-92. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Center MM, Jemal A, Smith RA, et al. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009a; 59:366-78. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2009b; 18:1688-94. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chan JK, Loizzi V, Lin YG, et al. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important? Obstet Gynecol 2003a; 102:156-61. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol 2003b; 102:765-73. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chan JK, Urban R, Cheung MK, et al. Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer 2006; 95:1314-20. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chan JK, Fuh K, Shin JY, et al. The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress? Br J Cancer 2008a ;98:1191-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chan JK, Tian C, Monk BJ, et al. Prognostic factors for high-risk early-stage epithelial ovarian cancer. Cancer. 2008b;112:2202-10. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chang CC, Chen CC, Chiu HF, et al. Higher parity associated with higher risk of death from gastric cancer. World J Gastroenterol 2011; 17:784-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chatenoud L, Bertuccio P, Bosetti C, et al. Trends in cancer mortality in Brazil, 1980-2004. Eur J Cancer Prev 2010; 19:79-86. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Chaudhry K, Luthra UK. Cancer registration in India: 50 years of cancer control in India. Available from: <URL:http://mohfw.nic.in/WriteReadData/l892s/pg22to34-72104673.pdf> [2011 ago 10] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chauvenet M, Cottet V, Lepage C, et al. Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population. BMC Cancer 2011; 11:282. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chen YT, Zheng T, Chou MC, et al. The increase of Hodgkin's disease incidence among young adults. Experience in Connecticut, 1935-1992. Cancer 1997; 79:220918. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009; 115:3801-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cheng L, Eng C, Nieman LZ, et al. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol 2011; 34:573-80. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cheung FY, Mang OW, Law SC. A population-based analysis of incidence, mortality, and stage-specific survival of cervical cancer patients in Hong Kong: 1997-2006. Hong Kong Med J 2011; 17:89-95. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chew GK, Cruickshank ME, Rooney PH, et al. Human papillomavirus 16 infection in adenocarcinoma of the cervix. Br J Cancer 2005; 93:1301-4. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chew MH, Koh PK, Ng KH, et al. Improved survival in an Asian cohort of young colorectal cancer patients: an analysis of 523 patients from a single institution. Int J Colorectal Dis 2009; 24:1075-83. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chien C, Morimoto LM, Tom J, et al. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer 2005; 104:629-39. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chirlaque MD, Salmerón D, Ardanaz E, et al. Cancer survival in Spain: estimate for nine major cancers. Ann Oncol 2010; 21:iii21-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Chung HW, Noh SH, Lim JB. Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol 2010; 16:25663. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Clarke CA, Glaser SL, Dorfman RF, et al. Expert review of non-Hodgkin’s lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications. Cancer Epidemiol Biomarkers Prev 2004; 13:138-43. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Clarke CA, Glaser SL, Keegan TH, et al. Neighborhood socioeconomic status and Hodgkin's lymphoma incidence in California. Cancer Epidemiol Biomarkers Prev 2005; 14:1441-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Clarke CA, Undurraga DM, Harasty PJ, et al. Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev 2006; 15:630-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366:991-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Coleman MP, Gatta G, Verdecchia A, et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003; 14:v128-49. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011; 377:127-38. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006; 118:1481-95. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007; 370:1609-21. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, et al. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008; 371:303-14. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Colonna M, Bossard N, Guizard AV, et al. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival. Ann Endocrinol 2010; 71:95101. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cook MB, Dawsey SM, Freedman ND, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 2009; 18:1174-82. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cooper N, Quinn MJ, Rachet B, et al. Survival from cancer of the ovary in England and Wales up to 2001. Br J Cancer 2008; 99:S70-2. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cotterill SJ, Parker L, Malcolm AJ, et al. Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry. Br J Cancer 2000; 83:397-403. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cramer JD, Fu P, Harth KC, Margevicius S, Wilhelm SM. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry. Surgery. 2010; 148:1147-52.";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cress RD, Morris C, Ellison GL, et al. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race / ethnicity, 1992-2001. Cancer 2006; 107:1142-52. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cucino C, Buchner AM, Sonnenberg A. Continued rightward shift of colorectal cancer. Dis Colon Rectum 2002; 45:1035-40. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Curado MP, Pontes T, Guerra-Yi ME, et al. Leukemia mortality trends among children, adolescents, and young adults in Latin America. Rev Panam Salud Publica 2011; 29:96-102. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high risk types of human papillomavirus: the HART study. Lancet 2003; 362:18716. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Dal Maso L, Bosetti C, La Vecchia C, et al. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 2009; 20:75-86. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Dal Maso L, Lise M, Zambon P, et al. Incidence of thyroid cancer in Italy, 19912005: time trends and age-period-cohort effects. Ann Oncol 2011; 22:957-63. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Das A, Chapman CA, Yap WM. Histological subtypes of symptomatic central nervous system tumours in Singapore. J Neurol Neurosurg Psychiatry 2000; 68:372-4. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Daubisse-Marliac L, Delafosse P, Boitard JB, et al. Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Ann Oncol 2011; 22:329-34. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Davies L, Welch HG. Increasing Incidence of Thyroid Cancer in the United States, 1973-2002. JAMA 2006; 295:2164-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Davies L, Ouellette M, Hunter M, et al. The increasing incidence of small thyroid cancers: where are the cases coming from?. Laryngoscope 2010; 120:2446-51. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Davis FS. Epidemiology of brain tumors. Expert Rev Anticancer Ther 2007; 7:S36.";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"De P, Ellison LF, Barr RD, et al. Canadian adolescents and young adults with cancer: opportunity to improve coordination and level of care. CMAJ 2011; 183:E187-94. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Deorah S, Lynch CF, Sibenaller ZA, et al. Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus 2006; 20:E1. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Derakhshan MH, Liptrot S, Paul J, et al. Oesophageal and gastric intestinal-type adenocarcinomas show same male predominance due to 17 year delayed development in females. Gut 2009; 58:16-23. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Derchain SF, Duarte-Franco E, Sarian LO. Panorama atual e perspectivas em relação ao diagnóstico precoce do câncer de ovário. Rev Bras Ginecol Obstet 2009; 31:15963. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Derossi AS, Paim JS, Aquino E, et al. Evolução da mortalidade e anos potenciais de vida perdidos por câncer cércico-uterino em Salvador (BA), 1979-1997. Rev Bras Cancerol 2001, 47:163-70. ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Derwinger K, Kodeda K, Gerjy R. Age aspects of demography, pathology and survival assessment in colorectal cancer. Anticancer Res 2010; 30:5227-31. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Desandes E. Survival from adolescent cancer. Cancer Treat Rev 2007; 33:609-15. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Di Cataldo A, Scilletta B, Latino R, et al. The surgeon as a prognostic factor in the surgical treatment of rectal cancer. Surg Oncol 2007; 16:S53-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Díaz-Montes TP, Zahurak ML, Giuntoli RL 2nd, et al. Uterine cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality. Gynecol Oncol 2006; 103:1043-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Dikshit RP, Mathur G, Mhatre S, et al. Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol 2011; 32:3-11. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Elgui de Oliveira D, Bacchi MM, Abreu ES, et al. Hodgkin disease in adult and juvenile groups from two different geographic regions in Brazil: characterization of clinicopathologic aspects and relationship with Epstein-Barr virus infection. Am J Clin Pathol 2002; 118:25-30. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"El-Hennawy MM, Moussa ME, El-Saeidy MK, et al. Rectal carcinoma in Egyptian patients less than 40 years of age. Int Surg 2003; 88:137-44. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Elisei R, Molinaro E, Agate L, et al. Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab 2010; 95:1516-27. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Elit L, Bondy SJ, Chen Z, et al. A tale of two time periods: ovarian cancer trends in Ontario. Curr Oncol 2007; 14:57-60. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"El-Khwsky FS, Maghraby HK, Rostom YA, et al. Multivariate analysis of reproductive risk factors for ovarian cancer in Alexandria, Egypt. J Egypt Natl Canc Inst 2006; 18:30-4. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Eltom MA, Jemal A, Mbulaiteye SM, et al. Trends in Kaposi's sarcoma and nonHodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002; 94:1204-10. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Endreseth BH, Romundstad P, Myrvold HE, et al. Rectal cancer in the young patient. Dis Colon Rectum 2006; 49:993-1001. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Engholm G, Gislum M, Bray F, et al. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964 – 2003 followed up to the end of 2006. Material and methods. Acta Oncologica 2010; 49:545-60. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Façanha MC, Pinheiro AC, Fauth S, et al. Busca ativa de óbitos em cemitérios da Região Metropolitana de Fortaleza, 1999 a 2000. Epidemiol Serv Saúde 2003; 12:131-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Fagö-Olsen CL, Hogdall C, Kehlet H, et al. Centralized treatment of advanced stages of ovarian cancer improves survival: a nationwide Danish survey. Acta Obstet Gynecol Scand 2010; 90:273-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Fairfield KM, Lucas FL, Earle CC, et al. Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the Medicare population. Cancer 2010; 116:4840-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Fairley TL, Cardinez CJ, Martin J, et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001. Cancer 2006; 107:1153-61. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Fazeli MS, Adel MG, Lebaschi AH. Colorectal carcinoma: a retrospective, descriptive study of age, gender, subsite, stage, and differentiation in Iran from 1995 to 2001 as observed in Tehran University. Dis Colon Rectum 2007; 50:990-5. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-917. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Fernandez CV, Barr RD. Adolescents and young adults with cancer: an orphaned population. Paediatr Child Health 2006; 11:103-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004; 23:6524-34. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Fisher JL, Schwartzbaum JA, Wrensch M, et al. Epidemiology of brain tumors. Neurol Clin 2007; 25:867-90, vii. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Fitzsimmons D, Osmond C, George S, et al. Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951-2000. Br J Surg 2007; 94:1162-71. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Foley G, Alston R, Geraci M, et al. Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006. Br J Cancer 2011; 105:177-84. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Franco-Marina F, Lazcano-Ponce E, López-Carrillo L. Breast cancer mortality in Mexico: an age-period-cohort analysis. Salud Pública Méx 2009; 51:S157-64. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Fredholm H, Eaker S, Frisell J, et al. Breast cancer in young women: poor survival despite intensive treatment. PLoS ONE 2009; 4:e7695. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Freedman ND, Chow WH, Gao YT, et al. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut 2007; 56:1671-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Freitas Junior R, Freitas NM, Curado MP, et al. Incidence trend for breast cancer among young women in Goiânia, Brazil. São Paulo Med J 2010; 128:81-4. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006; 55:285-91. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Frise S, Kreiger N, Gallinger S, et al. Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the canadian national enhanced cancer surveillance system. Ann Epidemiol 2006; 16:908-16. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Fuentes-Raspall R, Vilardell L, Perez-Bueno F, et al. Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain) 1994-2005. J Neurooncol 2011; 101:117-23. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"García Cuartero B, Gónzalez Vergaz A, Frías García E, et al. Valoración de la tendencia secular de la pubertad en niños y niñas. An Pediatr 2010; 73:320-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Gatta G, Capocaccia R, De Angelis R, et al. Cancer survival in European adolescents and young adults. Eur J Cancer 2003; 39:2600-10. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ghiasvand R, Maram ES, Tahmasebi S, et al. Risk factors for breast cancer among young women in southern Iran. Int J Cancer 2011; 129:1443-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ghoshal UC, Tiwari S, Dhingra S, et al. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci 2008; 53(5):1215-22. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Glaser SL, Keegan TH, Clarke CA, et al. Exposure to childhood infections and risk of Epstein-Barr virus--defined Hodgkin's lymphoma in women. Int J Cancer 2005; 115:599-605. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Gnagy S, Ming EE, Devesa SS, et al. Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use. Epidemiology 2000; 11:102-5. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"González CA, Sala N, Capellá, G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002; 100:249-60. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Goodman MT, Shvetsov YB. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. Cancer Epidemiol Biomarkers Prev 2009; 18:132-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Governo do Estado do Ceará. Secretaria de Planejamento e Gestão. IPECE: informe. estimativa do PIB cearense em 2010 e seu desempenho setorial. nº 2 2011a. Disponível em: <URL:http://www.ipece.ce.gov.br/publicacoes/ipeceinforme/IPECE_Informe_No2_PIB_2010.pdf>.[2011 ago 10]  ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Governo do Estado do Ceará. Secretaria de Saúde do Estado. Situação da saúde no Ceará. 2011b. Disponível em: <URL: www.saude.ce.gov.br/.../58-livros-revistas-efolderes-?...saude...ceara.pdf>. [2011 ago 10] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Grann AF, Norgaard M, Blaakær J, et al. Survival of patients with ovarian cancer in central and northern Denmark, 1998-2009. Clin Epidemiol 2011; 3:59-64. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Greenwood SA, Machado MFAS, Sampaio NMV. Motivos que levam mulheres a não retornarem para receber o resultado de exame Papanicolau. Rev Latinoam Enferm 2006; 14:503-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Grodski S, Brown T, Sidhu S, et al. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 2008; 144:1038-43. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Guerra MR, Gallo CVM, Mendonça GAS. Risco de câncer no Brasil: tendências e estudos epidemiológicos mais recentes. Rev Bras Cancerol 2005; 51: 227-34. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Guraya SY, Eltinay OE. Higher prevalence in young population and rightward shift of colorectal carcinoma. Saudi Med J 2006; 27:1391-3. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Gursoy A. Rising thyroid cancer incidence in the world might be related to insulin resistance. Med Hypotheses 2010; 74:35-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Haddadin WJ. Malignant lymphoma in Jordan: a retrospective analysis of 347 cases according to the World Health Organization classification. Ann Saudi Med 2005; 25:398-403. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hall SF, Walker H, Siemens R, et al. Increasing detection and increasing incidence in thyroid cancer. World J Surg 2009; 33:2567-71. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hamidou Z, Causeret S, Dabakuyo TS, et al. Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years. BMC Cancer 2010; 10:622. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hammal DM, Bell CL, Craft AW, et al. Second primary tumors in children and young adults in the North of England (1968-99). Pediatr Blood Cancer 2005; 45:155-61. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Han X, Kilfoy B, Zheng T, et al. Lymphoma survival patterns by WHO subtype in the United States, 1973-2003. Cancer Causes Control 2008; 19:841-58. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hao Y, Jemal A, Zhang X, et al. Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995-2004 (United States). Cancer Causes Control 2009; 20:1855-63. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hardell L, Eriksson M. Is the decline of the increasing incidence of non-Hodgkin lymphoma in Sweden and other countries a result of cancer preventive measures? Environ Health Perspect 2003; 111:1704-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hartley MC, McKinley BP, Rogers EA, et al. Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: a casecontrol study. Am Surg 2006; 72:1189-94. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hashemi-Bahremani M, Parwaresch MR, Tabrizchi H, et al. Lymphomas in Iran. Arch Iran Med 2007; 10:343-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hayat MJ, Howlader N, Reichman ME, et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007; 12:20-37. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Helseth A. The incidence of primary central nervous system neoplasms before and after computerized tomography availability. J Neurosurg 1995; 83:999-1003. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hemminki K, Li X, Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996. Eur J Obstet Gynecol Reprod Biol 2002; 101:64-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hemminki K, Mousavi SM, Sundquist J, et al. Does the breast cancer age at diagnosis differ by ethnicity? A study on immigrants to Sweden. Oncologist 2011; 16:146-54. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Heuch I, Kvale G. Menstrual and reproductive factors and risk of gastric cancer: a Norwegian cohort study. Cancer Causes Control 2000; 11:869-74. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Hiripi E, Gondos A, Emrich K, et al. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol. 2011 may 19. [Epub ahead of print]. ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hjalgrim H, Askling J, Pukkala E, et al. Incidence of Hodgkin's disease in nordic countries. Lancet 2001; 358:297-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hjalgrim H, Seow A, Rostgaard K, et al. Changing patterns of Hodgkin lymphoma incidence in Singapore. Int J Cancer 2008; 123:716-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol 2006; 8:27-37. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Holanda MC, Rosa ALT, Loureiro AOF, et al. O analfabetismo no Ceará: caracterização e tendências recentes. 2006. Disponível em: <URL:http://www.ipece.ce.gov.br/publicacoes/notas_tecnicas/NT_22.pdf> [2011 set 05]. ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Howlett RI, Marrett LD, Innes MK, et al. Decreasing incidence of cervical adenocarcinoma in Ontario: is this related to improved endocervical Pap test sampling? Int J Cancer 2007; 120:362-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;[IBGE] Instituto Brasileiro de Geografia e Estatística. Ministério do planejamento, orçamento e gestão. População residente – censo 2000: Brasil, unidades da federação e municípios. 2000. Disponível em: <URL:http://www.ibge.gov.br>. [2011 set 12] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;[IBGE] Instituto Brasileiro de Geografia e Estatística. Indicadores sociodemográficos e de saúde no Brasil 2009. 2009a. Disponível em: <URL:http://tabnet.datasus.gov.br/cgi/idb2009/matriz.htm> [2011 set 12] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;[IBGE] Instituto Brasileiro de Geografia e Estatística. Produto interno bruto dos municípios 2004-2008: análise dos resultados. 2009b. Disponível em: <URL:http://www.ibge.gov.br/home/estatistica/economia/pibmunicipios/2004_2008/ comentarios.pdf>. [2011 jun 22] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Igisinov N, Umaralieva G. Epidemiology of ovarian cancer in Kyrgyzstan women of reproductive age. Asian Pac J Cancer Prev 2008; 9:331-4. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Inghelmann R, Grande E, Francisci S, et al. Regional estimates of stomach cancer burden in Italy. Tumori 2007; 93:367-73. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ioka A, Ito Y, Tsukuma H. Factors relating to poor survival rates of aged cervical cancer patients: a population-based study with the relative survival model in Osaka, Japan. Asian Pac J Cancer Prev 2009; 10:457-62. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Iwasaki M, Mameri CP, Hamada GS, et al. Secular trends in cancer mortality among Japanese immigrants in the state of São Paulo, Brazil, 1979-2001. Eur J Cancer Prev 2008; 17:1-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Jarosz M, Seku?a W, Rychlik E, et al. Impact of diet on long-term decline in gastric cancer incidence in Poland. World J Gastroenterol 2011; 17:89-97. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Jekel JF, Katz DL, Elmore JG. Epidemiologia, bioestatística e medicina preventiva. 2ª ed. Porto Alegre: Artmed; 2001. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Jenab M, Riboli E, Ferrari P, et al. Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcinogenesis 2006; 27:2250-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Jorge MH, Laurenti R, Gotlieb SL. Quality analysis of Brazilian vital statistics: the experience of implementing the SIM and SINASC systems. Cien Saude Colet 2007; 12:643-54. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kac G, Velásquez-Meléndez G, Valente JG. Menarca, gravidez precoce e obesidade em mulheres brasileiras selecionadas em um Centro de Saúde de Belo Horizonte, Minas Gerais, Brasil. Cad Saúde Pública 2003; 19:S111-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kac G, Benicio MH, Velásquez-Meléndez G, et al. Nine months postpartum weight retention predictors for Brazilian women. Public Health Nutr 2004; 7:621-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kalakun L, Bozzetti MC. A evolução da mortalidade por câncer de colo do útero entre 1979 e 1998 no Rio Grande do Sul, Brasil. Cad Saúde Pública 2005; 21:299309. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kalyani R, Das S, Kumar ML. Pattern of cancer in adolescent and young adults--a ten year study in India. Asian Pac J Cancer Prev 2010; 11:655-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kanavos P. The rising burden of cancer in the developing world. Ann Oncol 2006; 17: viii15-viii23. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kaneko S, Nomura K, Yoshimura T, et al. Trend of brain tumor incidence by histological subtypes in Japan: estimation from the brain tumor registry of Japan, 1973-1993. J Neurooncol 2002; 60:61-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kaplowitz P. Pubertal development in girls: secular trends. Curr Opin Obstet Gynecol 2006; 18:487-91. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kee F, Wilson RH, Gilliland R, et al. Changing site distribution of colorectal cancer. BMJ 1992; 305:158. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kent EE, Sender LS, Largent JA, et al. Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors. Cancer Causes Control 2009; 20:1409-20. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kent WD, Hall SF, Isotalo PA, et al. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ 2007; 177:1357-61. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Khayamzadeh M, Khayamzadeh M, Tadayon N, et al. Survival of thyroid cancer and social determinants in iran, 2001-2005. Asian Pac J Cancer Prev 2011;12:95-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Khuhaprema T, Srivatanakul P. Colon and rectum cancer in Thailand: an overview. Jpn J Clin Oncol 2008; 38:237-43. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kilfoy BA, Zheng T, Holford TR, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009; 20:525-31. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kim DY, Joo JK, Ryu SY, et al. Clinicopathologic characteristics of gastric carcinoma in elderly patients: a comparison with young patients. World J Gastroenterol 2005; 11:22-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kim JH, Boo YJ, Park JM, et al. Incidence and long-term outcome of young patients with gastric carcinoma according to sex: does hormonal status affect prognosis? Arch Surg 2008; 143:1062-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kim KW, Park YJ, Kim EH, et al. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis. Head Neck 2011; 33:691-5. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kitahara CM, Platz EA, Freeman LE, et al. Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomark Prev 2011; 20:464-72. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kitamura K, Taniguchi H, Yamaguchi T, et al. Early gastric cancer in young adults. Tohoku J Exp Med 1996; 179:93-100. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kjaerbye-Thygesen A, Huusom LD, Frederiksen K, et al. Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries. Acta Obstet Gynecol Scand 2005; 84:1006-12. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Klint A, Engholm G, Storm HH, et al. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010a; 49:578-607. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Klint A, Tryggvadóttir L, Bray F, et al. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010b; 49:632-43. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kobayashi M, Tsubono Y, Sasazuki S, et al. Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC Study Cohort I. Int J Cancer 2002; 102:39-44. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011; 103:714-36. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kokawa K, Takekida S, Kamiura S, et al. The incidence, treatment and prognosis of cervical carcinoma in young women: a retrospective analysis of 4,975 cases in Japan. Eur J Gynaecol Oncol 2010; 31:37-43. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kroman N, Jensen MB, Wohlfahrt J, et al. Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 2000; 320:474-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kulig J, Popiela T, Kolodziejczyk P, et al. Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients. Langenbecks Arch Surg 2008; 393:37-43. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kus LH, Shah M, Eski S, et al. Thyroid cancer outcomes in Filipino patients. Arch Otolaryngol Head Neck Surg 2010; 136:138-42. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kwong A, Cheung P, Chan S, et al. Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? World J Sur 2008; 32:255461. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Kyndi M, Frederiksen K, Krüger Kjaer S. Cervical cancer incidence in Denmark over six decades (1943-2002). Acta Obstet Gynecol Scand 2006; 85:106-11. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"La Vecchia C. Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev 2001; 10:125-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Lacey JV Jr, Swanson CA, Brinton LA, et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003; 98:814-21. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Larsen IK, Bray F. Trends in colorectal cancer incidence in Norway 1962-2006: an interpretation of the temporal patterns by anatomic subsite. Int J Cancer 2010; 126:721-32. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Larsson SC, Bergkvist L, Wolk A. Fruit and vegetable consumption and incidence of gastric cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2006; 15:1998-2001. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Latorre MRDO. A mortalidade por câncer de estômago no Brasil: análise do período de 1977 a 1989. Cad Saude Publica 1997; 13:67-78. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Laukkanen P, Koskela P, Pukkala E, et al. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol 2003; 84:2105-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Laurenti R, Mello Jorge MHP, Gotlieb SLD. The accuracy of the official mortality and morbidity statistics related to chronic non-communicable diseases. Ciênc Saúde Coletiva 2004; 9:909-20. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Laurenti R, Mello Jorge MHP, Lebrão ML, et al. Estatísticas de saúde.2ª ed. São Paulo: EPU; 2005.  ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Leal EAS, Leal OS, Guimaraes MH, et al. Lesões precursoras do câncer de colo em mulheres adolescentes e adultas jovens do município de Rio Branco - Acre. Rev Bras Ginecol Obstet 2003; 25:81-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Lécuru F, Desfeux P, Camatte S, et al. Impact of initial surgical access on staging and survival of patients with stage I ovarian cancer. Int J Gynecol Cancer 2006; 16:87-94. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Lee CH, Jung KW, Yoo H, et al. Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc 2010; 48:145-52. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Lee JH, Ryu KW, Lee JS, et al. Decisions for extent of gastric surgery in gastric cancer patients: younger patients require more attention than the elderly. J Surg Oncol 2007; 95:485-90. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Leenhardt L, Grosclaude P. Épidémiologie des cancers thyroïdiens dans le monde. Ann Endocrinol 2011; 72:136-48. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Leff DR, Chen A, Roberts D, et al. Colorectal cancer in the young patient. Am Surg 2007; 73:42-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Legler JM, Ries LA, Smith MA, et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999; 91:1382-90. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Lerch E, Espeli V, Zucca E, et al. Prognosis of acute myeloid leukemia in the general population: data from southern Switzerland. Tumori 2009; 95:303-10. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Lessa I. Doenças não-transmissíveis. In: Rouquayrol MZ. Epidemiologia e saúde. 4ªed. São Paulo: MEDSI; 1994. p.269-79. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Levi F, La Vecchia C, Randimbison L, et al. Cancer incidence and mortality in young adults in Vaud, Switzerland, 1974-1992. Int J Cancer 1995; 61:606-10. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Levi F, Lucchini F, Negri E, et al. Cervical cancer mortality in young women in Europe - patterns and trends. Eur J Cancer 2000; 36:2266-71. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Levi F, Lucchini F, Gonzalez JR, et al. Monitoring falls in gastric cancer mortality in Europe. Ann Oncol 2004; 15:338-45. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Levy A, Diomin V, Gopas J, et al. Hodgkin's lymphoma in the Bedouin of southern Israel: epidemiological and clinical features. Isr Med Assoc J 2000; 2:501-3. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Lilienfeld AM, Lilienfeld DE. Foundations of epidemiology. 2ª ed. New York: Oxford University Press; 1980.  ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Lindblad M, Ye W, Rubio C, et al. Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev 2004; 13:2203-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Liu S, Semenciw R, Mao Y. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ 2001a; 164:1151-2. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Liu S, Semenciw R, Ugnat AM, et al. Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br J Cancer 2001b; 85:13359. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Liu Y, Kaneko S, Sobue T. Trends in reported incidences of gastric câncer by tumour location, from 1975 to 1989 in Japan. Int J Epidemiol 2004; 33:808-15. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Liu YX, Wikland KA, Karlberg J. New reference for the age at childhood onset of growth and secular trend in the timing of puberty in Swedish. Acta Paediatr 2000; 89:637-43. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Llanos O, Butte JM, Crovari F, et al. Survival of young patients after gastrectomy for gastric cancer. World J Surg 2006; 30:17-20. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Llorca J, Rodriguez-Cundin P, Dierssen-Sotos T, et al. Cervical cancer mortality is increasing in Spanish women younger than 50. Cancer Lett 2006; 240:36-40. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Loka A, Tsukuma H, Ajiki W, et al. Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci 2003; 94:292-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Lönn S, Klaeboe L, Hall P, et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer 2004; 108:450-5. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Luiz BM, Miranda PF, Maia EMC, et al. Estudo epidemiológico de pacientes com tumor de ovário no município de Jundiaí no período de junho de 2001 a junho de 2006. Rev Bras Cancerol 2009; 55:247-53. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Luke C, Nguyen AM, To B, et al. Myeloid leukaemia treatment and survival--the South Australian experience, 1977 to 2002. Asian Pac J Cancer Prev 2006; 7:22733. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer 2003; 106:953-60. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Mackay J, Amos A. Women and tobacco. Respirology 2003; 8:123-30. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Magalhães MLC, Mattar R, Furtado FM, et al. Características epidemiológicas del embarazo en la adolescência: estudio en la Maternidad Escuela de Fortaleza/Brasil. Rev Soc Chil Obstet Ginecol Infant Adolesc 2005; 12:49-70. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Malterling RR, Andersson RE, Falkmer S, et al. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life. Acta Oncol 2010; 49:454-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Malvezzi M, Bonifazi M, Bertuccio P, et al. An age-period-cohort analysis of gastric cancer mortality from 1950 to 2007 in Europe. Ann Epidemiol 2010; 20:898-905. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Manoharan N, Tyagi BB, Raina V. Cancer incidences in urban Delhi - 2001-05. Asian Pac J Cancer Prev 2009; 10:799-806. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Marcos-Gragera R, Gumà J, de Sanjosé S. Análisis de la incidencia, supervivência y mortalidade por cancer según las principales localizaciones, 1985-2019: linfomas noHodgkin. Med Clin 2008; 131:72-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Marcos-Gragera R, Pollán M, Chirlaque MD, et al. Attenuation of the epidemic increase in non-Hodgkin's lymphomas in Spain. Ann Oncol 2010; 21:iii90-6.";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Martin S, Ulrich C, Munsell M, et al. Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist 2007; 12:816-24. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Martins LFL, Thuler LCS, Valente JG. Cobertura do exame de Papanicolaou no Brasil e seus fatores determinantes: uma revisão sistemática da literatura. Rev Bras Ginecol Obstet 2005; 27: 485-92. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Materljan E, Materljan B, Sepci? J, et al. Epidemiology of central nervous system tumors in Labin area, Croatia, 1974-2001. Croat Med J 2004; 45:206-12. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Mathew A, George PS. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide. Asian Pac J Cancer Prev 2009; 10:645-50. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Mathias TAF, Jorge MHPM, Laurenti R, et al. Considerações sobre a qualidade de informações de mortalidade na população idosa residente no Município de Maringá, Estado do Paraná, Brasil, no período de 1979 a 1998. Epidemiol Serv Saude 2005; 14:159-69. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Matsuda T, Marugame T, Kamo K, et al. Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2008; 38:641-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"McKinley BP, Michalek AM, Fenstermaker RA, et al. The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J Neurosurg 2000; 93:932-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"McMillan DC, McArdle CS. The impact of young age on cancer-specific and noncancer-related survival after surgery for colorectal cancer: 10-year follow-up. Br J Cancer 2009; 101:557-60. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Medeiros VCRD, Medeiros RC, Moraes LM, et al. Cancer de colo de útero: análise epidemiológica e citopatológica no estado do Rio Grande do Norte. RBAC 2005; 37:227-31. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Medina-Franco H, Heslin MJ, Cortes-Gonzalez R. Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol 2000; 7:515-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Mehrazin M, Rahmat H, Yavari P. Epidemiology of primary intracranial tumors in Iran, 1978-2003. Asian Pac J Cancer Prev 2006; 7:283-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Memon A, Darif M, Al-Saleh K, et al. Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East. Int J Cancer 2002; 97:82-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Menczer J, Liphshitz I, Barchana M. A decreasing incidence of ovarian carcinoma in Israel. Int J Gynecol Cancer 2006; 16:41-4. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Mendonça VG. Mortalidade por câncer de colo do útero na cidade do Recife: tendência temporal e perfil sócio-demográfico. Recife; 2006. [Dissertação de Mestrado-Instituto Materno Infantil Professor Fernando Figueira – IMIP]. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Meyer JE, Narang T, Schnoll-Sussman FH, et al. Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer 2010; 116:4354-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Miedema MAB, Easley J, Hamilton R. Young adults' experiences with cancer: comments from patients and survivors. Can Fam Physician 2006; 52:1446-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Milne AN, Carvalho R, Morsink FM, et al. Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod Pathol 2006; 19:564-72. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ministério da Saúde. Instituto Nacional do Câncer. Câncer no Brasil: dados dos registros de base populacional. Rio de Janeiro: INCA; 2003.  ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Ministério da Saúde. Secretaria de Vigilância em Saúde. Saúde Brasil 2004: uma análise da situação de saúde: temas especiais: análise de séries temporais de causas de morte selecionadas. p.233-98. 2004.. Disponível em: <URL:http://portal.saude.gov.br/portal/arquivos/pdf/capitulo5_sb.pdf>. [2011 jul 22]. ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ministério da Saúde. Instituto Nacional do Câncer. Inquérito domiciliar sobre comportamentos de risco e morbidade referida de doenças e agravos não transmissíveis Brasil, 17 capitais e Distrito Federal 2002-2005. Rio de Janeiro: INCA; 2006. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Ministério da Saúde. Secretaria de em Saúde. Secretaria de Gestão Estratégica e Participativa. VIGETEL Brasil 2006: vigilâncias de fatores de risco e proteção para doenças crônica por inquérito telefônico. 2007. Disponível em: <URL:http://portal.saude.gov.br/portal/arquivos/pdf/vigitel_2006_brasil.pdf>. [2011 set 5] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Ministério da Saúde. Secretaria de em Saúde. Secretaria de Gestão Estratégica e Participativa. VIGETEL Brasil 2007: vigilâncias de fatores de risco e proteção para doenças crônica por inquérito telefônico. 2008a. Disponível em: <URL:http://portal.saude.gov.br/portal/arquivos/pdf/vigitel2007_final_web.pdf>. [2011 set 05] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Ministério da Saúde. PNDS 2006 Pesquisa nacional de demografia e saúde da criança e da mulher: relatório. 2008b. Disponível em: <URL:<http://bvsms.saude.gov.br/bvs/publicacoes/relatorio_pnds_2006.pdf>.[2011 jun 22]. ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Ministério da Saúde. Secretaria de em Saúde. Secretaria de Gestão Estratégica e Participativa. VIGETEL Brasil 2008: vigilâncias de fatores de risco e proteção para doenças crônica por inquérito telefônico. 2009a. Disponível em: <URL:http://bvsms.saude.gov.br/bvs/publicacoes/vigitel_2008.pdf> [2011 set 05] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ministério da Saúde. Instituto Nacional de Câncer. Estimativa/2010: incidência do câncer no Brasil. Rio de Janeiro: INCA; 2009b.  ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ministério da Saúde. Secretária Nacional de Saúde. Instituto Nacional do Câncer. Câncer no Brasil: dados dos registros de base populacional. Rio de Janeiro: INCA; 2010a.  ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Ministério da Saúde. Secretaria de em Saúde. Secretaria de Gestão Estratégica e Participativa. VIGETEL Brasil 2009: vigilâncias de fatores de risco e proteção para doenças crônica por inquérito telefônico. 2010b. Disponível em: <URL:http://portal.saude.gov.br/portal/arquivos/pdf/vigitel2009_220610.pdf> [2011 set 05] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Ministério da Saúde. Secretaria de Vigilância Saúde. DATASUS. Sistema de informações sobre mortalidade – SIM. Disponível em: <URL:http:www2.datasus.gov.br/DATASUS/index.php?area=0205>. [2011a set 12] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Ministério da Saúde. Secretaria de em Saúde. Secretaria de Gestão Estratégica e Participativa. VIGETEL Brasil 2010: vigilâncias de fatores de risco e proteção para doenças crônica por inquérito telefônico. Disponível em: <URL:http://portal.saude.gov.br/portal/arquivos/pdf/vigitel_180411.pdf>. [2011b set 5] ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Mink PJ, Sherman ME, Devesa SS. Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998. Cancer 2002; 95:2380-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Mitchell AE, Scarcella DL, Rigutto GL, Thursfield VJ, et al. Cancer in adolescents and young adults: treatment and outcome in Victoria. Med J Aust 2004; 180:59-62. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Mitry E, Benhamiche AM, Jouve JL, et al. Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum 2001; 44:380-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Miwa H, Go MF, Sato N. H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol 2002; 97:1106-12. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, et al. Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med 2009; 12:15-23. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Moorman PG, Calingaert B, Palmieri RT, et al. Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. Am J Epidemiol 2008; 167:1059-69. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Moreira H, Pinto-de-Sousa J, Carneiro F, et al. Early onset gastric cancer no longer presents as an advanced disease with ominous prognosis. Dig Surg 2009; 26:215-21. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Morettin PA, Toloi CM. Análise de séries temporais. São Paulo: Edgard Blücher; 2004. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Morris CR, Rodriguez AO, Epstein J, et al. Declining trends of epithelial ovarian cancer in California. Gynecol Oncol 2008; 108:207-13. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 2010; 200:454-61. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Mueller NE, Guifferman S. Hodgkin’s lymphoma. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. Oxford: Oxford University Press; 2006. p.872-897. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:51827. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Murphy G, Pfeiffer R, Camargo MC, et al. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 2009; 137:824-33. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Murphy G, Devesa SS, Cross AJ, et al. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer 2011; 128:1668-75. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Murthy NS, Shalini S, Suman G, et al. Changing trends in incidence of ovarian cancer - the Indian scenario. Asian Pac J Cancer Prev 2009; 10:1025-30. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;[NHS] National Health Service. Department of Health. Cancer. Available from: <URL:http://www.dh.gov.uk/en/Healthcare/NationalServiceFrameworks/Cancer/DH 4068586> [2011 ago 5]. ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Nandakumar A, Anantha N, Dhar M, et al. A case-control investigation on cancer of the ovary in Bangalore, India. Int J Cancer 1995; 63:361-5. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Naraynsingh V, Hariharan S, Dan D, et al. Trends in breast cancer mortality in Trinidad and Tobago--a 35-year study. Cancer Epidemiol 2010; 34:20-3. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Nath J, Wigley C, Keighley MR, et al. Rectal cancer in young adults: a series of 102 patients at a tertiary care centre in India. Colorectal Dis 2009; 11:475-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999; 91:1459-67. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Netea-Maier RT, Aben KK, Casparie MK, et al. Trends in incidence and mortality of thyroid carcinoma in The Netherlands between 1989 and 2003: correlation with thyroid fine-needle aspiration cytology and thyroid surgery. Int J Cancer 2008; 123:1681-4. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Neufeld D, Shpitz B, Bugaev N, et al. Young-age onset of colorectal cancer in Israel. Tech Coloproctol 2009; 13:201-4. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Niclis C, Del Pilar Díaz M, et al. Breast cancer mortality trends and patterns in Córdoba, Argentina in the period 1986-2006. Eur J Cancer Prev 2010; 19:94-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Nicolau AIO, Moraes MLC, Lima DJM, et al. Tubal ligation: the characterization of sterilized users of a public service. Rev Esc Enferm USP 2011; 45:55-61. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Nomura E, Ioka A, Tsukuma H. Trends in the incidence of primary intracranial tumors in Osaka, Japan. Jpn J Clin Oncol 2011; 41:291-4. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"O'Connell JB, Maggard MA, Liu JH, et al. Rates of colon and rectal cancers are increasing in young adults. Am Surg 2003; 69:866-72. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"O'Connell JB, Maggard MA, Liu JH, et al. Are survival rates different for young and older patients with rectal cancer? Dis Colon Rectum 2004; 47:2064-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Oksuzyan A, Juel K, Vaupel JW, et al. Men: good health and high mortality. Sex differences in health and aging. Aging Clin Exp Res 2008; 20:91-102. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Olaleye O, Ekrikpo U, Moorthy R, et al. Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006. Eur Arch Otorhinolaryngol 2011; 268:899-906.";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Oliveira Junior FJM, Cesse EAP. Morbi-mortalidade do câncer na cidade do Recife na década de 90. Rev Bras Cancerol 2005; 51:201-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Oliveira NC. Avaliação do seguimento de mulheres com diagnóstico de câncer de colo uterino. Fortaleza: 2011. [Tese de Doutorado - Faculdade de Farmácia, Odontologia e Enfermagem - UFC]. ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"[OMS] Organização Mundial da Saúde. CID-10: classificação estatística internacional de doenças e problemas relacionados com a saúde. 10ª ed. São Paulo: Universidade de São Paulo; 1997.  ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"[OMS] Organização Mundial da Saúde. CID-O: classificação estatística internacional de doenças para oncologia. 2ª ed. São Paulo: Fundação Oncocentro de São Paulo; 1998. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"[OMS] Organização Mundial da Saúde. CID-O: classificação estatística internacional de doenças para oncologia. 3ª ed. São Paulo: Fundação Oncocentro de São Paulo; 2005.  ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Oriel KA, Hartenbach EM, Remington PL. Trends in United States ovarian cancer mortality, 1979-1995. Obstet Gynecol 1999; 93:30-3. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Paes JE, Hua K, Nagy R, et al. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J Clin Endocrinol Metab 2010; 95:4244-50. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pakseresht M, Forman D, Malekzadeh R, et al. Dietary habits and gastric cancer risk in north-west Iran. Cancer Causes Control 2011; 22:725-36. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Park B, Park S, Kim TJ, et al. Epidemiological characteristics of ovarian cancer in Korea. J Gynecol Oncol 2010; 21:241-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Park JC, Lee YC, Kim JH, et al. Clinicopathological aspects and prognostic value with respect to age: an analysis of 3,362 consecutive gastric cancer patients. J Surg Oncol 2009; 99:395-401. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Park YK, Kim JC, Koh YS, et al. Early gastric carcinoma in young patients. Int Surg 2006; 91:316-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Parkin DM, Chen VW, Ferlay J, et al. Comparabilidad y control de calidad en los registros de cáncer. Lyon: IARC; 1995.  ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Parkin DM, Hakulinen T. Análise de sobrevida. In: Jensen OM, Parkin DM, MacLennan R, editores. Registros de câncer: princípios e métodos. Rio de Janeiro: Pró-Onco; 1995. p.159-176. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Parkin MD. Pharmacologocal practices of ancient Egypt. In: Anais do 10. Annual Proceedings of the History of Medicine Days; 2001 mar 23-24; Calgary, AB. Calgary: WA Whitelaw; 2001. p.5-11. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Parramore JB, Wei JP, Yeh KA. Colorectal cancer in patients under forty: presentation and outcome. Am Surg 1998; 64:563-7; discussion 567-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pavlidou E, Zafrakas M, Papadakis N, et al. Cervical, uterine corpus, and ovarian cancer mortality in Greece during 1980 to 2005: a trend analysis. Int J Gynecol Cancer 2010; 20:482-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pearce MS, Parker L, Windebank KP, et al. Cancer in adolescents and young adults aged 15-24 years: a report from the North of England young person's malignant disease registry, UK. Pediatr Blood Cancer 2005; 45:687-93. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pelayo Correa, Piazuelo Blanca M. Gastric cancer: the colombian enigma. Rev Col Gastroenterol 2010; 25:334-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pentheroudakis G, Pavlidis N. Juvenile cancer: improving care for adolescents and young adults within the frame of medical oncology. Ann Oncol 2005; 16:181-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pera M. Anastomotic dehiscence and recurrence of colorectal cancer: an association that strengthens the prognostic value of the surgeon in the oncological outcome. Cir Esp 2011; 89:69-71. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pérez-Irizarry J, Nazario-Delgado CM, De la Torre T, et al. Incidence trends of cervical cancer in Puerto Rico, 1987-2004. P R Health Sci J 2010; 29:364-71. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pinkerton R, Wills RA, Coory MD, et al. Survival from haematological malignancy in childhood, adolescence and young adulthood in Australia: is the age-related gap narrowing? Med J Aust 2010; 193:217-21. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pirouzmand F, Sadanand V. The incidence trends of primary brain tumors in Saskatchewan from 1970 to 2001. Can J Neurol Sci 2007; 34:181-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359:2105-20. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pollán M. Epidemiology of breast cancer in young women. Breast Cancer Res Treat 2010; 123:3-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Porter PL. Global trends in breast cancer incidence and mortality. Salud Pública Méx 2009; 51:S141-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pulte D, Gondos A, Brenner H. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica 2008; 93:594600. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Pulte D, Gondos A, Brenner H. Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006-2010. Ann Oncol 2010; 21:335-41. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Qiu MZ, Wang ZQ, Zhang DS, et al. Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China. Tumour Biol 2011; 32:509-14. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Quah HM, Joseph R, Schrag D, et al. Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol 2007; 14:2759-65. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Quinn M, Babb P, Jones J, et al. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999; 318:904-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Reedijk AM, Janssen-Heijnen ML, Louwman MW, et al. Increasing incidence and improved survival of cancer in children and young adults in Southern Netherlands, 1973-1999. Eur J Cancer 2005; 41:760-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335:1134. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Rego MF, Pinheiro GS, Metze K, et al. Acute leukemias in Piauí: comparison with features observed in other regions of Brazil. Braz J Med Biol Res 2003; 36:331-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Rego-Iraeta A, Pérez-Méndez LF, Mantinan B, et al. Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 2009; 19:333-40. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Rein BJ, Gupta S, Dada R, et al. Potential markers for detection and monitoring of ovarian cancer. J Oncol 2011; 2011:475983. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Reis RS, Santos MO, Bloch KV. Colorectal cancer in Porto Alegre and Fortaleza, Brazil: incidence trends and distribution pattern from 1990 to 1999. Cad Saude Publica 2009; 25:1046-53. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Resende AL, Mattos IE, Koifman S. Mortalidade por câncer gástrico no estado do Pará, sil, 1980-1997. Arq. Gastroenterol 2006; 43:247-51. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ribera JM, Oriol A. Acute lymphoblastic leukemia in adolescents and young adults. Hematol Oncol Clin North Am 2009; 23:1033-42. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003; 78:559S-569S. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Rigotto RM, Marinho AMCP, Teixeira ACA, et al. Estudo epidemiológico da população da região do Baixo Jaguaribe exposta à contaminação ambiental em área de uso de agrotóxicos: documento síntese dos resultados parciais da pesquisa. 2010. Disponível em: <URL:http://www.memorialapodi.com.br/linha-dotempo/docs/2010/08/Pesquisa%20,%20Estudo%20Epidemiologico%20da%20Popula cao%20do%20Baixo%20Jaguaribe%20,%20Doc%20Sintese%20dos%20Resultados %20Parciais%20da%20Pesquisa%20,%2008.2010.pdf> [2011 jul 10]. ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ristow CM, Yamamoto CT, Fávaro M. Fatores de risco e patogênese das neoplasias malignas epiteliais de ovário: revisão de literatura. Rev Bras Cancerol 2006; 52:185-95. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Roberto Neto A, Ribalta JCL, Focchi J, et al. Avaliação dos métodos empregados no Programa Nacional de Combate ao Câncer do Colo Uterino do Ministério da Saúde. Rev Bras Ginecol Obstet 2001; 23:209-15. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Rodrigues AD, Bustamante-Teixeira MT. Breast cancer and cervical cancer mortality trends in a medium-sized city in Southern Brazil, 1980-2006. Cad Saúde Pública 2011; 27:241-8.";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Rodrigues MN, Queiroz DM, Rodrigues RT, et al. Helicobacter pylori infection in adults from a poor urban community in northeastern Brazil: demographic, lifestyle and environmental factors. Braz J Infect Dis 2005a; 9:405-10. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Rodrigues MN, Queiroz DM, Rodrigues RT, et al. Prevalence of helicobacter pylori infection in Fortaleza, Northeastern Brazil. Rev Saude Publica 2005b; 39:847-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Roman E, Smith AG. Epidemiology of lymphomas. Histopathology 2011; 58:4-14. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998.  ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Saika K, Zhang M. Comparison of time trends in non-Hodgkin’s lymphoma mortality (1990–2006) between countries based on the WHO mortality database. Jpn J Clin Oncol 2011; 41:154-5. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Saltzstein SL, Behling CA, Savides TJ. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 1998; 82:1408-10. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Saltzstein SL, Behling CA. Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry. J Clin Gastroenterol 2007; 41:173-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sampaio HAC, Sabry MOD, Diniz DB, et al. Consumo de frutas e hortaliças por indivíduos atendidos pelo Programa Saúde da Família na periferia da cidade de Fortaleza-Ceará. Rev APS 2010; 13:175-81. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sánchez MJ, Payer T, De Angelis R, et al. Cancer incidence and mortality in Spain: estimates and projections for the period 1981-2012. Ann Oncol 2010; 21:iii30-36. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sandin S, Hjalgrim H, Glimelius B, et al. Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.  Cancer Epidemiol Biomarkers Prev 2006; 15:1295-300. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45:931-91. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Santoro R, Carboni F, Lepiane P, et al. Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg 2007; 94:737-42. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sariego J. Breast cancer in the young patient. Am Surg 2010; 76:1397-400. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet 2001; 357:1490-3. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ 2009; 339:b2968. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sassolas G, Hafdi-Nejjari Z, Schott AM, et al. Geographical correlation between incidence of benign disease and that of cancer of the thyroid among the population of the Rhône-Alpes région of France. Eur J Endocrinol 2010; 162:127–35. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Savas N, Dagli U, Akbulut S, et al. Colorectal cancer localization in young patients: should we expand the screening program? Dig Dis Sci 2007; 52:798-802. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Scheiden R, Sand J, Weber J, et al. Rectal cancer in Luxembourg: a national population-based data report, 1988-1998. BMC Cancer 2003; 3:27. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Scheiden R, Keipes M, Bock C, et al. Thyroid cancer in Luxembourg: a national population-based data report (1983-1999). BMC Cancer. 2006a; 6:102. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Scheiden R, Pescatore P, Wagener Y, et al. Colon cancer in Luxembourg: a national population-based data report, 1988-1998. BMC Cancer 2006b; 5:52 ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Semmens JB, Platell C, Threlfall TJ, et al. A population-based study of the incidence, mortality and outcomes in patients following surgery for colorectal cancer in Western Australia. Aust N Z J Surg 2000; 70:11-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Shannon C, Smith IE. Breast cancer in adolescents and young women. Eur J Cancer 2003; 39:2632-42. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sharma A, Radhakrishnan V. Gastric cancer in India. Indian J Med Paediatr Oncol 2011; 32:12-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Shemesh-Bar L, Kundel Y, Idelevich E, et al. Colorectal cancer in young patients in Israel: a distinct clinicopathological entity? World J Surg 2010; 34:2701-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Shiao YH, Bovo D, Guido M, et al. Microsatellite instability and/or loss of heterozygosity in young gastric cancer patients in Italy. Int J Cancer 1999; 82:5962. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 2009; 18:1695-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sigurdsson K. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995. Acta Obstet Gynecol Scand 1999; 78:478-85. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sigurdsson K, Sigvaldason H. Longitudinal trends in cervical cytological lesions and the effect of risk factors: a 30-year overview. Acta Obstet Gynecol Scand 2006; 85:350-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Silva ARV, Damasceno MM, Marinho NB, et al. Hábitos alimentares de adolescentes de escolas públicas de Fortaleza, CE, Brasil. Rev Bras Enferm 2009; 62:18-24. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Silva GA, Girianelli VR, Gamarra CJ, et al. Cervical cancer mortality trends in Brazil, 1981-2006. Cad Saúde Pública 2010; 26:2399-407. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Silva IS. El papel de los registros de cáncer. In: Epidemiología del cáncer: principios y métodos. Lyon: Agencia Internacional de Investigación sobre el Câncer; 1999. P. 408-429.   ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Singh H, Demers AA, Xue L, et al. Time trends in colon cancer incidence and distribution and lower gastrointestinal endoscopy utilization in Manitoba. Am J Gastroenterol 2008; 103:1249-56. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Skírnisdóttir I, Garmo H, Wilander E, et al. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 2008; 123:1897-901. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Smailyte G, Miseikyte-Kaubriene E, Kurtinaitis J. Increasing thyroid cancer incidence in Lithuania in 1978-2003. BMC Cancer 2006; 6:284. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Smith BR, Stabile BE. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young. Arch Surg 2009; 144:506-10. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Smith JS, Green J, Berrington de Gonzalez A, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 2003; 361:1159-67. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Snaebjornsson P, Jonasson L, Jonsson T, et al. Colon cancer in Iceland--a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age. Int J Cancer 2010; 127:2645-53. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sonnenberg A. Birth cohort patterns of gastric cancer and peptic ulcer among nonwhites in the USA. J Epidemiol Community Health 2011; 11:1059-64. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Soto-Salgado M, Suárez E, Calo W, et al. Incidence and mortality rates for colorectal cancer in Puerto Rico and among Hispanics, non-Hispanic whites, and non-Hispanic blacks in the United States, 1998-2002. Cancer 2009; 115:3016-23. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Souto Filho JT, Portugal RD, Loureiro M, et al. Characterization and analysis of the outcome of adults with acute myeloid leukemia treated in a Brazilian University hospital over three decades. Braz J Med Biol Res 2011; 44:660-5. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Souza CA. Avaliação da sobrevida das pacientes portadoras de câncer de colo uterino IIIB tratadas com radioterapia exclusiva e radioquimioterapia. São Paulo; 2011. [Tese de Doutorado em Ciência - Fundação Antônio Prudente / Hospital AC Camargo] ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Souza EP. Epidemiologia da infecção genital por HPV e anormalidades na citologia cervical em mulheres jovens brasileiras. Campinas(SP); 2004. [Tese de Doutorado em Tocoginecologia - Universidade Estadual de Campinas]. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Souza Filho O. Cirurgião Oncológico, fator de prognóstico no tratamento do câncer. Rev Bras Cancerol 2004; 50:91-3. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Sprague BL, Warren Andersen S, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control 2008; 19:585-93. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet 2004; 364:2097-105. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Stiller C. Epidemiology of cancer in adolescents. Med Pediatr Oncol 2002; 39:14955. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;Stewart B. W. and Kleihues P. (Eds): World Cancer Report. IARCPress. Lyon 2003. ;
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Swerdlow AJ. Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging 2003; 30:S3-12. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Takada H, Ohsawa T, Iwamoto S, et al. Changing site distribution of colorectal cancer in Japan. Dis Colon Rectum 2002; 45:1249-54. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Talukder MH, Jabeen S, Shaheen S, et al. Pattern of cancer in young adults at National Institute of Cancer Research and Hospital (NICRH), Bangladesh. Mymensingh Med J 2007; 16:S28-33. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Tan W, Stehman FB, Carter RL. Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001. Gynecol Oncol 2009; 114:346-52. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Tarone RE. Breast cancer trends among young women in the United States. Epidemiology 2006; 17:588-90. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Tavani A, Gallus S, La Vecchia C, et al. Risk factors for breast cancer in women under 40 years. Eur J Cancer 1999; 35:1361-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Tetsche MS, Dethlefsen C, Pedersen L, et al. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study. BMC Cancer 2008; 8:31. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Theuer CP, de Virgilio C, Keese G, et al. Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg 1996; 172:473-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Thomas RK, Re D, Zander T, et al. Epidemiology and etiology of Hodgkin’s lymphoma. Ann Oncol 2002; 13:147-52. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Thörn M, Bergström R, Kressner U, et al. Trends in colorectal cancer incidence in Sweden 1959-93 by gender, localization, time period, and birth cohort. Cancer Causes Control 1998; 9:145-52. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Thygesen LC, Nielsen OJ, Johansen C. Trends in adult leukemia incidence and survival in Denmark, 1943-2003. Cancer Causes Control 2009; 20:1671-80. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Tohmé C, Labaki M, Hajj G, et al. Colorectal cancer in young patients: presentation, clinicopathological characteristics and outcome. J Med Liban 2008; 56:208-14. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Tokui N, Yoshimura T, Fujino Y, et al. Dietary habits and stomach cancer risk in the JACC Study. J Epidemiol 2005;15:S98-108. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Toniato A, Boschin I, Casara D, et al. Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 2008; 15:1518-22. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Toyoda Y, Nakayama T, Ito Y, et al. Trends in colorectal cancer incidence by subsite in Osaka, Japan. Jpn J Clin Oncol 2009; 39:189-91. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Tracey EA, Roder DM, Francis J, et al. Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003: implications for cancer control. Int J Gynecol Cancer 2009; 19:591-9. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Trétarre B, Remontet L, Ménégoz F, et al. Cáncer de l’ovaire: incidence et mortalité en France. J Gynecol Obstet Biol Reprod 2005; 34:154-61. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Truong CD, Feng W, Li W, et al. Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A. J Exp Clin Cancer Res 2009; 28:14. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Truong T, Rougier Y, Dubourdieu D, et al. Time trends and geographic variations for thyroid cancer in New Caledonia, a very high incidence area (1985-1999). Eur J Cancer Prev 2007; 16:62-70. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ushijima K. Current status of gynecologic cancer in Japan. J Gynecol Oncol 2009; 20:67-71. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"van der Aa MA, de Kok IM, Siesling S, et al. Does lowering the screening age for cervical cancer in The Netherlands make sense? Int J Cancer 2008; 123:1403-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Vasconcelos AMN. Qualidade das estatísticas de óbitos no Brasil: uma classificação das Unidades da Federação [resumo]. In: Anais do XII Encontro de Estudos Populacionais da ABEP; 2000; Caxambu, Brasil. Caxambu (MG): ABEP; 2000.  ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Vasconcelos CTM, Pinheiro AKB, Castelo ARP, et al. Conhecimento, atitude e prática relacionada ao exame colpocitológico entre usuárias de uma unidade básica de saúde. Rev Latinoam Enferm 2011; 19:97-105. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Vernooij F, Heintz AP, Witteveen PO, et al. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study. J Natl Cancer Inst 2008; 100:399-406. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Viacava F, Souza-Junior PR; Moreira RS. Estimativas da cobertura de mamografia segundo inquéritos de saúde no Brasil. Rev Saúde Pública 2009; 43:117-25. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Vieira NBA. Análise de exames preventivos de uma unidade básica de saúde da periferia de Fortaleza no ano de 2007. Fortaleza; 2009. [Dissertação de MestradoCurso de Mestrado em Saúde Coletiva da UNIFOR]. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Viel JF, Fournier E, Danzon A. Age-period-cohort modelling of non-Hodgkin's lymphoma incidence in a French region: a period effect compatible with an environmental exposure. Environ Health 2010; 9:47. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Vinh-Hung V, Bourgain C, Vlastos G, et al. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer 2007; 7:164. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004; 100:1035-44. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Wartofsky L. Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones (Athens) 2010; 9:103-8. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998–2003. Cancer 2008; 113:2855-64. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Wessler JD, Pashayan N, Greenberg DC, et al. Age-period-cohort analysis of colorectal cancer in East Anglia, 1971-2005. Cancer Epidemiol 2010; 34:232-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Westergaard T, Melbye M, Pedersen JB, et al. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer 1997; 72:977-81. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"[WCRF] World Cancer Research Fund. American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007.  ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;[WHO] World Health Organization. Global cancer rates could increase by 50% to 15 million by 2020. 2003a. Avaliable from: <URL:http://www.who.int/mediacentre/releases/2003/ pr27/en> [2007 out 01];
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"[WHO] World Health Organization. World cancer report. Lyon, France: IARC Press; 2003b. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002; 4:278-99. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Wu H, Rusiecki JA, Zhu K, et al. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev 2009; 18:1945-52. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Wu TI, Lee CL, Liao PJ, et al. Survival impact of initial surgical approach in stage I ovarian cancer. Chang Gung Med J 2010; 33:558-67. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Wu X, Groves FD, McLauhlin CC, et al. Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes Control 2005; 16:309-20. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Wu XC, Chen VW, Steele B, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the US, 1992–1997. Cancer 2001; 92:2547-54. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Wu XC, Chen VW, Steele B, et al. Cancer incidence in adolescents and young adults in the United States, 1992-1997. J Adolesc Health 2003; 32:405-15. Wünsh Filho V, Moncau JE. Mortalidade por câncer no Brasil 1980-1995: padrões regionais e tendências temporais. Rev Assoc Med Bras 2002; 48:250-7. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Xie Y, Davies SM, Xiang Y, et al. Trends in Leukemia Incidence and Survival in the United States (1973–1998). Cancer 2003; 97:2229-35. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Xu AG, Yu ZJ, Jiang B, et al. Colorectal cancer in Guangdong Province of China: a demographic and anatomic survey. World J Gastroenterol 2010; 16:960-5. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Yang L, Parkin DM, Li L, et al. Time trends in cancer mortality in China: 1987– 1999. Int J Cancer 2003; 106:771-83. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Yeole BB, Kumar AV, Kurkure A, et al. Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India. Asian Pac J Cancer Prev 2004; 5:308-15. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Yeole BB. Trends in cancer incidence in female breast, cervix uteri, corpus uteri, and ovary in India. Asian Pac J Cancer Prev 2008a; 9:119-22. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Yeole BB. Trends in the incidence of Non-Hodgkin’s lymphoma in India. Asian Pac J Cancer Prev 2008b; 9:433-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Y?lmaz HH, Yaz?han N, Tunca D, et al. Cancer trends and incidence and mortality patterns in Turkey. Jpn J Clin Oncol 2011; 41:10-6. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Yin M, Hu Z, Tan D, et al. Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis. Am J Transl Res 2009; 1:44-54. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Ying AK, Huh W, Bottomley S, et al. Thyroid cancer in young adults. Semin Oncol 2009; 36:258-74. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Yiu HY, Whittemore AS, Shibata A. Increasing colorectal cancer incidence rates in Japan. Int J Cancer 2004; 109:777-81. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"You YN, Dozois EJ, Boardman LA, et al. Young-onset rectal cancer: presentation, pattern of care and long-term oncologic outcomes compared to a matched older-onset cohort. Ann Surg Oncol 2011; 18:2469-76. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Zbuk K, Sidebotham EL, Bleyer A, et al. Colorectal cancer in young adults. Semin Oncol 2009; 36:439-50. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Zeferino LC, Pinotti JA, Jorge JP, et al. Organization of cervical cancer screening in Campinas and surrounding region, São Paulo State, Brazil. Cad Saúde Pública 2006; 22:1909-14. ";
FAP;2012;MIREN MAITE URIBE ARREGI;José Humberto Tavares Guerreiro;Marcelo Gurgel Carlos da Silva;"Zhu C, Zheng T, Kilfoy BA, et al. A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid 2009; 19:1061-6. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Aluffi P, Policarpo M, Cherovac C, Olina M, Dosdegani R, Pia F. Postthyroidectomy superior laryngeal nerve injury. Eur Arch Otorhinolaryngol 2001; 258:451-4. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Arakawa-Sugueno L. Voz e deglutição de pacientes com e sem mobilidade laríngea após tireoidectomia. São Paulo; 2007. [Tese de Doutorado-Faculdade de Medicina da Universidade de São Paulo]. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Araújo Filho VJF. Patologia cirúrgica da tireóide. In: Araújo Filho VJF, Brandão LG, Ferraz AR, editores. Manual do residente de cirurgia de cabeça e pescoço. São Paulo: Keila & Rosenfeld; 1999. p.77-82. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Aviv JE. Prospective randomized outcome study of endoscopy versus modified barium swallow in patients with dysphagia. Laryngoscope 2000; 110:563-74. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Aviv JE, Murry T. FEESST Flexible endoscopic evaluation of swallowing with sensory testing. San Diego: Plural Publishing; 2005. FESST technique. p.25-43.  ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Aviv JE, Murry T, Zschommler A, Cohen M, Gartner C. Flexible endoscopic evaluation of swallowing with sensory testing: patient characteristics and analysis of safety in 1,340 consecutive examinations. Ann Otol Rhinol Laryngol 2005; 114:173-6. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Bandeira AKC. Qualidade de vida relacionada à voz e à deglutição após tratamento para câncer de língua. São Paulo; 2004. [Dissertação de Mestrado - Fundação Antônio Prudente] ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Banks CA, Ayers CM, Hornig JD, et al. Thyroid disease and compressive symptoms. Laryngoscope 2012; 122:13-6. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Bastian RW. Videoendoscopic evaluation of patients with dysphagia: an adjunct to modified barium swallow. Otolaryngol Head Neck Surg 1991; 104:339-50. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Beldi G, Kinsbergen T, Sclumpf R. Evaluation of intraoperative recurrent nerve monitoring in thyroid surgery. World J Surg 2004; 28:589-91. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Bellantone R, Lombardi CP, Raffaelli M, Rubino F, Boscherini M, Perilli W. Minimally invasive, totally gasless video-assisted thyroid lobectomy. Am J Surg 1999; 177:342-3. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Bellantone R, Lombardi CP, Bossola M, et al. Video-assisted vs conventional thyroid lobectomy: a randomized trial. Archi Surg 2002; 137:301-5. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Bérzin F. Eletriomografia no diagnostic dad or muscular. In: Teixeira MJ, Braum Filho L, Marquez O, editors, et al. Dor; contexto interdisciplinar. Curitiba: Editora Maio; 2003. p.103-14. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Bhattacharyya N, Fried MP. Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg 2002; 128:389-92. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Bryant M. Biofeedback in the treatment of a selected dysphagic patient. Dysphagia 1991; 6:140-4. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Burns P, Timon C. Thyroid pathology and the globus symptom: are they related? A two year prospective trial. J Laryngol Otol 2007; 121:242-5. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Butler SG, Stuart A, Kemp S. Flexible endoscopic evaluation of swallowing in healthy young and older adults. Ann Otol Rhinol Laryngol 2009a; 118:99-106. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Butler SG, Stuart A, Markley L, Rees C. Penetration and aspiration in healthy older adults as assessed during endoscopic evaluation of swallowing. Ann Otol Rhinol Laryngol 2009b; 118:190-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Butler SG, Stuart A, Leng X, Rees C, Williamson J, Kritchevsky SB. Factors influencing aspiration during swallowing in healthy older adults. Laryngoscope 2010; 120:2147-52. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Cernea CR, Ferraz AR, Cordeiro AC, et al. Complicações cirúrgicas das tiroidectomias. In: Dedivitis RA, Guimarães AV, editores. Patologias cirúrgicas da tireóide. São Paulo: Frôntis; 1999. p.271-4. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001; 127:870-6. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Chi-Fishman G, Sonies BC. Motor strategy in rapid sequential swallowing: new insights. J Speech Lang Hear Res 2000; 43:1481-92. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Clark AR, Lee S, Osborne J, Zullo T, Murry T. Development and validation of the voice handcap index-10. Laryngoscope 2004; 14:102-10. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Corbin-Lewis K, Liss JM, Sciortino KL. Anatomia clinica e fisiologia do mecanismo da degluticao. Sao Paulo: Cengage Learning; 2009. Base fisiológicas da disfagia neurogência e estratégias de tratamento, p 161. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Crary MA. A direct intervention program for chronic neurogenic dysphagia secondary to brainstem stroke. Dysphagia 1995; 10:6-18. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Crary MA, Carnaby Mann GD, Groher ME, Helseth E. Functional benefits of dysphagia therapy using adjunctive sEMG biofeedback. Dysphagia 2004; 19:160-4. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Crary MA, Carnaby Mann GD. Groher ME. Biomechanical correlates of surface electromyography signals obtained during swallowing by healthy adults. J Speech Lang Hear Res 2006; 49:186-93.";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Crumley RL. Repair of the recurrent laryngeal nerve. Otolaryngol Clin North Am 1990; 23:553-63. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Dall’Igna C, Teixeira VN, Dall´Igna DP, Rosito LPS. Resultados da cirurgia para otospongiose com dois tipos de prótese em procedimentos realizados por residentes.  Rev Bras Otorrinolaringol 2008; 74:826?32.";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Daggett A, Logemann J, Rademaker A, Pauloski B. Laryngeal penetration during deglutition in normal subjects of various ages. Dysphagia 2006; 21:270-4. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Daniels SK, Foundas AL. Swallowing physiology of sequential straw drinking. Dysphagia 2001; 16:176-82. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Daniels SK, Corey DM, Hadskey LD, et al. Mechanism of sequential swallowing during straw drinking in healthy young and older adults. J Speech Lang Hear Res 2004; 47:33-45. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Daniels SK, Schroeder MF, DeGeorge PC, Corey DM, Rosenbek JC. Effects of verbal cue on bolus flow during swallowing. Am J Speech Lang Pathol 2007; 16:140-7. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"de Pedro Netto I, Fae A, Vartanian JG, et al. Voice and vocal self-assessment after thyroidectomy. Head Neck 2006; 28:1106-14. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"de Roy van Zuidewijn DB, Songun I, Kievit J, van de Velde CJ. Complications of thyroid surgery. Ann Surg Oncol 1995; 2:56-60. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Debruyne F, Ostyn F, Delaere P, Wellens W, Decoster W. Temporary voice changes after uncomplicated thyroidectomy. Acta Otorhinolariryngol Belg 1997a; 51:13740. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Debruyne F, Ostyn F, Delaere P, Wellens, W. Acoustic analysis of the speaking voice after thiroidectomy. J Voice 1997b; 11:479-82. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Debry C, Renou G, Fingerhut A. Drainage after thyroid surgery: a prospective randomized study. J Laryngol Otol 1999; 113:49-51. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Dedivitis RA, Guimarães AV. Identificação do ramo externo do nervo laríngeo superior na tireoidectomia minimamente invasiva vídeo-assistida. Rev Bras Otorrinolaringol 2005; 71:326-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"De Luca CJ. The use of surface electromyography in biomechanics. J Appl Biomech 1997; 13:135-63. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Dozier TS, Brodsky MB, Michel Y, Walters BC Jr, Martin-Harris B. Coordination of swallowing and respiration in normal sequential cup swallows. Laryngoscope 2006; 116:1489-93. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Dralle H, Sekulla C, Haerting J, et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 2004; 136:1310-22. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue--is it useful? Dysphagia 2008; 23:7-15. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Ekberg O, Hamdy S, Woisard V, Wuttge-Hannig A, Ortega P. Social and psychological burden of dysphagia: its impact on diagnosis and treatment. Dysphagia 2002; 17:139-46. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Ervilha UF, Duarte M, Amadio AC. Estudo sobre procedimentos de normalização do sinal eletromiográfico durante o movimento humano. Rev Bras Fisiol 1998; 3:15-20. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Farrag TY, Salman RA, Lin FR, Tufano RP. The utility of evaluating true vocal fold motion before thyroid surgery. Laryngoscope 2006; 116:235-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Fazio MJ, Zitelli JA, Goslen JB. Cicatrização de feridas. In: Coleman III WP, Hanke CW, Alt TH, Asken S, editores, et al. Cirurgia cosmética: princípios e técnicas. 2ª ed. Rio de Janeiro: Revinter; 2000. p.23-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Ferzli GS, Sayad P, Abdo Z, Cacchione RN. Minimally invasive, nonendoscopic thyroid surgery. J Am Coll Surg 2001; 192:665-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Field C, Kerstein M. Overview of wound healing in a moist environment. Am J Surgery 1994; 167:2S-6S. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Gomes ACP. Estudo eletromiográfico simultâneos das regiões superior, média e inferior do músculo masseter em indivíduos portadores de maloclusão classe III de Angle. Ribeirão Preto; 2001. [Dissertação de Mestrado-Universidade de São Paulo]. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Gonçalves Filho J, Kowalski LP. Surgical complications after thyroid surgery performed in a câncer hospital. Otolaryngol Head Neck Surg 2005; 132:490-4. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Gonçalves Filho J, Kowalski LP. Complicações pós-operatórias em tireoidectomias com ou sem dreno. Rev Col Bras Cir 2006; 33:350-3. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Goyal RK. Disorders of the cricopharyngeus muscle. Otolaryngol Clin North America 1984; 17:115-30. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Greenblatt DY, Sippel R, Leverson G, Frydman J, Schaefer S, Chen H. Thyroid resection improves perception of swallowing function in patients with thyroid disease. World J Surg 2009; 33:255-60. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Grupta V, Reddy NP, Canilang EP. Surface EMG measurements at the throat during dry and wet swallow. Dysphagia 1996; 11:173-9. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Guedes RLV. Validação e aplicação do questionário de disfagia M.D. Anderson (MDADI) em pacientes tratados de câncer de cabeça e pescoço. São Paulo; 2010. [Dissertação de Mestrado-Fundação Antônio Prudente]. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Hassan SJ, Weymuller EA Jr. Assesment of quality of life in head and neck cancer patients. Head Neck 1993; 15:485-96. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Hermann M, Hellebart C, Freissmuth M. Neuromonitoring in thyroid surgery. Ann Surg 2004; 240:9-17. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Hirano M, Nozoe I, Shin T, Maeyama T. Electromyographic findings in recurrent laryngeal nerve paralysis: a study of 130 cases. Pract Otol Kyoto 1974; 67:231-42. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Hiraoka K. Changes in masseter muscle activity associated with swallowing. J Oral Rehabil 2004; 31:963-7. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Holt GR, McMurry GT, Joseph DJ. Recurrent laryngeal nerve injury following thyroid operations. Surg Gynecol Obstet 1977; 144:567-70. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Hong KH, Kim YK. Phonatory characteristics of patients undergoing thyroidectomy without laryngeal nerve injury. Otolaryngol Head Neck Surg 1997; 117:399-404. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Hurtado-López LM, López-Romero S, Rizzo-Fuentes C, Zaldívar-Ramírez FR, Cervantes-Sánchez C. Selective use of drains in thyroid surgery. Head Neck 2001; 23:189-93. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Jauregui R, Lilker ES, Bayley A. Upper airway obstruction in euthyroid goiter. JAMA 1977; 238:2163-6. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Kark AE, Kissin MW, Auerbach R, Meikle M. Voice changes after thyroidectomy: role of the external laryngeal nerve. Br J Med (Clin Res Ed) 1984; 289:1412-5. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Kobty MN, Haugen LK. Clinical application of electromiographic in vocal fold mobility disorders. Acta Otolaryngol 1970; 70:428-37. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Köhler HF, Costa RR, Verotti DLJ, Fillippini JAL. Estudo prospectivo randomizado para avaliação da drenagem após tireoidectomia. Rev Bras Cir Cabeça Pescoço 2008; 37:184-6. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Kotby MN, Fadly E, Madkour O, et al. Electromyographic and neurography inneurolaryngology. J Voice 1992; 6:159-87. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Koufman JA, Postma GN, Whang CS, et al. Diagnostic laryngeal electromyographic: the Wake Forest experience 1995-1999. Otolaryngol Head Neck Surgery 2001; 124:603-6. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Knutson LM, Soderberg GL, Ballantyne BT, Clarke WR. A study of various normalization procedures for within day electromyographic data. J Electromyogr Kinesiol 1994; 4:47-59. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Kulcsar MAV, Friguglietti CUM, Cividanes R, Brandão LG. Análise retrospectiva das tireoidectomias realizadas por residentes de cirurgia geral em hospital universitário. Rev Bras Cir Cabeça Pescoço 2008; 37:67-70. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngol Head Neck Surg 2003; 11:485-9. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Leder SB, Ross DA, Briskin KB, Sasaki CT. A prospective, double-blind, randomized study on the use of a topical anesthetic, vasoconstrictor, and placebo during transnasal flexible fiberoptic endoscopic. J Speech Lang Hear Res 1997; 40:1352-7. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Logemann JA. Evalution and treatment of swallowing disorders. San Diego, College-Hill Press; 1983. Anatomy and physiology of normal deglutition; p.13-52.  ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Logemann JA. Manual for the videofluorography study of swallowing. 2nd ed. Texas: Pro-ed; 1993. Radiographic symptoms and swallowing disorders; p.73-114.  ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Lombardi CP, Raffaelli M, Princi P, et al. Safety of video-assisted thyroidectomy versus conventional surgery. Head Neck 2005; 27:58-64. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Lombardi CP, Raffaelli M, D’Alatri L, et al. Voice and swallowing changes after thyroidectomy in patients without inferior laryngeal nerve injuries. Surgery 2006; 140:1026-34. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Lombardi CP, Raffaelli M, de Crea C, et al. Report on 8 years of experience with video-assisted thyroidectomy for papillary thyroid carcinoma. Surgery 2007; 142:944-51. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Lombardi CP, Raffaelli M, D’Alatri L, et al. Video-assisted thyroidectomy significantly reduces the risk of early postthyroidectomy voice and swallowing symptoms. World J Surg 2008; 32:693-700. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Lombardi CP, Raffaelli M, De Crea C, et al. Long-term outcome of functional postthyroidectomy voice and swallowing symptoms. Surgery 2009; 146:1174-81. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Lombardi CP, Raffaelli M, De Crea C, et al. Video-assisted thyroidectomy for papillary thyroid carcinoma. J Oncol 2010; 2010. pii:148542. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Mandelbaum SH, Di Santis EP, Mandelbaum MHS. Cicatrização, conceitos atuais e recursos auxiliares – Parte I. An Bras Dermatol 2003; 78:393-410. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Manolidis S, Takashima M, Kirby M, Scarlett M. Thyroid surgery: a comparison of outcomes between experts and surgeons in training. Otolaryngol Head Neck Surg 2001; 125:30-3. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Manrique D, Melo ECM, Bühler RB. Avaliação nasofibrolaringoscópica da deglutição em crianças. Rev Bras Otorrinolaringol 2001; 67:796-801. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Marchesan IQ. Fundamentos em fonoaudiologia: aspectos clínicos da motricidade oral. Guanabara Koogan: Rio de Janeiro; 1998. Deglutição: diagnóstico e possibilidades terapêuticas; p.51-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Martin-Harris B, Jones B. The videofluorographic swallowing study. Phys Med Rehabil Clin N Am 2008; 19:769-85. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Marx AG, Bergmann A. Tratado interdisciplinar em oncologia: prevenção e tratamento das complicações do câncer. Rio de Janeiro: Roca; 2009. Avaliação funcional da deglutição por fibronasofaringolaringoscopia. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"McHorney CA, Bricker DE, Kramer AE. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I – conceptual foundation and item development. Dysphagia 2000; 15:115-21. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"McHorney CA, Martin-Harris B, Robbins J, Rosenbek J. Clinical validity of the swal-qol and swal-care outcome tools with respect to bolus flow measures. Dysphagia 2006; 21:141-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"McKeown MJ, Torpey DC, Ghem WC. Non-invasive monitoring of functional distinct muscle activations during swallowing. Clin Neurophysiol 2002; 113:35466. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Merletti R, Di Torino P. Standards for reporting EMG data. J Electromyography Kinesiology 1999; 9(1):3-4. Available from: <URL:  http://www.isekonline.org/standards_emg.html > [2012 mar 05]. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Miccoli P, Berti P, Raffaelli M, Metrazzi G, Baldacci S, Rossi G. Comparison between minimally invasive videoassisted thyroidectomy and conventional thyroidectomy: a prospective randomised study. Surgery 2001; 130:1039-43. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Miccoli P, Pinchera A, Materazzi G, et al. Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy. J Clin Endocrinol Metab 2009; 94:1618-22. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Minuto MN, Berti P, Miccoli M, et al. Minimally invasive vídeo-assisted thyroidectomy: na analysis of results and a revision of indications. Surg Endosc 2012; 26:818-22. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Montesinos MR, Falco JE, Sinagra DL, et al. Morbilidad de la tiroidectomía total em el carcinoma diferenciado de tiroides. Rev Argent Cir 1999; 76:8-12. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Montoni NPC, Alves I, Bandeira AKC, Angelis EC. Cross-Cultural Adaptation of the SWAL-QOL and Swal-Care Questionnaires into Brazilian Portuguese. Applied Cancer Res 2008; 29:129-35. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Muñoz GC, Silva C, Misaki JK, Rahal A, Gomes ICD, Carvalho ARR. Análise dos potenciais elétricos do músculo masseter durante a mastigação de alimentos com rigidez variada. Rev CEFAC 2004; 6:127-34. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Murry T, Carrau RL. Functional tests of swallowing. In: Carrau RL, Murry T, editors. Comprehensive management of swallowing disorders. 2nd ed. San Diego: Singular Publishing Group; 1999. p.75-9. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Netto IP. Laringe, voz e deglutição pré e pós-tireoidectomia. São Paulo; 2005. [Dissertação de Mestrado-Fundação Antônio Prudente]. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Netto IP, Vartanian JG, Ferraz PR, et al. Vocal fold immobility after thyroidectomy with intraoperative recurrent laryngeal nerve monitoring. São Paulo Med J 2007; 125:186-90. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Netto IP. Avaliação da laringe, voz e deglutição pós-tireoidectomia relacionado ao uso do neuromonitor intra-operatório. São Paulo; 2010. [Tese de DoutoradoFundação Antônio Prudente] ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Olson S, Cheema Y, Harter J, Starling J, Chen H. Does frozen section alter surgical management of multinodular thyroid disease? J Surg Res 2006; 136:179-81. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;[OMS] Organização Mundial de Saúde. Divisão de Saúde Mental Grupo WHOQOL. Versão em português dos instrumentos de avaliação de qualidade de vida (WHOQOL) 1998. Disponível em: <URL:http://www.ufrgs.br/psiq/whoqol1.html> [2004 jun 1]. ;
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Palazzo FF, Sebag F, Henry JF. Endocrine surgical technique: endoscopic thyroidectomy via the lateral approach. Surg Endosc 2006; 20:339-42. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Palmer PM, Luschei ES, Jaffe D, McCulloch TM. Contributions of individual muscles to the submental surface electromyogram during swallowing. J Speech Lang Hear Res 1999; 42:1378-91. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Paula A, Fernandes JD, Fortinguerra MB. Estudo da fase faríngea da deglutição em voluntários sadios através da fibronasoscopia. Braz J Otorhinolaryngol 2000; 66:434-7. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Pearlman AL. Electromyography and the study of oropharyngeal swallowing. Dysphagia 1993; 8:351-5. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Perlman PW, Cohen MA, Setzen M, et al. The risk of aspiration of pureed food as determined by flexible endoscopic evaluation of swallowing with sensory testing. Otolaryngol Head Neck Surg 2004; 130:80-3. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Peix JL, Teboul F, Feldman H, Massard JL. Drainage after thyroidectomy: a randomized clinical trial. Int Surg 1992; 77:122-4. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Pereira JA, Girvent M, Sancho JJ, Parada C, Sitges-Serra A. Prevalence of long-term upper aerodigestive symptoms after uncomplicated bilateral thyroidectomy. Surgery 2003; 133:318-22. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Pernambuco LA. Atividade elétrica do músculo masseter durante a deglutição em laringectomizados totais. Pernambuco; 2010. [Dissertação de MestradoUniversidade Federal de Pernambuco]. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Pezzullo L, Delrio P, Losito NS, Caracò C, Mozzillo N. Post-operative complications after completion thyroidectomy for differentiated thyroid cancer. Eur J Surg Oncol 1997; 23:215-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Prim MP, de Diego JI, Hardisson D, Madero R, Gavilan J. Factors related to nerve injury and hypocalcemia in thyroid gland surgery. Otolaryngol Head Neck Surg 2001; 124:111-4. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Rahal A, Lopasso FP. Eletromiografia dos músculos masseteres e supra-hióideos em mulheres com oclusão normal e com má-oclusão classe I de Angle durante a fase oral da deglutição. Rev CEFAC 2004; 6:370-5. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Rahal A, Goffi-Gomez MVS. Avaliação eletromiográfica do músculo masseter em pessoas com paralisia facial periférica de longa duração. Rev CEFAC 2007; 9:20712. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Randolph GW, Kamani D. The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. Surgery 2006; 139:357-62.  ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;Rees CJ. Flexible endoscopic evaluation of swallowing with sensory testing. Curr Opin Otolaryngol Head Neck Surg 2006, 14:425-30. ;
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Robbins JA, Coyle J, Rosenbek J, Roecker E, Wood J. Differentiation of normal and abnormal airway protection during swallowing using the penetration-aspiration scale. Dysphagia 1999; 14:228-32. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Rodrigues KA, Rahal A. A influencia da tipologia facial na atividade eletromiografica do musculo masseter durante o apertamento dental em máxima intercuspidacao. Rev CEFAC 2003; 5:127-30. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Rogers SN, Laher H, Overend L, Lowe D. Importance-rating using the University of Washington quality-of-life questionnaire in patients treated by primary surgery for oral and oropharyngeal cancer. J Cranio-Maxillofacial Surg 2002; 30:125-32. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Rosato L, Avenia N, Bernante P, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patiens operation on Italy over 5 years. World J Surg 2004; 28:271-6. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Roy AD, Gardiner RH, Niblock WM. Thyroidectomy and the recurrent laryngeal nerve. Lancet 1956; 270:988-90. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Sataloff RT, Spiegel JR, Caroll LM, Heuer RJ. Male soprano voice: a rare complication of thyroidectomy. Laryngoscope 1992; 102:90-3. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Schoretsanitis G, Melissas J, Sanidas E, Christodoulakis M, Vlachonikolis JG, Tsiftsis DD. Does draining the neck affect morbidity following thyroid surgery? Am Surg 1998; 64:778-80. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Senise AT, Queija DS, Degani C, et al. Sintomas e sinais de alterações da deglutição após a tireoidectomia. Rev Bras Cir Cabeça Pescoço 2009; 38:67-71. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Shaha AR, Jaffe BM. Selective use of drains in thyroid surgery. J Surg Oncol 1993; 52:241-3. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Silva ICMS, Carrara-de Angelis E, Netto IP. Prevalência de sintomas de vias aéreas superiores pós-tireoidectomia. São Paulo; 2006. [Trabalho de iniciação cientifica-Fundação Antonio Prudente]. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Sinagra DL, Montesinos MR, Tacchi VA, et al. Voice changes after thyroidectomy without recurrent laryngeal nerve injury. J Am Coll Surg 2004; 199:556-60. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Siqueira R. Lesões nervosas periféricas: uma revisão. Rev Neurocienc 2007; 15/3:226-233. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Siqueira LDA. Análise eletromiográfica dos músculos masseter, infra-hióideos e submandibulares durante a deglutição de indivíduos adultos saudáveis. São Paulo; 2011. [Dissertação de Mestrado-Fundação Antônio Prudente]. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Soderberg GL, Cook TM. Electromyograph and Biomechanics. Phys Ter 1984; 64/12:1813-1820. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Song P, Shemen L. Electrophysiologic laryngeal nerve monitoring in high-risk thyroid surgery. Ear Nose Throat J 2005; 84:378-81. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Spector BC, Netterville JL, Billante C, Clary J, Reinisch L, Smith TL. Quality-of-life assessment in patients with unilateral vocal cord paralysis. Otolaryngol Head Neck Surg 2001; 125:176-82. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Stojadinovic A, Shaha AR, Orlikoff RF, et al. Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg 2002; 236:823-32. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Suiter DM, Moorhead MK. Effects of flexible fiberoptic endoscopy on pharyngeal swallow physiology. Otolaryngol Head Neck Surg 2007; 137:956-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Taniguchi H, Tsukada T, Ootaki S, Yamada Y, Inoue M. Correspondence between food consistency and suprahyoid muscle activity, tongue pressure, and bolus transit times during the oropharyngeal phase of swallowing. J Appl Physiol 2008; 105:7919. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Terris DJ, Chin E. Clinical implementation of endoscopic thyroidectomy in selected patients. Laryngoscope 2006; 116:1745-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Tulley WJ. Methods of recording patterns of behavior of the orofacil muscles using the eletromyograph. Dental Record 1953; 73:741-48. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Vaiman M, Eviatar E, Segal S. Evaluation of normal deglutition with the help of rectified surface electromyography records. Dysphagia 2004; 19:125-32. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Vaiman M. Standardization of surface electromyography utilized to evaluate patients with dysphagia. Head Face Med 2007; 3:26. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Vaiman M, Shoval G, Gavriel H. The electrodiagnostic examination of psychogenic swallowing disorders. Eur Arch Otorhinolaryngol 2008; 265:663-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;Vaiman M, Eviatar E. Surface electromyography as a screening method for evaluation of dysphagia and odynaphagia. Head Face Med 2009, 5:9. ;
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Vale-Prodomo LP. Caracterização videofluoroscópica da fase faríngea da deglutição. São Paulo; 2010 [Tese de Doutorado-Fundação Antônio Prudente]. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Vartanian JG, Carvalho AL, Yueh B, et al. Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country. Arch Otolaryngol Head Neck Surg 2004; 130: 1209-1213. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Wasserman JM, Sundaram K, Alfonso AE, Rosenfeld RM, Har-El G. Determination of the function of the internal branch of the superior laryngeal nerve after thyroidectomy. Head Neck 2008; 30:21-7. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Yeung P, ErskineC, Matheus P, Crowe PJ. Voice changes and thyroid surgery: is pre- operative indirect laryngoscopy necessary? Aust N Z J Surg 1999; 69:632-4. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Yin S, Qiu WW, Stucker FJ, Batchelor BM. Critical evaluation of neurolaryngological disorders. Aust Otol Rhinol Laryngol. 2000; 109:832-8. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Yoshikawa M, Yoshida M, Nagasaki T, et al. Aspects of swallowing in healthy dentate elderly persons older than 80 years. J Gerontol A Biol Sci Med Sci 2005; 60:506-9. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Zarzur AP, Shinzato G. Laryngeal electromyography: basic principles and new practical applications. Acta ORL 2007; 25:4-11. ";
FAP;2012;NEYLLER PATRIOTA CAVALCANTE MONTONI;José Guilherme Vartanian;Elisabete Carrara-de-Angelis;"Zollinger Jr RM, Zollinger RM. Atlas de cirurgia. Rio de Janeiro: Guanabara Koogan; 2003.  ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Akiyama SK. Integrins in cell adhesion and signaling. Hum Cell 1996; 9:1816. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Attwood JT, Yung RL, Richardson BC. DNA methylation and the regulation of gene transcription. Cell Mol Life Sci 2002; 59:241-57. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Aysegul A, Sahin MG, KH. Identification and biologic significance of micrometastases in axillary lymph nodes in patients with invasive breast cancer. Arch Pathol Lab Med 2009; 133:6:869-78. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Bandyopadhyay S, Pai SK, Gross SC, et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 2003; 63:1731-6. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Bandyopadhyay S, Pai SK, Hirota S, et al. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 2004; 23:5675-81. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72:141-96. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Bernstein LR, Liotta LA. Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr Opin Oncol 1994; 6:106-13. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Bertucci F, Birnbaum D, Goncalves A. Proteomics of breast cancer: principles and potential clinical applications. Mol Cell Proteomics 2006; 5:1772-86. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 7:248-54. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and darwinian selection in tumours. Trends Cell Biol 1999; 9:M57-60. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Calmon MF, Rodrigues RV, Kaneto CM, et al. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia 2009; 11:1329-39 ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Chang H, Jeung HC, Jung JJ, Kim TS, Rha SY, Chung HC. Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells. Breast Cancer Res Treat 2011; 125:55-63. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Christman JK. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 2002; 21:5483-95. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22:2990-7. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"De Donatis A, Ranaldi F, Cirri P. Reciprocal control of cell proliferation and migration. Cell Commun Signal 2010; 8:20. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Deng Y, Yao L, Chau L, et al. N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer 2003; 106:342-7 ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Ding W, Zhang J, Yoon JG, Shi D, Foltz G, Lin B. NDRG4 is Downregulated in Glioblastoma and Inhibits Cell Proliferation. OMICS 2012; 16:263-7. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Dumitrescu RG, Cotarla I. Understanding breast cancer risk -- where do we stand in 2005? J Cell Mol Med 2005; 9:208-21. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002; 21:5400-13. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002; 21:5427-40. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol 2003; 4:351-8. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Etzioni R, Urban N, Ramsey S, et al. The case for early detection. Nat Rev Cancer 2003; 3:243-52. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Fackler MJ, McVeigh M, Mehrotra J, et al. Quantitative multiplex methylationspecific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 2004; 64:4442-52. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Foty RA, Steinberg MS. Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy. Int J Dev Biol 2004; 48:397-409. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Freshney RL. Culture of animal cells: a manual of basic technique. 4th ed. New York: Wiley-Liss; 2000. Cell proliferation; p.11-50. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Galante PA, Parmigiani RB, Zhao Q, et al. Distinct patterns of somatic alterations in a lymphoblastoid and a tumor genome derived from the same individual. Nucleic Acids Res 2011; 39:6056-68.  ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196:261-82. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Goldenberg D, Harden S, Masayesva BG, et al. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg 2004; 130:39-44. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821-6. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Iwasa Y, Michor F. Evolutionary dynamics of intratumor heterogeneity. PLoS One 2011; 6:e17866. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Jones RL, Salter J, A'Hern R, et al. The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat 2009; 116:53-68. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993; 120:577-85. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Kim MS, Yamashita K, Baek JH, et al. N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res 2006; 66:3409-18. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Kovacevic Z, Richardson DR. The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis 2006; 27:2355-66. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003; 3:253-66. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Li J, Kretzner L. The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc. Mol Cell Biochem 2003; 250:91-105. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;Li S, Yang B, Li G, He S, Li Y. Downregulation of N-Myc downstreamregulated gene 4 influences patient survival in gliomas. Brain Tumor Pathol 2012 Mar 8. ;
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257:967-71. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Lo PK, Sukumar S. Epigenomics and breast cancer. Pharmacogenomics 2008; 9:1879-902. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Lusis EA, Watson MA, Chicoine MR, et al. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 2005; 65:71216. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Marchionni L, Wilson RF, Marinopoulos SS, et al. Impact of gene expression profiling tests on breast cancer outcomes. Evid Rep Technol Assess 2007; (160):1-105. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Martin P. Wound healing--aiming for perfect skin regeneration. Science 1997; 276:75-81. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Martín-Subero JI, Esteller M. Profiling epigenetic alterations in disease. Adv Exp Med Biol 2011; 711:162-77. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 2010; 1805:105-17. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"McClelland M, Ivarie R. Asymmetrical distribution of CpG in an 'average' mammalian gene. Nucleic Acids Res 1982; 10:7865-77. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Melotte V, Lentjes MH, van den Bosch SM, et al. N-Myc downstreamregulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst 2009; 101:916-27. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Melotte V, Qu X, Ongenaert M, et al. The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J 2010; 24:4153-66. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;Ministério da Saúde. Instituto Nacional de Câncer. Estimativa/2012 Incidência de câncer no Brasil. Rio de Janeiro: INCA, 2011.  ;
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Negm RS, Verma M, Srivastava S. The promise of biomarkers in cancer screening and detection. Trends Mol Med 2002; 8:288-93. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Nishimoto S, Tawara J, Toyoda H, Kitamura K, Komurasaki T. A novel homocysteine-responsive gene, smap8, modulates mitogenesis in rat vascular smooth muscle cells. Eur J Biochem 2003; 270:2521-31. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Ohki T, Hongo S, Nakada N, Maeda A, Takeda M. Inhibition of neurite outgrowth by reduced level of NDRG4 protein in antisense transfected PC12 cells. Brain Res Dev Brain Res 2002; 135:55-63. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Patel A, Groopman JD, Umar A. DNA methylation as a cancer-specific biomarker: from molecules to populations. Ann N Y Acad Sci 2003; 983:286- 97. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:e45. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Qu X, Zhai Y, Wei H, et al. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 2002; 229:35-44. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Qu X, Jia H, Garrity DM, et al. Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish. Dev Biol 2008; 317:486-96. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Radpour R, Barekati Z, Kohler C, et al. Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer. PLoS One 2011; 6:e16080. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Rakha EA, Green AR, Powe DG, Roylance R, Ellis IO. Chromosome 16 tumor-suppressor genes in breast cancer. Genes Chromosomes Cancer 2006; 45:527-35. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Razin A, Cedar H. Distribution of 5-methylcytosine in chromatin. Proc Natl Acad Sci U S A 1977; 74:2725-8. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Razin A, Shemer R. Epigenetic control of gene expression. Results Probl Cell Differ 1999; 25:189-204. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist 2009; 14:1061-9. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual, 3rd ed. New York: Cold Spring Harbor Laboratory Press, 2001. Isolation of high-molecular-weight DNA from mammalian cells using proteinase K and phenol; p.6.4-6.11 ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Schilling SH, Hjelmeland AB, Radiloff DR, et al. NDRG4 is required for cell cycle progression and survival in glioblastoma cells. J Biol Chem 2009; 284:25160-9. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Schmutte C, Jones PA. Involvement of DNA methylation in human carcinogenesis. Biol Chem 1998; 379:377-88. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Shaw E, McCue LA, Lawrence CE, Dordick JS. Identification of a novel class in the alpha/beta hydrolase fold superfamily: the N-myc differentiation-related proteins. Proteins 2002; 47:163-8. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Srinivas PR, Kramer BS, Srivastava S. Trends in biomarker research for cancer detection. Lancet Oncol 2001; 2:698-704. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Styblo MT, Wood WC. Traditional prognostic factors for breast cancer. In: Bland KI, Copeland EM, editors. The breast: comprehensive management of benign and malignant diseases. 2nd ed. Philadelphia: W. B. Saunders; 1998. p.419-25. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Suijkerbuijk KP, Pan X, van der Wall E, van Diest PJ, Vooijs M. Comparison of different promoter methylation assays in breast cancer. Anal Cell Pathol 2010; 33:133-41. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 2002; 99:3740-5. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Thompson EW, Paik S, Brünner N, et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992; 150:53444. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Thomssen C, Jänicke F, Harbeck N. Clinical relevance of prognostic factors in axillary node-negative breast cancer. Onkologie 2003; 26:438-45. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Toikkanen S, Pylkkänen L, Joensuu H. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer 1997; 76:1234-40. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Van Poznak C, Seidman AD. Breast cancer. In: Bertino JR, editor. Encyclopedia of cancer. San Diego: Academic Press; 2002. p.287-99. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Verbisck NV, Costa ET, Costa FF, et al. ADAM23 Negatively Modulates v?3 Integrin Activation during Metastasis. Cancer Res 2009; 69:5546-52. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Verma M, Srivastava S. Epigenetics in cancer: implications for early detection and prevention. Lancet Oncol 2002; 3:755-63. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Viale G, Regan MM, Maiorano E, et al. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98. J Clin Oncol 2007; 25:384652. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Wang W, Li Y, Li Y, et al. NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth. Int J Cancer 2009; 124:521-30. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer 2010; 17:R245-62. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene 2002; 21:5462-82. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Yamamoto H, Kokame K, Okuda T, Nakajo Y, Yanamoto H, Miyata T. NDRG4 protein-deficient mice exhibit spatial learning deficits and vulnerabilities to cerebral ischemia. J Biol Chem 2011; 286:26158-65. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Yamashita K, Upadhyay S, Osada M, et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2002; 2:485-95. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Yamashita K, Kim MS, Park HL, et al. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. Mol Cancer Res 2008; 6:31-41. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Yamauchi Y, Hongo S, Ohashi T, et al. Molecular cloning and characterization of a novel developmentally regulated gene, Bdm1, showing predominant expression in postnatal rat brain. Brain Res Mol Brain Res 1999; 68:149-58. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Yao L, Zhang J, Liu X. NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim Biophys Sin 2008; 40:625-35. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Zhao W, Tang R, Huang Y, et al. Cloning and expression pattern of the human NDRG3 gene. Biochim Biophys Acta 2001; 1519:134-8. ";
FAP;2012;RICARDO PEREIRA DE MOURA;Anamaria Aranha Camargo;Érico Tosoni Costa;"Zhou RH, Kokame K, Tsukamoto Y, Yutani C, Kato H, Miyata T. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 2001; 73:86-97. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Abreu ES. Doença de Hodgkin infanto-juvenil no Estado do Ceará e sua relação com o vírus de Epstein-Barr: parâmetros clínicos e análise morfológica, imunohistoquímica e por hibridização in situ. Fortaleza; 1996. [Dissertação de Mestrado-Universidade Federal do Ceará]. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Abreu ES, Ferreira FVA, Rocha Filho FD et al. Doença de Hodgkin infanto-juvenil no Estado do Ceará e sua relação com o vírus de Epstein-Barr: parâmetros clínicos e análise morfológica, imunohistoquímica e por hibridização in situ. J Bras Patol 1997; 33:178-84. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281:1322-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Addis BJ, Isaacson PG. Large cell lymphoma of the mediastinum: a B-cell tumor of probable thymic origin. Histopathology 1986; 10:379-90. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Agnarsson BA, Kadin ME. The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin’s disease using fixed frozen tissue. Cancer 1989; 63:2083-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Aldred V, Vassallo J, Froes M Campos AH, Augusto Soares F. CD20 expression by Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma is related to reduced overall survival in young adult patients. Leuk Lymphoma 2008; 49:2198-202. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Alexander FE, Daniel CP, Armstrong AA, et al. Case clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin’s disease: Results of a case control study. Eur J Cancer 1995; 31A:1479-86. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Almeida JMMF. Células dendríticas foliculares: avaliação imunofenotípica no linfoma de Hodgkin clássico subtipo esclerose nodular. Fortaleza; 2004. [Dissertação de Mestrado-Universidade Federal do Ceará]. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Ambinder RF, Browning PJ, Lorenzana I, et al. Epstein-Barr virus and childhood Hodgkin´s disease in Honduras and the United States. Blood 1993; 81:462-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Amini RM, Enblad G, Engström P, Christensson B, Glimelius B, Sundström C. Relapsed Hodgkin’s lymphoma: immunostaining patterns in relation to survival. Leuk Lymphoma 2002; 43:1253-60. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Amundson SA, Myers TG, Fornace AJ Jr. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 1998; 17:3287-99. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Anagnostopoulos I, Herbst H, Niedobitek G, Stein H. Demonstration of monoclonal Epstein-Barr virus genomes in Hodgkin’s disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989; 74:810-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Anagnostopoulos I, Hansmann ML, Franssila K, et al. European task force on lymphoma project on lymphocyte predominance Hodgkin’s disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin’s disease with a nodular growth patter and abundant lymphocytes. Blood 2000; 96:1889-99. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Anagnostopoulos I, Isaacson PG, Stein H. Lynphocyte-rich classical Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p.322-34. (IARC WHO Classification of Tumours, nº 2) ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Armstrong AA, Alexander FE, Paes RP et al. Association of Epstein-Barr virus with pediatric Hodgkin´s disease. Am J Pathol 1993; 142:1683-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Armstrong AA, Lennard A, Alexander FE, et al. Prognostic significance of EpsteinBarr virus association in Hodgkin’s disease. Eur J Cancer 1994; 30A:1045-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Asano N, Oshiro A, Matsuo K, et al. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin’s lymphoma: a clinicopathologic study. J Clin Oncol 2006; 24:4626-32. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Ashton-Key M, Thorpe PA, Allen JP, Isaacson PG. Folicular Hodgkin’s disease. Am J Surg Pathol 1995; 19:1294-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Audouin J, Diebold J, Nathwani B, et al. Epstein-Barr virus and Hodgkin’s lymphoma in Cairo, Egypt. J Hematop 2010; 3:11-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Axdorph U, Porwit-MacDonald A, Sjöberg J, et al. Epstein-Barr virus expression in Hodgkin’s disease in relation to patient characteristics, serum factors and blood lymphocyte function. Br J Cancer 1999; 81:1182-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Axdorph U, Sjöberg J, Grimfors G, Landgren O, Porwit-MacDonald A, Björkholm M. Biological markers may add to prediction of outcome achieved by the international prognostic score in Hodgkin’s disease. Ann Oncol 2000; 11:1405-11. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Bai MC, Jiwa NM, Horstman A, et al. Decreased expression of cellular markers in Epstein-Barr virus positive Hodgkin’s disease. J Pathol 1994; 174:49-55. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Banks PM. The pathology of Hodgkin´s disease. Semin Oncol 1990; 17:683-95. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Banks PM. Pathology of malignant lymphomas. In: Lichtman M, Beutler E, Kaushansky K, Kipps T, Seligsohn U, Prchal J, editors. Williams hematology. 5ª ed. Philadelphia: McGraw Hill; 1995. p.1049-75. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Bargou RC, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-kappa BRel A activation is required for proliferation and survival of Hodgkin’s disease tumor cells. J Clin Invest 1997; 100:2961-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Barisik NO, Bozkurt S, Gumus M, et al. Expression and prognostic significance of cox-2 and p-53 in Hodgkin lymphomas: a retrospective study. Diagn Pathol 2010; 5:19. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Barros MH, Zalcberg IR, Hassan R. Prognostic impact of CD15 expression and proliferative index in the outcome of children with classical Hodgkin lymphoma. Pediatr Blood Cancer 2008; 50:428-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Berild D, Bendtzen K, Badsberg E. Diagnosis of Hodgkin´s disease hampered by Epstein-Barr virus infection treated with acyclovir. Scand J Haematol 1984; 33:448-52. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Bishop PW, Harris M, Smith AP, Elsam KJ. Immunophenotypic study of lymphocyte predominance Hodgkin’s disease. Histopathology 1991; 18:19-241. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Bittencourt AL, Mendonça N; Carvalho EG, Bittencourt ARL, Nunes CAS. Doença de Hodgkin infantil na Bahia, Brasil: avaliaçäo de 43 casos. J Pediatr 1987; 62:18791. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Bittencourt AL, Barbosa HS. Pediatric Hodgkin´s disease in Bahia, Brazil. Oncol Life Science Advances 1992; 11:45-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Broecker Neto A, Lago S, Radke RC, Costa AJ. Doença de Hodgkin: estudo epidemiológico e clínico em uma população parcial no Rio Grande do Sul. Rev Bras Cancerol 1986; 32:245-50. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;Brousset P. Recent advances in Hodgkin´s disease. In: Congresso Brasileiro de Patologia. Curso curto CC11. Sociedade Brasileira de Patologia, Curitiba, 1999. ;
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Burke JS. Hodgkin’s disease: histopathology and differential diagnosis. In: Knowles DM. Neoplastic Hematopathology. Baltimore: Lippincott Williams and Wilkins; 1992. p.497-533. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Burroni D, Cintorino M, Leoncini L, Tosi P, Ceccarini C. Site-specific monoclonal antibodies against peanut agglutinin (PNA) from Arachis hypogaea: immunohistochemical study of tissue-cultured cells and of 27 cases of Hodgkin´s disease. Am J Pathol 1988; 131:351-60.  ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;[CDC] Centers for Disease Control and Prevention. Cancer prevention and control. 2007. Avaliable from: <URL:http://www.cdc.gov/cancer/> [2011 set 12] ;
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Canioni D, Deau-Fischer B, Taupin P, et al. Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases. PLoS One 2009; 4:e6341. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Chabay PA, Barros MH, Hassan R, et al. Pediatric Hodgkin lymphoma in 2 South American Series: A distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome. J Pediatr Hematol Oncol 2008; 30:28591. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Chan JK, Yip TT, Tsang WY, Lau WH, Wong CS, Ma VW. Detection of EpsteinBarr virus in Hodgkin’s disease occurring in an Oriental population. Hum Pathol 1995; 26:314-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Chan JK. The new World Health Organization classification of lymphomas: the past, the present and the future. Hematol Oncol 2001; 19:129-50. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Chang KC, Khen NT, Jones D, Su IJ. Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype. Hum Pathol 2005; 36:747-55. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Chang KC, Chen PC, Jones D, Su IJ. Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan. Cancer Sci 2008; 99:345-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Chaves E. Doença de Hodgkin em crianças (0-14 anos) – Estudo clínico-patológico de 18 casos. Rev Bras Cirurgia 1972; 62:25-35. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Chaves E. Hodgkin´s disease in the first decade. Cancer 1973; 31:925-30. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Chen WG, Chen YY, Kamel OW, Koo CH, Weiss LM. p53 mutations in Hodgkin’s disease. Lab Invest 1996; 75:519-27. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Chu PG, Chang KL, Arber DA, Weiss LM. Immunophenotyping of hematopoietic in neoplasms. Semin Diagn Pathol 2000; 17:236-56. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Clarke CA, Glaser SL, Dorfman RF, et al. Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women. Cancer 2001; 91:1579-87. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Claviez A, Tiemann M, Peters J, Kreipe H, Schneppenheim R, Parwaresch R. The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin’s disease in childhood. Ann Hematol 1994; 68:61-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Claviez A, Tiemann M, Lüders H, et al. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin’s lymphoma. J Clin Oncol 2005; 23:4048-56. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Costa PB. Doença de Hodgkin. In: Marinho HM, editor. Hematologia. São Paulo: Sarvier; 1984. p.179-88. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Cotran RS, Kumar V, Collins T. Robbins - Patologia estrutural e funcional. 7ª ed. Rio de Janeiro: Elsevier; 2005. Doenças de leucócitos, linfonodos, baço e timo, p.722-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"de Mascarel I, Trojani M, Eghbali H, Coindre JM, Bonichon F. Prognostic value of phenotyping by Ber-H2, Leu-M1, EMA in Hodgkin’s disease. Arch Pathol Lab Med 1990; 114:953-5. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"DeVita VT Jr, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 1970; 73:881-95. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Diehl V, Thomas RK, Re D. Part II: Hodgkin lymphoma – diagnosis and treatment. Lancet Oncol 2004; 5:19-26. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Dienstbier Z, Foltýnová V, Hermanská Z, et al. Prognostic factors in Hodgkin’s disease. Neoplasma 1986; 33:731-5. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Dienstbier Z, Chytrý P, Hermanská Z, Melínová L, P?nicka P, Maríková E. A multivariate analysis of prognostic factors in adult Hodgkin’s disease. Neoplasma 1989; 36:447-56. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Dinand V, Arya LS. Epidemiology of childhood Hodgkin’s disease: is it different in developing countries? Indian Pediatr 2006; 43:141-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Dinand V, Malik A, Unni R, Arya LS, Pandey RM, Dawar R. Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma. Pediatr Blood Cancer 2008; 50:280-3. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Dogan A, Burke JS, Goteri G, Stitson RN, Wotherspoon AC, Isaacson PG. Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype and differential diagnosis. Am J Surg Pathol 2003; 27:903-11. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Donnelly GB, Filippa D, Moskowitz CH, et al. Increased treatment failure in patients with CD 20 positive classic Hodgkin’s disease. Blood 1999; 94:598. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Dorfman RF, Gatter KC, Pulford KA, Mason DY. An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin´s disease. Am J Pathol 1986; 123:508-19. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Elgui de Oliveira D, Bacchi MM, Abreu ES, Niero-Melo L, Bacchi CE. Hodgkin’s disease in adult and juvenile groups from two different geographic regions in Brazil: characterization of clinicopathologic aspects and relationship with Epstein-Barr virus infection. Am J Clin Pathol 2002; 118:25-30. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Ellis PA, Hart DN, Colls BM, Nimmo JC, MacDonald JE, Angus HB. Hodgkin’s cells express a novel pattern of adhesion molecules. Clin Exp Immunol 1992; 90:117-23. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Enblad G, Sundstron C, Glimerlius B. Immunohistochemical characteristics of Hodgkin and Reed-Sternberg cells in relation to age and clinical outcome. Histopathology 1993; 22:535-41. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Enblad G, Sandvej K, Lennette E, et al. Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin’s disease. Int J Cancer 1997; 72:394-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Enblad G, Sandvej K, Sundström C, Pallesen G, Glimelius B. Epstein-Barr virus distribution in Hodgkin’s disease in an unselected Swedish population. Acta Oncol 1999; 38:425-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Engel M, Essop MF, Close P, Hartley P, Pallesen G, Sinclair-Smith C. Improved prognosis of Epstein-Barr virus associated childhood Hodgkin’s lymphoma: Study of 47 South African cases. J Clin Pathol 2000; 53:182-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Fellbaum C, Hansmann ML, Niedermeyer H, et al. Influence of Epstein-Barr virus genomes on patient survival in Hodgkin’s disease. Am J Clin Pathol 1992; 98:31923. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Ferreira FVA, Menezes DB. Doença de Hodgkin – Interrelação linfócitos-“célulasalvo”, como índice morfológico do prognóstico. Rev Med Univ Fed Ceará 1977; 17:19-23. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Ferreira FVA, Oliveira EG, Alencar JEB. Doença de Hodgkin: peculiaridades estatísticas em Fortaleza, Ceará, Brasil. Rev Med Univ Fed Ceará 1977; 17:15-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Ferry JA, Linggood RM, Convery KM, Efird JT, Eliseo R, Harris NL. Hodgkin’s disease, nodule sclerosis type. Cancer 1993; 71:457-63. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Finkbeiner JA, Craver LF, Diamond HD. Prognostic signs in Hodgkin’s disease. J Am Med Assoc 1954; 156:472-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Flavell KJ, Billingham LJ, Biddulph JP, et al. The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin’s disease. Ann Oncol 2003; 14:282-90. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Forni M, Hofman FM, Parker JW, Lukes RJ, Taylor CR. B and T lymphocytes in Hodgkin’s disease. An immunohistochemical study utilizing heterologous and monoclonal antibodies. Cancer 1985; 55:728-37. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Frierson HF Jr, Innes DJ Jr. Sensitivity of anti-Leu-M1 as a marker in Hodgkin´s disease. Arch Pathol Lab Med 1985; 109:1024-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Fu XH, Wang SS, Huang Y, et al. Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin’s lymphoma. Chinese J Cancer 2008; 27:450-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Gad El-Mawla N, El-Deeb BB, Abu-Gabal A, et al. Pediatric Hodgkin’s disease in Egypt. Cancer 1983; 52:1129-31. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Garcia R, Hernández JM, Caballero MD, et al. Serum lactate dehydrogenase level as a prognostic factor in Hodgkin’s disease. Br J Cancer 1993; 68:1227-31. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Garcia JF, Camacho FI, Morente M, et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle check-points: analyses using tissue microarrays. Blood 2003; 101:681-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Gause A, Pohl C, Tschiersch A, et al. Clinical significance of Soluble CD30 antigen in Sera of patients with untreated Hodgkin's disease. Blood 1991; 77:1983-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Giesta RP, Rocha Filho FD, Ferreira FVA, Quixadá ATS, Heukelbach J, Giesta MAG. Influencia do CD 20 na refratariedade do linfoma de Hodgkin clássico ao tratamento inicial com o esquema ABVD, no Ceará, Brasil. J Bras Patol Med Lab 2009; 45:247-52. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin’s disease: epidemiologic characteristics in international data. Int J Cancer 1997; 70:375-82. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Glavina-Durdov M, Jakic-Razumovic J, Capkun V, Murray P. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin’s disease. Br J Cancer 2001; 84:1227-34. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Gobbi PG, Cavalli P, Franzini B, Di Prisco U, Federico M, Bonacorsi G. Tonsillectomy: a prognostic factor in Hodgkin’s disease? Tumori 1981; 67:425-30. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Gregory CD, Dive C, Henderson S, et al. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991; 349:612-4. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Gulley ML, Eagan PA, Quintanilla-Martinez L, et al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin’s disease: association with mixed cellularity subtype and Hispanic American ethnicity. Blood 1994; 83:1595-602. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Gupta RK, Norton AJ, Thompson IW, Lister TA, Bodmer JG. P53 expression in Reed-Sternberg cells of Hodgkin’s disease. Br J Cancer 1992; 66:649-52. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Gupta RK, Patel K, Bodmer WF, Bodmer JG. Mutation of P53 in primary biopsy material and cell lines from Hodgkin disease. Proc Natl Acad Sci USA 1993; 90:2817-21. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Gutensohn N, Cole P. Epidemiology of Hodgkin’s disease. Semin Oncol 1980; 7:92. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Hall PA, D’Ardenne AJ. Value of CD15 immunostaining in diagnosing Hodgkin’s disease. J Clin Pathol 1987; 40:1298-304. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Hall PA, D’Ardenne AJ, Stansfeld AG. Paraffin section immunohistochemistry. I. Non-Hodgkin’s lymphoma. Histopathology 1988; 13:149-60. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Haluska FG, Brufsky AM, Canellos GP. The cellular biology of the Reed-Sternberg cell. Blood 1994; 84:1005-19. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Hancock BW, Dunsmore IR, Swan HT. Lymphopenia a bad prognostic factor in Hodgkin’s disease. Scand J Haematol 1982; 29:193-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasm: a proposal from the international lymphoma study group. Blood 1994; 84:1361-92. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Hasenclever D, Diehl V, Armitage JO, et al. A prognostic score for advanced Hodgkin´s disease. N Engl J Med 1998; 339:1506-14. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Hasenclever D. The disappearance of prognostic factors in Hodgkin's disease. Ann Oncol 2002; 13(Suppl 1):75-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by EpsteinBarr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65:1107-15. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Herling M, Rassidakis GZ, Medeiros LJ, et al. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin’s lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res 2003; 9:2114-20. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. N Engl J Med 2003; 349:1324-32. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Hsu SM, Jaffe ES. Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin´s disease. Am J Clin Pathol 1984; 82:29-32. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Hudson MM, Donalson SS. Hodgkin´s disease. Ped Clin North Am 1997; 4:897913. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Hummel M, Anagnostopoulos I, Dallenbach F, Korbjuhn P, Dimmler C, Stein H. EBV infection patterns in Hodgkin’s disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Haematol 1992; 82:689-94. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E, Stein H. Hodgkin’s disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med 1995; 333:901-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Hyder DM, Schnitzer B. Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin´s disease. Arch Pathol Lab Med 1986; 110:416-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Isaacson PG, Schmid C, Pan L, Wotherspoon AC, Wright DH. Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis. J Pathol 1992; 167:267-71. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Isaacson PG, Ashton-Key M. Phenotype of Hodgkin’s and Reed-Sternberg cells. Lancet 1996; 346:481. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Jack AS, Cunningham D, Soukop M, Liddle CN, Lee FD. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin’s disease. J Clin Pathol 1986; 39:267-70. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Jackson H, Parker F. Hodgkin’s Disease. N Engl J Med 1944; 231:35-44. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics: tumors of hematopoietic and lymphoid tissues. Lyon: IARC; 2001. (World Organization Classification of Tumors).  ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translation research. Hematology Am Soc Hematol Educ Program 2009:523-31. ;
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Jarrett RF, Stark GL, White J, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood 2005; 106:2444-51. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Kanavaros P, Sakalidou A, Tzardi M, et al. Frequent detection of Epstein-Barr virus (EBV), EBER transcripts and latent membrane protein-1 (LMP-1) in tumor cells in Hodgkin’s disease arising in childhood. Pathol Res Pract 1994; 190:1026-30. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Kant JA, Hubbard SM, Longo DL, Simon RM, DeVita VT Jr, Jaffe ES. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin’s disease. J Clin Oncol 1986; 4:284-94. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 1993; 90:9150-4. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Keegan TH, Glaser SL, Clarke CA, et al. Epstein-Barr virus as a marker of survival after Hodgkin’s lymphoma: a population-based study. J Clin Oncol 2005; 23:760413. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Kim HK, Silver B, Li S, Neuberg D, Mauch P. Hodgkin´s disease in elderly patients (?60): clinical outcome and treatment strategies. Int J Radiat Oncol Biol Phys 2003; 56:556-60. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Kirchhoff LV, Evans AS, McClelland KE, Carvalho RP, Pannuti CS. A case-control study of Hodgkin´s disease in Brazil. I. Epidemiologic aspects. Am J Epidemiol 1980; 112:595-608. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Kirsch DG, Kastan MB. Tumor-suppressor p53: implications for tumor development and prognosis. J Clin Oncol 1998; 16:3158-68. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;Kloofs Antiquarian Booksellers. Thomas Hodgkin. Avaliable from: <URL:http://www.morbus-hodgkin.de/infoserv/tomhod.htm> [2011 set 12]. ;
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Kornstein MJ, Bonner H, Gee B, Cohen R, Brooks JJ. Leu M1 and S100 in Hodgkin’s disease and non Hodgkin’s lymphomas. Am J Clin Pathol 1986; 85:4337. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Krugmann J, Tzankov A, Gschwendtner A, et al. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin’s lymphoma: A single-institution study. Mod Pathol 2003; 16:566-73. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Küpper M, Joos S, von Bonin F, et al. MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies. Br J Haematol 2001; 112:768-75. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Kuppers R, Rajewsky K. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin’s disease. Ann Rev Immunol 1998; 16:471-93. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Lauritzen AF, Ralfkiaer E. Use of monoclonal antibodies for the typing of malignant lymphomas in routinely processed biopsy samples. APMIS 1991; 99:631-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Lauritzen AF, Møller PH, Nedergaard T, Guldberg P, Hou-Jensen K, Ralfkiaer E. Apoptosis-related genes and proteins in Hodgkin’s disease. APMIS 1999; 107:63644. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Leite LP. Estudo analítico da associação da doença de Hodgkin com o vírus de Epstein-Barr em uma região tropical de Fortaleza, Ceará - Brasil. Comparação com dados oriundos de pesquisas em regiões com distintos níveis de desenvolvimento social e econômico. Fortaleza; 1998. [Dissertação de MestradoUniversidade Federal do Ceará]. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Leoncini L, Del Vecchio MT, Kraft R, et al. Hodgkin’s disease and CD30-positive anaplastic large cell lymphomas – a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol 1990; 137:1047-57. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351:453-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Levine PH, Pallesen G, Ebbesen P, Harris N, Evans AS, Müeller N. Evaluation of Epstein-Barr virus antibody patterns and detection of viral markers in the biopsies of patients with Hodgkin’s disease. Int J Cancer 1994; 59:48-50. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Levy A, Diomin V, Gopas J, Ariad S, Sacks M, Benharroch D. Hodgkin’s lymphoma in the Bedouin of Southern Israel: epidemiological and clinical features. Isr Med Assoc J 2000; 2:501-3. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Levy LM. Hodgkin’s disease in black Zimbabweans. A study of epidemiologic, histologic, and clinical features. Cancer 1988; 61:189-94. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staining of patients with Hodgkin’s disease: Cotswolds Meeting. J Clin Oncol 1989; 7:1630-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Löeffler M, Pfreundschuh M, Hasenclever D, et al. Prognostic risk factors in advanced Hodgkin’s lymphoma. Report of the German Hodgkin Study Group. Blut 1988; 56:273-81. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Löffler M, Mauch P, MacLennan K, Specht L, Henry-Amar M. The Second International Symposium on Hodgkin's Disease. Workshop I: Review on prognostic factors. Ann Oncol 1992; 3(Suppl 4):63-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Low SE, Horsman JM, Hancock H, Walters SJ, Hancock BW. Prognostic markers in malignant lymphoma: an analysis of 1,198 patients treated at a single centre. Int J Oncol 2001; 19:1203-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Lukes RJ, Graver LF, Hall TC, Rappaport H, Ruben P. Report of the nomenclature committee. Cancer Res 1966; 26:1311. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Machado JC, da Silveira Filho JF, Russo AD. Epidemiology of Hodgkin’s disease in children. A study of 36 cases. Mem Inst Butantan 1971; 35:55-61. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Mack TM, Cozen W, Shibata DK, et al. Concordance for Hodgkin´s disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995; 332:413-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"MacMahon B. Epidemiological of Hodgkin’s disease. Cancer Res 1966; 26:1189200. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Macsween KF, Crawford DH. Epstein-Barr virus-recent advances. Lancet Infect Dis 2003; 3:131-40. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Maggio E, Stekelenburg E, Van den Berg A, Poppema S. TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus. Int J Cancer 2001; 94:60-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Medeiros LJ, Weiss LM, Warnke RA, Dorfman RF. Utility of combing antigranulocyte with antileukocyte antibodies in differentiating Hodgkin’s disease from non-Hodgkin’s lymphoma. Cancer 1988; 62:2475-81. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Meis JM, Osborne BM, Butler JJ. A comparative marker study of large cell lymphoma, Hodgkin’s disease, and true histiocytic lymphoma in paraffin-embedded tissue. Am J Clin Pathol 1986; 86:591-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Menestrina F, Chilosi M, Scarpa A. Nodular lymphocyte predominant Hodgkin’s disease and anaplastic large-cell (CD 30+) lymphoma: distinct entitie or nonspecific patterns? Semin Diagn Pathol 1995; 12:256-69. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Milner J. Structures and functions of the tumor suppressor p53. Pathol Biol (Paris) 1997; 45:797-803. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;Ministério da Saúde. Instituto Nacional do Cancer. Câncer no Brasil: registro de base populacional. 2000. Disponível em: <URL:http://www.inca.gov.br/cancernobrasil/2010> [2011 set 12] ;
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;Ministério da Saúde. Instituto Nacional do Cancer. Estimativa/2010 incidência de câncer no Brasil. Rio de Janeiro: INCA, 2009. ;
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;Ministério da Saúde. Instituto Nacional de Câncer. Linfoma de Hodgkin. Disponível em: <URL:http://www.inca.gov.br/wps/wcm/connect/tiposdecancer/site/ home/linfoma_hodgkin> [2011 dez 20]. ;
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Molot RJ, Mendenhall NP, Barré DM, Braylan RC. The clinical relevance of L26, a B-cell-specific antibody, in Hodgkin’s disease. Am J Clin Oncol 1994; 17:185-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Montalbán C, Abraira V, Morente M, et al. Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin’s disease treated with chemotherapy. Leuk Lymphoma 2000; 39:563-72. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Montalbán C, García JF, Abraira V, et al. Influence of biologic markers on the outcome of Hodgkin’s lymphoma: a study by the Spanish Hodgkin’s lymphoma Study Group. J Clin Oncol 2004; 22:1664-73. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Montesinos-Rongen M, Roers A, Küppers R, Rajewsky K, Hansmann ML. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin’s disease. Blood 1999; 94:1755-60. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Morente MM, Piris MA, Abraira V, et al. Adverse clinical outcome in Hodgkin’s disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood 1997; 90:2429-36. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Mueller N, Evans A, Harris NL, et al. Hodgkin’s disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 1989; 320:689-95. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Muller CP, Trilling B, Steinke B. The prognostic significance of total serum cholesterol in patients with Hodgkin’s disease. Cancer 1992; 69:1042-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Murad AM. Abordagem terapêutica da doença de Hodgkin. In: Colégio Brasileiro de Hematologia organizador. Temas de hematologia – Programa Nacional do CNCBH. Belo Horizonte: Imprensa Universitária; 1997. p.180-5 ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Murray PG, Billingham LJ, Hassan HT, et al. Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin’s disease. Blood 1999; 94:442-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Myskow MW, Krajewski AS. Immunoreactivity of Reed-Sternberg cells in paraffin and frozen section. J Clin Pathol 1986; 39:1043-56. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;[NLM] National Library of Medicine. Dr Dorothy Reed Mendenhall. Available from: <URL:http://www.nlm.nih.gov/exhibition/changingthefaceofmedicine /physicians/biography_221.html> [2006 sep 05]. ;
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;[NCI] National Cancer Institute. National Institutes of Health. Surveillance, Epidemiology, and End Results (SEER). Estimated new cancer cases and deaths for 2009. Avaliable from: <URL:http://seer.cancer.gov/csr/1975_2006/results_single /sect_01_table.01.pdf> [2011 set 12] ;
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Nadali G, Vinante F, Ambrosetti A, et al. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. J Clin Oncol 1994; 12:793-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Naresh KN, O'Conor GT, Soman CS, et al. A study of p53 protein, proliferating cell nuclear antigen, and p21 in Hodgkin’s disease at presentation and relapse. Hum Pathol 1997; 28:549-55. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Naresh KN, Johnson J, Srinivas V, et al. Epstein-Barr virus association in classical Hodgkin’s disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol 2000; 11:916. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Neiman RS, Rosen PJ, Lukes RJ. Lymphocyte-depletion Hodgkin’s disease. A clinicopathological entity. N Engl J Med 1973; 288:751-5. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Neidobitek G, Rowlands DC, Young LS, et al. Overexpression of p53 in Hodgkin’s disease: lack of correlation with Epstein-Barr virus infection. J Pathol 1993; 169:207-12. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Norberg B, Dige U, Roos G, Johansson H, Lenner P. Hodgkin’s disease in Northern Sweden 1971-1981. II. A retrospective analysis of prognostic factors. Acta Oncol 1991; 30:597-601. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Norton AJ, Isaacson PJ. An immunocytochemical study of T cell lymphoma using monoclonal and polyclonal antibody effective in routinely wax embedded tissue. Histopathology 1986; 10:1243-60. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"O’Grady J, Stewart S, Elton RA, Krajewski AS. Epstein-Barr virus in Hodgkin’s disease and site of origin of tumour. Lancet 1994; 343:265-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Ohsawa M, Fukushima H, Ikura Y, et al. Expression of cyclooxygenase-2 in Hodgkin’s lymphoma: its role in cell proliferation and angiogenesis. Leuk Lymphoma 2006; 9:1863-71. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Oliveira HP. Hematologia clínica. Rio de Janeiro: Atheneu; 1990. Os linfomas: doença de Hodgkin - linfomas linfocíticos e histiocíticos; p.377-96. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Patkar N, Mehta J, Kulkarni B, Pande R, Advani S, Borges A. Immunoprofile of Hodgkin’s lymphoma in India. Indian J Cancer 2008; 45:59-63. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Patrício MB, De Sousa JV. Hodgkin´s disease in children: seventeen years experience at the Instituto Português de Oncologia de Francisco Gentil. Cancer 1981; 48:1550-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Petrella T, Michiels JF, Michiels R, et al. CD 15 antigen in Hodgkin's disease. Pathol Res Pract 1989; 185:886-90. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Pinheiro GS, Silva MR, Rodrigues CA, Kerbauy J, de Oliveira JS. Proliferating cell nuclear antigen (PCNA), p53 and MDM2 expression in Hodgkin’s disease. São Paulo Med J 2007; 125:77-84. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Pinkus GS, Thomas P, Said JW. Leu-M1 – a marker for Reed-Sternberg cells in Hodgkin’s disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol 1985; 119:244-52. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Pinto MT. Estudo comparativo da associação do vírus de Epstein-Barr com o linfoma de Hodgkin clássico em adulto. Estudo imuno-histoquímico e por hibridização in situ de casos do Ceará (Brasil) e da França. Fortaleza; 2003. [Dissertação de Mestrado-Universidade Federal do Ceará]. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Pinto MT, Ferreira FV, Pitombeira MS, et al. Analysis of the association between Epstein-Barr virus and classic Hodgkin's lymphoma in adults patients from Ceará (Brazil) by immunohistochemistry and in situ hibridization. J Bras Patol Med Lab 2006; 42:201-5. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Pitombeira MS. Doença de Hodgkin: análise de uma experiência. Fortaleza; 1980. [Tese de Doutorado–Universidade Federal do Ceará]. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Pitombeira MS, Martins JMC, Ferreira FVA, Ribeiro RA, Costa CMBE. Doença de Hodgkin na infância e na adolescência. Rev Hosp Clín Fac Med Univ São Paulo 1987; 42:253-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Poppema S, van Imhoff G, Torensma R, Smit J. Lymphadenopathy morphologically consistent with Hodgkin’s disease associated with Epstein-Barr virus infection. Am J Clin Pathol 1985; 84:385-90. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Poppema S. Lymphocyte predominance Hodgkin’s disease. Semin Diagn Pathol 1992; 9:257-64. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Portlock CS, Donnelly GB, Qin J, et al. Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin’s disease. Br J Haematol 2004; 125:701-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Quintanilla-Martinez L, Gamboa-Dom?quez A, Gamez-Ledesma I, Angeles-Angeles A, Mohar A. Association of Epstein-Barr virus latent membrane protein and Hodgkin’s disease in Mexico. Mod Pathol 1995; 8:675-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Rapaport SI. Hematologia. 2ª ed. São Paulo: Roca; 1990. Doença de Hodgkin; 26474. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, et al. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens. Blood 2002a; 100:3935-41. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Rassidakis GZ, Medeiros LJ, Viviani S, et al. CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin´s disease: Associations with presenting features and clinical outcome. J Clin Oncol 2002b; 20:1278-87. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Ree HJ, Neiman RS, Martins AW, Dallenbach F, Stein H. Paraffin section markers of Reed-Sternberg cells. A comparative study of peanut agglutinin, Leu-M1, LN2, and Ber H2. Cancer 1989; 63:2030-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Reyes F. Maladie de Hodgkin. Encycl Med Chir 1990; 2:13016A1-13016A17. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Rodrigues NR, Rowan A, Smith ME, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A 1990; 87:7555-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Said JW. The immunohistochemistry of Hodgkin’s disease. Semin Diagn Pathol 1992; 9:265-71. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Sarker AB, Akagi T, Jeon HJ, et al. Bauhinia purpurea – a new paraffin section marker for Reed-Sternberg cells of Hodgkin´s disease: a comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30). Am J Pathol 1992; 141:19-23. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Schmid C, Pan L, Diss T, Isaacson PG. Expression of B-cell antigen by Hodgkin’s disease and Reed-Sternberg cells. Am J Pathol 1991; 139:701-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Sheibani K, Battifora H, Burke JS, Rappaport H. Leu-M1 antigen in human neoplasms an immunohistologic study of 400 cases. Am J Surg Pathol 1986; 10:227-36. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Smolewski P, Robak T, Krykowski E, et al. Prognostic factors in Hodgkin’s disease: multivariate analysis of 327 patients from a single institution. Clin Cancer Res 2000; 6:1150-60. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Soares FA, Vassalo J, Paes RP, Teresa Cristina Bortolheiro TC. Sistema hemolinfopoético. In: Brasileiro Filho GB, editor. Bogliolo – patologia. 6ª ed. Rio de Janeiro: Guanabara Koogan; 2000. p.841-94. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Specht L, Nissen NI. Prognostic factors in Hodgkin's disease stage IV. Eur J Haematol 1988; 41:359-67. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Specht L, Nissen NI. Hodgkin's disease and age. Eur J Haematol 1989; 43:127-35. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Spector N, Costa MA, Pulcheri W, et al. C-MOPP/ABV yields good results in a public hospital population with Hodgkin disease in Brazil. Cancer 1993; 71:2823-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Stark GL, Wood KM, Jack F, et al. Hodgkin’s disease in the elderly: a populationbased study. Br J Haematol 2002; 119:432-40. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Steele RJ, Thompson AM, Hall PA, Lane DP. The p53 tumour suppressor gene. Br J Surg 1998; 85:1460-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin´s disease associate antigen Kil in reactive and neoplastic tissue: evidence that Reed Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66:848-58. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Stein H. Hodgkin´s disease in proposed world health organization classification of neoplastic disease of hematopoietic and lymphoid tissues. Am J Surg Pathol 1997; 1:119-21. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Strauchen JA, Dimitriu-Bona A. Immunopathology of Hodgkin’s disease. Characterization of Reed-Sternberg cells with monoclonal antibodies. Am J Pathol 1986; 123:293-300. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Sundeen J, Lipford E, Uppenkamp M, et al. Rearranged antigen receptor genes in Hodgkin’s disease. Blood 1987; 70:96-103. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Sup SJ, Alemañy CA, Pohlman B, et al. Expression of bcl-2 in Classical Hodgkin’s lymphoma: An independent predictor of poor outcome. J Clin Oncol 2005; 23:37739. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Swerdlow SH, Wrigth SA. The spectrum of Leu M1 staining in lymphoid and hematopoietic proliferations. Am J Clin Pathol 1986; 85:283-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Tamaru J, Mikata A, Azuma K, Takagi T. Reciprocal/dichotomic expression of vimentin and B cell differentiation antigens in Reed-Sternberg’s cells. Virchows Archiv A Pathol Anat Histopathol 1990; 416:213-20. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Thomas RK, Re D, Wolf J, Diehl V. Hodgkin´s lymphoma – molecular biology of Hodgkin and Reed-Sternberg cells. Lancet Oncol 2004; 5:11-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Thümper LH, Brady G, Bagg A, et al. Single-cell analysis of Hodgkin and ReedSternberg cells: molecular heterogeneity of gene expression and p53 mutations. Blood 1993; 81:3097-115. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Touhami H, Sotto JJ, Sotto MF, et al. Prognostic value of the epithelial membrane antigen (EMA) in the case of Hodgkin's disease. Neoplasma 1991; 38:433-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome break-point of neoplastic B cells with the t (14;18) chromosome translocation. Science 1984; 226:1097-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Tzankov A, Zimpfer A, Pehrs AC, et al. Expression of B-cell markers in classical Hodgkin lymphoma: a tissue microarray analysis of 330 cases. Mod Pathol 2003a; 16:1141-7. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Tzankov A, Krugmann J, Fend F, Fischhofer M, Greil R, Dirnhofer S. Prognostic significance of CD20 expression in classical Hodgkin lymphoma: A clinicopathological study of 119 cases. Clin Cancer Res 2003b; 9:1381-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Ultmann JE, Moran EM. Clinical course and complications in Hodgkin’s disease. Arch Intern Med 1973; 131:332-53. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;University of Wisconsin-Madison. School of Human Ecology. Mendenhall, Dorothy Reed (1874-1964). Available from: <URL:http://www.sohe.wisc.edu/ depts/history/bios/mendenhall.htm> [2011 set 12]. ;
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Vassalo J, Metze K, Traina F, de Souza CA, Lorand-Metze I. Expression of EpsteinBarr virus in classical Hodgkin’s lymphomas in Brazilian adult patients. Haematologica 2001; 86:1227-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Vassalo J, Metze K, Traina F, de Souza CA, Lorand-Metze I. Further remarks on the expression of CD20 in classical Hodgkin’s lymphomas. Haematologica 2002; 3:ELT17. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Vassalo J, Metze K, Traina F, de Souza CA, Lorand-Metze I. The prognostic relevance of apoptosis-related proteins in classical Hodgkin’s lymphomas. Leuk Lymphoma 2003; 44:483-8. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Vestlev PM, Pallesen G, Sandvej K, Hamilton-Dutoit SJ, Bendtzen SM. Prognosis of Hodgkin’s disease is not influenced by Epstein-Barr virus latent membrane protein. Int J Cancer 1992; 50:670-1. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Von Wasielewski R, Mengel M, Fischer R, et al. Classical Hodgkin's disease. Clinical impact of the immunophenotype. Am J Pathol 1997a; 151:1123-30. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Von Wasielewski R, Werner M, Fischer R, et al. Lymphocyte-predominant Hodgkin’s disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. Am J Pathol 1997b; 150:793803. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Wang J, Taylor CR. Apoptosis and cell cycle-related genes and proteins in classical Hodgkin lymphoma. Appl Immunohistochem Mol Morphol 2003; 3:206-13. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Wang S, Rowe M, Lundgren E. Expression of the Epstein-Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res 1996; 56:4610-3. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Weinreb M, Day PJ, Murray PG, et al. Epstein-Barr virus (EBV) and Hodgkin’s disease in children: incidence of EBV latent membrane protein in malignant cells. J Pathol 1992; 168:365-9. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Weinreb M, Day PJ, Niggli F, et al. The consistent association between Epstein-Barr virus and Hodgkin’s disease in children in Kenya. Blood 1996; 87:3828-36. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J. Epstein-Barr viral DNA in tissues of Hodgkin’s disease. Am J Pathol 1987; 129:86-91. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Werner M, Georgii A, Bernhards J, Hübner K, Schwarze EW, Fischer R. Characterization of giant cells in Hodgkin’s lymphomas by immunohistochemistry applies to randomly collected diagnostic biopsies from the German Hodgkin trial. Hematol Oncol 1990; 8:241-50. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Wieczorek R, Buck D, Bindl J, Knowles DM. Monoclonal antibody Leu-22 (L60) permits the demonstration of some neoplastic T cells in routinely fixed and paraffinembedded tissue sections. Hum Pathol 1988; 19:1434-43. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Xerri L, Bouabdallah R, Camerlo J, Hassoun J. Expression of the p53 gene in Hodgkin’s disease: dissociation between immunohistochemistry and clinicopathological data. Hum Pathol 1994; 25:449-54. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Xerri L, Parc P, Bouabdallah R, Camerlo J, Hassoun J. PCR–mismatch analysis of p53 gene mutation in Hodgkin’s disease. J Pathol 1995; 175:189-94. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Yung L, Linch D. Hodgkin´s lymphoma. Lancet 2003; 361:943-51. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Zarate-Osorno A, Roman LN, Kingma DW, Meneses-Garcia A, Jaffe ES. Hodgkin’s disease in Mexico: prevalence of Epstein-Barr virus sequences and correlations with histologic subtype. Cancer 1995; 75:1360-6. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Zhao P, Lu Y, Liu L, Zhong M. Aberrant expression of ID2 protein and its correlation with EBV-LMP1 and P16(INK4A) in classical Hodgkin lymphoma in China. BMC Cancer 2008; 8:379. ";
FAP;2012;ROGÉRIO PINTO GIESTA;Victor Piana de Andrade;Ronald Feitosa Pinheiro;"Zukerberg LR, Collins AB, Ferry JA, Harris NL. Coexpression of CD 15 and CD 20 by Reed-Sternberg cells in Hodgkin´s disease. Am J Pathol 1991; 139:475-83.";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Akishima-Fukasawa Y, Nakanishi Y, Ino Y, Moriya Y, Kanai Y, Hirohashi S. Prognostic significance of CXCL12 expression in patients with colorectal carcinoma. Am J Clin Pathol 2009; 132:202-10. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Al-Batran SE, Hartmann JT, Probst S, et al. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 2008; 26:1435-42. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Al-Moundhri MS, Nirmala V, Al-Hadabi I, et al. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. J Surg Oncol 2005; 91:243-52. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;[ACS] American Cancer Society. Global cancer facts & figures. 2nd ed. 2011. Avaliable from: <URL:http://www.cancer.org/Research/CancerFactsFigures/Global CancerFactsFigures/gloabla-cancer-facts-figures-2nd-edition> [2011 nov 20] ;
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010; 376:687-97. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Bakos E, Homolya L. Portrait of multifaceted transporter, the multidrug resistanceassociated protein 1 (MRP1/ABCC1). Pflugers Arch 2007; 453:621–41. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Bamias A, Hill ME, Cunningham D, et al. Epirubicin, cisplatin and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival. Cancer 1996; 77:1978-85. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Ban S. Early and advanced gastric cancer. In: Tan D, Gregory YL, editors. Advances in surgical pathology series – gastric cancer. Philadelphia; Lippincott Williams & Wilkins: 2011. p.73-93. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Baselga J, Trigo JM, Bourhis J, et al. Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 2005; 23:5568-77. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8:816-24. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Boldogh I, Roy C, Lee MS, et al. Reduced DNA double-strand breaks in chlorambucil resistant cells related to high DNA-PKcs activity and low oxidative stress. Toxicology 2003; 193:137-52. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Borrmann R. HandBuch der speziellen pathologischen anatomie und histologie. In: Von Henke FU, Lubarch O, editors. IV/lerster Teil. Berlin: Julius Springer Verlag; 1926. p.864 -71. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Brenner B, Hoshen MB, Purim O, et al. MicroRNAs as potential prognostic factor in gastric cancer. World J Gastroenterol 2011; 17:3976-85. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Bunt AM, Hermans J, Smit VT, van de Velde CJ, Fleuren GJ, Bruijn JA. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995; 13:19-25. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Bergamaschi A, Christensen BL, Katzenellenbogen BS. Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3?, FOXM1, and a gene signature associated with mitosis. Breast Cancer Res 2011; 13:R70. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999; 36:873-80. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Caldas C. Genetic predisposition to gastric cancer. In: American Society of Clinical Oncology. 2007 Gastrointestinal Cancers Symposium Program/Proceedings. Alexandria(VA): American Society of Clinical Oncology; 2007. p.45-6. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Cameron DA, Massie C, Kerr G, Leonard RC. Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer. Br J Cancer 2003; 89:183742. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Chen CN, Lin JJ, Chen JJ, et al. Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol 2005; 23:7286-95. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Chen CN, Hsieh FJ, Cheng YM, Chang KJ, Lee PH. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer. J Surg Oncol 2006; 94:226-33. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;Coburn NG, Swallow C, Quan ML, Law C. ASCO significant regional variation in treatment and survival of gastric cancer. J Clin Oncol 2005 23(supl.1):4004. ;
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Cole SP, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258:1650-4. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 2008; 358:36-46. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;Dako Herceptest for Immunoenzymatic Staining DAKO A/S, Glastrup, Dinamarca, 1999. ;
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Davies CC, Chakraborty A, Cipriani F, Haigh K, Haigh JJ, Behrens A. Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation. Nat Cell Biol 2010; 12:963-72. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol 2006; 13:12-30. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Devita VT Jr, Chu E. Principles of medical oncology. In: Devita VT Jr, Hellman S, Rosenberg AS, editors. Cancer principles e practice of oncology. 6th ed. Philadelphia: J.B. Lippincott; 2001. p.286-309. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Di Leo A, Desmedt C, Bartlett JM, and HER2/TOP2A Meta-analysis Study Group. HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data. Lancet Oncol 2011; 12:1134-42. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 1998; 95:15665–70. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Dong QM, Zhang JQ, Li Q, Bracher JC, Hendricks DT, Zhao XH. Clinical significance of serum expression of GRO? in esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17:2658-62. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Douillard JY, Siena S, Cassidy J, et al. Randomized, open label, phase III study of panitumumab (PMAB) with FOLFOX4 versus FOLFOX4 alone as first-line treatment (tx) for metastatic colorectal cancer (mCRC): Efficacy by skin toxicity (ST). J Clin Oncol 2010; 28: 4697-705. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2010. Digestive system; p.101250. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Eisenhauer E, Therasse P, Bogart J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45:228-47. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Eschrich S, Yang I, Bloom G, et al. Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 2005; 23:3526-35. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Globocan 2008: cancer incidence and mortality worldwide. France: IARC; 2010. Available from: <URL:http://globocan.iarc.fr.> [2011 nov 21] ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Findlay M, Cunningham D, Norman A, et al. A phase II study in advanced gastroesophageal cancer using epirrubicin and cisplatin in combination with continuous infusional 5-fluorouracil (ECF). Ann Oncol 1994; 5:609-16. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Galizia G, Lieto E, Orditura M, et al. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery. World J Surg 2007; 31:1458-68. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Gamboa-Dominguez A, Dominguez-Fonseca C, Chavarri-Guerra Y, et al. E-cadherin expression in sporadic gastric cancer from Mexico: exon 8 and 9 deletions are infrequent events associated with poor survival. Hum Pathol. 2005; 36:29-35. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Gao X, Wei S, Kairan L, et al. Nucleolar follistatin promotes cancer cell survival under glucose-deprived conditions through inhibiting cellular rRNA synthesis. J Biol Chem 2010; 281:36857-64. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Garcia I, Vizoso F, Martin A, et al. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Ann Surg Oncol 2003; 10:234-41. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;Genzyme Genetics. ERCC1 immunohistochemistry analysis: sample report 2009. Available from: <URL:http://www.genzymegenetics.com/~/media/Files/ Genetics/PDF/SampleReports/OncologyPathology/sample-report-ercc1immunohistochemistry-analysis.pdf> [2012 jan 20] ;
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Gutwein LG, Al-Quran SZ, Fernando S, Fletcher BS, Copeland EM, Grobmyer SR. Tumor endothelial marker 8 expression in triple-negative breast cancer. Anticancer Res 2011; 31:3417-22. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Gomes LI, Esteves GH, Carvalho AF, et al. Expression profile of malignant and nonmalignant lesions of esophagus and stomach: differential activity of functional modules related to inflammation and lipid metabolism. Cancer Res 2005; 65:712736. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of digestive system. Lyon: IARC Press; 2000. (World Health Classification of Tumours; 2) ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Harrison CA, Gray PC, Vale WW, Robertson DM. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 2005; 16:73-8. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Harrison LE, Karpeh MS, Brennan MF. Proximal gastric cancers resected via a transabdominal only aproach: Results and comparisons to distal adenocarcinoma of the stomach. Ann Surg 1997; 225:678-83. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Helland A, Anglesio MS, George J, et al. Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. PLoS One 2011; 6:e18064. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Hofmann M, Stoss O, Shi D, et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology 2008; 52: 797-805. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Huang Y, Zhu Z, Sun M, et al. Critical role of aquaporin-3 in the human epidermal growth factor-induced migration and proliferation in the human gastric adenocarcinoma cells. Cancer Biol Ther 2010; 9:1000-7. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the ""different disease"" hypothesis. Cancer 2000; 88:921-32. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Iiristo M, Wiklund T, Wilking N, Bergh J, Brandberg Y. Tailored chemotherapy doses based on toxicity in breast cancer result in similar quality of life values, irrespective of given dose levels. Acta Oncol 2011; 50:338-43. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 14th ed. 2010. Avaliable from: <URL:http://www.acronymfinder.com/JapaneseClassification-of-Gastric-Cancer-(JCGC).html> [2012 jan 12] ;
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Jørgensen JT, Hersom M. HER2 as a prognostic marker in gastric cancer - a systematic analysis of data from the literature. J Cancer 2012; 3:137-44. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Kang JU, Koo SH, Kwon KC, Park JW, Kim JM. Gain in chromosomal region 5p15.33 containing TERT is the most frequent genetic event in early stages of nonsmall cell lung cancer. Cancer Genet Cytogenet 2008; 182:1-11. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Kanta SY, Yamane T, Dobashi Y, Mitsui F, Kono K, Ooi A. Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study. Hum Pathol 2006; 37:1333-43. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Keeley EC, Mehrad B, Strieter RM. CXC Chemokines in cancer angiogenesis and metastases. Adv Cancer Res 2010; 106:91-111. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Kikuyama S, Inada T, Shimizu K, Miyakita M, Ogata Y. p53, bcl-2 and thymidine phosphorylase as predictive markers of chemotherapy in patients with advanced and recurrent gastric cancer. Anticancer Res 2001; 21:2149-53. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer 1998; 1:125-33. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Kim JH, Park JM, Jung CW, et al. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol 2008; 97:125-30. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Kim KH, Kwon HC, Oh SY, et al. Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy. Biomarkers 2011; 16:74-82. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"King CE, Wang L, Winograd R, et al. LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms. Oncogene 2011; 30:4185-93. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Knoop AS, Knudsen H, Balslev E, et al. retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group. J Clin Oncol 2005; 23:7483-90.  ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Kong U, Koo J, Choi K, Park J, Chang H. The expression of GAGE gene can predict aggressive biologic behavior of intestinal type of stomach cancer. Hepatogastroenterology 2004; 51:1519-23. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Kopp R, Ruge M, Rothbauer E, et al. Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patients. Anticancer Res 2002; 22:1161-7. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Kosaka Y, Mimori K, Fukagawa T, et al. Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood. Br J Cancer 2007; 96:1723-8. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Kuzuhara T, Suganuma M, Kurusu M, Fujiki H. Helicobacter pylori-secreting protein Tipalpha is a potent inducer of chemokine gene expressions in stomach cancer cells. J Cancer Res Clin Oncol 2007; 133:287-96. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Kwon HC, Roh MS, Oh SY, et al. Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer. Ann Oncol 2007; 18:504-9. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Lauren P. The two histological main types of gastric carcinomas: diffuse and socalled intestinal-type carcinoma: an attempt at histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Lee HK, Lee HS, Yang HK, et al. Prognostic significance of Bcl-2 and p53 expression in gastric cancer. Int J Colorectal Dis 2003; 18:518-25. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Lee KH, Kim JR. Regulation of HGF-mediated cell proliferation and invasion through NF-?B, JunB, and MMP-9 cascades in stomach cancer cells. Clin Exp Metastasis 2012; 29:263-72. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;Le Galés-Camus C, Resnikoff S, Sepulveda C. Palliative care: cancer control: knowledge into action. Avaliable from: <URL:http://www.who.int/cancer/media /FINAL-Palliative%20Care%20Module.pdf> [2012 jan 12].;
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Lenz H, Leichman C, Danaberg K, et al. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol 1996; 14:176-82. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;Liang Z, Zeng X, Gao J, et al. Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients. BMC Cancer 2008, 8:363. ;
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Lindman H, Aström G, Ahlgren J, et al. Individually tailored toxicity-based 5fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer. Acta Oncol 2007; 46:165-71. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA, Fryer JG. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schredule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. J Clin Oncol 1989; 7:452-32. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Ma XJ, Wang Z, Ryan PD, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004; 5:60716. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Mayers C, Panzarella T, Tannock IF. Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma. Cancer 2001; 91:2246-57. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Maiti AK. Gene network analysis of oxidative stress-mediated drug sensivity in resistant ovarian carcinoma cells. Pharmacogenomic 2010; 10:94-104. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Matsubara J, Nishina T, Yamada Y, et al. Impacts of excision repair crosscomplementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. Br J Cancer 2008; 98:832-9.";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Meireles SI, Cristo EB, Carvalho AF, et al. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res 2004; 64:1255-65. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Metzger R, Leichman CG, Danenberg KD, et al. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol 1998; 16:309-16. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Miao J, Wang Z, Provencher H, et al. HOXB13 promotes ovarian cancer progression. PNAS 2007; 104:17093-8. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2010 Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2009. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;Ministério da Saúde. Instituto Nacional de Câncer. Registros de base populacional. 2010. Disponível em: <URL:www.inca.gov.br/cancernobrasil/2010 [2011 nov 20] ;
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Moch H, Schraml P, Bubendorf L, et al. Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips. Verh Dtsch Ges Pathol 1999; 83:225-32. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Morowaki Y, Kunisaki C, Kobayashi S, et al. Progressive improvement of prognosis for patients with gastric cancer (dynamic stage grouping) with increasing survival interval from initial staging: How much can a given survival expect to live? Surgery 2003; 133:135-40. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993; 72:37-41. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;[NCCN] National Comprehensive Cancer Network. Gastric cancer: versão 2.2011. Available from: <URL:http://www.nccn.org> [2011 dez 21] ;
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Ohno R, Yoshinaga K, Fujita T, et al. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 2001; 91:1876881. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Ohshima K, Inoue K, Fujiwara A, et al. Let-7 MicroRNA Family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLos One 2010; 5:e13247. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5:649-55. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Okines AF, Norman AR, McCloud P, Kang YK, Cunningham D. Metaanalysis of the REAl-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer. Ann Oncol 2009; 20:1529-34. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;Okuyama T, Maehara Y, Kabashima A, Takahashi I, Kakeji Y, Sugimachi K. Combined evaluation of expressions of p53 an p21 proteins as prognostic factor for patients with gastric carcinoma. Oncology 2002, 63:353-61. ;
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Ozkan M, Akbudak IH, Deniz K, et al. Prognostic value of excision repair crosscomplementing gene 1 expression for cisplatin-based chemotherapy in advanced gastric cancer. Asian Pac J Cancer Prev 2010; 11:181-5. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Ougolkov A, Yamashita K, Bilim V, Takahashi Y, Mai M, Minamoto T. Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis. Inter J Colorectal Dis 2003; 18:160-6. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Park DI, Yun JW, Park JH, et al. HER-2/neu amplification is an independent prognostic factor in gastric cancer. Dig Dis Sci 2006; 51:1371-9. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Park JY, Park KH, Bang S, et al. CXCL5 overexpression is associated with late stage gastric cancer. J Cancer Res Clin Oncol 2007; 133:835-40. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Park DY, Han HS, Lauwers GY. Gastric carcinoma: classifications and morphologic variants. In: Tan D, Gregory YL, editors. Advances in surgical pathology series: gastric cancer. Philadelphia: Lippincott Williams & Wilkins; 2010. p.53-72. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Parkin DM. International variation. Oncogene 2004; 23:6329-40. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Perou CM, Jeffrey SS, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 1999; 96:9212-7. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-52. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Peter ME. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 2009; 8:843-52. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Pharoah PD, Guilford P, Caldas C, International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutations carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001; 121:1348-53. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Pollack JR, Van de Rijn M, Botstein D. Challenges in developing a molecular characterization of cancer. Semin Oncol 2002; 29:280-5.";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Prifti E, Zucker JD, Clement K, Henegar C. FunNet: an integrative tool for exploring transcriptional interactions. Bioinformatics 2008; 24:2636-8.";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Pyrhönen S, Kuitunen T, Nyandoto P, Kouri M. A randomized phase III trial comparing fluorouracil, epidoxorubicin and methotrexate (FEMTX) with best supportive care in non-resectable gastric cancer. Br J Cancer 1995; 71:587-91. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Rao S, Cunningham D, Benson R, et al. A prospective study to evaluate the role of gene expression profiles (GEP) in predicting clinical outcome of patients receiving preoperative chemotherapy for oesophagogastric cancer. J Clin Oncol 2007; 25(supl 20):4501. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Quackenbush J. Microarray analysis and tumor classification. N Engl J Med 2002; 354:2463-72. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2010. Available from: <URL:http://www.R-project.org> [2011 maio 20] ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Rhyu MG, Park WS, Meltzer SJ. Microsatelite instability occurs frequently in human gastric carcinoma. Oncogene 1994; 9:29-32. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Risbridger GP, Schmitt JF, Robertson DM. Activins and inhibins in endocrine and other tumors. Endocr Rev 2001; 22:836-58. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Roder DM. The epidemiology of gastric cancer. Gastric Cancer 2002; 5 Suppl 1:511. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194:1639-47. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346:1937-47. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Ross JS, McKenna BJ. The HER-2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest 2001; 19:554-68. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Ross P, Nicolson M, Cunningham D, et al: Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 2002; 20:1996-2004. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Roth A, Malbach R, Martinelli G, et al. Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). Ann Oncol 2000; 11:301-6. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Roth A, Malbach R, Fazio N, et al. 5-Fluorouracil as a protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere), cisplatin in advanced gastric carcinoma: a phase I-II trial. Ann Oncol 2004; 15:759-64. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Roth AD, Fazio N, Stupp R, et al. Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. J Clin Oncol 2007; 25:3217-23. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Saad AA, Awed NM, Abd Elkerim NN, ET al. Prognostic significance of E-cadherin expression and peripheral blood micrometastasis in gastric carcinoma patients. Ann Surg Oncol 2010; 17:3059-67.  ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Saeed AI, Bhagabati NK, Braisted JC, et al. TM4 microarray software suite. Methods Enzymol 2006; 411:134-93. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Scheithauer W, Kornek G, Hejna M, et al. Palliative chemotherapy versus best supportive care in patients with metastatic gastric cancer: A randomized trial. Ann Hematol 1994; 73(Suppl 2):A181. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Scheiman JM, Cutler AF. Helicobacter pylori and gastric cancer. Am J Med 1999; 106:222-6. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Schena M, Shalon D, Davies RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270:46770. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Shen L, Zhu Z, Huang Y, et al. Expression prolile of multiple aquaporins in human gastric carcinoma and its clinical significance. Biomed Pharmacother 2010; 64:313-8. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Schuell B, Gruenberger T, Kornek GV, et al. Side effects during chemotherapy predict tumour response in advanced colorectal cancer. Br J Cancer 2005; 93:744-8. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Shi H, Xu JM, Hu NZ, Xie HJ. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J Gastroenterol 2003; 9:1421-6. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K. Expression of multidrug-resistancerelated proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Cancer Invest 2008; 26:344-51. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Siewert JR, Bottcher K, Stein HJ, Roder JD and the German Gastric Carcinoma Study Group Relevant Prognostic Factors in Gastric Cancer Ten-Year Results of the German Gastric Cancer Study. Ann Surg 1998; 228:449-61. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Song ZJ, Gong P, Wu YE. Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 2002; 8:591-5.";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast cancer distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98:10869-74. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Tan BB, Li Y, Han J, et al. Relationship of cyclooxygenase-2 and multidrug resistance associated factors to chemosensitivities in gastrointestinal carcinomas. Sichuan Da Xue Xue Bao Yi Xue Ban 2010; 41:128-31. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Tanner M, Hollmén M, Junttila TT, et al. Amplification of HER-2 in gastric carcinoma: association with Topoisomerase II-alpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Oncol 2005; 16:273-8. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Tanner M, Isola J, Scandinavian Breast Group Trial 9401, et al. Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and doseescalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401. J Clin Oncol 2006; 24:2428-36. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Tsukuma H, Oshima A, Narahara H, et al. Natuara history of early gastric cancer: a non-concurrent, long term, follow up study. Gut 2000; 47:618-21. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Van Cutsem E, Moiseyenkon VM, Tjulandin S, et al. Phase iii study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the v325 study group. J Clin Oncol 2006; 24:4991-7. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"van de Vijver MJ, He YD, van’t Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347:1999-2009. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"van’t Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415:530-6. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Vanhoefer U, Rougier P, Wilke H, et al. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 2000; 18:2648-57. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Varis A, Zaika A, Puolakkainen P, et al. Coamplified and overexpressed genes at ERBB2 locus in gastric cancer. Int J Cancer 2004; 109:548-53. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Verma K, Gu J, Werner E. Tumor endothelial marker 8 amplifies canonical wnt signaling in blood vessels. PLoSOne 2011; 6:e22334. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Viswanathan SR, Powers JT, Einhorn W, et al. Lin28 Enhances Tumorigenesis and is Associated with Advanced Human Malignancies. Nat Genet 2009; 41:843-8. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Wacker B, Nagrani T, Weinberg J, Witt K, Clark G, Cagnoni PJ. Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies. Clin Cancer Res 2007; 13:3913-21. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Wagner AD, Grothe W, Haerting J, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006; 24:2903-9. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Wanebo HJ, Kenedy BJ, Chmiel J, et al. Cancer of the stomach. a patient care study by the American College of Surgeons. Ann Surg 1993; 218:583-92. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Webb A, Cunningham D, Scaffe J, et al. Randomised trial comparing epirrubicin, cisplatin and fluorouracil versus fluorouracil, doxorrubicin and methotrexate in advanced esophageal cancer. J Clin Oncol 1997; 15:261-7. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Xu H, Xu Y, Zhang W, Shen L, Yang L, Xu Z. Aquaporin-3 regulates metalloproteinases via PI3K/AKT signal pathway in human gastric carcinoma SGC7901 cells. J Exp Clin Cancer Res 2011; 30:86. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Xue YW, Zhang GF, Zhu ZB, Wang Q, Fu SB. Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma. World J Gastroenterol 2003; 9:250-3. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Yun J, Kim KM, Kim ST, et al. Predictive Value of the ERCC1 Expression for Treatment Response and Survival in Advanced Gastric Cancer Patients Receiving Cisplatin-based First-line Chemotherapy. Cancer Res Treat 2010; 42:101-6. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Zafirellis K, Karameris A, Milingos N, Androulakis G. Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors? Anticancer Res 2005; 25:3629-36. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Zali MR, Moaven O, Asadzadeh Aghdaee H, et al. Clinicopathological significance of E-cadherin, ?-catenin and p53 expression in gastric adenocarinoma. J Res Med Sci 2009; 14:239-47. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Zhang YZ, Zhang LH, Gao Y, et al. Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling. World J Gastroenterol 2011; 17:1710-7. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Zhao G, Guo LL, Xu JY, Yang H, Huang MX, Xiao G. Integrin-linked kinase in gastric cancer cell attachment, invasion and tumor growth. World J Gastroenterol 2011; 17:3487-96. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Zhong XY, Zhang LH, Jia SQ, et al. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Histopathology 2008; 52:560-8. ";
FAP;2012;ROSANE OLIVEIRA DE SANTANA;Vladmir Claudio Cordeior de Lima;Ronaldo de Albuquerque Ribeiro;"Zhou YN, Xu CP, Han B, et al. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002; 8:987-93. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Adamowicz M, Radlwimmer B, Rieker RJ, et al. Frequent amplifications and abundant expression of TRIO, NKD2, and IRX2 in soft tissue sarcomas. Genes Chromosomes Cancer 2006; 45:829-38. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Aguiar Junior S, Ferreira FO, Rossi BM, et al. Neoadjuvant chemoradiation therapy for soft tissue sarcomas of the extremities. Clinics (Sao Paulo) 2009; 64:1059-64. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Almal SH, Padh H. Implications of gene copy-number variation in health and diseases. J Hum Genet 2012; 57:6-13. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Armengol G, Tarkkanen M. Virolainen M, et al. Recurrent gains of Iq8 and 12 in the Ewing family of tumours by comparative genomic hybridisation. Br J Cancer 1997; 75:1403-9. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Baird K, Davis S, Antonescu CR, et al. Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res 2005; 65:9226-35. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Barretina J, Taylor BS, Banerji S, et al. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet 2010; 42:715-21. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Beck AH, Lee CH, Witten DM, et al. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Oncogene 2010; 29:84554. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Benjamin RS, Debiec-Rychter M, Le Cesne A, et al. Gastrointestinal stromal tumors II: Medical oncology and tumor response assessment. Semin Oncol 2009; 36:30211. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Blay JY, Le Cesne A. Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven. Oncologist 2009; 14:1013-20. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Borden EC, Baker LH, Bell RS, et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res 2003; 9:1941-56. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Boye K, Maelandsmo GM. S100A4 and metastasis: a small actor playing many roles. Am J Pathol 2010; 176:528-35. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Canter RJ, Beal S, Borys D, et al. Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg 2010; 210:191-8.e2. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Carneiro A, Francis P, Bendahl PO, et al. Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin? Lab Invest 2009; 89:668-75. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38:228-33. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Chibon F, Mairal A, Fréneaux P, et al. The RB1 gene is the target of chromosome 13 deletions in malignant fibrous histiocytoma. Cancer Res 2000; 60:6339-45. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Chibon F, Mariani O, Mairal A, et al. The use of clustering software for the classification of comparative genomic hybridization data. an analysis of 109 malignant fibrous histiocytomas. Cancer Genet Cytogenet 2003; 141:75-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Chibon F, Lagarde P, Salas S, et al. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 2010; 16:781-7.";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med 2005; 353:701-11. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Coindre JM, Terrier P, Bui NB, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996; 14:869-77. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001; 91:1914-26. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Coindre JM, Hostein I, Maire J, et al. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2and CDK4 status favour a single entity. J Pathol 2004; 203:822-30. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Coindre JM. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 2006; 130:1448-53. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Costa J, Wesley RA, Glatstein E, Rosemberg SA. The grading of soft tissue sarcomas: results of clinicohistopathologic correlation in a series of 163 cases. Cancer 1984; 53:530-41. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Curtis LJ, Li Y, Gerbault-Seureau M, et al. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines. Genomics 1998; 53:42-55. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Debant A, Serra-Pages C, Seipel K, et al. The multidomain protein trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-speci?c and rho-speci?c guanine nucleotide exchange factor domains. Proc Natl Acad Sci USA 1996; 93:5466-71.";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Dei Tos AP. Classification of pleomorphic sarcomas: where are we now? Histopathology 2006; 48:51-62. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Demetri GD, Antonia S, Benjamin RS, et al. National comprehensive cancer network soft tissue sarcoma panel. soft tissue sarcoma. J Natl Compr Cancer Netw 2010; 8:630-74. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Demicco EG, Lazar AJ. Clinicopathologic considerations: how can we fine tune our approach to sarcoma? Semin Oncol 2011; 38(Suppl 3):S3-18. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Derré J, Lagacé R, Nicolas A, et al. Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab Invest 2001; 81:211-5. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Deyrup AT, Lee VK, Hill CE, et al. Epstein–Barr virus associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol 2006; 30:75-82. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Diskin SJ, Eck T, Greshock J, et al. STAC: A method for testing the significance of DNA copy number aberrations across multiple array- experiments. Genome Res 2006; 16:1149-58. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Ducimetiere F, Lurkin A, Ranchère-Vince D, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One 2011; 6:e20294. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti. AJCC cancer staging manual. 7ª ed. New York: Springer-Verlag, 2010. Soft tissue sarcoma; p.291-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"El-Rifai W, Sarlomo-Rikala M, Knuutila S, Miettinen M. DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am J Pathol 1998; 153:985-90. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Eriksson M. Histology-driven chemotherapy of soft-tissue sarcoma. Ann Oncol 2010; 21:270-6. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Espinosa I, Beck AH, Lee CH, et al. Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gyne-cological and nongynecological leiomyosarcoma. Am J Pathol 2009; 174:2347-56. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Espinosa I, Edris B, Lee CH, et al. CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis. Am J Pathol 2011; 179:2100-7. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Estivill X, Armengol L. Copy number variants and common disorders: ?lling the gaps and exploring complexity in genome-wide association studies. PLoS Genet 2007; 3:1787-99. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006; 7:85-97. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Fletcher CDM. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992; 16:213-28. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Fletcher CDM, Dal Cin P, De Wever I, et al. Correlation between clinicopathologic features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP Study Group. Am J Pathol 1999; 154:1841-7. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Fletcher CDM, Gustafson P, Rydholm A, et al. Clinicopathologic re-evaluation of 100 malignant ?brous histiocytomas: Prognostic relevance of subclassi?cation. J Clin Oncol 2001; 12:3045-50. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Fletcher CDM, van den Berg E, Molenaar W. Pleomorphic malignant fibrous histiocytoma/Undifferentiated high grade pleomorphic sarcoma. In: Fletcher CDM, Unni KK, Mertens F, editors. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002. p.120-2. (IARC WHO Classification of Tumours). ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Fletcher CDM. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 2006; 48:3-12. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Forus A, Florenes VA, Maelandsmo GM, et al. Mapping of amplification units in the q13–q14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth Differ 1993; 4:1065-70. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Forus A, Weghuis DO, Smeets D, et al. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 1995; 14:8-14. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Forus A, Berner JM, Meza-Zepeda LA, et al. Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas. Br J Cancer 1998; 78:495-503. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Francis P, Namløs HM, Müller C, et al. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential. BMC Genomics 2007; 8:73. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Fujiwara M, Kashima TG, Kunita A, et al. Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma. Tumour Biol 2011; 32:611-22. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Ganjoo K, Jacobs C. Antiangiogenesis agents in the treatment of soft tissue sarcomas. Cancer 2010; 116:1177-83. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Garnis C, Davies JJ, Buys TP, et al. Chromosome 5p aberrations are early events in lung cancer: Implication of glial cell line-derived neurotrophic factor in disease progression. Oncogene 2005; 24:4806-12. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Gibault L, Pérot G, Chibon F, et al. New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics. J Pathol 2010; 223:64-71. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Gibault L, Ferreira C, Pérot G, et al. From PTEN loss of expression to RICTOR role in smooth muscle differentiation: complex involvement of the mTOR pathway in leiomyosarcomas and pleomorphic sarcomas. Mod Pathol 2012; 25:197-211. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Grossmann AH, Layfield LJ, Randall RL. Classification, molecular characterization, and the significance of pten alteration in leiomyosarcoma. Sarcoma 2012; 2012:380896. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997; 15:350-62. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Guillou L, Aurias A. Soft tissue sarcomas with complex genomic profiles. Virchows Arch 2010; 456:201-17. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Hallor KH, Sciot R, Staaf J, et al. Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. J Pathol 2009; 217:716-27. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Hasegawa T, Hasegawa F, Hirose T, et al. Expression of smooth muscle markers in so called malignant fibrous histiocytomas. J Clin Pathol 2003; 56:666-71. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Henderson SR, Guiliano D, Presneau N, et al. A molecular map of mesenchymal tumors. Genome Biol 2005; 6:R76. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Hernando E, Charytonowicz E, Dudas ME, et al. The AKT-mTOR pathway plays a critical role in the development ofleiomyosarcomas. Nat Med 2007; 13:748-53. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Hisaoka M, Tsuji S, Hashimoto H, et al. Dedifferentiated liposarcoma with an inflammatory malignant fibrous histiocytoma-like component presenting a leukemoid reaction. Pathol Int 1997; 47:642-6. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Hollowood K, Fletcher CD. Malignant fibrous histiocytoma: morphologic pattern or pathologic entity? Semin Diagn Pathol 1995; 12:210-20. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Hu J, Khanna V, Jones M, Surti U. Genomic alterations in uterine leiomyosarcomas: potential markers for clinical diagnosis and prognosis. Gen Chrom Cancer 2001; 31:117-24. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Hu J, Rao UN, Jasani S, Khanna V, Yaw K, Surti U. Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study. Cancer Genet Cytogenet 2005; 161:20-7. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Idbaih A, Coindre JM, Derré J, et al. Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest 2005; 85:176-81. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Ito M, Barys L, O'Reilly T, et al. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis. Clin Cancer Res 2011; 17:416-26. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin 2010; 60:277300. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Judson I. Targeted therapies in soft tissue sarcomas. Ann Oncol 2010; 21(Suppl 7):vii277-80. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Kawaguchi K, Oda Y, Saito T, et al. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis. J Pathol 2003; 201:487-95. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Kawaguchi K, Oda Y, Saito T, et al. Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma: promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression. Hum Pathol 2004; 35:1266-71. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Kempson RL, Kyriakos M: Fibroxanthoma of the soft tissues. A type of malignant ?brous histiocytoma. Cancer 1972; 29:961-76. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Kim S, Dodd RD, Mito JK, et al. Efficacy of phosphatidylinositol-3 kinase inhibitors in a primary mouse model of undifferentiated pleomorphic sarcoma. Sarcoma 2012; 2012:680708. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Konomoto T, Fukuda T, Hayashi K, Kumazawa J, Tsuneyoshi M. Leyomiosarcoma in soft tissue: examination of p53 status and cell proliferating factors in different locations. Human Pathol 1998; 29:74-81. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Konstantinopoulos PA, Fountzilas E, Goldsmith JD, et al. Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistance. PLoS One 2010; 5:e9747. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Kresse SH, Ohnstad HO, Bjerkehagen B, et al. DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation. PLoS One 2010; 5:e15378. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Kuhajda FP, Jenner K, Wood FD, et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A 1994; 91:6379-83. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Labrecque MP, Takhar MK, Hollingshead BD, Prefontaine GG, Perdew GH, Beischlag TV. Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines. PLoS One 2012; 7:e29545. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Lahat G, Dhuka AR, Lahat S, et al. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol 2009; 16:2579-86. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Lahat G, Zhang P, Zhu QS, et al. The expression of c-Met pathway components in unclassified pleomorphic sarcoma/ malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study. Histopathology 2011; 59:556-61. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Larramendy ML, Tarkkanen M, Blomqvist C, et al. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol 1997; 151:1153-61. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Larramendy ML, Kaur S, Svarvar C, Böhling T, Knuutila S. Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization. Cancer Genet Cytogenet 2006; 169:94-101. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Larramendy ML, Gentile M, Soloneski S, Knuutila S, Böhling T. Does comparative genomic hybridization reveal distinct differences in DNA copy number sequence patterns between leiomyosarcoma and malignant fibrous histiocytoma? Cancer Genet Cytogenet 2008; 187:1-11. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;Lee CH, Espinosa I, Vrijaldenhoven S, et al. Prognostic significance of macrophage infiltration in leiomyosarcomas. Clin Cancer Res 2008, 14:1423-30. ;
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Lee YF, John M, Edwards S, et al. Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling. Br J Cancer 2003; 88:510-5. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Lehnhardt M, Daigeler A, Homann HH, et al. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities – an analysis of 140 patients. Langenbecks Arch Surg 2009; 394:313-20. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Lemm D, Mugge LO, Mentzel T, et al: Current treatment options in dermato?brosarcoma protuberans. J Cancer Res Clin Oncol 2009;135:653-65. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Levy B, Mukherjee T, Hirschhorn K. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet Cytogenet 2000; 121:1-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Liu SL, Han Y, Zhang Y, et al. Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer. Target Oncol 2012; 7:135-43. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Louis-Brennetot C, Coindre JM, Ferreira C, Pérot G, Terrier P, Aurias A. The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis: an analysis of 104 tumors. Genes Chromosomes Cancer 2011; 50:896-907. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Luo J, Su F, Chen D, et al. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 2000; 408:377-81. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Luo X, Sharff KA, Chen J, He TC, Luu HH. S100A6 expression and function in human osteosarcoma. Clin Orthop Relat Res 2008; 466:2060-70. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Lupski JR. Structural variation in the human genome. N Engl J Med 2007; 356:1169-71. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Maeda T, Hashitani S, Zushi Y, et al. Establishment of a nude mouse transplan-table model of a human malignant fibrous histiocytoma of the mandible with high metastatic potential to the lung. J Cancer Res Clin Oncol 2008; 134:1005-11. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Maelandsmo GM, Berner JM, Florenes VA, et al. Homozygous deletion of the CDKN2 gene in human sarcomas: relationship to ampli?cation and mRNA levels of CDK4 and CCND1. Br J Cancer 1995; 72:393-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Mahalingam D, Mita A, Sankhala K, et al. Targeting sarcomas: novel biological agents and future perspectives. Curr Drug Targets 2009; 10:937-49. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Mairal A, Terrier P, Chibon F, Sastre X, Lecesne A, Aurias A. Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas. A comparative genomic hybridization analysis of a series of 30 cases. Cancer Genet Cytogenet 1999; 111:134-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Mairal A, Chibon F, Rousselet A, Couturier J, Terrier P, Aurias A. Establishment of a human malignant fibrous histiocytoma cell line, COMA. Characterization By conventional cytogenetics, comparative genomic hybridization, and multiplex fluorescence In situ hybridization. Cancer Genet Cytogenet 2000; 121:117-23. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Malfettone A, Silvestris N, Paradiso A, et al. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype. Exp Mol Pathol 2012; 92:296-303. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250:1233-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Manavathi B, Singh K, Kumar R. MTA family of coregulators in nuclear receptor biology and pathology. Nucl Recept Signal 2007; 5:e010. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Mangia A, Malfettone A, Saponaro C, et al. Human epidermal growth factor receptor 2, Na(+)/H(+) exchanger regulatory factor 1 and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers. Hum Pathol 2011; 42:1589-95. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Matushansky I, Hernando E, Socci ND, et al. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest 2007; 117:3248-57. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Mertens F, Fletcher CD, Dal Cin P, et al. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromos Morphlogy Genes Chromos Can 1998; 22:16-25. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Miettinen M, Fetsch JF Evaluation of biological potential of smooth muscle tumours. Histopathology 2006; 48:97-105. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Mills AM, Beck AH, Montgomery KD, et al. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry. Am J Surg Pathol 2011; 35:583-9. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;Mitelman F. Mitelman database of chromosome aberrations in cancer. Avaliable from: <URL:http://cgap.nci.nih.gov/Chromosomes/Mitelman> [2010 dez 12]. ;
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Muleris M, Almeida A, Gerbault-Seureau M, Malfoy B, Dutrillaux B. Identification of amplified DNA sequences in breast cancer and their organization within homogeneously staining regions. Genes Chromosomes Cancer 1995; 14:155-63. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Myllykangas S, Knuutila S. Manifestation, mechanisms and mysteries of gene ampli?cations. Cancer Lett 2006; 232:79-89. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Nakayama R, Nemoto T, Takahashi H, et al. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol 2007; 20:749-59. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Nascimento AF, Raut CP. Diagnosis and management of pleomorphic sarcomas (SoCalled ‘‘MFH’’) in adults. J Surg Oncol 2008; 97:330-9. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Nielsen GP, Burns KL, Rosenberg AE, Louis DN. CDKN2A gene deletions and loss of p16 expression occur in osteosarcoma that lack RB alterations. Am J Pathol 1998; 153:159-63. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Nielsen TO, West RB, Linn SC, et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 2002; 359:1301-7. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Nielsen TO, West RB. Translating gene expression into clinical care: sarcomas as a paradigm. J Clin Oncol 2010; 28:1796-805. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Nishio J, Iwasaki H, Ishiguro M, et al. Establishment of a new human malignant fibrous histiocytoma cell line, FU-MFH-1: cytogenetic characterization by comparative genomic hybridization and fluorescence in situ hybridization. Cancer Genet Cytogenet 2003; 144:44-51. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"O'brien JE, Stout AP. Malignant fibrous xanthomas. Cancer 1964; 17:1445-55. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Oda Y, Nakajima M, Mohri T, et al. Aryl hydrocarbon receptor nuclear translocator in human liver is regulated by miR-24. Toxicol Appl Pharmacol 2012; 1:260:22231. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Ognjanovic S, Olivier M, Bergemann TL, Hainaut P. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database. Cancer 2012; 118:1387-96. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Osuna D, de Alava E. Molecular pathology of sarcomas. Rev Recent Clin Trials 2009; 4:12-26. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Otaño-Joos M, Mechtersheimer G, Ohl S, et al. Detection of chromosomal imbalances in leiomyosarcoma by comparative genomic hybridization and interphase cytogenetics. Cytogenet Cell Genet 2000; 90:86-92. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Ozzello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 1963; 16:331-44. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Parente F, Grosgeorge J, Coindre JM, Terrier P, Vilain O, Turc-Carel C. Comparative genomic hybridization reveals novel chromosome deletions in 90 primary soft tissue tumors. Cancer Genet Cytogenet 1999; 115:89-95. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;Parenti R, Perris R, Vecchio GM, et al. Immunohistochemical expression of Wilms' tumor protein (WT1) in developing human epithelial and mesenchymal tissues. Acta Histochem 2012 Jun 4. [Epub ahead of print]. ;
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Patra SK. Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 2008; 1785:182-206. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Pawlak G, Helfman DM. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 2001; 11:41-7. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Pei Z, Fraisl P, Berger J, Jia Z, Forss-Petter S, Watkins PA. Mouse very long-chain Acyl-CoA synthetase 3/fatty acid transport protein 3 catalyzes fatty acid activation but not fatty acid transport in MA-10 cells. J Biol Chem 2004; 279:54454-62. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Pei Z, Sun P, Huang P, et al. Acyl-CoA synthetase VL3 knockdown inhibits human glioma cell proliferation and tumorigenicity. Cancer Res 2009; 69:9175-82. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;Pennacchioli E, Tosti G, Barberis M, et al. Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread? Clin Exp Metastasis 2012 Jun 15. [Epub ahead of print]. ;
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Pérot G, Derré J, Coindre JM, et al. Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas. Cancer Res 2009; 69:2269-78. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Pérot G, Chibon F, Montero A, et al. Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics. Am J Pathol 2010; 177:208090. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Picarda G, Lamoureux F, Geffroy L, et al. Preclinical evidence that use of TRAIL in Ewing’s sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival. Clin Cancer Res 2010; 16:2363-74. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma. Cancer Genet Cytogenet 2005; 161:1-19. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS. A census of amplified and overexpressed human cancer genes. Nat Rev Cancer 2010; 10:59-64. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Segal NH, Pavlidis P, Antonescu CR, et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol 2003; 163:691-700.";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;Setsu N, Kohashi K, Endo M, et al. Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis. Int J Cancer 2012 May 30. [Epub ahead of print] ;
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Sherr CJ. Cancer cell cycles. Science 1996; 274:1672-7.";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Shibata T, Chuma M, Kokubu A, Sakamoto M, Hirohashi S. EBP50, a betacateninassociating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 2003; 38:178-86. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Shlien A, Malkin D. Copy number variations and cancer. Genome Med 2009; 1:62. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Simons A, Schepens M, Jeuken J, et al. Frequent loss of 9p21 (p16(INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet 2000; 118:89-98. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Skubitz KM, D'Adamo DR. Sarcoma. Mayo Clin Proc 2007; 82:1409-32. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Skubitz KM, Pambuccian S, Manivel JC, Skubitz AP. Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors. J Transl Med 2008; 6:23. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Smith SH, Weiss SW, Jankowski SA, et al. SAS amplification in soft tissue sarcomas. Cancer Res 1992; 52:3746-9. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Sreekantaiah C. The cytogenetic and molecular characterization of benign and malignant soft tissue tumors. Cytogenet Cell Genet 1998; 82:13-29. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Steen S, Stephenson G. Current treatment of soft tissue sarcoma. Proc Bayl Univ Med Cent 2008; 21:392–6. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Subramanian S, Lui WO, Lee CH, et al. MicroRNA expression signature of human sarcomas. Oncogene 2008; 27:2015-26. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Szymanska J, Virolainen M, Tarkkanen M, et al. Overrepresentation of 1q21-23 and 12q13-21 in lipomalike liposarcomas but not in benign lipomas: A comparative genomic hybridization study. Cancer Genet Cytogenet 1997; 99:14-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Tarkkanen M, Larramendy ML, Böhling T, et al. Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and CMYC expression by immunohistochemistry. Eur J Cancer 2006; 42:1172-80. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Thompson FH, Nelson MA, Trent JM, et al. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Cancer Genet Cytogenet 1996; 87:55-62. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Thway K. Pathology of soft tissue sarcomas. Clin Oncol 2009; 21:695-705. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Toh Y, KuninakaS, Endo K, et al. Molecular analysis of a candidate metastasisassociated gene, MTA1: possible interaction with histone deacetylase 1. J Exp Clin Cancer Res 2000; 19:105-11. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Tolar J, Nauta AJ, Osborn MJ, et al. Sarcoma derived from cultured mesenchymal cells. Stem Cells 2007; 25:371-9. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Tsiatis AC, Herceg ME, Keedy VL, et al. Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma. Mod Pathol 2009; 22:1432-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Vasileios KA, Eward WC, Brigman BE. Surgical treatment and prognosis in patients with high-grade soft tissue malignant fibrous histiocytoma of the extremities. Arch Orthop Trauma Surg 2012; 132:955-61. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"van Unnik JA, Coindre JM, Contesso C, et al. Grading of soft tissue sarcomas: experience of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 1993; 29A:2089-93. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Verweij J, Casali P, Zalcberg J, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomized trial. Lancet 2004;364:112734. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Verweij J, Baker LH. Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrations. Eur J Cancer 2010; 46:863-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Wang CY, Wei Q, Han I, et al. Hedgehog and Notch signaling regulate self-renewal of undifferentiated pleomorphic sarcomas. Cancer Res 2012; 72:1013-22. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Wang R, Lu YJ, Fisher C, Bridge JA, Shipley J. Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer 2001; 31:54-64. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Wang R, Titley JC, Lu YJ, et al. Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Mod Pathol 2003; 16:778-85. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Wang S, Ren W, Liu J, et al. TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivo. Clin Cancer Res 2010; 16:2591-604. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Wang X, Yang Z, Zhang H, et al. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT. Biochim Biophys Acta 2008; 1783:1220-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Wardelmann E, Schildhaus HU, Merkelbach-Bruse S, et al. Soft tissue sarcoma: from molecular diagnosis to selection of treatment. Pathological diagnosis of soft tissue sarcoma amid molecular biology and targeted therapies. Ann Oncol 2010; 21:265-9. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Weiss SW, Enzinger FM: Malignant ?brous histiocytoma: An analysis of 200 cases. Cancer 1978; 41:2250-66. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Weissenbacher T, Kuhn C, Mayr D, et al. Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium. Anticancer Res 2011; 31:451-7. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Weng WH, Ahlén J, Lui WO, et al. Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis. Br J Cancer 2003; 89:720-6. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Weng WH, Wejde J, Ahlén J, et al. Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH. Cancer Genet Cytogenet 2004; 150:27-32. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Yamakuchi M, Lotterman CD, Bao C, et al. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci U S A 2010; 107:6334-9. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Yamamoto J, Ihara K, Nakayama H, et al. Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: organ-specific distribution and variable induction patterns in mononuclear cells. Life Sci 2004; 74:1039-49. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Yang D, Ylipaa A, Yang J, et al. An integrated study of aberrant gene copy number and gene expression in GIST and LMS. Technol Cancer Res Treat 2010; 9:171-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Yang J, Du X, Chen K, et al. Genetic aberrations in soft tissue leiomyosarcoma. Cancer Lett 2009; 275:1-8. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Yoo J, Lee HK, Kang CS, et al. p53 gene mutations and p53 protein expression in human soft tissue sarcomas. Arch Pathol Lab Med 1997; 121:395-9. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Zhai TL, Nikaido T, Orii A, Horiuchi A, Toki T, Fujii S. Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma. Gynecol Oncol 1999; 75:453-9. ";
FAP;2012;SARA MARTORELI DA SILVEIRA;Silvia Regina Rogatto;-x-xxxx;"Zheng M, Simon R, Mirlacher M, et al. TRIO ampli?cation and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Am J Pathol 2004; 165:63-9. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Agarwal JP, Mallick I, Bhutani R, et al. Prognostic factors in oropharyngeal cancer-analysis of 627 cases receiving definitive radiotherapy. Acta Oncol 2009; 48:102633. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Adelstein DJ, Lavertu P, Saxton JP, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV carcinoma of the head and neck. Cancer 2000; 88:87683. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;Barata LF, de Carvalho GB, Carrara-de Angelis E, de Faria JC, Kowalski LP. Swallowing, speech and quality of life in patients undergoing resection of soft palate. Eur Arch Otorhinolaringol 2012 Apr 22. [Epub ahead of print]. ;
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;Boyle P, Levin B. World Cancer Report 2008: global cancer control. Available from: <URL:http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/wcr_2008_. pdf> [2012 maio 12] ;
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Brizel DM, Albers ME, Fisher SR, et al. Hyperfractioned irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338:1798-804. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91:2081-6. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005; 114:806-16.";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Carvalho MB, Kowalski LP, Andrade Sobrinho J, et al. Exclusive radiotherapy and radiotherapy-intra-arterial chemotherapy combination in the treatment of advanced cancer of the oropharynx: retrospective study of 126 cases. Rev Laryngol Otol Rhinol (Bord) 1986; 107:119-25. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Chen AY, Schrag N, Hao Y, Stewart A, Ward E. Changes in treatment of advanced oropharyngeal cancer. Laryngoscope 2007; 117:16-21. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Cosmidis A, Rame JP, Dassonville O, et al. T1-T2 N0 oropharyngeal cancers treated with surgery alone. A GETTEC study. Eur Arch Otorhinolaryngol 2004; 261:27681. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Denis F, Garaud P, Bardet E, et al. Final results of the french head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004; 22:69-76. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Denittis AS, Machtay M, Rosenthal DI, et al. Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment. Am J Otolaryngol 2001; 22:329-35. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001; 345:1890-900. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Franco EL, Kowalski LP, Oliveira BV, et al. Risk factors for oral cancer in Brazil: a case control study. Int J Cancer 1989; 43:992-1000. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Franco EL, Kowalski LP, Kanda JL. Risk factors for second cancers of the upper respiratory and digestive systems: a case-control study. J Clin Epidemiol 1991; 44:615-25. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Franzi SA. Fatores prognósticos clínicos, histológicos, terapêuticos e biomarcadores em carcinoma epidermóide de região tonsilar. São Paulo; 2002. [Tese de Doutorado-Faculdade de Medicina da Universidade de São Paulo] ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Foote RL, Olsen KD, Davis DL, et al. Base of tongue carcinoma: patterns of failure and predictors of recurrence after surgery alone. Head Neck 1993; 15:300-7. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 2000; 11:489-95. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Galati LT, Myers EN, Johnson JT. Primary surgery as treatment for early squamous cell carcinoma of the tonsil. Head Neck 2000; 22:294-6. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Genden EM, Ferlito A, Scully C, Shaha AR, Higgins K, Rinaldo A. Current management of tonsillar cancer. Oral Oncology 2003; 39:337-42. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Genden EM, Park R, Smith Claris, Kotz T. The role of reconstruction for transoral robotic pharyngectomy and concomitant neck dissection. Arch Otolaryngol Head Neck Surg 2011; 137:151-6. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Gillison ML, Forastiere AA. Larynx preservation in head and neck cancers. A discussion of the National Comprehensive Cancer Network Practice Guidelines. Hematol Oncol Clin North Am 1999; 13:699-718. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Góis Filho JF. Tratamento cirúrgico do câncer da região tonsilar. Sao Paulo; 1993. [Dissertaçao de Mestrado-Complexo Hospitalar Heliópolis]. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Góis Filho JF, Rapoport A. Tratamento cirúrgico do carcinoma espinocelular da regiäo tonsilar. Rev Col Bras Cir 1995; 22:83-8. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Gourin CG, Johnson JT. Surgical treatment of squamous cell carcinoma of the base of tongue. Head Neck 2001; 23:653-60. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Hart AA, Mak-Kregar S, Hilgers FJ, et al. The importance of correct stage grouping in oncology. Results of a nationwide study of oropharyngeal carcinoma in The Netherlands. Cancer 1995; 75:2656-62. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Hockstein NG, Nolan JP, O’Malley BW Jr, Woo YJ. Robot-assisted pharyngeal and laryngeal microsurgery: results of robotic cadaver dissections. Laryngoscope 2005; 115:1003-8. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Jemal S, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56:106-30. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Jones AS, Fenton JE, Husband DJ. The treatment of squamous cell carcinoma of the tonsil with neck node metastasis. Head Neck 2003; 25:24-31. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Klug C, Wutzl A, Kermer C, et al. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients. Int J Oral Maxillofac Surg 2005; 34:143-8. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Klussmann JP, Weissenborn SJ, Wieland U, et al. Human papillomavirus-positive tonsillar carcinomas a different tumor entity. Med Microbiol Immunol 2003; 192:129-32. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Kofler B, Uecker FC, Muenscher A, Knecht R. New aspects of HPV-positive head and neck cancer: Highlights from the 2011 ASCO Congress. HNO 2012; 60:404-7. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Lim YC, Hong HJ, Baek SJ, et al. Combined surgery and postoperative radiotherapy for oropharyngeal squamous cell carcinoma in Korea: analysis of 110 cases. Int J Oral Maxillofac Surg 2008; 37:1099-105. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Machtay M, Perch S, Markiewicz D, et al. Combined surgery and postoperative radiotherapy for carcinoma of the base of tongue: analysis of treatment outcome and prognosis value of margin status. Head Neck 1997; 19:494-9. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Magrin J, Kowalski LP, Saboia M, Saboia RP. Major glossectomy: end results of 106 cases. Eur J Cancer B Oral Oncol 1996; 32B:407-12. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Mak-Kregar S, Hilgers FJ, Levendag PC, et al. Disease-specific survival and locoregional control in tonsillar carcinoma. Clin Otolaryngol Allied Sci 1996; 21:550-6. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Mendenhall WM, Stringer SP, Amdur RJ, Hinerman RW, Moore-Higgs GJ, Cassini NJ. Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue? J Clin Oncol 2000; 18:35-42.  ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2012 Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2011. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Moncrieff M, Sandilla J, Clark J, et al. Outcomes of primary surgical treatment of T1 and T2 of the oropharynx. Laryngoscope 2009; 119:307-11. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Moore EJ, Henstrom DK, Olsen KD, Kasperbauer JL, McGree ME. Transoral resection of tonsillar squamous cell carcinoma. Laryngoscope 2009; 119:508-15. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viralinduced carcinoma? Int J Cancer 2009; 125:362-366. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Netscher DT, Meade RA, Goodman CM, Alford EL, Stewart MG. Quality of life and disease-specific functional status following microvascular reconstruction for advanced oropharyngeal cancers. Plast Reconst Surg 2000; 105:1628-34. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Nijdam W, Levendag P, Noever I, Groot CU, Agthoven M. Cancer in the oropharynx: cost calculation of different modalities for controlled primaries, relapses and grade III/IV complications. Radiother Oncol 2005; 77:65-72.  ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.  ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 2002; 94:2967-80. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Pedruzzi PAG, Kowalski LP, Nishimoto IN, Oliveira BV, Tironi F, Ramos GH. Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy. Arch Otolaryngol Head Neck Surg 2008; 134:1196-204. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Pignat JC, Poupart M, Cosmidis A. Tumeurs T1 T2 N0 de l’oropharynx opérées sans radiothérapie complémentaire: à propos de 19 pacientes de 1995 à 2000. In: de Montreuil BC, editor. Cancers de l’oropharynx. Paris: Éditions EDK; 2002. p.1136.";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Perez CA, Patel MM, Chao KS, et al. Carcinoma of the tonsilar fossa: prognostic factors and long-term therapy outcome. Int J Radiat Oncol Biol Phys 1998; 42:1077-84. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Poulsen M, Porceddu SV, Kingsley PA, Tripcony L, Coman W. Locally advanced tonsillar squamous cell carcinoma: treatment approach revisited. Laryngoscope 2007; 117:45-50. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Preuss SF, Dinh V, Klussmann JP, Semrau R, Mueller R, Guntinas-Lichius O. Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience. Oral Oncol 2007a; 43:402-7. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Preuss SF, Quante G, Semrau R, Mueller R, Klussmann JP, Guntinas-Lichius O. An analysis of surgical complications, morbidity, and cost calculation in pacientes undergoing multimodal treatment for operable oropharyngeal carcinoma. Laryngoscope 2007b; 117:101-5. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Reddy AN, Eisele DW, Forastiere AA, Lee DJ, Westra WH, Califano JA. Neck dissection followed by radiotherapy or chemoradiotherapy for small primary oropharynx carcinoma with cervical metastasis. Laryngoscope 2005; 115:1196-200. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Röösli C, Tschudi DC, Studer G, Braun J, Stoeckli SJ. Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx. Laryngoscope 2009; 119:534-40. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Sapundzhiev NR, Barth PJ, Vacha P, et al. Effectiveness of radiochemotherapy on lymph node metastases in patients with stage IV oropharyngeal cancer. Oral Oncol 2004; 40:1007-16. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Seikaly H, Rieger JM, Wolfaardt J, Moysa G, Harris JR, Jha N. Functional outcomes after primary oropharyngeal cancer resection and reconstruction with the radial forearm free flap. J Otolaryngol Head Neck Surg 2003; 113:897-904. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 2004; 59:743-51. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Sessions DG, Lenox J, Spector GJ, Chao C, Chaudry OA. Analysis of treatment results for base of tongue cancer. Laryngoscope 2003; 113:1252-61. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2001; 61:212-36. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Sobin LH, Wittekind C. TNM Classificação de tumors malignos. [Trad. de Eisenberg ALM]. 6ª ed. Rio de Janeiro: INCA; 2004. Faringe; p.29-37. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Spiro JD, Spiro RH. Carcinoma of the tonsillar fossa. Arch Otolaryngol Head Neck Surg 1989; 115:1186-9. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Spring PM, Valentino J, Arnold SM et al. Long term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma. Cancer 2005; 104:1765-71. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;[STATA] Data Analysis and Statistical Software. StataCorp. 2007. Stata Statistical Software: Release 10. College Station, TX: StataCorp LP. Available from: <URL:http://www.stata.com> [2012 maio 12] ;
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Su CK, Bhattacharya J, Wang CC. Role of neck surgery in conjunction with radiation in regional control of node-positive cancer of the oropharynx. Am J Clin Oncol 2002; 25:109-16. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004; 57:449-55.  ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005; 32(Suppl 1):S59-66. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66:253-6. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Tschudi D, Stoeckli S, Schmid S. Quality of life after different treatment modalities for carcinoma of the oropharynx. Laryngoscope 2003; 113:1949-54. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Vartanian JG, Kowalski LP. Acceptance of major surgical procedures and quality of life among long-term survivors of advanced Head and Neck cancer. Arch Otolaryngol Head Neck Surg 2009; 135:376-9. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Vartanian JG, Magrin J, Kowalski LP. Total glossectomy in the organ preservation era. Curr Opin Otolaryngol Head Neck Surg 2010; 18:95-100. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Walvekar RR, Li RJ, Gooding WE, et al. Role of surgery in limited (T1-2, N0-1) cancers of the oropharynx. Laryngoscope 2008; 118:2129-34. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Weinstein GS, O’Malley BW, Cohen MA, Quon H. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2010; 136:1079-85. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998; 16:1318-24. ";
FAP;2012;TÂNIA REGINA BASTOS DE SOUZA;Luiz paulo Kowalski;Marcos Brasílio de Carvalho;"Zelefsky MJ, Harrison LB, Armstrong JG. Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma. Cancer 1992; 70:2388-95. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Abner AL, Recht A, Vicini FA, et al. Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1991; 21:331-8. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Acea Nebril B. ""Scarless"" surgery in the treatment of breast cancer. Cir Esp 2010; 87:210-7. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Acea-Nebril B, López S, Cereijo C, et al. Impact of conservative oncoplastic techniques in a surgery program for women with breast cancer. Cir Esp 2005; 78:175-82. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"[ACS] American Cancer Society. Cancer facts and figures 2012. Atlanta: American Cancer Society; 2012. Available from: <URL:http://www.cancer.org/acs/groups/content/@epidemiologysurvei lance/documents/document/acspc-031941.pdf> [2012 maio 10]. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Andrews JM, Yshizuki MM, Martins DM, Ramos RR. An areolar approach to reduction mammaplasty. Br J Plast Surg 1975; 28:16670. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Arenas M, Sabater S, Hernández V, et al. Cosmetic outcome of breast conservative treatment for early stage breast cancer. Clin Transl Oncol 2006; 8:334-8. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Arendt LM, Rudnick JA, Keller PJ, Kuperwasser C. Stroma in breast development and disease. Semin Cell Dev Biol 2010; 21:11-8. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Asgeirsson KS, Rasheed T, McCulley SJ, Macmillan RD. Oncological and cosmetic outcomes of oncoplastic breast conserving surgery. Eur J Surg Oncol 2005; 31:817-23. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Bajaj AK, Kon PS, Oberg KC, Miles DA. Aesthetic outcomes in patients undergoing breast conservation therapy for the treatment of localized breast cancer. Plast Reconstr Surg 2004; 114:1442-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Baldwin LM, Taplin SH, Friedman H, Moe R. Access to multidisciplinary cancer care: is it linked to the use of breastconserving surgery with radiation for early-stage breast carcinoma? Cancer 2004; 100:701-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Barnett GC, Wilkinson JS, Moody AM, et al. Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years. Int J Radiat Oncol Biol Phys 2012; 82:715-23. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Barry M, Kell MR. Re-evaluating the role of axillary lymph node dissection in screen-detected breast cancer patients. Breast 2012; 21:58-60. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Bartelink H. Commentary on the paper ""A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated"". A critical review of an innovative approach. Eur J Cancer 2001; 37:2143-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Bayerl A, Frank D, Lenz A, et al. [Local tumor control and cosmetic outcome following breast-conserving surgery and radiation up to a total dose of 56 Gy without boost in breast cancer]. Strahlenther Onkol 2001; 177:25-32. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Beal K, McCormick B, Zelefsky MJ, et al. Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results. Int J Radiat Oncol Biol Phys 2007; 69:19-24. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Behranwala KA, Dua RS, Ross GM, Ward A, A'hern R, Gui GP. The influence of radiotherapy on capsule formation and aesthetic outcome after immediate breast reconstruction using biodimensional anatomical expander implants. J Plast Reconstr Aesthet Surg 2006; 59:104351.";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Benelli L. A new periareolar mammaplasty: the ""round block"" technique. Aesthetic Plast Surg 1990; 14:93-100. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Benoit L, Franceschini C, Margarot A, Arnould L, Fraisse J, Cuisenier J. [Conservative surgery in breast cancer: combination skin incision for a better cosmetic result]. Ann Chir 2004; 129:310-2. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Blais JG, Grondin J. The influence of labels associated with anchor points of Likert-type response scales in survey questionnaires. J Appl Meas 2011; 12:370-86. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Blichert-Toft M, Nielsen M, Düring M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 2008; 47:672-81. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Boyages J, Barraclough B, Middledorp J, Gorman D, Langlands AO. Early breast cancer: cosmetic and functional results after treatment by conservative techniques. Aust N Z J Surg 1988; 58:111-21. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Boyle P, Levin B. World Cancer report, 2008. Lyon: IARC; 2009. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Bustos RA. Periareolar mammaplasty technique with silicone supporting sheeting. Plast Reconstr Surg 1993; 91:1173-4. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Calvo FA, Meirino RM, Orecchia R. Intraoperative radiation therapy part 2. Clinical results. Crit Rev Oncol Hematol 2006; 59:116-27. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Cardoso MJ, Cardoso JS, Wild T, Krois W, Fitzal F. Comparing two objective methods for the aesthetic evaluation of breast cancer conservative treatment. Breast Cancer Res Treat 2009; 116:149-52. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Cardoso MJ, Cardoso J, Santos AC, et al. Factors determining esthetic outcome after breast cancer conservative treatment. Breast J 2007; 13:140-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Cetinta? SK, Ozkan L, Kurt M, et al. Factors influencing cosmetic results after breast conserving management (Turkish experience). Breast 2002; 11:72-80. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Chen PY, Vicini FA. Partial breast irradiation. Patient selection, guidelines for treatment, and current results. Front Radiat Ther Oncol 2007; 40:253-71. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Chen Y, Trotti A, Coleman CN, et al. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation. Int J Radiat Oncol Biol Phys 2006; 64:1442-51. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Chin MS, Brooks GS, Stueber K, Hadaegh A, Griggs J, Johnson MA. Asymmetry correction in the irradiated breast: outcomes of reduction mammaplasty and mastopexy after breast-conserving therapy. Aesthet Surg J 2009; 29:106-12. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Ciocca M, Pedroli G, Orecchia R, et al. Radiation survey around a Liac mobile electron linear accelerator for intraoperative radiation therapy. J Appl Clin Med Phys 2009; 10:2950. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Clough KB, Soussaline M, Campana F, Salmon RJ. [Mammoplasty combined with irradiation: conservative treatment of breast cancer localized in the lower quadrant]. Ann Chir Plast Esthet 1990; 35:11722.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Clough KB, Baruch J. [Plastic surgery and conservative treatment of breast cancer. Indications and results]. Ann Chir Plast Esthet 1992; 37:682-92. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Clough KB, Nos C, Salmon RJ, Soussaline M, Durand JC. Conservative treatment of breast cancers by mammaplasty and irradiation: a new approach to lower quadrant tumors. Plast Reconstr Surg 1995; 96:363-70. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Clough KB, Cuminet J, Fitoussi A, Nos C, Mosseri V. Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction. Ann Plast Surg 1998; 41:471-81. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Clough KB, Lewis JS, Couturaud B, Fitoussi A, Nos C, Falcou MC. Oncoplastic techniques allow extensive resections for breastconserving therapy of breast carcinomas. Ann Surg 2003; 237:26-34. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Clough KB, Thomas SS, Fitoussi AD, Couturaud B, Reyal F, Falcou MC. Reconstruction after conservative treatment for breast cancer: cosmetic sequelae classification revisited. Plast Reconstr Surg 2004; 114:1743-53. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Clough KB, Nos C, Fitoussi A, Couturaud B, Inguenault C, Sarfati I. [Partial reconstruction after conservative treatment for breast cancer: classification of sequelae and treatment options]. Ann Chir Plast Esthet 2008; 53:88-101. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Cordeiro PG, Pusic AL, Disa JJ, McCormick B, VanZee K. Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg 2004; 113:877-81. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Cordeiro PG. Breast reconstruction after surgery for breast cancer. N Engl J Med 2008; 359:1590-601. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Cuttino LW, Keisch M, Jenrette JM, et al. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results. Int J Radiat Oncol Biol Phys 2008; 71:107-14. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;D'Angelo-Donovan DD, Dickson-Witmer D, Petrelli NJ. Sentinel lymph node biopsy in breast cancer: A history and current clinical recommendations. Surg Oncol 2012 Jan 9. [Epub ahead of print]. ;
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Della Sala SW, Pellegrini M, Bernardi D, et al. Mammographic and ultrasonographic comparison between intraoperative radiotherapy (IORT) and conventional external radiotherapy (RT) in limited-stage breast cancer, conservatively treated. Eur J Radiol 2006; 59:222-30. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Dessena M, Dessi M, Demontis B, et al. [Exclusive intra-operative radiation therapy (IORT) for early stage breast cancer: pilot study of feasibility]. G Chir 2011; 32:104-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Deutinger M, Tairych G, Resch A, Biber E. [Contour defects after breast preserving therapy of breast carcinoma. Primary and secondary possibilities of correction]. Strahlenther Onkol 1999; 175:577-82. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Dewar JA, Arriagada R, Benhamou S, et al. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 19701982). IGR Breast Cancer Group. Cancer 1995; 76:2260-5. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Dewar JA, Benhamou S, Benhamou E, et al. Cosmetic results following lumpectomy, axillary dissection and radiotherapy for small breast cancers. Radiother Oncol 1988; 12:273-80. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Dian D, Schwenn K, Mylonas I, Janni W, Jaenicke F, Friese K. Aesthetic result among breast cancer patients undergoing autologous breast reconstruction versus breast conserving therapy. Arch Gynecol Obstet 2007; 275:445-50. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Dubois JB, Hay M, Gely S, Saint-Aubert B, Rouanet P, Pujol H. IORT in breast carcinomas. Front Radiat Ther Oncol 1997; 31:131-7. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Dutra AK, Sabino Neto M, Garcia EB, et al. Patients' satisfaction with immediate breast reconstruction with a latissimus dorsi musculocutaneous flap. J Plast Surg Hand Surg 2012; 46:349-53. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Dutra AK, Andrade WP, Carvalho SM, et al. Immediate breast reconstruction using autologous skin graft associated with breast implant. J Plast Reconstr Aesthet Surg 2012; 65:187-94. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347:1233-41. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Fitzal F, Krois W, Trischler H, et al. The use of a breast symmetry index for objective evaluation of breast cosmesis. Breast 2007; 16:429-35. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Fitzpatrick R, Jenkinson C, Klassen A, Goodacre T. Methods of assessing health-related quality of life and outcome for plastic surgery. Br J Plast Surg 1999; 52:251-5. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;Fougo JL, Reis P, Giesteira L, Dias T, Araújo C, Dinis-Ribeiro M. The impact of the sentinel node concept on the aesthetic outcome of breast cancer conservative surgery. Breast Cancer 2012 Mar 31. [Epub ahead of print]. ;
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Franceschini G, Terribile D, Magno S, et al. Conservative treatment of the central breast cancer with nipple-areolar resection: an alternative oncoplastic technique. G Chir 2008; 29:23-7. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Frasson AL, Zerwes FP, Braga AP, Barbosa FS, Koch HA. Intraoperative radiotherapy in the conventional linear accelerator room for early breast cancer treatment: an alternative choice in developing countries. J Exp Clin Cancer Res 2007; 26:379-84. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Frazier RC, Kestin LL, Kini V, et al. Impact of boost technique on outcome in early-stage breast cancer patients treated with breastconserving therapy. Am J Clin Oncol 2001; 24:26-32. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Garusi C, Petit JY, Rietjens M, Lanfrey E. [Role of plastic surgery in the conservative treatment of breast cancer]. Ann Chir Plast Esthet 1997; 42:168-76. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Gatzemeier W, Orecchia R, Gatti G, Intra M, Veronesi U. [Intraoperative radiotherapy (IORT) in treatment of breast carcinoma-a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand]. Strahlenther Onkol 2001; 177:330-7. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Glück S, Mamounas T. Improving outcomes in early-stage breast cancer. Oncology (Williston Park) 2010; 24(Suppl 4):1-15. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Goyal S, Kearney T, Haffty BG. Current application and research directions for partial-breast irradiation. Oncology (Williston Park) 2007; 21:449-61; discussion 461-2, 464, 470. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Gray JR, McCormick B, Cox L, Yahalom J. Primary breast irradiation in large-breasted or heavy women: analysis of cosmetic outcome. Int J Radiat Oncol Biol Phys 1991; 21:347-54. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Gómez-Iturriaga A, Moreno Jiménez M, Martínez-Monge R. [Radiotherapy in breast cancer: standards and new directions, accelerated partial breast irradiation]. Rev Med Univ Navarra 2008; 52:25-36. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Hardee ME, Raza S, Becker SJ, et al. Prone hypofractionated wholebreast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique. Int J Radiat Oncol Biol Phys 2012; 82:e415-23. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Heil J, Dahlkamp J, Golatta M, et al. Aesthetics in breast conserving therapy: do objectively measured results match patients' evaluations? Ann Surg Oncol 2011; 18:134-8. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Holmberg L, Zarén E, Adami HO, Bergström R, Burns T. The patient's appraisal of the cosmetic result of segmental mastectomy in benign and malignant breast disease. Ann Surg 1988; 207:189-94. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Holmes DR, Baum M, Joseph D. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). Am J Surg 2007; 194:507-10. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;Immink JM, Putter H, Bartelink H, et al. Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial. Ann Oncol 2012 Apr 12. [Epub ahead of print]. ;
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Intra M, Luini A, Gatti G, et al. Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 procedures. Surgery 2006; 140:467-71. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Jacobsen PB, Donovan KA, Small BJ, Jim HS, Munster PN, Andrykowski MA. Fatigue after treatment for early stage breast cancer: a controlled comparison. Cancer 2007; 110:1851-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Kacsó G, Fekete Z. Adjuvant partial breast radiotherapy for early breast cancer--ready for a change? J BUON 2008; 13:169-75. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Kao RT, Hall J, Engel L, Stern R. The matrix of human breast tumor cells is mitogenic for fibroblasts. Am J Pathol 1984; 115:109-16. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Kelemen G, Varga Z, Lázár G, Thurzó L, Kahán Z. Cosmetic outcome 1-5 years after breast conservative surgery, irradiation and systemic therapy. Pathol Oncol Res 2012; 18:421-7. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Kraus-Tiefenbacher U, Bauer L, Scheda A, et al. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. Int J Radiat Oncol Biol Phys 2006; 66:377-81. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Kronowitz SJ, Hunt KK, Kuerer HM, et al. Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy. Plast Reconstr Surg 2007; 120:1755-68. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Kronowitz SJ, Robb GL. Radiation therapy and breast reconstruction: a critical review of the literature. Plast Reconstr Surg 2009; 124:395408.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Kuerer HM, Julian TB, Strom EA, et al. Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg 2004; 239:338-51. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Lanfrey E, Rietjens M, Garusi C, Petit JY. [Mammoplasty for symmetry of the contralateral breast and its oncologic value]. Ann Chir Plast Esthet 1997; 42:160-7. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Laxenaire A, Barreau-Pouhaer L, Arriagada R, Petit JY. [Role of immediate reduction mammaplasty and mammapexy in the conservative treatment of breast cancers]. Ann Chir Plast Esthet 1995; 40:83-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Lemanski C, Azria D, Gourgon-Bourgade S, et al. Intraoperative radiotherapy in early-stage breast cancer: results of the montpellier phase II trial. Int J Radiat Oncol Biol Phys 2010; 76:698-703. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Lemanski C, Azria D, Thezenas S, et al. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results. Int J Radiat Oncol Biol Phys 2006; 64:1410-5. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Leonardi MC, Maisonneuve P, Mastropasqua MG, et al. How Do the ASTRO Consensus Statement Guidelines for the Application of Accelerated Partial Breast Irradiation Fit Intraoperative Radiotherapy? A Retrospective Analysis of Patients Treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys 2012; 83:806-13. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Lipa JE, Qiu W, Huang N, Alman BA, Pang CY. Pathogenesis of radiation-induced capsular contracture in tissue expander and implant breast reconstruction. Plast Reconstr Surg 2010; 125:437-45. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Luini A, Gatti G, Zurrida S, et al. The evolution of the conservative approach to breast cancer. Breast 2007; 16:120-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Luini A, Orecchia R, Gatti G, et al. The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat 2005; 93:55-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"MacDonald SM, Taghian AG. Partial-breast irradiation: towards a replacement for whole-breast irradiation? Expert Rev Anticancer Ther 2007; 7:123-34. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Maessen D, Flentje M, Weischedel U. [Cosmetic results of breast conserving therapy for breast carcinoma. Treatment results from the Heidelberg Radiation Clinic in the years 1984 to 1992]. Strahlenther Onkol 1998; 174:251-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Mai GT, Choo E, Yang JL, et al. Regional radiotherapy may improve outcomes in patients with early stage breast cancer undergoing breast conservation therapy. Anticancer Res 2007; 27:647-52. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Majewski JM, Lopes AD, Davoglio T, Leite JC. [Quality of life of women recovering from breast cancer after being subjected to mastectomies compared with those who had conservative surgery: a review of the literature]. Cien Saude Colet 2012; 17:707-16. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Mariani L, Salvadori B, Marubini E, et al. Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer. Eur J Cancer 1998; 34:1156-62. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Merchant TE, McCormick B, Yahalom J, Borgen P.The influence of older age on breast cancer treatment decisions and outcome. Int J Radiat Oncol Biol Phys 1996; 34:565-70. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Merrick HW 3rd, Battle JA, Padgett BJ, Dobelbower RR Jr. IORT for early breast cancer: a report on long-term results. Front Radiat Ther Oncol 1997; 31:126-30. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Ministério da Saúde. Instituto Nacional do Câncer. Estimativa/2012 incidência de câncer no Brasil. Rio de Janeiro: INCA; 2011. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Mitov FS, Molov VV. Breast-conserving surgery in early-stage breast cancer (indications, local recurrences, survival, cosmetic results). Folia Med 2006; 48:23-30. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Mitsumori M, Hiraoka M. Current status of accelerated partial breast irradiation. Breast Cancer 2008; 15:101-7. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Moore-Higgs GJ. Radiation options for early stage breast cancer. Semin Oncol Nurs 2006; 22:233-41. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Moro G, Stasi M, Borca VC. Does concomitant chemoradiotherapy influence cosmetic outcome in conservative treatment of breast cancer? Tumori 1997; 83:743-7. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Moro G, Ciambellotti E. Evaluation of the esthetic results of conservative treatment of breast cancer. Tumori 1993; 79:258-61.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Mosahebi A, Ramakrishnan V, Gittos M, Collier J. Aesthetic outcome of different techniques of reconstruction following nipple-areolapreserving envelope mastectomy with immediate reconstruction. Plast Reconstr Surg 2007; 119:796-803. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Moyer HR, Carlson GW, Styblo TM, Losken A. Three-dimensional digital evaluation of breast symmetry after breast conservation therapy. J Am Coll Surg 2008; 207:227-32. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Munhoz AM, Filassi JR, Aldrighi C, et al. Bilateral reduction mammaplasty for immediate breast conservation surgery reconstruction and intraoperative radiotherapy: a preliminary report. Aesthetic Plast Surg 2007; 31:94-100.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Munshi A, Kakkar S, Bhutani R, Jalali R, Budrukkar A, Dinshaw KA. Factors influencing cosmetic outcome in breast conservation. Clin Oncol 2009; 21:285-93. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Mussari S, Sabino Della Sala W, Busana L, et al. Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol 2006; 182:589-95. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Nahabedian MY. Managing the opposite breast: contralateral symmetry procedures. Cancer J 2008; 14:258-63. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Nairz O, Deutschmann H, Kopp M, et al. A dosimetric comparison of IORT techniques in limited-stage breast cancer. Strahlenther Onkol 2006; 182:342-8.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Noguchi M, Saito Y, Mizukami Y, et al. Breast deformity, its correction, and assessment of breast conserving surgery. Breast Cancer Res Treat 1991; 18:111-8. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Nos C, Fitoussi A, Bourgeois D, Fourquet A, Salmon RJ, Clough KB. Conservative treatment of lower pole breast cancers by bilateral mammoplasty and radiotherapy. Eur J Surg Oncol 1998; 24:508-14. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Oliver M, Chen J, Wong E, Van Dyk J, Perera F. A treatment planning study comparing whole breast radiation therapy against conformal, IMRT and tomotherapy for accelerated partial breast irradiation. Radiother Oncol 2007; 82:317-23. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Olivotto IA, Rose MA, Osteen RT, et al. Late cosmetic outcome after conservative surgery and radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys 1989; 17:747-53. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Ollila DW, Klauber-DeMore N, Tesche LJ, et al. Feasibility of breast preserving therapy with single fraction in situ radiotherapy delivered intraoperatively. Ann Surg Oncol 2007; 14:660-9.";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Orecchia R, Ciocca M, Lazzari R, et al. Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast 2003; 12:483-90. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Orecchia R, Ciocca M, Tosi G, Franzetti S, Luini A, Gatti G, Veronesi U. Intraoperative electron beam radiotherapy (ELIOT) to the breast: a need for a quality assurance programme. Breast 2005; 14:541-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Orecchia R, Leonardo MC. Intraoperative radiation therapy: is it a standard now? Breast 2011; 20 Suppl 3:S111-5. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;Orecchia R. Results of seven year intraoperative radiation therapy trial. Avaliable from: <URL:http://ecancer.org/tv/conference/140/1329 /video> [2012 jul 12] ;
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Paganelli G, Ferrari M, Cremonesi M, et al. IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation. Breast 2007; 16:17-26.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Passage KJ, McCarthy NJ. Critical review of the management of earlystage breast cancer in elderly women. Intern Med J 2007; 37:181-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Pearl RM, Wisnicki J. Breast reconstruction following lumpectomy and irradiation. Plast Reconstr Surg 1985; 76:83-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Petit JY, Lehmann A, Margulis A, Rigaut L. Technics of plastic surgery of the breast in breast cancerology. Ann Chir Plast 1982; 27:45-51. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Petit JY, Rigaut L, Zekri A, Le M. Poor esthetic results after conservative treatment of breast cancer. Technics of partial breast reconstruction. Ann Chir Plast Esthet 1989; 34:103-8.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Petit JY, Lehmann A. Role of plastic surgery in the treatment of breast cancer. Bull Acad Natl Med 1996; 180:317-28; discussion 328-31. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Petit JY, Rietjens M, Contesso G, Bertin F, Gilles R. Contralateral mastoplasty for breast reconstruction: a good opportunity for glandular exploration and occult carcinomas diagnosis. Ann Surg Oncol 1997; 4:511-5. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Petit JY, Rietjens M, Garusi C, Greuze M, Perry C. Integration of plastic surgery in the course of breast-conserving surgery for cancer to improve cosmetic results and radicality of tumor excision. Recent Results Cancer Res 1998; 152:202-11. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Petit JY, De Lorenzi F, Rietjens M, et al. Technical tricks to improve the cosmetic results of breast-conserving treatment. Breast 2007; 16:13-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Pitanguy I. Evaluation of body contouring surgery today: a 30-year perspective. Plast Reconstr Surg 2000; 105:1499-516. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Polgár C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 2007; 69:694-702.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;R Development Core Team. R: A language and environment for statistical computing. 2009. Avaliable from: <URL:http://www.Rproject.org.> [2012 jul 25] ;
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Regnault P. Breast ptosis. Definition and treatment. Clin Plast Surg 1976; 3:193-203. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Reitsamer R, Peintinger F, Sedlmayer F, et al. Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients. Eur J Cancer 2002; 38:1607-10. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Reitsamer R, Sedlmayer F, Kopp M, et al. Concepts and techniques of intraoperative radiotherapy (IORT) for breast cancer. Breast Cancer 2008; 15:40-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Rietjens M, Urban CA, Rey PC, et al. Long-term oncological results of breast conservative treatment with oncoplastic surgery. Breast 2007; 16:387-95.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Rietjens M, De Lorenzi F, Veronesi P, et al. Breast conservative treatment in association with implant augmentation and intraoperative radiotherapy. J Plast Reconstr Aesthet Surg 2006; 59:532-5. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Roelstraete A, Van Lancker M, De Schryver A, Storme G. Adjuvant radiation after conservative surgery for early breast cancer. Local control and cosmetic outcome. Am J Clin Oncol 1993; 16:284-90. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;[RTOG] Radiation Therapy Oncology Group. Acute radiation morbidity scoring criteria. Available from: <URL:http://www.rtog.org/ResearchAssociates/AdverseEventReportin g/AcuteRadiationMorbidityScoringCriteria.aspx> [2012 maio 12]. ;
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Ruano-Ravina A, Cantero-Muñoz P, Eraso Urién A. Efficacy and safety of intraoperative radiotherapy in breast cancer: a systematic review. Cancer Lett 2011; 313:15-25.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Sacchini V, Beal K, Goldberg J, Montgomery L, Port E, McCormick B. Study of quadrant high-dose intraoperative radiation therapy for earlystage breast cancer. Br J Surg 2008; 95:1105-10. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Saksornchai K, Rojpornpradit P, Shotelersak K, Lertbutsayanukul C, Chakkabat C, Raiyawa T. Skin toxicity and cosmesis after hypofractionated whole breast irradiation for early breast cancer. J Med Assoc Thai 2012; 95:229-40. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Sampaio Góes JC. Periareolar mammaplasty: double-skin technique with application of mesh support. Clin Plast Surg 2002; 29:349-64, v. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Sauer R, Sautter-Bihl ML, Budach W, et al. Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies. Cancer 2007; 110:1187-94.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Schwartz GF, Veronesi U, Clough KB, et al. Consensus conference on breast conservation. J Am Coll Surg 2006; 203:198-207.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Sedlmayer F, Fastner G, Merz F, et al. IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: results of an ISIORT pooled analysis. Strahlenther Onkol 2007; 183 Spec No 2:32-4. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Shah NM, Tenenholz T, Arthur D, et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer 2004; 101:727-34. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Sher DJ, Wittenberg E, Taghian AG, Bellon JR, Punglia RS. Partial breast irradiation versus whole breast radiotherapy for early-stage breast cancer: a decision analysis. Int J Radiat Oncol Biol Phys 2008; 70:469-76. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Sorrentino S, Scappin S, Coppa F, Citta P, Caria GM. Conservative treatment of breast carcinoma in small breasts: new minimally invasive surgical technique. Suppl Tumori 2005; 4:S178-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Spear SL, Burke JB, Forman D, Zuurbier RA, Berg CD. Experience with reduction mammaplasty following breast conservation surgery and radiation therapy. Plast Reconstr Surg 1998; 102:1913-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Spear SL, Davison SP. Aesthetic subunits of the breast. Plast Reconstr Surg 2003; 112:440-7. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Spear SL, Pelletiere CV, Wolfe AJ, Tsangaris TN, Pennanen MF. Experience with reduction mammaplasty combined with breast conservation therapy in the treatment of breast cancer. Plast Reconstr Surg 2003; 111:1102-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Stitzenberg KB, Klauber-Demore N, Chang XS, et al. In vivo intraoperative radiotherapy: a novel approach to radiotherapy for early stage breast cancer. Ann Surg Oncol 2007; 14:1515-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Swanson TA, Vicini FA. Overview of accelerated partial breast irradiation. Curr Oncol Rep 2008; 10:54-60.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Taylor ME, Perez CA, Halverson KJ, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995; 31:753-64. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Toledano AH, Bollet MA, Fourquet A, et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views. Int J Radiat Oncol Biol Phys 2007; 68:66-72. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Tournieux TT. Predictive factors of good aesthetic results in conservative surgery for breast cancer. Rev Bras Cir Plast 2012; 27:37-48. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Triedman SA, Osteen R, Harris JR. Factors influencing cosmetic outcome of conservative surgery and radiotherapy for breast cancer. Surg Clin North Am 1990; 70:901-16. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Truong MT, Hirsch AE, Formenti SC. Novel approaches to postoperative radiation therapy as part of breast-conserving therapy for early-stage breast cancer. Clin Breast Cancer 2003; 4:253-63. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Truong PT, Wong E, Bernstein V, Berthelet E, Kader HA. Adjuvant radiation therapy after breast-conserving surgery in elderly women with early-stage breast cancer: controversy or consensus? Clin Breast Cancer 2004; 4:407-14. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U. Surgical treatment of primary breast cancer according to disease extent. Prog Clin Biol Res 1977; 12:347-57. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, Banfi A, Saccozzi R, et al. Conservative treatment of breast cancer. A trial in progress at the Cancer Institute of Milan. Cancer 1977; 39(6 Suppl):2822-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981; 305:6-11. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, del Vecchio M, Costa A, Luini A, Merson M, Rasponi A. Conservative surgery of breast carcinoma of small dimensions. Minerva Ginecol 1982; 34:913-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, Del Vecchio M, Luini A, Rasponi A, Zucali R. The quadrantectomy, axillary dissection and radiotherapy (QU.A.RT) technique in early breast cancer. Int Adv Surg Oncol 1983; 6:141-65. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U. Conservative treatment of breast cancer. Chirurgie 1985; 56:269-75. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U. Breast cancer: new trends in surgery and radiotherapy. Eur J Gynaecol Oncol 1989; 10:196-8. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, Banfi A, Salvadori B, et al. Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer 1990; 26:668-70. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, Salvadori B, Luini A, et al. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg 1990; 211:250-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breastpreserving surgery in women with localized cancer of the breast. N Engl J Med 1993; 328:1587-91. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U. Breast cancer--trials on conservative surgery. Eur J Surg Oncol 1995; 21:231-3. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer 1995; 31A:1574-9. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, Orecchia R, Luini A, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 2001; 37:2178-83. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347:122732. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, Gatti G, Luini A, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg 2003; 138:1253-6. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Veronesi U, Orecchia R, Luini A, et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat 2010; 124:141-51. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Viani GA, Castilho MS, Salvajoli JV, et al. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems. BMC Cancer 2007; Mar 26;7:53. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Vicini FA, Jaffray DA, Horwitz EM, et al. Implementation of 3D-virtual brachytherapy in the management of breast cancer: a description of a new method of interstitial brachytherapy. Int J Radiat Oncol Biol Phys 1998; 40:629-35. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Vrieling C, Collette L, Fourquet A, et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 2000; 55:219-32. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Wagner E, Schrenk P, Huemer GM, Sir A, Schreiner M, Wayand W. Central quadrantectomy with resection of the nipple-areola complex compared with mastectomy in patients with retroareolar breast cancer. Breast J 2007; 13:557-63.";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Waljee JF, Hu ES, Ubel PA, Smith DM, Newman LA, Alderman AK. Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol 2008; 26:3331-7. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Waljee JF, Hu ES, Newman LA, Alderman AK. Predictors of breast asymmetry after breast-conserving operation for breast cancer. J Am Coll Surg 2008; 206:274-80.  ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Walker RA. The complexities of breast cancer desmoplasia. Breast Cancer Res 2001; 3:143-5. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Wallner P, Arthur D, Bartelink H, et al. Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002. J Natl Cancer Inst 2004; 96:175-84. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Wasser K, Schoeber C, Kraus-Tiefenbacher U, et al. Early mammographic and sonographic findings after intraoperative radiotherapy (IORT) as a boost in patients with breast cancer. Eur Radiol 2007; 17:1865-74. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Wenz F, Welzel G, Keller A, et al. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer. Breast 2008; 17:617-22. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"White JR, Halberg FE, Rabinovitch R, et al. American College of Radiology appropriateness criteria on conservative surgery and radiation: stages I and II breast carcinoma. J Am Coll Radiol 2008; 5:701-13.";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Willett CG, Czito BG, Tyler DS. Intraoperative radiation therapy. J Clin Oncol 2007; 25:971-7. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Yang JD, Lee JW, Kim WW, Jung JH, Park HY. Oncoplastic surgical techniques for personalized breast conserving surgery in breast cancer patient with small to moderate sized breast. J Breast Cancer 2011; 14:253-61. ";
FAP;2012;TATIANA TOURINHO TOURNIEUX;João Victor Salvajoli;Alexandre Katalinic Dutra/Maria do Socorro Maciel;"Zucali R, Mariani L, Marubini E, Kenda R, Lozza L, Rilke F, Veronesi U. Early breast cancer: evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol 1998; 16:1363-6. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Abbas AK, Lichtman AH, Pober JS, editores. Imunologia celular e molecular. 4 ed. Rio de Janeiro: Revinter, 2003a. Imunidade inata; p.27090.";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Abbas AK, Lichtman AH, Pober JS, editores. Imunologia celular e molecular. 4 ed. Rio de Janeiro: Revinter, 2003b. Mecanismos efetores da imunidade humoral; p.309-34. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Adhikari N, Burns KE, Meade MO. Pharmacologic treatments for acute respiratory distress syndrome and acute lung injury: systematic review and meta-analysis. Treat Respir Med 2004; 3:307-28. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Altose MD. Pulmonary Mechanics. In: Fishman A, Elias J, Fishman J, Grippi M, Senior R, Pack A. Pulmonary diseases and disorders. USA: McGrawHill Book Company; 1980. p.359-72. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Alles VV, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A. Inducible expression of Ptx3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 1994; 84:3483-93. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347-54. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Amato MB, Carvalho CR, Isola A, et al. Mechanical ventilation in Acute Lung Injury (ALI)/Acute Respiratory Discomfort Syndrome (ARDS). J Bras Pneumol 2007; 33 Suppl 2S:S119-S27.";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Ardizzoia A, Lissoni P, Tancini G, et al. Respiratory distress syndrome in patients with advanced cancer treated with pentoxifylline: a randomized study. Support Care Cancer 1993; 1:331-3. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Azzurri A, Sow OY, Amedei A, et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 2005; 7:18. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Belperio JA, Keane MP, Burdick MD, et al. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis. J Clin Invest 2002; 110:1703-16. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Bermejo Martin JF, Jimenez JL, Munoz-Fernandez A. Pentoxifylline and severe acute respiratory syndrome (SARS): a drug to be considered. Med Sci Monit 2003; 9:SR29-34. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Biagi E, Col M, Migliavacca M, et al. PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immunocompromised pediatric patients. J Pediatr Hematol Oncol 2008; 30:881-5. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Bos A, Vever R, Roos D. Characterization and quantification of the peroxidase in human monocytes. Biochim Biophys Acta 1987; 525: 37-44. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;Bottazzi B, Doni A, Garlanda C, Mantovani A. An Integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 2009 Dec 7. [Epub ahead of print] ;
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Bottazzi B, Vouret-Craviari V, Bastone A, et al. Multimer formation and ligand recognition by the long pentraxin PTX3 - Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 1997; 272:32817-23. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Breviario F, Daniello EM, Golay J, et al. Interleukin-1-inducible genes in endothelial-cells - cloning of a new gene related to C-reactive protein and serum Amyloid-P component. J Biol Chem 1992; 267:22190-7. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Camozzi M, Rusnati M, Bugatti A, et al. Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3. J Biol Chem 2006; 281:22605-13. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Caruso P, Meireles SI, Reis LFL, Mauad T, Martins MA, Deheinzelin D. Low tidal volume ventilation induces proinflammatory and profibrogenic response in lungs of rats. Intens Care Med 2003; 29:1808-11. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Cepinskas G, Savickiene J, Ionescu CV, Kvietys PR. PMN transendothelial migration decreases nuclear NFkappaB in IL-1beta-activated endothelial cells: role of PECAM-1. J Cell Biol 2003; 161:641-51. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Checkley W, Brower R, Korpak A, Thompson BT. Effects of a clinical trial on mechanical ventilation practices in patients with acute lung injury. Am J Respir Crit Care Med 2008; 177:1215-22. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Choudhury S, Wilson MR, Goddard ME, O'Dea KP, Takata M. Mechanisms of early pulmonary neutrophil sequestration in ventilator-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2004; 287:L902-10. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Cotena A, Maina V, Sironi M, et al. Complement dependent amplification of the innate response to a cognate microbial ligand by the long pentraxin PTX3. J Immunol 2007; 179:6311-7. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Crimi E, Slutsky AS. Inflammation and the acute respiratory distress syndrome. Best Pract Res Clin Anaesthesiol 2004; 18:477-92. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"de Carvalho MEP, Dolhnikoff M, Meireles SI, et al. Effects of overinflation on procollagen type III expression in experimental acute lung injury. Crit Care 2007; 11 (1):R23. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Dias AAM, Goodman AR, dos Santos JL, et al. TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. J Leukocyte Biol 2001; 69:928-36. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Diniz SN, Nomizo R, Cisalpino PS, et al. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leuk Biol 2004; 75:649-56. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Donnelly SC, Strieter RM, Reid PT, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Int Med 1996; 125:191-6. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"dos Santos CC, Han B, Andrade CF, et al. DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNF alpha, LPS, and cyclic stretch. Physiol Genomics 2004; 19:331-42. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Frank JA, Parsons PE, Matthay MA. Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest 2006; 130:1906-14. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005; 23:337-66. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Garlanda C, Hirsch E, Bozza S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420:182-6. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Goodman AR, Cardozo T, Abagyan R, Altmeyer A, Wisniewski HG, Vilcek J. Long pentraxins: an emerging group of proteins with diverse functions. Cytokine Growth Factor Rev 1996; 7:191-202. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol 2005; 23:821-2. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Halbertsma FJJ, Vaneker M, Scheffer GJ, van der Hoeven JG. Cytokines and biotrauma in ventilator-induced lung injury: a critical review of the literature. Neth J Med 2005; 63:382-92. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Han B, Mura M, Andrade CF, et al. TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. J Immunol 2005; 175:8303-11. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"He X, Han B, Bai X, et al. PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation. Intensive Care Med 2009; Nov 18 [Epub ahead of print]. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"He X, Han B, Liu MY. Long pentraxin 3 in pulmonary infection and acute lung injury. Am J Physiol Lung Cell Mol Physiol 2007; 292:L1039-49. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Headley AS, Tolley E, Meduri GU. Infections and the inflammatory response in acute respiratory distress syndrome. Chest 1997; 111:1306-21. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Inforzato A, Peri G, Doni A, et al. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation. Biochemistry 2006; 45:11540-51. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007; 204:793-804. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Ji Q, Zhang L, Jia H, Xu J. Pentoxifylline inhibits endotoxin-induced NFkappa B activation and associated production of proinflammatory cytokines. Ann Clin Lab Sci 2004; 34:427-36. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Kambas K, Markiewski MM, Pneumatikos IA, et al. C5a and TNF-alpha upregulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome. J Immunol 2008; 180:7368-75. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Kobzik L. O pulmão. In: Cotran RS, Kumar V, Collins T, editores. Robins, patologia estrutural e funcional. 6 ed. Rio de Janeiro: Guanabara Koogan; 2000. p.626-79. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Latini R, Maggioni AP, Peri G, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004; 110:234954. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Lee GW, Lee TH, Vilcek J. Tsg-14, A Tumor Necrosis Factor-Inducible and Il1-Inducible Protein, Is A Novel Member of the Pentaxin Family of Acute Phase Proteins. J Immunol 1993; 150:1804-12. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Lessa A, Suguihara C, Xianyu S, Hehre D, Devia C, Bancalari E. The effect of pentoxifylline on the pulmonary response to high tidal volume ventilation in rats. Pulm Pharmacol Ther 2008; 21:54-60. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD. Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 2008; 456:989-992. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Lucangelo U, Bernabe F, Blanch L. Respiratory mechanics derived from signals in the ventilator circuit. Respir Care 2005; 50:55-65. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Macintyre NR. Current issues in mechanical ventilation for respiratory failure. Chest 2005; 128:561S-7. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U. Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med 1999; 159:508-11. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Mauri T, Coppadoro A, Bellani G, et al. Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity. Crit Care Med 2008; 36:2302-8. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Miller K, Louie A, Baltch AL, Smith RP, Davis PJ, Gordon MA. Pharmacokinetics of pentoxifylline and its metabolites in healthy mice and in mice infected with Candida albicans. Antimicrob Agents Chemother 1998; 42:2405-09. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Muller B, Peri G, Doni A, et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 2001; 29:1404-7. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Napoleone E, Di SA, Bastone A, et al. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol 2002; 22:782-787. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Nauta AJ, Bottazzi B, Mantovani A, et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol 2003; 33:465-73. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008; 8:34-47.";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Okutani D, Han B, Mura M, Waddell TK, Keshavjee S, Liu MY. High-volume ventilation induces pentraxin 3 expression in multiple acute lung injury models in rats. Am J Physiol Lung Cell Mol Physiol 2007; 292:L144-53. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Olesen R, Wejse C, Velez DR, et al. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immunol 2007; 8:456-67. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Oliveira-Junior IS, Pinheiro BV, Silva IDCG, Salomao R, Zollner RL, Beppu OS. Pentoxifylline decreases tumor necrosis factor and interleukin-1 during high tidal volume. Braz J Med Biol Res 2003; 36:1349-57. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Pfaffl MW A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:e45. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Ricard JD, Dreyfuss D, Saumon G. Production of inflammatory cytokines in ventilator-induced lung injury: a reappraisal. Am J Respir Crit Care Med 2001; 163:1176-80. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Robbins RA, Russ WD, Rasmussen JK, Clayton MM. Activation of the complement system in the adult respiratory distress syndrome. Am Rev Respir Dis 1987; 135:651-8. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:168593. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Ruf W, Riewald M. Tissue factor-dependent coagulation protease signaling in acute lung injury. Crit Care Med 2003; 31:S231-7. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Salazar E, Knowles JH. Analysis of Pressure-Volume Characteristics of Lungs. J Appl Physiol 1964; 19:97-104. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;Sanofi Aventis. Trental (Pentoxifylline). 2007. Avaliable from: <http://products.sanofi-aventis.us/trental/trental.pdf> [2009 Dec.20]. ;
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Santos FB, Nagato LKS, Boechem NM, et al. Time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury. J Appl Physiol 2006; 100:98-106. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Sibilla S, Tredici S, Porro A, et al. Equal increases in respiratory system elastance reflect similar lung damage in experimental ventilator-induced lung injury. Intensive Care Med 2002; 28(2):196-203. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Simon BA, Easley RB, Grigoryev DN, et al. Microarray analysis of regional cellular responses to local mechanical stress in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 291:L851-61. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Slutsky AS. Ventilator-induced lung injury: from barotrauma to biotrauma. Respir Care 2005; 50:646-59. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Soares AC, Souza DG, Pinho V, et al. Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice. Microbes Infect 2006; 8:1321-9. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Souza DG, Amaral FA, Fagundes CT, et al. The Long Pentraxin PTX3 Is Crucial for Tissue Inflammation after Intestinal Ischemia and Reperfusion in Mice. Am J Pathol 2009; 174:1309-18. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Souza DG, Soares AC, Pinho V, et al. Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury. Am J Pathol 2002; 160:1755-65.";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997; 99:944-52. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Vaneker M, Halbertsma FJ, VAN Egmond J, et al. Mechanical ventilation in healthy mice induces reversible pulmonary and systemic cytokine elevation with preserved alveolar integrity: an in vivo model using clinical relevant ventilation settings. Anesthesiology 2007; 107:419-26. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Varani S, Elvin JA, Yan CN, et al. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol Endocrinol 2002; 16:1154-67. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Villa P, Sartor G, Angelini M, et al. Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immunol 1995; 2:549-53. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"von Bethmann AN, Brasch F, Nusing R, et al. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 1998; 157:263-72. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-49. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Wilson MR, Choudhury S, Goddard ME, O'Dea KP, Nicholson AG, Takata M. High tidal volume upregulates intrapulmonary cytokines in an in vivo mouse model of ventilator-induced lung injury. J Appl Physiol 2003; 95:1385-93. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Wilson MR, Choudhury S, Takata M. Pulmonary inflammation induced by high-stretch ventilation is mediated by tumor necrosis factor signaling in mice. Am J Respir Crit Care Med 2005; 288:L599-607. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Wilson MR, O'Dea KP, Zhang D, Shearman AD, van Rooijen N, Takata M. Role of Lung-Marginated Monocytes in an In Vivo Mouse Model of VentilatorInduced Lung Injury. Am J Respir Crit Care Med 2009; 179:914-22. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Wu CC, Liao MH, Chen SJ, Yen MH. Pentoxifylline improves circulatory failure and survival in murine models of endotoxaemia. Eur J Pharmacol 1999; 373:41-9. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Wu Q, Shu H, Yao S, Xiang H. Mechanical stretch induces pentraxin 3 release by alveolar epithelial cells in vitro. Med Sci Monit 2009; 15:135-40. ";
FAP;2010;JULIANA MONTE REAL;Daniel Deheinzelin;Adriana Abalen M. Dias;"Yoshikawa S, King JA, Lausch RN, Penton AM, Eyal FG, Parker JC. Acute ventilator-induced vascular permeability and cytokine responses in isolated and in situ mouse lungs. J Appl Physiol 2004; 97:2190-9. ";
